Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific nTPM" "RNA single cell type specificity" "RNA single cell type distribution" "RNA single cell type specificity score" "RNA single cell type specific nTPM" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific nTPM" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific nTPM" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific nTPM" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific nTPM" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific nTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific nTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "CCD Protein" "CCD Transcript" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Blood expression cluster" "Tissue expression cluster" "Cell line expression cluster" "Single cell expression cluster" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [nTPM]" "Tissue RNA - adrenal gland [nTPM]" "Tissue RNA - amygdala [nTPM]" "Tissue RNA - appendix [nTPM]" "Tissue RNA - basal ganglia [nTPM]" "Tissue RNA - bone marrow [nTPM]" "Tissue RNA - breast [nTPM]" "Tissue RNA - cerebellum [nTPM]" "Tissue RNA - cerebral cortex [nTPM]" "Tissue RNA - cervix [nTPM]" "Tissue RNA - choroid plexus [nTPM]" "Tissue RNA - colon [nTPM]" "Tissue RNA - duodenum [nTPM]" "Tissue RNA - endometrium 1 [nTPM]" "Tissue RNA - epididymis [nTPM]" "Tissue RNA - esophagus [nTPM]" "Tissue RNA - fallopian tube [nTPM]" "Tissue RNA - gallbladder [nTPM]" "Tissue RNA - heart muscle [nTPM]" "Tissue RNA - hippocampal formation [nTPM]" "Tissue RNA - hypothalamus [nTPM]" "Tissue RNA - kidney [nTPM]" "Tissue RNA - liver [nTPM]" "Tissue RNA - lung [nTPM]" "Tissue RNA - lymph node [nTPM]" "Tissue RNA - medulla oblongata [nTPM]" "Tissue RNA - midbrain [nTPM]" "Tissue RNA - ovary [nTPM]" "Tissue RNA - pancreas [nTPM]" "Tissue RNA - parathyroid gland [nTPM]" "Tissue RNA - pituitary gland [nTPM]" "Tissue RNA - placenta [nTPM]" "Tissue RNA - pons [nTPM]" "Tissue RNA - prostate [nTPM]" "Tissue RNA - rectum [nTPM]" "Tissue RNA - retina [nTPM]" "Tissue RNA - salivary gland [nTPM]" "Tissue RNA - seminal vesicle [nTPM]" "Tissue RNA - skeletal muscle [nTPM]" "Tissue RNA - skin 1 [nTPM]" "Tissue RNA - small intestine [nTPM]" "Tissue RNA - smooth muscle [nTPM]" "Tissue RNA - spinal cord [nTPM]" "Tissue RNA - spleen [nTPM]" "Tissue RNA - stomach 1 [nTPM]" "Tissue RNA - testis [nTPM]" "Tissue RNA - thalamus [nTPM]" "Tissue RNA - thymus [nTPM]" "Tissue RNA - thyroid gland [nTPM]" "Tissue RNA - tongue [nTPM]" "Tissue RNA - tonsil [nTPM]" "Tissue RNA - urinary bladder [nTPM]" "Tissue RNA - vagina [nTPM]" "Tissue RNA - white matter [nTPM]" "Cell RNA - A-431 [nTPM]" "Cell RNA - A549 [nTPM]" "Cell RNA - AF22 [nTPM]" "Cell RNA - AN3-CA [nTPM]" "Cell RNA - ASC diff [nTPM]" "Cell RNA - ASC TERT1 [nTPM]" "Cell RNA - BEWO [nTPM]" "Cell RNA - BJ [nTPM]" "Cell RNA - BJ hTERT+ [nTPM]" "Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]" "Cell RNA - CACO-2 [nTPM]" "Cell RNA - CAPAN-2 [nTPM]" "Cell RNA - Daudi [nTPM]" "Cell RNA - EFO-21 [nTPM]" "Cell RNA - fHDF/TERT166 [nTPM]" "Cell RNA - GAMG [nTPM]" "Cell RNA - HaCaT [nTPM]" "Cell RNA - HAP1 [nTPM]" "Cell RNA - HBEC3-KT [nTPM]" "Cell RNA - HBF TERT88 [nTPM]" "Cell RNA - HDLM-2 [nTPM]" "Cell RNA - HEK 293 [nTPM]" "Cell RNA - HEL [nTPM]" "Cell RNA - HeLa [nTPM]" "Cell RNA - Hep G2 [nTPM]" "Cell RNA - HHSteC [nTPM]" "Cell RNA - HL-60 [nTPM]" "Cell RNA - HMC-1 [nTPM]" "Cell RNA - HSkMC [nTPM]" "Cell RNA - hTCEpi [nTPM]" "Cell RNA - hTEC/SVTERT24-B [nTPM]" "Cell RNA - hTERT-HME1 [nTPM]" "Cell RNA - hTERT-RPE1 [nTPM]" "Cell RNA - HUVEC TERT2 [nTPM]" "Cell RNA - JURKAT [nTPM]" "Cell RNA - K-562 [nTPM]" "Cell RNA - Karpas-707 [nTPM]" "Cell RNA - LHCN-M2 [nTPM]" "Cell RNA - MCF7 [nTPM]" "Cell RNA - MOLT-4 [nTPM]" "Cell RNA - NB-4 [nTPM]" "Cell RNA - NTERA-2 [nTPM]" "Cell RNA - OE19 [nTPM]" "Cell RNA - PC-3 [nTPM]" "Cell RNA - REH [nTPM]" "Cell RNA - RH-30 [nTPM]" "Cell RNA - RPMI-8226 [nTPM]" "Cell RNA - RPTEC TERT1 [nTPM]" "Cell RNA - RT4 [nTPM]" "Cell RNA - SCLC-21H [nTPM]" "Cell RNA - SH-SY5Y [nTPM]" "Cell RNA - SiHa [nTPM]" "Cell RNA - SK-BR-3 [nTPM]" "Cell RNA - SK-MEL-30 [nTPM]" "Cell RNA - SuSa [nTPM]" "Cell RNA - T-47d [nTPM]" "Cell RNA - THP-1 [nTPM]" "Cell RNA - TIME [nTPM]" "Cell RNA - U-138 MG [nTPM]" "Cell RNA - U-2 OS [nTPM]" "Cell RNA - U-2197 [nTPM]" "Cell RNA - U-251 MG [nTPM]" "Cell RNA - U-266/70 [nTPM]" "Cell RNA - U-266/84 [nTPM]" "Cell RNA - U-698 [nTPM]" "Cell RNA - U-87 MG [nTPM]" "Cell RNA - U-937 [nTPM]" "Cell RNA - WM-115 [nTPM]" "Blood RNA - basophil [nTPM]" "Blood RNA - classical monocyte [nTPM]" "Blood RNA - eosinophil [nTPM]" "Blood RNA - gdT-cell [nTPM]" "Blood RNA - intermediate monocyte [nTPM]" "Blood RNA - MAIT T-cell [nTPM]" "Blood RNA - memory B-cell [nTPM]" "Blood RNA - memory CD4 T-cell [nTPM]" "Blood RNA - memory CD8 T-cell [nTPM]" "Blood RNA - myeloid DC [nTPM]" "Blood RNA - naive B-cell [nTPM]" "Blood RNA - naive CD4 T-cell [nTPM]" "Blood RNA - naive CD8 T-cell [nTPM]" "Blood RNA - neutrophil [nTPM]" "Blood RNA - NK-cell [nTPM]" "Blood RNA - non-classical monocyte [nTPM]" "Blood RNA - plasmacytoid DC [nTPM]" "Blood RNA - T-reg [nTPM]" "Blood RNA - total PBMC [nTPM]" "Brain RNA - amygdala [nTPM]" "Brain RNA - basal ganglia [nTPM]" "Brain RNA - cerebellum [nTPM]" "Brain RNA - cerebral cortex [nTPM]" "Brain RNA - hippocampal formation [nTPM]" "Brain RNA - hypothalamus [nTPM]" "Brain RNA - medulla oblongata [nTPM]" "Brain RNA - midbrain [nTPM]" "Brain RNA - pons [nTPM]" "Brain RNA - spinal cord [nTPM]" "Brain RNA - thalamus [nTPM]" "Brain RNA - white matter [nTPM]" "Single Cell Type RNA - Adipocytes [nTPM]" "Single Cell Type RNA - Alveolar cells type 1 [nTPM]" "Single Cell Type RNA - Alveolar cells type 2 [nTPM]" "Single Cell Type RNA - Astrocytes [nTPM]" "Single Cell Type RNA - B-cells [nTPM]" "Single Cell Type RNA - Basal keratinocytes [nTPM]" "Single Cell Type RNA - Basal prostatic cells [nTPM]" "Single Cell Type RNA - Basal respiratory cells [nTPM]" "Single Cell Type RNA - Basal squamous epithelial cells [nTPM]" "Single Cell Type RNA - Bipolar cells [nTPM]" "Single Cell Type RNA - Breast glandular cells [nTPM]" "Single Cell Type RNA - Breast myoepithelial cells [nTPM]" "Single Cell Type RNA - Cardiomyocytes [nTPM]" "Single Cell Type RNA - Cholangiocytes [nTPM]" "Single Cell Type RNA - Club cells [nTPM]" "Single Cell Type RNA - Collecting duct cells [nTPM]" "Single Cell Type RNA - Cone photoreceptor cells [nTPM]" "Single Cell Type RNA - Cytotrophoblasts [nTPM]" "Single Cell Type RNA - dendritic cells [nTPM]" "Single Cell Type RNA - Distal enterocytes [nTPM]" "Single Cell Type RNA - Distal tubular cells [nTPM]" "Single Cell Type RNA - Ductal cells [nTPM]" "Single Cell Type RNA - Early spermatids [nTPM]" "Single Cell Type RNA - Endometrial ciliated cells [nTPM]" "Single Cell Type RNA - Endometrial stromal cells [nTPM]" "Single Cell Type RNA - Endothelial cells [nTPM]" "Single Cell Type RNA - Enteroendocrine cells [nTPM]" "Single Cell Type RNA - Erythroid cells [nTPM]" "Single Cell Type RNA - Excitatory neurons [nTPM]" "Single Cell Type RNA - Exocrine glandular cells [nTPM]" "Single Cell Type RNA - Extravillous trophoblasts [nTPM]" "Single Cell Type RNA - Fibroblasts [nTPM]" "Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]" "Single Cell Type RNA - Glandular and luminal cells [nTPM]" "Single Cell Type RNA - granulocytes [nTPM]" "Single Cell Type RNA - Granulosa cells [nTPM]" "Single Cell Type RNA - Hepatic stellate cells [nTPM]" "Single Cell Type RNA - Hepatocytes [nTPM]" "Single Cell Type RNA - Hofbauer cells [nTPM]" "Single Cell Type RNA - Horizontal cells [nTPM]" "Single Cell Type RNA - Inhibitory neurons [nTPM]" "Single Cell Type RNA - Intestinal goblet cells [nTPM]" "Single Cell Type RNA - Ionocytes [nTPM]" "Single Cell Type RNA - Kupffer cells [nTPM]" "Single Cell Type RNA - Langerhans cells [nTPM]" "Single Cell Type RNA - Late spermatids [nTPM]" "Single Cell Type RNA - Leydig cells [nTPM]" "Single Cell Type RNA - Macrophages [nTPM]" "Single Cell Type RNA - Melanocytes [nTPM]" "Single Cell Type RNA - Microglial cells [nTPM]" "Single Cell Type RNA - monocytes [nTPM]" "Single Cell Type RNA - Muller glia cells [nTPM]" "Single Cell Type RNA - NK-cells [nTPM]" "Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]" "Single Cell Type RNA - Oligodendrocytes [nTPM]" "Single Cell Type RNA - Pancreatic endocrine cells [nTPM]" "Single Cell Type RNA - Paneth cells [nTPM]" "Single Cell Type RNA - Peritubular cells [nTPM]" "Single Cell Type RNA - Plasma cells [nTPM]" "Single Cell Type RNA - Prostatic glandular cells [nTPM]" "Single Cell Type RNA - Proximal enterocytes [nTPM]" "Single Cell Type RNA - Proximal tubular cells [nTPM]" "Single Cell Type RNA - Respiratory ciliated cells [nTPM]" "Single Cell Type RNA - Rod photoreceptor cells [nTPM]" "Single Cell Type RNA - Sertoli cells [nTPM]" "Single Cell Type RNA - Skeletal myocytes [nTPM]" "Single Cell Type RNA - Smooth muscle cells [nTPM]" "Single Cell Type RNA - Spermatocytes [nTPM]" "Single Cell Type RNA - Spermatogonia [nTPM]" "Single Cell Type RNA - Squamous epithelial cells [nTPM]" "Single Cell Type RNA - Suprabasal keratinocytes [nTPM]" "Single Cell Type RNA - Syncytiotrophoblasts [nTPM]" "Single Cell Type RNA - T-cells [nTPM]" "Single Cell Type RNA - Theca cells [nTPM]" "Single Cell Type RNA - Undifferentiated cells [nTPM]" "Single Cell Type RNA - Urothelial cells [nTPM]" ABI2 "ABI-2, ABI2B, AblBP3, AIP-1, argBPIA, SSH3BP2" ENSG00000138443 "Abl interactor 2" Q9NYB9 2 203328280-203447728 "Predicted intracellular proteins" "Host-virus interaction, Neurogenesis" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070567 Enhanced Supported Nucleoplasm,Vesicles,Cytosol NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 12: NES - Nervous system development" "Cluster 44: Endometrium - Transcription" Nucleoplasm "Vesicles, Cytosol" "HPA070567: AB_2686281" "unprognostic (5.26e-3)" "unprognostic (5.26e-3)" "unprognostic (1.86e-1)" "unprognostic (4.11e-3)" "unprognostic (2.13e-1)" "unprognostic (1.97e-2)" "unprognostic (1.81e-3)" "unprognostic (7.05e-2)" "unprognostic (8.03e-2)" "unprognostic (8.56e-3)" "unprognostic (6.19e-3)" "unprognostic (1.95e-1)" "unprognostic (4.47e-2)" "unprognostic (4.24e-2)" "unprognostic (2.94e-1)" "unprognostic (9.21e-2)" "unprognostic (1.73e-1)" 10.5 13.2 31.0 9.5 41.9 3.3 15.2 22.9 38.4 19.0 10.0 18.7 5.7 28.0 18.7 11.9 22.5 13.4 32.7 40.4 33.0 20.9 7.4 16.1 8.2 16.3 24.1 27.9 7.5 20.4 20.5 19.4 17.3 18.7 10.7 30.0 8.6 23.0 7.4 7.6 8.9 25.2 21.3 12.9 9.3 27.5 36.0 22.2 26.5 15.8 8.7 14.6 11.9 22.5 19.3 29.4 102.5 64.4 23.9 40.5 22.6 33.0 29.0 27.9 32.2 27.3 35.5 0.0 22.0 39.0 38.8 20.9 47.1 34.6 54.8 9.5 27.4 47.9 30.9 21.4 36.3 20.6 21.1 28.8 16.5 51.2 39.5 80.5 52.6 54.1 34.7 41.8 49.7 35.0 52.8 20.4 53.5 18.2 64.8 34.5 51.4 3.5 29.3 19.6 43.2 55.3 6.2 19.2 37.4 76.8 25.0 23.9 39.9 50.4 43.0 27.8 36.2 29.3 28.7 26.6 54.7 8.5 33.2 0.2 1.4 0.0 3.3 1.6 3.6 1.4 3.7 3.7 4.0 1.3 4.4 3.9 0.2 3.9 3.8 12.7 4.4 3.2 31.0 41.9 22.9 38.4 40.4 33.0 16.3 24.1 17.3 21.3 36.0 22.5 39.7 54.5 26.5 123.4 14.7 30.1 55.7 37.7 34.1 111.9 39.5 38.7 56.7 28.6 32.8 53.3 162.6 23.7 33.1 10.1 33.2 24.3 128.2 62.3 68.4 43.6 49.2 30.3 201.3 13.1 15.7 54.1 25.0 72.3 15.8 100.0 65.7 12.3 16.7 102.6 128.6 10.9 20.3 11.4 62.3 81.6 46.6 22.1 49.8 57.1 18.6 67.6 26.8 114.1 94.2 15.5 19.4 63.2 18.3 44.2 11.1 38.5 83.1 89.6 26.3 70.5 67.9 89.0 52.4 22.0 26.1 19.7 21.7 69.9 17.0 37.5 AC244197.3 ENSG00000241489 "Novel protein" X 149477104-149540926 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 5 "Alveolar cells type 1: 3.2;Alveolar cells type 2: 2.2;granulocytes: 5.1;Respiratory ciliated cells: 2.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "eosinophil: 15.7" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 60: Granulocytes - Receptor signaling" "unprognostic (1.57e-2)" "unprognostic (2.77e-2)" "unprognostic (5.48e-2)" "unprognostic (4.27e-2)" "unprognostic (4.81e-2)" "unprognostic (9.16e-3)" "unprognostic (4.51e-3)" "unprognostic (1.08e-1)" "unprognostic (2.66e-1)" "unprognostic (1.69e-3)" "unprognostic (4.01e-3)" "unprognostic (4.33e-2)" "unprognostic (1.37e-5)" "unprognostic (1.84e-1)" "unprognostic (2.58e-1)" "unprognostic (3.90e-2)" "unprognostic (3.27e-4)" 8.9 12.7 29.4 7.5 20.4 8.7 10.0 0.0 30.7 12.0 10.3 10.1 9.6 23.6 61.4 9.4 26.4 10.9 17.8 33.0 3.4 10.3 5.1 16.1 9.2 9.7 3.0 24.6 14.9 11.4 45.4 8.3 7.0 17.9 15.0 20.5 17.2 19.4 6.9 20.1 10.2 12.6 0.2 12.6 11.4 8.1 7.6 8.0 15.3 5.7 9.9 11.0 10.7 7.7 5.9 20.1 12.4 4.4 6.3 5.8 2.1 3.8 3.9 3.1 8.9 2.8 9.8 10.2 9.4 8.5 7.8 17.3 1.7 6.4 2.8 11.8 5.9 1.8 15.2 1.5 2.4 2.6 14.3 10.5 5.4 7.7 5.7 18.5 3.5 4.7 1.6 12.6 4.1 15.4 2.3 1.9 1.0 8.4 6.0 2.4 3.1 6.9 8.9 6.2 6.4 6.5 2.7 4.8 1.2 6.4 4.2 2.0 8.9 6.0 7.4 5.5 4.1 11.0 4.6 3.9 8.9 4.7 2.7 0.3 3.1 15.7 5.7 2.9 3.0 1.6 1.8 2.7 1.9 0.9 0.9 0.8 11.5 3.1 5.1 2.0 5.6 5.4 29.4 20.4 0.0 30.7 33.0 3.4 9.7 3.0 7.0 0.2 7.6 7.7 0.0 3.2 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 5.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 AC244517.10 ENSG00000279983 "Novel protein" 5 141223372-141245861 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "epididymis: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 68: Epididymis - Unknown function" 0.2 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.5 0.3 0.0 0.1 0.0 0.5 1.6 0.4 0.2 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.2 0.1 0.2 0.1 0.0 0.0 0.2 0.1 0.0 0.1 0.3 0.0 0.0 0.1 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.2 0.3 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.5 0.0 0.2 0.2 0.2 0.2 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.5 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ACOXL FLJ11042 ENSG00000153093 "Acyl-CoA oxidase like" Q9NUZ1 2 110732539-111120610 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "epididymis: 7.2;lung: 9.3" "Cell type enriched" "Detected in some" 5 "Alveolar cells type 2: 41.9" "Group enriched" "Detected in some" 6 "lung cancer: 0.6;prostate cancer: 1.1;testis cancer: 2.1;urothelial cancer: 2.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "A-431: 12.1;RPMI-8226: 22.0;RT4: 29.3;U-266/70: 18.7" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA035392, HPA035393" Supported Nucleoli,Cytosol NA NA "Cluster 34: Basophils - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 25: RPMI-8226 - Immune response" "Cluster 11: Alveolar cells - Smell perception" Cytosol Nucleoli "HPA035392: AB_2674604, HPA035393: AB_2674605" "unprognostic (1.62e-1)" "unprognostic (7.30e-2)" "unprognostic (6.77e-4)" "unprognostic (2.93e-7)" "unprognostic (1.32e-2)" "unprognostic (7.84e-5)" "unprognostic (1.28e-1)" "unprognostic (1.53e-2)" "unprognostic (1.29e-1)" "unprognostic (7.31e-2)" "unprognostic (7.24e-2)" "unprognostic (3.24e-1)" "unprognostic (1.72e-1)" "unprognostic (2.11e-1)" "unprognostic (2.73e-1)" "unprognostic (1.72e-1)" "prognostic favorable (6.48e-4)" 1.1 0.6 0.4 0.5 0.7 1.5 0.1 0.2 0.4 0.4 0.0 0.5 0.5 0.5 7.2 0.4 0.3 0.6 1.2 0.3 0.1 0.5 0.3 9.3 0.9 0.4 0.4 0.2 1.0 2.9 0.3 0.7 0.3 3.2 0.3 0.7 0.6 0.0 1.3 0.7 0.6 0.1 0.0 0.6 0.5 3.2 0.2 0.3 0.8 0.0 1.2 4.6 0.1 0.5 12.1 0.2 0.3 0.2 0.1 0.0 0.8 0.1 0.0 0.0 0.0 0.9 0.7 0.3 0.5 0.1 0.3 1.3 0.0 0.1 0.0 0.3 3.5 0.2 0.5 0.5 0.0 0.0 0.3 0.1 1.2 0.0 0.1 0.3 0.0 0.6 1.8 1.8 0.1 4.4 0.9 0.4 4.2 0.0 0.3 0.6 0.2 22.0 0.0 29.3 2.5 1.0 0.3 0.5 0.1 0.6 0.4 1.2 0.3 0.2 1.0 0.2 0.1 18.7 4.8 0.7 0.0 0.1 0.1 0.7 0.3 0.3 0.1 0.1 0.1 0.2 0.1 0.1 0.0 0.1 0.1 0.0 0.9 0.2 0.2 0.2 0.1 0.1 0.4 0.7 0.2 0.4 0.3 0.1 0.4 0.4 0.3 0.0 0.2 0.5 0.3 0.0 41.9 0.0 1.0 0.3 0.3 0.0 0.0 0.6 0.1 0.3 0.5 0.0 0.7 0.0 0.0 0.0 0.1 1.3 0.0 0.2 5.4 0.2 0.1 0.2 1.2 0.0 2.2 0.0 0.0 0.4 0.0 0.8 0.0 5.9 0.0 0.0 0.1 0.0 2.0 0.3 0.0 0.0 0.8 8.1 0.0 0.2 0.0 0.0 0.0 0.1 1.0 1.0 1.3 0.1 2.3 0.0 7.5 0.8 0.0 0.1 0.1 0.3 0.0 0.2 0.3 1.6 2.7 0.0 0.3 0.0 1.1 0.0 0.2 0.8 ADCY8 "AC8, ADCY3, HBAC1" ENSG00000155897 "Adenylate cyclase 8" P40145 8 130780301-131040909 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "cAMP biosynthesis" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "brain: 29.4;epididymis: 22.8" "Group enriched" "Detected in some" 5 "Astrocytes: 151.8;Inhibitory neurons: 250.9;Oligodendrocyte precursor cells: 138.7" "Group enriched" "Detected in some" 5 "glioma: 6.0;ovarian cancer: 1.8;thyroid cancer: 1.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 5.0;GAMG: 8.2;U-138 MG: 17.6;U-87 MG: 34.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB018652, HPA024291" Supported NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "CAB018652: AB_633654, HPA024291: AB_1844597" "unprognostic (5.59e-3)" "unprognostic (3.10e-1)" "unprognostic (1.82e-1)" "unprognostic (1.09e-1)" "unprognostic (2.78e-2)" "unprognostic (1.74e-1)" "unprognostic (1.05e-1)" "unprognostic (8.22e-3)" "unprognostic (4.91e-2)" "unprognostic (7.39e-3)" "unprognostic (1.92e-1)" "unprognostic (2.44e-2)" "unprognostic (6.67e-2)" 0.0 0.0 17.0 0.0 13.4 0.0 0.5 19.7 9.6 0.4 1.7 0.0 0.0 0.0 22.8 0.0 3.9 0.0 0.0 11.9 14.0 0.2 0.0 1.2 0.0 17.2 22.6 0.0 0.0 0.0 0.0 0.0 15.2 0.0 0.0 3.1 1.1 1.4 0.1 2.1 0.0 0.5 25.9 0.0 0.1 0.5 29.4 0.0 0.0 0.0 0.0 0.0 0.0 23.3 0.0 0.0 0.0 0.1 1.3 5.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 17.6 0.4 0.0 0.0 0.0 0.0 0.0 34.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.0 13.4 19.7 9.6 11.9 14.0 17.2 22.6 15.2 25.9 29.4 23.3 0.0 0.0 1.5 151.8 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.0 0.0 0.0 32.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 250.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 8.4 0.0 0.1 0.0 138.7 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AGBL3 "CCP3, MGC32955" ENSG00000146856 "ATP/GTP binding protein like 3" Q8NEM8 7 134986508-135147963 "Enzymes, Predicted intracellular proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "epididymis: 7.9" "Cell type enhanced" "Detected in many" "Early spermatids: 70.5;Excitatory neurons: 40.7;Inhibitory neurons: 34.2;Oligodendrocytes: 37.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HEK 293: 5.5" "Low region specificity" "Detected in all" "HPA020397, HPA024150" Uncertain Approved Cytosol NA No "Cluster 22: NK-cells - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 23: Spermatids - Flagellum & Golgi organization" Cytosol "HPA020397: AB_2242453, HPA024150: AB_1844639" "unprognostic (8.84e-2)" "unprognostic (1.49e-2)" "unprognostic (4.72e-2)" "unprognostic (2.18e-1)" "unprognostic (1.47e-1)" "unprognostic (3.39e-3)" "unprognostic (3.32e-3)" "unprognostic (4.18e-2)" "unprognostic (7.15e-4)" "unprognostic (5.00e-3)" "unprognostic (6.10e-4)" "unprognostic (3.16e-2)" "prognostic unfavorable (4.02e-4)" "unprognostic (2.18e-2)" "unprognostic (2.14e-1)" "unprognostic (8.13e-2)" "unprognostic (1.11e-3)" 1.0 0.9 1.0 2.3 1.3 2.2 2.3 2.0 3.0 0.8 1.2 1.2 0.8 2.9 7.9 0.1 1.8 0.7 0.8 1.0 1.9 1.7 0.6 1.8 2.3 1.3 1.2 3.5 2.3 0.4 0.3 0.9 1.1 1.9 1.5 1.3 2.5 2.1 2.4 2.5 2.0 1.6 1.3 3.8 2.5 5.1 1.7 0.9 2.8 0.8 0.9 0.3 0.2 1.8 1.7 0.9 2.2 0.5 0.6 0.8 1.3 0.4 0.0 0.3 0.5 3.0 1.9 2.7 0.8 0.0 0.9 1.8 0.8 0.3 0.0 2.2 5.5 2.3 4.0 3.0 0.0 1.0 0.0 0.1 0.0 1.3 0.0 0.0 0.9 3.0 1.7 1.5 0.3 1.5 0.6 0.9 1.9 0.2 0.2 1.6 0.1 0.8 1.5 0.3 1.3 1.4 0.3 0.0 0.2 0.0 1.2 2.3 0.0 0.2 0.5 0.3 1.0 3.3 1.1 1.3 1.1 2.8 2.7 0.0 0.1 0.1 0.8 0.0 0.7 0.8 0.4 0.9 0.2 0.7 0.7 1.7 0.2 0.9 0.0 0.6 0.6 0.6 1.0 1.3 2.0 3.0 1.0 1.9 1.3 1.2 1.1 1.3 1.7 1.8 6.7 3.2 0.6 18.3 3.5 1.3 0.9 1.2 2.8 5.1 2.2 2.2 2.1 4.3 2.0 9.2 2.1 0.3 0.9 0.6 7.9 4.6 70.5 6.6 1.8 4.8 3.0 3.0 40.7 2.9 0.4 2.8 4.6 2.6 1.3 3.2 5.0 1.9 0.5 3.3 34.2 0.4 0.0 1.3 0.7 11.8 3.4 0.8 5.4 22.5 6.9 2.8 1.0 16.6 37.3 1.7 0.1 2.2 6.1 1.3 0.4 7.6 6.4 3.3 0.0 2.0 4.1 21.4 6.3 1.2 0.3 0.1 2.0 2.4 0.5 1.0 AGRP "Agrt, ART, ASIP2" ENSG00000159723 "Agouti related neuropeptide" O00253 16 67482571-67483547 "Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins" "Disease variant, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 122.5;epididymis: 37.1" "Group enriched" "Detected in some" 5 "Distal tubular cells: 3.9;Hofbauer cells: 8.8;Leydig cells: 3.1;Macrophages: 4.5;Peritubular cells: 2.6;Theca cells: 5.0" "Low cancer specificity" "Detected in single" "Region enriched" "Detected in many" 60 "hypothalamus: 122.5" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in single" "CACO-2: 1.2" "Region enriched" "Detected in single" 16 "hypothalamus: 16.0" "Region enhanced" "Detected in single" "hypothalamus: 2.0" HPA041017 Enhanced Supported "Secreted in brain" NA NA 255000 "Cluster 7: Monocytes - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 39: CACO-2 - Unknown function" "Cluster 11: Alveolar cells - Smell perception" "HPA041017: AB_10795498" "unprognostic (1.32e-1)" "unprognostic (6.26e-2)" "unprognostic (1.13e-1)" "unprognostic (4.16e-1)" "unprognostic (3.15e-1)" "unprognostic (1.10e-1)" "unprognostic (3.61e-1)" "unprognostic (3.34e-1)" "unprognostic (4.68e-1)" "unprognostic (1.29e-1)" "unprognostic (6.74e-2)" "unprognostic (3.17e-1)" "unprognostic (2.80e-1)" "unprognostic (1.72e-1)" "unprognostic (5.63e-2)" "unprognostic (1.09e-1)" "unprognostic (1.18e-2)" 0.0 12.4 1.2 0.2 1.0 0.2 0.0 0.8 2.0 0.0 1.6 0.1 0.0 0.0 37.1 0.0 0.0 0.0 0.1 1.0 122.5 1.0 0.1 3.7 0.4 1.7 1.1 0.1 0.0 0.2 0.7 0.1 1.0 0.1 0.0 0.2 0.0 0.0 0.1 0.6 0.3 0.0 0.3 0.5 0.3 0.4 2.0 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.8 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.4 0.5 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.4 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.3 0.3 0.4 0.0 0.1 0.1 0.0 1.6 0.5 0.9 1.1 0.3 0.7 0.2 0.3 0.7 0.4 0.6 0.6 0.2 0.0 0.4 0.5 0.3 0.4 1.2 1.0 0.8 2.0 1.0 122.5 1.7 1.1 1.0 0.3 2.0 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.3 0.0 0.1 0.0 0.6 0.0 0.0 8.8 0.0 0.1 0.0 0.0 0.6 0.0 0.4 3.1 4.5 0.0 0.0 0.9 0.9 0.0 0.0 0.0 0.0 0.0 2.6 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 5.0 0.0 0.0 AL163195.3 ENSG00000259060 "Novel protein" 14 20582892-20609795 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 7 "epididymis: 4.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 68: Epididymis - Unknown function" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 ALG14 MGC19780 ENSG00000172339 "ALG14 UDP-N-acetylglucosaminyltransferase subunit" Q96F25 1 94974405-95072951 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins" "Congenital myasthenic syndrome, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031829 Approved Approved Nucleoplasm,Nucleoli NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 68: Epididymis - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 55: Plasma cells - Humoral immune response" Nucleoli Nucleoplasm "HPA031829: AB_2674062" "unprognostic (7.79e-2)" "unprognostic (3.59e-2)" "unprognostic (1.51e-3)" "unprognostic (1.75e-3)" "unprognostic (1.36e-1)" "unprognostic (6.56e-2)" "unprognostic (4.00e-1)" "unprognostic (2.17e-2)" "unprognostic (3.18e-1)" "unprognostic (2.01e-1)" "unprognostic (7.79e-2)" "unprognostic (1.15e-1)" "unprognostic (1.24e-1)" "unprognostic (9.55e-2)" "unprognostic (6.01e-2)" "unprognostic (4.99e-2)" "unprognostic (1.93e-1)" 1.2 2.5 1.5 0.8 1.7 0.9 1.3 2.2 1.9 1.0 1.7 1.6 1.8 0.8 2.3 1.0 0.8 1.2 0.9 1.6 1.4 1.5 2.1 0.7 0.8 1.7 1.4 0.9 1.8 1.6 1.0 0.8 1.5 0.9 1.7 1.4 1.8 0.8 1.5 0.9 1.3 0.8 1.2 0.8 1.1 1.1 1.7 0.7 1.7 0.5 0.8 0.9 0.7 2.2 2.5 1.6 1.3 1.2 1.0 1.7 1.1 1.8 1.9 1.8 1.5 1.8 0.8 1.3 1.8 2.2 2.2 1.7 1.5 1.7 2.2 2.8 2.5 0.7 1.6 2.9 1.6 1.7 0.4 1.9 1.7 1.4 1.3 1.4 1.6 1.7 1.4 1.6 1.8 1.2 1.9 1.1 0.8 2.5 2.2 1.2 2.6 1.4 2.1 1.4 1.1 1.5 1.0 3.4 3.2 0.9 1.5 1.5 1.2 1.1 1.3 2.0 3.9 1.0 1.0 1.1 0.8 0.8 0.9 1.3 1.0 0.3 0.8 1.3 0.7 1.6 0.9 1.0 1.5 1.4 0.8 0.9 0.8 0.9 0.6 1.9 1.3 0.6 1.5 1.7 2.2 1.9 1.6 1.4 1.7 1.4 1.5 1.2 1.7 2.2 11.8 0.0 12.2 14.0 13.1 11.7 11.4 30.5 19.4 16.9 13.8 15.2 7.7 10.0 20.3 16.5 6.2 34.6 10.5 25.7 19.6 24.9 10.0 12.2 19.6 10.1 4.2 13.0 24.6 53.7 25.9 18.9 11.2 13.3 1.3 14.7 11.7 32.4 18.9 8.4 22.4 12.9 18.3 8.4 8.9 8.4 14.3 8.6 32.0 14.0 10.3 30.9 3.1 14.6 35.4 23.6 22.6 10.1 41.6 8.9 22.1 40.0 12.7 14.4 32.9 17.1 15.2 36.1 23.0 19.0 8.7 25.2 5.6 39.9 26.9 12.9 ALG1L ALG1L1 ENSG00000189366 "ALG1 chitobiosyldiphosphodolichol beta-mannosyltransferase like" Q6GMV1 3 125929275-125937039 "Metabolic proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "epididymis: 10.8;urinary bladder: 9.4" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 33.6;Club cells: 15.2;Endometrial ciliated cells: 10.5;Ionocytes: 12.2;Respiratory ciliated cells: 46.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 15.9;CAPAN-2: 14.3;HaCaT: 15.2;MCF7: 30.1;OE19: 19.1;T-47d: 19.7" HPA036108 Uncertain NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 6: T47d - Mammary gland" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "HPA036108: AB_10673344" "unprognostic (7.06e-3)" "unprognostic (1.50e-3)" "unprognostic (1.47e-1)" "unprognostic (4.14e-2)" "prognostic favorable (3.00e-4)" "unprognostic (2.40e-2)" "unprognostic (1.86e-1)" "unprognostic (1.15e-1)" "unprognostic (2.10e-1)" "unprognostic (1.47e-1)" "unprognostic (4.37e-2)" "unprognostic (5.79e-2)" "unprognostic (4.50e-6)" "unprognostic (1.35e-1)" "unprognostic (3.30e-1)" "unprognostic (1.57e-2)" "prognostic favorable (6.24e-4)" 0.5 1.1 2.5 1.1 2.7 0.3 1.4 2.0 3.0 1.6 1.4 1.4 0.4 1.4 10.8 1.6 2.2 0.8 0.7 2.4 2.6 1.7 1.4 1.0 0.4 2.5 2.4 2.3 1.3 0.6 1.8 1.5 2.5 1.8 0.8 0.6 1.9 0.9 6.7 5.8 0.5 0.5 2.1 0.3 1.5 1.2 2.4 1.1 1.6 2.6 2.7 9.4 1.5 2.5 1.1 0.8 0.4 0.0 0.0 0.2 1.8 0.1 0.0 0.2 0.4 15.9 14.3 4.4 6.8 0.0 0.3 15.2 0.4 0.0 0.8 0.6 3.6 0.8 2.4 0.0 0.2 0.2 0.2 0.1 0.1 0.0 0.1 0.0 0.0 4.1 1.2 1.4 0.0 30.1 1.0 0.3 6.4 19.1 3.8 0.1 0.1 7.4 0.0 0.9 2.4 0.9 0.5 0.2 0.7 3.2 19.7 0.4 0.3 0.2 2.2 0.2 0.1 10.9 1.7 5.9 0.2 0.0 1.0 2.5 0.0 0.1 2.0 0.1 1.1 1.6 1.0 2.2 0.0 0.9 1.2 0.7 0.4 3.2 0.0 1.3 2.7 0.9 2.5 2.7 2.0 3.0 2.4 2.6 2.5 2.4 2.5 2.1 2.4 2.5 0.2 0.0 0.5 0.3 0.7 3.3 1.7 33.6 0.6 0.3 2.1 2.4 0.0 0.0 15.2 1.8 0.0 3.5 0.5 0.3 1.9 0.4 1.7 10.5 0.8 0.3 1.8 0.0 1.2 0.4 2.0 1.1 0.0 0.4 1.3 1.4 0.0 0.1 0.3 0.0 1.7 0.2 12.2 0.0 1.2 1.8 1.8 0.1 1.8 0.0 0.2 1.5 2.1 1.0 0.6 0.6 1.4 3.0 0.4 0.5 0.0 1.0 46.0 0.0 0.0 2.7 2.6 1.4 1.6 0.3 5.1 1.4 0.5 2.4 0.4 8.2 AMOT KIAA1071 ENSG00000126016 Angiomotin Q4VCS5 X 112774503-112840889 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 145.6;tongue: 53.5" "Cell type enhanced" "Detected in many" "Astrocytes: 57.5;Collecting duct cells: 29.5;Cytotrophoblasts: 46.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 22.5;HAP1: 25.1;OE19: 21.2;SuSa: 34.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA067290, HPA067853" Enhanced Supported "Nucleoplasm,Cell Junctions" NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 12: NES - Nervous system development" "Cluster 47: Cytotrophoblasts - Unknown function" "Cell Junctions" Nucleoplasm "HPA067290: AB_2685819, HPA067853: AB_2732773" "unprognostic (1.08e-2)" "unprognostic (5.51e-2)" "unprognostic (2.38e-2)" "unprognostic (3.36e-1)" "unprognostic (3.20e-1)" "unprognostic (8.95e-2)" "unprognostic (3.82e-2)" "prognostic favorable (3.94e-4)" "unprognostic (4.46e-2)" "unprognostic (3.79e-1)" "unprognostic (2.17e-1)" "unprognostic (5.60e-2)" "prognostic favorable (4.21e-9)" "unprognostic (9.54e-2)" "unprognostic (2.59e-2)" "unprognostic (4.50e-2)" "unprognostic (6.44e-2)" 4.3 1.6 29.0 1.3 24.7 0.3 6.5 23.4 21.9 9.2 0.6 3.5 2.9 4.9 145.6 4.0 12.2 2.8 4.0 23.7 31.6 10.4 2.1 2.7 0.8 32.8 34.4 5.7 2.3 14.3 7.2 20.7 24.1 6.3 4.3 1.7 6.9 25.7 39.0 2.3 3.7 3.2 20.6 1.5 3.0 2.3 36.4 4.4 3.8 53.5 1.0 2.8 4.1 18.2 4.3 0.0 22.5 1.0 0.5 0.5 8.8 0.7 0.0 0.0 0.0 10.5 0.8 0.5 4.7 3.5 0.0 8.4 25.1 0.0 0.0 0.0 6.3 0.0 0.0 0.2 0.2 0.0 1.1 0.2 0.0 5.1 0.6 4.9 0.2 0.4 0.0 0.0 0.6 0.4 6.8 0.3 10.5 21.2 0.1 8.4 6.6 0.1 11.2 11.0 0.0 8.0 0.1 0.0 9.8 34.9 0.8 0.2 0.1 2.9 6.8 0.0 9.4 0.7 0.0 0.0 1.0 0.1 6.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 29.0 24.7 23.4 21.9 23.7 31.6 32.8 34.4 24.1 20.6 36.4 18.2 2.2 3.2 2.0 57.5 0.9 1.8 2.7 2.5 2.8 1.1 9.7 6.9 2.0 1.5 7.2 29.5 0.0 46.2 1.1 4.9 1.9 5.1 0.2 7.2 6.3 3.7 15.8 0.4 8.9 1.9 3.8 7.2 4.1 7.1 0.0 1.5 4.2 4.0 6.2 0.0 2.0 7.2 6.1 1.6 2.1 0.5 6.8 1.0 3.6 17.8 1.7 4.9 4.1 2.0 3.5 3.2 5.6 6.4 0.0 6.6 4.7 16.8 10.1 0.5 6.6 3.9 4.0 0.4 3.2 3.0 1.1 15.9 0.9 0.8 7.3 2.5 ANKRD28 "CFAP79, FAP79, KIAA0379, PITK, PP6-ARS-A, PPP1R65" ENSG00000206560 "Ankyrin repeat domain 28" O15084 3 15667236-15859771 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Melanocytes: 282.8;Oligodendrocyte precursor cells: 364.4;Oligodendrocytes: 284.4;Plasma cells: 733.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 27 "basophil: 17.0" "Lineage enriched" "Detected in single" 27 "granulocytes: 17.0" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 38: Basophils - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 55: Plasma cells - Humoral immune response" "unprognostic (4.72e-2)" "unprognostic (8.71e-2)" "unprognostic (1.91e-3)" "unprognostic (1.48e-2)" "unprognostic (9.73e-2)" "unprognostic (4.29e-3)" "unprognostic (1.38e-1)" "unprognostic (1.27e-1)" "unprognostic (8.04e-2)" "unprognostic (2.04e-1)" "unprognostic (5.39e-3)" "unprognostic (7.71e-2)" "prognostic favorable (2.85e-4)" "unprognostic (2.32e-1)" "unprognostic (1.24e-1)" "unprognostic (4.43e-2)" "unprognostic (1.06e-1)" 13.2 7.0 8.1 5.7 9.1 11.6 13.4 12.3 12.6 11.3 6.8 10.0 9.6 9.0 27.7 7.8 7.6 9.9 5.8 8.1 8.4 10.3 13.5 9.0 5.8 9.5 7.9 11.3 13.8 15.7 5.6 6.4 8.9 6.8 9.7 14.0 8.2 7.8 23.9 10.7 7.8 6.3 7.9 7.1 10.7 11.9 7.5 10.3 13.5 20.1 8.9 9.1 10.1 10.7 16.3 10.7 11.6 7.9 38.4 31.7 37.7 20.6 28.9 26.0 29.8 6.5 16.3 31.6 7.0 20.8 20.4 6.5 9.6 17.0 26.4 6.9 13.5 15.0 14.5 10.7 62.7 23.4 10.0 46.4 11.7 24.6 25.6 32.4 27.5 17.4 11.5 41.4 67.6 11.0 19.7 15.1 23.8 10.8 8.8 17.1 21.8 26.9 24.9 16.2 5.9 10.5 15.3 15.4 63.9 10.4 9.2 18.3 21.8 32.9 20.2 25.1 20.3 25.2 31.2 18.8 24.6 16.8 25.5 17.0 0.0 0.0 0.3 0.0 0.4 0.2 0.6 0.3 0.1 0.2 0.2 0.3 0.1 0.2 0.0 0.3 0.2 0.2 8.1 9.1 12.3 12.6 8.1 8.4 9.5 7.9 8.9 7.9 7.5 10.7 39.2 32.1 51.2 63.6 69.9 42.6 20.8 17.0 17.6 27.9 37.7 16.0 18.9 18.6 39.9 7.3 139.7 8.9 71.6 19.5 9.8 14.4 95.5 25.5 55.0 61.4 19.8 37.6 175.4 20.7 9.3 73.4 36.7 42.0 196.7 17.3 21.0 45.1 41.0 52.2 144.5 18.1 22.4 59.7 181.3 92.2 34.8 87.5 282.8 47.8 16.7 43.2 19.6 364.4 284.4 14.8 14.8 10.9 733.4 35.1 12.7 11.3 45.2 41.3 0.0 45.6 29.3 24.4 10.5 25.3 33.5 3.4 195.5 10.2 20.5 21.5 ANO3 "C11orf25, DYT23, GENX-3947, TMEM16C" ENSG00000134343 "Anoctamin 3" Q9BYT9 11 26188842-26663289 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Disease variant, Dystonia" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 19 "brain: 59.2;epididymis: 57.4" "Cell type enriched" "Detected in some" 5 "Excitatory neurons: 201.9" "Not detected" "Not detected" "Region enriched" "Detected in many" 5 "basal ganglia: 59.2" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 1.9;HDLM-2: 6.8;U-2 OS: 1.6;U-2197: 4.3" "Region enhanced" "Detected in all" "basal ganglia: 158.9" "Region enriched" "Detected in all" 7 "basal ganglia: 180.1" HPA041629 Uncertain NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 44: HDLM-2 - Immune response" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "HPA041629: AB_10793969" "unprognostic (7.01e-3)" "unprognostic (4.31e-1)" "unprognostic (2.94e-1)" "unprognostic (9.29e-2)" "unprognostic (9.28e-2)" "unprognostic (1.25e-1)" "unprognostic (1.35e-1)" "unprognostic (2.75e-2)" "unprognostic (1.66e-1)" "unprognostic (2.45e-2)" "unprognostic (7.02e-2)" "unprognostic (1.32e-1)" "unprognostic (7.81e-4)" "unprognostic (9.48e-3)" "unprognostic (3.50e-2)" "unprognostic (4.33e-1)" "unprognostic (4.01e-1)" 3.0 0.8 4.3 0.1 59.2 0.0 0.5 0.0 11.8 0.5 0.0 0.2 0.1 0.1 57.4 0.0 0.2 1.8 0.3 7.7 0.0 1.0 1.1 0.4 0.0 1.1 0.1 0.1 0.3 0.1 0.3 0.0 1.9 0.0 0.1 0.4 0.2 0.1 0.0 0.1 0.1 0.2 0.0 0.4 0.0 1.9 0.3 0.1 1.0 0.1 0.0 0.0 0.1 1.7 0.0 0.0 0.4 0.0 1.1 1.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.9 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 4.3 0.0 0.4 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 59.2 0.0 11.8 7.7 0.0 1.1 0.1 1.9 0.0 0.3 1.7 1.0 0.0 2.0 3.3 0.0 0.0 0.0 0.1 0.0 1.7 0.2 0.0 0.9 0.0 0.2 0.0 14.6 0.2 0.0 0.0 0.0 0.1 12.0 0.5 0.0 0.4 0.0 0.0 201.9 0.0 0.3 0.5 0.0 0.3 0.0 0.0 1.8 0.7 0.0 8.4 4.1 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 8.4 0.0 0.0 0.0 38.2 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.3 2.3 0.0 0.0 4.7 3.8 2.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 AP3B1 "ADTB3A, HPS2" ENSG00000132842 "Adaptor related protein complex 3 subunit beta 1" O00203 5 78002326-78294698 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Albinism, Disease variant, Hermansky-Pudlak syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 231.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038737, HPA045458" Approved Approved "Nucleoplasm,Golgi apparatus" NA NA 38000 "Cluster 23: Antigen presenting cells - Antigen presentation" "Cluster 68: Epididymis - Unknown function" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 59: Non-specific - Transcription" Nucleoplasm "Golgi apparatus" "HPA038737: AB_10670788, HPA045458: AB_2679333" "unprognostic (9.14e-2)" "unprognostic (2.02e-1)" "prognostic favorable (1.37e-5)" "unprognostic (8.17e-2)" "unprognostic (2.95e-2)" "unprognostic (2.14e-1)" "unprognostic (1.18e-3)" "unprognostic (7.47e-3)" "unprognostic (4.51e-1)" "unprognostic (9.05e-3)" "unprognostic (1.01e-1)" "unprognostic (6.97e-2)" "prognostic favorable (7.97e-6)" "unprognostic (1.65e-1)" "unprognostic (1.35e-1)" "unprognostic (1.98e-1)" "unprognostic (3.39e-2)" 21.5 21.5 21.1 19.6 26.1 21.9 21.3 22.3 26.4 20.7 23.0 24.1 19.8 17.8 53.9 30.8 15.8 15.9 19.0 19.6 23.4 30.3 15.9 17.2 22.5 23.4 24.4 13.0 24.9 29.3 40.4 19.6 24.5 16.9 28.3 8.8 26.4 16.4 15.8 22.5 20.8 20.5 23.3 21.6 23.0 13.2 23.6 23.2 27.2 13.0 24.8 20.1 21.9 26.5 51.3 40.3 45.4 63.1 53.2 64.5 39.5 56.3 66.1 50.1 67.5 31.4 44.1 53.7 32.5 69.4 41.7 36.6 45.0 94.1 62.7 61.7 31.7 37.4 33.9 55.5 31.1 33.7 47.1 46.2 34.0 42.3 42.5 47.7 64.1 10.9 27.3 34.3 86.9 31.6 43.4 52.2 24.1 37.4 23.9 45.2 80.2 74.4 72.7 47.5 16.0 25.7 52.3 33.7 49.7 37.1 40.9 55.6 65.0 37.4 29.1 45.4 57.4 26.3 43.3 36.3 48.5 48.5 48.4 18.3 12.6 11.3 9.6 12.5 10.6 31.3 8.0 10.0 17.2 40.1 6.6 8.8 15.4 9.6 17.3 14.2 10.4 8.1 21.1 26.1 22.3 26.4 19.6 23.4 23.4 24.4 24.5 23.3 23.6 26.5 31.6 44.8 33.7 82.3 59.0 15.8 22.1 28.1 22.8 16.2 18.8 14.1 29.0 10.0 37.5 31.3 22.9 30.9 37.1 36.9 25.4 35.8 12.0 27.7 38.8 33.3 19.2 27.3 59.7 38.0 38.7 32.0 35.2 40.8 32.9 26.1 23.2 17.0 39.5 20.2 57.3 34.1 26.4 41.9 24.8 20.2 15.8 47.3 26.6 118.0 66.5 21.5 32.0 86.5 231.0 43.5 25.0 16.6 44.0 20.7 30.0 27.2 29.8 27.5 26.3 36.2 28.5 16.1 10.1 28.9 23.4 29.8 39.9 31.2 28.0 22.2 AP3S1 CLAPS3 ENSG00000177879 "Adaptor related protein complex 3 subunit sigma 1" Q92572 5 115841592-115914081 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049270 Uncertain Approved Vesicles NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 68: Epididymis - Unknown function" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 26: Respiratory epithelial cells - Mucosal defense" Vesicles "HPA049270: AB_2680696" "prognostic unfavorable (1.22e-4)" "unprognostic (2.54e-2)" "unprognostic (8.05e-2)" "unprognostic (1.68e-2)" "prognostic unfavorable (3.33e-4)" "unprognostic (2.60e-2)" "unprognostic (3.83e-3)" "unprognostic (4.42e-3)" "unprognostic (1.36e-1)" "unprognostic (1.08e-1)" "prognostic unfavorable (1.13e-5)" "unprognostic (1.73e-1)" "prognostic unfavorable (9.57e-8)" "unprognostic (2.73e-2)" "unprognostic (3.62e-2)" "unprognostic (2.75e-1)" "unprognostic (1.64e-1)" 63.1 44.5 57.0 38.7 59.7 133.3 60.1 55.2 84.5 70.1 54.6 53.7 61.9 55.1 113.6 65.8 46.1 49.2 52.6 61.5 60.7 37.4 74.7 38.1 64.6 62.3 60.3 69.6 63.2 24.9 19.7 60.1 62.8 43.6 60.1 34.0 59.4 85.6 21.9 60.7 81.5 64.1 59.1 39.0 37.7 57.3 58.4 41.1 49.3 34.4 61.1 60.2 25.4 59.5 134.3 44.8 95.2 63.4 257.4 369.1 89.2 142.6 132.4 94.1 152.0 98.9 121.4 107.5 68.4 162.8 115.4 38.1 58.8 230.4 157.6 320.3 114.4 45.1 43.8 146.2 139.8 76.2 84.6 168.6 177.9 100.2 112.1 123.5 109.4 122.1 47.1 80.9 150.3 49.9 87.3 129.0 71.1 65.5 74.4 85.0 141.9 172.0 123.2 58.8 35.1 53.8 222.8 42.7 146.3 86.2 70.3 116.1 115.4 173.1 116.5 127.1 113.4 71.6 47.3 91.8 129.9 144.2 73.5 81.9 70.7 174.8 37.6 79.2 63.7 67.1 47.1 52.3 54.5 47.3 39.9 41.6 110.0 48.3 75.8 94.8 60.3 70.6 57.0 59.7 55.2 84.5 61.5 60.7 62.3 60.3 62.8 59.1 58.4 59.5 75.6 22.4 21.9 31.3 90.1 203.0 92.8 308.5 95.0 68.0 72.9 59.3 26.4 67.2 115.0 46.0 25.0 74.1 95.0 129.7 70.5 93.6 130.2 37.8 62.1 73.9 76.1 31.7 83.1 86.5 309.4 158.3 43.8 35.1 83.6 39.6 81.8 87.2 152.6 26.9 61.2 131.5 105.8 111.7 185.7 217.4 173.1 88.4 115.6 68.4 103.9 19.6 74.2 46.3 49.9 111.4 105.5 111.3 103.6 118.3 361.1 156.7 59.8 77.7 32.9 48.2 118.0 108.8 104.7 131.5 227.9 128.7 79.0 60.7 74.9 112.5 ARMCX2 "ALEX2, GASP9, KIAA0512" ENSG00000184867 "Armadillo repeat containing X-linked 2" Q7L311 X 101655281-101659850 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 154.8" "Cell type enhanced" "Detected in many" "Sertoli cells: 59.2" "Cancer enhanced" "Detected in all" "thyroid cancer: 47.7" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "LHCN-M2: 164.1;NTERA-2: 117.2;SuSa: 90.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005761 Enhanced Approved Nucleoplasm,Mitochondria Yes No "Cluster 21: B-cells - Adaptive immune response" "Cluster 68: Epididymis - Unknown function" "Cluster 5: NTERA-2 - Transcription" "Cluster 48: Smooth muscle cells - ECM organization" Mitochondria Nucleoplasm "HPA005761: AB_10600782" "unprognostic (1.33e-1)" "unprognostic (2.26e-2)" "unprognostic (4.25e-2)" "unprognostic (1.48e-1)" "unprognostic (9.59e-2)" "unprognostic (6.96e-2)" "unprognostic (5.00e-2)" "unprognostic (1.87e-1)" "unprognostic (7.17e-2)" "unprognostic (3.41e-2)" "prognostic favorable (3.45e-5)" "unprognostic (9.06e-2)" "unprognostic (1.10e-1)" "prognostic unfavorable (2.69e-4)" "unprognostic (1.12e-1)" "unprognostic (6.73e-2)" "unprognostic (1.25e-1)" 17.0 46.2 28.7 11.5 29.1 0.5 17.6 22.8 29.7 36.9 26.5 25.4 5.4 30.6 154.8 9.2 28.8 20.6 33.2 29.1 31.6 28.3 3.2 16.8 8.5 25.9 26.2 47.8 18.9 71.2 78.3 26.3 27.5 28.3 7.9 15.3 44.5 67.9 6.2 6.5 13.0 32.3 23.4 21.3 16.3 5.8 28.1 7.7 59.7 7.5 6.5 26.9 20.1 25.4 0.0 0.0 50.8 0.4 43.6 39.4 0.4 56.0 70.4 1.4 1.4 0.0 21.8 0.0 0.0 74.6 0.0 1.5 0.0 1.3 0.6 0.0 2.0 0.2 60.9 0.0 46.4 0.4 0.1 63.7 17.6 43.5 0.4 68.3 59.7 0.0 0.2 0.3 164.1 0.0 0.0 0.6 117.2 3.4 0.3 14.5 88.9 0.3 2.8 0.0 20.4 36.6 0.0 0.2 1.7 90.3 25.9 0.1 13.0 61.9 65.1 38.8 0.4 0.0 0.0 0.2 55.7 0.1 1.2 0.0 0.4 0.0 1.0 0.9 0.4 2.8 0.9 0.9 0.7 4.0 2.4 2.5 0.0 2.8 0.6 0.9 0.7 1.1 28.7 29.1 22.8 29.7 29.1 31.6 25.9 26.2 27.5 23.4 28.1 25.4 10.4 16.0 6.4 8.5 8.2 4.2 16.4 5.8 21.1 12.5 18.0 20.8 28.7 5.7 11.4 33.1 8.4 1.2 2.4 0.1 3.9 9.6 0.2 11.2 23.4 13.3 9.1 3.2 15.4 2.0 0.7 28.4 4.6 15.2 2.5 18.1 19.2 0.7 3.8 1.7 14.3 3.0 2.0 2.4 6.5 1.3 24.2 7.4 5.4 11.2 7.1 9.3 0.0 16.1 14.0 2.2 0.1 24.5 2.8 16.5 0.3 4.3 4.9 11.3 59.2 31.8 23.9 1.4 1.9 3.8 3.0 5.1 2.5 4.6 1.6 7.2 ARMCX6 "FLJ20811, GASP10" ENSG00000198960 "Armadillo repeat containing X-linked 6" Q7L4S7 X 101615118-101618001 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043030, HPA048125" Approved Supported "Nucleoplasm,Nuclear membrane,Cytosol" NA NA "Cluster 37: B-cells - Transcription" "Cluster 68: Epididymis - Unknown function" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 51: Myeloid cells - Hemostasis" Cytosol "Nucleoplasm, Nuclear membrane" "HPA043030: AB_2678277, HPA048125: AB_2680275" "unprognostic (1.20e-1)" "unprognostic (2.80e-1)" "unprognostic (8.82e-3)" "unprognostic (1.04e-1)" "unprognostic (1.02e-1)" "unprognostic (1.80e-2)" "unprognostic (1.73e-3)" "unprognostic (1.92e-3)" "unprognostic (4.13e-2)" "unprognostic (1.07e-1)" "unprognostic (2.26e-2)" "unprognostic (3.31e-1)" "unprognostic (3.74e-1)" "unprognostic (1.51e-1)" "unprognostic (2.85e-1)" "unprognostic (7.82e-3)" "unprognostic (2.38e-2)" 9.4 14.6 11.8 9.6 12.1 8.2 11.7 13.0 13.8 14.2 11.9 11.1 6.2 15.8 22.7 9.3 12.6 10.5 15.3 11.7 12.7 13.0 7.6 9.6 12.8 13.9 12.6 19.1 17.4 26.3 17.1 15.7 13.5 13.7 8.1 5.3 24.5 18.3 6.7 10.7 9.0 14.8 12.9 19.2 9.5 4.4 12.4 13.8 14.2 8.3 13.8 11.2 11.3 14.6 13.7 15.7 24.2 13.8 48.4 28.6 4.8 28.0 27.0 24.5 47.5 9.4 12.8 14.4 28.0 26.4 25.5 13.9 23.8 11.3 19.1 12.6 14.4 13.5 22.6 12.8 22.2 13.4 16.4 17.9 11.3 15.1 7.8 34.3 25.4 7.4 11.3 18.0 37.3 33.0 19.8 0.2 17.5 17.7 3.1 20.0 32.5 5.5 17.7 1.8 13.3 12.5 16.4 0.1 21.0 18.3 11.4 6.4 19.8 29.7 13.4 41.8 6.6 22.1 12.6 0.0 8.9 3.5 9.9 11.3 3.7 6.1 5.8 6.7 7.5 13.2 6.1 6.4 7.6 9.0 7.3 6.9 0.4 8.3 5.1 13.2 3.6 6.2 11.8 12.1 13.0 13.8 11.7 12.7 13.9 12.6 13.5 12.9 12.4 14.6 23.9 9.6 9.1 5.2 28.5 13.4 14.4 28.3 26.2 5.5 39.3 44.4 9.7 14.3 16.3 31.3 16.7 37.8 40.6 2.2 23.5 44.2 0.6 21.9 23.7 27.2 16.4 13.0 1.9 27.7 17.3 24.6 19.9 38.0 14.5 30.2 25.4 15.7 67.9 10.1 3.3 14.2 16.2 29.0 32.3 2.2 18.6 40.8 37.4 5.6 28.5 30.3 36.0 8.5 4.9 26.5 11.2 19.9 23.8 18.3 7.6 25.0 5.5 4.6 26.3 13.1 22.4 2.6 2.3 32.7 16.1 34.5 26.0 29.5 11.7 20.8 ASMT "ASMTY, HIOMT, HIOMTY" ENSG00000196433 "Acetylserotonin O-methyltransferase" P46597 X 1615059-1643081 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Melatonin biosynthesis" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in some" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 1.8;Early spermatids: 1.1;Excitatory neurons: 1.5;Extravillous trophoblasts: 1.0;Inhibitory neurons: 1.3;Oligodendrocytes: 1.3;Theca cells: 3.4" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Immune cell enhanced" "Detected in single" "naive B-cell: 2.1" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 24: B-cells - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 10: Non-specific - Unknown function" "unprognostic (1.84e-2)" "unprognostic (1.63e-3)" "unprognostic (1.89e-1)" "unprognostic (1.40e-1)" "unprognostic (3.02e-1)" "unprognostic (8.55e-4)" "unprognostic (1.54e-1)" "unprognostic (2.27e-2)" "unprognostic (4.30e-3)" "unprognostic (1.56e-1)" "unprognostic (1.43e-3)" "unprognostic (2.64e-1)" "unprognostic (4.04e-3)" "unprognostic (1.49e-1)" "unprognostic (3.27e-2)" "unprognostic (2.23e-1)" "unprognostic (2.79e-3)" 0.4 0.8 0.6 0.3 0.6 0.7 0.4 0.6 0.9 0.8 1.4 0.5 0.0 0.6 1.8 0.2 0.5 0.2 0.4 0.6 1.1 0.3 0.3 0.3 0.2 0.4 0.4 0.4 0.4 0.1 1.4 0.1 0.4 0.5 0.0 0.4 0.3 0.2 0.2 0.4 0.4 0.2 0.3 0.6 0.4 0.4 0.5 0.1 0.5 0.1 0.1 0.5 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.5 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.6 0.0 2.1 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.6 0.6 0.6 0.9 0.6 1.1 0.4 0.4 0.4 0.3 0.5 0.6 0.2 0.0 1.8 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 1.1 0.0 0.1 0.2 0.0 0.0 1.5 0.0 1.0 0.1 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.3 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.2 0.0 0.0 0.1 0.5 3.4 0.0 0.1 ATP13A4 "DKFZp761I1011, FLJ37958" ENSG00000127249 "ATPase 13A4" Q4VNC1 3 193398967-193593111 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Translocase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 64.5;parathyroid gland: 58.4;thyroid gland: 51.9" "Group enriched" "Detected in many" 4 "Astrocytes: 409.4;Oligodendrocyte precursor cells: 163.3" "Cancer enriched" "Detected in many" 5 "thyroid cancer: 23.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SCLC-21H: 3.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051932 Approved Nucleoplasm NA NA "Cluster 34: Basophils - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 64: Astrocytes - Nervous system maintenance" Nucleoplasm "HPA051932: " "unprognostic (4.97e-2)" "unprognostic (1.50e-3)" "unprognostic (4.86e-3)" "unprognostic (2.52e-3)" "unprognostic (2.72e-2)" "prognostic favorable (3.91e-4)" "unprognostic (1.55e-1)" "unprognostic (3.99e-3)" "unprognostic (2.65e-1)" "unprognostic (1.36e-1)" "unprognostic (4.39e-2)" "unprognostic (1.34e-1)" "unprognostic (4.29e-5)" "unprognostic (1.91e-1)" "unprognostic (1.70e-1)" "unprognostic (5.75e-3)" "unprognostic (2.00e-1)" 0.1 0.3 19.5 0.2 20.9 0.2 22.7 18.1 20.1 2.8 28.2 2.0 0.3 0.1 64.5 20.1 2.4 4.6 0.1 18.0 17.0 0.7 0.6 27.3 0.4 18.5 21.5 0.3 5.3 58.4 4.8 0.1 17.9 0.1 3.4 2.5 7.2 2.4 0.5 16.9 0.3 0.1 15.2 0.3 9.6 0.5 21.6 0.3 51.9 0.0 4.8 0.1 6.7 15.8 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.7 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.4 0.6 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 19.5 20.9 18.1 20.1 18.0 17.0 18.5 21.5 17.9 15.2 21.6 15.8 0.2 64.1 30.5 409.4 1.1 0.1 0.0 1.7 0.0 1.6 6.1 3.6 0.4 11.5 15.3 0.0 0.0 1.2 0.5 1.6 0.0 3.3 0.4 4.0 0.7 0.1 0.0 0.0 5.8 0.2 0.1 0.2 17.3 6.4 1.3 0.3 1.4 0.1 0.2 1.7 10.9 1.9 0.0 0.3 0.5 1.0 0.0 0.5 1.8 13.1 0.0 0.5 0.0 163.3 20.6 1.3 1.7 0.4 0.2 0.0 0.0 0.4 8.5 1.0 0.0 0.1 0.2 0.7 1.5 2.2 1.6 0.7 0.9 0.1 2.2 0.1 ATP6AP1 "16A, Ac45, ATP6IP1, ATP6S1, CF2, ORF, VATPS1, XAP-3, XAP3" ENSG00000071553 "ATPase H+ transporting accessory protein 1" Q15904 X 154428633-154436516 "Disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Hydrogen ion transport, Ion transport, Transport" "Congenital disorder of glycosylation, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB015218 Uncertain NA NA 700000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 68: Epididymis - Unknown function" "Cluster 38: EFO-21 - Unknown function" "Cluster 4: Macrophages - Innate immune response" "CAB015218: " "prognostic unfavorable (2.40e-4)" "unprognostic (1.95e-2)" "unprognostic (2.06e-3)" "unprognostic (2.20e-1)" "prognostic unfavorable (8.94e-4)" "unprognostic (1.84e-3)" "unprognostic (4.99e-3)" "unprognostic (2.57e-1)" "unprognostic (1.10e-2)" "unprognostic (1.84e-1)" "prognostic favorable (7.83e-4)" "unprognostic (1.07e-1)" "prognostic favorable (5.26e-8)" "unprognostic (2.45e-1)" "unprognostic (4.66e-2)" "unprognostic (3.39e-1)" "unprognostic (1.62e-1)" 56.3 93.5 108.3 43.1 109.2 59.1 56.7 99.6 118.0 59.6 123.6 61.5 48.4 54.2 145.1 85.2 60.0 46.0 92.7 116.2 115.4 104.3 51.4 96.8 46.9 114.0 96.8 63.3 86.6 176.0 110.4 77.9 121.6 85.1 57.0 74.0 87.4 54.8 53.8 83.6 57.4 49.0 104.6 94.7 70.4 47.5 104.2 40.9 81.9 54.4 42.5 63.7 60.9 121.6 110.1 101.6 88.2 146.2 145.7 77.4 162.2 78.5 116.6 122.5 176.1 93.4 135.1 64.7 337.8 177.1 216.5 112.3 133.8 71.9 76.6 58.6 135.1 37.5 113.7 100.0 170.6 60.9 260.2 98.1 126.7 112.4 68.2 139.5 177.0 47.8 45.6 176.4 84.7 158.1 43.6 96.8 32.1 171.0 100.8 66.6 59.1 170.7 139.9 87.3 84.6 89.7 72.6 289.7 159.3 87.3 123.1 157.8 135.5 87.4 79.0 151.1 135.6 256.3 311.8 77.0 104.4 132.8 90.2 246.6 295.1 363.9 147.3 313.8 148.6 91.7 118.4 127.8 376.7 113.6 107.1 117.8 326.9 140.3 255.6 215.9 155.2 216.9 108.3 109.2 99.6 118.0 116.2 115.4 114.0 96.8 121.6 104.6 104.2 121.6 39.4 38.5 57.5 17.0 32.3 30.2 42.7 122.4 25.6 105.8 58.5 42.2 37.7 54.3 102.1 97.5 47.9 145.1 40.1 84.3 19.6 65.4 3.1 52.5 33.7 50.1 89.0 35.8 17.0 52.5 104.5 48.8 36.7 57.4 77.3 51.8 54.3 46.6 246.3 129.5 24.2 59.0 160.7 143.6 88.2 5.5 41.3 130.3 72.9 15.0 79.9 68.4 27.8 22.1 26.4 42.4 67.5 42.5 61.7 34.1 63.7 49.1 112.5 69.2 65.7 35.7 45.5 64.4 10.7 31.6 32.8 196.5 36.3 74.1 54.6 47.2 ATP6V0E1 "ATP6H, ATP6V0E, M9.2" ENSG00000113732 "ATPase H+ transporting V0 subunit e1" O15342 5 172983771-173035445 "Metabolic proteins, Predicted membrane proteins" "Hydrogen ion transport, Ion transport, Transport" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 68: Epididymis - Unknown function" "Cluster 44: HDLM-2 - Immune response" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "unprognostic (2.24e-1)" "unprognostic (3.08e-1)" "unprognostic (3.61e-1)" "unprognostic (1.51e-1)" "unprognostic (5.34e-2)" "unprognostic (1.54e-3)" "unprognostic (2.25e-3)" "unprognostic (1.66e-2)" "unprognostic (1.39e-1)" "unprognostic (6.63e-2)" "unprognostic (1.47e-1)" "unprognostic (8.33e-2)" "unprognostic (1.01e-1)" "unprognostic (2.46e-1)" "unprognostic (2.93e-2)" "unprognostic (1.37e-1)" "unprognostic (2.02e-1)" 265.1 267.9 135.7 158.7 142.2 89.7 223.2 145.3 192.0 220.8 181.0 204.6 127.0 199.1 634.0 228.9 193.3 163.3 262.4 133.0 154.4 338.2 237.0 253.3 191.4 156.2 145.1 189.3 179.4 145.9 314.2 171.7 154.5 232.3 154.6 45.8 245.0 154.1 225.0 178.9 189.5 157.9 150.3 270.1 233.3 93.4 144.5 130.1 241.2 137.6 188.3 227.2 199.1 158.3 249.4 263.6 85.5 259.5 777.8 310.6 200.6 475.7 444.6 235.3 361.6 299.2 376.6 107.0 663.0 567.4 622.2 174.6 173.4 342.2 260.6 741.8 170.9 100.8 242.1 287.3 379.5 192.9 340.6 413.0 413.3 270.7 149.1 284.0 287.0 116.9 67.3 306.3 519.3 487.6 121.7 278.0 99.2 195.8 228.5 128.8 121.9 193.0 471.5 312.4 123.9 82.8 208.6 255.7 400.5 235.1 282.5 265.5 430.2 553.0 125.9 397.8 405.3 263.2 587.5 120.2 299.5 318.6 185.2 2395.6 1150.2 1781.5 671.3 865.7 620.8 1088.5 761.2 706.6 734.6 951.6 734.7 761.7 2193.1 655.2 852.2 1099.7 853.8 2168.0 135.7 142.2 145.3 192.0 133.0 154.4 156.2 145.1 154.5 150.3 144.5 158.3 226.2 131.4 226.0 23.5 271.9 293.2 327.6 796.7 177.0 17.7 261.1 275.0 199.9 248.8 444.4 518.6 6.2 492.6 279.9 279.8 324.8 619.5 24.0 296.8 188.8 269.7 213.1 138.2 22.9 366.4 553.7 308.2 112.7 394.7 254.1 217.1 258.5 373.6 720.3 37.0 21.6 206.2 565.6 452.1 606.7 40.8 342.3 439.7 368.2 37.5 897.8 295.3 409.9 22.6 44.8 555.1 375.0 335.9 185.1 463.0 362.9 687.5 332.6 21.5 243.3 110.2 238.4 124.6 138.2 219.4 284.6 842.7 275.9 214.7 205.2 405.9 ATRAID "APR3, C2orf28, HSPC013, p18" ENSG00000138085 "All-trans retinoic acid induced differentiation factor" Q6UW56 2 27212027-27217178 "Predicted intracellular proteins, Predicted membrane proteins" Differentiation "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051353 Uncertain NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 68: Epididymis - Unknown function" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "HPA051353: AB_2681451" "unprognostic (4.58e-2)" "unprognostic (9.41e-3)" "unprognostic (1.25e-1)" "unprognostic (1.34e-1)" "unprognostic (3.85e-2)" "unprognostic (4.41e-2)" "unprognostic (1.59e-2)" "unprognostic (2.15e-1)" "unprognostic (1.29e-1)" "unprognostic (1.25e-2)" "unprognostic (5.73e-2)" "unprognostic (5.35e-3)" "unprognostic (2.36e-2)" "unprognostic (4.86e-2)" "unprognostic (1.77e-1)" "unprognostic (3.76e-1)" "unprognostic (1.92e-1)" 86.5 79.6 57.3 48.0 62.2 72.2 109.9 62.7 70.8 108.8 73.8 82.0 59.8 82.1 343.6 59.1 123.7 68.0 129.7 56.9 61.8 133.2 72.0 74.8 63.8 64.5 60.1 119.6 120.2 120.5 40.7 74.8 64.2 81.5 92.3 56.7 107.7 107.3 142.6 55.9 59.4 72.7 61.7 64.4 73.3 96.1 59.3 68.4 114.1 139.1 66.2 79.2 38.1 66.4 126.9 145.6 82.4 144.9 408.7 242.2 126.9 75.6 227.6 93.8 87.0 116.2 184.4 63.5 126.6 201.3 134.8 108.7 75.9 132.2 81.1 101.2 77.2 75.0 79.4 182.6 185.9 65.2 93.6 192.5 275.5 80.2 179.3 213.3 123.7 110.5 76.4 191.7 144.5 161.8 78.8 174.0 124.0 263.3 123.0 70.5 218.7 293.2 161.2 68.6 90.7 136.5 89.7 112.4 122.8 118.4 96.3 98.5 82.8 147.9 87.4 54.1 77.8 302.4 249.6 166.2 152.9 124.8 143.5 188.4 242.1 206.7 198.5 223.2 202.9 278.5 227.6 226.9 251.1 271.1 238.8 219.6 54.1 189.1 240.7 293.2 277.5 443.1 57.3 62.2 62.7 70.8 56.9 61.8 64.5 60.1 64.2 61.7 59.3 66.4 143.0 60.9 82.1 7.8 96.4 102.2 176.4 306.4 112.1 44.2 135.0 155.7 163.2 114.4 169.9 143.5 18.8 273.0 95.0 68.6 181.9 182.5 159.6 113.7 109.5 118.4 91.8 47.1 4.3 191.3 328.2 200.0 57.6 96.8 90.7 124.6 113.2 82.7 209.4 28.6 6.6 134.6 205.4 110.7 104.8 223.9 196.3 100.9 176.1 9.4 157.6 153.9 92.7 9.5 13.9 126.1 123.1 141.1 177.0 109.6 135.1 212.0 160.8 48.9 52.6 103.8 137.8 374.7 162.6 110.2 100.7 250.5 93.5 167.8 137.6 153.7 BASP1 "CAP-23, CAP23, NAP-22, NAP22" ENSG00000176788 "Brain abundant membrane attached signal protein 1" P80723 5 17065598-17276843 "Plasma proteins, Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "brain: 486.3;epididymis: 303.3" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 345.6;Extravillous trophoblasts: 362.9;Langerhans cells: 489.4;Muller glia cells: 796.9;Syncytiotrophoblasts: 738.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 5 "neutrophil: 128.5" "Lineage enriched" "Detected in many" 16 "granulocytes: 128.5" "Cell line enhanced" "Detected in many" "GAMG: 467.0;HeLa: 800.8;SiHa: 830.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045218, HPA050333" Enhanced Enhanced "Plasma membrane" NA NA 63000000 "Cluster 50: Neutrophils - Cellular senescence" "Cluster 68: Epididymis - Unknown function" "Cluster 20: HeLa - Mitochondria" "Cluster 41: Macrophages - Immune response" "Plasma membrane" "HPA045218: AB_2679263, HPA050333: AB_2681090" "unprognostic (3.35e-2)" "unprognostic (3.13e-2)" "unprognostic (1.04e-1)" "unprognostic (1.32e-1)" "unprognostic (2.78e-1)" "prognostic unfavorable (5.63e-4)" "unprognostic (2.40e-1)" "unprognostic (1.02e-2)" "unprognostic (2.39e-1)" "unprognostic (1.89e-1)" "unprognostic (2.52e-1)" "unprognostic (2.31e-1)" "prognostic unfavorable (5.25e-11)" "unprognostic (1.95e-3)" "unprognostic (1.04e-1)" "unprognostic (3.61e-2)" "unprognostic (1.70e-1)" 35.3 13.8 235.9 73.6 257.0 87.6 14.0 103.0 486.3 56.9 79.9 12.5 7.3 37.3 303.3 10.9 11.4 29.2 13.9 247.3 210.9 15.1 17.2 36.5 80.9 134.7 153.1 36.6 3.7 3.4 21.2 92.1 184.3 79.7 10.8 74.3 13.2 21.6 2.3 22.0 22.2 33.4 107.7 76.5 22.7 2.9 157.1 24.1 11.3 6.8 91.5 57.9 27.3 281.8 0.1 125.6 152.7 0.2 71.7 76.1 227.1 161.7 50.9 127.9 135.0 6.1 0.1 51.3 22.4 112.0 467.0 10.6 98.2 109.2 164.8 21.3 57.9 0.4 800.8 0.3 158.9 101.3 1.4 131.2 132.7 145.6 121.0 163.9 140.1 0.2 0.4 0.5 138.2 183.7 0.3 92.5 115.7 0.3 39.6 0.1 0.5 28.0 46.5 31.3 99.3 21.3 830.7 72.3 0.2 336.5 0.3 101.9 187.7 169.3 0.6 14.2 26.1 1.7 0.2 27.1 171.2 123.0 23.1 25.0 3.1 25.3 0.0 1.5 0.0 5.4 0.0 0.0 4.9 7.9 0.0 0.0 128.5 1.8 2.1 0.5 0.3 0.8 235.9 257.0 103.0 486.3 247.3 210.9 134.7 153.1 184.3 107.7 157.1 281.8 8.0 9.6 4.8 22.2 158.7 215.9 88.0 21.3 58.1 54.8 9.8 10.2 1.6 0.0 15.8 9.2 12.5 155.0 3.8 0.6 0.0 0.6 0.9 98.4 345.6 30.2 0.0 18.1 254.0 3.4 362.9 102.6 23.4 156.4 27.3 18.1 35.7 2.5 53.8 244.0 125.3 0.7 12.2 227.9 489.4 0.0 0.6 298.5 28.4 53.4 275.1 796.9 1.0 115.1 23.7 1.0 0.2 0.0 173.0 121.0 0.0 0.3 93.5 58.4 0.0 2.0 66.2 0.4 3.4 21.0 58.8 738.5 11.9 8.3 1.8 13.2 BBS10 "C12orf58, FLJ23560" ENSG00000179941 "Bardet-Biedl syndrome 10" Q8TAM1 12 76344474-76348415 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Sensory transduction, Vision" Chaperone "Bardet-Biedl syndrome, Ciliopathy, Disease variant, Mental retardation, Obesity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058743 Approved NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 68: Epididymis - Unknown function" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 50: Fibroblasts - ECM organization" "HPA058743: AB_2683806" "unprognostic (2.49e-1)" "unprognostic (1.46e-1)" "unprognostic (1.53e-1)" "unprognostic (1.18e-1)" "unprognostic (4.48e-3)" "unprognostic (3.14e-2)" "unprognostic (1.57e-2)" "unprognostic (2.22e-2)" "unprognostic (4.12e-2)" "unprognostic (6.86e-2)" "unprognostic (5.82e-2)" "unprognostic (7.35e-2)" "unprognostic (6.77e-2)" "unprognostic (3.49e-2)" "unprognostic (1.09e-1)" "unprognostic (1.15e-1)" "unprognostic (2.74e-1)" 11.6 12.0 7.3 6.0 7.9 0.9 11.8 8.8 10.8 7.6 6.5 4.2 3.9 8.2 9.8 6.6 7.6 5.5 10.3 7.0 7.1 9.8 9.1 6.0 9.0 7.7 7.2 12.6 4.4 7.6 4.3 7.6 8.3 8.2 3.9 11.4 9.8 7.9 5.5 7.3 4.4 6.1 8.4 9.2 5.1 6.2 7.0 8.9 9.3 7.8 7.7 5.4 4.8 10.3 10.9 6.9 14.2 7.4 19.9 21.0 6.0 11.9 8.6 10.0 7.5 5.7 5.1 5.2 11.9 6.4 8.8 11.6 9.7 10.2 14.0 9.0 10.3 7.1 7.7 8.1 25.2 7.6 5.4 13.8 14.5 13.3 16.1 26.8 14.0 15.0 8.9 4.0 19.4 6.9 7.7 8.2 8.8 5.3 9.6 7.9 17.6 8.4 9.9 5.6 8.7 16.4 15.5 3.0 11.1 13.6 16.2 8.1 10.9 12.3 7.2 12.5 7.8 8.4 11.3 4.6 8.9 6.1 9.4 2.6 2.1 5.0 0.5 4.0 1.2 1.6 1.0 0.8 2.5 1.2 2.2 1.4 1.8 0.7 7.2 1.6 0.9 1.2 7.3 7.9 8.8 10.8 7.0 7.1 7.7 7.2 8.3 8.4 7.0 10.3 4.0 3.2 3.6 5.9 3.7 4.0 3.7 3.5 5.2 4.4 3.4 3.2 8.8 1.5 5.1 3.7 0.0 3.7 3.8 0.4 3.9 3.1 0.1 2.8 7.3 4.0 3.0 4.0 5.4 2.5 1.0 6.2 2.0 1.8 0.0 4.1 4.6 8.7 3.0 1.7 5.2 1.6 2.0 7.3 2.1 0.6 8.7 3.4 0.0 6.5 2.4 8.7 1.0 4.5 9.9 3.2 1.7 11.3 0.3 2.2 1.5 8.4 6.7 4.3 6.6 6.5 3.9 8.7 6.5 4.9 4.1 0.8 2.1 2.1 1.6 1.7 BEX2 DJ79P11.1 ENSG00000133134 "Brain expressed X-linked 2" Q9BXY8 X 103309346-103311007 "Predicted intracellular proteins" "Apoptosis, Cell cycle" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pituitary gland: 194.6" "Cell type enhanced" "Detected in many" "Distal tubular cells: 418.7;Muller glia cells: 285.9;Proximal tubular cells: 201.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 5 "B-cells: 52.7;NK-cells: 62.0;T-cells: 68.6" "Cell line enhanced" "Detected in many" "hTCEpi: 94.7;NTERA-2: 91.4;SCLC-21H: 135.2;SH-SY5Y: 61.4" "HPA045384, HPA078630" Uncertain Uncertain Cytosol NA NA "Cluster 30: Non-specific - Translation" "Cluster 68: Epididymis - Unknown function" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 39: Non-specific - Basic cellular processes" Cytosol "HPA045384: AB_2679305, HPA078630: " "unprognostic (7.56e-2)" "unprognostic (7.08e-2)" "unprognostic (3.46e-2)" "prognostic unfavorable (8.54e-7)" "unprognostic (3.21e-1)" "unprognostic (1.65e-1)" "unprognostic (4.27e-2)" "prognostic favorable (1.52e-4)" "unprognostic (7.36e-3)" "unprognostic (6.82e-2)" "unprognostic (8.22e-3)" "unprognostic (6.63e-2)" "prognostic favorable (3.05e-13)" "unprognostic (4.14e-3)" "unprognostic (6.80e-2)" "unprognostic (1.40e-1)" "unprognostic (2.38e-3)" 5.8 73.6 133.5 6.8 134.9 13.7 19.4 119.0 167.3 16.4 98.2 10.2 3.4 27.6 123.8 9.9 15.5 7.6 29.5 134.4 153.2 58.7 2.5 12.7 14.2 120.7 125.6 62.8 35.5 123.1 194.6 8.0 123.7 24.2 6.0 83.5 26.7 21.0 9.1 17.1 14.0 8.7 117.7 18.5 16.7 43.1 138.6 21.0 103.3 11.5 16.9 8.7 10.7 132.2 0.0 2.8 11.3 0.1 0.2 0.0 45.5 0.3 6.1 7.7 11.3 8.4 3.8 0.0 31.6 0.0 55.4 2.0 0.1 9.4 6.6 0.1 25.4 1.4 1.4 0.4 46.0 0.1 25.4 2.8 94.7 3.7 29.1 17.8 0.5 33.6 17.4 0.7 1.0 4.2 20.1 0.2 91.4 0.0 8.4 0.1 0.0 0.2 3.8 3.7 135.2 61.4 5.9 1.4 22.2 10.7 11.2 0.1 0.0 0.1 9.0 0.3 2.1 30.8 21.6 0.1 15.3 0.0 1.3 13.4 0.4 1.1 21.8 0.4 31.0 52.7 43.8 25.7 1.6 42.3 68.6 50.0 1.4 62.0 0.1 10.0 33.7 18.4 133.5 134.9 119.0 167.3 134.4 153.2 120.7 125.6 123.7 117.7 138.6 132.2 3.7 16.0 68.5 15.0 41.6 31.6 95.6 17.4 100.7 184.7 65.8 145.5 27.0 60.1 43.4 114.0 43.8 72.2 20.9 5.0 418.7 47.5 17.9 11.6 3.3 13.7 100.5 9.4 56.7 42.7 19.9 13.1 23.0 17.0 12.7 87.6 3.6 0.9 7.0 121.1 53.0 29.6 16.2 0.3 5.3 69.4 15.8 4.6 26.6 7.5 2.5 285.9 27.8 35.2 25.8 19.8 8.4 22.2 16.5 64.5 3.7 201.3 9.0 120.5 6.6 32.0 11.4 16.8 5.8 25.7 26.7 63.8 30.2 22.3 22.3 51.1 BEX3 "Bex, DXS6984E, HGR74, NADE, NGFRAP1" ENSG00000166681 "Brain expressed X-linked 3" Q00994 X 103376395-103378164 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 1607.8;Distal tubular cells: 1453.7;Granulosa cells: 700.3;Proximal tubular cells: 688.0;Syncytiotrophoblasts: 804.2;Theca cells: 696.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "naive CD4 T-cell: 150.9;T-reg: 137.1" "Lineage enriched" "Detected in all" 5 "T-cells: 150.9" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018886 Approved Supported Cytosol NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 68: Epididymis - Unknown function" "Cluster 5: NTERA-2 - Transcription" "Cluster 47: Cytotrophoblasts - Unknown function" Cytosol "HPA018886: AB_1854453" "unprognostic (7.74e-2)" "unprognostic (6.56e-2)" "unprognostic (8.15e-3)" "prognostic unfavorable (7.23e-5)" "unprognostic (2.70e-1)" "unprognostic (1.93e-3)" "unprognostic (7.15e-2)" "unprognostic (2.19e-1)" "unprognostic (1.79e-1)" "unprognostic (1.10e-2)" "unprognostic (3.85e-3)" "unprognostic (2.00e-1)" "prognostic favorable (1.28e-4)" "prognostic unfavorable (3.48e-4)" "unprognostic (1.38e-1)" "unprognostic (3.32e-2)" "unprognostic (8.68e-2)" 106.8 345.8 382.4 39.6 395.3 31.1 111.0 353.0 432.9 144.6 462.7 123.4 31.2 149.1 499.4 72.8 150.9 77.1 244.7 401.5 491.6 263.6 92.8 116.8 29.3 368.8 392.1 463.7 120.0 231.1 373.7 207.0 384.1 166.7 53.0 135.9 99.5 224.9 19.8 61.6 56.3 116.5 364.9 97.3 94.6 139.9 419.3 97.0 274.6 44.5 28.4 107.8 104.6 365.7 218.5 305.3 561.5 222.3 508.5 567.3 256.6 244.7 409.8 299.5 475.0 317.9 238.1 0.3 427.8 288.7 222.0 85.3 394.1 302.5 299.4 0.8 280.6 98.7 502.9 87.4 396.2 0.8 37.4 613.4 252.2 397.3 348.0 533.6 469.5 225.0 0.1 1.0 542.2 486.1 227.2 2.7 750.5 0.1 232.3 0.4 350.3 0.5 317.9 365.3 377.3 391.4 264.7 3.2 380.3 359.8 142.4 31.8 291.5 191.6 123.3 374.6 110.0 2.2 1.0 1.6 395.3 0.3 189.1 0.3 3.7 1.1 4.1 0.9 2.2 4.6 71.8 19.1 6.4 1.2 150.9 70.8 13.9 28.9 0.8 14.5 137.1 66.5 382.4 395.3 353.0 432.9 401.5 491.6 368.8 392.1 384.1 364.9 419.3 365.7 118.5 326.9 227.7 0.0 12.6 0.0 0.0 0.0 0.0 0.0 217.4 433.2 0.0 0.0 104.0 518.6 0.0 1607.8 4.7 0.0 1453.7 201.3 0.0 187.0 284.8 132.3 0.0 0.0 0.0 70.9 471.7 189.2 0.0 144.1 16.4 700.3 0.0 0.0 172.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.7 0.0 0.0 2.0 0.0 0.0 0.0 0.0 49.0 0.0 0.0 1.7 0.0 0.0 688.0 23.3 0.0 0.0 0.0 117.8 0.0 0.0 0.0 0.0 804.2 12.8 696.8 0.0 0.0 BEX4 "BEXL1, FLJ10097" ENSG00000102409 "Brain expressed X-linked 4" Q9NWD9 X 103215108-103217246 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 309.3;Syncytiotrophoblasts: 364.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 162.5;HMC-1: 188.1;K-562: 232.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045105, HPA051935" Uncertain Supported Nucleoplasm,Cytosol NA NA "Cluster 6: Non-specific - Transcription" "Cluster 68: Epididymis - Unknown function" "Cluster 1: K-562 - Erythropoiesis" "Cluster 47: Cytotrophoblasts - Unknown function" "Nucleoplasm, Cytosol" "HPA045105: AB_10966792, HPA051935: AB_2681667" "unprognostic (1.45e-1)" "unprognostic (2.12e-1)" "unprognostic (1.01e-2)" "unprognostic (2.55e-3)" "unprognostic (1.75e-3)" "unprognostic (3.69e-1)" "unprognostic (1.52e-1)" "unprognostic (1.06e-3)" "unprognostic (3.03e-1)" "unprognostic (6.33e-2)" "prognostic favorable (9.41e-4)" "unprognostic (1.62e-2)" "prognostic favorable (2.54e-14)" "unprognostic (1.62e-3)" "unprognostic (2.60e-2)" "unprognostic (1.13e-1)" "unprognostic (5.33e-2)" 32.2 99.9 186.5 24.8 187.5 71.4 56.3 173.4 225.0 53.0 154.9 63.6 17.0 70.3 265.9 48.0 65.7 40.2 101.9 188.8 209.2 97.6 13.5 44.0 32.9 185.7 185.7 102.6 34.7 126.0 134.0 60.6 184.6 80.2 26.4 92.0 74.6 83.1 6.8 26.6 32.2 56.4 183.7 68.7 36.2 46.1 195.1 57.0 131.1 13.6 34.8 46.6 44.3 188.2 0.0 0.2 96.4 0.0 24.1 16.6 86.5 23.2 19.8 42.6 77.7 0.0 1.4 0.3 38.1 16.2 36.0 0.7 39.1 5.3 46.8 0.1 36.8 162.5 0.0 0.1 73.7 123.0 188.1 62.3 12.9 22.3 0.0 47.3 50.2 62.2 232.5 0.5 13.1 0.5 86.4 1.0 117.0 0.0 6.9 0.2 28.0 0.6 39.1 2.4 71.7 109.3 8.1 1.5 5.1 93.0 3.9 1.3 1.3 5.5 34.3 0.8 0.3 12.5 6.0 0.2 16.0 0.0 4.9 118.6 23.1 42.3 31.6 30.0 26.5 37.6 38.2 32.0 51.3 33.7 65.5 52.2 5.2 100.5 26.4 79.0 40.3 43.9 186.5 187.5 173.4 225.0 188.8 209.2 185.7 185.7 184.6 183.7 195.1 188.2 45.7 35.3 40.4 25.5 38.7 27.3 133.8 86.0 87.0 174.9 99.0 105.4 81.3 81.5 64.0 99.3 25.0 309.3 47.5 6.8 299.3 66.4 4.7 31.2 35.5 59.2 63.1 35.1 70.0 13.7 156.0 65.1 19.4 38.1 109.2 147.8 73.2 0.7 88.3 222.1 69.6 37.2 52.9 55.5 53.2 12.9 63.3 68.9 115.6 22.5 118.4 217.8 34.0 34.2 64.3 10.8 23.3 61.3 22.2 118.1 8.1 186.5 33.2 81.0 52.6 64.4 57.4 27.4 14.3 42.5 24.2 364.3 37.2 115.0 28.7 111.7 BHLHB9 "GASP3, KIAA1701, p60TRP" ENSG00000198908 "Basic helix-loop-helix family member b9" Q6PI77 X 102720688-102753540 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 24.6;Inhibitory neurons: 28.5;Oligodendrocyte precursor cells: 17.6;Oligodendrocytes: 16.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "NK-cell: 1.7" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" HPA000887 Supported Nucleoplasm,Cytosol NA NA "Cluster 15: NK-cells - Transcription" "Cluster 68: Epididymis - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Cytosol Nucleoplasm "HPA000887: AB_2666130" "unprognostic (4.07e-2)" "unprognostic (4.15e-2)" "unprognostic (4.87e-2)" "unprognostic (1.70e-3)" "unprognostic (6.42e-3)" "unprognostic (2.36e-1)" "unprognostic (2.40e-3)" "unprognostic (5.06e-3)" "unprognostic (2.65e-1)" "unprognostic (7.65e-2)" "unprognostic (2.74e-2)" "unprognostic (4.27e-2)" "unprognostic (1.29e-3)" "unprognostic (1.43e-1)" "unprognostic (7.46e-2)" "unprognostic (4.95e-2)" "unprognostic (8.88e-2)" 1.6 3.0 6.6 0.8 7.6 1.7 1.9 5.0 7.1 3.6 2.3 2.5 1.2 3.6 2.6 1.2 2.2 1.4 2.4 7.4 8.8 3.4 2.1 1.3 0.8 6.8 4.8 4.4 1.8 3.4 4.5 2.6 7.1 3.6 1.3 6.9 2.0 3.9 3.0 1.7 1.3 3.5 5.1 1.4 1.4 2.5 7.2 2.4 3.2 2.4 1.0 2.4 2.3 5.3 0.4 3.1 8.6 2.6 2.4 1.4 4.1 2.8 3.7 4.7 8.6 2.9 2.0 0.0 2.9 3.3 2.3 2.3 4.7 3.4 5.4 0.0 2.8 0.9 1.8 0.4 5.5 0.6 0.6 3.1 2.4 1.9 0.3 3.5 4.6 0.1 2.6 3.1 3.6 1.9 1.9 0.2 6.0 0.8 1.9 0.9 2.5 0.0 3.2 5.0 4.6 4.1 2.8 0.8 0.2 3.4 2.7 1.5 4.9 0.8 2.8 1.4 2.6 1.6 4.2 0.0 2.0 0.5 1.7 0.4 0.0 0.0 0.3 0.0 0.3 0.1 0.2 0.6 0.0 0.1 0.3 0.5 0.2 1.7 0.0 0.0 0.5 0.1 6.6 7.6 5.0 7.1 7.4 8.8 6.8 4.8 7.1 5.1 7.2 5.3 3.4 6.4 1.5 12.1 0.6 1.8 1.2 0.7 4.6 11.3 1.9 1.7 6.9 2.8 1.0 3.7 12.5 4.3 0.5 0.7 7.9 1.2 0.2 1.2 5.3 3.5 4.8 0.8 24.6 0.8 0.8 5.4 0.5 1.0 0.0 7.3 3.9 1.4 1.4 3.3 28.5 0.7 0.0 1.3 0.0 0.9 2.8 0.2 0.0 1.9 0.7 12.5 2.1 17.6 16.9 0.4 0.5 2.6 0.1 1.4 0.8 1.9 0.3 5.8 6.6 3.7 2.8 9.1 7.5 2.1 1.1 1.4 1.6 3.6 1.1 0.6 BLVRA BLVR ENSG00000106605 "Biliverdin reductase A" P53004 7 43758680-43807342 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Hofbauer cells: 259.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019709, HPA042865, HPA054322" Approved Supported Cytosol NA NA 1200000 "Cluster 7: Monocytes - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 25: RPMI-8226 - Immune response" "Cluster 4: Macrophages - Innate immune response" Cytosol "HPA019709: AB_2670239, HPA042865: AB_10797024, HPA054322: AB_2682450" "unprognostic (2.47e-2)" "unprognostic (8.38e-3)" "unprognostic (1.79e-2)" "unprognostic (2.16e-3)" "unprognostic (6.45e-3)" "unprognostic (5.01e-2)" "unprognostic (1.63e-2)" "prognostic favorable (8.65e-4)" "unprognostic (1.42e-1)" "unprognostic (1.75e-2)" "unprognostic (2.93e-1)" "unprognostic (9.27e-2)" "unprognostic (1.15e-2)" "unprognostic (5.63e-3)" "unprognostic (3.18e-1)" "unprognostic (2.13e-3)" "unprognostic (4.56e-2)" 53.2 28.0 31.4 39.7 33.4 65.6 49.9 32.0 40.1 44.3 31.4 61.4 12.5 38.5 129.9 67.5 40.9 33.4 52.7 32.3 34.7 41.3 14.6 62.7 58.6 34.1 33.6 46.6 23.5 54.9 26.2 28.9 34.2 38.4 19.8 25.4 36.5 46.0 59.7 33.4 27.7 54.1 33.1 82.0 35.3 13.1 34.0 43.0 31.3 69.3 52.6 43.5 40.4 32.0 48.6 92.2 26.2 110.5 55.0 72.7 1.3 32.3 99.3 54.0 65.4 22.2 28.3 0.3 60.6 51.5 190.7 62.1 82.1 81.7 46.2 227.3 56.8 104.1 86.6 138.1 139.5 11.8 37.5 49.9 135.7 57.2 37.8 108.5 92.7 51.1 70.2 55.7 41.4 52.5 37.0 6.3 35.9 11.0 104.7 80.4 45.6 261.4 121.1 26.6 34.0 104.4 65.9 65.1 55.2 46.2 146.7 77.7 57.0 49.3 53.9 21.8 56.0 74.7 63.2 0.2 80.8 46.9 78.4 51.1 291.9 169.2 39.1 374.9 36.7 26.9 75.7 64.9 135.4 17.0 39.7 31.0 26.5 22.4 368.4 20.1 82.2 208.5 31.4 33.4 32.0 40.1 32.3 34.7 34.1 33.6 34.2 33.1 34.0 32.0 22.0 60.9 85.0 7.5 10.7 29.1 64.2 102.4 34.1 18.0 29.6 36.1 59.4 17.2 75.7 35.0 2.1 9.7 9.3 0.3 56.7 52.6 0.7 31.6 20.2 27.3 0.0 74.7 8.4 35.1 8.1 39.7 8.2 41.4 111.5 17.2 24.3 1.9 259.1 8.4 11.5 0.4 59.0 136.5 53.7 1.6 37.0 80.4 46.2 2.8 147.3 36.6 13.4 7.5 4.3 25.2 1.2 29.0 16.6 87.9 7.1 110.5 69.6 13.0 46.0 23.0 50.6 3.0 14.2 52.9 34.4 5.2 23.4 4.9 0.6 48.7 BRD8 "p120, SMAP" ENSG00000112983 "Bromodomain containing 8" Q9H0E9 5 138139770-138178953 "Predicted intracellular proteins" "Growth regulation, Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 120.8;Spermatocytes: 226.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001841 Supported Supported Nucleoplasm,Mitochondria NA Yes "Cluster 15: NK-cells - Transcription" "Cluster 68: Epididymis - Unknown function" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 66: Spermatocytes - Spermatogenesis" Nucleoplasm Mitochondria "HPA001841: AB_1845438" "unprognostic (1.25e-1)" "unprognostic (1.20e-1)" "unprognostic (2.81e-3)" "unprognostic (2.31e-2)" "unprognostic (9.01e-2)" "unprognostic (3.56e-2)" "prognostic unfavorable (1.09e-6)" "unprognostic (1.73e-1)" "unprognostic (7.01e-2)" "unprognostic (6.06e-2)" "unprognostic (1.51e-2)" "unprognostic (4.87e-2)" "prognostic unfavorable (7.80e-4)" "unprognostic (4.29e-1)" "unprognostic (1.28e-1)" "unprognostic (2.22e-1)" "unprognostic (2.07e-2)" 21.8 21.5 23.4 15.4 24.2 22.4 25.1 27.4 28.5 30.1 21.5 30.5 15.5 28.4 41.3 23.5 26.6 16.4 19.5 22.0 23.4 25.0 25.4 19.5 20.6 21.5 21.1 32.7 30.6 26.2 46.6 24.9 22.2 27.3 24.8 38.7 25.1 23.9 27.8 23.6 23.3 25.1 20.8 27.6 24.9 83.1 22.7 38.0 34.3 25.1 22.1 24.3 24.8 29.6 28.7 36.8 63.1 101.8 45.0 42.0 57.0 43.4 47.9 61.6 64.4 55.4 62.6 28.6 42.2 40.3 62.9 32.9 67.4 41.5 65.9 50.3 50.1 38.5 93.6 38.0 25.0 23.6 39.2 31.4 27.2 48.7 44.1 49.3 39.7 52.2 35.2 35.8 41.3 31.8 48.4 37.6 28.6 32.9 18.8 46.4 52.2 35.1 41.4 41.3 55.7 27.9 51.9 22.4 40.1 85.0 38.5 43.2 25.0 30.2 34.7 21.2 38.1 31.5 37.9 39.1 23.1 34.7 28.5 16.2 10.8 14.1 14.6 8.0 15.8 10.7 12.7 13.2 12.0 11.0 15.9 16.0 20.2 23.8 8.8 8.4 13.0 9.8 23.4 24.2 27.4 28.5 22.0 23.4 21.5 21.1 22.2 20.8 22.7 29.6 21.0 25.6 38.3 28.1 17.8 6.9 10.6 16.4 31.9 33.7 19.8 20.3 44.8 14.3 27.0 27.6 37.5 27.7 19.0 17.0 19.6 19.5 120.8 30.1 51.1 24.3 31.2 26.5 26.2 12.4 13.2 32.5 20.9 29.7 24.0 43.2 13.6 17.2 11.9 30.3 23.7 23.3 14.2 14.8 9.8 43.9 31.4 14.3 24.9 12.2 31.3 27.1 19.6 27.6 30.8 16.0 16.8 24.0 21.8 18.1 15.4 22.4 29.0 34.9 26.3 23.2 31.7 226.9 65.0 23.2 7.0 25.3 19.1 41.9 18.6 10.1 BRS3 "BB3, BB3R, BBR3" ENSG00000102239 "Bombesin receptor subtype 3" P32247 X 136487947-136493780 "G-protein coupled receptors, Plasma proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 26 "epididymis: 25.7" "Cell type enhanced" "Detected in single" "Spermatogonia: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in some" 4 "hypothalamus: 6.1" "Low region specificity" "Detected in many" NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 1: Pancreatic cells - Digestion" "unprognostic (1.49e-1)" "unprognostic (1.31e-1)" "unprognostic (2.07e-1)" "unprognostic (1.79e-2)" "unprognostic (3.73e-6)" "unprognostic (1.59e-1)" "unprognostic (1.86e-1)" "unprognostic (5.59e-2)" 0.0 0.0 0.3 0.0 0.3 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 25.7 0.0 0.8 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.1 0.2 0.7 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 BTG3 "ANA, ANA/BTG3, APRO4, tob55" ENSG00000154640 "BTG anti-proliferation factor 3" Q14201 21 17593653-17612945 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 526.3;Syncytiotrophoblasts: 1692.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "T-reg: 31.7" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018400 Approved NA Yes "Cluster 4: T-regs - Cell cycle regulation" "Cluster 68: Epididymis - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" "HPA018400: AB_1845487" "unprognostic (2.39e-1)" "unprognostic (1.15e-2)" "unprognostic (6.39e-2)" "unprognostic (2.27e-1)" "unprognostic (2.34e-1)" "unprognostic (2.98e-3)" "prognostic unfavorable (1.16e-4)" "unprognostic (4.50e-3)" "unprognostic (1.75e-1)" "unprognostic (1.43e-2)" "unprognostic (2.67e-1)" "unprognostic (1.18e-1)" "prognostic unfavorable (7.37e-4)" "unprognostic (2.42e-2)" "unprognostic (3.08e-1)" "unprognostic (9.92e-2)" "unprognostic (2.40e-1)" 30.8 27.9 13.1 14.0 14.6 55.9 24.2 13.3 16.1 32.0 14.0 28.8 16.5 48.2 110.3 25.4 51.5 22.8 28.8 14.4 16.2 23.5 12.9 44.7 13.9 14.8 13.4 28.4 21.0 35.3 43.7 61.1 15.0 25.2 26.9 5.1 27.2 20.5 4.9 42.5 16.4 28.4 14.7 15.1 21.2 47.5 15.5 27.4 27.2 5.3 16.4 39.3 37.7 17.8 70.5 14.4 84.9 6.8 28.4 50.9 62.6 96.0 109.8 83.5 84.9 33.0 29.3 31.5 44.7 34.8 108.7 17.1 42.5 63.3 91.9 99.6 60.6 23.5 30.9 31.5 59.4 26.6 44.3 44.4 88.2 70.8 67.7 47.7 42.0 30.7 22.9 113.6 78.3 0.0 51.2 4.0 44.4 9.7 4.2 16.6 110.5 23.1 55.2 31.3 43.2 34.9 71.9 36.6 86.7 96.0 1.2 28.6 27.7 84.0 89.1 65.6 96.9 74.1 64.6 29.5 84.4 0.2 102.2 1.0 2.3 4.0 8.1 1.7 9.4 7.4 13.6 13.0 1.9 6.3 6.6 9.1 0.2 6.2 1.9 8.8 31.7 5.5 13.1 14.6 13.3 16.1 14.4 16.2 14.8 13.4 15.0 14.7 15.5 17.8 65.2 205.1 156.5 0.7 44.7 360.1 526.3 309.9 178.7 1.1 64.8 55.0 9.3 34.3 195.5 58.8 0.0 436.5 61.6 25.3 39.2 56.9 8.6 197.0 97.1 51.0 108.3 99.1 2.2 39.3 88.6 132.5 17.9 147.3 65.4 13.5 32.2 5.5 55.6 23.5 3.1 47.9 69.2 16.5 140.4 24.8 70.2 54.5 85.4 16.9 33.5 19.5 12.3 20.1 14.6 52.9 22.7 46.6 75.1 463.0 2.6 2.1 104.3 1.0 92.1 95.5 99.1 300.0 267.2 92.7 294.4 1692.7 99.2 47.5 48.6 470.3 C11orf1 FLJ23499 ENSG00000137720 "Chromosome 11 open reading frame 1" Q9H5F2 11 111878935-111885975 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 402.4;Late spermatids: 1147.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038410, HPA057519" Uncertain Enhanced Nucleoplasm NA NA "Cluster 29: Plasmacytoid DCs - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 1: K-562 - Erythropoiesis" "Cluster 31: Spermatids - Spermatogenesis" Nucleoplasm "HPA038410: AB_10672591, HPA057519: AB_2683454" "unprognostic (1.33e-2)" "unprognostic (1.61e-1)" "unprognostic (1.96e-1)" "prognostic favorable (9.32e-4)" "unprognostic (1.30e-1)" "unprognostic (1.42e-2)" "unprognostic (1.10e-1)" "unprognostic (1.14e-1)" "unprognostic (9.26e-2)" "unprognostic (3.23e-2)" "unprognostic (1.41e-2)" "unprognostic (2.86e-2)" "prognostic favorable (1.39e-4)" "unprognostic (3.76e-2)" "unprognostic (2.12e-1)" "unprognostic (1.97e-1)" "unprognostic (2.08e-1)" 21.5 37.0 25.9 10.4 29.0 18.1 49.2 26.4 36.1 20.5 24.6 26.3 20.4 17.2 64.2 24.0 28.6 19.6 33.0 26.1 27.5 70.3 54.9 16.3 15.1 26.1 26.7 28.0 48.0 39.9 28.4 9.4 26.5 27.4 26.4 22.3 33.0 26.8 16.2 34.8 21.4 14.9 25.7 11.6 30.6 61.2 27.1 20.3 41.1 21.1 17.8 22.7 18.4 27.0 25.1 31.9 40.3 44.6 45.6 34.3 42.0 13.5 34.2 10.9 13.8 54.5 45.6 91.9 63.5 23.2 31.4 28.9 16.5 50.2 17.0 40.6 23.4 30.9 6.9 42.0 28.6 45.7 20.9 63.8 76.9 39.0 74.4 48.4 13.5 96.2 45.3 66.8 36.9 25.0 62.2 70.8 46.3 86.8 48.0 31.5 42.0 127.6 69.4 46.0 36.3 34.1 8.7 31.5 31.3 38.4 63.1 31.8 11.7 40.2 28.8 17.6 19.1 38.8 61.2 136.7 20.3 53.1 24.9 6.5 7.4 9.0 13.0 14.6 24.9 26.0 22.0 17.0 11.1 17.7 34.5 26.5 1.7 16.7 10.1 32.8 17.6 10.2 25.9 29.0 26.4 36.1 26.1 27.5 26.1 26.7 26.5 25.7 27.1 27.0 14.3 25.6 19.8 3.6 22.6 23.7 67.5 60.6 71.2 8.6 56.5 79.6 57.6 28.6 43.4 35.0 6.2 28.9 17.3 15.1 201.5 21.8 402.4 30.5 17.3 15.3 26.4 26.3 3.5 27.2 22.5 16.5 22.4 22.6 29.2 23.3 11.0 43.4 23.0 15.2 4.7 39.8 28.5 7.9 11.4 1147.2 27.4 14.3 24.9 3.7 19.3 43.5 20.6 1.0 3.7 18.9 22.3 24.5 41.9 36.4 40.6 197.9 44.4 15.5 19.7 10.8 17.0 54.4 30.9 53.4 29.5 21.1 22.6 49.2 44.4 72.7 C1GALT1C1L ENSG00000223658 "C1GALT1 specific chaperone 1 like" P0DN25 2 43675151-43676429 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Endometrial stromal cells: 7.0;Muller glia cells: 5.1;Spermatocytes: 18.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SH-SY5Y: 13.1;U-2 OS: 8.2" NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 66: Spermatocytes - Spermatogenesis" "unprognostic (2.18e-1)" "unprognostic (3.71e-2)" "unprognostic (2.50e-2)" "unprognostic (1.02e-2)" "unprognostic (2.32e-1)" "unprognostic (5.71e-3)" "unprognostic (2.19e-3)" "unprognostic (4.91e-2)" "unprognostic (2.78e-2)" "unprognostic (2.71e-1)" "unprognostic (2.03e-1)" "unprognostic (1.67e-1)" "unprognostic (7.73e-2)" "unprognostic (3.81e-3)" "unprognostic (8.88e-2)" "unprognostic (1.39e-2)" "unprognostic (8.86e-2)" 1.7 1.8 0.7 0.4 1.0 0.0 2.0 1.0 1.1 2.1 0.8 2.3 0.3 4.0 6.0 0.3 1.1 0.6 2.3 0.7 0.9 1.8 0.1 0.3 0.2 0.9 1.0 1.1 1.0 2.0 0.7 0.9 0.9 1.5 0.7 3.9 1.2 2.4 0.5 0.5 0.5 3.2 0.9 0.3 0.5 5.8 0.9 0.2 1.2 0.8 0.3 1.0 0.7 1.0 0.0 0.3 0.0 0.0 2.4 1.2 0.1 0.2 0.4 0.8 1.0 0.5 3.8 0.0 3.7 0.3 3.3 0.3 0.0 0.2 2.0 0.0 2.9 1.7 1.1 0.8 0.8 0.0 0.0 1.6 0.6 2.5 0.1 1.3 2.6 0.0 2.0 0.0 0.2 4.0 0.0 3.7 0.0 0.0 0.0 0.0 1.4 0.0 3.2 0.8 0.1 13.1 0.0 0.2 2.7 0.3 0.9 2.7 0.0 3.3 8.2 0.2 0.8 0.0 2.0 0.0 2.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.0 1.0 1.1 0.7 0.9 0.9 1.0 0.9 0.9 0.9 1.0 0.9 0.0 0.5 0.0 0.0 0.0 0.5 0.0 1.8 1.0 0.5 1.0 0.5 2.8 0.6 0.0 0.0 0.3 0.1 0.0 0.0 1.3 2.8 1.0 7.0 0.5 0.0 0.0 0.0 0.6 0.3 2.4 0.0 0.3 0.0 1.6 0.7 0.1 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.8 2.5 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.2 0.1 1.9 0.0 0.1 0.1 0.2 1.5 3.7 0.0 1.9 2.1 18.8 2.4 0.2 0.0 0.1 0.0 2.2 0.3 0.1 C2orf76 "AIM29, LOC130355, MGC104437" ENSG00000186132 "Chromosome 2 open reading frame 76" Q3KRA6 2 119302225-119366834 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 78.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044977, HPA055362" Approved Approved "Endoplasmic reticulum" NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 68: Epididymis - Unknown function" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 39: Non-specific - Basic cellular processes" "Endoplasmic reticulum" "HPA044977: AB_10961918, HPA055362: AB_2682794" "unprognostic (4.29e-1)" "unprognostic (2.07e-1)" "unprognostic (5.40e-3)" "unprognostic (1.04e-1)" "unprognostic (1.16e-2)" "unprognostic (2.20e-2)" "unprognostic (1.47e-3)" "unprognostic (5.51e-2)" "unprognostic (3.26e-3)" "unprognostic (1.16e-1)" "unprognostic (4.77e-2)" "unprognostic (1.14e-1)" "prognostic unfavorable (2.16e-8)" "unprognostic (3.42e-2)" "unprognostic (2.91e-2)" "unprognostic (7.55e-2)" "unprognostic (9.19e-2)" 20.2 19.7 23.2 10.2 23.3 10.0 22.4 23.8 29.5 13.0 21.3 12.3 6.9 17.1 43.4 16.2 20.5 12.6 16.1 22.2 23.5 19.9 14.1 9.9 15.2 24.3 23.2 17.8 15.7 20.6 10.7 11.3 24.4 16.0 11.7 9.4 16.0 15.4 10.3 20.6 7.6 16.7 24.2 10.9 11.3 19.3 23.0 13.5 20.5 14.5 14.0 13.9 10.9 26.6 17.0 15.7 22.4 14.3 31.7 38.3 12.8 23.4 16.7 15.0 16.3 10.1 11.3 20.7 40.6 24.7 17.4 7.8 10.1 14.9 15.0 17.7 33.5 39.1 11.7 13.5 21.8 15.0 24.6 20.4 25.3 21.3 13.8 19.3 21.7 15.7 12.6 19.6 22.5 25.7 15.7 28.5 12.4 13.3 12.4 9.6 4.7 29.1 33.9 18.0 14.8 16.7 17.0 24.1 33.7 21.0 13.2 52.5 20.3 17.4 13.5 14.6 12.7 12.8 22.5 22.1 17.5 11.1 20.0 29.1 20.9 21.9 19.9 20.2 18.0 20.0 15.2 18.3 21.3 14.7 13.8 19.3 37.2 32.5 12.7 20.1 16.8 11.9 23.2 23.3 23.8 29.5 22.2 23.5 24.3 23.2 24.4 24.2 23.0 26.6 30.3 6.4 11.4 22.5 11.1 25.0 17.2 47.7 17.1 3.3 18.5 19.7 18.5 12.8 24.4 14.7 0.0 26.4 15.2 7.1 78.2 14.7 11.7 27.6 15.4 20.4 10.9 16.4 12.4 17.8 32.4 20.7 9.7 19.7 22.2 8.4 15.0 11.6 26.7 1.7 8.6 11.2 22.4 15.0 23.4 7.7 19.3 13.8 44.4 12.2 20.6 19.8 26.8 14.6 25.2 14.0 9.2 17.0 8.9 11.8 12.2 47.0 42.8 4.6 6.6 13.8 18.8 38.8 22.4 18.8 35.7 20.7 15.3 11.4 10.0 13.0 C5orf51 LOC285636 ENSG00000205765 "Chromosome 5 open reading frame 51" A6NDU8 5 41904188-41921636 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 34.3" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043779, HPA063816" Uncertain Enhanced Nucleoplasm,Cytosol NA NA "Cluster 18: Basophils - Vesicular transport" "Cluster 68: Epididymis - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 59: Non-specific - Transcription" Nucleoplasm Cytosol "HPA043779: AB_2678666, HPA063816: AB_2685130" "unprognostic (6.64e-2)" "unprognostic (2.24e-2)" "unprognostic (9.92e-2)" "unprognostic (6.92e-3)" "unprognostic (3.93e-2)" "unprognostic (3.41e-2)" "prognostic unfavorable (1.90e-4)" "unprognostic (4.98e-2)" "unprognostic (1.59e-1)" "unprognostic (4.90e-3)" "unprognostic (2.10e-2)" "unprognostic (4.58e-2)" "unprognostic (1.01e-1)" "unprognostic (3.97e-1)" "unprognostic (3.75e-1)" "unprognostic (2.30e-2)" "unprognostic (1.67e-2)" 11.0 8.7 10.4 9.8 13.2 2.7 11.5 12.6 14.3 9.9 6.0 8.0 7.8 10.2 15.3 10.8 7.9 8.8 9.6 10.1 12.3 10.9 10.4 7.9 10.5 12.4 12.4 15.5 8.8 15.3 5.0 12.9 12.4 11.5 9.0 15.6 8.9 10.5 4.5 9.1 7.8 12.2 12.0 9.8 7.5 7.1 12.0 15.9 13.7 7.5 10.6 10.5 7.4 16.7 14.8 11.2 22.3 46.9 44.7 35.0 24.3 17.1 29.6 23.7 25.2 11.3 14.9 15.9 20.7 19.2 41.3 9.4 29.8 16.2 34.2 21.4 9.1 15.4 33.0 17.0 54.0 19.8 11.2 34.2 23.0 27.9 31.9 15.1 20.8 19.0 27.8 26.5 25.4 15.5 18.7 20.2 22.4 9.0 6.0 16.2 31.0 24.7 15.9 14.1 13.5 21.2 54.9 25.9 29.0 19.9 28.9 20.0 15.1 28.0 16.7 21.5 16.8 13.3 23.2 15.7 31.2 34.1 20.4 34.3 8.0 7.8 4.9 6.2 6.4 5.6 5.7 5.4 7.8 5.8 7.6 5.2 5.3 6.5 9.2 4.5 4.4 9.8 10.4 13.2 12.6 14.3 10.1 12.3 12.4 12.4 12.4 12.0 12.0 16.7 13.3 32.1 11.5 12.7 16.6 9.9 8.7 10.4 21.6 11.5 13.9 12.4 14.5 8.6 9.5 14.7 6.2 12.5 10.4 7.1 9.8 12.0 13.1 8.1 14.4 11.9 10.8 14.1 11.8 7.6 12.4 19.2 11.2 10.0 5.1 10.3 10.4 20.2 15.0 8.4 13.8 9.1 6.1 17.6 7.9 11.8 9.0 13.0 7.2 4.7 13.8 18.6 10.3 16.6 20.9 8.1 7.3 7.9 11.0 11.6 5.7 12.8 9.6 11.2 13.1 12.8 16.5 9.0 8.3 30.1 13.2 16.8 10.6 9.0 7.1 9.9 CACNA1D "CACH3, CACN4, CACNL1A2, Cav1.3, CCHL1A2" ENSG00000157388 "Calcium voltage-gated channel subunit alpha1 D" Q01668 3 53328963-53813733 "Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Cancer-related genes, Deafness, Disease variant, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 10.4" "Cell type enhanced" "Detected in many" "Excitatory neurons: 251.2;Inhibitory neurons: 354.1;Microglial cells: 126.5;Oligodendrocyte precursor cells: 197.5" "Cancer enhanced" "Detected in many" "prostate cancer: 5.9" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 10 "basophil: 3.7" "Lineage enriched" "Detected in single" 21 "granulocytes: 3.7" "Cell line enhanced" "Detected in some" "HMC-1: 22.7;RPMI-8226: 55.5;SK-BR-3: 10.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020215 Uncertain Approved "Nuclear membrane" NA NA "Cluster 46: Basophils - DNA binding" "Cluster 68: Epididymis - Unknown function" "Cluster 25: RPMI-8226 - Immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Nuclear membrane" "HPA020215: AB_1845860" "unprognostic (5.85e-2)" "unprognostic (4.90e-3)" "unprognostic (5.09e-2)" "unprognostic (2.24e-2)" "unprognostic (7.55e-2)" "unprognostic (1.77e-2)" "unprognostic (1.92e-1)" "unprognostic (2.32e-2)" "unprognostic (2.95e-1)" "unprognostic (4.42e-2)" "unprognostic (3.90e-3)" "unprognostic (1.53e-1)" "prognostic favorable (8.34e-8)" "unprognostic (1.14e-1)" "unprognostic (3.05e-2)" "unprognostic (8.09e-3)" "unprognostic (6.70e-3)" 0.1 6.6 7.0 0.2 4.3 0.7 1.8 2.3 10.4 6.0 0.0 1.5 1.7 3.7 7.3 0.5 7.7 2.0 0.6 3.6 0.8 2.2 1.0 3.7 0.1 0.0 1.2 0.5 2.8 1.2 3.5 0.6 0.4 3.0 1.5 4.3 0.5 1.8 0.2 0.7 2.4 0.7 3.5 1.8 0.8 1.6 6.1 0.2 2.9 0.2 0.1 0.6 0.1 6.0 0.0 0.5 0.1 0.0 0.0 0.0 1.4 0.0 0.1 0.0 0.0 2.7 2.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 22.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 2.1 0.1 0.0 0.4 0.9 0.0 0.0 0.2 55.5 0.5 3.6 4.7 2.1 0.3 10.1 1.1 0.0 2.8 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.4 3.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 7.0 4.3 2.3 10.4 3.6 0.8 0.0 1.2 0.4 3.5 6.1 6.0 0.6 3.2 36.2 7.8 0.6 0.9 0.8 4.6 2.2 33.3 7.2 1.8 2.3 10.0 9.1 1.8 35.5 0.9 0.5 3.0 0.0 7.2 4.9 4.3 40.1 2.4 59.4 2.7 251.2 2.3 0.2 3.4 5.1 3.3 12.6 1.7 0.0 3.4 0.2 8.4 354.1 3.8 2.0 0.8 4.0 8.3 4.4 2.1 5.4 126.5 0.5 4.0 0.0 197.5 29.9 3.8 5.6 27.1 0.1 1.7 9.5 2.7 9.5 12.9 0.0 0.2 8.6 1.0 3.7 0.5 1.0 0.3 1.7 9.6 7.6 0.9 CALHM1 FAM26C ENSG00000185933 "Calcium homeostasis modulator 1" Q8IU99 10 103453240-103458900 "Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Sensory transduction, Taste, Transport" "Calcium channel, Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "brain: 2.1" "Group enriched" "Detected in some" 4 "Excitatory neurons: 1.6;NK-cells: 1.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "RPMI-8226: 1.3;U-266/70: 1.1;U-266/84: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA061816 Enhanced NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 16: U-266 - Nucleosome" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "HPA061816: " "unprognostic (2.46e-1)" "unprognostic (2.66e-1)" "unprognostic (2.38e-1)" "unprognostic (1.30e-1)" "unprognostic (5.65e-3)" "unprognostic (3.44e-2)" "unprognostic (2.86e-2)" "unprognostic (1.67e-2)" "unprognostic (2.51e-1)" "unprognostic (1.40e-1)" "unprognostic (3.44e-1)" "unprognostic (2.21e-8)" "unprognostic (1.96e-1)" "unprognostic (1.37e-1)" "unprognostic (1.06e-1)" "unprognostic (1.38e-2)" 0.0 0.0 0.8 0.1 0.6 0.1 0.0 1.1 1.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.7 1.2 0.8 0.0 0.0 0.0 1.9 0.9 0.0 0.1 0.0 0.1 0.0 2.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.1 1.6 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.8 0.6 1.1 1.1 0.7 1.2 1.9 0.9 2.1 0.1 0.5 0.6 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CCDC90B "MDS011, MDS025" ENSG00000137500 "Coiled-coil domain containing 90B" Q9GZT6 11 83259097-83286407 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 447.3;Late spermatids: 233.9;Spermatocytes: 333.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011130, HPA011931" Supported Enhanced Mitochondria NA NA "Cluster 10: Basophils - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 21: OE19 - Mitochondria" "Cluster 34: Spermatids - Unknown function" Mitochondria "HPA011130: AB_1846170, HPA011931: AB_2072332" "unprognostic (5.85e-2)" "unprognostic (1.33e-1)" "unprognostic (7.34e-2)" "unprognostic (9.71e-2)" "unprognostic (1.34e-1)" "unprognostic (7.48e-2)" "unprognostic (2.99e-1)" "unprognostic (3.57e-3)" "unprognostic (5.76e-3)" "unprognostic (3.53e-2)" "unprognostic (6.01e-3)" "unprognostic (2.01e-2)" "unprognostic (1.00e-2)" "unprognostic (2.31e-1)" "unprognostic (3.03e-1)" "unprognostic (1.62e-1)" "unprognostic (2.41e-1)" 16.4 37.3 23.2 13.0 24.5 16.1 21.3 24.2 29.8 17.1 23.3 18.1 14.7 14.7 33.8 16.2 15.6 18.2 22.1 22.9 25.4 18.4 38.9 13.5 20.5 25.3 25.0 22.3 18.3 14.9 19.4 22.2 25.0 16.0 17.3 12.6 17.1 16.3 16.2 14.1 16.6 16.7 25.2 15.5 16.9 54.5 24.4 17.2 25.6 17.7 17.0 15.3 14.2 27.1 19.1 27.3 46.1 15.2 59.6 44.7 27.7 37.4 31.6 22.7 24.3 32.2 63.0 46.7 47.7 55.0 47.5 23.5 20.1 47.3 30.3 31.9 16.0 28.2 17.7 27.3 50.1 29.2 23.5 50.2 62.3 29.5 83.8 45.3 52.3 49.6 41.9 37.9 83.7 33.5 29.4 36.7 37.9 80.2 33.4 33.1 40.9 39.3 47.3 27.5 22.2 50.9 26.4 21.0 26.1 60.8 53.9 26.4 51.6 44.8 28.8 85.9 26.0 36.3 51.2 46.8 18.1 23.2 45.5 77.7 18.7 71.6 24.2 41.3 31.2 39.8 34.7 34.2 27.0 37.9 30.2 30.2 9.8 50.7 43.8 20.4 46.0 27.4 23.2 24.5 24.2 29.8 22.9 25.4 25.3 25.0 25.0 25.2 24.4 27.1 50.8 12.8 13.1 14.0 40.5 23.6 49.6 102.8 26.7 36.3 33.5 49.7 58.0 28.6 48.3 36.8 14.6 74.0 41.4 21.0 68.4 59.4 447.3 39.5 38.0 45.8 33.6 36.2 16.0 48.5 55.4 44.5 26.5 31.4 49.4 83.0 35.7 43.3 63.7 42.1 23.3 35.2 52.9 34.6 32.4 233.9 42.6 38.6 21.4 10.3 52.8 35.3 53.5 31.2 48.2 67.6 32.9 25.6 44.6 38.9 44.1 78.0 32.6 50.0 26.3 40.3 43.5 333.0 107.8 32.5 29.0 51.7 37.1 86.8 31.2 49.9 CCNB3 ENSG00000147082 "Cyclin B3" Q8WWL7 X 50202713-50351914 "Predicted intracellular proteins" "Cell cycle, Cell division, Meiosis" Cyclin "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 4.8;testis: 5.9" "Cell type enhanced" "Detected in some" "Oligodendrocytes: 9.1;Sertoli cells: 13.1;Spermatocytes: 48.2;Spermatogonia: 12.4" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 1.7;GAMG: 2.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA000496 Approved "Nuclear speckles" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 68: Epididymis - Unknown function" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "Nuclear speckles" "HPA000496: AB_1078605" "unprognostic (1.57e-1)" "unprognostic (1.99e-1)" "unprognostic (7.19e-2)" "unprognostic (1.06e-1)" "unprognostic (9.96e-3)" "unprognostic (8.11e-2)" "unprognostic (1.86e-1)" "unprognostic (1.82e-2)" "unprognostic (1.34e-2)" "unprognostic (1.48e-3)" "unprognostic (6.93e-2)" "unprognostic (2.50e-1)" "unprognostic (1.67e-1)" "unprognostic (4.73e-2)" "unprognostic (1.87e-1)" "unprognostic (4.51e-2)" "unprognostic (2.63e-2)" 0.2 0.3 0.4 0.0 0.8 0.0 0.2 0.8 0.9 0.0 0.2 0.1 0.0 0.0 4.8 0.1 0.2 0.1 0.1 0.4 0.6 0.6 0.4 0.3 0.1 1.0 0.9 0.1 0.4 0.1 0.7 0.0 0.9 0.1 0.1 0.5 0.1 0.2 0.5 0.3 0.1 0.0 0.6 0.3 0.4 5.9 0.8 0.2 0.3 0.0 0.1 0.1 0.1 1.4 0.1 0.5 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.4 1.7 0.5 0.3 0.1 2.3 0.1 0.2 0.1 0.1 0.4 0.5 0.3 0.0 0.0 0.4 0.4 0.3 0.2 0.0 0.1 0.3 0.0 0.1 1.2 0.0 1.3 0.4 0.0 0.2 0.0 0.2 0.2 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.3 0.1 0.1 0.3 0.1 1.1 0.1 0.1 0.7 1.2 0.3 0.2 0.3 0.2 0.7 0.2 0.1 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.8 0.8 0.9 0.4 0.6 1.0 0.9 0.9 0.6 0.8 1.4 0.0 0.0 0.0 1.6 0.4 0.0 0.1 0.1 0.0 0.6 0.2 0.1 0.4 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.2 1.6 1.2 0.2 0.2 0.0 0.0 0.5 0.2 0.0 0.1 2.0 0.2 0.0 0.1 0.4 0.9 0.1 0.0 0.4 0.1 2.0 1.0 0.3 1.3 0.3 0.6 0.0 1.9 0.0 0.2 5.2 0.0 9.1 0.1 0.1 0.0 0.4 0.1 0.0 0.3 2.0 0.4 13.1 0.3 0.1 48.2 12.4 0.4 0.1 0.0 0.3 1.7 0.1 0.0 CD63 "ME491, MLA1, TSPAN30" ENSG00000135404 "CD63 molecule" P08962 12 55725323-55729707 "CD markers, Plasma proteins, Predicted membrane proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "eosinophil: 1857.5" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 4897.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010088, CAB026356, HPA073506" Supported Supported Vesicles "Intracellular and membrane" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 68: Epididymis - Unknown function" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 16: Pancreatic endocrine cells - Mixed function" Vesicles "CAB026356: AB_629864, HPA010088: AB_1846323, HPA073506: " "unprognostic (8.76e-3)" "unprognostic (8.81e-2)" "unprognostic (1.27e-1)" "unprognostic (1.28e-3)" "unprognostic (9.48e-2)" "unprognostic (3.66e-3)" "prognostic unfavorable (1.37e-4)" "unprognostic (1.11e-1)" "unprognostic (6.50e-2)" "unprognostic (1.08e-1)" "unprognostic (1.66e-2)" "unprognostic (3.10e-1)" "unprognostic (2.70e-2)" "unprognostic (4.82e-2)" "unprognostic (5.21e-2)" "unprognostic (1.85e-3)" "unprognostic (9.02e-2)" 954.0 882.1 509.4 457.9 526.5 747.2 769.6 532.6 717.1 715.6 611.8 809.3 394.5 854.6 1492.1 396.1 647.3 607.0 1152.2 508.5 565.7 625.3 565.1 882.2 325.0 564.7 539.9 645.9 830.1 524.7 486.6 588.0 544.3 520.0 736.0 269.1 871.6 547.4 919.3 410.0 559.3 744.5 534.9 597.7 790.8 224.3 583.6 193.3 657.7 587.4 284.9 835.3 539.7 561.7 481.0 669.0 432.6 430.8 4897.7 2932.4 577.5 1914.8 3104.6 979.2 1048.9 750.3 939.2 120.5 581.2 2608.7 787.7 436.3 301.7 732.6 1197.9 372.5 248.7 760.9 542.8 443.3 2006.7 338.5 1699.0 2315.1 639.7 1164.8 979.2 2305.1 1052.2 64.6 386.8 936.3 3062.5 626.3 64.1 439.5 395.7 1062.7 880.7 146.0 949.3 345.7 1699.3 1433.6 170.1 425.8 528.3 392.5 3348.6 630.4 546.4 1089.6 948.0 710.1 514.8 984.9 649.8 377.3 239.3 92.5 2023.9 208.1 1326.3 1279.9 610.3 1857.5 323.2 458.8 235.2 111.0 126.9 260.0 473.0 73.9 55.9 186.0 656.0 733.0 320.4 309.8 121.6 850.4 509.4 526.5 532.6 717.1 508.5 565.7 564.7 539.9 544.3 534.9 583.6 561.7 798.7 512.8 689.0 28.1 147.6 567.2 1382.5 3135.4 155.4 190.3 606.5 601.1 820.9 836.4 1789.7 875.4 152.2 608.3 322.0 1083.4 232.8 2621.2 16.7 446.7 766.7 916.3 581.1 97.0 8.8 3429.0 2756.5 1538.0 371.1 727.3 1030.0 531.6 739.6 423.9 3372.5 33.7 9.3 1251.6 1715.1 854.6 1698.3 65.5 1727.3 1146.7 1993.9 11.2 575.7 893.8 487.1 21.1 26.5 3437.4 1394.0 1157.0 326.9 2039.2 878.1 794.2 1012.6 258.8 1255.6 1845.2 1278.7 43.8 68.9 137.1 400.5 2708.1 310.4 645.8 761.6 1868.9 CDK15 "ALS2CR7, PFTAIRE2, PFTK2" ENSG00000138395 "Cyclin dependent kinase 15" Q96Q40 2 201790461-201895550 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "epididymis: 15.2;ovary: 6.1" "Group enriched" "Detected in some" 13 "Early spermatids: 27.1;granulocytes: 79.1;Late spermatids: 40.3" "Not detected" "Not detected" "Region enriched" "Detected in single" 4 "cerebellum: 2.4" "Group enriched" "Detected in some" 28 "basophil: 1.8;eosinophil: 3.7" "Lineage enriched" "Detected in single" 37 "granulocytes: 3.7" "Cell line enhanced" "Detected in some" "BJ hTERT+: 22.6;BJ hTERT+ SV40 Large T+ RasG12V: 20.7;HBF TERT88: 30.9;HMC-1: 58.4;LHCN-M2: 19.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA015786 Uncertain Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 68: Epididymis - Unknown function" "Cluster 3: HMC-1 - Innate immune response" "Cluster 60: Granulocytes - Receptor signaling" Nucleoplasm "Golgi apparatus" "HPA015786: AB_1844780" "unprognostic (2.51e-1)" "unprognostic (2.73e-1)" "unprognostic (2.84e-2)" "unprognostic (1.30e-2)" "unprognostic (1.42e-1)" "unprognostic (2.94e-1)" "unprognostic (4.79e-2)" "unprognostic (1.07e-1)" "unprognostic (1.52e-1)" "unprognostic (1.52e-2)" "unprognostic (1.64e-2)" "unprognostic (1.80e-2)" "unprognostic (7.38e-2)" "unprognostic (9.99e-5)" "unprognostic (6.31e-2)" "unprognostic (1.48e-2)" "unprognostic (1.05e-2)" 0.7 0.3 0.0 0.2 0.0 0.0 0.8 2.4 0.4 0.8 0.0 0.5 0.3 0.6 15.2 0.6 0.5 1.9 0.2 0.5 0.0 0.3 0.0 1.0 0.1 0.4 0.1 6.1 0.1 0.2 0.3 0.0 0.4 0.7 0.7 0.0 0.3 0.3 0.9 0.6 0.8 0.4 0.1 0.0 0.7 1.9 0.1 0.2 0.1 0.7 0.1 0.8 0.5 0.3 0.3 0.0 0.0 0.0 1.6 2.8 0.0 5.9 22.6 10.2 20.7 0.0 3.0 0.0 0.0 2.3 0.5 0.0 0.0 0.0 30.9 0.0 0.1 1.9 0.0 0.0 0.3 0.1 58.4 3.4 0.0 2.7 1.5 0.4 0.0 0.0 0.0 0.1 19.1 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.2 0.5 2.5 0.1 0.0 0.0 0.0 0.3 0.0 0.0 1.8 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.4 0.5 0.0 0.4 0.1 0.4 0.1 0.1 0.3 0.1 0.0 1.3 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.1 0.0 0.0 0.1 0.0 0.0 2.4 0.0 0.0 0.8 0.0 0.0 79.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.3 40.3 0.3 0.1 3.6 1.0 0.0 0.0 0.0 1.0 0.3 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.4 0.5 0.2 0.0 0.1 0.0 0.9 0.1 0.0 0.0 CDY2A CDY2 ENSG00000182415 "Chromodomain Y-linked 2A" Q9Y6F7 Y 18025787-18027746 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 16 "epididymis: 1.1;testis: 2.0" "Cell type enriched" "Detected in single" 18 "Collecting duct cells: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA066682 Supported NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "HPA066682: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CER1 DAND4 ENSG00000147869 "Cerberus 1, DAN family BMP antagonist" O95813 9 14719724-14722733 "Predicted secreted proteins" Cytokine "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "epididymis: 1.0" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 82 "testis cancer: 17.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HEL: 4.0;NTERA-2: 7.0;SCLC-21H: 2.6" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA019917 Uncertain "Secreted - unknown location" NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 5: NTERA-2 - Transcription" "Cluster 50: Fibroblasts - ECM organization" "HPA019917: AB_1846539" "unprognostic (2.98e-2)" "unprognostic (5.36e-2)" "unprognostic (5.99e-2)" 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.4 0.2 0.0 0.0 0.1 0.1 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.2 0.0 0.1 0.3 0.0 0.5 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 CHST10 HNK-1ST ENSG00000115526 "Carbohydrate sulfotransferase 10" O43529 2 100391860-100417668 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Carbohydrate metabolism" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 33.6" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 16.0;Astrocytes: 21.5;Muller glia cells: 16.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012884, HPA051545" Approved Approved Cytosol "Intracellular and membrane" NA NA 680000 "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 68: Epididymis - Unknown function" "Cluster 5: NTERA-2 - Transcription" "Cluster 64: Astrocytes - Nervous system maintenance" Cytosol "HPA012884: AB_1846710, HPA051545: AB_2681529" "unprognostic (5.40e-3)" "unprognostic (3.62e-2)" "unprognostic (3.44e-2)" "unprognostic (2.03e-1)" "unprognostic (3.28e-1)" "unprognostic (1.30e-1)" "unprognostic (1.89e-2)" "unprognostic (1.44e-1)" "unprognostic (1.78e-1)" "unprognostic (4.54e-2)" "prognostic favorable (4.05e-4)" "unprognostic (8.02e-2)" "unprognostic (2.18e-1)" "unprognostic (1.78e-2)" "unprognostic (3.73e-2)" "unprognostic (3.06e-2)" "unprognostic (3.27e-1)" 4.3 6.7 26.5 4.2 28.2 3.2 5.1 24.3 33.6 7.1 18.8 6.3 2.3 11.5 13.3 4.2 9.7 5.5 11.0 27.2 23.2 4.3 1.2 8.1 4.4 24.6 26.4 12.7 5.6 9.6 11.5 8.2 23.2 8.0 2.4 9.4 6.1 5.2 6.0 2.2 3.6 12.0 24.8 5.0 4.4 6.1 28.6 5.7 10.0 8.3 5.4 5.5 3.7 25.1 0.2 14.6 28.4 14.6 8.5 11.9 14.2 16.7 11.8 22.4 14.3 0.3 8.5 20.4 14.1 10.1 39.6 0.0 20.2 2.2 14.3 29.1 21.2 10.5 8.3 23.1 10.1 21.5 26.5 8.8 2.7 10.6 2.0 10.7 17.8 19.5 31.0 0.1 9.7 4.8 19.1 16.8 42.0 0.2 17.7 13.6 17.6 0.2 6.2 6.4 30.5 24.9 1.2 0.1 23.3 20.0 7.8 29.0 16.4 15.5 24.5 11.7 15.7 0.0 0.1 21.2 19.0 18.7 18.6 0.0 0.0 0.0 1.3 0.0 0.4 0.8 0.2 1.0 0.2 0.6 0.3 0.7 0.0 0.0 0.0 1.1 0.0 0.5 26.5 28.2 24.3 33.6 27.2 23.2 24.6 26.4 23.2 24.8 28.6 25.1 2.8 16.0 3.1 21.5 4.4 0.9 1.1 0.3 0.6 9.7 2.4 2.0 6.3 1.5 4.4 1.8 0.0 5.4 2.3 0.0 3.9 3.5 1.5 2.7 6.7 4.9 1.8 3.0 10.7 2.9 10.5 5.0 0.0 6.2 0.0 6.5 0.4 0.0 6.2 6.7 7.5 0.0 0.0 0.8 1.1 0.4 2.1 1.3 0.0 6.5 3.2 16.7 1.0 12.5 5.9 2.2 0.0 5.3 2.3 1.5 0.0 1.1 0.7 4.8 0.0 3.7 3.5 1.5 5.1 0.3 0.6 1.4 3.4 8.5 0.1 0.2 CIBAR1 "FAM92A, FAM92A1, FLJ38979" ENSG00000188343 "CBY1 interacting BAR domain containing 1" A1XBS5 8 93698561-93731527 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "testis: 110.2" "Cell type enhanced" "Detected in some" "Cytotrophoblasts: 13.3;Extravillous trophoblasts: 14.1;Fibroblasts: 8.4;Hofbauer cells: 6.4;Syncytiotrophoblasts: 3.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "myeloid DC: 2.9" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034760, HPA058942" Enhanced Approved Mitochondria NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 68: Epididymis - Unknown function" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 33: Fibroblasts - ECM organization" Mitochondria "HPA034760: AB_10599947, HPA058942: AB_2732628" "unprognostic (2.65e-3)" "unprognostic (6.81e-2)" "unprognostic (2.48e-3)" "unprognostic (2.44e-1)" "unprognostic (1.62e-2)" "unprognostic (2.93e-1)" "unprognostic (3.56e-1)" "unprognostic (3.13e-1)" "unprognostic (1.20e-1)" "unprognostic (2.14e-1)" "unprognostic (2.28e-3)" "unprognostic (1.97e-1)" "unprognostic (1.71e-1)" "unprognostic (6.85e-3)" "unprognostic (1.97e-1)" "unprognostic (1.48e-1)" "unprognostic (3.07e-2)" 14.3 23.9 17.5 5.6 18.8 3.5 10.9 18.6 25.0 16.5 22.9 14.2 3.2 16.0 26.2 5.0 13.1 14.1 25.3 17.8 16.2 20.2 18.5 9.9 5.7 13.4 14.5 18.0 21.1 21.5 20.8 10.1 13.3 12.1 5.9 14.1 5.7 11.6 10.3 6.6 7.7 15.0 12.9 5.7 9.8 110.2 17.1 5.0 14.5 11.1 3.1 14.6 9.3 17.4 37.8 20.0 52.9 54.6 55.8 78.9 14.0 34.2 49.8 45.2 43.5 3.5 8.6 3.2 42.7 50.7 52.0 26.6 54.0 32.5 41.0 1.2 29.5 21.5 20.8 18.7 64.1 1.0 5.5 50.4 14.3 44.3 36.0 64.9 49.0 18.1 13.4 1.7 35.8 14.2 23.8 4.1 22.2 0.8 1.1 2.3 39.7 0.8 35.3 8.7 15.3 18.7 24.4 0.5 41.6 23.7 8.2 11.8 27.2 44.2 17.4 46.3 28.0 2.6 2.7 1.2 38.8 3.0 15.8 0.1 1.7 0.0 0.1 1.2 0.2 0.4 0.4 0.1 2.9 0.0 0.1 0.3 0.0 1.3 0.1 0.3 0.8 0.5 17.5 18.8 18.6 25.0 17.8 16.2 13.4 14.5 13.3 12.9 17.1 17.4 2.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 14.1 8.4 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 CITED1 MSG1 ENSG00000125931 "Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 1" Q99966 X 72301638-72307187 "Predicted intracellular proteins" "Apoptosis, Differentiation, Transcription, Transcription regulation" "Activator, Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "epididymis: 1473.6" "Cell type enhanced" "Detected in many" "Breast glandular cells: 87.4;Breast myoepithelial cells: 47.6;Granulosa cells: 31.0;Late spermatids: 58.4;Paneth cells: 33.8" "Cancer enriched" "Detected in many" 6 "thyroid cancer: 134.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 4 "SK-MEL-30: 244.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049051 Supported Supported Nucleoplasm,Cytosol NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 35: Glandular cells - Unknown function" Nucleoplasm Cytosol "HPA049051: AB_2680612" "unprognostic (7.04e-2)" "unprognostic (3.39e-2)" "unprognostic (1.34e-1)" "unprognostic (1.79e-3)" "unprognostic (8.81e-2)" "unprognostic (5.67e-4)" "unprognostic (3.40e-1)" "unprognostic (9.55e-2)" "unprognostic (4.60e-3)" "unprognostic (4.38e-2)" "unprognostic (6.33e-3)" "unprognostic (1.18e-1)" "unprognostic (1.38e-1)" "unprognostic (2.62e-1)" "prognostic favorable (6.10e-4)" "prognostic favorable (3.95e-4)" "unprognostic (2.99e-2)" 2.3 5.1 13.0 0.3 6.9 0.2 23.1 5.1 12.2 5.9 3.4 1.0 0.7 3.6 1473.6 0.3 1.5 0.0 0.7 6.7 56.2 5.1 0.4 0.6 0.3 8.5 8.8 1.5 1.5 0.0 209.9 0.0 24.5 11.2 0.2 4.5 0.8 3.0 0.4 0.6 1.0 8.1 4.3 0.4 1.0 199.9 30.6 0.2 8.0 0.4 0.1 0.5 1.0 6.2 0.4 0.3 2.2 57.1 2.5 0.0 2.1 0.0 0.5 0.4 0.3 0.1 0.6 0.0 0.2 0.0 0.6 0.0 20.5 1.4 0.1 6.1 8.0 0.9 0.4 0.0 0.0 0.2 10.4 1.1 0.8 0.5 1.0 0.2 0.2 0.2 2.5 0.0 0.4 0.8 0.2 4.4 3.3 0.0 3.6 0.1 3.6 3.2 0.1 0.4 25.8 12.5 0.4 5.1 244.4 0.2 1.4 1.0 0.0 0.2 1.9 0.4 0.8 0.2 0.5 0.2 0.5 0.4 5.3 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.0 6.9 5.1 12.2 6.7 56.2 8.5 8.8 24.5 4.3 30.6 6.2 2.2 0.0 0.0 0.0 0.0 0.1 1.0 0.4 0.0 5.6 87.4 47.6 0.4 1.5 0.1 3.7 6.2 0.1 0.3 0.3 0.0 0.1 20.4 0.5 0.8 1.0 1.2 0.0 0.7 0.8 0.1 0.7 0.0 0.3 0.0 31.0 0.4 0.1 0.1 0.0 1.5 0.2 0.0 0.0 0.7 58.4 7.5 0.8 3.6 1.9 0.1 1.7 0.0 0.0 0.1 0.4 33.8 3.0 0.0 19.3 0.7 0.3 0.0 3.8 13.1 1.2 3.2 12.6 6.8 0.0 0.0 0.0 0.1 0.5 0.5 1.0 CLSTN1 "CDHR12, CSTN1, KIAA0911" ENSG00000171603 "Calsyntenin 1" O94985 1 9728926-9823984 "Cancer-related genes, Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 437.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012412, HPA077705" Enhanced NA NA 86000000 "Cluster 41: Basophils - Cellular respiration" "Cluster 68: Epididymis - Unknown function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 53: Intestinal epithelial cells - Unknown function" "HPA012412: AB_1846981, HPA077705: " "unprognostic (4.63e-2)" "unprognostic (2.89e-1)" "unprognostic (9.76e-2)" "unprognostic (1.43e-1)" "unprognostic (9.79e-2)" "unprognostic (1.63e-1)" "unprognostic (2.44e-3)" "unprognostic (3.07e-2)" "unprognostic (2.54e-1)" "unprognostic (3.24e-2)" "unprognostic (1.34e-1)" "unprognostic (1.25e-1)" "prognostic favorable (4.10e-7)" "unprognostic (1.12e-1)" "unprognostic (2.65e-1)" "unprognostic (4.05e-2)" "unprognostic (4.72e-2)" 28.1 27.4 49.7 23.1 65.8 10.8 31.7 29.5 137.5 61.2 80.6 59.5 29.2 85.4 21.4 51.4 69.8 48.1 35.9 79.6 15.5 41.3 6.1 29.6 33.5 24.7 18.4 60.2 65.7 36.2 48.4 35.7 32.8 61.8 38.2 110.8 79.0 45.7 23.1 83.5 41.1 49.4 7.0 28.3 31.0 15.0 23.5 35.0 40.0 28.9 27.1 38.0 59.9 45.9 120.9 55.4 52.5 64.8 71.1 50.1 35.0 80.5 71.4 82.0 70.2 32.1 235.0 90.5 203.1 95.2 52.6 157.7 41.2 245.6 32.1 114.2 74.6 27.3 53.0 39.6 116.1 46.3 41.4 58.0 156.5 105.9 50.0 78.6 113.9 52.7 13.1 52.6 35.8 47.2 53.2 26.6 37.9 53.1 59.7 80.6 21.4 42.9 73.1 20.9 91.4 53.7 94.8 160.1 79.1 22.1 34.7 73.9 155.0 89.3 80.5 56.6 109.9 75.6 75.4 124.3 72.2 79.6 95.7 6.2 0.6 2.3 3.0 0.8 1.5 0.8 1.9 2.3 1.4 1.0 1.3 1.2 0.2 0.4 0.9 0.8 1.6 1.5 49.7 65.8 29.5 137.5 79.6 15.5 24.7 18.4 32.8 7.0 23.5 45.9 40.2 28.9 15.7 63.6 23.7 43.8 61.0 73.7 84.2 205.1 53.3 47.0 14.7 55.8 44.6 51.5 437.9 34.1 35.0 221.1 1.9 29.2 4.5 44.6 47.0 36.0 30.7 17.9 150.9 38.8 14.3 40.6 29.6 52.2 11.4 54.0 35.3 2.2 28.8 180.0 138.1 96.5 14.2 24.2 13.3 5.6 46.3 21.3 32.0 46.9 21.0 160.9 28.8 90.0 56.0 59.7 66.9 50.4 31.2 42.4 54.9 27.9 68.3 165.6 85.5 39.5 31.4 24.6 37.5 44.5 26.1 19.2 33.8 47.2 59.6 42.7 CLU "APOJ, CLI, CLU1, CLU2, KUB1, SGP-2, SP-40, TRPM-2" ENSG00000120885 Clusterin P10909 8 27596917-27614700 "Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Apoptosis, Complement pathway, Immunity, Innate immunity" Chaperone "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 10230.8;liver: 9779.1" "Group enriched" "Detected in all" 4 "Cholangiocytes: 2586.5;Collecting duct cells: 3525.7;Hepatocytes: 4230.2;Muller glia cells: 8522.6" "Cancer enhanced" "Detected in all" "glioma: 1485.6" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 10 "basophil: 767.1" "Lineage enriched" "Detected in all" 33 "granulocytes: 767.1" "Cell line enhanced" "Detected in all" "HeLa: 3644.3;SK-BR-3: 3500.4;T-47d: 2562.4;U-2 OS: 2225.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000572, CAB016253, HPA075983" Enhanced Supported Cytosol "Secreted to blood" NA NA 169000000000 29000000000 "Cluster 38: Basophils - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 20: HeLa - Mitochondria" "Cluster 5: Muller glia cells - Visual perception" Cytosol "CAB016253: AB_673562, HPA000572: AB_1078539, HPA075983: " "unprognostic (1.10e-2)" "unprognostic (1.81e-2)" "unprognostic (1.14e-3)" "unprognostic (2.74e-2)" "unprognostic (5.59e-2)" "unprognostic (4.13e-2)" "unprognostic (1.76e-2)" "unprognostic (2.37e-1)" "unprognostic (1.46e-1)" "unprognostic (1.05e-1)" "unprognostic (2.87e-2)" "unprognostic (1.41e-1)" "unprognostic (1.80e-2)" "unprognostic (2.33e-2)" "unprognostic (1.72e-1)" "prognostic favorable (7.66e-5)" "unprognostic (5.29e-2)" 1438.7 3809.7 6730.2 897.0 6536.5 53.2 1423.8 6992.3 8050.5 1389.4 6057.7 1407.9 323.9 1152.5 9148.8 768.6 3543.7 2863.5 617.7 6660.5 8149.9 1170.5 9779.1 827.8 2309.4 10230.8 8450.9 756.7 2246.3 1689.2 827.2 131.2 8001.8 986.4 276.1 3274.6 1453.0 5466.4 114.1 281.9 662.7 1439.9 8813.6 295.4 1081.6 2709.4 7385.0 388.1 2406.8 267.7 2343.1 1777.4 741.0 9752.3 13.0 1673.1 73.2 86.4 401.4 546.1 230.7 297.8 584.8 77.3 40.1 323.4 265.5 6.6 1159.9 267.1 926.6 561.2 318.4 48.1 50.3 1268.7 306.4 741.8 3644.3 403.7 348.8 19.2 1891.2 923.4 189.1 334.0 95.5 719.5 1028.1 10.6 10.1 842.2 27.5 288.4 5.7 56.5 603.3 505.3 197.6 6.5 276.1 236.3 763.0 1220.2 66.7 41.7 412.3 3500.4 18.1 349.1 2562.4 10.3 153.2 24.0 2225.3 131.8 101.9 108.1 419.0 16.1 1808.8 122.4 10.3 767.1 18.4 8.9 19.8 6.2 7.4 0.7 23.1 21.3 6.2 1.6 2.8 7.0 79.8 9.3 1.1 11.8 6.5 1073.6 6730.2 6536.5 6992.3 8050.5 6660.5 8149.9 10230.8 8450.9 8001.8 8813.6 7385.0 9752.3 255.3 32.1 91.8 720.5 16.1 81.3 944.6 134.1 118.9 74.3 475.3 480.4 86.1 2586.5 514.0 3525.7 77.2 116.3 15.2 23.6 41.1 488.3 311.3 196.9 31.1 442.0 9.5 92.4 73.4 620.7 22.7 614.8 226.8 185.6 803.0 31.4 1037.7 4230.2 12.6 30.3 81.0 30.9 28.5 180.5 88.9 789.3 114.3 244.6 206.3 69.3 25.1 8522.6 11.3 61.3 54.3 174.8 15.0 57.2 11.6 200.5 9.9 459.2 709.1 221.4 13.1 334.4 157.7 189.8 20.3 58.8 55.3 85.6 58.7 288.9 49.3 353.7 CNPY4 "MGC40499, PRAT4B" ENSG00000166997 "Canopy FGF signaling regulator 4" Q8N129 7 100119634-100125508 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 35.3;Leydig cells: 35.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014166, HPA025240" Uncertain Approved Vesicles "Intracellular and membrane" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 68: Epididymis - Unknown function" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 33: Fibroblasts - ECM organization" Vesicles "HPA014166: AB_1853895, HPA025240: AB_2082630" "unprognostic (9.64e-2)" "unprognostic (1.59e-2)" "unprognostic (4.09e-3)" "unprognostic (8.44e-2)" "prognostic unfavorable (9.76e-4)" "unprognostic (2.71e-1)" "prognostic unfavorable (3.99e-4)" "unprognostic (2.86e-1)" "unprognostic (1.35e-1)" "unprognostic (1.47e-1)" "unprognostic (6.16e-3)" "unprognostic (1.07e-1)" "prognostic unfavorable (3.59e-5)" "unprognostic (6.92e-2)" "unprognostic (1.80e-1)" "unprognostic (1.88e-1)" "unprognostic (1.35e-2)" 13.7 16.8 13.3 9.6 13.9 6.1 11.0 14.3 14.9 24.6 14.7 14.1 6.4 21.2 14.8 5.7 15.4 16.7 13.1 13.1 13.7 10.4 6.6 9.2 10.8 14.2 13.8 24.5 4.5 12.8 16.6 21.3 14.1 10.8 9.9 17.2 5.7 15.9 5.1 8.3 9.7 21.4 13.8 13.6 7.8 6.8 13.6 14.3 10.4 7.1 9.8 12.4 14.8 14.3 7.9 13.5 33.2 59.6 76.0 36.5 16.6 29.0 31.2 14.9 27.8 7.5 7.0 17.2 32.9 52.5 10.9 7.9 13.0 14.2 15.6 16.2 13.4 7.1 23.3 10.4 21.5 12.1 12.8 33.4 3.8 13.7 6.2 32.7 52.4 8.2 6.0 11.1 21.5 22.9 25.8 15.9 17.1 5.0 19.2 7.5 24.9 9.2 15.4 2.0 8.3 16.9 27.8 22.4 15.4 21.4 11.3 6.7 42.9 47.5 28.5 20.2 13.3 9.4 16.3 15.3 27.8 18.4 19.7 11.8 5.1 8.6 15.1 11.2 19.8 3.9 15.6 19.0 7.2 2.9 12.7 19.0 2.3 12.3 13.9 4.6 13.8 6.7 13.3 13.9 14.3 14.9 13.1 13.7 14.2 13.8 14.1 13.8 13.6 14.3 15.2 6.4 2.6 4.2 3.4 3.6 2.3 7.9 2.8 6.9 3.4 6.2 3.4 5.7 4.0 12.9 2.1 35.3 5.2 3.7 1.9 6.4 0.5 5.1 20.2 15.0 2.4 11.8 3.4 2.5 10.3 28.4 1.1 4.2 9.5 16.1 18.2 1.3 14.0 8.4 4.0 1.9 4.1 2.5 2.4 2.2 35.1 4.7 16.0 2.8 5.1 26.6 8.2 2.0 2.8 2.4 2.8 31.6 1.9 0.5 2.8 3.3 4.4 15.8 13.1 12.7 15.5 1.1 4.5 2.1 3.8 18.3 8.6 30.5 2.3 1.0 COL2A1 "AOM, SEDC, STL1" ENSG00000139219 "Collagen type II alpha 1 chain" P02458 12 47972967-48004554 "Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted secreted proteins" "Cancer-related genes, Cataract, Deafness, Disease variant, Dwarfism, FDA approved drug targets, Stickler syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "epididymis: 19.1;pituitary gland: 9.2;retina: 5.6;stomach 1: 12.5" "Cell type enhanced" "Detected in some" "Early spermatids: 15.4;Enteroendocrine cells: 43.9;Late spermatids: 9.7;Muller glia cells: 22.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 156.3;HAP1: 98.9;HEK 293: 36.3" "Not detected" "Not detected" "Low region specificity" "Detected in some" "CAB002214, HPA055753" Approved Approved Nucleoplasm "Secreted to extracellular matrix" No NA 1400000 "Cluster 68: Epididymis - Unknown function" "Cluster 12: NES - Nervous system development" "Cluster 17: Intestinal endocrine cells - Hormone signaling" Nucleoplasm "CAB002214: AB_563666, HPA055753: AB_2682908" "unprognostic (7.25e-2)" "unprognostic (1.20e-1)" "unprognostic (2.58e-1)" "unprognostic (3.44e-1)" "unprognostic (2.88e-2)" "unprognostic (3.08e-2)" "unprognostic (8.63e-2)" "unprognostic (2.77e-1)" "unprognostic (1.22e-1)" "unprognostic (3.12e-2)" "unprognostic (1.31e-4)" "unprognostic (2.64e-1)" "unprognostic (3.44e-3)" "unprognostic (1.89e-1)" "unprognostic (2.93e-1)" "unprognostic (2.07e-1)" "unprognostic (1.02e-1)" 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.1 0.2 0.1 0.0 0.2 0.0 0.2 19.1 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.2 0.0 0.2 0.2 1.3 0.0 0.0 9.2 0.3 0.3 1.0 0.3 5.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 12.5 2.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 156.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.7 0.0 0.0 0.0 98.9 0.0 0.0 0.0 36.3 0.2 0.0 5.7 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 2.0 0.0 0.1 0.0 2.9 0.0 0.0 0.1 2.2 0.1 0.0 0.0 0.0 11.0 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.2 0.3 0.2 0.2 0.3 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 5.0 0.6 5.7 0.9 0.0 0.0 0.0 0.0 1.8 0.0 0.3 0.0 0.0 15.4 0.3 0.1 0.2 43.9 0.0 0.2 0.0 0.3 0.5 0.0 0.2 0.0 1.3 0.0 0.0 0.2 0.0 0.1 0.6 0.0 0.0 0.0 9.7 0.9 0.0 0.0 0.0 0.0 22.6 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.4 0.2 0.0 1.7 0.0 0.9 0.3 0.6 1.1 0.0 0.0 0.8 0.1 0.1 1.7 0.1 COPA HEP-COP ENSG00000122218 "COPI coat complex subunit alpha" P53621 1 160288594-160343273 "Disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "ER-Golgi transport, Protein transport, Transport" Hormone "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028024 Supported Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Secreted to blood" NA NA 150000 "Cluster 18: Basophils - Vesicular transport" "Cluster 68: Epididymis - Unknown function" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 65: Plasmacytoid DCs - Unknown function" "Nucleoplasm, Cytosol" "Golgi apparatus" "HPA028024: AB_10603787" "unprognostic (1.59e-2)" "prognostic unfavorable (6.54e-4)" "unprognostic (2.77e-2)" "unprognostic (2.34e-2)" "unprognostic (3.54e-2)" "unprognostic (5.41e-3)" "prognostic unfavorable (1.08e-4)" "unprognostic (8.42e-2)" "unprognostic (3.14e-1)" "unprognostic (2.21e-1)" "unprognostic (5.03e-2)" "unprognostic (3.10e-1)" "unprognostic (2.05e-2)" "unprognostic (8.70e-2)" "unprognostic (2.03e-1)" "unprognostic (4.94e-2)" "unprognostic (1.39e-1)" 47.7 43.1 46.6 38.5 48.9 30.0 42.0 57.2 57.1 52.9 67.4 42.3 53.7 46.7 55.1 38.3 41.2 38.6 55.1 48.6 53.7 48.6 55.0 47.0 36.1 57.9 51.0 46.9 49.9 51.8 59.8 48.3 60.0 43.5 47.9 26.2 57.6 39.4 59.1 40.0 49.0 50.0 53.9 42.7 43.5 24.4 51.1 37.6 60.1 38.2 38.9 41.3 37.9 66.4 91.0 68.5 70.1 66.9 164.9 154.7 78.6 116.5 144.3 103.1 138.7 72.0 60.5 64.4 73.3 194.0 57.7 86.0 92.0 81.3 126.5 68.6 64.3 76.8 95.2 79.0 115.1 94.1 74.5 134.8 49.1 140.0 128.9 126.3 126.4 64.4 71.9 69.7 124.4 43.6 49.3 53.3 80.1 97.3 79.0 49.2 89.2 118.9 94.3 94.7 62.1 84.3 157.3 109.2 148.0 115.0 140.4 133.9 162.8 84.3 54.1 108.2 80.2 106.8 76.3 106.6 104.2 51.3 122.8 48.1 39.0 25.4 18.6 36.7 25.5 17.8 16.7 21.3 40.4 14.2 14.3 17.9 10.9 26.7 36.2 17.8 22.9 35.5 46.6 48.9 57.2 57.1 48.6 53.7 57.9 51.0 60.0 53.9 51.1 66.4 53.6 76.9 54.7 44.7 66.4 28.2 35.5 41.6 29.6 52.4 53.0 41.3 51.8 42.9 49.7 40.5 81.3 41.0 83.2 66.8 13.7 49.9 14.7 50.7 68.1 50.4 55.3 37.0 77.6 49.6 63.3 66.2 65.2 64.3 45.6 63.0 52.8 71.1 51.2 45.4 73.8 83.8 30.5 93.7 58.0 6.4 71.1 84.3 26.6 67.5 75.0 41.0 38.1 65.9 178.9 55.5 48.1 56.8 115.9 52.9 98.9 41.4 66.2 53.7 39.5 57.6 52.4 37.6 25.7 35.8 31.8 69.2 58.3 58.1 66.6 61.2 COPRS "C17orf79, COPR5, HSA272196, TTP1" ENSG00000172301 "Coordinator of PRMT5 and differentiation stimulator" Q9NQ92 17 31851871-31859291 "Predicted intracellular proteins" "Myogenesis, Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 253.2;Late spermatids: 288.9;Spermatocytes: 575.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052552 Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Cluster 24: B-cells - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 66: Spermatocytes - Spermatogenesis" Nucleoplasm "Plasma membrane, Cytosol" "HPA052552: AB_2681868" "unprognostic (1.65e-2)" "unprognostic (4.88e-2)" "unprognostic (2.46e-1)" "unprognostic (4.01e-3)" "unprognostic (3.12e-2)" "unprognostic (1.12e-2)" "prognostic unfavorable (3.69e-4)" "unprognostic (6.88e-2)" "unprognostic (3.10e-1)" "unprognostic (4.44e-2)" "unprognostic (5.28e-3)" "unprognostic (1.01e-2)" "unprognostic (1.19e-3)" "unprognostic (1.02e-1)" "unprognostic (1.35e-1)" "unprognostic (1.48e-1)" "unprognostic (3.11e-2)" 51.1 46.5 127.4 20.1 130.0 14.2 49.8 124.6 172.8 42.8 129.5 99.0 16.0 43.4 117.6 26.4 51.7 32.0 66.1 128.7 136.2 55.8 68.1 33.9 21.0 123.6 126.7 51.7 41.9 49.0 67.4 19.7 128.8 60.2 27.4 56.0 35.4 46.3 53.5 30.3 31.1 44.4 123.3 25.1 51.6 241.4 131.2 13.2 63.2 53.3 27.8 57.1 33.3 124.1 101.5 132.9 64.4 66.6 104.3 99.5 45.2 109.7 140.3 125.8 127.8 83.4 27.0 53.0 58.8 135.1 245.0 58.5 116.0 67.6 142.3 18.7 153.8 15.4 79.7 99.5 105.5 53.2 43.4 64.2 87.4 169.3 92.4 135.7 68.6 75.2 75.0 46.9 139.6 89.9 79.6 170.7 49.1 65.2 62.8 61.8 120.8 104.4 74.5 62.8 58.4 44.2 65.9 32.6 107.1 56.1 104.4 57.9 37.0 327.8 85.9 116.6 156.3 76.2 77.2 58.3 170.8 50.1 44.9 1.8 2.0 0.0 0.6 2.0 1.6 1.9 0.5 0.1 2.6 3.6 0.3 0.3 0.6 0.0 0.9 1.0 0.8 0.3 127.4 130.0 124.6 172.8 128.7 136.2 123.6 126.7 128.8 123.3 131.2 124.1 54.2 22.4 8.3 13.7 20.9 34.4 69.0 15.3 29.6 43.1 79.2 88.4 78.9 68.6 13.4 86.5 10.4 31.9 10.7 12.1 225.0 99.6 253.2 142.2 38.5 53.5 19.7 18.7 14.6 80.8 54.9 65.7 14.3 40.5 3.8 39.9 62.4 95.4 87.6 26.9 14.8 15.9 40.7 30.3 34.7 288.9 62.4 36.5 58.7 7.5 47.9 136.3 9.2 3.5 9.2 70.7 8.4 65.1 27.4 127.4 6.4 212.0 55.8 43.0 19.7 46.9 63.5 575.6 63.8 21.4 31.7 27.4 11.2 49.6 21.3 39.6 CRACDL "C2orf55, KIAA1211L, MGC42367" ENSG00000196872 "CRACD like" Q6NV74 2 98793846-98936259 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.8;epididymis: 31.6" "Cell type enriched" "Detected in some" 9 "Adipocytes: 35.9" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in many" 6 "amygdala: 12.8;basal ganglia: 20.0;cerebral cortex: 30.8;hippocampal formation: 29.7" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 41.0;HDLM-2: 61.7;Karpas-707: 17.4;MCF7: 16.3;SiHa: 17.3;SK-BR-3: 22.5" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 16 "amygdala: 19.1;basal ganglia: 45.5;cerebral cortex: 36.9;hippocampal formation: 54.9;olfactory bulb: 15.9" "HPA051082, HPA061678" Enhanced Approved "Microtubules,Cytokinetic bridge,Centrosome" Yes No "Cluster 68: Epididymis - Unknown function" "Cluster 28: BEWO - Transcription regulation" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Microtubules, Centrosome" "Cytokinetic bridge" "HPA051082: AB_2681337, HPA061678: AB_2684584" "unprognostic (3.56e-3)" "unprognostic (1.23e-3)" "unprognostic (5.88e-2)" "unprognostic (6.43e-2)" "unprognostic (1.34e-1)" "unprognostic (1.24e-1)" "unprognostic (3.67e-3)" "unprognostic (2.12e-1)" "unprognostic (5.10e-2)" "unprognostic (7.65e-2)" "unprognostic (3.23e-2)" "unprognostic (3.61e-2)" "prognostic favorable (1.13e-5)" "unprognostic (1.22e-1)" "unprognostic (3.34e-1)" "prognostic favorable (1.33e-5)" "unprognostic (2.22e-2)" 5.0 0.9 12.8 1.5 20.0 0.5 5.1 0.0 30.8 5.1 0.0 5.9 8.0 2.1 31.6 11.2 22.6 2.9 3.4 29.7 0.0 4.1 0.3 6.0 0.8 0.0 0.0 0.6 4.7 7.7 6.6 4.5 0.0 2.3 4.6 0.1 11.0 4.6 1.7 6.4 7.5 2.3 0.0 1.3 8.3 6.2 0.0 1.0 5.0 1.5 1.8 2.2 5.5 3.6 8.4 0.4 0.2 3.2 0.0 0.0 41.0 0.0 0.0 0.0 0.0 0.4 4.9 0.0 10.4 0.0 0.2 7.4 0.3 0.4 0.0 61.7 1.2 0.0 0.5 0.5 0.0 0.0 0.1 0.3 2.3 0.1 1.2 0.1 2.5 0.0 0.0 17.4 0.0 16.3 0.2 1.3 0.1 8.3 0.9 0.0 0.0 0.8 3.2 6.5 5.8 0.9 17.3 22.5 0.1 0.0 8.7 1.4 10.7 0.0 1.3 0.0 0.1 0.0 0.0 0.2 0.1 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 12.8 20.0 0.0 30.8 29.7 0.0 0.0 0.0 0.0 0.0 0.0 3.6 35.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 3.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 CRYBA4 ENSG00000196431 "Crystallin beta A4" P53673 22 26621963-26630669 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Eye lens protein" "Cataract, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 1.5;testis: 1.1" "Cell type enhanced" "Detected in some" "Early spermatids: 3.3;NK-cells: 1.0;Spermatogonia: 3.2" "Cancer enhanced" "Detected in some" "endometrial cancer: 2.0;testis cancer: 2.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "HEL: 7.3" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 4 "cerebral cortex: 4.3;hippocampal formation: 4.0" HPA071178 Supported NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 36: HEL - Hemostasis" "Cluster 23: Spermatids - Flagellum & Golgi organization" "HPA071178: AB_2686354" "unprognostic (6.69e-2)" "unprognostic (3.94e-3)" "unprognostic (5.61e-5)" "unprognostic (1.74e-2)" "unprognostic (5.57e-2)" "unprognostic (2.32e-2)" "unprognostic (2.71e-1)" "unprognostic (7.92e-2)" "unprognostic (3.50e-2)" "unprognostic (1.85e-1)" "unprognostic (9.05e-6)" "unprognostic (2.86e-1)" "unprognostic (1.20e-6)" "unprognostic (1.87e-2)" "unprognostic (7.23e-2)" "unprognostic (7.71e-2)" "unprognostic (3.70e-1)" 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.2 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.4 0.0 0.0 3.3 0.0 0.0 0.1 0.0 0.4 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.8 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.9 3.2 0.0 0.0 0.3 0.1 0.0 0.5 0.1 CRYBB1 ENSG00000100122 "Crystallin beta B1" P53674 22 26599278-26618027 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Eye lens protein" "Cataract, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 9.6" "Cell type enriched" "Detected in some" 21 "Hofbauer cells: 82.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "intermediate monocyte: 10.3;non-classical monocyte: 7.5" "Lineage enriched" "Detected in many" 7 "monocytes: 10.3" "Group enriched" "Detected in some" 5 "Karpas-707: 43.3;RPMI-8226: 82.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" "HPA003448, CAB010058" Supported NA NA 89000 "Cluster 51: Monocytes - Innate immune response" "Cluster 68: Epididymis - Unknown function" "Cluster 25: RPMI-8226 - Immune response" "Cluster 4: Macrophages - Innate immune response" "CAB010058: AB_668166, HPA003448: AB_2732396" "unprognostic (1.31e-1)" "unprognostic (5.56e-3)" "unprognostic (1.39e-2)" "unprognostic (1.44e-2)" "unprognostic (2.29e-1)" "unprognostic (2.18e-1)" "unprognostic (7.89e-3)" "unprognostic (1.51e-1)" "unprognostic (9.51e-2)" "unprognostic (1.05e-1)" "unprognostic (1.10e-1)" "unprognostic (1.33e-1)" "unprognostic (3.88e-4)" "unprognostic (2.62e-2)" "unprognostic (1.23e-2)" "unprognostic (3.22e-1)" "unprognostic (1.76e-2)" 1.3 1.6 1.5 0.9 1.6 0.6 0.6 1.6 2.4 0.6 1.3 0.5 0.4 0.3 9.6 0.4 0.4 1.2 0.4 1.6 1.6 0.2 0.4 0.5 1.2 1.9 1.8 0.2 0.2 0.3 0.5 3.3 2.3 0.2 0.4 0.0 0.4 0.2 0.1 0.1 0.4 0.9 1.9 1.6 0.3 0.3 2.2 0.4 0.2 0.2 0.5 1.1 0.2 2.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 1.5 12.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 43.3 0.0 0.0 0.0 0.3 1.8 0.0 0.0 0.8 0.0 82.3 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 4.6 0.0 0.2 0.5 0.0 0.0 0.7 0.2 1.8 0.0 2.2 0.0 0.0 1.0 0.0 0.0 10.3 0.0 0.2 0.0 0.0 1.5 0.0 0.0 0.0 0.4 0.5 7.5 0.0 0.0 0.6 1.5 1.6 1.6 2.4 1.6 1.6 1.9 1.8 2.3 1.9 2.2 2.1 0.1 0.0 0.0 0.7 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.1 1.3 0.0 0.0 0.9 0.0 0.5 0.2 0.0 0.1 1.3 0.0 0.0 0.2 82.6 0.0 0.2 0.0 0.0 3.5 0.8 0.6 0.0 2.8 1.8 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.7 0.1 0.2 0.0 0.0 CST9L "bA218C14.1, CTES7B" ENSG00000101435 "Cystatin 9 like" Q9H4G1 20 23564732-23568484 "Predicted secreted proteins" "Protease inhibitor, Thiol protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 337 "epididymis: 26.4;testis: 87.9" "Cell type enhanced" "Detected in some" "Early spermatids: 4.0;Late spermatids: 13.2;Leydig cells: 2.5;Peritubular cells: 1.5;Spermatocytes: 1.6" "Cancer enhanced" "Detected in single" "testis cancer: 0.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 20 "HEL: 2.1" "Not detected" "Not detected" "Secreted in male reproductive system" NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 36: HEL - Hemostasis" "Cluster 31: Spermatids - Spermatogenesis" "unprognostic (2.10e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 87.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.2 2.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CSTF3 CstF-77 ENSG00000176102 "Cleavage stimulation factor subunit 3" Q12996 11 33077188-33162371 "Predicted intracellular proteins" "mRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039743, HPA040168" Enhanced Enhanced Nucleoplasm NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 68: Epididymis - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" Nucleoplasm "HPA039743: AB_10795682, HPA040168: AB_10794025" "unprognostic (2.38e-1)" "unprognostic (1.46e-1)" "prognostic favorable (1.63e-4)" "unprognostic (3.77e-1)" "unprognostic (4.04e-2)" "unprognostic (4.35e-2)" "prognostic unfavorable (8.20e-6)" "unprognostic (1.47e-1)" "unprognostic (1.67e-2)" "unprognostic (6.42e-3)" "unprognostic (9.73e-2)" "unprognostic (2.41e-1)" "prognostic unfavorable (1.61e-5)" "unprognostic (4.64e-2)" "unprognostic (1.86e-2)" "unprognostic (1.15e-2)" "unprognostic (1.01e-3)" 13.8 21.2 28.5 20.8 30.9 12.7 19.5 34.7 39.8 24.2 30.5 20.3 19.1 19.8 61.1 26.7 21.2 14.9 17.1 30.0 32.4 28.9 34.6 21.3 26.6 26.3 26.8 25.9 21.1 18.2 57.6 19.1 27.4 30.4 20.0 31.9 20.6 15.0 16.9 26.1 20.2 13.7 26.1 25.5 18.6 32.9 31.1 23.8 29.8 11.8 21.5 22.0 24.7 32.9 45.8 43.3 82.8 56.4 22.0 38.7 59.8 44.2 28.5 48.5 66.2 31.7 34.9 49.3 31.2 28.5 32.4 58.5 73.8 42.9 77.5 52.7 128.3 50.6 109.1 58.2 24.9 66.5 30.9 28.2 30.6 37.6 36.7 39.1 64.4 39.2 67.9 34.2 66.4 32.3 66.8 35.7 40.3 34.6 54.0 52.2 80.5 39.7 54.6 58.2 61.4 34.9 50.9 29.9 37.6 52.7 54.4 44.1 39.5 40.3 49.7 64.5 59.7 32.3 46.8 41.9 47.4 68.9 40.2 4.6 4.8 7.0 5.8 6.9 6.8 6.5 7.2 5.8 7.7 5.0 7.5 7.9 1.9 6.9 8.3 5.7 9.1 3.7 28.5 30.9 34.7 39.8 30.0 32.4 26.3 26.8 27.4 26.1 31.1 32.9 12.8 19.2 18.7 38.5 19.0 18.9 50.6 50.1 10.2 33.3 22.3 19.9 21.8 17.2 43.5 58.8 6.2 63.0 12.7 15.1 62.6 24.3 37.6 31.4 20.7 21.2 31.8 34.9 75.2 16.9 32.0 23.1 15.3 18.9 14.5 29.0 11.0 57.3 28.4 13.5 59.1 30.0 77.3 22.0 21.1 10.3 29.8 17.0 28.4 42.2 28.1 35.7 14.4 62.4 56.9 20.8 18.6 29.7 14.0 33.0 20.6 47.0 68.0 25.2 26.3 26.1 25.4 77.3 57.6 19.1 19.5 33.8 18.3 25.3 29.6 55.6 CUL4B ENSG00000158290 "Cullin 4B" Q13620 X 120505920-120604074 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, DNA damage, DNA repair, Ubl conjugation pathway" "Cancer-related genes, Disease variant, Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 106.9;Late spermatids: 169.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003046, HPA011880, CAB017786, HPA058979" Enhanced Enhanced Nucleoplasm NA NA 18000 "Cluster 9: Neutrophils - Innate immune response" "Cluster 68: Epididymis - Unknown function" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 31: Spermatids - Spermatogenesis" Nucleoplasm "CAB017786: , HPA003046: , HPA011880: AB_1847340, HPA058979: AB_2683868" "unprognostic (2.34e-2)" "unprognostic (2.74e-2)" "unprognostic (2.69e-2)" "unprognostic (7.73e-3)" "unprognostic (9.66e-2)" "unprognostic (3.91e-1)" "unprognostic (3.88e-3)" "unprognostic (8.99e-2)" "unprognostic (8.12e-3)" "unprognostic (3.20e-2)" "unprognostic (1.07e-1)" "unprognostic (1.90e-1)" "unprognostic (2.87e-3)" "unprognostic (3.83e-2)" "unprognostic (1.35e-1)" "unprognostic (6.82e-2)" "unprognostic (2.84e-1)" 18.7 20.5 15.3 14.4 16.5 9.8 20.0 18.2 19.3 24.6 15.7 20.0 12.3 18.7 27.3 23.4 19.6 15.5 15.5 16.0 19.2 18.1 19.5 14.5 20.5 14.4 16.4 25.2 17.0 24.2 26.9 15.5 15.7 18.2 13.5 19.9 15.1 22.5 10.0 15.2 15.4 15.6 13.7 17.7 15.5 28.0 16.2 25.3 15.8 12.5 21.8 18.2 20.3 16.1 41.9 37.3 28.7 31.4 129.5 57.0 22.4 89.8 104.1 71.3 69.4 30.4 110.6 40.1 35.5 206.8 127.7 29.9 61.1 27.7 84.8 26.1 26.6 20.5 42.1 25.9 50.6 22.6 28.1 65.6 22.2 45.1 37.5 134.8 133.2 22.6 33.6 31.7 78.4 24.5 30.7 19.0 45.4 52.6 39.5 23.4 27.1 43.4 23.2 19.5 32.9 27.4 74.2 36.8 36.5 35.0 28.8 20.9 177.6 57.1 30.5 76.3 88.6 21.2 50.0 52.2 59.9 28.2 55.2 6.6 3.8 8.1 5.6 3.1 6.1 5.7 5.2 5.2 4.4 4.4 6.0 6.2 14.4 4.4 2.4 7.0 6.9 4.1 15.3 16.5 18.2 19.3 16.0 19.2 14.4 16.4 15.7 13.7 16.2 16.1 18.7 22.4 14.4 11.8 15.5 15.2 9.6 12.9 12.5 15.7 17.3 14.7 14.6 8.6 11.7 14.7 14.6 10.1 19.9 14.7 13.7 10.1 106.9 12.4 15.6 18.2 24.6 13.3 18.4 8.9 25.0 21.2 14.3 15.8 14.0 20.5 40.7 16.4 17.5 25.2 20.9 13.9 8.2 30.5 13.9 169.3 21.5 18.4 12.4 14.0 17.6 15.0 7.2 23.1 21.0 16.7 7.3 21.4 18.9 9.5 11.0 14.4 17.8 14.1 13.1 17.0 16.6 12.6 13.9 23.0 13.8 10.0 14.1 21.7 12.7 9.5 CYB5D2 MGC32124 ENSG00000167740 "Cytochrome b5 domain containing 2" Q8WUJ1 17 4143168-4187310 "Predicted intracellular proteins, Predicted secreted proteins" Neurogenesis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Spermatocytes: 130.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 74.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011032, HPA042299" Approved Approved "Endoplasmic reticulum,Plasma membrane" "Secreted to blood" NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 68: Epididymis - Unknown function" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 66: Spermatocytes - Spermatogenesis" "Endoplasmic reticulum, Plasma membrane" "HPA011032: , HPA042299: AB_10793879" "unprognostic (2.57e-2)" "unprognostic (2.89e-2)" "unprognostic (4.16e-2)" "prognostic favorable (6.19e-4)" "unprognostic (1.88e-2)" "unprognostic (1.75e-2)" "prognostic favorable (4.98e-6)" "unprognostic (1.57e-1)" "unprognostic (2.47e-1)" "unprognostic (9.71e-3)" "prognostic favorable (7.76e-5)" "unprognostic (2.04e-1)" "prognostic favorable (2.03e-10)" "unprognostic (2.01e-3)" "unprognostic (8.73e-2)" "unprognostic (1.82e-1)" "unprognostic (2.97e-1)" 19.0 21.7 17.4 6.1 17.3 4.3 18.2 17.4 20.1 15.9 14.2 10.7 15.2 15.6 28.5 10.9 18.7 16.3 14.0 16.7 19.6 25.5 29.0 9.7 9.3 18.1 17.6 20.8 19.7 30.9 24.1 10.8 17.8 13.5 7.4 9.2 20.0 17.6 16.2 14.4 12.1 8.4 17.6 9.6 16.0 29.3 17.9 10.2 22.7 14.9 7.2 12.9 11.7 18.7 16.2 21.6 11.8 12.7 74.7 22.5 5.2 15.7 31.5 11.0 10.9 6.3 10.3 5.3 13.6 17.4 9.2 22.5 4.9 7.1 4.4 17.9 25.7 5.0 13.5 10.5 13.7 2.1 9.5 28.8 17.0 6.2 11.7 22.3 20.1 11.5 5.1 31.2 8.3 20.6 7.8 3.4 4.3 13.7 11.5 9.2 10.6 12.5 25.1 8.5 9.3 8.1 17.2 9.9 23.5 13.1 25.6 3.2 28.5 15.7 4.0 14.5 8.0 5.8 4.9 3.9 19.9 4.5 6.2 0.6 10.8 13.6 5.9 9.2 6.7 8.1 9.3 7.4 10.5 7.1 8.6 8.0 9.5 5.5 8.7 11.3 11.2 8.2 17.4 17.3 17.4 20.1 16.7 19.6 18.1 17.6 17.8 17.6 17.9 18.7 57.4 12.8 10.3 9.1 17.2 53.7 18.4 36.0 12.5 26.9 35.4 36.7 9.8 45.8 21.8 31.3 58.4 55.7 11.4 18.5 52.8 34.3 28.5 36.6 20.0 34.4 13.8 33.3 7.6 27.0 29.1 23.8 19.4 23.4 11.4 22.3 41.0 32.9 21.4 40.4 10.4 16.0 36.7 24.0 23.8 30.6 28.9 17.3 14.2 4.7 15.4 37.6 15.5 8.5 10.0 26.9 18.9 28.6 17.6 8.3 39.7 55.7 38.5 30.4 0.0 15.2 20.1 130.3 29.2 9.5 42.9 38.6 15.8 39.3 16.6 15.8 DAD1 OST2 ENSG00000129562 "Defender against cell death 1" P61803 14 22564907-22589224 "Cancer-related genes, Metabolic proteins, Predicted membrane proteins, Transporters" Apoptosis "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028882 Uncertain Uncertain "Endoplasmic reticulum,Cytosol" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 68: Epididymis - Unknown function" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 55: Plasma cells - Humoral immune response" Cytosol "Endoplasmic reticulum" "HPA028882: AB_10602214" "unprognostic (2.76e-1)" "unprognostic (1.21e-1)" "unprognostic (1.15e-1)" "unprognostic (1.97e-2)" "unprognostic (2.02e-1)" "unprognostic (1.18e-3)" "prognostic unfavorable (7.73e-4)" "unprognostic (9.43e-3)" "unprognostic (3.06e-2)" "unprognostic (6.09e-2)" "unprognostic (1.99e-2)" "unprognostic (9.64e-2)" "unprognostic (6.62e-3)" "unprognostic (1.19e-1)" "unprognostic (3.08e-1)" "unprognostic (1.93e-1)" "unprognostic (1.37e-3)" 204.0 229.3 209.2 159.1 224.4 129.0 224.0 236.2 259.4 229.6 252.2 197.7 165.8 184.3 473.8 187.0 230.5 190.8 202.6 211.4 238.0 296.8 275.7 183.4 169.6 240.2 218.7 174.5 200.2 254.1 201.6 141.8 238.7 145.5 209.9 86.2 286.3 205.5 156.6 137.2 173.8 206.6 237.2 165.3 197.0 150.7 219.2 211.6 272.8 197.5 191.0 200.0 163.4 252.0 373.3 344.7 274.6 375.8 740.2 529.9 238.3 387.0 473.0 340.5 478.1 219.6 520.1 233.7 242.1 453.1 381.4 330.0 291.1 375.7 543.3 319.8 265.1 228.5 180.9 886.0 514.5 321.2 315.8 395.8 498.7 356.0 454.4 383.1 506.2 220.9 176.4 532.1 509.9 459.3 153.6 391.4 169.7 816.1 557.8 211.7 232.4 306.7 503.2 306.1 211.5 263.4 294.9 416.1 445.9 328.7 251.4 323.1 381.1 291.8 232.2 358.2 248.3 391.2 502.6 308.5 263.8 225.5 431.0 532.4 421.9 460.9 528.4 371.9 518.9 527.2 543.8 501.4 401.0 477.1 564.8 497.6 481.5 437.2 332.3 783.9 560.3 941.8 209.2 224.4 236.2 259.4 211.4 238.0 240.2 218.7 238.7 237.2 219.2 252.0 357.9 160.3 161.7 15.0 183.9 198.3 188.3 581.8 149.7 25.1 201.0 274.6 173.8 187.3 315.2 255.6 27.1 260.9 204.6 174.8 215.2 525.4 196.8 270.3 242.9 267.8 135.7 130.2 10.6 415.2 383.1 276.5 145.2 255.6 302.6 150.8 187.7 231.9 350.3 21.9 11.0 242.3 360.1 146.2 224.8 101.5 214.3 166.8 330.8 8.4 217.3 216.8 198.8 18.1 42.5 396.8 160.7 199.0 408.6 172.5 244.8 420.8 393.7 42.6 151.2 141.5 291.0 300.3 128.1 179.6 215.8 289.0 211.7 266.6 183.8 174.4 DBF4B "ASKL1, chifb, DRF1, FLJ13087, ZDBF1B" ENSG00000161692 "DBF4 zinc finger B" Q8NFT6 17 44708608-44752264 "Predicted intracellular proteins" "Cell cycle" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Bipolar cells: 30.0;Horizontal cells: 30.3;Oligodendrocytes: 30.9;Spermatocytes: 35.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA048465, HPA077959" Approved Supported Nucleoplasm,Vesicles NA Yes "Cluster 52: Eosinophils - Transcription" "Cluster 68: Epididymis - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" Nucleoplasm Vesicles "HPA048465: AB_2680405, HPA077959: " "unprognostic (2.44e-1)" "unprognostic (1.26e-1)" "unprognostic (6.37e-2)" "unprognostic (2.15e-3)" "unprognostic (1.62e-1)" "unprognostic (6.13e-2)" "unprognostic (1.53e-4)" "unprognostic (7.61e-2)" "unprognostic (1.54e-2)" "unprognostic (4.08e-2)" "unprognostic (8.43e-3)" "unprognostic (1.83e-1)" "unprognostic (4.23e-6)" "unprognostic (1.50e-1)" "unprognostic (3.36e-1)" "unprognostic (2.57e-1)" "unprognostic (1.39e-1)" 0.9 0.7 1.1 1.2 1.1 2.0 1.3 1.2 1.8 1.5 0.5 1.9 0.6 1.9 3.5 1.4 1.8 0.7 0.8 1.1 1.0 1.6 0.6 0.8 1.5 1.1 1.0 1.7 0.9 0.8 1.7 0.9 1.1 2.3 1.2 2.9 1.1 1.3 0.6 2.0 1.5 1.5 0.8 1.6 1.3 5.1 1.2 1.9 2.7 0.4 1.3 1.6 1.3 1.2 3.7 7.7 5.7 4.2 0.5 1.1 4.9 3.9 1.7 8.1 7.9 3.3 3.1 5.5 2.1 1.3 7.2 3.6 5.0 1.7 9.3 9.2 8.2 7.0 6.2 4.3 0.2 4.8 5.9 0.5 0.6 4.4 1.4 1.8 4.1 9.3 8.9 5.6 4.4 4.0 7.1 2.9 2.5 7.7 4.0 6.2 6.6 2.3 1.8 2.2 3.1 3.4 3.8 1.2 2.9 6.1 3.9 3.1 1.8 2.8 5.2 3.6 7.2 2.6 3.5 7.2 2.1 4.1 4.3 0.0 0.1 0.4 0.0 0.3 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.2 0.1 0.1 0.1 1.1 1.1 1.2 1.8 1.1 1.0 1.1 1.0 1.1 0.8 1.2 1.2 2.1 0.0 1.1 15.0 4.0 0.6 2.6 1.2 1.2 30.0 1.5 1.3 1.1 0.0 2.1 5.5 12.5 4.2 5.8 0.6 0.0 0.3 8.1 2.0 2.2 2.8 4.2 5.5 11.4 0.8 1.4 2.3 1.5 1.1 3.8 9.6 3.3 0.3 1.4 30.3 11.0 0.3 0.0 1.3 3.1 7.4 1.2 2.5 5.4 5.6 1.4 7.2 2.1 7.5 30.9 0.2 0.2 3.0 3.4 2.0 0.7 0.5 1.9 15.7 0.0 4.5 2.0 35.7 16.5 1.9 0.1 1.4 1.4 5.3 1.1 2.3 DCAF12L1 "KIAA1892L, WDR40B" ENSG00000198889 "DDB1 and CUL4 associated factor 12 like 1" Q5VU92 X 126549383-126552814 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 4.9;testis: 6.2" "Group enriched" "Detected in some" 4 "Early spermatids: 20.7;Late spermatids: 44.4;Spermatogonia: 14.4" "Cancer enhanced" "Detected in some" "renal cancer: 1.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 14 "EFO-21: 15.2;U-2 OS: 8.4" "HPA044737, HPA048981, HPA053138" Approved Uncertain Cytosol NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 38: EFO-21 - Unknown function" "Cluster 31: Spermatids - Spermatogenesis" Cytosol "HPA044737: AB_2679067, HPA048981: AB_2680586, HPA053138: AB_2682054" "unprognostic (2.62e-5)" "unprognostic (2.88e-1)" "unprognostic (1.19e-1)" "unprognostic (3.40e-1)" "unprognostic (1.39e-3)" "unprognostic (1.34e-1)" "unprognostic (2.34e-1)" "unprognostic (1.74e-1)" 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 4.9 0.0 2.5 1.2 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 1.0 0.8 6.2 0.1 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.0 0.0 8.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 20.7 3.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.3 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 44.4 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.3 3.8 14.4 0.0 0.0 0.0 0.0 1.2 0.0 0.0 DCAF12L2 WDR40C ENSG00000198354 "DDB1 and CUL4 associated factor 12 like 2" Q5VW00 X 126163499-126166289 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 9.3;epididymis: 21.4" "Cell type enriched" "Detected in some" 7 "Granulosa cells: 11.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "HAP1: 2.6;NTERA-2: 2.2;U-2 OS: 3.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA044737, HPA048981, HPA053138" Approved Uncertain Cytosol NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 5: NTERA-2 - Transcription" "Cluster 40: Granulosa cells - Unknown function" Cytosol "HPA044737: AB_2679067, HPA048981: AB_2680586, HPA053138: AB_2682054" "unprognostic (1.16e-4)" "unprognostic (8.83e-3)" "unprognostic (2.93e-1)" "unprognostic (2.52e-2)" "unprognostic (2.72e-1)" "unprognostic (3.02e-1)" "unprognostic (3.34e-3)" "unprognostic (1.16e-1)" "unprognostic (8.47e-4)" "unprognostic (1.56e-2)" "unprognostic (4.05e-2)" "unprognostic (3.86e-2)" "unprognostic (2.51e-1)" 0.8 0.9 1.9 0.0 2.0 0.0 0.4 0.1 2.2 1.4 0.0 0.7 0.0 2.4 21.4 0.1 2.3 0.1 0.0 2.5 3.5 0.2 0.0 0.0 0.1 9.3 1.5 1.4 0.0 2.5 1.3 0.0 4.2 1.5 0.0 0.2 0.3 4.3 0.1 0.2 0.2 1.3 1.6 0.0 0.3 5.5 3.1 0.0 0.1 0.9 0.2 1.2 0.5 1.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 2.0 0.1 2.2 2.5 3.5 9.3 1.5 4.2 1.6 3.1 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.7 0.0 0.0 0.0 11.5 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 DEFB115 DEFB-15 ENSG00000215547 "Defensin beta 115" Q30KQ5 20 31257664-31259632 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 10 "epididymis: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 9 "U-2 OS: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA053160 Uncertain "Secreted in male reproductive system" NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 9: U-2 OS - Unknown function" "HPA053160: AB_2682062" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DEFB119 "DEFB-19, DEFB-20, DEFB120" ENSG00000180483 "Defensin beta 119" Q8N690 20 31377164-31390590 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "epididymis: 1925.5" "Cell type enhanced" "Detected in some" "Bipolar cells: 42.6;Cone photoreceptor cells: 39.6;Early spermatids: 61.9;Late spermatids: 99.8;Rod photoreceptor cells: 150.2" "Cancer enriched" "Detected in single" 67 "testis cancer: 3.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "NB-4: 1.5" HPA043059 Supported "Secreted in male reproductive system" NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 46: Photoreceptor cells - Phototransduction" "HPA043059: AB_10797025" "unprognostic (2.03e-1)" 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.4 0.1 1925.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 155.7 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.1 331.5 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 42.6 0.0 0.0 0.0 0.0 0.0 0.0 39.6 0.0 0.0 0.0 0.0 0.0 61.9 0.0 0.0 1.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.1 0.1 0.0 0.0 0.0 0.0 99.8 12.5 0.8 0.0 0.0 0.0 22.0 0.0 0.0 0.1 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 150.2 13.1 0.0 0.0 17.4 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DEFB123 DEFB-23 ENSG00000180424 "Defensin beta 123" Q8N688 20 31440632-31450257 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 370 "epididymis: 158.8;testis: 148.1" "Group enriched" "Detected in some" 4 "Early spermatids: 14.0;Late spermatids: 50.4" "Cancer enriched" "Detected in single" 17 "testis cancer: 3.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in other tissues" NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 31: Spermatids - Spermatogenesis" "unprognostic (9.16e-2)" 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 158.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 148.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 50.4 5.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 5.2 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DEFB125 DEFB-25 ENSG00000178591 "Defensin beta 125" Q8N687 20 87250-97094 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 10 "epididymis: 1.5;seminal vesicle: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in male reproductive system" NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 66: Spermatocytes - Spermatogenesis" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DEFB131B ENSG00000225805 "Defensin beta 131B" A0A096LNP1 11 71878453-71884561 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 19 "epididymis: 68.9" "Not detected" "Not detected" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "RH-30: 15.6" "Secreted in male reproductive system" NA NA "Cluster 40: NK-cells - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "unprognostic (5.87e-2)" "unprognostic (1.44e-1)" "unprognostic (4.78e-2)" "unprognostic (7.44e-2)" "unprognostic (3.57e-2)" "unprognostic (3.55e-2)" "unprognostic (3.11e-3)" "unprognostic (1.91e-1)" "unprognostic (3.09e-3)" "unprognostic (7.45e-2)" "unprognostic (1.41e-1)" "unprognostic (1.43e-1)" "unprognostic (5.21e-2)" "unprognostic (3.39e-1)" "unprognostic (1.05e-2)" "unprognostic (3.62e-1)" 0.2 0.6 0.7 1.1 0.5 0.4 0.0 0.7 1.3 0.0 0.0 0.7 1.8 0.4 68.9 0.1 0.0 2.5 0.4 0.4 0.2 0.5 0.0 0.2 1.8 0.5 0.5 1.2 0.0 0.0 0.0 0.2 1.7 0.4 0.0 3.6 0.7 0.1 0.4 0.8 1.0 0.0 0.2 0.7 0.6 0.8 0.7 0.0 3.2 0.0 0.0 1.0 0.0 1.3 0.5 0.0 3.1 1.4 0.0 0.0 0.4 3.6 0.0 0.0 0.0 4.4 2.8 3.0 1.1 0.0 1.5 3.4 0.0 0.0 0.0 2.8 2.8 3.8 0.0 2.5 0.0 4.8 1.6 0.0 0.0 0.0 0.0 1.1 0.0 6.2 7.3 5.9 0.0 3.2 2.1 0.9 0.5 3.7 3.7 3.0 15.6 1.0 0.0 1.1 2.9 1.6 2.5 1.4 2.6 2.5 3.0 0.4 2.1 1.2 3.4 2.0 0.3 2.5 1.1 4.4 2.0 2.8 0.8 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.1 0.7 0.2 0.0 0.7 0.5 0.7 1.3 0.4 0.2 0.5 0.5 1.7 0.2 0.7 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DEFB134 ENSG00000205882 "Defensin beta 134" Q4QY38 8 11993174-11996312 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 6 "epididymis: 13.0" "Group enriched" "Detected in some" 21 "Early spermatids: 48.3;Late spermatids: 33.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Secreted in male reproductive system" NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 34: Spermatids - Unknown function" "unprognostic (3.80e-2)" "unprognostic (2.20e-1)" 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.4 0.7 0.0 0.0 0.0 0.2 0.0 13.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.1 0.3 0.0 0.1 0.1 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.4 0.7 0.1 0.1 0.2 0.0 0.1 0.0 0.1 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 48.3 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 33.8 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DEFB136 DEFB137 ENSG00000205884 "Defensin beta 136" Q30KP8 8 11973937-11974599 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "epididymis: 1.2" "Cell type enhanced" "Detected in single" "Late spermatids: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA068255 Enhanced "Secreted in male reproductive system" NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 34: Spermatids - Unknown function" "HPA068255: AB_2732780" 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.5 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DHX57 DDX57 ENSG00000163214 "DExH-box helicase 57" Q6P158 2 38797729-38875934 "Enzymes, Predicted intracellular proteins" "Helicase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Early spermatids: 136.3;Late spermatids: 352.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036160 Uncertain Approved "Nucleoli,Intermediate filaments,Microtubules,Cytosol" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 68: Epididymis - Unknown function" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 25: Spermatids - Spermatogenesis" "Intermediate filaments, Microtubules" "Nucleoli, Cytosol" "HPA036160: AB_10670711" "unprognostic (6.78e-2)" "unprognostic (3.08e-1)" "unprognostic (3.49e-2)" "unprognostic (2.03e-3)" "unprognostic (3.25e-2)" "unprognostic (3.43e-1)" "prognostic unfavorable (3.32e-6)" "unprognostic (1.75e-2)" "unprognostic (2.74e-1)" "unprognostic (1.45e-1)" "unprognostic (7.35e-2)" "unprognostic (1.82e-2)" "unprognostic (2.55e-2)" "unprognostic (1.47e-1)" "unprognostic (3.88e-2)" "unprognostic (7.03e-3)" "unprognostic (1.77e-1)" 6.1 9.2 6.6 5.2 6.9 4.8 6.5 6.4 8.8 8.1 6.9 7.1 2.2 7.7 10.3 5.4 6.6 4.2 5.3 7.1 7.2 6.8 5.3 4.9 6.2 5.8 6.5 7.8 7.0 9.7 10.0 5.8 6.0 6.2 5.5 8.5 5.6 6.3 9.1 7.1 5.2 7.3 6.0 5.9 5.7 23.4 6.6 6.7 7.2 5.5 6.3 7.4 6.2 6.5 23.4 19.3 21.0 15.8 13.5 16.6 16.2 15.5 15.9 15.2 14.7 15.7 7.2 7.1 15.6 16.9 17.1 11.8 23.6 18.2 24.9 28.0 18.4 13.3 11.5 21.3 12.2 14.5 7.3 16.0 10.8 20.0 12.5 10.8 20.7 5.2 17.8 9.5 16.7 17.7 14.7 12.9 25.1 10.1 11.4 7.0 27.7 13.9 14.2 8.6 16.8 24.8 15.8 16.4 17.4 14.7 11.7 8.0 15.4 15.1 16.5 10.9 17.7 9.3 12.2 2.8 11.4 10.1 10.2 1.6 6.3 1.2 2.8 4.5 3.6 3.8 2.3 2.1 3.2 4.6 2.9 1.7 0.4 2.3 5.6 1.2 2.5 2.9 6.6 6.9 6.4 8.8 7.1 7.2 5.8 6.5 6.0 6.0 6.6 6.5 6.2 3.2 10.9 24.2 8.8 2.7 2.7 5.9 6.2 24.7 5.2 7.6 6.2 10.0 10.9 23.9 56.3 7.2 4.7 2.5 0.0 7.7 136.3 18.0 13.4 6.3 11.9 8.2 36.7 7.6 6.7 9.3 7.1 6.2 10.8 19.4 9.7 6.2 7.0 18.5 38.0 5.7 4.1 11.7 3.8 352.8 15.8 8.5 1.8 25.3 23.9 9.5 8.2 33.2 20.9 8.5 3.1 13.9 8.1 2.0 2.1 6.0 27.3 27.7 0.0 8.8 6.0 19.3 9.8 5.3 2.6 2.9 7.9 14.7 5.0 2.2 DNAH8 hdhc9 ENSG00000124721 "Dynein axonemal heavy chain 8" Q96JB1 6 38715311-39030792 "Plasma proteins, Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 2.6;prostate: 2.1;testis: 7.8" "Group enriched" "Detected in some" 4 "Early spermatids: 35.4;Late spermatids: 13.2;Spermatocytes: 33.3" "Cancer enriched" "Detected in single" 7 "prostate cancer: 2.5" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 8 "basophil: 2.5" "Lineage enriched" "Detected in single" 8 "granulocytes: 2.5" "Cell line enriched" "Detected in some" 8 "HMC-1: 47.1" "Not detected" "Not detected" HPA028447 Uncertain NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 68: Epididymis - Unknown function" "Cluster 3: HMC-1 - Innate immune response" "Cluster 66: Spermatocytes - Spermatogenesis" "HPA028447: AB_10599600" "unprognostic (2.83e-1)" "unprognostic (4.46e-4)" "unprognostic (1.27e-1)" "unprognostic (5.24e-2)" "unprognostic (1.23e-1)" "unprognostic (2.00e-3)" "unprognostic (1.02e-1)" "unprognostic (1.22e-2)" "unprognostic (1.41e-1)" "unprognostic (3.47e-3)" "unprognostic (1.19e-1)" "unprognostic (1.39e-1)" "unprognostic (2.17e-9)" "unprognostic (1.46e-3)" "unprognostic (1.56e-1)" "unprognostic (1.62e-1)" "unprognostic (1.48e-3)" 0.0 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.1 2.1 0.0 0.0 0.0 0.1 0.0 1.6 0.1 0.0 0.0 0.9 0.1 7.8 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 47.1 0.0 0.0 0.0 0.0 0.0 5.9 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.7 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.9 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 35.4 0.0 0.0 0.2 0.0 0.0 2.7 0.0 0.1 0.2 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 13.2 1.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 1.7 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.1 33.3 5.7 0.0 0.0 0.0 0.6 0.0 0.0 0.0 DNAJC10 "ERdj5, PDIA19" ENSG00000077232 "DnaJ heat shock protein family (Hsp40) member C10" Q8IXB1 2 182716255-182794464 "Predicted intracellular proteins, Predicted membrane proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 113.9" "Cell type enhanced" "Detected in all" "Early spermatids: 219.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031111 Approved NA NA "Cluster 43: B-cells - Humoral immune response" "Cluster 68: Epididymis - Unknown function" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 44: Endometrium - Transcription" "HPA031111: AB_10601211" "unprognostic (3.29e-2)" "unprognostic (5.20e-3)" "unprognostic (3.10e-3)" "prognostic favorable (6.42e-5)" "unprognostic (1.89e-1)" "unprognostic (1.18e-1)" "unprognostic (4.34e-3)" "unprognostic (1.82e-2)" "unprognostic (1.54e-2)" "unprognostic (4.34e-2)" "unprognostic (2.29e-1)" "unprognostic (9.76e-2)" "prognostic unfavorable (2.19e-7)" "unprognostic (2.91e-1)" "unprognostic (8.96e-2)" "prognostic unfavorable (7.27e-4)" "unprognostic (2.87e-2)" 21.2 15.0 5.5 30.1 6.4 8.4 22.5 5.9 6.3 29.0 7.7 20.5 19.4 40.4 113.9 13.6 30.2 27.3 18.2 6.5 10.0 19.7 15.0 18.5 32.4 7.9 7.4 24.6 33.0 28.5 20.2 24.6 7.6 24.0 28.0 15.6 24.1 28.9 9.2 8.3 20.3 28.0 7.1 26.1 35.2 38.9 6.6 18.7 37.0 10.8 40.1 22.6 12.3 9.5 25.6 29.0 42.8 28.5 60.2 72.7 45.4 49.6 85.5 34.9 49.4 43.6 65.9 126.0 50.0 58.0 53.1 29.4 26.5 47.4 64.4 44.5 22.4 23.5 35.1 43.9 55.6 68.0 51.4 41.3 57.3 47.3 109.0 70.1 87.7 23.9 32.3 52.4 41.1 16.4 21.0 10.8 48.5 46.3 46.0 28.6 31.7 114.9 48.2 38.4 30.6 33.1 35.1 42.6 28.5 69.9 21.0 21.9 79.6 70.8 44.9 36.0 39.8 32.5 51.0 45.2 83.0 43.7 58.5 1.7 12.3 0.9 5.5 10.6 7.2 22.4 5.8 6.5 15.7 16.7 4.7 5.7 0.9 7.2 9.8 5.9 4.8 9.3 5.5 6.4 5.9 6.3 6.5 10.0 7.9 7.4 7.6 7.1 6.6 9.5 49.6 44.8 22.0 34.3 79.9 17.2 21.1 18.8 18.2 36.0 38.6 27.8 44.1 34.3 39.5 57.0 18.8 11.7 22.9 12.5 5.9 45.3 219.8 103.0 61.5 51.9 32.4 23.4 46.2 61.9 41.5 49.4 43.8 115.5 30.9 46.0 34.6 23.4 38.7 23.5 38.3 117.3 40.7 29.3 29.1 55.1 36.4 40.6 19.6 48.7 41.2 22.8 27.8 37.7 47.2 44.0 19.9 44.4 67.9 38.8 6.8 19.4 132.0 30.5 46.0 40.2 53.8 112.6 41.7 20.6 14.8 10.8 28.8 32.8 21.5 18.6 DNAJC5G "CSP-gamma, FLJ40417" ENSG00000163793 "DnaJ heat shock protein family (Hsp40) member C5 gamma" Q8N7S2 2 27275433-27281499 "Predicted membrane proteins" Chaperone "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 14 "epididymis: 46.9;testis: 22.8" "Group enriched" "Detected in some" 4 "Early spermatids: 69.1;Late spermatids: 83.6;Spermatocytes: 105.1" "Not detected" "Not detected" "Region enhanced" "Detected in single" "cerebral cortex: 2.5" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HAP1: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA041445 Approved NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 66: Spermatocytes - Spermatogenesis" "HPA041445: AB_2677485" "unprognostic (1.43e-1)" "unprognostic (1.07e-1)" "unprognostic (2.61e-2)" "unprognostic (2.26e-1)" "unprognostic (3.99e-1)" "unprognostic (2.77e-1)" "unprognostic (1.56e-2)" "unprognostic (1.48e-2)" "unprognostic (1.13e-1)" "unprognostic (4.06e-1)" "unprognostic (1.75e-4)" "unprognostic (2.08e-1)" "unprognostic (2.26e-1)" "unprognostic (1.75e-1)" "unprognostic (1.76e-1)" "unprognostic (7.67e-2)" "unprognostic (1.97e-2)" 0.1 0.8 0.8 0.0 0.1 0.0 0.0 0.0 2.5 0.4 0.0 0.1 0.0 0.4 46.9 0.0 0.4 0.0 1.3 0.8 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 22.8 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.7 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.1 0.4 0.0 0.0 0.0 0.1 0.1 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.3 0.1 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.2 0.8 0.1 0.0 2.5 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 69.1 0.0 0.0 0.3 0.0 0.0 8.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.3 83.6 0.9 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 1.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 105.1 19.8 0.0 0.0 0.0 0.0 0.0 0.1 0.1 DPY30 "Cps25, HDPY-30, Saf19" ENSG00000162961 "Dpy-30 histone methyltransferase complex regulatory subunit" Q9C005 2 31867809-32039805 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 388.8;Respiratory ciliated cells: 396.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043761 Supported Supported "Nucleoplasm,Golgi apparatus" NA NA 29000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 68: Epididymis - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 49: Ciliated cells - Cilium organization" Nucleoplasm "Golgi apparatus" "HPA043761: AB_10960501" "unprognostic (2.76e-2)" "unprognostic (1.48e-1)" "unprognostic (2.52e-2)" "unprognostic (1.07e-2)" "unprognostic (1.64e-1)" "unprognostic (4.57e-3)" "unprognostic (4.14e-3)" "unprognostic (1.91e-1)" "unprognostic (7.87e-2)" "unprognostic (1.01e-3)" "unprognostic (1.45e-2)" "unprognostic (5.75e-2)" "prognostic unfavorable (4.26e-4)" "unprognostic (2.70e-1)" "unprognostic (6.77e-2)" "unprognostic (2.79e-2)" "unprognostic (1.49e-1)" 40.2 75.2 66.9 34.3 68.6 31.4 61.3 72.1 84.4 53.2 73.6 50.9 43.4 38.3 78.3 60.2 90.5 42.4 46.7 68.4 73.6 79.1 84.8 44.1 51.8 71.6 71.5 42.7 48.1 58.3 50.9 43.9 73.6 57.3 46.4 33.3 64.6 47.0 48.8 49.7 44.4 37.4 73.2 36.1 46.8 22.6 69.1 52.3 81.6 45.4 49.3 51.8 50.0 77.5 201.8 136.8 100.8 78.1 86.7 128.8 134.9 102.1 90.8 81.2 79.5 197.2 158.3 123.2 102.2 90.8 148.3 79.9 93.1 118.6 88.1 146.4 149.5 110.8 89.7 225.5 76.5 114.3 66.8 87.4 135.6 87.4 76.9 109.1 130.4 55.1 132.5 85.3 125.6 219.4 128.8 228.9 139.2 184.3 140.5 104.0 118.9 155.7 144.2 137.1 162.5 115.9 101.2 141.1 143.6 118.2 98.3 82.1 100.5 73.9 119.1 69.2 125.4 99.9 161.3 166.2 77.6 123.2 91.7 177.6 101.0 150.8 95.5 99.9 116.5 165.9 133.5 119.4 100.5 135.6 118.1 112.0 117.3 105.8 112.8 91.5 200.3 130.6 66.9 68.6 72.1 84.4 68.4 73.6 71.6 71.5 73.6 73.2 69.1 77.5 65.7 51.3 61.5 10.1 61.7 98.0 107.7 233.5 53.5 17.9 110.5 135.1 71.3 80.1 140.8 103.0 0.0 190.2 41.0 84.2 283.7 114.3 64.5 388.8 59.7 62.9 92.1 55.5 16.0 117.2 252.4 63.1 44.4 107.3 46.9 65.1 63.1 102.7 123.5 21.9 17.7 107.6 175.0 65.4 67.2 18.5 72.4 58.7 65.8 13.1 106.8 50.8 55.6 13.6 26.7 125.7 117.8 88.0 40.6 130.5 138.4 296.7 396.4 26.8 85.5 52.4 108.4 65.7 57.4 72.0 122.6 138.7 67.3 67.7 109.0 127.5 DRICH1 C22orf43 ENSG00000189269 "Aspartate rich 1" Q6PGQ1 22 23608452-23632321 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 17.0;testis: 46.4" "Group enriched" "Detected in some" 44 "Early spermatids: 405.5;Late spermatids: 589.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "CACO-2: 11.1" HPA020446 Approved Nucleoplasm,Nucleoli No No "Cluster 68: Epididymis - Unknown function" "Cluster 39: CACO-2 - Unknown function" "Cluster 34: Spermatids - Unknown function" "Nucleoplasm, Nucleoli" "HPA020446: AB_1853151" "unprognostic (7.48e-3)" "unprognostic (3.91e-2)" "unprognostic (2.02e-2)" "unprognostic (6.22e-4)" "unprognostic (6.46e-2)" "unprognostic (8.35e-4)" "unprognostic (2.74e-1)" "unprognostic (2.24e-1)" "unprognostic (1.06e-2)" "unprognostic (2.65e-2)" "unprognostic (5.73e-4)" "unprognostic (3.05e-1)" "unprognostic (1.92e-1)" "unprognostic (8.65e-2)" "unprognostic (8.68e-3)" "unprognostic (7.70e-4)" "unprognostic (1.08e-3)" 0.8 1.4 1.3 1.1 1.5 3.7 2.2 3.0 1.9 1.0 2.4 1.3 1.1 3.3 17.0 0.6 1.7 1.8 0.4 0.9 1.1 2.6 0.7 1.3 2.3 1.1 1.2 3.0 2.4 9.2 1.4 0.8 1.1 1.4 1.3 3.9 1.5 2.0 0.2 3.3 1.1 1.5 0.7 2.0 0.8 46.4 1.1 1.4 1.7 0.0 0.8 0.6 0.7 1.0 0.5 0.6 1.5 0.4 1.8 0.4 1.3 0.0 0.0 0.0 0.0 11.1 0.4 0.7 0.1 0.4 0.3 1.1 2.1 0.1 0.3 0.1 1.0 0.4 1.1 0.5 0.6 0.2 1.6 0.8 0.9 0.3 0.0 0.6 0.3 0.3 0.9 0.2 0.1 0.5 0.2 0.5 0.1 0.5 0.6 1.2 0.0 0.0 0.3 1.2 0.6 0.5 0.0 0.9 0.7 0.3 0.2 0.0 0.3 0.0 1.8 1.7 0.2 0.6 1.1 0.1 1.8 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 1.5 3.0 1.9 0.9 1.1 1.1 1.2 1.1 0.7 1.1 1.0 0.1 0.0 0.0 4.9 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 1.8 0.0 0.1 0.3 0.1 0.0 0.1 405.5 0.4 0.0 0.3 1.8 0.0 9.1 0.0 0.1 0.1 0.0 0.1 0.0 0.4 0.0 0.0 0.1 0.0 11.3 0.4 0.0 0.0 0.0 589.5 4.1 0.2 0.0 3.7 0.0 0.0 0.0 1.5 1.4 0.1 1.2 1.5 0.0 0.1 0.4 0.3 0.0 0.0 0.0 0.0 0.0 4.4 2.2 0.0 0.0 0.1 0.1 0.1 0.2 0.0 DTD2 "C14orf126, MGC9912" ENSG00000129480 "D-aminoacyl-tRNA deacylase 2" Q96FN9 14 31446036-31457506 "Enzymes, Predicted intracellular proteins" "Hydrolase, RNA-binding, tRNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocyte precursor cells: 35.2;Oligodendrocytes: 40.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001117 Approved Approved Vesicles NA NA "Cluster 15: NK-cells - Transcription" "Cluster 68: Epididymis - Unknown function" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Vesicles "HPA001117: AB_2666204" "unprognostic (2.56e-3)" "unprognostic (9.38e-2)" "unprognostic (1.27e-3)" "unprognostic (3.24e-2)" "unprognostic (8.45e-2)" "prognostic unfavorable (9.33e-4)" "unprognostic (3.04e-2)" "unprognostic (1.64e-1)" "unprognostic (8.74e-3)" "unprognostic (2.91e-1)" "unprognostic (5.28e-2)" "unprognostic (6.96e-2)" "unprognostic (1.24e-1)" "unprognostic (2.32e-1)" "unprognostic (3.06e-2)" "unprognostic (1.22e-2)" "prognostic unfavorable (5.74e-6)" 8.6 6.3 4.7 4.9 6.8 2.3 7.1 5.2 6.5 4.0 5.2 4.8 3.9 5.2 5.0 5.7 4.9 3.5 3.1 5.3 5.3 5.8 8.1 5.8 5.5 5.5 5.9 5.3 6.3 6.1 4.4 4.3 5.9 5.7 5.4 5.0 6.0 3.9 1.6 5.6 3.7 5.5 4.9 4.9 4.0 4.0 6.2 5.0 6.2 1.6 5.5 4.7 3.8 8.1 11.4 9.5 8.1 10.6 14.6 12.3 5.5 10.3 10.0 8.0 7.1 5.2 10.7 21.6 6.8 11.8 8.6 10.8 13.0 11.6 13.6 11.7 5.7 6.2 6.5 29.0 15.7 12.6 7.3 14.0 12.9 7.1 15.9 6.7 11.8 12.8 12.3 9.9 10.7 13.7 18.3 11.3 11.0 19.6 9.7 12.3 6.0 11.3 15.0 9.8 12.1 8.0 16.8 21.6 12.4 6.9 19.8 6.5 8.6 8.7 7.7 7.1 9.1 12.3 24.5 20.7 3.8 11.4 14.3 2.5 2.6 1.0 2.0 2.2 2.9 2.7 3.0 2.2 3.7 3.2 4.5 3.0 1.5 3.7 1.2 2.2 1.6 2.8 4.7 6.8 5.2 6.5 5.3 5.3 5.5 5.9 5.9 4.9 6.2 8.1 2.9 9.6 9.0 10.1 7.6 5.2 5.7 5.1 13.1 5.9 6.1 4.3 4.8 15.7 4.9 3.7 8.4 9.1 4.9 3.3 3.9 5.7 4.4 6.8 7.2 3.8 3.0 8.0 9.2 6.2 6.3 6.2 5.1 3.0 1.3 5.9 3.9 11.6 5.1 5.0 12.7 6.7 14.2 5.5 3.7 6.6 7.5 4.0 3.6 2.8 4.8 9.5 7.2 35.2 40.2 5.2 3.9 8.2 7.1 6.0 3.3 9.7 6.2 9.2 0.0 7.4 6.8 10.1 2.7 16.2 5.4 2.7 5.4 10.3 7.2 4.2 DUSP19 "DUSP17, SKRP1" ENSG00000162999 "Dual specificity phosphatase 19" Q8WTR2 2 183078559-183100008 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 15.2;Endometrial ciliated cells: 17.7;Respiratory ciliated cells: 15.7;Spermatocytes: 15.5" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 6 "amygdala: 1.3;basal ganglia: 2.4;cerebral cortex: 2.7;hippocampal formation: 3.8" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 7.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021501 Approved Approved Nucleoplasm Yes No "Cluster 35: T-regs - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 3: HMC-1 - Innate immune response" "Cluster 49: Ciliated cells - Cilium organization" Nucleoplasm "HPA021501: AB_1847892" "unprognostic (1.24e-1)" "unprognostic (2.13e-2)" "unprognostic (1.21e-1)" "unprognostic (1.64e-1)" "unprognostic (5.18e-2)" "unprognostic (2.44e-1)" "unprognostic (1.21e-1)" "unprognostic (1.88e-1)" "unprognostic (8.30e-2)" "unprognostic (1.49e-2)" "unprognostic (3.33e-2)" "unprognostic (6.53e-2)" "unprognostic (5.80e-3)" "unprognostic (6.97e-2)" "unprognostic (2.91e-2)" "unprognostic (2.16e-2)" "unprognostic (2.75e-2)" 1.1 1.4 1.3 0.8 2.4 0.3 1.1 0.0 2.7 1.2 0.1 1.4 1.4 1.4 3.5 1.4 3.2 1.3 3.1 3.8 0.1 1.8 1.1 1.3 1.0 0.1 0.0 1.6 0.9 1.6 1.2 1.0 0.0 1.5 1.0 1.2 0.9 1.9 1.6 1.3 1.1 1.9 0.0 1.6 3.9 3.7 0.0 1.2 1.7 1.7 0.7 1.1 0.6 0.4 0.1 1.6 1.8 0.9 2.5 1.4 0.0 0.7 1.1 2.9 1.0 1.5 1.9 0.6 3.8 0.8 2.1 0.2 3.8 0.5 2.3 3.9 1.8 7.1 1.1 1.0 1.0 1.8 4.2 1.1 0.3 1.3 0.7 1.8 1.5 0.0 2.2 1.0 1.8 0.6 3.4 1.6 1.5 0.6 1.2 3.3 2.9 0.2 0.6 0.7 2.3 0.9 2.6 1.1 2.0 0.1 0.5 0.6 1.3 1.6 1.3 1.1 0.6 1.3 1.6 0.0 2.0 0.3 2.4 0.7 0.1 0.6 0.6 0.2 0.6 1.1 0.5 0.8 0.1 0.5 0.7 0.7 0.3 0.7 0.1 0.4 1.0 0.3 1.3 2.4 0.0 2.7 3.8 0.1 0.1 0.0 0.0 0.0 0.0 0.4 2.5 0.0 3.2 0.7 1.6 1.0 1.3 1.1 3.4 1.8 2.1 2.7 8.3 1.5 1.8 1.8 2.1 2.0 0.8 1.5 5.9 0.9 15.2 17.7 2.3 3.3 2.4 0.0 9.9 0.7 1.5 1.7 3.6 1.5 1.3 3.0 2.9 1.9 0.6 1.7 7.8 1.9 0.0 0.8 0.3 6.0 1.8 2.2 0.0 1.0 1.1 4.8 2.1 4.0 3.1 0.6 3.4 2.6 0.3 0.7 2.2 2.9 15.7 1.5 0.0 1.9 4.4 15.5 3.8 2.3 1.6 0.7 1.2 3.6 1.8 1.1 DYRK4 ENSG00000010219 "Dual specificity tyrosine phosphorylation regulated kinase 4" Q9NR20 12 4562204-4615302 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 36.7" "Group enriched" "Detected in all" 5 "Early spermatids: 392.2;Late spermatids: 393.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA028065, HPA056073" Enhanced Enhanced Vesicles No No "Cluster 14: Monocytes - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 34: Spermatids - Unknown function" Vesicles "HPA028065: AB_10601212, HPA056073: AB_2683028" "unprognostic (2.50e-1)" "unprognostic (1.55e-1)" "unprognostic (1.22e-1)" "unprognostic (3.56e-3)" "unprognostic (2.62e-1)" "unprognostic (4.07e-3)" "unprognostic (2.03e-2)" "unprognostic (4.69e-2)" "unprognostic (1.29e-1)" "unprognostic (7.13e-2)" "unprognostic (1.22e-2)" "unprognostic (2.46e-1)" "prognostic unfavorable (6.52e-6)" "unprognostic (1.86e-1)" "unprognostic (9.71e-2)" "unprognostic (1.04e-1)" "unprognostic (3.98e-2)" 2.1 4.2 3.9 3.4 4.2 4.6 6.4 5.1 7.6 5.9 4.2 5.4 4.6 5.0 17.0 4.0 5.0 4.4 4.7 4.2 4.4 3.5 4.2 4.7 5.9 4.4 4.5 5.1 3.0 5.0 3.6 6.8 4.8 5.0 6.2 7.7 3.7 7.2 2.2 4.9 4.0 5.1 4.1 6.2 3.2 36.7 4.8 4.3 9.1 4.1 5.4 4.7 2.0 5.7 2.0 3.2 3.9 4.3 5.8 7.1 4.7 2.4 4.8 5.4 5.9 0.6 3.2 6.1 0.3 6.9 3.7 4.2 3.0 4.5 4.2 4.7 6.8 4.2 1.0 3.6 16.4 3.7 3.3 4.9 9.6 3.8 12.4 10.1 7.8 6.5 1.8 6.7 4.9 4.3 3.5 9.1 5.3 1.0 1.8 0.7 2.8 2.6 6.7 1.9 0.0 1.5 0.5 2.4 3.3 8.4 1.9 3.3 0.5 6.3 4.9 0.6 3.1 1.9 2.6 3.8 3.3 5.8 3.3 0.3 1.7 0.8 0.5 1.3 0.6 4.4 0.8 0.9 1.6 3.0 0.8 0.9 0.0 0.7 3.5 0.8 0.7 0.8 3.9 4.2 5.1 7.6 4.2 4.4 4.4 4.5 4.8 4.1 4.8 5.7 13.0 12.8 16.2 11.1 15.8 8.9 13.2 31.2 14.8 20.7 21.2 30.4 23.8 7.2 19.9 16.5 10.4 15.7 16.7 5.2 31.3 25.1 392.2 14.0 22.5 15.5 5.4 12.2 10.3 27.1 12.0 17.3 14.3 13.3 17.7 19.0 8.2 9.8 49.7 13.5 10.4 75.4 14.2 16.1 9.3 393.1 15.2 18.7 16.0 9.4 14.5 19.4 13.4 14.1 16.1 20.1 14.2 31.6 22.9 16.4 7.3 35.6 13.9 21.7 6.6 15.2 17.6 23.7 39.0 20.4 7.5 9.9 12.7 40.6 17.3 11.8 EGR2 KROX20 ENSG00000122877 "Early growth response 2" P11161 10 62811996-62919900 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation, Ubl conjugation pathway" "Activator, DNA-binding, Transferase" "Charcot-Marie-Tooth disease, Dejerine-Sottas syndrome, Disease variant, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 59.9;thyroid gland: 136.4" "Cell type enhanced" "Detected in many" "Breast glandular cells: 55.5;Breast myoepithelial cells: 68.1;Enteroendocrine cells: 73.1" "Cancer enhanced" "Detected in all" "thyroid cancer: 19.7" "Group enriched" "Detected in many" 5 "cerebral cortex: 10.2;hippocampal formation: 5.2" "Immune cell enhanced" "Detected in some" "intermediate monocyte: 2.5;non-classical monocyte: 2.3" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 5 "U-87 MG: 22.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA031165 Supported Nucleoplasm NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "HPA031165: AB_2673768" "prognostic favorable (7.30e-5)" "unprognostic (1.86e-3)" "unprognostic (1.45e-2)" "unprognostic (8.72e-2)" "unprognostic (2.92e-2)" "unprognostic (1.29e-1)" "unprognostic (2.70e-1)" "unprognostic (1.75e-1)" "unprognostic (9.79e-2)" "unprognostic (1.15e-1)" "unprognostic (1.18e-1)" "unprognostic (1.27e-1)" "unprognostic (2.47e-3)" "unprognostic (6.54e-2)" "unprognostic (1.74e-2)" "unprognostic (3.46e-1)" "unprognostic (1.11e-3)" 13.7 10.6 0.4 9.8 1.2 8.2 8.6 1.3 10.2 18.5 2.0 3.3 1.9 6.0 59.9 8.8 4.5 31.9 14.9 5.2 0.2 7.9 5.4 15.2 14.4 0.3 0.3 9.4 4.2 7.0 8.7 3.0 0.7 17.5 3.7 1.4 2.9 1.9 0.9 14.2 4.6 16.8 0.1 4.5 2.3 4.1 0.6 26.4 136.4 9.1 7.1 15.7 1.7 1.5 0.0 0.2 2.5 1.0 1.8 2.4 0.4 0.5 0.2 0.6 0.8 0.0 0.3 0.6 0.0 0.6 0.7 0.3 0.2 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.6 3.8 0.3 0.6 1.3 0.2 0.8 0.1 0.3 0.2 0.8 0.1 1.2 0.0 1.8 0.2 0.1 1.1 0.1 0.3 0.4 0.0 0.2 0.1 0.3 0.2 0.5 4.2 0.5 0.0 0.5 0.1 0.5 0.4 0.2 0.3 1.3 0.7 0.3 22.5 0.5 0.4 0.0 0.5 0.2 0.1 2.5 0.0 0.4 0.0 0.1 0.5 0.4 0.0 0.1 0.7 0.2 2.3 0.0 0.0 0.4 0.4 1.2 1.3 10.2 5.2 0.2 0.3 0.3 0.7 0.1 0.6 1.5 15.9 0.0 12.6 0.0 14.0 21.3 30.1 36.0 33.0 1.4 55.5 68.1 7.8 0.0 9.4 0.0 0.0 1.1 9.9 9.5 0.0 1.4 8.9 13.9 14.0 16.7 73.1 0.0 1.7 0.6 1.6 30.4 13.3 26.1 20.8 2.3 5.3 2.4 25.2 0.0 0.5 29.4 14.2 28.1 39.5 4.3 1.8 40.5 8.8 0.0 0.8 4.1 0.0 0.0 0.1 1.0 4.4 7.2 6.4 5.5 7.7 0.0 7.1 0.7 6.6 20.7 12.0 0.1 2.0 14.8 12.5 1.1 13.6 5.1 25.8 3.1 EMILIN3 "C20orf130, dJ620E11.4, EMILIN5" ENSG00000183798 "Elastin microfibril interfacer 3" Q9NT22 20 41359962-41366818 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "epididymis: 53.6" "Cell type enhanced" "Detected in some" "Endometrial stromal cells: 17.7;Granulosa cells: 7.6;Microglial cells: 4.7;Oligodendrocyte precursor cells: 3.5;Peritubular cells: 4.9;Skeletal myocytes: 3.2" "Group enriched" "Detected in many" 5 "glioma: 10.8;testis cancer: 2.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 6.3;HAP1: 11.1;NTERA-2: 7.0;SCLC-21H: 13.0" "Region enriched" "Detected in single" 30 "cerebellum: 3.3" "Region enriched" "Detected in single" 4 "spinal cord: 4.1" "HPA044034, HPA059912, HPA078559" Enhanced Approved "Golgi apparatus,Microtubules,Cytokinetic bridge" "Secreted to extracellular matrix" Yes NA 1200000 "Cluster 68: Epididymis - Unknown function" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 36: Stromal cells - Cell proliferation" "Golgi apparatus" "Microtubules, Cytokinetic bridge" "HPA044034: AB_2678783, HPA059912: AB_2684158, HPA078559: " "unprognostic (1.66e-4)" "unprognostic (1.85e-2)" "unprognostic (2.50e-2)" "unprognostic (2.14e-1)" "unprognostic (2.65e-1)" "unprognostic (2.15e-2)" "unprognostic (1.71e-1)" "unprognostic (7.66e-2)" "unprognostic (2.18e-3)" "unprognostic (2.57e-1)" "unprognostic (6.54e-2)" "unprognostic (7.66e-2)" "unprognostic (3.13e-7)" "unprognostic (2.64e-2)" "unprognostic (1.05e-1)" "unprognostic (1.97e-1)" "unprognostic (9.62e-2)" 0.6 1.4 2.5 0.1 2.4 0.0 3.5 2.3 3.8 8.6 1.8 4.9 0.6 2.3 53.6 0.8 4.2 0.3 7.8 2.1 2.2 1.0 0.6 0.3 0.1 3.7 2.7 8.9 0.2 0.1 1.8 0.0 3.0 6.7 0.3 0.0 1.0 9.9 0.9 3.9 1.7 0.9 2.5 0.1 2.0 1.7 2.6 0.5 0.3 2.6 0.2 2.3 4.7 3.0 0.0 0.1 6.3 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.3 0.0 0.0 0.1 0.0 0.4 0.0 11.1 0.0 0.2 0.0 1.3 0.0 0.0 0.4 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 13.0 1.3 0.0 0.0 0.0 2.5 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 2.4 2.3 3.8 2.1 2.2 3.7 2.7 3.0 2.5 2.6 3.0 0.6 0.0 0.0 0.7 0.0 0.9 0.2 0.0 0.0 0.3 1.2 2.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 17.7 0.4 0.0 0.0 1.1 0.0 0.0 0.8 0.0 0.7 0.0 7.6 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.3 1.8 0.1 0.0 4.7 0.0 0.1 0.0 3.5 0.1 0.0 1.2 4.9 0.0 0.2 0.3 0.1 0.0 0.0 0.0 3.2 0.6 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.2 0.1 EMX2 ENSG00000170370 "Empty spiracles homeobox 2" Q04743 10 117542445-117549546 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 79.0;epididymis: 104.3" "Cell type enhanced" "Detected in many" "Collecting duct cells: 239.1;Distal tubular cells: 90.1;Endometrial ciliated cells: 75.6;Endometrial stromal cells: 126.5;Glandular and luminal cells: 68.6;Granulosa cells: 88.3;Proximal tubular cells: 185.0" "Group enriched" "Detected in many" 13 "endometrial cancer: 40.8;ovarian cancer: 52.8;renal cancer: 18.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 25.4;fHDF/TERT166: 31.6;RPTEC TERT1: 31.1;RT4: 9.4" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "amygdala: 13.3;basal ganglia: 14.2;cerebral cortex: 17.8;hippocampal formation: 22.8;white matter: 8.1" "HPA003497, HPA065294" Enhanced Supported Approved Nucleoplasm NA NA "Cluster 42: Non-specific - Transcription" "Cluster 68: Epididymis - Unknown function" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Nucleoplasm "HPA003497: , HPA065294: AB_2685455" "unprognostic (1.53e-1)" "prognostic favorable (2.80e-4)" "unprognostic (7.21e-3)" "unprognostic (5.41e-3)" "unprognostic (1.69e-1)" "unprognostic (3.53e-2)" "unprognostic (1.34e-1)" "unprognostic (2.41e-1)" "unprognostic (7.33e-2)" "unprognostic (1.76e-1)" "unprognostic (2.77e-1)" "prognostic favorable (2.28e-13)" "unprognostic (3.65e-2)" "unprognostic (1.05e-1)" "unprognostic (4.17e-2)" "unprognostic (1.88e-2)" 10.4 0.1 23.2 0.2 25.6 0.2 2.8 16.9 31.3 58.2 16.7 0.4 0.1 79.0 104.3 0.4 53.0 1.5 0.8 26.9 16.5 39.1 0.1 0.1 0.6 15.8 18.0 11.9 0.0 0.1 1.8 0.4 16.4 1.1 0.1 0.3 2.4 52.6 10.8 10.5 0.1 45.0 14.7 0.2 0.1 1.2 19.6 0.1 0.3 5.2 0.4 4.7 4.4 22.9 0.0 0.0 0.0 2.6 0.0 0.3 0.1 1.9 0.0 0.0 0.0 0.0 0.1 0.0 25.4 31.6 0.0 0.1 0.6 0.0 0.0 0.1 2.8 0.8 0.1 0.2 0.0 0.1 0.2 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 6.1 0.2 31.1 9.4 0.2 0.2 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.1 2.6 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 23.2 25.6 16.9 31.3 26.9 16.5 15.8 18.0 16.4 14.7 19.6 22.9 4.6 0.0 0.0 43.4 1.0 10.7 2.0 0.0 0.0 0.0 0.1 0.5 1.0 0.0 0.0 239.1 0.0 0.2 0.0 0.1 90.1 0.0 1.4 75.6 126.5 3.1 0.0 0.0 0.1 0.0 0.3 18.0 0.0 68.6 0.0 88.3 0.0 0.0 0.6 0.0 0.1 0.2 0.0 0.0 8.0 2.6 60.3 2.5 21.4 1.9 0.0 0.0 0.0 1.5 0.1 0.0 0.0 41.0 0.0 2.5 0.1 185.0 0.0 0.1 52.6 8.6 32.1 0.3 0.3 0.0 7.5 0.1 2.2 2.2 0.3 1.7 ENPP5 ENSG00000112796 "Ectonucleotide pyrophosphatase/phosphodiesterase family member 5" Q9UJA9 6 46159185-46170980 "Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "epididymis: 243.6" "Cell type enhanced" "Detected in many" "Muller glia cells: 100.1;Respiratory ciliated cells: 47.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "gdT-cell: 14.9" "Lineage enriched" "Detected in many" 5 "T-cells: 14.9" "Cell line enhanced" "Detected in some" "CAPAN-2: 11.1;HSkMC: 7.1;SuSa: 6.2;T-47d: 8.7;U-266/84: 7.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016902 Enhanced Approved Nucleoplasm,Cytosol "Intracellular and membrane" NA NA 620000 "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 68: Epididymis - Unknown function" "Cluster 29: U-266 - Adaptive immune response" "Cluster 5: Muller glia cells - Visual perception" Cytosol Nucleoplasm "HPA016902: AB_1848172" "unprognostic (1.12e-1)" "unprognostic (5.19e-2)" "unprognostic (1.98e-1)" "unprognostic (1.32e-1)" "unprognostic (7.61e-2)" "unprognostic (1.63e-1)" "unprognostic (5.01e-2)" "prognostic favorable (4.57e-4)" "unprognostic (1.96e-1)" "unprognostic (9.89e-2)" "prognostic favorable (4.04e-4)" "unprognostic (7.00e-2)" "prognostic favorable (4.44e-13)" "unprognostic (4.40e-2)" "unprognostic (2.78e-2)" "unprognostic (1.61e-1)" "unprognostic (1.60e-1)" 1.8 8.6 6.2 1.1 7.6 0.2 13.4 6.9 12.6 12.8 4.0 2.6 1.5 1.8 243.6 1.8 15.4 7.0 4.4 7.0 9.7 24.3 0.5 8.8 1.2 5.8 13.0 9.7 9.7 46.3 19.8 1.7 6.2 29.4 3.2 30.6 14.4 31.0 10.7 1.6 1.9 0.9 4.5 5.7 6.7 35.5 14.0 8.2 51.0 10.3 1.4 5.6 1.8 6.3 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.5 0.1 0.3 11.1 1.8 3.6 0.2 3.7 0.0 0.6 1.5 0.1 0.0 2.4 0.7 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.4 1.9 0.0 0.5 2.3 5.4 0.0 0.0 0.2 0.2 4.5 0.6 4.7 0.2 0.0 4.6 0.0 6.2 8.7 0.0 0.0 0.0 1.2 0.0 0.1 5.3 7.9 0.0 2.8 0.0 0.1 0.0 0.0 0.0 14.9 0.1 8.0 0.5 3.0 9.7 0.0 0.8 0.9 8.7 1.1 2.8 0.0 0.0 0.0 3.2 6.2 7.6 6.9 12.6 7.0 9.7 5.8 13.0 6.2 4.5 14.0 6.3 0.4 12.8 12.2 16.3 1.6 0.9 4.8 0.5 1.2 10.6 18.1 10.8 7.5 8.6 6.1 23.9 4.2 4.9 4.2 1.9 1.9 11.6 0.7 15.3 0.8 0.4 8.3 0.0 24.6 7.5 2.9 4.2 2.0 5.4 4.5 4.0 0.4 0.1 0.4 10.1 14.5 2.8 2.0 0.0 0.4 3.8 2.8 0.5 0.0 1.9 0.6 100.1 23.7 9.0 10.5 2.2 2.3 12.0 0.1 12.0 1.7 16.3 47.3 3.4 6.6 25.7 1.8 0.5 2.4 1.1 0.6 0.3 3.2 21.2 2.9 3.3 EPB41L4A NBL4 ENSG00000129595 "Erythrocyte membrane protein band 4.1 like 4A" Q9HCS5 5 112142441-112419313 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cholangiocytes: 64.3;Oligodendrocyte precursor cells: 164.4;Oligodendrocytes: 65.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "EFO-21: 30.1;HeLa: 36.5;RT4: 21.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA036580 Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 68: Epididymis - Unknown function" "Cluster 20: HeLa - Mitochondria" "Cluster 68: Oligodendrocytes - Mixed function" "Plasma membrane" Nucleoplasm "HPA036580: AB_10669908" "unprognostic (1.40e-1)" "unprognostic (1.90e-1)" "unprognostic (1.92e-3)" "unprognostic (3.64e-2)" "unprognostic (4.73e-2)" "unprognostic (5.59e-3)" "unprognostic (4.40e-2)" "unprognostic (8.38e-2)" "unprognostic (1.90e-1)" "unprognostic (3.97e-2)" "unprognostic (1.22e-1)" "unprognostic (1.23e-3)" "prognostic favorable (3.65e-5)" "unprognostic (1.68e-1)" "unprognostic (3.35e-2)" "unprognostic (2.73e-1)" "unprognostic (1.92e-1)" 8.7 4.5 4.8 3.2 5.7 3.6 5.3 4.1 4.8 4.1 9.0 4.0 2.6 4.3 12.7 10.1 7.4 13.8 9.2 6.0 5.1 11.7 3.3 7.7 3.3 5.7 4.6 5.7 4.9 8.0 0.5 9.3 4.8 5.8 4.8 16.0 7.2 5.4 4.2 8.8 3.4 2.7 4.9 4.7 5.6 6.1 4.8 3.6 13.5 4.2 3.6 5.1 2.3 4.8 0.8 5.5 14.3 1.5 0.0 0.0 2.9 2.1 0.0 0.0 0.0 3.0 12.3 6.2 30.1 0.0 0.8 7.4 1.1 6.9 0.0 1.0 5.0 9.8 36.5 2.0 0.1 2.6 3.1 0.0 3.0 0.0 0.0 1.6 9.2 1.7 1.9 5.6 0.0 1.8 4.6 3.5 2.7 1.2 1.1 2.3 10.7 1.3 8.4 21.6 11.8 6.1 10.7 5.2 4.5 9.8 15.9 1.4 15.7 0.7 2.4 1.9 4.4 5.6 1.3 4.6 1.4 5.2 0.8 0.5 0.2 0.1 2.0 0.3 1.1 1.4 0.6 0.6 0.2 1.6 0.9 1.8 0.2 0.1 0.5 0.1 0.6 0.5 4.8 5.7 4.1 4.8 6.0 5.1 5.7 4.6 4.8 4.9 4.8 4.8 55.9 28.9 7.7 17.3 4.7 6.0 16.8 11.2 13.6 5.0 11.2 4.7 8.3 64.3 24.2 14.7 4.2 7.4 4.5 8.5 11.7 15.0 20.8 19.7 3.1 35.2 1.2 2.1 28.6 7.5 0.7 8.4 7.1 17.1 8.8 11.9 34.6 1.7 2.7 1.7 31.8 6.3 16.2 4.6 2.1 23.0 1.8 1.8 3.6 56.2 3.2 8.2 14.4 164.4 65.4 14.1 10.9 1.9 6.5 13.7 1.9 30.4 39.5 32.1 0.0 8.7 6.0 1.8 9.1 16.0 8.1 2.5 3.7 2.2 7.5 19.1 EPPIN "CT71, dJ461P17.2, EPPIN1, EPPIN2, EPPIN3, SPINLW1, WAP7, WFDC7" ENSG00000101448 "Epididymal peptidase inhibitor" O95925 20 45540626-45547752 "Predicted intracellular proteins, Predicted secreted proteins" "Antimicrobial, Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 83 "epididymis: 327.9;testis: 84.2" "Group enriched" "Detected in some" 4 "Endometrial ciliated cells: 30.0;Granulosa cells: 13.6;Late spermatids: 29.2;Respiratory ciliated cells: 32.5;Sertoli cells: 13.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 1.8;U-87 MG: 2.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA067335 Supported "Secreted in male reproductive system" NA NA "Cluster 38: Basophils - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 49: Ciliated cells - Cilium organization" "HPA067335: " "unprognostic (1.17e-1)" "unprognostic (1.79e-1)" "unprognostic (3.08e-3)" "unprognostic (1.06e-2)" "unprognostic (3.75e-2)" "unprognostic (1.69e-1)" "unprognostic (2.94e-2)" "unprognostic (2.00e-2)" 0.3 0.3 0.7 0.3 1.1 2.4 0.2 1.9 2.4 0.5 0.1 0.4 0.7 0.7 327.9 0.3 1.3 0.2 0.1 0.9 0.0 0.2 2.3 0.4 0.5 0.1 0.0 0.2 0.1 0.0 0.0 0.2 0.6 0.2 0.4 1.2 0.3 0.8 0.2 0.8 0.7 0.1 0.0 0.4 0.2 84.2 0.4 0.0 0.7 0.0 0.2 0.1 0.0 2.0 0.8 0.1 0.3 0.3 0.0 0.1 0.5 0.8 0.0 0.0 0.0 0.5 0.3 0.6 0.3 0.0 0.6 0.3 0.1 0.0 0.0 0.5 0.1 0.3 0.5 0.4 0.0 0.2 0.8 0.0 0.0 0.1 0.0 0.1 0.0 0.4 0.6 1.8 0.0 0.4 0.2 0.7 0.8 0.1 0.2 0.7 0.2 0.5 0.1 0.2 0.3 0.5 0.3 0.1 0.3 0.3 0.4 0.4 0.7 0.7 0.6 0.9 0.5 0.6 0.8 0.3 2.6 0.2 0.8 0.8 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.7 1.1 1.9 2.4 0.9 0.0 0.1 0.0 0.6 0.0 0.4 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.1 0.1 0.4 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 30.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 13.6 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 29.2 4.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 32.5 0.0 13.1 0.0 0.4 5.6 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 EPPIN-WFDC6 SPINLW1-WFDC6 ENSG00000249139 "EPPIN-WFDC6 readthrough" O95925 20 45534196-45547662 "Predicted secreted proteins" "Antimicrobial, Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 78 "epididymis: 63.6;testis: 53.6" "Cell type enriched" "Detected in single" 6 "Respiratory ciliated cells: 3.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA067335 Supported "Secreted in male reproductive system" NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 49: Ciliated cells - Cilium organization" "HPA067335: " "unprognostic (1.46e-3)" "unprognostic (6.38e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 63.6 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 53.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ERG28 "C14orf1, NET51" ENSG00000133935 "Ergosterol biosynthesis 28 homolog" Q9UKR5 14 75649791-75660876 "Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 152.0;Ductal cells: 95.4;Exocrine glandular cells: 110.3;Extravillous trophoblasts: 154.2;Syncytiotrophoblasts: 116.3;Theca cells: 121.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043172 Approved NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 68: Epididymis - Unknown function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 7: Non-specific - Mitochondria" "HPA043172: AB_10793942" "unprognostic (2.68e-3)" "unprognostic (2.11e-2)" "unprognostic (4.55e-1)" "unprognostic (2.05e-1)" "unprognostic (1.75e-1)" "unprognostic (1.34e-3)" "unprognostic (6.25e-2)" "unprognostic (7.66e-2)" "unprognostic (4.64e-1)" "unprognostic (2.66e-2)" "unprognostic (2.47e-1)" "unprognostic (3.01e-2)" "prognostic favorable (4.30e-5)" "unprognostic (1.28e-1)" "unprognostic (2.77e-1)" "unprognostic (9.58e-3)" "unprognostic (2.20e-1)" 9.8 27.7 24.0 9.1 23.3 13.2 17.3 24.6 26.2 16.9 25.1 16.5 21.6 14.9 40.6 34.6 16.9 11.9 13.6 24.6 25.0 18.5 70.2 22.6 11.5 26.2 25.2 20.0 16.1 29.7 17.4 14.9 25.4 21.2 15.5 19.4 19.9 13.8 10.3 24.8 14.5 14.6 25.4 8.3 13.6 47.1 25.8 10.2 21.5 11.3 14.6 12.5 20.1 27.5 39.2 21.6 42.7 33.5 28.6 53.1 26.6 15.6 48.2 29.9 51.0 33.8 91.4 16.6 22.3 19.6 59.7 42.4 38.5 67.0 34.0 31.2 25.4 17.8 20.5 48.4 41.4 19.7 25.5 66.5 56.7 42.9 23.8 24.0 35.3 44.7 16.0 39.3 20.9 77.7 30.2 21.8 41.8 62.5 34.7 23.9 28.7 33.0 99.8 50.5 36.6 20.1 39.2 33.5 24.1 37.8 56.1 28.3 25.1 16.1 32.0 15.8 15.8 25.3 32.5 36.1 25.7 28.5 27.7 33.5 12.3 20.0 40.0 12.7 39.5 39.4 43.1 41.8 29.8 34.5 39.1 38.5 6.6 31.8 13.2 38.4 42.7 31.9 24.0 23.3 24.6 26.2 24.6 25.0 26.2 25.2 25.4 25.4 25.8 27.5 18.8 22.4 57.5 0.0 9.3 0.0 0.0 0.0 0.0 0.0 74.7 57.7 0.0 0.0 11.2 60.7 0.0 152.0 23.6 0.0 49.0 95.4 0.0 43.4 11.5 18.0 0.0 0.0 0.0 110.3 154.2 21.4 0.0 30.3 5.1 63.2 0.0 0.0 64.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.4 0.0 0.0 37.7 0.0 0.0 0.0 0.0 76.9 0.0 0.0 3.5 0.0 0.0 47.1 18.2 0.0 0.0 0.0 14.4 0.0 0.0 0.0 0.0 116.3 12.4 121.2 0.0 0.0 ERGIC3 "C20orf47, CGI-54, Erv46, NY-BR-84, PRO0989, SDBCAG84" ENSG00000125991 "ERGIC and golgi 3" Q9Y282 20 35542038-35557634 "Predicted intracellular proteins, Predicted membrane proteins" "ER-Golgi transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 711.0;Late spermatids: 708.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015242, HPA015968" Approved NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 68: Epididymis - Unknown function" "Cluster 21: OE19 - Mitochondria" "Cluster 34: Spermatids - Unknown function" "HPA015242: AB_1848238, HPA015968: AB_1848239" "unprognostic (4.36e-2)" "unprognostic (3.43e-2)" "unprognostic (1.18e-1)" "unprognostic (1.16e-1)" "unprognostic (1.93e-1)" "unprognostic (1.93e-2)" "prognostic unfavorable (2.20e-7)" "unprognostic (2.61e-1)" "unprognostic (2.90e-2)" "unprognostic (9.59e-2)" "unprognostic (8.59e-2)" "unprognostic (2.37e-1)" "prognostic unfavorable (9.81e-5)" "unprognostic (9.53e-2)" "unprognostic (1.43e-1)" "unprognostic (1.12e-1)" "unprognostic (8.64e-2)" 123.3 167.5 123.4 77.7 124.6 164.5 174.9 124.4 180.6 161.8 183.3 154.6 124.2 127.4 456.9 146.9 325.4 135.1 123.8 123.8 131.5 145.3 181.0 115.1 99.4 128.2 129.9 188.3 270.3 188.0 86.9 151.3 128.2 125.9 190.9 67.0 196.9 142.3 103.5 151.4 110.4 142.6 124.7 108.3 162.0 211.6 133.9 119.9 199.8 95.2 154.6 154.0 137.5 128.2 173.2 317.5 161.8 282.4 553.6 417.1 210.1 234.4 503.7 378.3 374.0 726.9 354.2 127.4 214.4 495.4 332.8 249.5 137.7 371.9 279.0 62.8 252.5 272.6 221.1 453.2 285.2 240.1 193.2 462.8 578.1 235.1 298.7 432.5 251.1 163.0 189.8 399.3 307.0 379.1 191.4 354.0 93.4 645.1 305.1 143.1 378.8 365.5 315.6 298.7 155.4 225.5 353.4 286.0 284.7 159.8 276.5 389.0 209.8 429.5 169.0 178.0 208.1 164.7 107.0 102.5 461.2 126.4 235.5 98.5 188.7 106.7 117.9 182.2 143.3 157.9 139.2 130.4 228.7 146.6 136.0 139.9 62.0 150.7 158.9 226.6 177.0 237.8 123.4 124.6 124.4 180.6 123.8 131.5 128.2 129.9 128.2 124.7 133.9 128.2 48.1 35.3 79.9 14.4 107.1 184.2 209.7 289.4 150.2 27.1 194.3 150.2 37.1 153.0 190.7 62.5 18.8 476.5 80.6 224.5 117.4 210.6 711.0 215.5 99.4 101.8 112.6 93.2 8.9 269.8 490.7 122.7 114.7 77.5 78.0 94.7 146.3 146.4 208.1 16.8 10.1 246.9 152.5 148.2 192.5 708.4 105.3 100.4 190.3 8.4 126.7 76.8 82.4 8.0 13.6 185.0 283.1 94.0 344.1 189.8 213.4 207.5 340.2 31.3 118.3 100.5 122.0 415.9 170.5 172.6 200.6 589.4 86.8 111.3 264.6 292.3 ERV3-1 "envR, ERV-R, ERV3, H-PLK, HERV-R" ENSG00000213462 "Endogenous retrovirus group 3 member 1, envelope" Q14264 7 64990356-65006743 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 7.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AN3-CA: 27.7" "HPA017209, HPA046508" Enhanced Approved Vesicles NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 68: Epididymis - Unknown function" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 52: Non-specific - Transcription" Vesicles "HPA017209: AB_2732419, HPA046508: AB_2732525" "unprognostic (2.74e-2)" "unprognostic (1.84e-1)" "unprognostic (2.11e-1)" "unprognostic (1.27e-2)" "unprognostic (4.48e-1)" "unprognostic (2.03e-1)" "unprognostic (7.00e-2)" "unprognostic (1.79e-1)" "unprognostic (4.05e-3)" "unprognostic (3.55e-1)" "unprognostic (1.57e-2)" "unprognostic (4.45e-2)" "unprognostic (4.27e-3)" "unprognostic (2.11e-1)" "unprognostic (2.19e-1)" "unprognostic (9.39e-2)" "unprognostic (1.88e-2)" 22.8 33.0 4.8 8.5 4.5 9.3 15.0 4.1 6.4 10.0 5.1 5.7 3.5 10.0 32.5 15.2 8.0 16.4 6.2 4.7 6.2 4.8 3.2 9.7 5.7 6.2 7.9 7.3 5.3 15.3 8.2 13.4 5.4 7.3 5.7 13.5 12.1 7.5 3.6 12.3 4.5 7.6 4.8 6.9 6.3 8.7 5.9 6.6 7.6 1.8 7.4 6.2 11.5 5.1 3.3 1.0 17.4 27.7 11.3 4.7 12.4 5.7 6.3 2.0 4.6 1.2 20.5 5.5 5.3 2.2 4.0 3.9 2.6 1.5 3.2 4.1 1.5 2.8 1.6 11.5 1.0 6.7 3.7 5.1 1.6 1.8 0.6 10.4 11.6 6.0 12.7 10.3 8.1 8.1 4.9 5.0 5.1 10.8 1.2 11.4 0.7 3.7 3.5 6.8 3.6 16.8 6.2 1.9 0.7 18.9 4.7 16.4 9.2 6.7 1.0 5.1 2.8 3.2 7.8 1.6 5.7 20.8 4.1 0.0 1.0 2.4 0.6 1.8 0.5 0.4 0.1 0.4 0.8 0.5 0.3 0.4 7.0 1.1 0.5 0.4 1.2 0.6 4.8 4.5 4.1 6.4 4.7 6.2 6.2 7.9 5.4 4.8 5.9 5.1 7.1 3.2 13.1 17.9 32.5 4.2 15.6 17.0 7.4 24.8 13.7 10.4 2.1 24.3 25.5 16.5 29.2 16.5 21.6 4.4 9.8 14.4 7.3 6.2 8.6 10.9 13.8 19.4 12.2 17.9 12.7 8.3 12.8 5.9 8.2 20.4 13.6 3.6 9.7 18.5 13.0 9.1 16.2 21.8 16.5 4.8 11.5 19.8 10.6 14.0 16.7 11.3 36.0 24.1 14.0 17.6 7.8 9.8 10.0 12.5 15.4 4.9 14.0 21.4 6.6 7.6 8.7 12.2 11.8 8.6 5.7 40.2 20.5 10.7 6.7 31.1 FADS6 ENSG00000172782 "Fatty acid desaturase 6" 17 74877302-74893781 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 10.7;epididymis: 18.2;intestine: 14.8" "Cell type enriched" "Detected in some" 13 "Proximal enterocytes: 72.2" "Cancer enhanced" "Detected in some" "liver cancer: 2.6" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in some" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016802 Uncertain NA NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 68: Epididymis - Unknown function" "Cluster 20: HeLa - Mitochondria" "Cluster 45: Enterocytes - Digestion" "HPA016802: AB_2669448" "unprognostic (2.41e-2)" "unprognostic (6.80e-3)" "unprognostic (2.64e-1)" "unprognostic (4.68e-3)" "unprognostic (4.73e-2)" "unprognostic (1.47e-1)" "unprognostic (1.83e-1)" "unprognostic (1.07e-1)" "unprognostic (6.41e-2)" "unprognostic (6.98e-4)" "unprognostic (3.38e-2)" "unprognostic (7.53e-2)" "unprognostic (1.14e-2)" "unprognostic (6.71e-2)" "unprognostic (2.27e-1)" "unprognostic (8.45e-2)" "unprognostic (1.79e-1)" 0.2 7.1 4.5 0.5 3.5 1.5 0.5 6.6 9.1 0.6 0.0 0.8 7.5 0.2 18.2 3.2 0.1 0.0 0.2 2.0 2.0 1.1 6.1 0.2 0.6 10.2 2.4 0.3 0.4 0.5 0.1 0.2 10.7 0.1 0.7 1.2 0.3 0.3 0.4 7.7 14.8 0.2 0.9 4.1 0.2 0.7 5.1 0.4 0.4 0.2 0.8 1.2 1.1 3.6 0.2 0.3 0.5 0.4 0.0 1.0 0.7 0.5 0.0 0.1 0.2 0.8 0.3 0.3 0.1 0.5 0.3 0.3 0.7 0.0 0.2 0.1 0.0 0.5 1.6 0.6 0.3 0.4 0.4 0.3 0.0 1.1 0.4 0.2 0.0 0.4 0.4 1.4 0.6 0.6 0.3 1.1 0.3 0.2 0.5 0.2 0.1 0.5 0.3 0.3 0.4 0.4 0.5 0.2 0.1 0.5 0.2 0.5 0.3 0.3 0.7 0.6 0.5 0.5 0.2 0.3 1.0 0.3 0.5 1.1 0.6 0.4 0.2 0.6 0.2 0.3 0.3 0.3 0.1 0.5 0.3 0.4 2.0 0.8 1.5 0.5 0.2 0.0 4.5 3.5 6.6 9.1 2.0 2.0 10.2 2.4 10.7 0.9 5.1 3.6 0.0 0.0 0.0 0.0 0.0 0.1 1.3 0.0 1.8 1.5 0.1 0.0 1.1 0.0 0.0 0.0 0.0 2.1 0.0 3.7 0.0 0.0 0.8 0.0 0.1 0.3 0.0 0.0 5.2 0.2 0.1 0.3 0.0 0.2 0.0 1.1 0.4 4.0 0.3 1.7 5.4 1.1 0.0 0.0 0.4 0.2 0.0 0.1 0.0 1.0 0.0 0.1 0.0 0.0 0.2 0.0 5.1 0.0 0.0 1.1 72.2 1.9 0.0 0.5 0.0 1.1 0.4 0.0 2.0 1.7 0.6 3.8 0.2 0.4 0.7 1.3 FAM104B "CXorf44, FLJ20434" ENSG00000182518 "Family with sequence similarity 104 member B" Q5XKR9 X 55143102-55161310 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 134.0;Late spermatids: 238.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049082 Approved NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 68: Epididymis - Unknown function" "Cluster 18: U-2197 - ECM organization" "Cluster 49: Ciliated cells - Cilium organization" "HPA049082: AB_2680625" "unprognostic (2.46e-2)" "unprognostic (1.10e-3)" "unprognostic (1.90e-1)" "unprognostic (5.98e-2)" "unprognostic (1.74e-1)" "unprognostic (2.13e-1)" "prognostic unfavorable (2.23e-4)" "prognostic favorable (1.22e-4)" "unprognostic (9.35e-2)" "unprognostic (5.12e-3)" "unprognostic (2.17e-2)" "unprognostic (1.81e-3)" "unprognostic (9.32e-3)" "unprognostic (1.05e-1)" "unprognostic (2.40e-3)" "unprognostic (1.65e-1)" "unprognostic (5.27e-3)" 11.1 16.1 28.1 10.9 30.9 12.6 17.1 29.8 37.8 23.2 26.0 20.4 8.4 20.3 49.0 14.7 46.0 10.3 16.5 28.2 29.3 37.8 18.9 14.1 15.2 29.7 28.8 18.4 10.5 27.7 15.1 11.3 29.9 13.5 16.3 30.6 10.8 16.8 20.5 17.5 10.5 16.4 28.9 10.7 13.5 15.0 29.4 19.9 33.8 22.4 16.3 16.6 13.3 33.0 26.9 20.9 24.3 22.2 16.4 21.3 7.2 13.8 10.2 14.2 12.2 12.4 23.9 12.8 28.5 12.6 25.4 18.6 36.7 21.4 22.7 12.1 36.7 17.5 23.7 14.9 13.2 23.1 14.4 18.6 18.7 22.7 17.5 16.7 17.3 26.3 22.7 17.7 18.2 23.9 30.9 21.7 36.1 25.1 37.4 17.6 30.8 30.5 41.1 29.0 31.3 25.3 23.0 17.9 28.0 35.4 34.4 15.2 17.2 16.5 21.7 40.8 18.2 13.1 12.6 12.2 21.0 40.3 14.5 12.7 16.1 11.0 14.5 22.6 15.7 17.8 16.6 17.5 22.6 14.9 18.9 18.6 7.9 17.9 19.5 21.9 19.1 12.7 28.1 30.9 29.8 37.8 28.2 29.3 29.7 28.8 29.9 28.9 29.4 33.0 13.3 41.7 17.2 6.5 12.2 15.2 19.2 60.3 18.8 8.0 22.6 26.7 49.0 22.8 24.4 25.8 0.0 35.9 10.6 21.3 45.0 35.6 134.0 63.6 19.9 16.7 18.8 51.1 7.4 29.4 52.8 23.0 9.2 18.5 50.0 14.2 16.4 26.0 33.3 5.0 7.3 25.3 26.4 16.2 15.4 238.3 19.6 14.3 26.6 8.4 12.7 27.2 20.6 10.6 10.7 18.4 47.6 22.2 11.5 15.3 12.2 115.4 96.9 12.5 19.7 17.1 23.4 31.6 22.2 23.6 25.3 27.2 13.8 27.7 26.6 20.9 FAM120AOS C9orf10OS ENSG00000188938 "Family with sequence similarity 120A opposite strand" Q5T036 9 93431441-93453581 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 155.5;Syncytiotrophoblasts: 249.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA021475 Approved NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 68: Epididymis - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" "HPA021475: AB_2670718" "unprognostic (1.20e-1)" "unprognostic (2.33e-1)" "unprognostic (1.56e-1)" "unprognostic (1.48e-2)" "unprognostic (1.10e-2)" "unprognostic (8.07e-2)" "prognostic unfavorable (2.95e-5)" "unprognostic (3.10e-1)" "unprognostic (3.42e-1)" "unprognostic (3.63e-1)" "unprognostic (1.83e-1)" "unprognostic (1.93e-1)" "prognostic favorable (6.04e-4)" "unprognostic (2.33e-1)" "unprognostic (7.91e-2)" "unprognostic (8.45e-3)" "unprognostic (1.42e-1)" 21.5 19.0 27.7 14.7 27.4 12.2 23.5 27.3 34.2 18.0 27.1 25.1 14.5 18.0 35.4 16.7 16.4 16.7 22.7 27.7 27.4 23.4 18.4 17.7 17.2 28.5 27.1 18.8 23.5 27.9 32.3 23.6 27.3 23.5 24.4 23.6 20.1 20.3 20.8 19.9 16.6 16.0 27.4 14.4 24.2 8.6 28.1 18.6 29.1 19.8 18.8 21.2 15.6 28.9 31.3 29.0 20.2 22.5 28.1 12.1 31.6 19.1 19.8 20.7 15.8 21.5 24.1 26.7 23.8 21.8 29.8 39.1 20.2 20.1 18.9 43.5 16.0 27.6 26.5 24.5 28.6 22.3 17.1 15.6 28.1 20.6 33.2 23.2 22.5 23.5 29.1 37.5 20.0 74.4 30.6 12.1 27.3 42.9 31.0 24.5 27.5 27.8 28.3 27.8 42.1 20.3 28.7 30.8 28.9 22.9 33.0 18.0 15.0 13.1 21.0 45.6 27.2 26.1 37.6 11.6 21.2 13.5 27.6 12.9 9.0 6.7 4.1 8.9 5.8 11.8 6.5 5.8 7.3 8.8 7.9 6.0 10.5 8.0 11.3 8.0 6.8 4.4 27.7 27.4 27.3 34.2 27.7 27.4 28.5 27.1 27.3 27.4 28.1 28.9 29.8 35.3 45.4 22.2 30.8 12.6 45.8 21.6 40.5 25.4 47.6 37.6 38.9 14.3 46.1 18.4 14.6 100.9 25.8 60.6 39.2 37.5 0.5 31.0 31.2 28.4 28.3 26.1 22.2 47.8 155.5 37.3 55.0 45.1 22.8 15.1 24.3 22.3 41.2 6.7 17.5 42.8 14.2 31.8 20.0 3.4 23.9 29.7 12.4 12.2 36.6 30.8 19.6 7.5 17.5 37.9 41.0 33.4 37.0 38.9 33.2 33.9 24.7 32.7 26.3 31.6 36.0 13.7 17.1 34.8 25.9 249.0 30.6 21.3 30.6 59.4 FAM167A "C8orf13, DIORA-1" ENSG00000154319 "Family with sequence similarity 167 member A" Q96KS9 8 11421476-11475908 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 31.1;thyroid gland: 53.2" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 16.0;Astrocytes: 28.4;Distal tubular cells: 13.7;Early spermatids: 24.8;Enteroendocrine cells: 19.1;Late spermatids: 41.1" "Cancer enhanced" "Detected in many" "thyroid cancer: 16.0" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "memory B-cell: 1.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "Daudi: 57.6;RPMI-8226: 61.5;SH-SY5Y: 44.4;U-698: 44.8;U-87 MG: 36.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA023915, HPA030426" Approved Approved Mitochondria NA NA "Cluster 23: Antigen presenting cells - Antigen presentation" "Cluster 68: Epididymis - Unknown function" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 57: B-cells - Immune response" Mitochondria "HPA023915: AB_1845768, HPA030426: AB_10601318" "unprognostic (8.51e-3)" "unprognostic (2.43e-1)" "unprognostic (1.25e-3)" "prognostic unfavorable (5.96e-4)" "unprognostic (3.08e-2)" "unprognostic (4.62e-3)" "unprognostic (1.79e-1)" "unprognostic (1.45e-1)" "unprognostic (1.51e-1)" "unprognostic (1.39e-1)" "unprognostic (4.06e-2)" "unprognostic (7.17e-2)" "unprognostic (1.77e-2)" "unprognostic (7.13e-2)" "unprognostic (1.56e-1)" "unprognostic (4.30e-2)" "unprognostic (2.21e-2)" 0.6 0.8 25.8 1.2 25.1 0.7 1.3 23.9 25.3 0.8 17.0 0.7 0.3 0.1 0.5 0.9 1.3 1.0 0.2 26.6 26.7 6.4 0.3 10.2 2.4 29.8 27.6 0.0 2.1 1.7 17.4 0.9 27.9 1.5 0.7 5.2 2.6 4.6 0.0 11.8 1.3 0.0 26.6 1.2 2.0 3.8 31.1 3.0 53.2 0.1 3.0 0.3 1.6 25.1 4.8 3.0 6.1 0.6 0.4 2.5 0.2 16.8 16.0 10.1 4.4 0.2 1.5 57.6 0.9 18.3 4.7 1.6 0.1 4.0 11.9 24.8 0.8 0.0 0.1 0.0 20.8 0.0 0.1 2.9 2.6 5.3 32.2 32.3 0.0 0.0 0.2 2.2 6.0 1.8 0.1 0.0 1.6 0.1 0.1 0.3 0.0 61.5 5.1 0.5 26.3 44.4 0.8 4.7 2.2 0.8 1.8 0.1 28.5 1.0 1.6 25.8 0.2 17.7 14.0 44.8 36.3 0.1 1.6 0.0 0.0 0.0 0.0 0.5 0.0 1.2 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.3 0.5 0.4 0.0 0.0 25.8 25.1 23.9 25.3 26.6 26.7 29.8 27.6 27.9 26.6 31.1 25.1 0.0 16.0 1.8 28.4 5.4 5.9 0.6 0.5 0.0 0.1 1.2 1.3 0.7 1.5 0.5 5.5 10.4 0.0 1.1 0.2 13.7 2.1 24.8 2.1 0.2 0.2 19.1 0.0 0.6 1.8 0.0 0.3 2.6 0.9 0.0 0.0 0.0 0.0 0.1 0.0 1.4 1.3 0.0 0.3 0.3 41.1 0.3 0.3 0.0 3.7 0.3 1.7 0.0 0.0 1.3 1.1 2.4 0.4 0.9 0.8 0.1 0.2 1.9 1.8 0.0 0.3 0.2 3.9 2.2 0.0 3.4 0.0 1.0 0.1 0.1 0.2 FAM199X CXorf39 ENSG00000123575 "Family with sequence similarity 199, X-linked" Q6PEV8 X 104166453-104195902 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003093 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 68: Epididymis - Unknown function" "Cluster 20: HeLa - Mitochondria" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA003093: AB_1078597" "unprognostic (2.03e-3)" "unprognostic (4.39e-2)" "unprognostic (1.32e-1)" "unprognostic (1.55e-2)" "unprognostic (1.47e-1)" "unprognostic (1.18e-2)" "unprognostic (1.89e-2)" "unprognostic (6.49e-2)" "unprognostic (1.34e-1)" "unprognostic (1.03e-1)" "unprognostic (1.18e-1)" "unprognostic (9.13e-2)" "unprognostic (6.07e-3)" "unprognostic (1.08e-2)" "unprognostic (4.73e-2)" "unprognostic (4.00e-2)" "unprognostic (2.39e-2)" 19.9 11.7 17.0 7.1 16.9 13.8 11.6 18.2 18.7 9.2 10.2 8.4 7.9 10.6 34.8 7.8 9.1 6.8 7.3 15.2 18.8 15.1 7.7 8.1 8.6 15.5 19.1 11.9 11.1 19.9 8.5 9.0 17.5 10.2 8.4 16.1 10.2 13.9 9.4 9.5 7.2 8.7 16.8 8.8 8.3 10.1 20.5 9.0 17.5 9.7 7.8 8.0 7.6 18.8 23.9 14.9 13.2 14.5 9.6 11.5 13.3 12.4 11.6 15.8 14.7 11.6 19.4 13.1 15.0 11.4 12.5 17.6 23.9 18.3 25.7 6.4 13.4 10.4 19.0 13.2 13.7 20.0 14.1 9.0 22.9 15.5 15.6 24.7 16.2 8.3 11.5 28.6 17.8 17.1 10.8 14.2 13.2 20.9 17.3 11.4 8.6 16.5 26.9 15.8 7.1 8.8 30.0 19.7 21.4 12.9 9.8 9.8 20.1 17.6 6.4 13.8 13.5 13.6 12.1 14.4 19.8 21.1 13.1 0.6 0.5 0.3 0.7 0.4 0.7 0.4 0.6 0.8 0.6 1.3 0.9 0.5 0.6 0.3 0.5 0.3 0.8 0.3 17.0 16.9 18.2 18.7 15.2 18.8 15.5 19.1 17.5 16.8 20.5 18.8 18.6 16.0 14.5 33.0 17.8 24.0 11.5 12.6 13.6 23.3 21.3 14.7 13.7 17.2 12.2 62.5 14.6 11.8 23.1 23.9 23.5 11.9 0.6 20.6 27.3 15.7 16.8 9.4 25.9 18.7 13.0 11.7 18.3 31.5 9.5 16.8 14.6 18.8 17.6 33.7 24.5 17.0 16.2 21.4 27.0 3.9 11.8 15.7 10.6 15.9 14.6 20.0 22.6 26.2 21.6 15.4 18.9 14.7 20.2 14.6 14.2 34.8 10.3 16.9 26.3 17.1 13.7 4.1 9.7 21.0 26.3 14.6 15.9 21.6 15.9 15.5 FAM9B TEX39B ENSG00000177138 "Family with sequence similarity 9 member B" Q8IZU0 X 9024232-9295682 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "liver: 3.1;testis: 5.9" "Group enriched" "Detected in some" 16 "Spermatocytes: 114.8;Spermatogonia: 96.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 65 "U-266/70: 27.8;U-266/84: 32.1" HPA035135 Uncertain Uncertain Nucleoplasm NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 68: Epididymis - Unknown function" "Cluster 29: U-266 - Adaptive immune response" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" Nucleoplasm "HPA035135: AB_10669999" "unprognostic (3.95e-1)" "unprognostic (4.49e-1)" "unprognostic (3.76e-2)" "unprognostic (1.28e-1)" "unprognostic (1.48e-1)" "unprognostic (1.40e-2)" "unprognostic (2.62e-1)" "unprognostic (6.08e-10)" "unprognostic (4.08e-1)" "unprognostic (1.21e-1)" "unprognostic (1.54e-2)" 0.0 0.1 0.3 0.0 0.2 0.3 0.0 0.3 0.3 0.1 0.2 0.2 0.0 1.5 1.4 0.0 0.0 0.0 0.0 0.2 0.3 0.0 3.1 0.1 0.0 0.2 0.2 0.3 0.2 0.0 0.0 0.0 0.2 0.4 0.0 0.1 0.0 0.7 0.0 0.1 0.3 0.8 0.0 0.4 0.2 5.9 0.4 0.0 0.1 0.0 0.0 0.0 0.3 0.5 0.4 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.3 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 27.8 32.1 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.3 0.3 0.2 0.3 0.2 0.2 0.2 0.0 0.4 0.5 0.1 0.0 1.1 0.0 0.1 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.4 4.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.8 0.1 0.2 0.2 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 4.9 0.2 1.7 0.4 0.0 0.0 0.3 0.0 2.8 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.5 6.6 0.6 0.2 114.8 96.5 0.0 0.3 0.0 0.2 0.0 0.0 0.2 FAXC "C6orf168, dJ273F20, MGC2817" ENSG00000146267 "Failed axon connections homolog, metaxin like GST domain containing" Q5TGI0 6 99271168-99350062 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 22.7" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 25.6;Excitatory neurons: 57.1;Inhibitory neurons: 60.1;Oligodendrocyte precursor cells: 43.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "GAMG: 26.0;HAP1: 23.8;SCLC-21H: 34.2;SH-SY5Y: 23.7;SK-MEL-30: 22.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039106 Uncertain Approved Nucleoplasm NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Nucleoplasm "HPA039106: AB_10697546" "unprognostic (8.03e-2)" "unprognostic (4.91e-2)" "unprognostic (5.04e-3)" "unprognostic (6.44e-2)" "unprognostic (3.80e-1)" "unprognostic (5.00e-3)" "unprognostic (7.56e-2)" "unprognostic (7.29e-2)" "unprognostic (7.08e-2)" "unprognostic (1.34e-2)" "unprognostic (2.79e-3)" "unprognostic (2.47e-3)" "unprognostic (6.70e-4)" "unprognostic (1.13e-2)" "unprognostic (1.71e-1)" "unprognostic (4.86e-2)" "unprognostic (3.49e-3)" 0.7 2.2 11.0 1.5 12.7 0.0 3.2 9.3 19.0 2.5 2.0 22.7 1.5 6.5 11.0 6.2 3.7 2.4 0.8 14.1 7.6 2.7 0.0 1.7 0.1 7.2 5.6 2.2 2.5 6.5 15.9 0.8 6.3 8.2 2.9 10.4 7.4 10.6 0.5 0.9 3.3 7.8 4.4 0.4 7.1 2.1 8.5 2.2 1.7 0.6 0.1 14.3 2.9 11.4 4.0 3.2 10.3 14.3 0.0 0.0 3.8 5.0 3.2 8.1 7.0 1.9 1.3 0.0 0.6 1.0 26.0 0.1 23.8 4.7 7.0 0.0 11.8 0.1 1.9 0.7 0.6 0.0 0.0 0.5 7.5 0.2 3.8 5.9 0.0 2.0 0.5 0.0 2.7 7.0 0.0 0.0 12.2 0.0 4.8 0.0 1.0 0.0 4.3 0.3 34.2 23.7 4.5 3.2 22.6 4.2 10.0 0.0 1.0 2.5 4.7 0.0 15.5 0.0 0.0 0.0 0.1 0.0 19.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.0 12.7 9.3 19.0 14.1 7.6 7.2 5.6 6.3 4.4 8.5 11.4 0.2 25.6 15.2 5.5 0.5 0.4 4.2 4.2 5.7 14.4 5.3 9.0 1.1 0.0 8.1 1.8 10.4 1.2 0.4 0.2 9.8 2.3 2.6 0.6 1.0 1.7 0.0 0.0 57.1 0.7 0.2 1.4 0.0 0.4 3.8 0.4 1.4 0.1 0.2 3.3 60.1 0.2 4.1 0.6 1.1 5.0 0.0 1.2 1.8 2.8 0.1 3.6 2.1 43.7 4.4 1.0 0.1 1.9 0.1 4.8 0.0 1.0 2.1 13.6 0.0 0.2 1.3 1.3 8.9 1.2 0.3 0.3 1.2 0.2 0.4 1.2 FBXO16 FBX16 ENSG00000214050 "F-box protein 16" Q8IX29 8 28348287-28490278 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 18.4;pituitary gland: 17.3" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 35.5;Excitatory neurons: 44.4;Inhibitory neurons: 43.6;Rod photoreceptor cells: 48.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 10 "plasmacytoid DC: 9.6" "Lineage enriched" "Detected in single" 10 "dendritic cells: 9.6" "Cell line enhanced" "Detected in many" "AF22: 20.3;Karpas-707: 22.4" "Low region specificity" "Detected in all" "HPA058676, HPA076472" Approved Approved "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 2: Karpas-707 - Immune response" "Cluster 46: Photoreceptor cells - Phototransduction" "Nucleoplasm, Vesicles, Plasma membrane, Cytosol" "HPA058676: AB_2683795, HPA076472: " "unprognostic (3.44e-1)" "unprognostic (1.44e-1)" "unprognostic (3.37e-3)" "unprognostic (5.56e-3)" "unprognostic (1.87e-1)" "unprognostic (1.40e-2)" "unprognostic (2.55e-3)" "unprognostic (4.95e-3)" "unprognostic (6.49e-2)" "prognostic favorable (6.70e-5)" "unprognostic (3.41e-3)" "unprognostic (4.90e-2)" "unprognostic (7.15e-2)" "unprognostic (1.71e-2)" "unprognostic (4.85e-2)" "unprognostic (2.72e-2)" "unprognostic (2.07e-1)" 0.5 1.8 3.9 0.9 5.0 2.2 2.6 6.8 7.0 4.1 2.9 1.6 2.0 1.1 18.4 0.7 4.4 1.4 1.4 4.6 3.9 3.2 6.0 1.5 1.4 1.1 1.7 0.7 4.7 7.1 17.3 0.6 2.0 3.5 2.0 14.3 3.4 5.1 1.1 0.4 2.9 0.7 0.3 1.2 2.2 4.2 3.5 0.6 7.0 0.9 2.8 1.2 0.7 4.3 16.5 2.9 20.3 7.5 0.5 0.0 0.3 0.2 0.5 3.0 5.5 3.1 4.6 5.8 7.2 0.1 8.1 5.1 2.3 3.5 3.0 2.6 3.6 2.7 0.3 1.7 0.0 3.5 1.9 0.2 10.8 0.7 3.2 1.5 0.0 5.6 1.1 22.4 1.0 5.7 0.5 5.0 3.9 2.2 4.5 0.2 4.5 8.2 3.9 2.4 13.1 5.4 0.4 3.3 9.5 3.5 13.8 5.9 0.6 1.6 5.8 3.2 3.0 5.2 5.0 5.2 6.8 0.7 3.5 0.3 0.1 0.1 0.1 0.1 0.3 0.3 0.2 0.1 0.7 0.2 0.1 0.2 0.9 0.0 0.1 9.6 0.2 0.1 3.9 5.0 6.8 7.0 4.6 3.9 1.1 1.7 2.0 0.3 3.5 4.3 0.0 3.2 4.1 7.5 1.7 0.1 3.0 10.9 5.2 8.2 3.9 3.4 2.1 8.6 7.9 3.7 35.5 0.6 0.0 0.5 7.9 5.3 12.1 13.5 1.3 0.2 10.2 0.0 44.4 4.6 0.4 0.9 1.5 6.4 0.0 1.9 0.4 1.9 2.7 5.0 43.6 3.9 4.1 0.8 2.3 12.4 1.2 0.4 0.0 2.8 0.0 9.3 0.0 23.6 3.2 3.1 0.4 0.7 11.1 1.7 0.2 4.7 23.4 48.6 0.0 0.5 1.8 10.5 5.6 1.2 0.0 0.0 0.5 4.2 1.0 1.7 FBXO21 "FBX21, KIAA0875" ENSG00000135108 "F-box protein 21" O94952 12 117141991-117190471 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "fallopian tube: 128.9" "Cell type enhanced" "Detected in all" "Peritubular cells: 222.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA062411, HPA071452" Approved Approved Mitochondria NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 68: Epididymis - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 44: Endometrium - Transcription" Mitochondria "HPA062411: AB_2684755, HPA071452: AB_2686398" "unprognostic (6.38e-2)" "unprognostic (4.43e-2)" "unprognostic (2.58e-2)" "unprognostic (9.00e-3)" "unprognostic (1.57e-1)" "unprognostic (8.89e-2)" "unprognostic (1.84e-1)" "unprognostic (1.37e-1)" "unprognostic (8.99e-2)" "unprognostic (7.01e-3)" "unprognostic (1.28e-2)" "unprognostic (9.44e-2)" "prognostic favorable (2.05e-8)" "unprognostic (1.69e-2)" "unprognostic (1.17e-1)" "unprognostic (2.01e-1)" "unprognostic (7.29e-2)" 12.2 40.9 21.7 10.7 23.0 8.5 17.5 22.2 24.7 18.5 25.7 15.6 16.5 25.0 110.8 15.4 128.9 17.0 31.1 27.2 29.7 53.7 27.5 17.5 13.7 17.5 18.7 60.3 30.7 24.8 20.2 19.5 17.2 26.5 14.6 24.3 16.5 29.3 23.8 16.9 14.3 19.5 20.4 15.2 18.7 42.2 30.2 13.7 28.3 28.5 14.1 16.2 13.8 23.5 20.3 47.3 29.2 16.2 23.5 24.4 33.4 26.6 28.6 24.3 19.7 30.8 14.0 26.5 25.7 27.3 18.2 27.0 34.7 26.6 29.1 15.0 31.2 1.3 24.9 25.0 21.3 8.7 9.0 24.1 25.1 19.5 31.0 39.7 34.4 23.0 10.7 8.6 21.2 33.0 25.0 6.3 43.7 30.9 30.6 29.3 42.5 27.8 24.4 47.7 57.6 34.9 66.4 17.3 14.5 23.3 40.6 3.5 26.8 16.1 20.7 19.1 17.4 15.0 16.6 34.4 23.5 13.5 23.1 1.2 7.0 4.5 11.6 12.2 12.1 10.4 12.0 12.1 9.7 14.3 13.6 12.6 0.6 11.4 12.7 6.6 13.6 8.8 21.7 23.0 22.2 24.7 27.2 29.7 17.5 18.7 17.2 20.4 30.2 23.5 28.5 32.1 35.4 44.1 44.0 37.2 49.1 29.5 40.5 44.3 32.3 26.7 65.4 42.9 39.6 51.5 41.7 58.3 26.3 16.4 45.0 62.5 37.2 108.6 38.3 46.2 39.0 12.0 50.7 50.5 38.0 44.3 24.5 113.1 3.8 57.0 60.0 38.9 15.6 74.0 51.4 23.7 54.9 22.3 17.2 60.4 99.7 17.3 23.2 23.4 18.4 54.1 16.5 41.7 67.5 36.9 16.4 222.3 23.4 48.8 19.0 95.4 29.9 34.1 105.2 35.3 40.6 21.6 43.9 33.9 45.3 65.5 34.1 44.2 27.2 38.3 FCGR1A "CD64, CD64A" ENSG00000150337 "Fc fragment of IgG receptor Ia" P12314 1 149782671-149791675 "CD markers, FDA approved drug targets, Predicted membrane proteins" "Immunity, Innate immunity" "IgG-binding protein, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 93.3;lymphoid tissue: 41.3" "Cell type enhanced" "Detected in some" "Hofbauer cells: 283.3;Kupffer cells: 140.9;Late spermatids: 64.9;Macrophages: 94.9" "Cancer enriched" "Detected in many" 4 "glioma: 10.3" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "classical monocyte: 131.5;intermediate monocyte: 54.7;myeloid DC: 35.6;neutrophil: 93.4" "Group enriched" "Detected in many" 53 "dendritic cells: 35.6;granulocytes: 93.4;monocytes: 131.5" "Cell line enriched" "Detected in some" 5 "THP-1: 191.6" "Low region specificity" "Detected in all" HPA026910 Uncertain "Golgi apparatus,Vesicles,Plasma membrane" NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 68: Epididymis - Unknown function" "Cluster 43: THP-1 - Innate immune response" "Cluster 4: Macrophages - Innate immune response" Vesicles "Golgi apparatus, Plasma membrane" "HPA026910: " "unprognostic (5.27e-2)" "unprognostic (2.89e-2)" "unprognostic (2.34e-2)" "unprognostic (7.97e-2)" "unprognostic (8.44e-3)" "unprognostic (1.73e-1)" "unprognostic (7.69e-2)" "unprognostic (1.04e-1)" "unprognostic (1.88e-2)" "unprognostic (1.72e-1)" "unprognostic (1.98e-2)" "unprognostic (6.18e-2)" "prognostic unfavorable (4.83e-8)" "unprognostic (1.28e-1)" "unprognostic (4.51e-2)" "unprognostic (9.99e-2)" "unprognostic (9.03e-2)" 12.2 7.2 8.4 41.3 8.9 17.9 3.6 8.8 12.8 4.2 8.4 2.3 1.1 1.6 93.3 1.7 1.8 8.2 2.2 8.6 9.4 2.8 4.2 28.6 14.4 14.6 10.6 2.3 4.3 2.7 2.5 32.6 13.0 1.6 2.1 2.3 1.9 2.4 0.3 0.4 1.3 19.1 13.2 12.5 2.1 3.7 12.2 1.4 1.4 0.8 0.8 14.7 0.8 18.9 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 13.3 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 41.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.1 1.0 0.0 0.0 0.1 0.3 191.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 24.4 0.0 2.0 131.5 1.6 0.0 54.7 0.7 1.6 0.0 0.3 35.6 0.0 0.0 0.1 93.4 0.0 11.8 0.9 0.3 48.5 8.4 8.9 8.8 12.8 8.6 9.4 14.6 10.6 13.0 13.2 12.2 18.9 0.3 0.0 3.1 0.0 0.8 0.1 0.0 0.0 0.6 1.5 0.2 0.8 1.7 1.5 1.3 0.0 2.1 2.7 0.0 0.0 0.0 0.0 30.8 0.1 0.1 9.3 0.0 2.7 0.1 0.0 1.3 1.0 0.0 0.1 0.0 0.2 1.8 0.5 283.3 0.0 0.1 0.0 0.0 140.9 6.0 64.9 0.3 94.9 0.0 7.5 34.7 0.3 0.0 0.5 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.2 0.7 1.3 6.6 0.2 0.3 0.6 0.4 0.1 0.0 4.1 0.6 0.1 0.1 0.0 FCGR1B CD64b ENSG00000198019 "Fc fragment of IgG receptor Ib" Q92637 1 121087345-121097161 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" "IgG-binding protein, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 51.5;lymphoid tissue: 18.9" "Cell type enhanced" "Detected in some" "Hofbauer cells: 86.5;Kupffer cells: 51.5;Late spermatids: 14.6;Macrophages: 36.6;monocytes: 16.4;Sertoli cells: 19.7" "Cancer enriched" "Detected in single" 4 "glioma: 1.6" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "classical monocyte: 31.2;neutrophil: 36.3" "Group enriched" "Detected in many" 4 "granulocytes: 36.3;monocytes: 31.2" "Group enriched" "Detected in some" 6 "NB-4: 19.8;THP-1: 73.9" HPA026910 Uncertain "Golgi apparatus,Vesicles,Plasma membrane" "Intracellular and membrane" NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 68: Epididymis - Unknown function" "Cluster 43: THP-1 - Innate immune response" "Cluster 19: Monocytes & Neutrophils - Innate immune response" Vesicles "Golgi apparatus, Plasma membrane" "HPA026910: " "unprognostic (3.21e-2)" "unprognostic (4.35e-2)" "unprognostic (1.13e-2)" "unprognostic (2.84e-1)" "unprognostic (1.85e-1)" "unprognostic (9.60e-2)" "unprognostic (1.56e-2)" "unprognostic (6.42e-2)" "unprognostic (3.10e-2)" "unprognostic (8.17e-2)" "unprognostic (1.91e-1)" "unprognostic (3.65e-1)" "unprognostic (3.24e-10)" "unprognostic (8.99e-2)" "unprognostic (2.85e-2)" "unprognostic (7.86e-3)" "unprognostic (8.93e-2)" 5.0 3.0 4.4 18.9 4.5 6.6 1.8 4.5 7.8 1.0 3.7 0.7 0.5 0.7 51.5 0.7 0.8 1.9 1.1 4.6 4.7 1.4 1.7 6.8 2.2 6.1 5.7 0.6 2.6 0.7 1.0 11.0 6.2 0.8 0.8 0.8 0.9 0.6 0.4 0.2 0.7 5.8 6.0 7.2 0.9 0.7 6.2 0.4 2.1 0.1 0.3 4.0 0.4 6.4 0.3 0.0 0.0 0.0 0.0 0.0 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 5.9 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.0 0.0 19.8 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.8 0.1 0.0 0.3 1.0 73.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 31.2 0.6 0.0 19.0 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 36.3 0.0 12.4 0.3 0.0 8.8 4.4 4.5 4.5 7.8 4.6 4.7 6.1 5.7 6.2 6.0 6.2 6.4 0.4 0.0 2.0 0.0 0.7 0.0 0.0 0.0 0.0 0.6 0.1 0.6 2.2 0.0 0.6 0.0 2.1 0.8 0.1 0.1 0.0 0.0 7.7 0.2 0.2 2.0 0.0 0.8 0.0 0.0 0.3 1.1 0.0 0.0 0.0 0.4 0.4 0.3 86.5 3.3 0.1 0.0 0.0 51.5 4.1 14.6 1.2 36.6 0.0 11.2 16.4 0.1 1.0 0.5 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.4 19.7 0.6 0.1 0.5 0.2 0.0 0.0 0.4 0.1 0.0 0.0 0.1 FICD "HIP13, HYPE" ENSG00000198855 "FIC domain protein adenylyltransferase" Q9BVA6 12 108515277-108525837 "Enzymes, Predicted intracellular proteins" "Unfolded protein response" "Hydrolase, Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 62.8;Late spermatids: 52.0;Syncytiotrophoblasts: 31.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021390, HPA071134" Approved Approved Nucleoplasm "Intracellular and membrane" NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 68: Epididymis - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 29: Early spermatids - Spermatogenesis" Nucleoplasm "HPA021390: AB_1851340, HPA071134: AB_2686347" "unprognostic (1.00e-1)" "unprognostic (8.76e-2)" "unprognostic (1.76e-2)" "prognostic favorable (4.61e-5)" "unprognostic (6.92e-2)" "unprognostic (2.68e-2)" "unprognostic (5.73e-2)" "unprognostic (2.84e-2)" "unprognostic (8.68e-2)" "unprognostic (2.57e-1)" "unprognostic (3.15e-2)" "unprognostic (1.19e-1)" "unprognostic (7.66e-2)" "unprognostic (1.56e-2)" "unprognostic (6.22e-2)" "unprognostic (3.12e-2)" "unprognostic (3.65e-2)" 3.5 7.5 5.1 5.3 6.5 2.9 3.6 6.2 5.9 6.3 4.5 3.2 3.3 3.3 12.2 1.8 3.2 3.0 2.7 5.3 6.3 3.0 8.2 3.9 4.0 7.0 6.6 2.6 12.7 4.7 11.6 3.7 6.3 4.7 2.9 2.4 8.9 6.0 2.0 2.8 2.7 3.8 6.4 3.5 4.3 7.6 6.3 2.4 10.9 2.0 5.3 3.3 1.6 7.4 2.5 6.3 2.5 5.0 5.9 4.1 6.8 16.5 8.7 7.6 5.3 3.9 2.4 3.5 6.0 8.0 9.0 3.2 2.7 1.8 6.7 6.1 4.0 2.0 4.6 5.6 23.0 3.0 7.2 1.9 3.8 10.7 15.2 9.4 5.5 3.3 1.4 11.6 6.9 5.9 4.0 3.1 2.7 2.7 10.2 2.3 3.4 8.7 3.6 4.9 2.4 1.6 7.4 3.4 8.3 3.7 5.4 2.9 6.2 7.8 2.8 13.8 6.4 22.9 4.0 1.2 10.7 2.6 5.5 11.5 2.7 4.5 6.3 4.8 7.7 4.7 4.6 5.9 2.7 2.9 2.7 5.2 5.4 3.3 5.8 15.3 3.1 1.9 5.1 6.5 6.2 5.9 5.3 6.3 7.0 6.6 6.3 6.4 6.3 7.4 3.8 0.0 3.7 6.5 6.5 0.8 4.5 4.4 1.2 5.5 5.9 3.4 2.9 4.3 3.3 7.3 2.1 6.2 4.3 2.3 5.9 5.8 62.8 2.7 6.9 4.2 1.8 2.7 2.3 9.5 5.5 6.5 5.6 7.3 13.4 3.2 4.6 5.1 6.1 13.5 2.9 4.0 0.0 2.9 3.5 52.0 3.4 4.6 7.2 1.9 2.8 11.8 5.2 3.5 4.5 7.6 1.4 9.8 15.0 8.9 1.9 2.4 4.4 7.8 13.1 4.2 4.7 9.6 9.3 1.7 3.3 31.1 4.7 5.0 2.5 4.8 FKBP2 "FKBP-13, FKBP13, PPIase" ENSG00000173486 "FKBP prolyl isomerase 2" P26885 11 64241003-64244132 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Isomerase, Rotamase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "plasmacytoid DC: 929.1" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025561, HPA049405" Enhanced Approved "Plasma membrane" "Intracellular and membrane" No No 510000 "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 68: Epididymis - Unknown function" "Cluster 25: RPMI-8226 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "Plasma membrane" "CAB025561: , HPA049405: AB_2680749" "unprognostic (4.94e-2)" "unprognostic (1.12e-1)" "unprognostic (5.77e-2)" "unprognostic (2.66e-3)" "unprognostic (7.40e-2)" "unprognostic (1.92e-2)" "unprognostic (8.64e-2)" "unprognostic (1.62e-1)" "unprognostic (3.23e-1)" "unprognostic (5.91e-3)" "unprognostic (5.86e-2)" "unprognostic (7.18e-2)" "unprognostic (1.70e-2)" "unprognostic (1.58e-1)" "unprognostic (5.23e-1)" "unprognostic (2.30e-1)" "unprognostic (3.57e-2)" 64.7 127.6 185.1 77.5 187.6 50.1 58.3 192.7 234.7 113.1 210.8 105.7 136.3 81.1 397.7 68.4 94.4 77.2 117.4 185.0 196.9 122.7 197.3 62.7 70.7 199.9 199.6 75.3 280.1 160.4 200.9 73.1 197.7 92.5 84.2 37.1 208.9 146.7 33.3 60.9 107.3 72.6 183.4 67.5 113.4 74.7 194.3 59.0 187.6 48.4 70.4 85.7 61.6 196.0 101.2 144.8 82.8 165.9 178.5 98.2 94.6 132.9 146.4 108.8 101.4 148.1 257.0 80.8 195.4 186.5 148.2 134.7 70.5 121.0 51.3 101.4 54.5 90.0 196.5 158.3 231.6 74.5 125.5 116.0 169.3 145.4 163.5 156.9 86.9 76.6 61.0 253.6 138.1 186.7 85.1 112.6 92.6 211.1 130.0 70.8 70.9 299.2 198.9 120.7 110.0 91.3 85.4 263.2 147.9 59.5 98.1 69.5 68.9 123.8 100.9 182.8 72.6 128.5 48.6 69.0 156.7 80.6 142.8 276.8 173.1 25.9 178.9 191.2 230.8 170.1 139.2 176.4 172.2 165.0 90.4 131.5 68.6 162.9 162.7 929.1 55.9 126.7 185.1 187.6 192.7 234.7 185.0 196.9 199.9 199.6 197.7 183.4 194.3 196.0 129.5 147.4 168.0 20.9 179.7 164.4 251.0 447.2 125.2 86.4 205.0 185.4 134.7 275.9 270.6 389.9 22.9 279.8 174.4 534.1 412.8 270.8 126.4 212.5 206.3 138.6 342.6 41.4 11.3 254.2 386.9 167.0 179.4 258.5 144.0 146.5 148.5 754.4 228.4 32.0 14.8 508.2 305.2 100.1 201.7 99.0 230.2 140.7 300.6 16.9 151.7 181.7 111.2 11.1 20.6 292.2 424.7 255.1 765.2 315.5 594.7 792.2 241.9 83.3 184.1 138.4 221.3 327.1 282.1 136.6 168.1 620.5 123.6 138.8 339.4 312.0 FREM1 "C9orf143, C9orf145, C9orf154, DKFZp686M16108, FLJ25461, TILRR" ENSG00000164946 "FRAS1 related extracellular matrix 1" Q5H8C1 9 14737152-14910995 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Developmental protein" "Craniosynostosis, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 36.4" "Group enriched" "Detected in many" 7 "Early spermatids: 73.7;Inhibitory neurons: 126.1;Late spermatids: 144.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "HEL: 163.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "Secreted to extracellular matrix" NA NA 58000 "Cluster 68: Epididymis - Unknown function" "Cluster 36: HEL - Hemostasis" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "unprognostic (1.13e-5)" "unprognostic (2.59e-3)" "unprognostic (2.89e-1)" "unprognostic (1.13e-1)" "unprognostic (1.97e-1)" "unprognostic (6.27e-3)" "unprognostic (2.50e-1)" "unprognostic (4.66e-3)" "unprognostic (4.43e-1)" "unprognostic (1.31e-1)" "unprognostic (3.62e-2)" "unprognostic (6.23e-2)" "unprognostic (8.95e-13)" "unprognostic (2.28e-3)" "unprognostic (8.53e-2)" "unprognostic (3.41e-2)" "unprognostic (2.86e-1)" 5.3 2.5 0.9 0.8 1.1 0.2 4.8 4.2 1.3 5.0 2.0 6.4 2.1 19.7 36.4 1.0 4.1 3.7 6.4 1.1 1.3 17.0 0.9 2.4 0.0 2.0 1.3 1.4 6.6 5.0 1.0 5.5 1.2 1.1 1.7 1.3 0.8 3.4 0.9 3.3 5.4 14.2 3.0 0.4 1.0 4.2 1.2 1.2 0.7 0.8 0.5 2.1 2.3 3.8 0.0 0.0 20.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 163.8 0.0 2.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.1 0.0 0.0 1.4 0.4 3.7 0.0 0.0 0.2 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.1 4.2 1.3 1.1 1.3 2.0 1.3 1.2 3.0 1.2 3.8 0.4 0.0 0.6 13.1 0.3 1.3 0.2 0.0 0.6 2.0 0.1 0.1 2.9 2.8 0.0 1.8 0.0 0.5 0.0 0.2 0.0 0.3 73.7 1.5 7.7 0.4 0.0 3.0 16.2 0.0 0.3 11.2 0.5 1.3 5.1 0.2 3.9 0.0 0.5 0.0 126.1 2.4 0.0 0.6 1.2 144.7 0.6 0.1 0.0 6.5 0.6 4.0 0.0 7.1 4.3 0.2 0.0 1.5 0.0 0.1 13.0 1.3 0.0 0.1 0.0 0.6 2.8 0.8 0.9 0.0 1.1 0.3 0.1 6.1 4.7 0.1 GAGE10 ENSG00000215274 "G antigen 10" A6NGK3 X 49303669-49319844 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 2.0;testis: 1.6" "Cell type enhanced" "Detected in some" "Granulosa cells: 2.1;Leydig cells: 1.2;Microglial cells: 1.0;Peritubular cells: 1.2;Spermatocytes: 3.2;Spermatogonia: 5.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 2.5;WM-115: 1.0" HPA043232 Supported Uncertain "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" "Plasma membrane" "Golgi apparatus, Cytosol" "HPA043232: AB_2678376" "unprognostic (2.81e-2)" "unprognostic (2.26e-1)" "unprognostic (3.97e-1)" 0.0 0.0 1.0 0.0 1.4 0.0 0.2 0.9 2.0 0.1 0.8 0.1 0.0 0.1 0.5 0.0 0.4 0.0 0.1 1.0 0.8 0.0 0.0 0.0 0.2 0.9 1.1 0.9 0.0 0.0 0.8 0.0 1.0 0.1 0.1 0.6 0.0 0.3 0.1 0.0 0.0 0.3 0.9 0.1 0.0 1.6 0.8 0.0 0.2 0.0 0.1 0.1 0.0 1.0 0.0 0.0 0.2 2.5 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.4 0.9 2.0 1.0 0.8 0.9 1.1 1.0 0.9 0.8 1.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 2.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 1.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 3.2 5.2 0.0 0.1 0.0 0.0 0.6 0.0 0.1 GANC ENSG00000214013 "Glucosidase alpha, neutral C" Q8TET4 15 42273233-42356935 "Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins" "Glycosidase, Hydrolase" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Alveolar cells type 2: 47.9;Oligodendrocytes: 86.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016949, HPA051522" Approved Approved Cytosol NA NA "Cluster 19: B-cells - Humoral immune response" "Cluster 68: Epididymis - Unknown function" "Cluster 32: U-937 - Innate immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Cytosol "HPA016949: AB_1849465, HPA051522: " "unprognostic (8.83e-2)" "unprognostic (1.68e-1)" "unprognostic (2.24e-1)" "unprognostic (3.04e-3)" "unprognostic (2.51e-2)" "unprognostic (9.85e-2)" "unprognostic (2.49e-2)" "prognostic favorable (9.76e-4)" "unprognostic (1.73e-1)" "unprognostic (1.43e-1)" "unprognostic (1.66e-2)" "unprognostic (1.46e-1)" "unprognostic (1.14e-1)" "unprognostic (1.05e-2)" "unprognostic (3.14e-1)" "unprognostic (1.55e-2)" "unprognostic (3.74e-2)" 8.9 7.6 8.2 10.3 13.0 14.3 8.8 9.8 10.4 9.6 10.4 10.6 8.9 11.0 17.8 12.1 8.6 9.4 8.5 7.8 9.2 9.4 13.3 20.4 10.0 12.4 11.1 13.0 8.4 11.3 7.9 8.0 13.2 8.5 12.4 9.7 14.5 8.7 12.9 10.1 9.8 9.8 10.0 11.9 8.5 12.3 10.8 10.3 12.1 10.6 10.2 8.3 9.3 19.2 9.0 4.9 10.7 11.6 12.3 17.2 7.1 19.2 19.7 19.7 16.4 6.4 6.2 4.9 10.2 18.6 14.3 18.3 12.6 19.5 13.6 12.3 6.0 11.9 12.1 12.8 10.4 11.6 10.1 11.8 11.4 8.1 13.6 11.7 13.5 12.0 12.6 13.0 15.8 1.7 7.9 12.7 6.7 4.3 5.5 14.7 12.4 17.0 14.7 8.4 8.2 11.7 10.8 9.4 7.0 5.6 3.3 27.0 13.6 21.6 5.7 17.8 12.1 13.9 20.7 9.7 10.4 20.9 12.1 16.8 11.8 10.2 4.5 13.1 6.2 19.6 7.2 8.6 15.5 23.1 8.9 5.4 6.7 5.7 10.9 12.3 7.3 6.5 8.2 13.0 9.8 10.4 7.8 9.2 12.4 11.1 13.2 10.0 10.8 19.2 6.2 19.2 47.9 35.6 14.5 10.5 17.1 7.9 12.0 5.6 5.6 6.2 8.2 4.3 8.9 1.8 10.4 5.3 4.0 9.5 5.9 5.9 18.6 7.7 11.1 5.0 4.2 5.0 18.9 3.8 5.1 8.1 9.7 11.9 10.8 8.1 5.7 12.4 6.5 3.3 28.5 5.7 10.2 11.7 5.4 4.7 7.2 10.9 14.2 36.5 14.0 9.5 7.2 31.7 86.7 5.4 15.7 6.4 7.1 9.1 7.9 7.7 9.8 8.5 13.1 9.2 7.0 20.5 15.7 18.9 5.3 2.9 6.9 6.4 8.5 20.7 GDF9 ENSG00000164404 "Growth differentiation factor 9" O60383 5 132861181-132866884 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Cytokine, Growth factor" "Premature ovarian failure" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "testis: 8.9" "Cell type enhanced" "Detected in some" "Early spermatids: 19.9;Late spermatids: 5.2;Spermatocytes: 15.2" "Cancer enriched" "Detected in some" 5 "breast cancer: 2.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "JURKAT: 3.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA069146 Supported Approved "Golgi apparatus,Cytosol" "Secreted in female reproductive system" NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 66: Spermatocytes - Spermatogenesis" "Golgi apparatus" Cytosol "HPA069146: AB_2686094" "unprognostic (4.64e-1)" "unprognostic (1.22e-1)" "unprognostic (1.25e-2)" "unprognostic (5.11e-2)" "unprognostic (1.58e-2)" "unprognostic (2.39e-2)" "unprognostic (1.55e-1)" "unprognostic (4.61e-2)" "unprognostic (4.88e-2)" "unprognostic (1.68e-1)" "unprognostic (6.70e-3)" "unprognostic (1.04e-1)" "unprognostic (1.38e-2)" "unprognostic (1.46e-1)" "unprognostic (1.80e-1)" "unprognostic (4.75e-3)" "unprognostic (3.10e-2)" 0.3 0.6 1.3 0.2 1.5 0.3 0.8 1.3 2.0 0.4 0.9 0.3 0.4 0.3 4.1 0.3 0.8 0.2 0.3 1.3 1.4 1.4 0.6 0.3 0.5 1.2 1.4 0.5 1.0 0.7 1.7 0.2 1.4 0.6 0.3 1.3 0.8 0.5 0.7 1.0 0.4 0.2 1.4 0.4 1.0 8.9 1.3 0.7 1.0 0.7 0.4 0.6 0.3 1.4 0.2 0.1 0.5 1.1 0.7 0.3 0.1 0.0 0.1 0.1 0.1 0.3 0.8 0.2 0.6 0.1 0.9 0.2 0.4 0.4 0.1 0.4 0.7 0.5 0.5 0.1 0.1 0.1 0.0 0.3 0.6 0.0 0.3 0.1 0.0 3.9 0.0 1.2 0.2 0.2 0.7 0.8 0.2 0.1 0.0 0.6 0.0 0.2 0.3 0.2 1.0 0.9 0.2 0.1 0.5 0.7 0.5 0.1 0.1 0.9 0.4 0.2 0.1 1.3 1.7 0.1 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.3 1.5 1.3 2.0 1.3 1.4 1.2 1.4 1.4 1.4 1.3 1.4 0.9 0.0 0.0 1.6 0.1 0.1 0.4 0.1 0.0 0.4 1.9 2.2 0.6 0.0 0.1 0.0 4.2 0.4 0.3 0.7 3.9 0.1 19.9 1.4 0.9 0.5 0.0 0.0 0.5 0.2 0.3 0.4 0.0 1.9 0.0 0.5 0.4 0.2 0.1 0.0 0.8 0.9 0.0 0.3 0.0 5.2 0.6 0.5 0.0 0.0 0.0 1.0 0.0 2.0 0.9 0.1 0.1 0.4 0.1 0.6 0.3 0.4 0.6 1.0 0.0 1.6 0.8 15.2 2.5 1.1 0.1 0.7 0.2 0.2 0.5 0.2 GFRA1 "GDNFR, GDNFRA, GFR-ALPHA-1, RET1L, RETL1, TRNR1" ENSG00000151892 "GDNF family receptor alpha 1" P56159 10 116056925-116273284 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 40.5;Breast glandular cells: 33.1;Fibroblasts: 51.2;Hepatocytes: 42.2;Oligodendrocyte precursor cells: 91.0;Skeletal myocytes: 100.1" "Cancer enriched" "Detected in many" 11 "breast cancer: 40.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+: 44.7;BJ hTERT+ SV40 Large T+ RasG12V: 77.2;EFO-21: 46.5;fHDF/TERT166: 89.3;HBF TERT88: 63.2;MCF7: 59.5;U-251 MG: 53.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043829 Uncertain Approved "Nucleoplasm,Golgi apparatus" NA NA 140000 "Cluster 68: Epididymis - Unknown function" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 50: Fibroblasts - ECM organization" "Golgi apparatus" Nucleoplasm "HPA043829: AB_2678689" "unprognostic (2.07e-2)" "unprognostic (2.46e-1)" "unprognostic (7.60e-2)" "unprognostic (1.06e-3)" "unprognostic (4.10e-2)" "unprognostic (6.95e-3)" "unprognostic (2.35e-3)" "unprognostic (1.48e-3)" "unprognostic (3.16e-1)" "unprognostic (2.06e-3)" "unprognostic (1.31e-2)" "unprognostic (2.46e-2)" "unprognostic (1.94e-1)" "unprognostic (1.20e-3)" "unprognostic (1.69e-1)" "unprognostic (2.27e-2)" "unprognostic (3.64e-2)" 10.9 3.4 7.2 4.2 14.9 0.0 23.2 2.6 9.5 9.9 0.3 18.3 1.7 4.9 20.5 6.9 17.2 5.6 4.8 9.7 18.0 6.0 16.0 2.8 4.0 7.8 28.5 4.5 6.6 2.7 3.2 0.0 7.2 4.5 3.9 3.2 6.0 5.4 4.3 7.2 8.2 4.8 6.2 3.9 8.2 3.1 7.6 4.1 2.8 13.9 6.4 7.0 9.2 6.1 0.1 3.7 12.2 0.0 0.0 0.1 0.0 7.9 0.4 44.7 77.2 0.0 0.0 0.0 46.5 89.3 0.0 0.0 0.1 0.0 63.2 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 2.5 0.0 11.5 0.0 3.9 0.0 9.1 0.0 0.0 5.6 59.5 7.6 0.0 5.0 0.0 0.0 0.0 1.9 0.0 5.0 0.0 1.6 0.1 0.0 0.0 0.1 2.1 0.4 0.0 0.4 0.0 0.4 0.1 53.5 0.0 0.0 0.1 0.0 0.0 19.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 14.9 2.6 9.5 9.7 18.0 7.8 28.5 7.2 6.2 7.6 6.1 6.1 0.0 0.0 40.5 0.5 5.7 0.0 0.0 1.8 4.1 33.1 11.0 1.9 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.2 13.2 0.0 0.2 3.2 6.0 0.0 5.1 13.5 0.0 51.2 3.1 0.0 6.3 0.1 0.4 42.2 0.0 0.0 6.6 0.0 0.0 1.0 9.6 12.8 8.1 1.0 5.4 1.9 0.0 12.6 0.0 91.0 0.2 0.2 0.0 0.0 0.1 0.2 0.0 0.9 0.0 0.5 0.0 100.1 16.7 0.1 10.4 0.7 4.5 0.0 0.7 0.1 0.0 0.2 GLB1L3 FLJ90231 ENSG00000166105 "Galactosidase beta 1 like 3" Q8NCI6 11 134274245-134319564 "Predicted intracellular proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 4.0;prostate: 7.9;seminal vesicle: 4.3" "Cell type enhanced" "Detected in some" "Early spermatids: 9.8;Excitatory neurons: 39.5;Inhibitory neurons: 20.9;Oligodendrocyte precursor cells: 11.6;Spermatogonia: 7.5" "Cancer enhanced" "Detected in some" "prostate cancer: 5.0" "Region enhanced" "Detected in some" "cerebral cortex: 4.0" "Group enriched" "Detected in many" 11 "gdT-cell: 1.2;memory CD4 T-cell: 3.1;memory CD8 T-cell: 1.9;naive CD4 T-cell: 2.4;naive CD8 T-cell: 1.9;T-reg: 1.5" "Lineage enriched" "Detected in single" 31 "T-cells: 3.1" "Cell line enhanced" "Detected in some" "HEK 293: 5.5;JURKAT: 11.4;NTERA-2: 3.4;PC-3: 4.5;SCLC-21H: 6.8" "Not detected" "Not detected" HPA039916 Uncertain NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 68: Epididymis - Unknown function" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "HPA039916: AB_2676746" "unprognostic (1.64e-3)" "unprognostic (7.80e-3)" "unprognostic (5.12e-2)" "unprognostic (1.27e-1)" "unprognostic (1.35e-1)" "unprognostic (1.55e-2)" "unprognostic (8.69e-3)" "prognostic favorable (1.97e-4)" "unprognostic (6.58e-3)" "unprognostic (3.81e-1)" "unprognostic (6.95e-3)" "unprognostic (9.73e-2)" "unprognostic (1.52e-5)" "unprognostic (1.39e-1)" "unprognostic (6.40e-2)" "unprognostic (1.52e-1)" "unprognostic (2.07e-1)" 0.0 1.0 0.9 0.4 1.0 0.1 0.3 2.3 4.0 0.4 0.0 0.9 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.4 0.0 0.0 0.9 0.5 0.0 0.0 0.0 0.0 0.7 0.0 0.2 7.9 0.0 1.6 2.7 4.3 0.0 3.3 0.1 0.0 0.0 0.1 0.0 1.3 0.2 0.1 1.3 0.0 0.1 0.1 0.8 0.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.8 0.2 0.0 2.1 5.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 11.4 0.0 0.0 0.0 0.0 2.2 0.0 3.4 0.0 4.5 0.0 0.0 0.0 0.0 0.0 6.8 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.3 0.0 0.7 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.0 3.1 1.9 0.0 0.0 2.4 1.9 0.0 0.0 0.0 0.0 1.5 0.6 0.9 1.0 2.3 4.0 0.4 0.1 0.5 0.0 0.2 0.0 0.2 0.8 0.0 0.0 0.0 1.3 0.1 0.5 0.1 1.3 0.0 0.5 0.4 1.3 0.7 0.0 0.1 0.0 0.0 1.3 0.3 0.0 0.0 0.0 9.8 0.1 0.3 0.3 0.0 0.0 39.5 0.0 3.4 0.2 0.0 0.0 0.0 1.2 0.0 0.0 0.4 0.0 20.9 0.0 0.0 0.0 0.0 1.2 0.6 0.1 0.0 1.9 0.0 0.3 0.0 11.6 0.9 0.1 0.0 0.0 0.3 0.4 0.0 0.5 0.0 0.7 0.0 0.0 0.1 4.3 7.5 0.0 0.1 1.2 0.3 0.0 0.0 0.1 GNA14 ENSG00000156049 "G protein subunit alpha 14" O95837 9 77423079-77648322 "Predicted intracellular proteins" Transducer "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 219.1;Early spermatids: 50.2;Hepatic stellate cells: 61.4;Late spermatids: 38.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 95 "basophil: 27.3" "Lineage enriched" "Detected in single" 95 "granulocytes: 27.3" "Cell line enhanced" "Detected in some" "BJ hTERT+: 2.3;HUVEC TERT2: 1.6;PC-3: 3.2;THP-1: 1.6;U-2197: 2.1" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA048886 Approved NA NA "Cluster 38: Basophils - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 18: U-2197 - ECM organization" "Cluster 64: Astrocytes - Nervous system maintenance" "HPA048886: AB_2680544" "unprognostic (7.80e-3)" "unprognostic (1.10e-2)" "unprognostic (1.09e-2)" "unprognostic (1.18e-3)" "unprognostic (2.03e-1)" "unprognostic (1.53e-4)" "unprognostic (2.48e-6)" "unprognostic (6.35e-3)" "unprognostic (3.34e-1)" "unprognostic (9.04e-2)" "unprognostic (1.21e-1)" "unprognostic (2.43e-1)" "unprognostic (2.92e-2)" "unprognostic (1.04e-3)" "unprognostic (1.79e-1)" "unprognostic (1.75e-3)" "unprognostic (2.03e-1)" 3.4 2.2 7.3 4.0 6.5 0.0 2.4 2.7 8.4 3.6 11.8 5.8 1.7 15.6 5.2 4.8 3.6 4.9 4.1 9.2 4.5 11.7 6.0 8.8 3.3 9.7 5.0 6.0 1.4 1.4 3.1 7.0 7.0 6.8 6.1 0.1 8.0 13.7 0.6 0.9 3.0 13.8 8.1 7.3 3.3 2.1 5.6 0.7 17.6 0.6 2.1 7.6 4.8 13.9 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 2.3 1.0 0.3 0.0 0.6 0.0 0.9 1.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.2 0.0 0.0 1.6 0.0 0.0 0.0 0.0 1.0 0.0 0.2 0.9 0.4 3.2 0.0 0.0 0.0 0.0 1.2 0.1 0.1 0.8 0.4 0.0 1.2 0.3 1.6 0.4 0.0 0.0 2.1 0.0 0.1 0.0 0.0 0.0 0.1 0.1 27.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 7.3 6.5 2.7 8.4 9.2 4.5 9.7 5.0 7.0 8.1 5.6 13.9 2.3 0.0 1.1 219.1 0.2 0.6 2.0 0.2 0.0 0.0 1.0 0.4 0.8 0.0 6.5 0.0 0.0 0.1 0.0 2.6 0.0 0.7 50.2 1.7 4.9 12.8 3.0 2.7 15.8 1.0 0.1 4.2 0.0 1.8 4.5 0.1 61.4 1.2 0.3 0.0 4.4 13.7 2.0 2.5 1.1 38.8 3.7 0.2 1.8 15.9 0.0 0.0 0.0 7.1 12.4 0.1 2.7 1.9 0.0 1.0 0.5 7.1 20.8 0.0 0.0 19.4 0.9 0.4 0.7 0.3 0.6 0.1 0.2 0.5 2.9 4.9 GOLGA7B "bA451M19.3, bA459F3.4, C10orf132, C10orf133" ENSG00000155265 "Golgin A7 family member B" Q2TAP0 10 97849843-97871580 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 36.0;choroid plexus: 26.2;epididymis: 23.4" "Cell type enhanced" "Detected in many" "Astrocytes: 25.5;Excitatory neurons: 33.6;Inhibitory neurons: 21.2;Late spermatids: 16.6;Rod photoreceptor cells: 18.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 5.3;GAMG: 14.5;HDLM-2: 5.7;SK-MEL-30: 22.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046878 Uncertain NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 68: Epididymis - Unknown function" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "HPA046878: AB_2679854" "unprognostic (7.90e-2)" "unprognostic (1.70e-3)" "unprognostic (7.10e-3)" "unprognostic (1.06e-2)" "unprognostic (8.97e-2)" "unprognostic (1.54e-1)" "unprognostic (6.20e-4)" "unprognostic (1.95e-1)" "unprognostic (4.45e-1)" "unprognostic (2.49e-1)" "unprognostic (8.89e-2)" "unprognostic (4.13e-2)" "unprognostic (1.15e-7)" "unprognostic (2.12e-1)" "unprognostic (1.47e-1)" "unprognostic (1.04e-3)" "unprognostic (5.90e-3)" 1.2 2.3 28.7 0.8 30.7 0.2 1.1 33.9 36.0 1.0 26.2 1.1 1.5 0.2 23.4 2.6 0.4 0.4 5.6 32.9 28.0 0.2 0.6 0.7 1.4 29.2 29.2 0.1 8.0 0.0 9.3 0.2 27.5 0.5 0.5 16.9 0.7 0.5 4.6 14.5 2.0 0.1 25.1 0.5 1.0 1.3 29.8 0.3 0.9 3.2 1.1 0.6 2.0 30.0 5.3 1.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 2.0 0.0 0.1 0.0 14.5 1.9 0.0 0.4 0.0 5.7 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.1 0.0 1.0 0.3 0.0 1.8 0.1 0.1 0.3 0.8 1.4 0.0 1.0 22.6 0.0 2.1 0.1 0.1 0.1 0.0 0.0 0.2 1.7 0.8 0.0 3.9 2.3 2.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.3 0.0 28.7 30.7 33.9 36.0 32.9 28.0 29.2 29.2 27.5 25.1 29.8 30.0 0.2 0.0 0.5 25.5 0.0 12.5 0.1 0.7 0.0 6.4 0.6 4.4 2.3 12.8 0.2 1.8 2.1 0.0 3.2 0.3 0.0 6.4 5.4 0.3 0.4 0.5 12.0 0.0 33.6 4.3 0.0 0.6 0.0 0.4 0.0 0.0 0.4 0.0 5.1 3.3 21.2 1.1 0.0 0.0 1.2 16.6 0.3 0.2 7.2 5.6 0.6 3.2 3.1 2.5 1.9 7.4 0.1 0.4 0.0 0.3 1.2 0.0 0.0 18.7 0.0 1.5 0.3 3.9 2.3 0.0 5.1 0.0 2.9 0.0 0.4 0.3 GOLGA8O ENSG00000206127 "Golgin A8 family member O" A6NCC3 15 32441914-32455634 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "bone marrow: 20.0;epididymis: 33.0;testis: 11.5;thyroid gland: 27.5" "Cell type enhanced" "Detected in some" "Early spermatids: 4.0;Endometrial ciliated cells: 1.3;granulocytes: 1.3;NK-cells: 1.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 8 "gdT-cell: 1.0;NK-cell: 2.4" "Group enriched" "Detected in many" 8 "NK-cells: 2.4;T-cells: 1.0" "Group enriched" "Detected in many" 8 "HEL: 70.0;THP-1: 38.6;U-937: 133.7" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 68: Epididymis - Unknown function" "Cluster 32: U-937 - Innate immune response" "Cluster 43: Cardiomyocytes - Nuclear processes" "unprognostic (2.68e-2)" "unprognostic (4.10e-1)" "unprognostic (1.20e-1)" "unprognostic (1.14e-1)" "unprognostic (1.11e-1)" "unprognostic (3.71e-1)" "unprognostic (3.13e-3)" "unprognostic (1.43e-1)" "unprognostic (8.17e-2)" "unprognostic (8.25e-2)" "unprognostic (6.04e-2)" "unprognostic (3.06e-2)" 4.6 1.2 3.2 2.8 3.8 20.0 3.7 3.4 3.9 2.1 3.9 1.5 1.8 3.4 33.0 1.3 2.8 3.1 3.3 3.4 3.4 1.7 2.9 2.7 2.4 3.8 3.8 4.2 3.4 3.5 1.9 1.4 3.7 2.3 1.9 3.6 3.0 1.6 4.4 4.0 1.5 2.2 3.5 3.6 1.9 11.5 3.6 1.3 27.5 2.0 1.4 1.5 1.2 4.5 0.3 0.5 1.0 0.0 2.6 3.8 0.1 1.7 1.0 0.4 0.8 0.0 0.2 0.4 0.5 0.3 1.0 0.1 0.7 0.1 0.4 0.1 0.6 70.0 0.0 0.0 1.1 1.5 2.6 0.9 1.0 0.5 0.3 4.4 0.8 1.3 0.2 0.0 1.0 0.8 0.0 10.2 0.3 0.0 0.3 0.2 2.1 0.0 1.6 0.3 0.0 1.0 0.4 0.1 0.0 0.5 0.6 38.6 3.8 0.8 0.3 0.1 0.6 1.7 2.5 0.6 0.4 133.7 0.8 0.0 0.0 0.0 1.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.0 2.4 0.0 0.2 0.0 0.1 3.2 3.8 3.4 3.9 3.4 3.4 3.8 3.8 3.7 3.5 3.6 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 1.3 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.6 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.8 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 GPX5 ENSG00000224586 "Glutathione peroxidase 5" O75715 6 28525881-28534955 "Enzymes, Metabolic proteins, Predicted secreted proteins" "Oxidoreductase, Peroxidase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "epididymis: 9.3" "Group enriched" "Detected in some" 46 "Early spermatids: 14.3;Late spermatids: 41.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in male reproductive system" NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 25: Spermatids - Spermatogenesis" "unprognostic (3.34e-2)" "unprognostic (3.74e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 14.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 41.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GPX6 GPXP3 ENSG00000198704 "Glutathione peroxidase 6" P59796 6 28503296-28528215 "Enzymes, Metabolic proteins, Predicted secreted proteins" "Oxidoreductase, Peroxidase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 15 "epididymis: 3.3" "Group enriched" "Detected in some" 6 "Early spermatids: 3.3;Late spermatids: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in some" 16 "basal ganglia: 23.8" "Low region specificity" "Detected in single" "Secreted in male reproductive system" NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 25: Spermatids - Spermatogenesis" "unprognostic (2.99e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GRAMD2A GRAMD2 ENSG00000175318 "GRAM domain containing 2A" Q8IUY3 15 72159806-72197787 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 35.9;placenta: 48.7" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 70.5;Cytotrophoblasts: 106.2;Extravillous trophoblasts: 29.5;Syncytiotrophoblasts: 147.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 12 "BEWO: 165.5;SK-BR-3: 75.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA029435 Uncertain Approved "Nucleoli,Nuclear speckles,Cytosol" NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 28: BEWO - Transcription regulation" "Cluster 47: Cytotrophoblasts - Unknown function" "Nucleoli, Nuclear speckles" Cytosol "HPA029435: AB_10601811" "unprognostic (5.70e-2)" "unprognostic (7.55e-2)" "unprognostic (3.33e-1)" "unprognostic (1.24e-1)" "unprognostic (9.51e-3)" "unprognostic (2.95e-1)" "unprognostic (9.96e-2)" "unprognostic (3.90e-3)" "unprognostic (2.80e-1)" "unprognostic (1.96e-1)" "unprognostic (2.62e-1)" "unprognostic (5.77e-2)" "unprognostic (4.45e-1)" "unprognostic (2.35e-1)" "unprognostic (6.33e-2)" "prognostic unfavorable (7.01e-4)" "unprognostic (7.29e-2)" 0.0 0.0 2.1 0.5 1.7 0.0 10.2 2.0 1.3 1.9 2.1 1.2 1.0 0.4 35.9 1.1 5.8 0.3 0.1 2.2 3.9 3.2 0.0 15.0 0.4 6.5 13.1 0.1 0.5 0.1 0.7 48.7 10.1 1.3 0.8 0.9 2.1 5.2 0.0 2.5 3.3 0.2 2.6 0.2 0.8 0.4 3.0 0.2 8.9 0.0 0.4 0.3 0.7 2.0 2.1 0.0 0.1 0.0 0.0 0.0 165.5 0.0 0.0 0.0 0.0 0.2 0.4 0.2 0.6 0.0 0.0 1.2 0.0 10.0 0.2 0.0 0.2 0.3 0.1 0.0 1.2 0.0 0.0 0.1 2.1 0.0 7.5 0.0 0.2 0.0 0.1 0.0 0.0 1.0 0.1 0.0 0.5 0.6 0.0 0.1 0.0 0.1 0.2 0.1 1.7 0.1 0.3 75.8 0.1 5.5 3.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 1.7 2.0 1.3 2.2 3.9 6.5 13.1 10.1 2.6 3.0 2.0 0.1 70.5 15.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 5.3 0.0 0.0 7.4 3.7 0.0 106.2 0.1 0.0 0.0 0.1 0.0 14.0 0.2 0.2 0.0 0.0 0.0 0.0 29.5 0.8 0.0 0.7 1.3 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.5 10.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 147.1 0.3 0.1 0.0 0.0 GSTM3 GST5 ENSG00000134202 "Glutathione S-transferase mu 3" P21266 1 109733932-109741038 "Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins" Transferase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 377.9" "Cell type enhanced" "Detected in all" "Distal tubular cells: 802.2;Early spermatids: 2092.4;Late spermatids: 3843.4;Spermatocytes: 1177.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "eosinophil: 3.4;gdT-cell: 3.1;memory CD4 T-cell: 3.9;memory CD8 T-cell: 2.2;naive CD4 T-cell: 7.8;naive CD8 T-cell: 4.3;T-reg: 1.9" "Group enriched" "Detected in many" 7 "granulocytes: 3.4;T-cells: 7.8" "Cell line enhanced" "Detected in many" "SK-BR-3: 228.4;T-47d: 479.6;WM-115: 186.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB017130, HPA035190, CAB040583, HPA055972" Enhanced Approved Cytosol NA NA 790000 "Cluster 32: T-cells - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 6: T47d - Mammary gland" "Cluster 25: Spermatids - Spermatogenesis" Cytosol "CAB017130: , CAB040583: , HPA035190: AB_10795023, HPA055972: AB_2682992" "unprognostic (2.13e-2)" "unprognostic (2.76e-2)" "unprognostic (1.95e-1)" "unprognostic (5.87e-2)" "unprognostic (1.25e-1)" "unprognostic (7.28e-2)" "unprognostic (3.28e-3)" "unprognostic (1.98e-1)" "prognostic unfavorable (1.89e-4)" "unprognostic (3.45e-1)" "unprognostic (1.51e-1)" "unprognostic (2.30e-1)" "unprognostic (6.16e-3)" "unprognostic (1.38e-2)" "unprognostic (1.21e-2)" "unprognostic (1.90e-2)" "unprognostic (3.48e-2)" 38.7 39.0 56.9 11.0 61.1 3.3 83.5 50.3 69.1 52.7 109.7 45.0 46.8 32.1 243.2 53.6 35.1 47.0 74.8 56.9 63.6 188.1 20.0 23.6 6.2 54.4 54.8 120.4 101.0 41.1 33.7 21.6 55.5 47.5 19.9 21.1 22.6 165.9 65.8 57.2 27.8 58.3 57.5 14.1 76.2 377.9 61.6 13.2 57.9 51.2 7.9 57.1 53.2 58.3 0.2 6.9 49.3 0.1 64.5 39.9 8.5 54.3 9.4 58.2 56.2 21.8 1.9 0.1 30.8 27.8 40.1 2.6 10.0 22.3 80.5 0.3 14.9 50.8 152.1 33.9 69.5 0.0 115.2 40.3 27.0 87.8 0.1 63.5 73.1 61.9 4.7 0.6 26.6 30.0 14.5 1.2 5.3 0.2 93.1 0.4 31.9 2.3 16.3 117.1 86.1 46.0 112.5 228.4 10.5 14.1 479.6 75.3 57.9 0.8 20.9 59.6 36.3 7.7 13.1 0.2 0.6 0.1 186.9 0.3 0.1 3.4 3.1 0.1 0.8 0.3 3.9 2.2 0.1 0.2 7.8 4.3 0.9 0.7 0.1 0.5 1.9 1.5 56.9 61.1 50.3 69.1 56.9 63.6 54.4 54.8 55.5 57.5 61.6 58.3 22.2 6.4 11.5 18.3 7.0 143.5 97.2 104.4 50.1 17.5 196.1 176.8 88.0 50.1 35.9 222.5 6.2 16.3 8.7 17.3 802.2 88.0 2092.4 51.4 40.6 32.9 50.4 33.0 7.5 149.5 9.0 131.6 43.8 93.6 9.5 22.7 58.2 14.2 10.6 15.2 8.0 24.9 28.5 13.9 54.1 3843.4 385.5 15.1 60.5 2.8 3.5 247.5 2.1 14.6 1.7 126.4 32.5 276.1 3.4 53.7 116.9 38.9 5.4 19.2 190.7 23.8 94.4 1177.6 54.4 71.9 107.4 10.3 24.4 121.4 44.1 80.8 GULP1 "CED-6, CED6, GULP" ENSG00000144366 "GULP PTB domain containing engulfment adaptor 1" Q9UBP9 2 188291669-188595931 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Lipid transport, Phagocytosis, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 83.0" "Cell type enhanced" "Detected in many" "Enteroendocrine cells: 136.5;Inhibitory neurons: 115.5;Muller glia cells: 129.4;Syncytiotrophoblasts: 204.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 106.9;SH-SY5Y: 83.4;WM-115: 228.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020587 Enhanced Approved Vesicles NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 17: WM-115 - Nervous system development" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Vesicles "HPA020587: AB_1850452" "unprognostic (1.95e-1)" "unprognostic (3.32e-1)" "unprognostic (3.80e-2)" "unprognostic (5.19e-2)" "unprognostic (2.12e-2)" "unprognostic (2.41e-1)" "unprognostic (8.69e-4)" "unprognostic (3.86e-2)" "unprognostic (1.06e-1)" "unprognostic (9.28e-2)" "unprognostic (8.25e-3)" "unprognostic (2.23e-1)" "prognostic favorable (4.25e-6)" "prognostic unfavorable (6.17e-4)" "unprognostic (1.29e-1)" "unprognostic (7.33e-2)" "unprognostic (3.04e-4)" 9.4 24.5 2.0 5.8 6.4 0.2 13.1 0.0 4.3 27.7 33.0 13.3 13.5 35.3 83.0 19.2 18.2 17.5 5.2 3.6 7.3 21.3 0.8 13.3 1.7 22.7 4.1 31.8 22.2 26.1 3.4 19.7 23.2 27.7 7.8 17.7 16.1 28.1 9.6 6.2 15.8 21.7 0.3 5.9 22.6 28.0 4.0 1.7 7.8 16.7 3.3 11.9 14.3 0.1 12.5 26.9 106.9 23.8 17.1 15.5 18.6 16.5 27.0 25.1 19.9 18.9 62.6 0.0 13.2 13.2 28.2 8.3 20.0 1.5 18.9 0.0 13.9 27.0 20.5 0.2 15.1 0.0 0.2 10.1 4.2 13.0 14.2 42.9 12.7 0.0 22.5 0.5 19.3 1.8 0.0 0.4 27.4 18.1 46.0 0.1 25.1 14.0 60.0 4.7 0.5 83.4 0.0 14.6 40.2 47.9 4.7 0.1 5.9 7.8 3.8 26.3 9.6 0.0 0.1 0.0 4.6 0.0 228.6 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 2.0 6.4 0.0 4.3 3.6 7.3 22.7 4.1 23.2 0.3 4.0 0.1 22.8 16.0 13.4 43.4 1.6 15.7 23.9 3.6 10.2 1.5 10.6 12.2 1.6 45.8 28.2 23.9 0.0 41.1 0.6 3.7 45.0 33.0 5.0 23.9 35.4 32.1 136.5 0.0 82.7 38.2 5.9 55.3 39.8 52.1 0.0 2.2 10.0 1.5 3.2 1.7 115.5 4.6 14.2 1.0 10.5 7.9 20.5 2.0 35.6 53.4 1.1 129.4 0.0 3.0 3.1 51.3 9.8 61.3 1.4 79.8 30.8 43.2 43.5 3.7 6.6 42.2 27.9 79.6 23.9 38.9 27.6 204.4 2.7 27.0 4.7 34.5 HDAC8 "HDACL1, KDAC8, MRXS6, RPD3, WTS" ENSG00000147099 "Histone deacetylase 8" Q9BY41 X 72329516-72573101 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Hydrolase, Repressor" "Disease variant, FDA approved drug targets, Mental retardation, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 120.8;Excitatory neurons: 186.8;Inhibitory neurons: 191.3;Microglial cells: 134.9;Oligodendrocyte precursor cells: 146.8;Oligodendrocytes: 141.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA048560 Supported NA NA "Cluster 22: NK-cells - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "HPA048560: AB_2680442" "unprognostic (1.42e-1)" "unprognostic (6.62e-3)" "unprognostic (3.20e-2)" "unprognostic (9.24e-3)" "unprognostic (1.10e-1)" "unprognostic (1.10e-1)" "unprognostic (4.64e-2)" "unprognostic (6.03e-2)" "unprognostic (1.58e-1)" "unprognostic (2.81e-2)" "unprognostic (3.17e-2)" "unprognostic (9.68e-2)" "unprognostic (8.42e-2)" "unprognostic (2.33e-3)" "unprognostic (9.10e-2)" "unprognostic (7.15e-3)" "unprognostic (2.12e-3)" 9.2 21.2 16.1 9.8 16.2 17.5 10.3 23.2 19.1 10.3 14.4 9.8 8.5 9.5 22.8 10.2 8.8 9.7 11.9 15.8 19.4 15.1 16.3 9.0 10.9 14.4 13.2 11.2 11.0 11.5 13.4 9.5 15.1 11.2 11.8 16.5 11.4 8.1 10.7 11.5 8.1 10.6 9.7 8.4 10.2 4.2 16.2 8.6 13.0 10.4 10.9 9.7 9.6 20.8 21.0 27.2 20.5 29.9 26.9 24.4 13.5 14.0 21.3 15.9 19.1 20.8 23.3 15.2 38.6 17.2 27.5 14.5 37.0 23.1 21.7 25.9 25.5 21.5 32.7 22.4 14.2 29.9 30.4 22.3 15.4 20.2 15.1 27.6 27.1 20.3 22.4 38.4 24.4 24.8 15.9 53.8 25.9 31.2 38.1 19.7 24.0 26.7 32.8 21.0 16.5 33.0 26.7 19.7 26.9 25.9 12.0 26.9 21.8 15.0 21.3 19.4 13.5 13.5 28.1 18.1 18.5 34.7 20.3 13.8 16.5 28.1 10.5 13.8 8.7 11.9 11.2 9.6 17.2 12.2 8.4 7.5 1.7 10.9 14.5 6.0 15.6 9.8 16.1 16.2 23.2 19.1 15.8 19.4 14.4 13.2 15.1 9.7 16.2 20.8 13.0 3.2 25.7 120.8 14.5 6.1 12.7 15.3 17.1 15.4 9.5 9.7 11.3 12.8 15.7 7.3 43.8 16.4 8.0 7.2 9.8 13.9 0.9 8.8 11.3 12.5 9.1 17.1 186.8 12.4 13.2 14.0 10.7 8.4 12.0 19.2 12.5 10.3 15.8 23.5 191.3 9.3 16.2 8.2 9.0 1.2 11.8 13.3 7.2 134.9 10.9 10.3 8.2 146.8 141.1 11.2 4.7 10.5 19.9 10.6 9.3 22.6 17.4 17.3 26.3 10.1 16.0 4.7 0.8 12.6 6.3 13.5 11.8 15.1 9.7 12.6 HDC ENSG00000140287 "Histidine decarboxylase" P19113 15 50241947-50265965 "Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Catecholamine biosynthesis" "Decarboxylase, Lyase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 102.9;epididymis: 46.1" "Cell type enriched" "Detected in some" 12 "granulocytes: 596.0" "Cancer enhanced" "Detected in some" "breast cancer: 2.9;testis cancer: 2.7" "Region enriched" "Detected in many" 6 "hypothalamus: 102.9" "Immune cell enriched" "Detected in single" 2140 "basophil: 686.2" "Lineage enriched" "Detected in single" 2140 "granulocytes: 686.2" "Group enriched" "Detected in some" 4 "HEL: 460.8;HMC-1: 1051.3" "Region enriched" "Detected in many" 5 "hypothalamus: 43.9" "Group enriched" "Detected in some" 10 "hypothalamus: 16.5;midbrain: 4.2" HPA038891 Enhanced Approved "Nuclear bodies" NA NA "Cluster 38: Basophils - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 3: HMC-1 - Innate immune response" "Cluster 60: Granulocytes - Receptor signaling" "Nuclear bodies" "HPA038891: AB_10673231" "unprognostic (4.97e-2)" "unprognostic (7.42e-2)" "unprognostic (1.43e-4)" "unprognostic (1.08e-1)" "unprognostic (6.16e-2)" "unprognostic (3.93e-7)" "unprognostic (4.18e-5)" "unprognostic (8.79e-3)" "unprognostic (1.48e-1)" "unprognostic (8.46e-2)" "unprognostic (4.60e-2)" "unprognostic (1.05e-1)" "unprognostic (2.53e-1)" "unprognostic (7.20e-2)" "unprognostic (9.78e-2)" "unprognostic (2.15e-1)" "unprognostic (1.50e-1)" 2.3 0.4 0.0 3.5 5.6 4.7 1.4 0.0 0.2 2.3 0.7 3.8 4.1 2.5 46.1 4.8 0.8 11.2 0.7 0.2 102.9 0.4 0.5 6.9 0.9 0.0 13.7 0.1 1.2 0.5 0.4 0.4 0.0 1.7 3.6 0.8 1.3 0.9 0.3 2.3 4.6 2.5 0.0 0.5 12.9 1.3 17.8 0.9 0.1 0.8 1.0 3.8 1.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.1 0.0 460.8 0.2 0.0 0.0 1.2 1051.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.2 0.0 0.0 0.5 181.8 0.3 0.0 0.0 0.2 0.4 0.4 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.5 0.2 0.4 686.2 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.1 0.0 0.0 1.6 0.0 5.6 0.0 0.2 0.2 102.9 0.0 13.7 0.0 0.0 17.8 0.1 0.0 12.8 47.5 0.3 0.0 0.8 0.0 0.0 0.0 2.6 0.0 0.0 0.5 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.2 0.0 10.9 0.3 0.0 0.0 2.3 9.2 0.0 596.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 1.8 0.4 0.0 1.2 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 3.8 0.0 0.0 0.0 4.5 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.9 0.0 3.5 0.0 0.1 0.1 HMGN5 NSBP1 ENSG00000198157 "High mobility group nucleosome binding domain 5" P82970 X 81113699-81201913 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 107.4" "Cell type enhanced" "Detected in many" "Proximal tubular cells: 113.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 209.6;Karpas-707: 298.5" "Low region specificity" "Detected in all" "HPA000511, HPA076238" Approved Supported Nucleoplasm,Mitochondria NA NA 41000 "Cluster 29: Plasmacytoid DCs - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 2: Karpas-707 - Immune response" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Nucleoplasm Mitochondria "HPA000511: AB_1079505, HPA076238: " "unprognostic (1.49e-2)" "unprognostic (1.44e-1)" "unprognostic (3.72e-2)" "unprognostic (1.55e-1)" "unprognostic (1.07e-1)" "unprognostic (3.98e-2)" "unprognostic (1.08e-1)" "unprognostic (1.96e-1)" "unprognostic (9.63e-3)" "prognostic favorable (6.60e-4)" "unprognostic (2.78e-3)" "unprognostic (1.16e-1)" "unprognostic (2.32e-3)" "unprognostic (3.06e-2)" "unprognostic (1.07e-1)" "unprognostic (6.53e-2)" "unprognostic (1.08e-1)" 13.2 24.6 31.6 6.1 31.8 34.0 14.5 28.8 60.6 12.7 27.7 16.6 23.0 17.2 65.2 14.8 17.5 11.0 10.2 29.3 32.3 27.6 23.0 8.7 5.3 35.3 32.5 20.4 12.7 20.3 29.7 4.8 32.6 15.4 16.3 7.3 13.0 19.4 9.4 12.0 21.5 10.8 32.1 12.9 13.8 107.4 32.7 30.7 17.9 8.7 6.6 12.1 11.6 33.1 1.1 9.6 26.4 130.0 22.2 6.8 5.5 7.4 11.5 2.2 3.2 3.1 49.6 209.6 22.7 3.1 2.1 8.9 158.6 19.2 4.8 123.5 62.9 87.6 97.0 1.6 2.6 147.9 83.1 5.6 4.9 8.1 7.9 7.3 10.4 132.2 118.2 298.5 13.3 4.4 135.2 51.8 117.9 29.5 34.5 5.1 110.1 98.3 32.0 3.5 1.1 3.1 0.9 2.9 9.1 22.6 16.3 34.6 12.2 4.2 33.5 20.4 28.5 20.7 9.4 33.8 12.4 57.5 7.4 1.3 3.1 1.2 7.5 1.6 6.6 3.8 4.4 4.0 5.2 6.0 8.7 7.6 1.4 3.4 2.2 10.0 1.7 2.9 31.6 31.8 28.8 60.6 29.3 32.3 35.3 32.5 32.6 32.1 32.7 33.1 18.1 9.6 16.4 19.9 9.0 15.9 27.6 12.8 17.6 3.5 18.9 17.5 11.1 27.1 16.2 46.0 0.0 0.6 6.4 22.7 68.4 12.8 24.5 44.0 11.0 18.1 17.4 64.8 11.6 18.7 0.4 15.4 16.8 31.1 13.3 39.4 22.1 87.2 15.7 1.7 16.5 34.2 28.5 11.3 10.8 79.7 29.5 10.2 8.8 13.1 2.9 25.8 7.2 25.6 8.5 7.1 19.6 41.0 9.6 15.0 27.4 113.6 55.9 1.7 46.0 13.3 19.6 18.9 8.7 32.8 14.9 0.4 8.3 31.0 45.0 24.4 HMX2 NKX5-2 ENSG00000188816 "H6 family homeobox 2" A2RU54 10 123148136-123150672 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 10 "brain: 2.2;kidney: 1.8" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "cervical cancer: 0.9" "Region enhanced" "Detected in some" "midbrain: 2.2" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 14 "REH: 38.2" "Not detected" "Not detected" "Region enhanced" "Detected in single" "hypothalamus: 2.3" "CAB013268, CAB022752" Approved NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 14: REH - Unknown function" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" "CAB013268: , CAB022752: " "unprognostic (3.98e-2)" "unprognostic (1.00e-3)" "unprognostic (1.44e-1)" "unprognostic (7.18e-2)" "unprognostic (2.73e-2)" "unprognostic (7.64e-2)" "unprognostic (3.29e-1)" "unprognostic (2.10e-3)" "unprognostic (5.29e-1)" "unprognostic (5.01e-2)" "unprognostic (2.25e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 1.8 0.0 0.0 0.0 0.3 2.2 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 1.3 0.0 0.2 0.0 2.2 0.0 0.0 0.0 0.4 0.4 1.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.5 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 38.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 2.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.3 2.2 0.7 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.9 0.0 0.0 0.0 0.1 0.0 0.1 0.0 HOXA2 HOX1K ENSG00000105996 "Homeobox A2" O43364 7 27100354-27102686 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Basal squamous epithelial cells: 23.3;Breast myoepithelial cells: 3.8;Enteroendocrine cells: 4.8;Hepatic stellate cells: 6.4;Squamous epithelial cells: 6.3" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 16 "medulla oblongata: 4.5;pons: 3.3;spinal cord: 4.7;white matter: 4.3" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 14.5;HaCaT: 6.2;RPTEC TERT1: 4.9" "Region enriched" "Detected in single" 36 "pons and medulla: 5.8" "Group enriched" "Detected in some" 17 "medulla oblongata: 4.2;pons: 1.1;spinal cord: 3.0" HPA078220 Approved Nucleoplasm,Vesicles Yes NA "Cluster 1: Neutrophils - Mixed function" "Cluster 68: Epididymis - Unknown function" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 50: Fibroblasts - ECM organization" "Nucleoplasm, Vesicles" "HPA078220: AB_2686880" "unprognostic (7.30e-2)" "unprognostic (4.90e-4)" "unprognostic (2.81e-1)" "unprognostic (7.43e-4)" "unprognostic (1.44e-1)" "unprognostic (2.01e-2)" "unprognostic (1.17e-1)" "unprognostic (2.96e-1)" "unprognostic (1.85e-3)" "unprognostic (1.48e-2)" "unprognostic (1.84e-1)" "unprognostic (1.58e-2)" "unprognostic (4.98e-9)" "unprognostic (1.34e-1)" "unprognostic (1.33e-1)" "unprognostic (9.36e-2)" "unprognostic (1.28e-2)" 1.9 1.0 0.0 0.6 0.0 0.0 1.6 0.0 0.0 1.6 0.0 3.3 0.9 2.0 5.1 2.3 4.1 1.0 0.2 0.0 0.0 4.4 0.2 1.7 0.2 4.5 0.2 0.6 0.3 5.7 0.0 0.0 3.3 1.7 1.8 0.0 0.0 2.1 0.7 1.6 2.6 0.9 4.7 1.2 2.2 0.1 0.1 1.8 0.8 3.0 0.6 2.0 0.9 4.3 1.1 0.6 4.0 14.5 0.0 0.0 0.0 0.2 0.1 0.0 0.1 1.6 3.4 0.1 1.5 0.1 1.8 6.2 0.2 0.0 0.0 0.0 2.0 0.0 0.1 0.2 1.8 0.1 0.3 0.8 0.0 3.1 3.1 0.0 2.5 0.3 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.1 0.9 1.0 0.7 0.0 4.9 0.5 0.9 0.0 0.2 0.0 0.9 0.2 0.0 0.0 2.5 0.0 0.2 1.1 0.5 0.0 0.0 0.1 0.0 0.6 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.2 3.3 4.7 0.1 4.3 1.0 0.0 0.0 0.0 0.0 1.0 0.4 0.0 23.3 0.0 1.2 3.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.4 0.1 1.3 2.5 4.8 0.0 0.0 0.0 0.0 1.7 0.0 0.1 0.0 0.0 6.4 0.1 0.1 0.0 0.0 1.3 0.0 0.0 0.7 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.1 1.1 0.5 0.0 0.0 0.0 1.0 1.9 0.0 0.0 6.3 0.3 0.0 0.1 0.0 1.7 0.7 HOXA6 "HOX1, HOX1B" ENSG00000106006 "Homeobox A6" P31267 7 27145396-27150603 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 10.0" "Cell type enhanced" "Detected in some" "Breast myoepithelial cells: 5.2;Distal enterocytes: 7.5;Distal tubular cells: 5.9;Endometrial stromal cells: 14.8;Enteroendocrine cells: 9.0;Smooth muscle cells: 6.2;Undifferentiated cells: 8.0" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "spinal cord: 7.7" "Immune cell enhanced" "Detected in single" "basophil: 3.1" "Lineage enhanced" "Detected in single" "granulocytes: 3.1" "Group enriched" "Detected in many" 9 "AN3-CA: 61.7;HEK 293: 84.4" "Region enriched" "Detected in single" 34 "pons and medulla: 3.3" "HPA004203, HPA077900" Approved Supported "Nucleoplasm,Nuclear speckles" NA NA "Cluster 38: Basophils - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 36: Stromal cells - Cell proliferation" Nucleoplasm "Nuclear speckles" "HPA004203: AB_1079079, HPA077900: " "unprognostic (1.70e-1)" "unprognostic (6.76e-3)" "unprognostic (2.70e-2)" "prognostic unfavorable (1.40e-4)" "unprognostic (1.06e-1)" "unprognostic (6.06e-2)" "unprognostic (9.73e-2)" "unprognostic (6.32e-2)" "unprognostic (2.94e-2)" "unprognostic (7.82e-2)" "unprognostic (2.17e-1)" "prognostic favorable (2.03e-4)" "unprognostic (1.45e-1)" "unprognostic (2.81e-2)" "unprognostic (3.93e-1)" 3.0 2.7 0.1 1.4 0.1 0.2 2.4 0.0 0.2 2.5 0.0 6.6 0.2 5.4 3.7 0.3 10.0 0.2 0.0 0.1 0.0 4.5 0.0 2.1 1.1 7.1 0.0 0.2 0.0 0.3 0.0 0.1 1.8 2.5 1.5 0.0 0.1 1.9 1.2 2.9 4.2 1.4 7.7 0.2 1.3 0.0 0.0 0.1 0.2 0.0 0.0 3.0 1.4 5.4 1.2 2.1 0.1 61.7 0.1 0.0 0.2 0.5 0.6 0.4 0.6 1.5 7.2 1.5 2.3 0.5 0.2 2.8 1.5 0.0 0.0 1.9 84.4 1.0 1.2 0.8 0.0 1.3 2.1 4.9 0.1 0.0 0.8 0.1 2.9 2.0 0.4 0.0 0.7 0.8 0.1 0.3 0.1 0.4 2.1 8.4 0.0 0.0 5.9 3.9 6.4 0.0 2.9 0.3 1.3 0.0 0.8 0.8 0.0 0.1 0.9 3.3 2.3 0.0 0.0 1.4 0.0 6.2 6.1 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.2 0.1 0.0 7.1 0.0 1.8 7.7 0.0 5.4 2.1 0.0 0.0 0.0 0.3 0.3 1.6 0.0 0.0 0.0 4.0 5.2 0.0 0.0 0.0 1.8 0.0 0.0 0.5 7.5 5.9 0.0 0.0 0.6 14.8 1.9 9.0 0.0 0.0 0.0 0.0 1.8 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.7 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 3.9 0.0 0.0 1.0 3.4 1.3 0.1 0.0 0.0 3.7 6.2 0.0 0.0 0.3 0.4 0.0 0.4 0.1 8.0 1.4 HOXB4 "HOX2, HOX2F" ENSG00000182742 "Homeobox B4" P17483 17 48575507-48578350 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 19.6" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 28.5;Collecting duct cells: 64.4;Glandular and luminal cells: 25.1;Hepatic stellate cells: 24.3;NK-cells: 38.1" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 30 "medulla oblongata: 11.3;pons: 4.6;spinal cord: 9.1;white matter: 5.8" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "EFO-21: 63.7;HMC-1: 37.5;K-562: 33.7" "Region enriched" "Detected in single" 36 "pons and medulla: 3.5" "Group enriched" "Detected in some" 13 "medulla oblongata: 3.7;spinal cord: 4.7" HPA057432 Uncertain Supported Nucleoplasm,Centrosome NA NA "Cluster 40: NK-cells - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 1: K-562 - Erythropoiesis" "Cluster 44: Endometrium - Transcription" Nucleoplasm Centrosome "HPA057432: AB_2683437" "unprognostic (2.71e-2)" "unprognostic (3.87e-2)" "unprognostic (8.97e-3)" "unprognostic (5.39e-3)" "unprognostic (1.14e-2)" "unprognostic (1.66e-1)" "unprognostic (2.65e-2)" "unprognostic (1.59e-2)" "unprognostic (2.14e-1)" "prognostic unfavorable (2.23e-4)" "unprognostic (3.22e-2)" "unprognostic (1.14e-1)" "unprognostic (3.41e-1)" "unprognostic (2.10e-1)" "unprognostic (4.85e-2)" "unprognostic (9.25e-3)" "unprognostic (3.41e-3)" 6.9 3.1 0.1 3.7 0.0 0.7 3.5 0.0 0.1 6.8 0.1 9.8 2.6 3.4 19.6 3.4 12.8 3.3 1.0 0.0 0.0 8.7 1.1 4.6 2.3 11.3 0.2 0.3 1.2 4.4 0.0 2.6 4.6 1.0 2.4 0.0 0.3 7.6 2.6 2.5 5.1 4.3 9.1 4.4 4.3 1.2 0.2 1.9 1.0 3.9 1.4 2.9 2.2 5.8 0.3 0.5 0.0 0.2 12.2 9.2 5.2 0.0 0.0 0.8 0.4 6.2 3.1 9.2 63.7 3.3 0.7 0.3 11.8 0.0 0.2 23.3 21.5 21.9 1.6 0.0 12.5 0.0 37.5 10.0 0.0 14.9 0.0 1.2 18.4 14.6 33.7 0.6 15.1 0.0 5.5 0.2 0.0 5.8 0.0 0.0 12.3 4.5 12.5 5.4 0.0 0.0 1.7 0.0 8.7 4.2 0.5 4.3 6.0 0.4 0.5 2.2 0.4 5.0 11.9 2.1 4.3 0.0 5.4 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 11.3 0.2 4.6 9.1 0.2 5.8 19.9 0.0 0.0 0.0 3.0 3.8 1.3 0.0 28.5 0.0 2.7 1.7 0.9 0.0 0.0 64.4 0.0 23.5 18.4 1.0 11.7 0.2 0.2 18.5 2.7 19.0 0.0 5.0 0.0 0.0 13.1 8.2 0.5 25.1 3.8 0.0 24.3 0.2 4.0 0.0 0.0 2.3 0.0 2.8 4.4 0.2 0.3 2.1 5.4 0.0 1.3 0.0 38.1 0.0 0.0 0.0 1.9 0.0 6.6 0.5 1.0 2.0 0.7 0.0 0.0 5.9 6.4 6.0 23.2 15.5 1.8 6.0 9.9 0.1 1.8 3.1 HOXB5 "HOX2, HOX2A" ENSG00000120075 "Homeobox B5" P09067 17 48591257-48593779 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 39.1;kidney: 32.5" "Cell type enhanced" "Detected in some" "Collecting duct cells: 53.3;Distal tubular cells: 25.4;Endometrial ciliated cells: 48.8;Glandular and luminal cells: 46.0" "Cancer enhanced" "Detected in many" "endometrial cancer: 28.1" "Region enhanced" "Detected in many" "medulla oblongata: 39.1" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HEK 293: 28.8;HeLa: 8.7;RPTEC TERT1: 21.7" "Region enriched" "Detected in single" 230 "pons and medulla: 22.9" "Group enriched" "Detected in some" 9 "medulla oblongata: 19.3;spinal cord: 14.3" "HPA043851, HPA074454" Supported "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 44: Endometrium - Transcription" Nucleoplasm "Nucleoli fibrillar center, Cytosol" "HPA043851: AB_2732509, HPA074454: AB_2686690" "unprognostic (6.50e-2)" "unprognostic (1.63e-1)" "unprognostic (4.22e-2)" "prognostic favorable (6.28e-4)" "unprognostic (6.48e-3)" "unprognostic (7.12e-2)" "unprognostic (8.14e-2)" "prognostic unfavorable (4.61e-4)" "unprognostic (2.47e-1)" "unprognostic (1.47e-3)" "unprognostic (5.10e-2)" "unprognostic (9.64e-2)" "unprognostic (7.61e-3)" "unprognostic (8.08e-3)" "unprognostic (1.35e-1)" "unprognostic (2.86e-2)" "prognostic favorable (8.59e-5)" 4.8 3.9 0.1 2.5 0.0 0.1 1.8 0.0 0.1 6.2 0.0 16.6 1.7 2.3 18.4 0.2 7.4 0.2 0.1 0.1 0.0 32.5 0.6 5.9 0.1 39.1 0.3 0.2 0.7 1.0 0.0 1.2 10.9 1.1 4.9 0.0 0.0 6.9 0.4 0.8 12.2 1.9 24.8 2.6 4.9 0.8 0.0 0.0 0.5 0.2 0.0 2.8 1.5 9.0 2.6 6.5 0.0 3.2 3.2 3.5 0.0 0.0 0.0 0.0 0.0 0.1 3.5 0.0 6.5 3.7 0.7 0.0 0.3 0.0 0.0 0.0 28.8 1.3 8.7 0.0 5.5 0.0 1.4 1.8 0.0 3.9 0.0 1.1 2.0 0.2 2.1 0.0 4.4 0.0 0.0 0.0 0.0 3.6 2.3 0.0 1.2 0.0 21.7 2.2 0.0 0.0 0.2 0.0 3.3 0.1 0.6 0.0 6.5 0.9 2.6 0.7 0.4 0.0 0.0 0.0 0.2 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 39.1 0.3 10.9 24.8 0.0 9.0 4.9 0.0 1.1 0.0 0.0 0.9 0.2 0.0 1.2 0.0 0.3 0.3 0.4 0.0 0.0 53.3 0.0 0.0 0.1 13.5 25.4 0.0 0.9 48.8 4.1 6.6 4.2 2.7 0.0 0.0 0.0 3.8 1.1 46.0 0.0 0.0 8.2 0.0 0.7 0.0 0.0 11.4 0.0 4.2 0.8 0.5 0.0 0.5 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.4 0.0 0.1 7.0 0.5 0.0 0.0 0.0 0.2 4.9 8.6 11.0 0.3 0.3 0.0 0.6 0.0 11.3 0.1 HOXB8 "HOX2, HOX2D" ENSG00000120068 "Homeobox B8" P17481 17 48611377-48615292 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 114.1;epididymis: 48.1;kidney: 37.6" "Cell type enhanced" "Detected in some" "Collecting duct cells: 88.3;Distal tubular cells: 72.4;Endometrial ciliated cells: 21.3;Enteroendocrine cells: 44.1;Glandular and luminal cells: 26.6" "Cancer enhanced" "Detected in many" "endometrial cancer: 33.3" "Region enhanced" "Detected in many" "spinal cord: 114.1" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 34.0;HDLM-2: 17.2;HEK 293: 36.9;LHCN-M2: 17.3;RPTEC TERT1: 35.3" "Region enriched" "Detected in single" 65 "pons and medulla: 6.5" "Region enriched" "Detected in all" 5 "spinal cord: 51.2" HPA075905 Supported Nucleoplasm NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 44: Endometrium - Transcription" Nucleoplasm "HPA075905: AB_2686767" "unprognostic (4.44e-1)" "unprognostic (2.60e-1)" "unprognostic (1.01e-1)" "unprognostic (2.13e-1)" "unprognostic (1.94e-2)" "unprognostic (9.07e-5)" "unprognostic (6.63e-3)" "unprognostic (1.40e-3)" "unprognostic (6.00e-2)" "unprognostic (5.66e-3)" "unprognostic (2.93e-2)" "unprognostic (1.14e-2)" "prognostic favorable (1.30e-7)" "unprognostic (1.77e-2)" "unprognostic (6.64e-2)" "unprognostic (4.57e-2)" "unprognostic (2.88e-3)" 7.2 7.2 0.1 1.5 0.0 0.0 2.7 0.0 0.0 10.7 0.0 4.7 0.0 2.8 48.1 0.0 1.4 0.0 0.0 0.0 0.0 37.6 0.0 0.4 0.0 36.4 0.0 0.1 0.1 0.8 0.1 0.3 1.8 1.0 1.2 0.0 0.0 20.8 0.4 0.5 7.1 1.5 114.1 0.1 6.6 1.0 0.0 0.0 0.1 0.0 0.0 3.7 0.7 20.8 2.1 5.3 0.0 0.8 0.7 1.0 0.8 0.0 0.0 0.0 0.0 0.3 0.8 0.0 34.0 5.3 0.6 0.0 0.1 0.0 0.0 17.2 36.9 1.0 0.1 0.0 0.3 0.0 5.5 1.1 0.0 0.1 0.0 0.7 2.1 0.2 11.6 0.0 17.3 0.0 0.0 0.4 0.0 11.3 0.0 0.0 3.6 0.1 35.3 1.0 0.0 0.1 0.6 0.0 5.4 0.1 0.4 0.0 8.8 0.0 1.6 0.1 0.7 0.0 0.0 0.0 0.1 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 36.4 0.0 1.8 114.1 0.0 20.8 4.9 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.1 0.4 1.0 0.0 0.0 88.3 0.0 0.0 0.1 1.8 72.4 0.0 0.3 21.3 2.1 2.6 44.1 0.0 0.0 0.0 0.8 0.3 0.0 26.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 4.2 0.0 0.0 0.7 0.8 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.2 2.7 8.9 0.0 0.0 0.0 0.1 0.8 2.3 9.2 0.0 0.0 0.0 0.3 0.0 5.0 0.0 HOXC5 "HOX3, HOX3D" ENSG00000172789 "Homeobox C5" Q00444 12 54033050-54035361 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 3.6;fallopian tube: 4.1" "Cell type enhanced" "Detected in some" "Basal squamous epithelial cells: 5.2;Fibroblasts: 2.6;Granulosa cells: 2.5;Leydig cells: 2.5;Peritubular cells: 2.6;Skeletal myocytes: 2.6;Smooth muscle cells: 2.5;Spermatocytes: 3.2;Squamous epithelial cells: 2.2" "Cancer enhanced" "Detected in single" "ovarian cancer: 0.7" "Group enriched" "Detected in many" 15 "medulla oblongata: 3.4;pons: 3.6;spinal cord: 1.9;white matter: 1.2" "Immune cell enhanced" "Detected in single" "gdT-cell: 3.0" "Lineage enriched" "Detected in single" 31 "T-cells: 3.0" "Cell line enhanced" "Detected in some" "AN3-CA: 7.1;ASC TERT1: 4.8;HSkMC: 4.5;SH-SY5Y: 7.6" "Region enriched" "Detected in single" 46 "pons and medulla: 4.6" "Group enriched" "Detected in some" 5 "medulla oblongata: 1.5;spinal cord: 2.1" HPA026794 Uncertain Supported "Nucleoplasm,Cell Junctions" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 68: Epididymis - Unknown function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 50: Fibroblasts - ECM organization" Nucleoplasm "Cell Junctions" "HPA026794: AB_10612118" "unprognostic (1.57e-1)" "unprognostic (7.73e-3)" "unprognostic (1.70e-2)" "unprognostic (2.49e-1)" "unprognostic (1.16e-3)" "unprognostic (2.87e-3)" "unprognostic (6.89e-2)" "unprognostic (9.53e-3)" "unprognostic (1.86e-2)" "unprognostic (2.69e-2)" "unprognostic (2.01e-3)" "unprognostic (1.17e-2)" "unprognostic (7.53e-3)" "unprognostic (2.19e-3)" "unprognostic (1.08e-2)" 1.0 0.9 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.2 0.2 0.3 2.7 0.9 4.1 0.1 0.0 0.0 0.0 0.9 0.0 0.1 0.2 3.4 0.1 2.6 0.0 0.0 0.0 0.8 3.6 0.0 0.0 0.0 0.0 0.2 1.2 1.1 0.7 1.5 1.9 0.0 2.1 1.4 0.0 0.0 0.2 0.0 0.0 0.1 0.1 1.2 0.8 1.9 0.0 7.1 4.0 4.8 0.0 0.4 0.3 0.8 0.6 3.0 0.4 0.0 0.5 2.1 0.0 1.1 0.1 0.0 0.3 2.4 2.4 0.0 1.0 0.1 0.1 0.0 0.1 4.5 0.4 3.3 0.4 0.0 0.0 0.0 0.0 0.0 1.5 1.1 0.0 0.1 0.0 1.3 0.2 0.0 0.0 0.0 1.0 0.0 0.0 7.6 0.5 0.2 3.9 0.9 1.4 0.0 0.0 1.2 0.7 2.6 0.2 0.0 0.0 0.0 0.1 0.1 2.8 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.1 3.6 1.9 0.0 1.2 0.5 0.0 0.0 0.0 0.0 0.9 0.0 0.0 5.2 0.0 0.3 0.9 0.1 0.0 0.0 1.8 0.0 0.1 0.8 0.0 1.9 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.1 2.6 0.0 0.0 0.0 2.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.5 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 1.5 0.0 0.0 0.0 2.6 2.5 3.2 1.0 2.2 0.9 0.3 0.1 1.0 0.1 0.0 HOXD1 "HOX4, HOX4G" ENSG00000128645 "Homeobox D1" Q9GZZ0 2 176188668-176190907 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.9;epididymis: 7.5" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 18.5;Distal enterocytes: 20.3;Distal tubular cells: 25.4;Endothelial cells: 18.8;Intestinal goblet cells: 20.6;Oligodendrocytes: 28.0;Proximal enterocytes: 22.0;Undifferentiated cells: 28.6" "Cancer enriched" "Detected in many" 5 "ovarian cancer: 6.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 6.6;Hep G2: 7.2;RPTEC TERT1: 21.3;RT4: 16.9;SCLC-21H: 5.7" "Region enriched" "Detected in single" 5 "pons and medulla: 1.1" "Low region specificity" "Detected in many" "HPA040062, HPA056900" Enhanced Nucleoplasm NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 53: Intestinal epithelial cells - Unknown function" Nucleoplasm "HPA040062: AB_2676826, HPA056900: AB_2683270" "unprognostic (8.78e-2)" "unprognostic (9.97e-2)" "unprognostic (7.11e-3)" "unprognostic (1.06e-3)" "unprognostic (2.70e-1)" "unprognostic (3.19e-2)" "unprognostic (7.33e-2)" "unprognostic (4.10e-2)" "unprognostic (2.85e-1)" "unprognostic (2.44e-1)" "unprognostic (9.64e-2)" "unprognostic (4.02e-1)" "unprognostic (1.54e-5)" "unprognostic (4.33e-3)" "unprognostic (1.56e-1)" "unprognostic (1.36e-1)" "unprognostic (1.32e-1)" 2.0 0.2 1.7 0.5 5.2 0.0 1.6 6.1 5.0 0.3 0.8 2.9 0.3 0.4 7.5 0.5 4.8 0.7 0.1 1.6 3.3 6.5 0.0 3.2 0.4 19.9 5.8 0.4 0.2 0.0 0.0 0.0 8.2 1.0 2.0 0.0 0.2 2.6 0.1 0.6 3.3 0.3 6.5 1.1 0.4 1.7 5.3 0.1 0.1 0.3 0.1 2.2 0.4 10.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.1 0.0 0.0 0.0 6.6 0.4 0.5 0.0 0.0 0.0 0.0 0.0 1.6 0.2 0.0 7.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.0 21.3 16.9 5.7 1.0 0.0 0.0 1.2 0.8 0.0 0.0 3.9 0.0 0.2 0.8 0.3 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 5.2 6.1 5.0 1.6 3.3 19.9 5.8 8.2 6.5 5.3 10.1 14.2 3.2 18.5 0.0 0.1 4.2 0.2 0.0 0.0 0.0 0.9 1.3 0.1 0.0 2.5 7.3 0.0 0.0 0.1 20.3 25.4 0.0 0.1 0.2 0.2 18.8 6.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 2.5 0.0 0.0 0.0 0.0 0.0 0.0 20.6 0.0 0.0 5.6 0.4 0.0 0.3 3.6 0.0 0.0 0.0 0.0 0.0 28.0 0.1 13.2 0.4 0.9 0.7 22.0 3.2 0.0 0.0 0.0 0.6 1.1 3.4 9.5 0.3 2.6 0.0 0.5 0.5 28.6 2.7 HOXD3 "HOX1D, HOX4, HOX4A" ENSG00000128652 "Homeobox D3" P31249 2 176136612-176173102 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "epididymis: 42.1" "Cell type enhanced" "Detected in some" "Adipocytes: 6.6;Collecting duct cells: 9.2;Distal tubular cells: 15.6;Early spermatids: 14.4;Endothelial cells: 6.5;Theca cells: 4.7" "Cancer enhanced" "Detected in some" "ovarian cancer: 1.2" "Group enriched" "Detected in many" 8 "medulla oblongata: 8.9;pons: 5.7;spinal cord: 5.7;white matter: 4.9" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 9.7;HSkMC: 11.2;RPTEC TERT1: 12.0;SCLC-21H: 14.5;SH-SY5Y: 10.1" "Region enriched" "Detected in single" 35 "pons and medulla: 3.5" "Group enriched" "Detected in some" 6 "medulla oblongata: 4.1;pons: 1.1;spinal cord: 3.0" "HPA051831, HPA063671" Supported "Nucleoplasm,Nuclear bodies" No NA "Cluster 68: Epididymis - Unknown function" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 29: Early spermatids - Spermatogenesis" Nucleoplasm "Nuclear bodies" "HPA051831: , HPA063671: AB_2685083" "unprognostic (1.13e-1)" "unprognostic (3.28e-1)" "unprognostic (1.52e-2)" "unprognostic (6.50e-2)" "unprognostic (1.31e-1)" "unprognostic (7.07e-2)" "unprognostic (1.97e-2)" "unprognostic (1.54e-2)" "unprognostic (9.56e-2)" "unprognostic (5.57e-2)" "unprognostic (1.08e-1)" "unprognostic (1.56e-1)" "unprognostic (2.57e-4)" "unprognostic (1.47e-3)" "unprognostic (1.55e-1)" "unprognostic (3.44e-1)" "unprognostic (7.44e-2)" 3.2 2.3 0.2 0.8 0.4 0.0 2.8 0.4 0.3 3.2 0.1 1.0 0.3 6.9 42.1 0.7 6.8 0.6 0.2 0.2 0.4 7.9 0.0 0.2 0.8 8.9 0.8 5.5 0.2 0.1 0.0 0.1 5.7 1.7 0.6 0.0 0.5 7.1 0.7 0.9 0.8 4.1 5.7 0.7 0.3 1.7 0.4 0.2 0.4 0.0 0.2 1.0 2.0 4.9 0.0 0.0 0.0 0.0 0.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.7 1.7 0.2 0.0 0.4 0.0 0.0 0.1 3.6 0.0 0.0 0.1 0.0 0.0 0.0 11.2 0.9 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.1 0.0 0.0 0.0 12.0 0.9 14.5 10.1 0.2 0.1 4.6 0.2 0.0 0.0 1.0 0.2 0.2 1.5 0.8 0.0 0.2 0.0 0.5 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.4 0.3 0.2 0.4 8.9 0.8 5.7 5.7 0.4 4.9 6.6 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.3 15.6 0.0 14.4 0.1 2.1 6.5 1.2 0.0 0.2 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.8 3.5 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 2.0 0.0 0.3 4.5 0.0 0.1 0.3 2.9 0.0 0.0 0.0 1.3 1.1 0.8 0.5 0.0 1.3 0.0 0.1 4.7 0.6 0.1 HOXD4 "HOX4, HOX4B" ENSG00000170166 "Homeobox D4" P09016 2 176151550-176153226 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 24.4;epididymis: 28.0" "Cell type enhanced" "Detected in some" "Adipocytes: 5.5;Collecting duct cells: 16.5;Early spermatids: 3.7;Endothelial cells: 3.6;Leydig cells: 4.7;Proximal tubular cells: 6.5;Sertoli cells: 6.6" "Cancer enhanced" "Detected in many" "ovarian cancer: 5.3" "Group enriched" "Detected in many" 21 "medulla oblongata: 10.6;pons: 5.6;spinal cord: 8.1;white matter: 7.3" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 16.6;HEK 293: 39.7;RPTEC TERT1: 29.6;SK-MEL-30: 11.0" "Region enriched" "Detected in single" 46 "pons and medulla: 4.5" "Group enriched" "Detected in some" 4 "medulla oblongata: 6.0;spinal cord: 7.8" "HPA054383, HPA070349" Approved Supported "Nucleoplasm,Cell Junctions" NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Nucleoplasm "Cell Junctions" "HPA054383: AB_2682470, HPA070349: AB_2686258" "unprognostic (9.37e-2)" "unprognostic (1.54e-1)" "unprognostic (1.03e-3)" "unprognostic (1.10e-3)" "unprognostic (9.21e-2)" "unprognostic (5.17e-3)" "unprognostic (5.19e-2)" "unprognostic (6.69e-3)" "unprognostic (1.66e-1)" "unprognostic (3.47e-1)" "unprognostic (1.49e-1)" "unprognostic (2.50e-1)" "unprognostic (7.78e-2)" "unprognostic (1.12e-2)" "unprognostic (9.93e-2)" "unprognostic (5.81e-2)" "unprognostic (1.61e-1)" 6.9 8.3 0.0 1.6 0.0 0.0 7.4 0.0 0.1 7.1 0.0 7.3 1.0 24.4 28.0 1.1 14.3 1.5 0.6 0.0 0.0 18.5 0.0 0.4 1.7 10.6 0.3 15.1 0.6 0.1 0.0 0.4 5.6 2.9 2.0 0.0 0.7 11.1 2.8 2.4 6.2 9.7 8.1 7.2 1.0 3.0 0.0 0.2 1.2 0.5 0.4 2.7 4.0 7.3 0.5 0.3 0.0 0.0 2.0 3.0 0.0 0.2 0.9 0.1 1.1 0.9 0.0 0.0 16.6 3.4 0.7 0.2 2.6 0.0 0.4 0.0 39.7 0.5 0.0 0.0 0.5 0.0 0.1 9.3 2.6 0.0 0.5 0.2 6.2 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.4 0.0 0.0 0.0 29.6 4.1 2.5 4.2 0.6 0.0 11.0 0.6 0.0 0.0 5.0 0.5 0.2 2.9 2.1 0.0 0.1 0.0 2.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 10.6 0.3 5.6 8.1 0.0 7.3 5.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.0 16.5 0.0 0.0 0.0 0.9 0.0 0.0 3.7 0.1 1.1 3.6 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.7 2.6 4.7 0.1 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 3.0 0.0 0.1 0.3 6.5 0.0 0.0 6.6 0.6 0.9 0.3 0.4 0.0 0.6 0.0 0.1 3.0 1.3 0.0 HOXD8 "HOX4, HOX4E" ENSG00000175879 "Homeobox D8" P13378 2 176129694-176132695 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 99.6;kidney: 76.2" "Cell type enhanced" "Detected in many" "Adipocytes: 51.8;Collecting duct cells: 60.7;Distal tubular cells: 213.2;Early spermatids: 124.6;Leydig cells: 51.3;Peritubular cells: 53.8;Spermatocytes: 82.1" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 4 "medulla oblongata: 1.5;spinal cord: 4.0;white matter: 5.8" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTCEpi: 45.4;RPTEC TERT1: 74.8;TIME: 32.5" "Not detected" "Not detected" "Region enriched" "Detected in single" 70 "spinal cord: 34.6" NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 66: Spermatocytes - Spermatogenesis" "unprognostic (1.22e-1)" "unprognostic (6.31e-2)" "unprognostic (2.19e-3)" "unprognostic (2.68e-2)" "unprognostic (3.35e-1)" "unprognostic (3.49e-1)" "unprognostic (2.56e-3)" "prognostic unfavorable (3.78e-4)" "unprognostic (2.79e-1)" "unprognostic (1.40e-2)" "unprognostic (3.93e-1)" "unprognostic (3.05e-1)" "unprognostic (3.63e-2)" "unprognostic (4.80e-2)" "unprognostic (5.21e-2)" "unprognostic (8.31e-2)" "unprognostic (2.80e-2)" 16.4 20.6 0.0 4.8 0.0 0.0 18.8 0.0 0.0 13.3 0.0 10.8 1.2 19.5 99.6 2.7 17.2 3.1 0.9 0.0 0.0 76.2 0.3 0.9 4.9 1.5 0.0 34.2 1.4 1.1 0.0 0.7 0.8 6.0 4.9 0.0 1.7 24.0 7.8 4.8 8.6 13.1 4.0 10.5 1.6 20.1 0.0 1.0 3.5 1.5 1.3 6.5 9.2 5.8 13.7 2.1 0.0 0.0 8.8 14.1 0.3 1.7 7.2 2.2 0.2 0.1 0.1 0.0 16.7 10.8 1.7 0.1 4.7 0.5 5.4 0.0 6.4 2.3 0.8 0.0 2.9 1.3 0.8 24.7 45.4 0.3 6.7 0.0 22.9 4.4 0.2 0.1 3.7 0.1 0.1 0.4 0.2 0.0 2.6 0.0 4.9 0.2 74.8 9.6 14.2 26.4 4.3 0.0 28.4 1.2 0.0 0.1 32.5 1.1 8.9 15.4 9.1 0.0 0.0 0.0 21.1 0.0 26.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.8 4.0 0.0 5.8 51.8 0.0 1.1 0.0 0.5 2.7 2.1 0.0 0.6 0.0 0.7 0.6 2.3 0.0 0.0 60.7 0.0 0.0 0.2 2.7 213.2 0.0 124.6 0.7 9.4 36.4 4.8 0.0 0.0 0.0 0.0 14.9 0.0 0.3 0.0 0.0 2.5 0.0 0.1 0.0 0.0 1.8 0.0 0.0 3.4 29.9 51.3 0.5 10.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 53.8 0.0 1.3 0.5 25.1 0.7 0.0 32.9 14.1 9.8 82.1 20.4 0.2 2.8 0.1 1.0 31.9 3.4 1.1 HSFX1 LW-1 ENSG00000171116 "Heat shock transcription factor family, X-linked 1" Q9UBD0 X 149774068-149776867 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in some" "HPA051700, HPA063040" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" Nucleoplasm "Plasma membrane, Cytosol" "HPA051700: AB_2681578, HPA063040: AB_2732695" "unprognostic (3.50e-2)" "unprognostic (2.86e-1)" "unprognostic (2.30e-2)" "unprognostic (6.32e-2)" "unprognostic (3.38e-2)" "unprognostic (3.78e-1)" "unprognostic (5.03e-2)" "unprognostic (3.70e-1)" "unprognostic (3.56e-1)" "unprognostic (1.47e-1)" "unprognostic (1.68e-2)" "unprognostic (1.92e-1)" "unprognostic (2.46e-1)" "unprognostic (3.10e-1)" 0.8 0.8 1.5 0.3 1.8 0.0 1.1 1.9 2.6 1.7 2.8 1.8 0.5 1.3 3.3 1.2 1.5 0.8 1.9 2.0 1.4 1.0 1.0 0.9 0.4 1.5 1.5 3.1 1.0 0.8 1.2 1.2 2.2 2.0 0.1 0.7 1.3 0.6 1.3 1.2 1.0 0.4 1.0 2.5 1.0 3.4 1.8 0.1 1.5 0.0 0.4 1.4 1.5 1.8 0.0 1.1 0.0 0.4 1.4 0.9 0.2 0.2 0.0 0.2 0.0 0.8 0.7 0.7 1.2 0.1 0.7 0.0 0.6 0.2 0.1 0.1 0.0 0.2 0.5 0.1 0.8 0.1 0.1 0.0 0.0 0.0 0.6 1.1 0.3 0.0 0.0 0.2 0.1 1.3 0.1 0.5 0.3 0.1 0.6 0.3 0.8 0.0 1.0 0.5 0.5 0.2 0.1 0.0 0.2 0.8 0.1 0.2 0.2 0.0 0.6 0.2 0.4 0.2 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 1.5 1.8 1.9 2.6 2.0 1.4 1.5 1.5 2.2 1.0 1.8 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HSPA13 STCH ENSG00000155304 "Heat shock protein family A (Hsp70) member 13" P48723 21 14371115-14383484 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Plasma cells: 131.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 231.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014797 Approved "Intracellular and membrane" NA NA 3300000 "Cluster 46: Basophils - DNA binding" "Cluster 68: Epididymis - Unknown function" "Cluster 2: Karpas-707 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "HPA014797: AB_1857567" "unprognostic (2.03e-2)" "unprognostic (1.13e-1)" "unprognostic (1.38e-1)" "unprognostic (5.77e-3)" "unprognostic (1.06e-1)" "unprognostic (1.72e-1)" "unprognostic (2.85e-3)" "unprognostic (1.41e-2)" "unprognostic (7.86e-2)" "unprognostic (1.64e-1)" "unprognostic (2.46e-1)" "unprognostic (5.62e-2)" "unprognostic (1.52e-2)" "unprognostic (1.65e-1)" "unprognostic (2.29e-1)" "unprognostic (2.61e-1)" "unprognostic (1.16e-2)" 13.5 24.0 12.3 17.7 14.3 23.5 15.7 11.1 16.0 19.1 8.4 12.4 10.0 21.9 26.4 9.1 8.5 12.3 13.8 13.9 21.1 16.3 13.3 12.9 15.8 12.6 14.0 16.4 9.3 24.0 17.3 22.8 17.0 15.4 12.6 23.3 9.4 16.9 3.4 3.8 10.0 19.2 13.8 15.1 12.7 22.7 16.7 16.9 27.7 8.0 17.4 18.4 5.0 13.4 21.2 17.0 65.7 38.2 46.6 37.4 41.8 58.6 68.9 47.8 54.5 16.1 22.8 36.7 40.3 42.4 71.1 9.1 30.8 20.1 79.6 38.5 24.0 35.8 16.4 30.4 119.5 58.8 44.0 33.4 64.4 68.4 117.0 60.5 40.6 32.6 30.5 231.9 52.7 21.2 39.6 17.9 49.0 9.9 23.2 36.6 57.8 81.2 25.1 8.1 15.0 36.7 43.6 22.6 84.6 33.4 31.1 38.7 40.7 62.1 51.7 49.3 43.4 87.5 70.5 29.2 69.9 37.2 79.5 23.1 4.8 4.9 6.6 5.4 11.4 7.1 7.0 7.1 5.5 3.7 7.7 7.4 1.9 12.1 4.9 8.3 6.0 6.1 12.3 14.3 11.1 16.0 13.9 21.1 12.6 14.0 17.0 13.8 16.7 13.4 14.0 9.6 14.1 11.4 29.7 12.7 14.7 16.9 20.5 41.0 15.6 8.6 14.6 4.3 10.8 3.7 14.6 22.1 25.1 5.1 0.0 8.6 6.8 6.6 31.4 14.6 14.9 26.7 21.0 10.4 31.1 26.4 5.6 15.1 19.0 21.2 12.5 11.8 14.5 60.6 28.2 8.1 4.1 15.8 28.9 2.8 9.9 16.7 23.2 12.2 8.6 34.8 8.2 31.7 15.5 9.3 3.7 19.2 131.4 15.2 2.9 7.5 7.8 21.9 13.1 23.6 25.0 40.2 12.7 12.9 10.2 64.2 24.6 11.9 4.1 13.6 HTRA1 "ARMD7, HtrA, IGFBP5-protease, PRSS11" ENSG00000166033 "HtrA serine peptidase 1" Q92743 10 122458551-122514907 "Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Growth factor binding, Hydrolase, Protease, Serine protease" "Age-related macular degeneration, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Fibroblasts: 269.3;Granulosa cells: 731.6;Horizontal cells: 625.9;Muller glia cells: 373.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 2417.8;ASC TERT1: 889.4;fHDF/TERT166: 862.3;HSkMC: 1581.4;LHCN-M2: 1238.2;U-87 MG: 1004.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036655 Approved Supported "Plasma membrane" "Secreted to blood" NA NA 24800000 7600000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 68: Epididymis - Unknown function" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 40: Granulosa cells - Unknown function" "Plasma membrane" "HPA036655: AB_10671966" "unprognostic (3.84e-1)" "unprognostic (3.42e-2)" "unprognostic (1.57e-2)" "unprognostic (1.86e-2)" "unprognostic (1.22e-3)" "unprognostic (8.71e-3)" "unprognostic (2.33e-2)" "unprognostic (3.83e-1)" "unprognostic (7.22e-2)" "unprognostic (3.36e-2)" "unprognostic (1.32e-1)" "unprognostic (1.54e-1)" "prognostic unfavorable (7.90e-7)" "unprognostic (7.12e-3)" "unprognostic (9.13e-2)" "unprognostic (1.69e-1)" "prognostic unfavorable (5.62e-6)" 246.0 81.3 382.1 37.0 436.6 0.5 202.8 422.6 595.7 352.1 316.2 154.8 20.8 197.1 247.1 57.8 122.9 301.2 114.7 377.7 411.4 230.9 226.4 69.9 39.9 427.1 447.0 425.5 55.9 111.8 184.1 281.9 425.3 85.7 51.8 243.6 101.1 114.5 31.1 130.5 73.5 152.3 382.1 54.2 87.3 19.5 423.6 21.2 78.8 80.9 27.3 137.3 188.3 464.2 0.3 45.6 19.4 5.7 2417.8 889.4 0.8 108.3 196.8 44.4 23.6 0.2 0.6 0.0 29.0 862.3 68.6 12.8 7.6 124.4 6.2 0.1 4.9 0.1 65.4 0.3 123.7 0.1 0.9 1581.4 444.6 25.8 205.3 503.6 207.1 0.0 0.1 1.5 1238.2 22.3 0.1 0.7 20.9 0.2 67.6 0.2 1.3 0.4 282.6 2.2 1.2 3.9 272.1 0.2 122.2 91.4 8.6 0.2 136.0 309.9 4.5 141.3 94.1 0.2 0.1 0.3 1004.6 0.2 148.5 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 382.1 436.6 422.6 595.7 377.7 411.4 427.1 447.0 425.3 382.1 423.6 464.2 55.1 22.4 6.9 116.5 0.9 44.1 32.5 10.8 23.9 53.3 5.4 31.2 26.4 14.3 0.9 64.4 54.2 30.9 1.3 0.0 0.0 2.0 3.5 11.3 76.5 107.0 0.0 2.7 2.2 4.6 164.6 269.3 4.6 14.4 1.3 731.6 57.8 157.8 51.3 625.9 31.2 0.3 8.2 18.1 59.9 4.2 31.7 22.0 46.2 86.2 8.5 373.8 0.0 193.0 112.5 2.7 1.3 77.5 1.9 8.7 0.2 22.6 10.1 150.3 6.6 63.3 140.5 0.2 0.7 7.0 30.5 87.7 7.2 2.5 0.6 11.9 IFITM1 "9-27, CD225, DSPA2a, IFI17" ENSG00000185885 "Interferon induced transmembrane protein 1" P13164 11 310041-315272 "CD markers, Plasma proteins, Predicted membrane proteins, Transporters" "Antiviral defense, Immunity, Innate immunity, Osteogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 673.8;Endothelial cells: 364.4;Leydig cells: 300.8;Sertoli cells: 276.1;T-cells: 595.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "eosinophil: 1494.7;gdT-cell: 2906.3;MAIT T-cell: 2003.4;memory CD4 T-cell: 3120.6;memory CD8 T-cell: 3000.3;naive CD4 T-cell: 2939.3;naive CD8 T-cell: 2996.4;neutrophil: 2741.6;NK-cell: 4679.9;T-reg: 1944.8" "Group enriched" "Detected in all" 7 "granulocytes: 2741.6;NK-cells: 4679.9;T-cells: 3120.6" "Cell line enhanced" "Detected in many" "BJ hTERT+: 1038.8;BJ hTERT+ SV40 Large T+: 2266.3;BJ hTERT+ SV40 Large T+ RasG12V: 4016.8;HMC-1: 1138.9" "HPA004810, CAB017615" Enhanced Uncertain "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 58: T-cells - T-cell receptor" "Golgi apparatus" "Plasma membrane, Cytosol" "CAB017615: AB_2264496, HPA004810: AB_1851419" "unprognostic (1.03e-3)" "unprognostic (6.79e-2)" "unprognostic (1.03e-1)" "unprognostic (2.98e-1)" "unprognostic (2.57e-1)" "unprognostic (9.06e-2)" "unprognostic (7.58e-2)" "unprognostic (3.03e-1)" "unprognostic (6.21e-2)" "unprognostic (5.53e-2)" "unprognostic (6.64e-3)" "unprognostic (1.48e-2)" "prognostic unfavorable (5.77e-9)" "unprognostic (7.29e-2)" "unprognostic (6.29e-2)" "unprognostic (3.15e-2)" "unprognostic (3.82e-2)" 477.7 102.3 291.8 282.0 303.4 367.1 401.7 293.8 402.1 563.3 321.5 249.0 128.4 314.6 1152.4 147.4 537.4 247.9 368.4 292.6 305.4 317.5 191.4 246.5 417.2 324.8 295.6 607.5 78.8 154.0 145.1 278.5 322.5 190.6 172.0 14.9 199.8 324.3 134.2 164.6 252.4 367.4 308.6 679.7 141.6 56.3 317.5 296.5 263.4 259.3 295.9 307.4 364.7 304.3 125.7 5.5 1011.4 74.5 79.1 279.8 7.4 250.1 1038.8 2266.3 4016.8 3.7 782.2 3.0 157.9 257.1 23.5 269.0 36.5 26.2 52.0 255.3 51.8 125.9 77.5 11.8 668.2 182.8 1138.9 496.3 0.2 26.6 2.6 27.0 4.2 41.1 450.0 880.7 1.7 23.9 85.1 318.2 264.5 0.5 33.5 27.1 3.1 24.5 654.9 0.0 1.0 2.2 122.7 11.9 196.9 138.5 42.1 17.0 8.8 3.8 4.7 1.5 1.1 61.6 44.8 6.8 3.4 253.8 3.1 544.4 62.1 1494.7 2906.3 312.7 2003.4 364.9 3120.6 3000.3 114.2 323.6 2939.3 2996.4 2741.6 4679.9 539.0 33.7 1944.8 4673.8 291.8 303.4 293.8 402.1 292.6 305.4 324.8 295.6 322.5 308.6 317.5 304.3 240.7 35.3 119.4 2.6 88.2 27.9 17.1 70.2 673.8 0.0 13.0 12.6 8.4 2.8 115.3 33.1 0.0 3.3 258.6 13.7 5.9 1.7 1.4 14.6 96.5 364.4 1.2 27.8 0.0 1.4 30.7 236.0 33.6 20.8 18.9 5.6 164.6 24.6 11.8 0.0 0.0 17.3 10.2 10.1 26.8 3.8 300.8 45.4 78.2 42.2 2.1 0.0 126.7 0.0 0.2 0.7 15.0 124.5 141.2 2.3 15.0 1.0 26.0 0.0 276.1 16.4 213.4 0.6 1.5 50.4 14.3 4.0 595.8 2.1 29.2 5.7 ITGB8 ENSG00000105855 "Integrin subunit beta 8" P26012 7 20330702-20415754 "Cancer-related genes, Predicted membrane proteins" "Cell adhesion" "Integrin, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 53.9;choroid plexus: 39.4" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 376.2;Glandular and luminal cells: 551.9;Oligodendrocyte precursor cells: 192.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 133 "basophil: 16.5" "Lineage enriched" "Detected in single" 133 "granulocytes: 16.5" "Cell line enhanced" "Detected in many" "AF22: 44.3;EFO-21: 54.6;RPTEC TERT1: 88.1;WM-115: 127.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027796, HPA027797" Enhanced Approved "Plasma membrane,Cytosol" NA NA "Cluster 38: Basophils - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 17: WM-115 - Nervous system development" "Cluster 44: Endometrium - Transcription" "Plasma membrane, Cytosol" "HPA027796: AB_10600299, HPA027797: AB_10600879" "unprognostic (8.32e-3)" "unprognostic (1.42e-1)" "unprognostic (1.03e-1)" "unprognostic (3.37e-3)" "unprognostic (5.63e-2)" "unprognostic (3.53e-1)" "unprognostic (1.75e-1)" "unprognostic (1.46e-1)" "unprognostic (4.36e-2)" "unprognostic (1.75e-2)" "unprognostic (2.49e-3)" "unprognostic (8.47e-2)" "prognostic favorable (1.77e-4)" "unprognostic (2.90e-1)" "unprognostic (1.56e-1)" "unprognostic (4.63e-2)" "unprognostic (6.92e-3)" 3.8 2.6 25.7 4.2 41.8 0.3 9.6 53.9 19.2 15.4 39.4 3.7 3.2 7.7 14.0 6.4 7.5 8.7 2.9 19.5 37.5 21.6 0.8 2.4 0.5 38.9 48.4 4.7 13.3 5.1 5.4 5.2 42.7 6.7 2.8 4.6 13.6 9.0 0.2 6.3 4.2 3.0 39.7 0.0 4.2 6.5 35.6 0.8 2.1 0.9 6.9 7.2 9.0 48.6 28.2 1.1 44.3 5.6 3.7 15.2 0.0 0.1 0.5 0.2 1.5 0.3 6.9 0.0 54.6 2.0 1.7 30.1 1.9 4.5 0.5 0.0 0.7 0.0 23.1 0.0 1.8 0.0 0.1 1.8 12.6 0.5 2.4 27.1 2.4 0.0 0.0 8.3 0.8 0.1 0.0 0.0 3.3 0.4 4.8 0.0 3.7 0.0 88.1 2.5 0.7 1.9 8.6 0.2 23.5 0.8 0.7 0.1 3.0 11.2 7.1 3.2 5.8 10.2 0.1 0.0 2.7 0.0 127.0 16.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 25.7 41.8 53.9 19.2 19.5 37.5 38.9 48.4 42.7 39.7 35.6 48.6 0.7 12.8 4.8 106.4 2.5 33.1 117.2 39.4 34.7 13.3 26.3 18.7 3.0 38.6 57.9 38.6 0.0 20.0 0.4 5.0 7.9 26.3 3.0 376.2 150.6 5.2 34.0 0.0 28.1 17.4 1.2 15.5 7.7 551.9 1.3 0.9 1.4 0.2 3.3 1.7 8.2 7.4 34.6 1.0 4.7 6.5 44.1 9.8 3.6 4.7 31.6 24.3 0.0 192.0 119.2 35.8 6.1 44.8 2.0 149.7 14.5 76.7 100.1 1.4 0.0 4.8 7.0 1.4 1.1 34.6 12.4 4.9 5.5 1.9 9.6 150.7 ITM2B "BRI, BRI2, BRICD2B, E25B, E3-16" ENSG00000136156 "Integral membrane protein 2B" Q9Y287 13 48232612-48270357 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters" "Amyloidosis, Deafness, Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 4375.2" "Lineage enriched" "Detected in all" 5 "granulocytes: 4375.2" "Cell line enhanced" "Detected in all" "HMC-1: 731.2;RPTEC TERT1: 1718.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029292, HPA071992" Enhanced Enhanced "Golgi apparatus,Vesicles" "Secreted to blood" NA NA 5800000 "Cluster 5: Granulocytes - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Golgi apparatus, Vesicles" "HPA029292: AB_10601917, HPA071992: AB_2686480" "unprognostic (4.66e-2)" "unprognostic (2.02e-1)" "unprognostic (1.03e-2)" "unprognostic (1.00e-1)" "unprognostic (4.41e-2)" "unprognostic (6.84e-2)" "unprognostic (2.52e-1)" "unprognostic (1.29e-1)" "unprognostic (9.88e-2)" "unprognostic (2.42e-1)" "unprognostic (5.89e-2)" "unprognostic (2.87e-2)" "prognostic favorable (3.73e-5)" "unprognostic (4.38e-2)" "unprognostic (4.09e-2)" "unprognostic (6.00e-2)" "unprognostic (1.22e-1)" 510.2 367.4 286.9 172.5 301.0 125.6 323.8 328.6 489.0 416.1 406.6 260.1 289.2 388.8 1171.8 399.9 305.4 257.5 381.0 320.1 339.2 1306.3 391.2 376.1 236.7 334.9 308.0 507.2 179.6 233.7 290.5 573.8 304.4 312.5 191.4 174.4 408.7 386.2 164.7 399.6 287.4 232.5 373.6 435.2 312.8 121.4 308.8 188.3 386.1 206.2 187.4 305.1 402.2 394.8 67.6 51.8 73.1 116.3 348.5 254.5 119.2 215.0 202.2 87.5 100.6 29.1 248.3 16.6 168.8 121.6 48.5 214.1 61.3 107.0 107.4 69.9 147.3 137.9 29.0 99.0 138.5 140.6 731.2 113.4 149.1 45.1 62.0 375.7 131.2 78.3 24.5 90.9 174.8 29.6 200.4 310.1 266.0 116.5 103.6 100.1 100.5 73.6 1718.9 268.6 26.2 119.5 154.5 110.2 111.0 306.0 74.0 119.4 180.5 62.9 73.8 95.7 85.4 72.9 59.6 2.5 78.0 75.3 155.3 3091.4 864.5 2737.9 387.4 661.3 512.5 235.3 523.1 476.4 428.9 245.3 551.3 466.8 4375.2 356.5 692.7 196.2 563.4 1723.5 286.9 301.0 328.6 489.0 320.1 339.2 334.9 308.0 304.4 373.6 308.8 394.8 1380.0 695.5 300.4 174.6 408.6 862.4 1661.1 2606.2 1006.2 653.1 460.1 573.5 384.8 722.0 1121.9 1991.8 187.7 1164.3 448.2 754.2 545.9 910.2 23.6 751.8 802.2 1166.2 283.3 307.0 114.2 682.9 2362.8 1334.0 302.8 1177.2 578.0 421.2 1319.7 557.3 2117.8 353.3 142.6 503.2 1129.1 1569.8 900.6 76.7 1867.0 1381.5 681.3 252.0 1415.7 1634.9 425.3 174.4 237.9 515.7 788.3 2011.6 445.4 922.5 1259.3 2748.9 795.6 219.4 1222.7 602.4 1022.9 143.6 256.4 1384.6 1149.6 1471.5 723.2 665.5 440.9 1613.4 JADE3 "JADE-3, KIAA0215, PHF16" ENSG00000102221 "Jade family PHD finger 3" Q92613 X 46912276-47061242 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocyte precursor cells: 37.2;Oligodendrocytes: 36.8;Spermatocytes: 42.7;Spermatogonia: 35.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "memory B-cell: 1.8;naive B-cell: 1.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "BEWO: 65.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA006007, HPA064697" Uncertain Approved Nucleoplasm,Nucleoli NA NA "Cluster 43: B-cells - Humoral immune response" "Cluster 68: Epididymis - Unknown function" "Cluster 28: BEWO - Transcription regulation" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "Nucleoplasm, Nucleoli" "HPA006007: AB_1079605, HPA064697: AB_2685326" "unprognostic (1.39e-1)" "unprognostic (2.53e-1)" "unprognostic (2.24e-1)" "unprognostic (1.52e-3)" "unprognostic (1.18e-2)" "unprognostic (3.01e-2)" "unprognostic (1.05e-3)" "unprognostic (1.59e-1)" "unprognostic (6.83e-3)" "unprognostic (4.55e-2)" "unprognostic (8.97e-3)" "unprognostic (2.82e-1)" "unprognostic (4.25e-2)" "unprognostic (4.42e-2)" "unprognostic (2.69e-1)" "unprognostic (8.18e-2)" "unprognostic (9.70e-2)" 3.5 10.7 3.5 3.1 4.9 2.0 6.3 5.1 5.1 5.6 2.7 3.6 2.2 6.0 15.9 3.5 3.9 3.2 3.1 3.2 4.1 3.7 7.6 3.6 4.9 6.6 4.4 7.1 8.3 3.3 1.1 15.4 6.2 4.2 3.4 2.5 3.5 7.2 1.7 3.3 4.6 5.0 5.0 5.0 4.1 12.1 5.2 7.2 4.1 2.6 6.1 4.7 2.6 8.8 12.1 10.6 17.2 11.9 6.2 4.6 65.7 7.1 5.9 7.8 8.7 12.3 10.3 0.1 4.9 5.2 11.6 4.7 21.1 5.7 11.2 32.6 13.8 9.6 11.9 12.0 10.2 7.3 5.0 3.5 7.8 5.5 17.7 4.8 14.9 18.1 6.7 5.6 6.1 12.5 26.5 8.9 13.6 7.8 9.0 27.0 19.4 16.9 6.6 11.0 14.8 13.1 20.4 18.7 11.3 28.3 12.4 7.6 9.3 8.2 14.2 11.7 4.7 4.3 4.0 22.7 2.3 6.1 8.1 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.1 0.1 0.7 0.0 0.2 3.5 4.9 5.1 5.1 3.2 4.1 6.6 4.4 6.2 5.0 5.2 8.8 4.1 0.0 7.8 1.0 14.4 4.2 2.3 1.8 2.2 1.5 9.9 4.2 5.4 1.5 1.6 5.5 0.0 9.6 0.1 2.0 0.0 2.4 1.1 3.9 3.9 5.1 8.4 6.5 5.5 3.6 10.3 2.0 2.6 4.4 0.0 9.7 6.1 13.3 1.8 0.0 12.7 2.6 6.1 1.0 5.7 3.7 4.7 1.4 3.6 14.0 2.8 1.2 1.0 37.2 36.8 3.1 1.1 3.8 1.9 4.1 0.5 2.9 1.2 2.3 6.6 1.9 2.8 42.7 35.3 5.8 8.1 14.2 0.7 3.5 2.4 3.7 KCNAB1 "AKR6A3, hKvb3, hKvBeta3, KCNA1B, Kvb1.3" ENSG00000169282 "Potassium voltage-gated channel subfamily A member regulatory beta subunit 1" Q14722 3 156037701-156539138 "Predicted intracellular proteins, Transporters" "Ion transport, Potassium transport, Transport" "Ion channel, Oxidoreductase, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 52.7" "Cell type enhanced" "Detected in many" "Bipolar cells: 85.8;Excitatory neurons: 108.6;Inhibitory neurons: 605.4;Oligodendrocyte precursor cells: 206.6;Oligodendrocytes: 97.5;Sertoli cells: 78.9" "Cancer enhanced" "Detected in many" "thyroid cancer: 7.4" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HEL: 3.4;hTEC/SVTERT24-B: 5.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036110, HPA044550" Approved Approved "Nucleoplasm,Vesicles,Plasma membrane" NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 68: Epididymis - Unknown function" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Vesicles "Nucleoplasm, Plasma membrane" "HPA036110: , HPA044550: AB_10797032" "unprognostic (1.52e-1)" "unprognostic (3.73e-1)" "unprognostic (1.33e-1)" "unprognostic (2.98e-4)" "unprognostic (1.24e-2)" "unprognostic (1.64e-1)" "unprognostic (1.81e-1)" "unprognostic (2.83e-2)" "unprognostic (8.51e-2)" "unprognostic (3.72e-2)" "unprognostic (5.87e-2)" "unprognostic (9.70e-2)" "unprognostic (2.17e-3)" "unprognostic (2.60e-1)" "unprognostic (1.95e-1)" "unprognostic (1.06e-1)" "unprognostic (4.00e-1)" 15.8 6.3 12.7 1.2 52.7 1.6 7.3 15.5 17.3 8.4 4.2 4.1 1.7 5.4 12.8 2.2 4.3 2.9 5.5 25.9 11.6 1.8 2.6 3.3 0.9 7.2 12.1 2.9 4.0 2.0 1.8 1.3 7.2 22.4 1.8 12.8 3.9 19.2 2.0 2.2 2.7 2.7 8.4 5.2 1.6 3.1 14.1 1.8 28.7 5.1 0.3 2.9 5.0 15.4 0.5 0.5 0.7 0.2 0.0 0.0 1.4 1.2 0.0 0.0 0.1 0.9 0.1 0.4 0.7 0.0 0.3 0.3 0.0 0.0 0.0 0.4 1.0 3.4 0.6 1.6 0.0 1.0 0.2 0.0 0.0 5.2 0.0 1.1 2.1 0.5 0.1 0.3 0.2 0.1 0.3 0.6 1.1 1.5 0.2 0.6 0.7 2.8 0.0 0.2 0.8 0.8 0.3 0.6 0.7 0.5 0.8 0.5 2.2 0.8 0.5 1.4 1.2 1.8 0.4 0.4 2.6 1.1 1.0 0.8 0.1 0.0 0.4 0.2 0.8 0.2 0.4 0.3 0.2 0.2 0.3 0.3 0.0 0.3 0.3 1.2 0.5 0.1 12.7 52.7 15.5 17.3 25.9 11.6 7.2 12.1 7.2 8.4 14.1 15.4 7.2 0.0 0.0 7.5 0.7 0.8 0.3 0.0 0.0 85.8 1.4 1.4 4.3 0.0 0.7 0.0 31.3 0.1 0.5 0.1 0.0 0.4 13.7 0.6 2.4 2.8 0.0 0.0 108.6 0.0 0.0 3.8 0.0 2.1 0.0 0.4 0.7 0.0 4.6 0.0 605.4 0.0 0.0 11.1 1.0 7.0 0.0 1.2 1.8 24.4 0.0 2.7 0.0 206.6 97.5 0.0 0.0 2.6 2.3 0.2 0.0 0.1 0.0 6.7 78.9 1.3 73.3 0.3 4.2 1.2 0.9 0.1 0.5 0.2 0.0 0.2 KCNIP1 KCHIP1 ENSG00000182132 "Potassium voltage-gated channel interacting protein 1" Q9NZI2 5 170353487-170736632 "Predicted intracellular proteins, Transporters" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.7;choroid plexus: 15.1;epididymis: 21.6" "Cell type enhanced" "Detected in some" "Astrocytes: 57.8;Horizontal cells: 50.5;Inhibitory neurons: 221.4;Microglial cells: 167.7;Oligodendrocyte precursor cells: 196.1" "Cancer enriched" "Detected in some" 18 "glioma: 22.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 24 "RPTEC TERT1: 58.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022864, HPA066717" Uncertain Approved Vesicles NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Vesicles "HPA022864: AB_1858712, HPA066717: " "unprognostic (7.75e-5)" "unprognostic (2.66e-2)" "unprognostic (6.78e-2)" "unprognostic (3.22e-4)" "unprognostic (4.51e-2)" "unprognostic (3.49e-1)" "unprognostic (1.25e-2)" "unprognostic (2.69e-1)" "unprognostic (5.46e-2)" "unprognostic (6.62e-3)" "unprognostic (4.74e-2)" "unprognostic (7.52e-2)" "unprognostic (2.55e-1)" "unprognostic (2.58e-2)" "unprognostic (1.63e-1)" "unprognostic (2.39e-1)" "unprognostic (6.05e-2)" 0.5 4.2 23.5 0.5 26.5 0.0 1.0 19.4 28.3 2.7 15.1 0.7 0.2 1.6 21.6 0.3 1.7 1.8 0.4 21.8 32.6 3.8 0.1 1.0 0.5 24.3 26.6 0.3 1.4 1.3 1.0 1.2 24.7 1.5 0.5 5.8 0.4 5.6 0.1 0.4 0.3 1.1 28.7 1.5 0.4 2.7 32.7 0.1 0.7 0.2 0.4 0.5 0.6 19.6 0.0 0.0 1.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 58.7 0.0 0.6 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.5 26.5 19.4 28.3 21.8 32.6 24.3 26.6 24.7 28.7 32.7 19.6 0.0 0.0 0.0 57.8 0.0 0.4 0.1 0.0 0.0 0.4 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 2.0 1.2 0.0 0.0 18.6 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 50.5 221.4 0.0 0.0 0.0 0.6 0.7 5.0 0.1 0.0 167.7 0.0 0.2 0.0 196.1 2.8 0.0 0.0 11.7 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.1 0.3 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 KCNMB2 ENSG00000197584 "Potassium calcium-activated channel subfamily M regulatory beta subunit 2" Q9Y691 3 178272932-178844429 "FDA approved drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 35.4;fallopian tube: 13.9;ovary: 12.7" "Group enriched" "Detected in some" 4 "Inhibitory neurons: 791.1;Oligodendrocyte precursor cells: 1982.5" "Cancer enhanced" "Detected in some" "pancreatic cancer: 1.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 2.4;SCLC-21H: 3.3" CAB022649 Uncertain NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "CAB022649: " "unprognostic (9.52e-2)" "unprognostic (1.13e-1)" "unprognostic (6.82e-2)" "unprognostic (2.07e-1)" "unprognostic (2.19e-2)" "unprognostic (1.04e-2)" "unprognostic (2.43e-2)" "unprognostic (6.97e-2)" "unprognostic (6.74e-2)" "unprognostic (2.15e-1)" "unprognostic (3.58e-3)" "unprognostic (3.57e-2)" "unprognostic (1.71e-2)" "unprognostic (2.07e-1)" "unprognostic (1.68e-1)" "unprognostic (6.89e-4)" "unprognostic (7.85e-2)" 0.3 5.1 2.5 0.0 3.0 0.0 0.7 1.5 4.0 1.4 0.9 1.2 0.5 2.9 35.4 0.4 13.9 0.5 5.8 4.0 2.3 3.4 0.2 1.1 0.0 3.0 2.7 12.7 4.0 0.2 1.7 0.1 2.3 0.5 0.3 0.2 0.2 1.1 0.2 0.3 0.5 1.9 2.2 1.3 3.0 0.2 2.1 0.0 0.3 0.2 0.0 0.2 0.7 2.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.2 0.0 0.0 0.6 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.9 0.0 0.5 3.3 0.0 0.0 0.1 0.0 0.2 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 3.0 1.5 4.0 4.0 2.3 3.0 2.7 2.3 2.2 2.1 2.1 0.0 0.0 0.0 18.3 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 3.3 0.0 0.8 0.0 0.0 0.0 0.0 0.1 3.9 0.0 0.1 8.7 0.2 0.0 13.8 0.0 311.8 0.0 0.0 2.7 0.0 1.9 0.0 12.7 1.8 0.0 0.0 0.0 791.1 0.0 4.1 0.0 0.0 0.1 2.8 0.1 0.0 12.2 0.0 0.0 0.0 1982.5 6.8 0.1 0.0 0.0 0.0 0.0 0.0 1.3 10.0 0.0 0.0 0.8 0.4 0.0 0.0 0.1 0.0 0.0 0.1 1.7 0.0 0.1 KIAA1210 ENSG00000250423 KIAA1210 Q9ULL0 X 119078635-119150579 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "epididymis: 39.4;seminal vesicle: 19.8;testis: 30.9" "Cell type enhanced" "Detected in some" "Early spermatids: 4.0;Endometrial stromal cells: 25.2;Granulosa cells: 11.1;Late spermatids: 11.5;Peritubular cells: 6.0" "Cancer enhanced" "Detected in single" "prostate cancer: 1.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "MCF7: 1.0" "Not detected" "Not detected" "HPA000551, HPA048322" Enhanced Approved "Golgi apparatus,Vesicles" NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 36: Stromal cells - Cell proliferation" "Golgi apparatus, Vesicles" "HPA000551: AB_1079165, HPA048322: AB_2680358" "unprognostic (2.48e-1)" "unprognostic (5.63e-2)" "unprognostic (1.77e-1)" "unprognostic (1.43e-1)" "unprognostic (3.90e-1)" "unprognostic (2.25e-2)" "unprognostic (1.16e-2)" "unprognostic (6.29e-2)" "unprognostic (2.53e-1)" "unprognostic (1.06e-1)" "unprognostic (2.92e-2)" "unprognostic (5.69e-2)" "unprognostic (1.05e-1)" "unprognostic (8.45e-2)" "unprognostic (1.04e-1)" "unprognostic (1.24e-1)" "unprognostic (6.26e-4)" 0.0 1.4 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.0 0.0 0.0 1.6 39.4 0.0 5.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 4.7 0.0 0.0 0.0 19.8 0.3 0.0 0.0 0.2 0.0 0.0 0.0 30.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.2 0.4 1.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 4.0 1.9 25.2 0.2 0.0 0.0 0.1 0.0 0.2 0.3 0.0 1.6 0.0 11.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.3 11.5 3.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 6.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.5 2.4 1.1 0.0 0.0 0.3 0.1 0.3 0.0 0.0 KRBOX4 "FLJ20344, ZNF673" ENSG00000147121 "KRAB box domain containing 4" Q5JUW0 X 46447292-46497422 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocyte precursor cells: 43.2;Oligodendrocytes: 36.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA065295 Approved Nucleoplasm NA NA "Cluster 44: Non-specific - Transcription" "Cluster 68: Epididymis - Unknown function" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA065295: AB_2685456" "unprognostic (4.12e-1)" "unprognostic (6.40e-2)" "unprognostic (1.74e-2)" "unprognostic (1.64e-2)" "unprognostic (1.17e-1)" "unprognostic (2.25e-1)" "prognostic unfavorable (2.87e-6)" "prognostic favorable (4.67e-5)" "unprognostic (1.73e-2)" "unprognostic (2.61e-3)" "unprognostic (3.27e-2)" "unprognostic (4.75e-3)" "prognostic unfavorable (1.98e-7)" "unprognostic (7.94e-2)" "unprognostic (1.08e-1)" "unprognostic (1.00e-1)" "prognostic favorable (2.17e-4)" 13.1 10.0 20.1 9.6 19.5 6.4 14.3 19.1 22.5 18.4 19.6 14.0 6.7 18.1 22.6 7.4 13.2 11.9 10.2 19.3 20.8 11.4 16.5 11.6 14.6 18.8 18.2 18.2 8.8 13.8 13.1 17.6 18.9 15.7 9.1 14.6 8.8 11.5 8.3 11.5 9.8 15.0 17.6 18.5 9.3 5.5 23.7 14.4 14.7 9.0 12.8 12.3 11.2 20.0 23.0 13.2 20.1 15.6 19.6 20.1 12.3 21.8 19.8 19.9 18.0 11.3 20.8 12.7 14.1 19.4 32.9 16.0 25.1 12.2 23.4 12.7 10.7 10.9 29.7 11.0 20.9 16.3 16.8 22.7 13.6 27.1 22.8 17.7 18.7 19.7 11.7 13.8 18.0 13.2 16.6 8.1 18.3 9.1 23.4 11.6 18.6 16.0 13.2 9.4 7.3 14.3 18.6 9.2 21.5 34.2 15.3 15.9 17.2 22.0 22.0 29.2 17.9 15.1 18.3 18.5 19.1 0.8 20.6 18.0 7.2 15.5 12.7 9.0 13.4 13.6 13.9 12.5 7.1 18.6 17.3 13.1 4.3 15.6 10.3 13.4 13.1 9.4 20.1 19.5 19.1 22.5 19.3 20.8 18.8 18.2 18.9 17.6 23.7 20.0 16.9 6.4 6.1 25.1 11.8 2.2 4.5 7.4 14.2 6.4 5.6 7.0 6.6 8.6 5.1 5.5 4.2 15.2 10.5 1.9 9.8 7.5 0.2 4.9 10.1 15.4 1.2 7.2 22.4 4.5 8.0 10.5 5.6 3.6 7.6 8.8 16.8 5.3 9.5 10.1 22.2 3.9 4.1 6.3 2.6 1.3 7.8 5.1 7.2 20.6 5.5 8.9 13.4 43.2 36.9 3.6 6.5 11.3 8.3 3.8 3.1 5.8 5.1 8.4 13.1 6.4 8.1 4.3 5.4 4.2 2.7 13.5 10.9 11.1 3.6 1.9 KRTAP5-9 "KRN1, KRTAP5-1, KRTAP5.9" ENSG00000254997 "Keratin associated protein 5-9" P26371 11 71548420-71549608 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "testis: 3.1" "Group enriched" "Detected in some" 7 "Early spermatids: 2.3;Late spermatids: 5.6" "Cancer enhanced" "Detected in some" "urothelial cancer: 2.0" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 21 "RT4: 8.6" NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 15: RT4 - Unknown function" "Cluster 31: Spermatids - Spermatogenesis" "unprognostic (1.72e-3)" "unprognostic (2.20e-1)" "unprognostic (2.22e-2)" "unprognostic (2.16e-1)" "unprognostic (4.13e-1)" "unprognostic (6.53e-2)" "unprognostic (8.10e-2)" "unprognostic (2.09e-1)" "unprognostic (1.06e-1)" "unprognostic (7.76e-2)" "unprognostic (7.23e-2)" "unprognostic (2.56e-1)" "unprognostic (3.29e-1)" "unprognostic (2.05e-2)" "unprognostic (2.01e-1)" "unprognostic (4.82e-4)" "prognostic favorable (9.25e-4)" 0.4 0.3 0.7 0.0 0.7 0.2 0.3 0.3 1.2 0.3 0.3 0.5 0.1 0.2 1.7 0.5 0.4 0.3 0.1 0.7 0.6 0.5 0.8 0.4 0.1 0.5 0.8 0.1 0.2 0.2 0.8 0.1 0.5 0.6 0.2 0.3 0.3 0.3 0.4 0.9 0.5 0.0 0.3 0.6 0.2 3.1 0.5 0.0 0.3 0.0 0.1 1.3 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.4 0.0 0.2 0.0 0.3 0.0 0.1 0.0 0.0 0.0 8.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.7 0.3 1.2 0.7 0.6 0.5 0.8 0.5 0.3 0.5 0.5 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.3 0.4 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 LCN10 ENSG00000187922 "Lipocalin 10" Q6JVE6 9 136738167-136743356 "Predicted secreted proteins" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 32.3" "Cell type enriched" "Detected in single" 32 "B-cells: 6.4" "Cancer enriched" "Detected in single" 8 "thyroid cancer: 1.2" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 18 "memory B-cell: 6.5;naive B-cell: 6.4" "Lineage enriched" "Detected in single" 18 "B-cells: 6.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA055919 Approved "Secreted in male reproductive system" NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 68: Epididymis - Unknown function" "Cluster 57: B-cells - Immune response" "HPA055919: AB_2682969" "unprognostic (2.02e-1)" "unprognostic (1.35e-2)" "unprognostic (2.62e-1)" "unprognostic (1.89e-1)" "unprognostic (5.85e-2)" "unprognostic (6.54e-3)" "unprognostic (2.22e-4)" "unprognostic (4.54e-2)" "unprognostic (3.97e-1)" "unprognostic (1.31e-1)" "unprognostic (4.14e-3)" "unprognostic (2.96e-1)" "unprognostic (2.77e-2)" "unprognostic (3.11e-2)" "unprognostic (2.52e-1)" "unprognostic (8.32e-2)" "unprognostic (3.86e-1)" 3.5 0.1 1.4 1.0 1.3 0.8 2.8 1.2 2.3 6.1 1.2 1.7 0.1 7.7 32.3 1.2 7.8 0.4 8.2 1.3 1.2 0.1 0.1 0.9 1.3 1.3 1.3 2.1 1.0 0.3 0.1 0.0 1.3 2.7 0.7 0.0 1.6 1.0 0.8 0.7 2.7 3.1 1.2 1.6 2.2 1.2 1.6 0.3 2.1 2.0 1.1 3.2 2.4 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.5 0.1 0.0 0.0 0.7 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 6.4 0.2 0.0 0.0 0.2 0.0 0.0 0.3 0.3 1.4 1.3 1.2 2.3 1.3 1.2 1.3 1.3 1.3 1.2 1.6 1.3 0.2 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 LEMD1 "CT50, LEMP-1" ENSG00000186007 "LEM domain containing 1" Q68G75 1 205381378-205455954 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 12 "epididymis: 14.8;testis: 55.1" "Cell type enriched" "Detected in many" 4 "Late spermatids: 4203.7" "Cancer enhanced" "Detected in many" "ovarian cancer: 10.6" "Group enriched" "Detected in many" 5 "cerebellum: 2.6;medulla oblongata: 2.4;midbrain: 1.2;pons: 2.8;thalamus: 2.2" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "CAPAN-2: 39.6" "Low region specificity" "Detected in all" "Region enriched" "Detected in single" 6 "cerebellum: 3.9" HPA045425 Approved Nucleoli,Cytosol NA NA "Cluster 22: NK-cells - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 31: Spermatids - Spermatogenesis" "Nucleoli, Cytosol" "HPA045425: AB_10960538" "unprognostic (1.78e-1)" "unprognostic (2.00e-1)" "unprognostic (1.88e-2)" "unprognostic (4.20e-3)" "unprognostic (7.27e-2)" "unprognostic (1.48e-1)" "unprognostic (2.72e-2)" "unprognostic (1.01e-1)" "prognostic favorable (1.26e-4)" "prognostic unfavorable (1.70e-4)" "unprognostic (3.31e-1)" "unprognostic (5.66e-6)" "unprognostic (2.49e-2)" "unprognostic (2.07e-1)" "unprognostic (1.66e-1)" "unprognostic (1.38e-2)" 0.1 0.3 0.2 0.0 0.2 0.0 0.3 2.6 0.4 0.3 0.0 0.0 0.6 0.3 14.8 0.8 1.6 0.1 0.0 0.1 0.4 1.0 0.0 0.4 0.0 2.4 1.2 0.6 0.0 0.0 0.5 0.1 2.8 0.2 0.0 1.4 1.9 0.4 0.0 0.4 0.2 0.1 0.4 0.0 0.9 55.1 2.2 0.0 0.6 0.0 0.7 0.1 0.5 0.3 4.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 39.6 0.0 3.7 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.3 0.0 0.0 0.1 0.3 0.0 0.0 0.3 0.0 0.0 0.0 2.4 1.3 0.0 0.0 0.0 0.0 2.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.2 2.6 0.4 0.1 0.4 2.4 1.2 2.8 0.4 2.2 0.3 0.0 0.0 2.6 1.0 0.0 0.0 1.2 8.4 4.6 12.1 1.6 0.9 0.0 0.0 6.4 0.0 4.2 0.1 0.0 0.0 0.0 1.9 968.7 0.8 0.1 0.7 0.0 0.0 1.4 0.7 0.1 0.2 0.0 1.1 0.0 0.6 1.1 0.0 0.1 0.0 1.4 0.0 0.0 0.0 0.0 4203.7 12.8 1.1 0.0 0.0 0.0 1.3 0.0 1.0 0.5 6.8 0.1 13.9 0.0 8.5 0.3 4.3 1.6 0.7 6.6 0.0 0.4 15.6 9.7 0.7 0.0 0.4 0.1 0.1 0.3 4.4 LINGO2 "LERN3, LRRN6C" ENSG00000174482 "Leucine rich repeat and Ig domain containing 2" Q7L985 9 27948078-28670286 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "endometrium 1: 7.5;smooth muscle: 8.8" "Group enriched" "Detected in some" 29 "Excitatory neurons: 1591.2;Inhibitory neurons: 988.0" "Cancer enhanced" "Detected in single" "melanoma: 0.8" "Low region specificity" "Detected in some" "Immune cell enriched" "Detected in single" 9 "NK-cell: 1.0" "Lineage enriched" "Detected in single" 9 "NK-cells: 1.0" "Cell line enhanced" "Detected in some" "AN3-CA: 2.2;hTERT-HME1: 1.5;SH-SY5Y: 9.1;U-87 MG: 1.6;WM-115: 4.1" "Low region specificity" "Detected in all" "HPA016633, CAB025361" Approved NA NA "Cluster 40: NK-cells - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "CAB025361: , HPA016633: AB_1853362" "unprognostic (1.27e-1)" "unprognostic (3.58e-1)" "unprognostic (1.20e-2)" "unprognostic (1.98e-4)" "unprognostic (9.86e-4)" "unprognostic (7.55e-3)" "unprognostic (2.67e-6)" "unprognostic (1.08e-1)" "unprognostic (2.38e-1)" "unprognostic (2.34e-2)" "unprognostic (3.74e-2)" "unprognostic (8.13e-2)" "unprognostic (1.07e-1)" "unprognostic (4.08e-2)" "unprognostic (2.30e-2)" "unprognostic (1.95e-4)" 0.0 0.4 0.5 0.0 0.8 0.2 0.0 0.0 3.3 0.6 0.0 0.1 0.0 7.5 0.9 0.0 0.4 0.9 0.0 2.9 3.0 0.7 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.8 0.6 1.7 0.0 0.6 0.0 2.4 0.0 1.5 0.0 0.1 0.0 8.8 0.1 0.1 0.6 1.7 0.4 0.2 2.9 0.0 0.0 0.2 0.3 0.0 0.0 0.3 0.2 2.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.7 0.2 1.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.0 9.1 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 1.6 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.5 0.5 0.8 0.0 3.3 2.9 3.0 0.0 0.1 0.0 0.1 0.4 0.0 0.0 0.0 0.0 34.6 0.0 0.0 0.0 0.0 0.0 8.8 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.1 1.6 0.0 0.0 0.0 17.5 0.4 4.6 0.2 1.8 0.0 1591.2 0.0 0.1 1.4 0.0 0.9 1.3 29.6 0.0 0.0 0.2 0.0 988.0 0.0 0.0 0.0 0.0 16.4 0.0 0.1 0.0 43.1 0.1 0.9 5.2 17.6 20.0 0.0 0.0 0.4 0.1 0.0 0.0 0.4 0.0 0.7 0.0 0.1 0.3 2.8 1.0 0.0 0.0 0.3 0.5 0.1 0.0 0.0 LIPT1 "MGC12290, MGC13378" ENSG00000144182 "Lipoyltransferase 1" Q9Y234 2 99154955-99163157 "Disease related genes, Metabolic proteins, Predicted intracellular proteins" "Acyltransferase, Transferase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 41.0;Spermatocytes: 40.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034802 Approved NA NA "Cluster 44: Non-specific - Transcription" "Cluster 68: Epididymis - Unknown function" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 66: Spermatocytes - Spermatogenesis" "HPA034802: AB_10669851" "unprognostic (1.13e-2)" "unprognostic (7.21e-3)" "unprognostic (1.75e-1)" "unprognostic (1.32e-2)" "unprognostic (7.46e-2)" "unprognostic (6.48e-2)" "unprognostic (1.13e-3)" "prognostic favorable (5.70e-4)" "unprognostic (1.49e-2)" "unprognostic (4.11e-2)" "unprognostic (1.82e-2)" "unprognostic (1.59e-1)" "unprognostic (1.32e-3)" "unprognostic (1.72e-1)" "unprognostic (4.92e-2)" "unprognostic (3.16e-1)" "prognostic favorable (9.60e-8)" 7.1 7.8 6.7 6.8 7.5 12.3 10.9 7.4 8.3 8.1 6.3 6.7 8.4 8.1 14.1 5.1 8.1 6.5 8.5 6.9 7.8 11.2 8.1 5.7 10.7 7.2 7.1 11.8 7.3 6.3 6.7 4.9 7.2 9.2 7.3 7.5 8.9 6.0 9.1 7.0 8.4 5.6 7.2 11.9 6.9 13.5 7.2 5.3 11.3 8.9 7.4 6.3 5.6 10.4 6.2 4.0 5.4 9.2 9.3 11.0 13.0 4.0 4.7 3.1 3.4 9.8 10.3 9.9 8.4 2.4 8.4 5.4 6.6 5.0 6.1 10.6 12.0 10.3 5.1 8.7 9.9 7.0 5.1 6.5 8.0 5.6 12.7 6.3 8.8 11.4 10.0 5.8 5.4 5.0 6.9 13.4 13.8 6.0 9.9 11.7 5.8 10.4 10.1 9.2 5.2 5.0 5.6 6.2 14.8 9.8 6.6 14.2 6.4 4.6 6.4 4.1 3.8 9.1 12.9 10.7 4.8 11.4 6.7 15.4 10.3 16.1 16.8 9.6 20.9 14.2 18.9 18.5 5.6 12.4 23.6 19.9 2.7 18.4 9.5 5.6 12.3 11.6 6.7 7.5 7.4 8.3 6.9 7.8 7.2 7.1 7.2 7.2 7.2 10.4 9.3 3.2 6.7 6.5 7.5 3.6 10.8 14.5 6.2 5.2 3.9 7.9 6.6 2.8 8.5 12.9 2.1 7.6 9.7 3.3 13.7 5.1 41.0 3.6 6.5 7.8 6.1 3.2 5.3 3.4 4.3 7.2 3.1 3.4 5.1 8.3 12.8 2.2 7.2 11.8 5.5 6.1 6.1 7.9 2.2 25.4 9.6 4.6 1.8 1.9 8.5 12.1 18.6 9.5 14.3 3.4 6.9 7.5 2.7 5.6 15.9 11.8 9.0 10.6 6.6 13.1 5.8 40.6 12.8 3.0 4.3 5.3 8.9 5.0 6.2 6.2 LONRF2 "FLJ45273, RNF192" ENSG00000170500 "LON peptidase N-terminal domain and ring finger 2" Q1L5Z9 2 100271875-100322501 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 42.2;fallopian tube: 45.6" "Cell type enhanced" "Detected in many" "Bipolar cells: 72.6;Excitatory neurons: 166.8;Horizontal cells: 111.0;Inhibitory neurons: 126.2;Oligodendrocyte precursor cells: 58.3" "Cancer enriched" "Detected in many" 5 "thyroid cancer: 15.3" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 6.0;GAMG: 7.3;HAP1: 5.8;HEK 293: 6.2;HMC-1: 5.1;PC-3: 5.3;SCLC-21H: 12.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034595, HPA057366" Approved Approved Nucleoplasm NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 44: Endometrium - Transcription" Nucleoplasm "HPA034595: , HPA057366: AB_2683420" "unprognostic (9.81e-2)" "unprognostic (4.97e-2)" "unprognostic (2.68e-2)" "unprognostic (3.20e-2)" "unprognostic (7.10e-2)" "unprognostic (7.72e-2)" "unprognostic (9.50e-2)" "unprognostic (9.86e-3)" "unprognostic (6.33e-2)" "unprognostic (1.32e-1)" "prognostic favorable (6.42e-5)" "unprognostic (1.14e-1)" "unprognostic (6.06e-2)" "unprognostic (3.45e-2)" "unprognostic (2.50e-2)" "unprognostic (2.66e-3)" "unprognostic (6.34e-2)" 3.2 31.9 20.1 0.5 20.0 0.1 3.2 7.6 25.5 11.6 5.8 5.6 0.5 26.4 42.2 2.6 45.6 2.3 6.4 26.7 40.4 2.2 1.0 1.8 0.5 2.6 3.3 24.3 6.3 9.6 18.0 0.7 9.9 4.1 0.7 11.2 2.4 4.0 7.1 1.1 1.6 28.2 0.2 0.8 4.6 2.2 27.4 0.4 4.9 4.1 0.3 4.2 3.7 9.9 0.0 6.0 1.8 2.1 0.0 0.0 0.0 0.0 0.1 0.3 0.2 0.0 1.1 0.0 1.0 0.0 7.3 0.0 5.8 0.0 0.0 0.5 6.2 0.0 0.4 0.0 0.2 0.1 5.1 0.0 0.0 0.2 0.0 0.4 0.0 1.6 3.5 0.1 0.0 4.0 0.0 0.3 0.3 1.1 5.3 0.0 0.0 0.0 1.4 0.2 12.5 3.4 0.0 0.0 0.8 1.9 3.2 0.0 0.1 0.0 0.7 0.0 0.4 0.0 0.0 0.0 2.4 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 20.1 20.0 7.6 25.5 26.7 40.4 2.6 3.3 9.9 0.2 27.4 9.9 0.5 0.0 11.7 52.5 0.5 0.8 1.4 0.0 1.2 72.6 5.1 2.3 37.4 8.6 3.1 5.5 31.3 2.3 0.1 0.3 5.9 3.7 0.6 22.5 43.6 1.8 11.4 2.7 166.8 2.2 0.2 12.7 4.1 37.1 5.7 25.8 0.0 0.6 0.4 111.0 126.2 0.5 0.0 0.0 1.2 2.3 3.4 0.6 1.8 7.5 0.0 8.4 0.0 58.3 38.7 1.5 0.1 11.7 0.1 4.9 0.0 0.3 3.4 20.6 6.6 3.3 5.3 0.8 0.6 0.8 0.1 2.9 1.6 0.9 0.4 0.4 LOXHD1 "DFNB77, FLJ32670, LH2D1" ENSG00000167210 "Lipoxygenase homology domains 1" Q8IVV2 18 46476972-46657220 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Hearing "Deafness, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 7.2;kidney: 6.9;testis: 23.0" "Group enriched" "Detected in some" 70 "Early spermatids: 199.3;Late spermatids: 439.4" "Cancer enhanced" "Detected in single" "testis cancer: 0.5" "Region enhanced" "Detected in some" "basal ganglia: 3.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA077128 Approved "Plasma membrane" NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 25: Spermatids - Spermatogenesis" "Plasma membrane" "HPA077128: " "unprognostic (6.95e-2)" "unprognostic (1.88e-2)" "unprognostic (4.81e-3)" "unprognostic (2.65e-1)" "unprognostic (1.30e-2)" "unprognostic (7.75e-4)" "unprognostic (9.53e-2)" "unprognostic (7.91e-2)" "unprognostic (7.61e-2)" "unprognostic (9.44e-2)" "unprognostic (1.26e-2)" "unprognostic (1.93e-2)" "unprognostic (7.43e-3)" "unprognostic (6.48e-5)" "unprognostic (2.30e-1)" "unprognostic (8.10e-3)" "unprognostic (1.66e-3)" 2.3 0.0 0.5 0.0 3.4 2.8 0.6 0.0 2.1 0.0 0.1 0.1 0.0 0.1 7.2 0.0 1.7 0.2 0.9 0.3 0.0 6.9 0.0 1.0 0.0 0.0 0.1 0.1 0.2 0.2 1.9 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.2 0.1 0.0 0.0 0.8 0.1 23.0 0.3 0.1 0.2 0.2 0.0 0.2 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 3.4 0.0 2.1 0.3 0.0 0.0 0.1 0.0 0.0 0.3 0.9 1.2 3.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 199.3 0.0 0.1 0.9 0.0 0.0 4.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.6 0.0 0.0 0.0 0.0 439.4 1.8 0.3 0.0 0.0 0.3 0.0 0.0 1.5 0.6 0.0 0.0 2.2 0.0 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.1 4.5 1.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 MACROD2 "C20orf133, dJ631M13.5" ENSG00000172264 "Mono-ADP ribosylhydrolase 2" A1Z1Q3 20 13995369-16053197 "Metabolic proteins, Predicted intracellular proteins" "DNA damage" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 349.7;Excitatory neurons: 752.7;Inhibitory neurons: 1058.5;Oligodendrocyte precursor cells: 672.0;Oligodendrocytes: 301.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "memory B-cell: 8.9;naive B-cell: 13.2;neutrophil: 3.4" "Group enriched" "Detected in many" 5 "B-cells: 13.2;granulocytes: 3.4" "Cell line enhanced" "Detected in many" "EFO-21: 15.5;Karpas-707: 19.1;RT4: 8.4;SCLC-21H: 10.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049076 Enhanced Supported Nucleoplasm,Nucleoli NA NA "Cluster 37: B-cells - Transcription" "Cluster 68: Epididymis - Unknown function" "Cluster 2: Karpas-707 - Immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Nucleoplasm, Nucleoli" "HPA049076: " "unprognostic (1.70e-1)" "unprognostic (7.36e-2)" "unprognostic (1.59e-1)" "unprognostic (5.68e-3)" "unprognostic (2.03e-1)" "unprognostic (1.63e-3)" "unprognostic (1.24e-1)" "unprognostic (2.32e-2)" "unprognostic (3.02e-1)" "unprognostic (2.96e-2)" "unprognostic (4.02e-1)" "unprognostic (7.83e-2)" "unprognostic (4.15e-5)" "unprognostic (9.80e-2)" "unprognostic (9.91e-3)" "unprognostic (3.23e-1)" "unprognostic (2.02e-2)" 1.9 3.1 3.9 2.2 8.4 1.2 2.8 2.3 4.7 3.1 0.1 1.3 0.7 5.0 2.3 1.4 7.3 2.8 1.1 4.8 2.8 3.9 1.8 10.9 4.0 3.3 3.6 2.9 2.9 2.5 2.2 1.1 3.7 4.7 1.3 4.9 1.3 9.9 1.5 2.7 0.9 4.0 2.1 5.0 2.3 5.1 7.3 1.8 2.6 0.6 5.3 4.5 1.2 4.3 1.0 0.4 3.0 1.2 0.8 0.7 0.5 0.3 2.1 1.2 0.7 0.4 0.7 2.0 15.5 1.4 2.6 1.5 0.3 0.7 1.9 1.0 0.9 1.2 1.2 2.4 3.4 0.3 0.3 1.9 1.3 0.0 0.5 1.1 1.1 0.2 1.4 19.1 3.1 0.5 0.5 0.8 0.9 7.1 0.6 1.2 0.5 4.0 2.2 8.4 10.6 1.9 1.6 0.2 0.6 1.1 1.0 1.8 0.7 1.4 3.2 0.3 0.0 0.7 0.3 2.1 0.9 1.0 1.7 0.1 0.5 0.5 0.2 1.2 0.2 8.9 0.2 0.2 0.4 13.2 0.2 0.3 3.4 0.1 1.6 0.2 0.0 0.5 3.9 8.4 2.3 4.7 4.8 2.8 3.3 3.6 3.7 2.1 7.3 4.3 1.6 51.3 203.8 349.7 18.3 4.5 49.8 1.4 5.2 94.0 7.6 6.9 5.9 11.5 37.5 12.9 39.6 7.1 0.1 1.8 9.8 11.9 35.4 8.6 2.5 3.0 1.2 0.4 752.7 1.6 0.4 4.6 9.2 6.7 1.3 7.6 7.1 4.8 0.9 8.4 1058.5 4.5 0.0 0.3 2.1 62.2 3.4 0.9 3.6 87.1 0.0 10.2 0.0 672.0 301.4 6.6 1.7 17.7 2.8 6.2 2.4 8.6 9.8 20.3 6.6 2.1 6.0 23.7 18.8 5.8 6.7 2.1 0.9 13.2 2.8 5.4 MAGEA11 "CT1.11, MAGE-11, MAGE11, MAGEA-11, MGC10511" ENSG00000185247 "MAGE family member A11" P43364 X 149688228-149717268 "Predicted intracellular proteins" "Tumor antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "epididymis: 21.0" "Group enriched" "Detected in some" 5 "Spermatocytes: 29.4;Spermatogonia: 30.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "U-2 OS: 23.8" HPA052687 Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 9: U-2 OS - Unknown function" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "Nucleoplasm, Nuclear bodies" Cytosol "HPA052687: AB_2681915" "unprognostic (4.06e-3)" "unprognostic (2.05e-1)" "unprognostic (7.21e-2)" "unprognostic (1.09e-2)" "unprognostic (9.64e-2)" "unprognostic (1.32e-1)" "unprognostic (6.13e-2)" "unprognostic (1.16e-1)" "unprognostic (6.67e-4)" "unprognostic (1.14e-1)" "unprognostic (1.33e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.1 0.1 0.0 0.0 0.0 0.0 23.8 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.1 0.0 0.0 0.3 0.0 0.2 0.1 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.4 30.9 0.0 0.0 5.9 0.0 0.0 0.0 0.0 MAGEB3 CT3.5 ENSG00000198798 "MAGE family member B3" O15480 X 30230436-30237492 "Predicted intracellular proteins" "Tumor antigen" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 114 "epididymis: 17.7;testis: 5.1" "Group enriched" "Detected in some" 8 "Spermatocytes: 13.0;Spermatogonia: 6.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "SuSa: 1.3;U-266/70: 2.1" "Not detected" "Not detected" HPA072203 Approved NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 29: U-266 - Adaptive immune response" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "HPA072203: AB_2686492" "unprognostic (3.34e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MAGEB4 "CT3.6, MGC33144" ENSG00000120289 "MAGE family member B4" O15481 X 30242000-30244187 "Predicted intracellular proteins" "Tumor antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 100 "epididymis: 27.2;testis: 8.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA030456 Enhanced NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 31: Spermatids - Spermatogenesis" "HPA030456: AB_10602707" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MAGEH1 APR1 ENSG00000187601 "MAGE family member H1" Q9H213 X 55452127-55453566 "Predicted membrane proteins" "Tumor antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 9 "epididymis: 515.9" "Cell type enhanced" "Detected in many" "Peritubular cells: 63.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011324, HPA011971" Uncertain Supported "Nucleoli,Nucleoli rim" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 68: Epididymis - Unknown function" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 33: Fibroblasts - ECM organization" "Nucleoli, Nucleoli rim" "HPA011324: AB_1853499, HPA011971: " "unprognostic (2.50e-1)" "unprognostic (3.01e-1)" "unprognostic (4.07e-2)" "prognostic unfavorable (1.37e-4)" "unprognostic (3.95e-2)" "unprognostic (8.50e-2)" "unprognostic (1.13e-2)" "unprognostic (9.93e-3)" "unprognostic (1.47e-1)" "unprognostic (3.20e-3)" "prognostic favorable (2.60e-4)" "unprognostic (6.37e-2)" "unprognostic (1.81e-2)" "unprognostic (1.29e-3)" "unprognostic (1.90e-1)" "unprognostic (3.95e-2)" "unprognostic (2.52e-1)" 20.2 29.9 46.8 17.6 48.2 5.1 18.4 40.9 59.3 29.6 59.4 21.0 10.2 30.9 515.9 10.0 45.3 18.1 24.1 47.1 60.0 25.5 19.6 23.5 22.7 41.9 47.7 36.3 28.1 25.5 54.1 20.9 45.7 48.8 11.5 22.0 18.6 44.3 12.9 11.3 17.1 27.3 45.5 20.4 25.3 33.8 50.3 32.0 28.6 16.9 17.0 17.9 16.7 48.8 0.1 5.7 32.6 0.0 51.5 31.0 0.4 36.0 32.9 9.7 26.0 0.1 7.4 0.0 48.2 36.4 18.4 4.9 12.5 13.5 15.2 42.5 2.0 11.4 0.0 4.6 17.0 0.6 14.1 25.8 1.2 5.6 4.1 9.1 15.0 12.0 6.5 43.8 10.8 22.0 30.8 9.8 9.3 0.0 6.8 19.1 4.1 24.0 17.9 0.0 0.2 24.5 0.0 9.5 15.5 24.4 4.7 8.5 17.7 13.3 15.4 8.2 1.9 25.9 35.1 4.9 24.8 15.8 17.2 14.0 9.0 20.5 21.5 14.3 19.4 18.9 35.4 24.6 13.7 17.9 48.2 30.5 1.2 18.9 18.5 28.5 52.1 19.0 46.8 48.2 40.9 59.3 47.1 60.0 41.9 47.7 45.7 45.5 50.3 48.8 24.9 6.4 14.4 4.9 18.3 8.0 7.8 20.0 5.2 36.7 8.0 14.1 10.4 18.6 12.5 12.9 10.4 2.8 15.7 1.9 13.7 32.2 1.6 2.8 33.5 29.0 15.8 3.0 14.2 10.7 2.0 42.9 3.1 1.9 12.7 11.1 32.9 14.0 15.0 37.0 17.5 8.4 4.1 3.8 11.2 4.0 47.2 6.2 21.4 6.5 9.3 56.8 23.7 18.6 28.4 4.7 8.8 63.9 39.8 13.7 0.8 20.1 6.7 19.6 26.3 44.5 35.0 1.4 2.7 3.3 6.3 1.6 19.9 19.7 4.6 4.8 MAP3K13 "LZK, MEKK13" ENSG00000073803 "Mitogen-activated protein kinase kinase kinase 13" O43283 3 185282941-185489094 "Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016497, HPA036691, HPA036692" Uncertain Approved "Nucleoplasm,Centriolar satellite,Cytosol" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 68: Epididymis - Unknown function" "Cluster 6: T47d - Mammary gland" "Cluster 22: Epithelial cell types - Mixed function" "Centriolar satellite" "Nucleoplasm, Cytosol" "HPA016497: AB_10670027, HPA036691: AB_10673661, HPA036692: AB_10670845" "unprognostic (8.95e-2)" "unprognostic (6.72e-3)" "unprognostic (9.46e-2)" "prognostic unfavorable (1.28e-5)" "unprognostic (5.16e-2)" "unprognostic (2.81e-1)" "unprognostic (2.61e-1)" "unprognostic (1.23e-2)" "unprognostic (9.04e-2)" "prognostic favorable (1.11e-4)" "prognostic unfavorable (7.27e-5)" "unprognostic (2.70e-3)" "unprognostic (1.54e-2)" "unprognostic (2.94e-2)" "unprognostic (2.82e-1)" "unprognostic (6.64e-2)" "unprognostic (9.31e-3)" 14.7 34.0 18.5 13.0 19.8 15.8 21.0 23.2 25.8 17.0 18.5 24.6 24.3 17.9 56.8 19.7 20.2 18.1 10.4 19.7 20.4 30.9 29.6 17.5 11.7 20.7 21.7 22.2 25.9 34.6 20.7 13.1 21.1 19.7 26.2 36.2 26.2 14.9 4.7 14.0 25.0 17.0 21.2 13.1 23.9 18.8 21.5 11.1 25.7 6.8 15.0 23.2 15.8 23.5 73.9 14.5 27.4 0.7 24.4 29.9 16.1 16.5 11.2 26.2 31.5 27.9 27.0 0.6 55.1 30.4 43.7 41.1 0.8 38.4 46.5 82.1 36.8 0.3 18.9 23.3 26.5 39.2 20.1 27.2 32.8 22.6 28.1 27.1 29.6 0.7 0.9 57.5 23.8 23.0 4.6 18.2 31.5 56.5 33.4 0.6 32.8 40.5 46.9 18.8 44.7 29.8 28.0 41.5 59.9 29.8 62.8 21.5 19.7 21.5 27.8 39.4 36.5 29.3 40.8 24.4 31.4 19.5 36.1 14.0 21.6 9.4 16.6 22.1 25.7 42.8 19.6 21.0 37.4 34.9 27.2 26.6 35.9 20.8 15.9 16.4 8.6 12.4 18.5 19.8 23.2 25.8 19.7 20.4 20.7 21.7 21.1 21.2 21.5 23.5 69.5 54.5 82.7 80.0 41.8 141.6 219.1 196.7 100.7 117.9 144.0 115.1 25.2 144.4 131.6 79.1 91.8 139.5 22.9 96.1 287.6 106.6 134.8 76.5 50.7 65.9 106.4 43.8 170.7 127.5 38.9 49.0 72.4 73.1 29.8 96.6 93.5 99.4 64.9 45.4 184.5 130.9 138.4 53.2 193.0 213.0 43.2 52.7 85.4 28.1 283.9 137.5 22.6 102.1 89.8 137.5 95.1 54.2 40.6 322.2 111.6 283.9 125.7 88.8 46.0 38.5 62.7 119.5 39.1 94.6 145.6 203.4 32.2 50.0 109.3 279.4 MAP7D2 FLJ14503 ENSG00000184368 "MAP7 domain containing 2" Q96T17 X 20006713-20116907 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 66.6;epididymis: 36.4" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 93.0;Excitatory neurons: 45.5;Inhibitory neurons: 55.2;Spermatocytes: 57.8;Spermatogonia: 134.9" "Cancer enhanced" "Detected in many" "testis cancer: 7.7" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 9 "basophil: 3.0" "Lineage enriched" "Detected in single" 9 "granulocytes: 3.0" "Cell line enhanced" "Detected in some" "A549: 13.3;CACO-2: 19.3;HEK 293: 25.0;HeLa: 21.4;Hep G2: 11.4;SCLC-21H: 29.1;SiHa: 12.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051508, HPA059537" Enhanced Approved Nucleoplasm,Cytosol NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 68: Epididymis - Unknown function" "Cluster 20: HeLa - Mitochondria" "Cluster 47: Cytotrophoblasts - Unknown function" Nucleoplasm Cytosol "HPA051508: AB_2681513, HPA059537: AB_2684054" "unprognostic (1.51e-1)" "unprognostic (9.19e-2)" "unprognostic (3.76e-1)" "unprognostic (1.45e-5)" "unprognostic (5.65e-2)" "unprognostic (9.77e-3)" "unprognostic (1.50e-1)" "unprognostic (1.50e-1)" "unprognostic (5.95e-2)" "unprognostic (7.77e-3)" "unprognostic (3.58e-4)" "unprognostic (2.21e-2)" "prognostic unfavorable (7.27e-5)" "unprognostic (9.12e-3)" "unprognostic (3.60e-2)" "unprognostic (2.54e-3)" "unprognostic (3.19e-1)" 0.2 2.8 11.6 0.3 15.3 0.7 0.4 12.5 66.6 0.3 0.0 0.7 0.7 0.6 36.4 0.2 2.3 0.5 0.4 13.9 16.3 3.5 0.1 0.2 0.2 35.8 7.0 0.3 1.1 0.0 3.9 7.6 28.9 0.8 0.8 14.6 0.2 2.0 0.5 0.9 1.2 0.4 3.0 0.1 8.7 9.6 17.1 2.3 0.1 0.1 0.3 0.1 0.3 20.0 0.0 13.3 1.1 0.1 0.1 0.3 0.0 1.4 0.0 0.2 0.1 19.3 0.5 2.3 2.0 0.0 0.2 0.0 0.0 0.0 0.1 1.0 25.0 0.0 21.4 11.4 0.0 0.0 0.0 0.1 0.2 0.2 0.0 0.2 0.0 0.2 0.1 0.1 0.0 0.1 0.0 0.2 5.0 1.0 0.0 0.3 0.0 0.0 1.5 0.0 29.1 5.0 12.8 4.4 0.0 2.8 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.1 0.0 0.5 1.4 0.1 1.4 3.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 11.6 15.3 12.5 66.6 13.9 16.3 35.8 7.0 28.9 3.0 17.1 20.0 0.2 3.2 0.0 4.6 0.6 1.8 0.3 7.2 0.6 29.1 0.9 1.1 1.2 0.0 2.5 0.0 2.1 93.0 0.8 2.2 3.9 1.3 16.4 0.6 0.2 0.7 9.6 0.0 45.5 0.9 9.2 1.1 28.1 0.7 0.0 12.3 0.0 0.2 6.1 18.5 55.2 0.6 2.0 0.0 0.7 17.8 0.6 0.7 0.0 6.5 0.0 2.8 0.0 11.1 3.6 0.8 4.8 1.9 0.9 1.0 3.5 18.8 6.9 8.1 0.0 0.6 0.8 57.8 134.9 0.9 1.6 30.6 0.4 0.9 1.3 0.5 MARCOL ENSG00000248109 "MARCO like" A0A1B0GUY1 5 148221650-148243580 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "urinary bladder: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 9 "HeLa: 808.2" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 20: HeLa - Mitochondria" 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.3 0.1 0.0 0.2 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 808.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 85.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.3 0.1 0.1 0.3 0.2 0.3 0.1 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MBLAC2 "DKFZp686P15118, MGC46734" ENSG00000176055 "Metallo-beta-lactamase domain containing 2" Q68D91 5 90458209-90474771 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037757, HPA037758" Uncertain Approved Nucleoplasm,Mitochondria NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 68: Epididymis - Unknown function" "Cluster 25: RPMI-8226 - Immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Mitochondria Nucleoplasm "HPA037757: AB_10670528, HPA037758: " "unprognostic (6.32e-2)" "unprognostic (2.48e-1)" "unprognostic (9.22e-3)" "unprognostic (1.21e-2)" "unprognostic (9.27e-2)" "unprognostic (1.96e-3)" "unprognostic (9.98e-3)" "unprognostic (1.82e-2)" "unprognostic (3.33e-2)" "unprognostic (4.00e-3)" "unprognostic (4.16e-2)" "unprognostic (1.95e-1)" "unprognostic (1.83e-2)" "unprognostic (1.44e-1)" "unprognostic (3.34e-1)" "unprognostic (6.31e-2)" "unprognostic (1.63e-2)" 2.6 3.8 4.3 3.3 4.4 1.5 5.2 4.7 5.9 4.4 1.2 3.1 3.3 5.1 3.3 3.8 3.8 2.4 2.8 4.6 4.8 5.0 6.3 2.3 4.2 3.0 5.1 8.6 3.1 8.1 2.4 2.9 3.5 4.5 3.2 3.4 4.6 3.9 2.3 5.2 3.0 3.7 3.3 3.8 2.6 3.1 6.4 4.3 5.2 2.2 3.9 2.5 2.9 4.7 6.4 2.7 4.6 5.9 6.0 8.0 5.6 5.0 4.5 4.2 4.4 2.1 4.7 14.9 2.9 4.4 5.8 6.4 6.0 7.5 6.6 8.5 4.1 6.7 4.6 4.8 6.3 6.7 2.8 7.0 9.9 3.0 11.6 4.9 5.4 7.9 10.2 8.0 7.2 3.9 6.5 9.1 3.0 1.3 13.1 6.9 7.7 20.5 6.3 2.3 7.9 9.3 4.5 6.5 12.1 2.7 5.4 4.9 6.7 5.2 3.6 6.4 6.5 5.6 6.8 6.5 4.5 13.8 7.2 0.0 0.7 0.5 1.4 1.8 1.6 1.3 1.5 1.5 1.3 2.4 2.0 1.6 0.0 1.6 0.9 0.4 0.6 1.1 4.3 4.4 4.7 5.9 4.6 4.8 3.0 5.1 3.5 3.3 6.4 4.7 3.8 3.2 3.6 2.9 4.7 2.7 1.2 2.8 8.6 8.1 4.6 5.0 4.9 2.8 1.7 1.8 8.4 3.9 3.9 1.9 1.9 1.6 0.3 2.0 5.0 4.2 4.2 6.3 14.4 1.3 3.1 3.5 3.1 2.0 0.0 5.3 3.6 5.8 2.6 3.3 16.4 2.9 4.1 5.1 1.0 0.6 4.1 2.1 1.8 6.5 2.1 5.5 3.1 8.5 15.6 1.8 1.8 5.3 2.1 1.2 3.0 5.5 2.4 6.7 0.0 4.3 4.9 2.5 6.1 7.3 3.3 0.8 3.7 12.6 3.9 0.7 MC5R ENSG00000176136 "Melanocortin 5 receptor" P33032 18 13824149-13827323 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 2.4;lymphoid tissue: 1.0" "Cell type enriched" "Detected in single" 17 "Squamous epithelial cells: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-138 MG: 1.8" "Low region specificity" "Detected in some" "Not detected" "Not detected" "HPA042365, HPA058088" Approved Supported "Plasma membrane" NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 61: Squamous epithelial cells - Keratinization" "Plasma membrane" "HPA042365: AB_2677961, HPA058088: " "unprognostic (1.57e-2)" "unprognostic (1.37e-1)" "unprognostic (8.77e-2)" "unprognostic (7.10e-2)" "unprognostic (2.64e-2)" "unprognostic (1.30e-2)" "unprognostic (9.04e-3)" "unprognostic (1.54e-1)" 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.2 0.0 0.0 0.0 2.4 0.5 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.3 1.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 1.8 0.4 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.2 0.1 0.3 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 MCF2 "ARHGEF21, DBL" ENSG00000101977 "MCF.2 cell line derived transforming sequence" P10911 X 139581770-139708227 "Plasma proteins, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" Proto-oncogene "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 29.5;seminal vesicle: 17.0;testis: 18.6" "Cell type enhanced" "Detected in some" "Cone photoreceptor cells: 98.0;Excitatory neurons: 27.8;Inhibitory neurons: 36.2;Oligodendrocyte precursor cells: 20.6;Theca cells: 22.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 12 "U-251 MG: 37.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "unprognostic (2.42e-1)" "unprognostic (2.18e-2)" "unprognostic (1.46e-2)" "unprognostic (5.11e-4)" "unprognostic (8.95e-2)" "unprognostic (3.99e-2)" "unprognostic (1.24e-1)" "unprognostic (2.28e-1)" "unprognostic (1.80e-1)" "unprognostic (1.28e-1)" "unprognostic (2.63e-2)" "unprognostic (7.77e-2)" "unprognostic (2.33e-3)" "unprognostic (3.68e-2)" "unprognostic (2.92e-2)" "unprognostic (4.62e-4)" "unprognostic (4.02e-2)" 0.2 29.5 5.8 0.4 4.5 0.7 0.1 6.4 8.8 0.0 1.7 0.1 0.0 0.1 12.3 0.0 0.8 0.7 1.0 4.4 7.0 1.5 0.2 0.1 0.6 9.1 7.4 10.2 0.2 0.0 3.4 0.0 9.7 1.2 0.0 9.2 1.0 17.0 0.1 0.1 0.3 0.0 5.5 1.1 0.2 18.6 14.1 0.5 1.1 0.2 0.1 0.2 0.1 5.9 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.1 0.1 0.3 0.0 0.0 0.0 1.6 0.0 0.2 0.0 0.2 0.0 0.0 0.2 0.0 0.5 3.1 0.0 0.5 0.6 2.5 0.0 0.0 0.1 1.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.3 0.6 37.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 5.8 4.5 6.4 8.8 4.4 7.0 9.1 7.4 9.7 5.5 14.1 5.9 0.2 0.0 0.0 3.6 0.3 0.1 0.3 0.2 0.6 2.2 0.6 0.4 1.8 0.0 0.0 0.0 98.0 0.0 0.3 0.1 0.0 0.0 1.0 0.1 0.1 0.1 0.0 0.0 27.8 0.0 0.0 0.7 0.0 0.1 0.0 2.2 0.4 0.2 0.1 0.0 36.2 0.0 0.0 0.6 0.3 2.5 1.2 0.2 0.0 4.7 1.4 1.0 4.1 20.6 7.6 0.1 0.0 8.2 0.1 0.4 0.0 0.6 0.0 2.4 0.0 0.1 0.4 0.6 0.8 0.1 0.0 0.0 0.3 22.8 0.0 0.2 MCM9 "C6orf61, dJ329L24.3, FLJ20170, MCMDC1, MGC35304" ENSG00000111877 "Minichromosome maintenance 9 homologous recombination repair factor" Q9NXL9 6 118813442-118935162 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-binding, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 32.0;Microglial cells: 40.3;Oligodendrocyte precursor cells: 35.7;Oligodendrocytes: 39.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031137 Approved Approved Nucleoplasm NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 59: Non-specific - Transcription" Nucleoplasm "HPA031137: AB_10602027" "unprognostic (3.11e-2)" "unprognostic (1.99e-1)" "unprognostic (4.33e-3)" "unprognostic (2.90e-1)" "unprognostic (2.78e-2)" "unprognostic (2.82e-1)" "unprognostic (3.00e-2)" "unprognostic (2.29e-1)" "unprognostic (3.61e-2)" "unprognostic (7.76e-2)" "unprognostic (1.53e-1)" "unprognostic (2.99e-1)" "unprognostic (8.30e-2)" "unprognostic (2.16e-1)" "unprognostic (3.95e-1)" "unprognostic (2.26e-1)" "unprognostic (8.79e-2)" 5.7 4.4 2.5 5.7 3.3 12.7 7.0 2.4 2.9 6.8 3.5 5.1 4.9 5.3 10.2 6.5 5.8 3.7 3.4 2.2 2.5 6.6 5.0 5.2 7.5 3.2 3.2 5.1 6.9 5.3 4.6 7.0 3.1 6.8 5.7 4.1 7.5 4.7 2.6 6.5 5.8 4.2 2.8 6.3 4.9 5.7 3.0 8.0 8.0 2.1 7.1 5.8 6.9 3.7 4.2 6.5 10.3 11.8 4.2 4.8 7.3 3.9 7.1 5.4 6.8 5.2 6.7 12.1 4.5 6.2 3.9 12.5 7.1 4.7 7.2 7.5 10.1 11.4 9.5 5.5 3.0 11.7 7.3 5.2 5.7 6.0 7.3 3.7 5.5 8.0 12.9 6.3 4.2 9.4 10.0 9.4 4.7 7.3 3.1 8.3 7.0 4.2 5.4 7.9 8.5 6.0 6.9 5.7 3.7 2.9 7.3 15.8 6.0 4.3 3.7 2.9 5.7 7.8 7.2 13.9 5.5 8.7 5.6 4.3 2.6 4.4 2.2 2.7 1.8 1.5 1.4 2.3 2.9 1.4 1.7 1.6 2.9 4.8 1.7 2.1 3.5 2.1 2.5 3.3 2.4 2.9 2.2 2.5 3.2 3.2 3.1 2.8 3.0 3.7 6.6 6.4 6.7 32.0 10.8 2.9 3.8 2.9 7.4 3.5 6.4 4.1 6.0 2.8 4.4 7.3 10.4 11.8 7.6 7.2 3.9 3.0 2.9 7.4 6.0 6.3 7.2 4.6 16.8 2.8 3.4 5.0 9.2 6.9 7.0 8.1 2.9 3.9 3.5 1.7 15.2 6.0 6.1 5.5 2.8 2.6 3.7 7.4 0.0 40.3 6.3 1.6 11.3 35.7 39.7 2.7 5.6 4.1 10.9 3.9 6.8 3.3 10.6 5.6 0.0 5.7 5.8 6.3 4.6 8.6 2.0 7.3 9.8 4.7 4.1 4.3 MGAT4C HGNT-IV-H ENSG00000182050 "MGAT4 family member C" Q9UBM8 12 85955666-86838904 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "epididymis: 3.7;pituitary gland: 3.1;testis: 4.7;thyroid gland: 6.2" "Group enriched" "Detected in some" 8 "Astrocytes: 876.3;Excitatory neurons: 988.4;Inhibitory neurons: 1438.9" "Cancer enriched" "Detected in single" 19 "thyroid cancer: 2.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 10 "NTERA-2: 6.0;SCLC-21H: 2.5;SuSa: 1.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016418 Approved Approved "Vesicles,Plasma membrane,Centriolar satellite" NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 5: NTERA-2 - Transcription" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Vesicles, Plasma membrane" "Centriolar satellite" "HPA016418: AB_2732416" "unprognostic (5.23e-2)" "unprognostic (2.33e-1)" "unprognostic (1.84e-1)" "unprognostic (3.32e-4)" "unprognostic (1.07e-1)" "unprognostic (9.64e-2)" "unprognostic (5.94e-3)" "unprognostic (1.88e-1)" "unprognostic (8.05e-2)" "unprognostic (1.89e-1)" "unprognostic (6.32e-3)" "unprognostic (3.51e-2)" "unprognostic (6.85e-10)" "unprognostic (3.15e-2)" "unprognostic (1.77e-1)" "unprognostic (1.97e-1)" "unprognostic (4.74e-3)" 0.3 0.8 1.7 0.0 2.0 0.1 0.0 0.2 1.4 0.1 0.0 0.4 0.0 0.0 3.7 0.0 0.1 0.1 1.7 1.0 1.8 0.0 0.1 0.1 0.0 1.0 2.4 0.0 0.1 0.0 3.1 0.0 1.6 0.2 0.1 0.5 0.0 0.6 0.0 0.0 0.1 0.0 1.1 0.0 0.1 4.7 2.3 0.0 6.2 0.0 0.0 0.1 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 1.9 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 2.0 0.2 1.4 1.0 1.8 1.0 2.4 1.6 1.1 2.3 0.7 0.1 6.4 1.1 876.3 0.0 0.1 0.2 1.5 0.0 11.2 0.0 0.0 10.4 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 123.9 0.1 0.1 4.2 0.0 0.0 988.4 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1438.9 0.0 4.1 0.0 0.0 98.9 16.1 0.3 0.0 34.7 0.2 0.5 0.0 32.2 17.2 0.4 0.0 4.1 0.0 0.3 0.0 0.1 0.0 1.8 0.0 0.4 0.2 3.8 1.5 0.0 0.1 0.0 0.5 6.2 0.0 0.3 MIB1 "DIP-1, KIAA1323, MIB, ZZANK2, ZZZ6" ENSG00000101752 "Mindbomb E3 ubiquitin protein ligase 1" Q86YT6 18 21704957-21870953 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Notch signaling pathway, Ubl conjugation pathway" Transferase "Cardiomyopathy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocyte precursor cells: 121.2;Oligodendrocytes: 109.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in all" "REH: 121.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019100, CAB037044" Approved Supported "Vesicles,Plasma membrane" NA NA "Cluster 10: Basophils - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 14: REH - Unknown function" "Cluster 44: Endometrium - Transcription" "Plasma membrane" Vesicles "CAB037044: AB_1841007, HPA019100: AB_1853934" "unprognostic (1.38e-1)" "unprognostic (6.92e-2)" "unprognostic (7.29e-2)" "unprognostic (6.99e-2)" "unprognostic (5.66e-2)" "unprognostic (3.23e-2)" "unprognostic (8.45e-3)" "unprognostic (2.70e-1)" "unprognostic (5.42e-2)" "unprognostic (4.69e-2)" "unprognostic (3.78e-2)" "unprognostic (4.70e-2)" "unprognostic (8.33e-3)" "unprognostic (4.91e-3)" "unprognostic (1.73e-1)" "unprognostic (4.86e-2)" "unprognostic (1.85e-2)" 8.1 6.3 9.1 6.0 9.1 4.9 11.2 9.2 8.5 11.0 8.0 7.1 5.1 13.0 9.5 8.0 7.1 8.6 6.0 8.4 9.2 11.1 10.4 7.2 7.6 9.5 10.2 11.7 8.1 9.8 5.2 11.0 8.6 10.1 7.0 8.3 8.4 8.5 5.8 9.1 5.2 10.2 10.1 7.2 7.6 8.7 10.3 11.5 13.6 7.0 7.9 8.4 8.2 9.6 19.9 7.6 36.4 25.8 19.5 23.0 9.0 15.6 17.2 10.8 15.6 11.3 7.1 16.9 14.1 21.4 11.8 13.2 21.4 21.0 24.4 22.4 10.4 18.8 9.7 15.9 15.8 38.3 7.8 14.8 23.0 12.6 32.0 16.0 27.8 6.6 26.5 47.5 17.2 9.5 18.9 14.7 9.5 12.2 10.2 121.1 30.3 42.5 18.7 16.9 12.1 30.1 26.8 12.4 13.9 18.6 8.8 25.1 23.9 27.8 14.2 11.7 21.1 25.6 9.5 25.4 11.8 24.1 16.9 0.7 0.3 0.1 0.2 0.1 0.2 0.2 0.3 0.2 0.1 0.1 0.2 0.1 0.3 0.5 0.1 0.2 0.4 0.1 9.1 9.1 9.2 8.5 8.4 9.2 9.5 10.2 8.6 10.1 10.3 9.6 35.7 48.1 22.7 68.2 11.9 21.9 15.1 19.8 24.5 28.8 24.1 19.7 18.1 25.8 31.8 16.5 25.0 13.3 18.2 20.8 3.9 13.4 7.0 29.0 59.2 30.8 24.0 23.1 106.7 12.9 7.5 33.1 10.2 32.4 14.5 16.8 24.3 30.0 12.9 15.2 92.6 17.1 26.4 17.2 16.2 5.6 20.5 14.2 26.6 67.5 19.4 17.7 15.5 121.2 109.6 18.8 7.0 24.8 18.1 48.5 8.7 15.9 30.6 14.5 0.0 35.4 26.9 26.2 12.0 23.4 24.6 25.3 14.5 21.8 10.4 25.3 MMP21 ENSG00000154485 "Matrix metallopeptidase 21" Q8N119 10 125753580-125775821 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Metalloprotease, Protease" Heterotaxy "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 14 "epididymis: 53.9" "Cell type enhanced" "Detected in some" "Distal tubular cells: 1.9;Granulosa cells: 1.4;Microglial cells: 1.9" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted to extracellular matrix" NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 40: Granulosa cells - Unknown function" "unprognostic (1.32e-2)" "unprognostic (1.28e-1)" "unprognostic (8.51e-2)" "unprognostic (2.19e-2)" "unprognostic (4.02e-2)" "unprognostic (2.21e-2)" "unprognostic (4.22e-3)" "unprognostic (1.01e-1)" "unprognostic (2.12e-1)" "unprognostic (1.48e-1)" "unprognostic (2.89e-2)" "unprognostic (3.62e-2)" "unprognostic (9.70e-8)" "unprognostic (1.30e-2)" "unprognostic (7.69e-2)" "unprognostic (7.00e-2)" "unprognostic (2.18e-1)" 0.2 0.3 0.4 0.6 0.7 0.7 0.2 1.7 0.7 0.2 0.2 0.2 0.5 0.5 53.9 0.5 0.4 0.7 0.8 0.5 0.4 0.1 0.3 0.2 1.0 0.3 0.3 3.7 0.7 0.0 0.1 0.1 0.2 0.5 0.1 1.8 1.2 0.2 0.3 1.2 0.4 0.2 0.1 0.6 0.4 1.0 0.5 0.0 0.5 0.0 0.2 0.2 0.0 0.9 0.4 0.2 0.6 0.4 0.1 0.0 0.6 0.4 0.0 0.0 0.0 0.4 0.0 0.5 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.2 0.4 0.1 0.9 0.4 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.1 0.3 0.0 0.2 0.2 0.3 0.3 0.0 0.3 0.2 0.1 0.1 0.0 0.3 0.1 0.2 0.2 0.0 0.0 0.2 0.1 0.1 0.2 0.5 0.2 0.2 0.3 0.5 0.4 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.7 1.7 0.7 0.5 0.4 0.3 0.3 0.2 0.1 0.5 0.9 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.1 0.0 1.4 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.9 0.0 0.5 0.0 0.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.3 0.1 0.4 0.0 0.0 0.0 0.0 0.2 0.1 0.0 MORF4L2 "KIAA0026, MRGX" ENSG00000123562 "Mortality factor 4 like 2" Q15014 X 103675496-103688158 "Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Growth regulation, Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Extravillous trophoblasts: 1214.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031872, HPA054102" Supported Enhanced Nucleoplasm NA Yes "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 68: Epididymis - Unknown function" "Cluster 18: U-2197 - ECM organization" "Cluster 38: Extravillous trophoblasts - Unknown function" Nucleoplasm "HPA031872: AB_2674081, HPA054102: AB_2682379" "prognostic unfavorable (9.83e-4)" "unprognostic (2.04e-1)" "unprognostic (1.81e-1)" "unprognostic (7.14e-3)" "unprognostic (2.59e-1)" "prognostic unfavorable (4.29e-5)" "unprognostic (5.27e-2)" "unprognostic (6.34e-3)" "unprognostic (2.41e-1)" "unprognostic (4.49e-3)" "unprognostic (1.88e-1)" "unprognostic (1.10e-2)" "prognostic unfavorable (7.86e-7)" "unprognostic (8.54e-2)" "unprognostic (2.65e-2)" "unprognostic (1.78e-1)" "unprognostic (4.05e-1)" 142.9 184.7 173.9 97.3 180.9 99.0 179.3 156.9 261.5 249.3 183.1 113.4 89.5 262.5 217.7 121.1 209.8 129.2 138.4 180.9 210.1 130.2 204.9 132.6 72.5 170.8 180.3 358.2 137.2 137.2 198.8 242.6 191.2 161.9 140.1 94.1 121.2 191.6 175.6 103.9 99.6 328.5 166.9 90.6 118.0 90.1 183.6 79.3 159.2 130.7 109.6 172.1 143.1 179.1 404.7 257.2 372.6 167.3 541.7 388.2 486.6 533.0 479.4 437.1 462.2 259.6 369.5 289.1 401.4 533.5 522.0 272.0 477.1 406.9 535.6 120.9 219.0 157.5 413.9 308.9 602.7 212.2 141.6 449.6 351.2 380.8 489.6 389.2 478.9 142.2 249.5 383.0 551.5 403.7 188.0 207.6 355.5 512.0 322.3 186.9 340.9 292.1 456.5 221.4 347.3 275.5 425.7 310.1 418.5 385.2 203.3 198.1 433.8 263.2 171.2 459.1 289.3 179.3 221.3 241.2 472.1 420.1 403.8 54.1 40.9 32.9 41.2 44.0 46.9 37.0 38.9 38.2 41.8 32.3 41.7 37.0 16.1 46.0 47.3 70.2 36.1 40.3 173.9 180.9 156.9 261.5 180.9 210.1 170.8 180.3 191.2 166.9 183.6 179.1 102.5 125.0 160.1 39.8 75.8 363.5 572.5 292.0 75.1 46.9 198.6 103.6 130.1 123.0 242.0 110.3 10.4 443.3 106.2 103.2 246.5 269.1 46.9 231.7 235.5 146.6 178.6 68.5 109.6 129.9 1214.1 266.0 90.7 187.2 155.8 153.5 118.5 196.8 163.6 58.9 104.4 202.0 219.7 61.7 254.9 34.2 330.9 90.8 188.5 32.8 68.7 117.0 40.2 59.3 78.2 176.8 118.9 574.8 120.9 332.7 105.1 282.9 429.7 38.8 144.7 164.9 287.9 37.2 48.0 112.7 317.8 583.5 118.2 171.5 134.4 396.8 MPP2 "DKFZp761D0712, DLG2" ENSG00000108852 "Membrane palmitoylated protein 2" Q14168 17 43875357-43909711 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 41.6" "Cell type enhanced" "Detected in many" "Bipolar cells: 91.0;Early spermatids: 69.6;Horizontal cells: 35.3;Oligodendrocytes: 59.6;Spermatogonia: 31.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "T-47d: 24.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026486, HPA073483" Enhanced Approved Mitochondria,Cytosol NA NA "Cluster 32: T-cells - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 6: T47d - Mammary gland" "Cluster 56: Bipolar cells - Visual perception" "Mitochondria, Cytosol" "HPA026486: AB_1854085, HPA073483: " "unprognostic (1.18e-1)" "unprognostic (1.68e-1)" "unprognostic (1.30e-5)" "prognostic unfavorable (1.87e-4)" "unprognostic (4.37e-2)" "unprognostic (2.86e-2)" "unprognostic (7.95e-3)" "unprognostic (2.34e-1)" "unprognostic (1.25e-1)" "unprognostic (3.69e-2)" "unprognostic (3.03e-3)" "unprognostic (2.11e-1)" "unprognostic (2.72e-2)" "unprognostic (4.93e-2)" "unprognostic (1.85e-1)" "unprognostic (7.23e-2)" "unprognostic (6.89e-4)" 2.5 3.8 22.2 1.3 25.7 0.5 3.3 25.0 27.0 5.3 7.3 9.4 1.1 5.6 26.0 3.0 5.0 2.2 8.9 23.3 24.2 1.6 0.2 1.4 0.5 30.0 27.1 3.2 3.4 15.8 13.7 2.5 26.5 7.5 1.2 15.7 1.4 8.7 1.0 1.8 2.5 5.0 24.7 0.7 3.7 16.9 28.0 0.7 3.5 1.5 0.6 6.7 4.4 41.6 7.2 10.5 11.0 15.7 1.4 1.0 6.0 2.5 0.3 9.9 9.0 3.7 4.7 10.4 5.7 2.5 12.2 2.9 15.1 6.0 7.0 0.0 11.5 0.9 9.2 0.2 0.3 0.0 2.9 1.5 0.5 6.8 0.1 5.4 0.7 16.6 3.9 0.0 2.5 2.8 1.5 0.8 19.7 0.8 6.4 7.4 15.5 0.7 0.2 0.2 11.6 10.7 3.0 1.0 4.1 9.8 24.5 4.9 0.1 10.5 13.2 4.0 4.5 3.4 7.4 0.0 15.8 6.9 2.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.1 22.2 25.7 25.0 27.0 23.3 24.2 30.0 27.1 26.5 24.7 28.0 41.6 2.1 0.0 0.0 11.1 0.0 0.4 1.4 1.0 0.0 91.0 0.5 2.9 10.5 0.0 0.0 0.0 2.1 5.8 0.1 0.1 0.0 0.7 69.6 0.1 0.4 1.4 0.0 0.0 20.4 0.4 0.4 2.7 0.0 0.1 0.0 1.2 0.0 0.0 0.7 35.3 19.0 0.0 0.0 0.0 0.4 21.1 3.7 0.2 0.0 1.9 0.0 16.1 0.0 13.6 59.6 0.5 0.0 5.7 0.1 0.0 0.0 0.1 0.0 7.1 0.0 1.5 1.9 23.2 31.4 0.2 0.1 2.7 0.3 0.1 0.0 0.0 MPV17 SYM1 ENSG00000115204 "Mitochondrial inner membrane protein MPV17" P39210 2 27309492-27325680 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 68: Epididymis - Unknown function" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "unprognostic (9.34e-3)" "unprognostic (2.70e-1)" "unprognostic (9.50e-2)" "unprognostic (2.21e-1)" "unprognostic (1.54e-1)" "unprognostic (1.89e-2)" "prognostic unfavorable (6.99e-6)" "unprognostic (1.05e-1)" "unprognostic (1.37e-1)" "unprognostic (1.56e-1)" "unprognostic (2.22e-1)" "unprognostic (1.48e-1)" "unprognostic (1.44e-3)" "unprognostic (2.59e-3)" "unprognostic (2.52e-1)" "unprognostic (5.10e-3)" "unprognostic (4.62e-2)" 50.2 86.5 56.4 37.8 58.1 31.3 39.9 59.1 58.4 36.0 59.3 32.5 25.0 37.9 47.7 32.6 37.7 36.7 78.2 56.3 59.1 48.6 22.6 39.1 43.2 58.8 57.1 43.7 33.2 70.0 38.9 35.0 58.1 34.1 34.1 26.7 35.9 35.0 18.3 32.0 27.5 57.7 56.9 37.1 29.1 15.5 60.3 46.0 51.6 30.0 48.1 44.9 28.1 63.2 74.1 68.2 49.7 42.6 202.7 237.0 46.6 70.8 143.6 67.2 60.7 55.0 52.0 41.5 72.8 97.2 124.0 61.3 64.1 134.1 69.5 56.9 63.7 79.5 58.8 105.6 125.4 47.3 48.7 229.3 116.3 118.6 169.4 94.3 100.2 49.8 77.0 77.1 113.9 107.4 46.9 71.5 55.7 106.7 69.1 64.6 73.2 85.2 149.2 58.5 33.1 107.2 37.6 43.7 82.1 49.3 49.0 60.6 88.6 67.0 68.8 83.4 76.4 108.1 106.1 130.4 109.2 105.4 76.1 59.5 93.7 42.9 59.3 81.4 64.4 84.5 60.5 67.4 120.5 73.6 58.0 67.8 7.8 76.0 81.7 87.4 81.4 92.1 56.4 58.1 59.1 58.4 56.3 59.1 58.8 57.1 58.1 56.9 60.3 63.2 36.0 25.6 29.3 10.7 26.3 17.2 32.8 69.2 33.0 20.5 49.5 52.8 48.9 18.6 46.5 33.1 8.4 51.1 26.3 8.8 64.6 43.3 27.4 17.3 32.6 35.9 16.8 21.6 18.4 24.3 60.2 37.5 12.2 17.5 42.5 28.7 28.2 9.9 116.9 8.4 22.7 15.0 59.0 28.5 24.0 34.2 35.4 33.7 40.9 8.4 38.1 38.9 28.8 13.6 15.5 20.7 12.9 35.0 31.4 32.1 17.6 87.1 36.7 12.7 0.0 30.1 30.8 15.5 21.2 33.9 18.8 59.4 22.2 41.8 17.7 30.7 MRPS14 HSMRPS14 ENSG00000120333 "Mitochondrial ribosomal protein S14" O60783 1 175010789-175023425 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051087 Uncertain Supported "Nuclear membrane,Mitochondria" "Intracellular and membrane" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 68: Epididymis - Unknown function" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 10: Non-specific - Unknown function" Mitochondria "Nuclear membrane" "HPA051087: AB_2681339" "unprognostic (9.24e-2)" "unprognostic (6.37e-2)" "unprognostic (1.50e-1)" "unprognostic (3.46e-1)" "unprognostic (3.44e-2)" "unprognostic (5.39e-2)" "unprognostic (1.61e-2)" "unprognostic (3.01e-2)" "unprognostic (7.32e-2)" "unprognostic (4.85e-2)" "unprognostic (7.67e-2)" "unprognostic (3.10e-2)" "unprognostic (1.31e-3)" "unprognostic (1.67e-1)" "unprognostic (8.04e-2)" "unprognostic (2.42e-1)" "unprognostic (3.21e-2)" 17.2 20.3 24.9 11.2 26.8 4.5 20.6 26.5 28.3 16.2 20.0 13.4 12.4 17.4 21.7 9.5 15.4 13.9 15.1 23.4 26.9 20.4 19.2 13.2 15.8 26.7 25.8 18.4 14.8 28.0 12.2 13.9 26.7 20.2 15.7 22.5 17.0 16.9 13.0 11.4 11.9 14.9 26.6 14.3 14.1 11.2 25.0 17.5 23.2 14.2 15.1 12.0 9.3 28.3 16.2 12.8 29.5 10.5 32.6 23.4 9.4 13.8 16.8 23.0 23.7 16.7 13.9 20.4 16.5 18.6 10.1 14.0 18.5 16.1 24.3 22.6 25.4 16.8 25.6 19.2 13.8 18.9 14.5 25.6 19.4 13.6 9.4 20.3 19.4 17.4 20.7 17.6 16.2 8.9 20.8 13.7 16.2 30.1 6.7 17.8 15.6 24.4 15.8 12.8 24.8 17.4 20.0 18.3 13.8 23.1 21.7 19.7 15.9 7.8 8.6 16.4 12.5 19.1 17.5 25.1 11.1 17.5 16.6 9.3 15.2 7.7 14.8 15.1 21.2 17.5 15.5 15.8 16.2 17.3 20.8 17.6 5.2 18.2 12.3 14.0 19.0 14.3 24.9 26.8 26.5 28.3 23.4 26.9 26.7 25.8 26.7 26.6 25.0 28.3 29.8 28.9 24.5 5.5 38.4 22.0 52.6 105.9 22.2 17.5 31.6 33.8 78.1 44.3 64.0 55.2 14.6 95.4 26.7 26.4 137.0 69.8 23.8 26.5 35.8 39.1 31.8 46.3 7.8 44.8 107.0 41.4 20.4 26.6 18.3 34.8 33.9 67.2 80.7 1.7 9.4 35.8 103.7 34.7 23.9 12.9 46.6 25.6 49.8 9.4 73.9 46.1 45.3 6.6 10.4 47.7 45.7 42.9 48.7 50.0 35.3 126.1 50.6 22.6 39.5 25.1 66.4 96.9 39.1 36.7 29.3 56.1 28.8 43.0 48.8 52.6 MTCH1 "CGI-64, PSAP, SLC25A49" ENSG00000137409 "Mitochondrial carrier 1" Q9NZJ7 6 36968141-36986298 "Predicted membrane proteins, Transporters" "Apoptosis, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 1002.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015971 Approved NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 68: Epididymis - Unknown function" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 54: Cardiomyocytes - Muscle contraction" "HPA015971: AB_1854171" "unprognostic (3.17e-2)" "unprognostic (1.37e-1)" "unprognostic (1.71e-1)" "prognostic unfavorable (2.06e-4)" "unprognostic (1.40e-1)" "unprognostic (1.87e-1)" "prognostic unfavorable (1.17e-4)" "unprognostic (1.29e-1)" "unprognostic (2.88e-2)" "unprognostic (1.54e-1)" "unprognostic (7.49e-2)" "unprognostic (1.35e-3)" "prognostic favorable (1.16e-7)" "unprognostic (1.32e-2)" "unprognostic (3.11e-1)" "unprognostic (6.68e-2)" "unprognostic (4.70e-2)" 151.0 279.7 314.7 97.4 331.9 194.1 140.2 290.1 341.2 194.5 257.9 151.7 93.7 136.3 312.1 130.8 154.2 99.6 259.7 326.1 333.3 168.1 117.2 202.5 95.4 306.1 310.3 177.3 165.4 142.1 284.8 106.0 333.1 183.1 96.4 92.0 144.2 196.5 133.7 176.6 125.2 114.7 305.1 148.7 156.2 81.1 349.0 88.2 364.1 89.0 88.6 156.4 166.2 340.8 196.3 130.8 173.3 214.0 254.7 171.9 99.0 225.3 208.2 312.1 322.1 218.0 118.3 97.1 197.7 379.8 301.8 167.1 189.2 181.8 360.2 104.5 183.9 101.3 223.4 165.4 184.1 65.7 92.1 194.5 140.5 289.7 140.5 271.8 269.3 133.0 186.1 97.5 199.8 221.4 134.3 149.8 170.1 175.2 147.5 122.9 135.4 102.6 169.1 160.5 278.8 119.9 163.9 141.2 206.8 173.6 182.5 181.9 299.6 311.5 246.1 241.3 247.3 85.3 92.5 1002.9 112.1 179.4 250.1 11.0 34.7 45.4 14.5 34.9 13.5 18.8 27.5 29.2 31.1 31.2 26.2 15.4 37.8 18.4 44.7 17.3 22.4 17.3 314.7 331.9 290.1 341.2 326.1 333.3 306.1 310.3 333.1 305.1 349.0 340.8 133.7 48.1 99.1 47.3 79.1 113.7 177.1 138.6 71.7 0.0 152.7 125.2 162.5 117.2 101.2 69.9 0.0 183.5 91.8 149.9 168.3 213.0 8.2 99.0 139.4 112.3 149.3 67.6 54.1 170.0 224.0 163.4 94.3 177.3 29.2 193.6 85.6 50.9 189.2 0.0 52.8 133.0 105.8 97.2 150.6 16.3 138.2 109.5 136.9 44.0 173.2 0.0 55.6 28.1 106.4 181.7 162.3 132.4 57.6 255.0 144.3 129.4 68.0 0.0 52.6 108.8 133.5 18.5 46.4 86.2 123.5 248.3 85.8 118.5 145.1 208.5 MTHFR ENSG00000177000 "Methylenetetrahydrofolate reductase" P42898 1 11785723-11806455 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Allosteric enzyme, Oxidoreductase" "Disease variant, Schizophrenia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "K-562: 44.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA063389, HPA076180, HPA077255" Enhanced Approved "Cell Junctions" NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 1: K-562 - Erythropoiesis" "Cluster 44: Endometrium - Transcription" "Cell Junctions" "HPA063389: AB_2685001, HPA076180: , HPA077255: " "unprognostic (3.25e-2)" "unprognostic (8.19e-2)" "unprognostic (4.48e-2)" "unprognostic (2.11e-2)" "unprognostic (1.34e-1)" "prognostic favorable (3.97e-5)" "prognostic unfavorable (1.19e-4)" "unprognostic (1.75e-2)" "unprognostic (2.85e-1)" "unprognostic (8.69e-2)" "prognostic favorable (4.81e-5)" "unprognostic (3.10e-1)" "prognostic favorable (2.12e-4)" "unprognostic (2.35e-3)" "unprognostic (2.94e-1)" "unprognostic (4.14e-2)" "unprognostic (1.80e-2)" 12.3 11.3 7.1 10.8 10.3 28.9 10.2 12.8 8.8 9.0 5.0 11.1 10.8 8.9 53.5 10.3 12.3 10.1 23.9 10.4 6.2 12.8 13.1 16.8 12.3 9.9 7.0 19.7 11.4 6.6 17.7 7.1 9.4 10.2 8.7 12.6 6.8 6.7 17.9 13.4 14.7 10.8 5.1 18.3 14.6 10.9 8.0 7.9 16.3 16.8 12.2 10.3 7.9 8.9 2.2 9.4 10.9 12.3 10.2 15.1 2.0 5.2 14.6 6.0 5.1 8.1 13.2 18.0 3.6 7.5 16.3 4.1 8.1 7.7 2.4 9.3 6.8 13.4 13.3 3.2 13.7 7.4 16.4 13.6 6.1 8.0 6.4 10.0 10.7 17.2 44.1 11.0 6.7 3.3 8.2 3.5 3.6 9.5 3.0 8.9 6.0 20.3 8.8 11.7 10.5 17.6 8.1 7.8 10.9 6.2 12.9 11.7 8.5 6.0 4.9 7.2 1.6 6.4 9.4 32.8 7.6 16.8 5.6 0.7 2.3 1.1 2.7 4.3 0.9 1.6 0.8 1.4 1.7 2.3 1.2 1.4 2.5 2.0 6.1 0.9 0.6 1.6 7.1 10.3 12.8 8.8 10.4 6.2 9.9 7.0 9.4 5.1 8.0 8.9 15.9 25.6 48.0 8.1 18.3 8.4 6.8 11.9 15.9 0.0 17.9 10.8 37.0 11.5 13.0 27.6 0.0 5.1 6.0 44.2 1.9 8.9 18.2 32.0 25.8 16.9 12.1 29.5 15.8 25.3 3.3 21.0 52.5 55.5 8.2 10.7 37.5 23.4 22.2 0.0 15.2 18.0 6.1 39.3 39.9 42.4 18.3 32.1 12.4 16.9 26.5 0.0 20.6 9.0 13.3 21.9 20.6 9.1 10.3 10.2 36.0 17.2 12.3 0.0 19.7 22.8 23.3 6.8 5.2 15.0 9.2 2.9 10.6 21.3 18.6 9.6 MYO3B ENSG00000071909 "Myosin IIIB" Q8WXR4 2 170178145-170655171 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Hearing, Sensory transduction, Vision" "Actin-binding, Kinase, Motor protein, Myosin, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 14.1;kidney: 5.3;parathyroid gland: 8.8;retina: 5.8" "Cell type enhanced" "Detected in some" "Cone photoreceptor cells: 85.5;Early spermatids: 34.2;Inhibitory neurons: 18.3;Late spermatids: 29.6;Rod photoreceptor cells: 51.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "HDLM-2: 11.2;HEL: 8.8;RT4: 11.7" "Region enriched" "Detected in some" 5 "basal ganglia: 5.2" "Not detected" "Not detected" HPA045483 Approved NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 36: HEL - Hemostasis" "Cluster 9: Photoreceptor cells - Phototransduction" "HPA045483: AB_2679344" "unprognostic (1.65e-1)" "unprognostic (7.87e-2)" "unprognostic (1.96e-2)" "unprognostic (1.43e-2)" "unprognostic (1.67e-1)" "unprognostic (7.15e-3)" "unprognostic (5.07e-2)" "unprognostic (2.61e-2)" "unprognostic (5.84e-3)" "unprognostic (2.12e-1)" "unprognostic (7.99e-3)" "unprognostic (2.59e-1)" "unprognostic (4.25e-5)" "unprognostic (2.34e-1)" "unprognostic (8.12e-3)" "unprognostic (1.18e-1)" "unprognostic (1.07e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.1 14.1 0.4 0.6 0.1 0.0 0.0 0.3 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 8.8 0.3 0.0 0.0 0.0 0.0 5.8 0.1 1.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.4 1.3 0.0 0.1 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 11.2 0.0 8.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 1.1 11.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.3 0.3 0.6 0.5 0.3 0.0 3.1 0.2 0.3 0.7 0.0 0.5 3.7 85.5 0.0 0.6 0.1 13.7 0.3 34.2 5.3 0.4 0.3 1.8 0.0 1.8 0.0 0.0 0.8 0.0 1.7 0.0 0.1 0.0 0.2 0.0 0.0 18.3 0.6 0.0 0.3 1.1 29.6 0.3 0.2 0.0 1.9 0.0 3.0 0.0 5.5 2.9 0.1 0.0 0.4 0.0 0.2 0.0 0.2 0.2 51.0 0.0 1.7 0.5 1.5 0.8 0.3 0.4 0.1 0.3 0.3 0.0 0.1 MYOCOS ENSG00000283683 "Myocilin opposite strand" A0A1B0GUC4 1 171600621-171638799 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "cervix: 5.4;epididymis: 3.4;fallopian tube: 3.0" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 3.2;Endometrial ciliated cells: 14.7;Glandular and luminal cells: 4.3;Proximal tubular cells: 5.4" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "HEL: 27.6" "Not detected" "Not detected" NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 36: HEL - Hemostasis" "Cluster 49: Ciliated cells - Cilium organization" 0.0 0.0 0.6 0.1 0.6 0.4 0.1 1.1 0.7 5.4 0.5 0.1 0.2 1.2 3.4 0.2 3.0 0.3 0.1 0.6 0.5 1.0 0.2 0.2 0.3 0.4 0.4 0.2 0.6 0.0 0.0 0.3 0.4 0.2 0.2 0.7 0.1 0.7 0.4 0.2 0.2 0.1 0.3 0.1 0.3 1.1 0.5 0.0 0.8 0.0 0.2 0.3 0.0 0.6 0.0 0.5 0.4 0.1 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.2 0.3 0.1 3.3 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.0 27.6 0.5 0.5 0.1 0.1 2.9 0.0 0.1 0.0 0.0 0.0 0.0 0.2 4.8 0.5 0.1 0.2 0.0 0.1 0.1 0.5 0.1 0.0 0.0 0.1 0.9 1.8 0.2 0.0 0.0 0.0 0.1 0.3 0.3 0.1 0.0 0.1 0.0 0.2 0.1 0.7 0.1 0.4 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.6 0.6 1.1 0.7 0.6 0.5 0.4 0.4 0.4 0.3 0.5 0.6 0.1 3.2 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 14.7 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 NBDY "LINC01420, NoBody" ENSG00000204272 "Negative regulator of P-body association" A0A0U1RRE5 X 56729241-56819179 "Predicted intracellular proteins" "mRNA processing" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 336.5;Extravillous trophoblasts: 257.1;Proximal tubular cells: 262.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 68: Epididymis - Unknown function" "Cluster 38: EFO-21 - Unknown function" "Cluster 7: Non-specific - Mitochondria" "unprognostic (8.38e-3)" "unprognostic (2.46e-1)" "unprognostic (1.96e-3)" "prognostic unfavorable (3.14e-5)" "unprognostic (2.07e-1)" "prognostic unfavorable (3.11e-4)" "unprognostic (1.01e-2)" "unprognostic (2.23e-1)" "unprognostic (2.83e-1)" "unprognostic (2.59e-2)" "unprognostic (2.77e-1)" "unprognostic (2.09e-1)" "unprognostic (2.01e-2)" "unprognostic (2.18e-3)" "unprognostic (2.38e-1)" "unprognostic (1.47e-1)" "unprognostic (1.51e-2)" 27.5 39.3 36.3 20.9 36.2 18.8 25.8 34.5 48.0 29.0 32.7 25.2 17.8 27.6 47.5 25.8 31.9 27.5 27.5 34.9 42.2 43.9 13.8 29.6 26.9 34.6 39.9 29.6 15.6 34.6 41.4 24.7 39.4 28.7 22.4 23.4 20.3 27.9 11.1 30.5 21.2 30.3 35.1 27.9 22.5 13.0 39.1 35.9 41.5 18.2 24.9 35.1 27.9 34.5 34.2 52.1 63.6 53.7 74.2 66.4 15.5 46.6 75.4 25.7 42.1 25.0 67.4 14.7 111.1 54.2 52.8 23.0 59.0 58.0 32.9 0.2 73.5 43.6 49.6 6.4 76.7 49.5 44.4 80.2 68.9 45.3 81.0 77.8 68.8 48.7 17.7 36.7 50.4 59.0 62.3 14.3 84.2 55.5 92.2 30.2 42.8 53.0 68.8 49.3 27.7 43.1 100.8 47.1 46.7 113.7 60.7 22.7 59.3 42.9 35.3 75.5 29.0 40.7 26.3 39.8 36.2 26.9 34.6 66.4 54.7 6.0 70.5 62.5 73.1 86.1 89.1 78.6 98.7 86.7 85.6 82.1 5.0 103.4 66.9 175.9 93.2 68.2 36.3 36.2 34.5 48.0 34.9 42.2 34.6 39.9 39.4 35.1 39.1 34.5 128.6 28.9 34.5 0.0 24.6 0.0 0.0 0.0 0.0 0.0 83.2 88.9 0.0 0.0 18.0 117.7 0.0 143.1 40.5 0.0 336.5 110.8 0.0 71.9 60.4 55.2 0.0 0.0 0.0 95.5 257.1 31.0 0.0 68.5 39.1 67.2 0.0 0.0 142.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 45.4 0.0 0.0 91.5 0.0 0.0 0.0 0.0 126.2 0.0 0.0 5.4 0.0 0.0 262.5 29.9 0.0 0.0 0.0 39.3 0.0 0.0 0.0 0.0 148.9 25.6 119.5 0.0 0.0 NDFIP1 "MGC10924, N4WBP5" ENSG00000131507 "Nedd4 family interacting protein 1" Q9BT67 5 142108779-142154440 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Theca cells: 678.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA009682 Approved "Intracellular and membrane" NA NA "Cluster 32: T-cells - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 25: RPMI-8226 - Immune response" "Cluster 40: Granulosa cells - Unknown function" "HPA009682: AB_1079455" "unprognostic (2.78e-2)" "unprognostic (1.62e-1)" "unprognostic (9.26e-2)" "unprognostic (5.66e-3)" "unprognostic (4.74e-2)" "prognostic unfavorable (2.33e-7)" "unprognostic (6.95e-2)" "unprognostic (4.96e-2)" "unprognostic (5.97e-2)" "unprognostic (1.74e-2)" "unprognostic (3.28e-1)" "unprognostic (4.46e-2)" "prognostic favorable (2.39e-7)" "unprognostic (9.18e-2)" "unprognostic (2.06e-1)" "unprognostic (6.23e-2)" "unprognostic (8.76e-2)" 62.1 81.6 87.4 33.8 93.8 26.2 56.3 63.1 100.7 54.7 70.8 40.3 49.3 45.2 135.9 30.2 46.4 45.4 55.1 94.2 96.8 94.8 120.2 49.7 39.0 70.7 73.6 61.5 64.5 152.6 51.7 45.2 77.2 67.7 38.4 164.1 99.5 63.5 45.7 26.6 47.6 40.9 75.3 56.4 50.4 40.8 90.8 41.9 103.4 40.9 34.8 48.3 31.1 73.9 53.3 35.2 61.8 83.6 128.2 72.5 41.4 56.6 59.1 48.0 54.6 39.5 87.3 4.8 115.0 62.2 66.4 51.9 39.6 59.6 56.2 61.2 48.8 69.2 30.8 28.7 55.8 38.3 23.9 55.8 55.3 33.8 43.6 68.4 55.9 54.0 23.4 83.3 60.1 27.4 42.9 12.0 33.2 52.0 33.4 16.1 34.2 122.1 119.1 56.0 65.0 67.3 61.9 91.7 88.3 46.0 64.7 37.6 64.5 58.7 22.1 48.0 56.8 53.6 65.8 22.0 62.1 24.9 45.6 70.4 32.1 26.4 22.9 39.9 29.2 12.8 40.6 28.2 37.0 10.4 80.9 63.9 19.5 23.5 40.1 11.2 50.6 62.4 87.4 93.8 63.1 100.7 94.2 96.8 70.7 73.6 77.2 75.3 90.8 73.9 100.3 57.7 62.6 74.7 76.4 111.5 176.4 133.4 82.0 196.4 134.3 68.5 70.0 143.0 101.4 154.5 141.8 146.9 94.0 98.0 140.8 207.4 20.2 69.5 91.5 103.7 137.6 184.9 189.5 145.3 263.8 164.1 62.7 118.2 60.2 365.2 116.0 169.8 154.1 318.0 184.9 81.9 177.0 205.9 154.9 15.4 116.5 137.0 170.7 69.3 176.1 300.6 87.6 114.1 125.4 179.8 100.5 156.9 107.6 262.6 198.5 173.0 67.7 322.9 131.5 74.3 149.3 26.6 33.2 71.1 101.3 191.5 156.4 678.1 83.3 256.2 NDP "EVR2, norrin" ENSG00000124479 "Norrin cystine knot growth factor NDP" Q00604 X 43948776-43973395 "Disease related genes, Human disease related genes, Predicted secreted proteins" "Sensory transduction, Vision, Wnt signaling pathway" "Deafness, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 35.8;ovary: 46.2" "Group enriched" "Detected in some" 4 "Granulosa cells: 181.3;Muller glia cells: 105.5" "Cancer enriched" "Detected in many" 5 "glioma: 25.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 16 "U-87 MG: 72.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003095 Supported Nucleoplasm,Nucleoli,Vesicles "Secreted to extracellular matrix" NA NA "Cluster 32: T-cells - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 40: Granulosa cells - Unknown function" Vesicles "Nucleoplasm, Nucleoli" "HPA003095: AB_1079457" "unprognostic (1.12e-1)" "unprognostic (7.12e-2)" "unprognostic (2.27e-2)" "unprognostic (2.55e-3)" "unprognostic (6.84e-3)" "unprognostic (1.51e-1)" "unprognostic (9.09e-2)" "unprognostic (2.29e-1)" "unprognostic (1.22e-1)" "unprognostic (1.86e-1)" "unprognostic (1.40e-1)" "unprognostic (3.02e-2)" "unprognostic (2.22e-2)" "unprognostic (1.47e-1)" "unprognostic (1.13e-1)" "unprognostic (2.87e-3)" 0.5 0.0 31.5 0.0 33.4 0.0 3.3 30.9 35.8 20.9 22.4 0.2 0.1 15.4 22.0 0.0 20.8 0.4 0.3 31.5 29.6 0.1 0.0 0.0 0.2 30.1 33.2 46.2 0.0 0.2 0.1 4.0 31.6 7.1 0.2 19.2 0.1 13.1 0.0 0.6 0.2 11.4 32.4 0.1 0.3 1.0 34.2 0.0 0.2 0.0 0.2 0.5 2.3 32.4 0.0 0.0 0.2 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.0 1.5 0.0 0.0 0.1 1.9 0.0 0.0 0.0 1.8 0.0 4.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.2 0.0 0.0 2.2 0.0 0.0 0.0 72.9 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.5 33.4 30.9 35.8 31.5 29.6 30.1 33.2 31.6 32.4 34.2 32.4 0.0 0.0 0.0 29.0 0.0 0.1 0.0 1.2 0.0 0.6 1.3 0.1 0.3 0.0 0.5 0.0 0.0 0.1 0.1 0.0 0.0 2.0 0.0 9.1 17.7 0.2 0.0 0.0 4.2 0.0 0.3 0.9 0.0 17.0 0.0 181.3 0.0 0.0 0.1 0.0 0.8 0.0 2.0 0.0 0.0 0.7 13.4 0.6 0.0 0.0 0.0 105.5 0.0 1.5 9.5 1.2 0.0 9.8 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 5.4 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.2 NFXL1 HOZFP ENSG00000170448 "Nuclear transcription factor, X-box binding like 1" Q6ZNB6 4 47847233-47914667 "Predicted membrane proteins, Transcription factors" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 213.2;Spermatocytes: 81.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059132 Approved Approved Nucleoplasm NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 68: Epididymis - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 54: Cardiomyocytes - Muscle contraction" Nucleoplasm "HPA059132: AB_2683917" "unprognostic (5.37e-2)" "unprognostic (2.89e-1)" "unprognostic (5.14e-3)" "unprognostic (6.13e-2)" "unprognostic (1.81e-2)" "unprognostic (4.33e-2)" "prognostic unfavorable (9.28e-4)" "unprognostic (1.13e-2)" "unprognostic (6.26e-3)" "unprognostic (8.48e-3)" "unprognostic (8.34e-2)" "unprognostic (4.47e-2)" "unprognostic (4.72e-3)" "unprognostic (8.89e-2)" "unprognostic (3.15e-1)" "unprognostic (6.67e-2)" "unprognostic (8.01e-2)" 3.0 2.2 1.6 4.4 1.8 4.2 6.4 3.2 1.9 5.4 1.1 3.7 4.6 5.3 10.9 3.8 5.4 3.3 1.8 1.3 1.6 4.1 3.9 3.0 4.1 1.9 1.9 6.1 4.6 6.6 3.2 3.8 1.9 5.0 4.8 3.7 5.2 4.4 2.7 3.9 3.9 5.0 2.0 3.7 4.8 13.7 2.3 4.3 10.1 2.8 4.6 4.3 3.6 1.8 7.0 4.4 4.8 9.9 8.9 14.6 16.2 4.7 6.7 7.6 9.3 7.4 15.6 5.5 8.8 3.1 14.6 7.1 12.4 9.4 8.9 4.3 4.8 6.0 8.7 13.6 11.5 14.8 11.5 9.6 12.3 5.2 30.7 8.9 6.6 11.5 10.8 6.7 7.8 7.0 11.7 6.9 11.6 9.7 6.7 10.3 9.2 9.3 9.6 13.2 15.1 7.3 3.5 9.8 6.8 9.1 6.8 4.2 5.5 9.8 6.2 4.6 10.6 10.8 7.0 11.2 5.7 8.2 8.8 0.0 0.5 0.6 0.7 0.7 0.9 0.8 1.0 0.8 0.5 0.8 1.1 1.0 1.9 0.4 0.4 0.6 0.7 0.6 1.6 1.8 3.2 1.9 1.3 1.6 1.9 1.9 1.9 2.0 2.3 1.8 6.9 6.4 8.7 15.0 6.3 5.4 4.0 5.2 7.4 19.6 10.0 7.0 213.2 11.5 9.9 7.3 10.4 5.6 10.5 6.2 11.7 9.2 36.9 15.7 16.7 7.8 11.4 6.9 35.6 7.1 11.5 27.3 7.1 18.4 2.5 10.9 7.9 7.5 4.8 8.4 35.0 11.2 12.2 6.5 4.3 20.2 12.8 9.9 1.8 17.8 7.3 11.0 8.2 33.7 30.7 7.4 4.7 10.1 13.8 7.0 6.5 4.2 9.9 16.5 0.0 8.1 9.1 81.1 27.2 9.9 4.3 6.7 6.8 5.5 8.1 5.2 NLGN3 "ASPGX1, AUTSX1, HNL3, KIAA1480" ENSG00000196338 "Neuroligin 3" Q9NZ94 X 71144831-71171201 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Asperger syndrome, Autism, Autism spectrum disorder, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 11.1;seminal vesicle: 12.5" "Cell type enhanced" "Detected in some" "Astrocytes: 19.6;Inhibitory neurons: 12.7;Oligodendrocyte precursor cells: 92.0;Oligodendrocytes: 43.7;Peritubular cells: 17.3" "Cancer enriched" "Detected in many" 19 "glioma: 37.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 6.7;NTERA-2: 5.3;SH-SY5Y: 2.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003183, HPA004066" Enhanced Supported "Golgi apparatus,Cell Junctions" "Intracellular and membrane" NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 12: NES - Nervous system development" "Cluster 68: Oligodendrocytes - Mixed function" "Golgi apparatus, Cell Junctions" "HPA003183: AB_1079469, HPA004066: AB_2732397" "unprognostic (4.06e-2)" "unprognostic (1.77e-1)" "unprognostic (1.59e-2)" "unprognostic (2.38e-2)" "unprognostic (2.42e-1)" "unprognostic (3.87e-1)" "unprognostic (6.52e-2)" "unprognostic (1.63e-1)" "unprognostic (7.10e-2)" "unprognostic (1.17e-1)" "unprognostic (1.94e-1)" "unprognostic (6.18e-2)" "unprognostic (4.27e-9)" "unprognostic (4.28e-2)" "unprognostic (1.90e-1)" "unprognostic (2.22e-5)" "unprognostic (9.01e-2)" 0.5 6.6 10.1 0.8 8.5 1.4 0.4 6.4 11.1 1.9 0.0 1.8 0.2 2.7 6.4 0.6 4.3 1.4 1.1 10.3 10.2 0.3 0.1 0.6 0.4 7.3 7.0 4.4 0.3 0.5 1.0 0.6 4.8 6.0 0.5 1.9 0.6 12.5 0.1 0.7 0.7 1.9 5.5 0.6 0.6 2.6 7.3 0.4 0.4 0.4 0.2 0.7 1.2 9.7 0.0 0.5 6.7 0.2 1.6 0.6 1.2 0.0 0.0 0.0 0.1 0.1 0.3 0.5 0.5 0.1 0.0 0.1 0.2 0.0 0.1 0.4 0.9 0.4 0.4 0.0 0.0 0.1 0.4 0.4 0.1 0.2 0.0 0.3 0.1 2.0 0.5 1.5 0.0 0.3 0.5 1.2 5.3 0.0 0.0 0.6 0.2 0.3 0.0 0.8 1.7 2.5 0.2 0.0 0.6 0.8 0.0 0.3 0.1 0.1 0.8 0.2 0.0 1.1 1.1 0.5 0.1 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 10.1 8.5 6.4 11.1 10.3 10.2 7.3 7.0 4.8 5.5 7.3 9.7 0.3 0.0 0.0 19.6 0.0 0.6 0.3 0.2 1.2 2.6 0.3 0.9 0.4 0.0 0.1 0.0 0.0 1.0 0.2 0.2 0.0 0.1 1.3 0.2 1.1 0.5 0.0 0.0 11.3 0.0 0.2 1.3 0.0 0.4 0.0 1.0 0.7 0.0 0.1 0.0 12.7 0.0 0.0 0.0 0.8 3.9 2.1 0.2 0.0 2.8 0.1 2.5 0.0 92.0 43.7 0.2 0.1 17.3 0.0 0.2 0.0 0.0 0.0 0.7 0.0 0.2 0.6 0.2 0.0 0.1 0.4 0.3 0.2 4.5 0.1 0.3 NLGN4Y KIAA0951 ENSG00000165246 "Neuroligin 4 Y-linked" Q8NFZ3 Y 14522573-14845650 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "prostate: 6.3;seminal vesicle: 7.5" "Cell type enhanced" "Detected in many" "Astrocytes: 48.0;Basal squamous epithelial cells: 45.5;Excitatory neurons: 146.1;Inhibitory neurons: 108.0;Oligodendrocyte precursor cells: 220.7;Oligodendrocytes: 46.7" "Cancer enhanced" "Detected in many" "glioma: 2.2" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ hTERT+: 32.1;fHDF/TERT166: 25.3;HDLM-2: 30.2;hTCEpi: 21.1;SuSa: 19.9;U-138 MG: 23.1" HPA001651 Approved "Intracellular and membrane" NA NA "Cluster 43: B-cells - Humoral immune response" "Cluster 68: Epididymis - Unknown function" "Cluster 44: HDLM-2 - Immune response" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "HPA001651: AB_1079470" "unprognostic (2.31e-1)" "unprognostic (9.19e-2)" "unprognostic (2.84e-5)" "unprognostic (7.85e-2)" "unprognostic (6.46e-2)" "unprognostic (8.80e-3)" "unprognostic (7.71e-2)" "unprognostic (6.26e-2)" "unprognostic (5.89e-2)" "unprognostic (7.20e-3)" "unprognostic (1.88e-1)" "unprognostic (5.65e-2)" 1.2 1.3 1.3 0.5 1.5 0.0 1.1 1.7 4.1 0.0 0.3 2.0 0.4 0.0 1.8 2.0 0.0 2.4 0.5 2.1 1.6 1.3 2.1 0.6 0.4 0.8 0.6 0.0 1.6 1.7 2.1 0.3 0.8 6.3 1.4 1.3 1.8 7.5 0.3 1.1 0.9 0.0 0.9 0.4 0.9 0.5 0.5 0.1 1.1 2.2 1.1 3.4 0.0 2.5 0.0 1.3 0.0 0.0 0.0 0.0 0.0 7.1 32.1 2.0 2.6 0.0 0.0 0.0 0.0 25.3 0.0 0.0 0.0 0.0 5.0 30.2 0.0 0.0 0.0 4.9 3.3 0.1 0.0 10.7 21.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 2.2 0.0 6.4 0.1 0.0 0.0 2.0 0.0 7.5 12.4 4.2 0.0 0.0 0.0 0.1 19.9 0.0 0.7 9.3 23.1 0.0 0.0 5.3 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.3 1.5 1.7 4.1 2.1 1.6 0.8 0.6 0.8 0.9 0.5 2.5 0.0 0.0 1.3 48.0 1.1 3.4 10.8 12.0 45.5 9.0 0.0 0.0 1.0 5.7 6.4 7.3 0.0 0.3 0.0 0.0 0.0 2.6 0.1 0.0 0.0 3.0 0.0 0.0 146.1 0.0 0.2 8.6 2.0 0.0 0.0 0.0 0.0 0.6 0.2 6.7 108.0 0.0 4.1 0.0 5.1 0.2 2.8 0.1 1.8 29.0 2.6 4.3 0.0 220.7 46.7 0.0 0.0 8.2 0.4 14.1 0.0 0.8 3.3 0.7 0.0 4.7 1.1 0.4 0.8 12.3 3.1 0.3 0.9 0.0 0.2 11.8 NLRP11 "CLR19.6, NALP11, NOD17, PAN10, PYPAF6" ENSG00000179873 "NLR family pyrin domain containing 11" P59045 19 55785397-55836800 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 1.1;liver: 1.0" "Group enriched" "Detected in some" 5 "Early spermatids: 13.0;Late spermatids: 5.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 115.6;RPMI-8226: 66.1;U-266/70: 110.2;U-266/84: 51.2;U-698: 83.9" "Not detected" "Not detected" "HPA046402, HPA078027" Uncertain Supported Cytosol NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 34: Spermatids - Unknown function" Cytosol "HPA046402: AB_10962951, HPA078027: AB_2732369" "unprognostic (2.36e-2)" "unprognostic (3.59e-1)" "unprognostic (1.09e-1)" "unprognostic (4.36e-3)" "unprognostic (3.31e-2)" "unprognostic (7.88e-2)" "unprognostic (9.95e-3)" "unprognostic (8.04e-2)" "unprognostic (1.94e-1)" "unprognostic (2.52e-1)" "unprognostic (3.75e-2)" "unprognostic (3.14e-2)" "unprognostic (1.10e-2)" "unprognostic (2.06e-1)" "unprognostic (2.89e-2)" "unprognostic (1.76e-2)" "unprognostic (7.61e-2)" 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 1.0 0.0 0.2 0.0 0.0 0.3 0.1 0.2 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.8 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 115.6 0.0 0.0 1.4 0.0 0.5 0.0 0.0 0.0 3.2 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 24.0 0.0 0.0 0.4 0.7 0.1 0.0 0.4 0.0 2.0 66.1 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.6 0.1 1.8 1.9 0.1 0.1 110.2 51.2 83.9 2.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 13.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.3 0.3 5.1 0.3 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.8 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 NR2F1 "COUP-TFI, COUPTF1, EAR-3, ERBAL3, SVP44, TCFCOUP1, TFCOUP1" ENSG00000175745 "Nuclear receptor subfamily 2 group F member 1" P10589 5 93583222-93594611 "Disease related genes, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Receptor, Repressor" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 294.1;Hepatic stellate cells: 171.4;Leydig cells: 93.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 232.4;AN3-CA: 92.9;HHSteC: 174.1;hTERT-RPE1: 155.1;PC-3: 194.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB019281, HPA058974" Approved Nucleoplasm,Cytosol NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 12: NES - Nervous system development" "Cluster 36: Stromal cells - Cell proliferation" Nucleoplasm Cytosol "CAB019281: , HPA058974: AB_2732629" "unprognostic (8.07e-2)" "unprognostic (1.06e-2)" "unprognostic (3.86e-2)" "unprognostic (2.26e-1)" "unprognostic (4.75e-1)" "unprognostic (7.68e-3)" "unprognostic (3.18e-3)" "unprognostic (3.07e-2)" "unprognostic (2.21e-1)" "unprognostic (2.71e-3)" "unprognostic (5.24e-3)" "unprognostic (2.37e-1)" "prognostic unfavorable (3.47e-4)" "unprognostic (1.32e-2)" "unprognostic (1.61e-1)" "unprognostic (9.28e-2)" "prognostic unfavorable (1.47e-4)" 42.2 40.3 41.8 5.0 39.0 0.2 20.4 32.9 50.7 65.1 12.8 11.3 2.6 29.4 25.2 10.4 77.9 34.3 16.1 44.7 25.6 32.8 13.0 44.4 8.3 31.6 41.1 62.7 7.6 1.6 21.6 52.6 23.8 44.9 3.0 8.7 6.9 40.3 0.3 2.0 7.4 11.8 31.5 7.2 28.8 3.8 42.4 2.1 16.9 3.6 3.8 49.1 40.6 30.8 20.1 9.5 232.4 92.9 48.3 14.8 11.0 11.6 4.7 6.9 7.1 1.3 3.6 0.1 0.7 4.7 2.8 5.0 5.7 0.4 3.0 24.7 45.2 9.2 61.9 15.1 174.1 1.9 0.9 69.7 0.1 3.3 1.3 155.1 26.3 0.1 0.1 0.1 21.4 0.1 0.0 2.7 0.1 1.4 194.2 2.8 1.9 0.1 1.4 0.8 23.9 48.4 5.2 0.0 0.6 4.0 1.9 3.7 26.7 39.3 1.8 20.6 29.4 0.0 0.0 0.1 64.2 0.8 17.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 41.8 39.0 32.9 50.7 44.7 25.6 31.6 41.1 23.8 31.5 42.4 30.8 16.1 0.0 1.7 68.2 1.5 1.3 0.2 0.4 1.8 32.8 3.8 2.4 37.3 1.5 3.5 14.7 54.2 0.6 0.0 0.2 7.9 4.0 3.8 10.1 294.1 70.1 0.0 0.0 23.3 1.6 0.6 69.1 0.5 5.7 0.0 29.7 171.4 5.0 1.3 0.0 47.1 0.0 0.0 15.8 0.4 5.9 93.5 1.9 0.0 59.0 0.0 69.0 0.0 13.0 1.7 3.6 0.0 10.5 0.0 0.5 0.1 37.3 10.8 3.7 13.1 2.9 51.6 4.8 4.4 2.8 0.6 1.1 2.2 11.8 0.0 0.6 NUDT10 "DIPP3a, hDIPP3alpha" ENSG00000122824 "Nudix hydrolase 10" Q8NFP7 X 51332231-51337525 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 26.3" "Group enriched" "Detected in many" 5 "Hepatic stellate cells: 60.3;Peritubular cells: 29.0" "Group enriched" "Detected in many" 6 "glioma: 5.0;prostate cancer: 5.4;testis cancer: 7.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 7.5;HAP1: 14.2;HEK 293: 10.5;NTERA-2: 25.8;SH-SY5Y: 5.6;U-2 OS: 12.7" "HPA047027, HPA057684" Approved Approved Cytosol NA NA "Cluster 22: NK-cells - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 5: NTERA-2 - Transcription" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" Cytosol "HPA047027: AB_2679907, HPA057684: AB_2683501" "unprognostic (2.61e-2)" "unprognostic (1.12e-2)" "unprognostic (7.40e-3)" "unprognostic (7.84e-2)" "unprognostic (1.82e-1)" "unprognostic (2.51e-2)" "unprognostic (1.16e-1)" "unprognostic (2.06e-1)" "unprognostic (2.54e-2)" "unprognostic (1.11e-1)" "unprognostic (2.49e-2)" "unprognostic (1.27e-1)" "unprognostic (1.51e-3)" "unprognostic (1.80e-3)" "unprognostic (1.04e-2)" "unprognostic (1.12e-2)" "unprognostic (5.04e-5)" 0.6 1.6 11.2 0.8 9.8 1.5 0.8 3.8 9.8 6.2 2.3 3.1 0.5 5.3 16.1 1.0 3.6 1.4 1.0 9.2 10.0 3.9 1.3 0.3 0.3 5.0 7.1 16.9 0.3 0.0 2.1 0.0 7.1 14.9 0.7 1.5 0.5 14.6 0.1 0.4 1.0 4.1 4.1 3.4 1.2 26.3 11.9 0.4 0.6 0.2 0.3 3.9 3.6 9.3 0.0 0.0 7.5 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 1.2 0.0 14.2 0.6 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 25.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 12.7 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 11.2 9.8 3.8 9.8 9.2 10.0 5.0 7.1 7.1 4.1 11.9 9.3 0.2 0.0 1.3 0.7 0.2 1.0 4.9 0.6 1.8 0.5 0.1 1.5 0.2 0.0 0.6 0.0 0.0 0.7 0.4 0.0 0.0 0.0 1.5 0.7 3.5 2.5 0.0 0.8 5.0 0.0 1.0 3.1 0.0 0.1 0.0 5.0 60.3 0.3 0.2 0.0 1.9 0.0 0.0 1.9 0.4 6.2 5.9 0.1 1.8 1.0 0.0 1.7 0.0 3.5 0.6 0.0 0.0 29.0 1.4 2.8 0.0 0.1 0.0 0.5 0.0 1.5 1.9 3.8 7.8 0.4 0.1 0.4 0.2 0.9 0.0 0.2 NXF2 "CT39, TAPL-2" ENSG00000269405 "Nuclear RNA export factor 2" Q9GZY0 X 102247167-102326722 "Predicted intracellular proteins" "mRNA transport, Transport" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "epididymis: 15.3;testis: 12.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 59 "U-266/84: 35.6" HPA002079 Uncertain NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 16: U-266 - Nucleosome" "HPA002079: AB_1079515" 0.0 0.1 0.2 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 15.3 0.0 0.9 0.0 0.0 0.1 0.6 0.0 0.0 0.2 0.0 0.4 0.3 0.0 0.0 0.0 3.3 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 12.8 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 35.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.2 0.1 0.6 0.4 0.3 0.3 0.2 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NXF2B bA353J17.1 ENSG00000269437 "Nuclear RNA export factor 2B" Q9GZY0 X 102360396-102439932 "Predicted intracellular proteins" "mRNA transport, Transport" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "epididymis: 15.3;testis: 7.1" "Cell type enhanced" "Detected in some" "Late spermatids: 1.8;Respiratory ciliated cells: 1.2;Spermatocytes: 2.1;Spermatogonia: 4.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 59 "U-266/84: 35.6" HPA002079 Uncertain NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 16: U-266 - Nucleosome" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" "HPA002079: AB_1079515" 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.2 0.0 0.0 0.0 15.3 0.0 0.9 0.0 0.0 0.1 0.4 0.0 0.0 0.3 0.0 0.2 0.3 0.0 0.1 0.0 2.4 0.0 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 7.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 35.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.1 0.1 0.4 0.2 0.3 0.2 0.2 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 2.1 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NYNRIN "CGIN1, FLJ11811, KIAA1305" ENSG00000205978 "NYN domain and retroviral integrase containing" Q9P2P1 14 24399003-24419283 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Hepatic stellate cells: 18.2;Squamous epithelial cells: 18.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CAPAN-2: 14.4;HEL: 14.7;HUVEC TERT2: 35.6;RT4: 29.8;TIME: 17.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018945 Approved Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Golgi apparatus" "Nucleoplasm, Vesicles" "HPA018945: AB_1859538" "unprognostic (9.41e-3)" "unprognostic (3.96e-2)" "unprognostic (2.02e-1)" "unprognostic (4.49e-3)" "unprognostic (5.08e-2)" "unprognostic (1.14e-2)" "unprognostic (2.56e-1)" "unprognostic (2.65e-2)" "unprognostic (1.44e-3)" "unprognostic (4.21e-1)" "unprognostic (1.01e-1)" "unprognostic (4.51e-2)" "unprognostic (3.59e-2)" "unprognostic (2.39e-2)" "unprognostic (1.86e-1)" "unprognostic (3.39e-1)" "unprognostic (2.43e-1)" 8.7 3.7 4.3 3.1 3.9 0.4 6.3 16.3 4.6 16.8 5.4 7.6 4.0 11.5 28.0 11.6 16.9 8.6 7.5 3.2 6.6 6.3 4.5 8.1 1.9 5.8 5.4 35.1 3.8 5.8 5.8 12.8 6.3 7.5 5.5 1.8 7.4 14.9 3.8 13.3 5.3 10.5 3.2 4.4 6.0 5.1 7.8 4.5 7.8 4.2 2.9 9.5 14.0 2.8 0.2 0.1 4.6 0.0 6.3 13.0 0.3 2.2 2.3 1.5 1.6 3.3 14.4 0.4 0.6 8.6 0.2 0.0 7.5 0.2 1.5 0.0 0.8 14.7 2.0 0.3 4.7 0.0 0.0 13.3 0.6 1.0 0.0 2.6 35.6 0.1 2.4 0.0 0.2 0.6 0.0 0.8 2.7 1.0 0.0 1.9 0.0 0.0 0.0 29.8 0.6 10.0 0.0 1.3 0.2 11.2 2.5 2.1 17.4 0.1 8.2 0.0 0.0 0.0 0.4 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 4.3 3.9 16.3 4.6 3.2 6.6 5.8 5.4 6.3 3.2 7.8 2.8 15.2 3.2 1.7 4.9 0.1 4.6 3.9 9.5 15.4 0.5 1.8 3.6 3.1 8.6 15.6 9.2 0.0 1.1 1.6 2.7 0.0 4.1 0.8 1.4 10.8 15.0 5.4 3.6 1.0 3.0 1.0 10.1 10.7 1.7 0.0 12.0 18.2 2.7 10.7 0.0 3.9 9.0 4.1 9.0 1.4 0.2 2.5 1.4 3.6 3.7 0.7 5.4 0.0 0.5 0.1 4.8 5.1 0.4 1.2 1.2 1.0 0.3 10.8 0.2 0.0 1.2 7.3 0.3 1.2 18.0 3.8 1.1 0.3 1.5 8.8 4.5 OR2H2 hs6M1-12 ENSG00000204657 "Olfactory receptor family 2 subfamily H member 2" O95918 6 29585121-29590500 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 1.8;epididymis: 4.8;testis: 2.2" "Cell type enriched" "Detected in some" 5 "Early spermatids: 15.2" "Not detected" "Not detected" "Region enhanced" "Detected in single" "basal ganglia: 1.8" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 29: Early spermatids - Spermatogenesis" "unprognostic (2.95e-1)" "unprognostic (3.76e-1)" "unprognostic (2.33e-2)" "unprognostic (2.42e-1)" "unprognostic (2.34e-1)" "unprognostic (3.11e-1)" "unprognostic (2.76e-1)" "unprognostic (3.20e-1)" "unprognostic (1.34e-1)" "unprognostic (2.04e-1)" 0.1 0.0 0.5 0.1 1.8 0.7 0.0 0.8 0.6 0.3 0.0 0.1 0.0 0.1 4.8 0.1 0.2 0.0 0.3 0.5 0.0 0.0 0.0 0.1 0.2 0.0 0.2 0.3 0.0 0.0 0.5 0.0 0.0 0.3 0.0 1.5 0.0 0.3 0.0 0.1 0.1 0.0 0.0 0.1 0.1 2.2 0.2 0.0 0.1 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.8 0.8 0.6 0.5 0.0 0.0 0.2 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ORC5 "ORC5L, Orc5p, ORC5T, PPP1R117" ENSG00000164815 "Origin recognition complex subunit 5" O43913 7 104126341-104208047 "Predicted intracellular proteins" "DNA replication" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 54.4;Inhibitory neurons: 48.8;Oligodendrocytes: 55.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019730 Approved Supported Nucleoplasm,Cytosol NA NA "Cluster 44: Non-specific - Transcription" "Cluster 68: Epididymis - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 59: Non-specific - Transcription" Nucleoplasm Cytosol "HPA019730: AB_10696205" "unprognostic (1.82e-1)" "unprognostic (1.49e-1)" "unprognostic (6.72e-2)" "unprognostic (4.77e-2)" "unprognostic (7.42e-2)" "unprognostic (3.11e-2)" "unprognostic (2.53e-3)" "unprognostic (3.47e-2)" "unprognostic (9.26e-2)" "unprognostic (2.33e-1)" "unprognostic (1.77e-1)" "unprognostic (2.00e-2)" "unprognostic (3.83e-2)" "unprognostic (6.52e-2)" "unprognostic (9.71e-2)" "unprognostic (2.53e-2)" "unprognostic (7.73e-2)" 9.7 9.8 10.5 7.8 11.5 5.8 13.2 14.3 12.5 10.2 7.8 12.0 8.4 10.8 13.7 10.6 8.9 6.6 6.3 11.2 10.5 10.4 17.4 6.4 12.2 10.3 10.0 10.7 14.5 10.1 7.5 9.5 9.7 16.9 12.8 14.1 8.9 10.6 9.0 11.6 7.5 10.9 9.3 9.0 10.3 19.3 11.6 13.3 10.2 7.9 13.4 11.0 10.0 11.2 37.1 39.2 21.2 38.1 21.8 21.5 18.8 31.0 30.8 34.2 28.5 25.9 23.7 55.4 26.9 19.5 37.9 33.1 42.4 29.9 40.8 32.3 30.5 20.2 19.1 24.8 30.8 37.9 16.5 22.3 27.9 39.4 36.2 14.4 32.8 30.1 65.0 29.3 30.8 52.6 52.4 38.7 23.2 48.6 37.9 21.6 38.0 53.4 26.4 26.4 28.9 23.5 30.2 58.7 41.3 16.5 19.7 28.4 19.2 32.8 36.0 51.8 41.6 33.7 75.8 69.3 22.2 49.7 39.8 14.2 10.6 8.4 20.2 12.7 26.5 24.0 21.6 23.9 12.3 18.7 25.7 28.9 1.4 20.6 10.9 11.4 18.4 13.7 10.5 11.5 14.3 12.5 11.2 10.5 10.3 10.0 9.7 9.3 11.6 11.2 6.7 3.2 7.2 22.2 11.2 4.5 3.6 11.4 10.8 6.6 6.6 5.7 6.2 8.6 9.8 3.7 0.0 22.1 2.6 4.4 1.9 10.3 5.7 3.8 9.8 9.1 5.4 12.8 54.4 9.0 14.3 8.6 9.7 4.5 5.1 11.6 4.6 9.7 8.8 3.3 48.8 8.9 6.1 4.8 4.2 5.7 6.2 6.0 1.8 35.6 7.8 3.4 7.2 31.2 55.9 7.4 5.4 7.9 13.9 4.9 5.9 7.2 12.9 12.5 0.0 4.1 10.9 40.1 24.6 12.6 8.5 10.5 9.5 10.3 8.1 2.0 OSTN ENSG00000188729 Osteocrin P61366 3 191199241-191265615 "Predicted secreted proteins" Differentiation "Developmental protein, Hormone" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in some" "Cell type enhanced" "Detected in some" "Early spermatids: 4.2;Excitatory neurons: 1.0;Inhibitory neurons: 5.9;Late spermatids: 1.4;Oligodendrocyte precursor cells: 2.5" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 6 "memory B-cell: 4.0;naive B-cell: 1.3" "Lineage enriched" "Detected in single" 9 "B-cells: 4.0" "Cell line enriched" "Detected in some" 24 "U-2197: 39.1" "Region enriched" "Detected in single" 4 "cerebellum: 1.0" "Low region specificity" "Detected in single" "CAB024997, CAB025649, HPA030878" Uncertain "Secreted in other tissues" NA NA "Cluster 19: B-cells - Humoral immune response" "Cluster 68: Epididymis - Unknown function" "Cluster 18: U-2197 - ECM organization" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "CAB024997: , CAB025649: , HPA030878: AB_2673642" "unprognostic (2.35e-2)" "unprognostic (9.12e-2)" "unprognostic (6.30e-2)" "unprognostic (2.34e-1)" "unprognostic (2.51e-1)" "unprognostic (3.01e-2)" "unprognostic (2.52e-1)" "unprognostic (8.11e-3)" "unprognostic (2.90e-1)" "unprognostic (1.45e-1)" 0.3 0.1 0.6 0.7 0.9 0.0 0.1 0.1 1.2 1.2 0.2 0.1 0.0 0.1 1.6 0.0 0.7 0.8 0.4 0.8 0.8 0.1 0.6 0.2 0.6 0.5 0.2 0.2 0.0 0.0 0.0 0.4 0.5 0.6 0.0 0.1 0.2 0.1 0.8 1.2 0.1 0.0 0.4 0.2 0.3 0.4 0.3 0.1 0.1 1.0 0.0 1.3 0.2 0.5 0.0 0.0 0.1 0.0 0.0 0.4 0.1 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39.1 0.0 1.6 0.0 0.2 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.6 0.9 0.1 1.2 0.8 0.8 0.5 0.2 0.5 0.4 0.3 0.5 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.1 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.3 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 5.9 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OVCH2 OVTN ENSG00000183378 "Ovochymase 2" 11 7689437-7706421 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 15 "epididymis: 189.0;retina: 92.2" "Group enriched" "Detected in some" 7 "Collecting duct cells: 7.3;Rod photoreceptor cells: 16.6" "Cancer enhanced" "Detected in single" "urothelial cancer: 0.5" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "REH: 25.2" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in male reproductive system" NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 14: REH - Unknown function" "Cluster 46: Photoreceptor cells - Phototransduction" "unprognostic (1.59e-2)" "unprognostic (3.74e-1)" "unprognostic (8.03e-2)" "unprognostic (9.77e-2)" "unprognostic (1.85e-1)" "unprognostic (1.70e-2)" "unprognostic (2.02e-1)" "unprognostic (1.13e-1)" "unprognostic (1.28e-1)" "unprognostic (2.84e-2)" "unprognostic (3.06e-1)" "unprognostic (9.27e-2)" "unprognostic (7.65e-2)" "unprognostic (1.22e-2)" 0.0 0.0 0.1 0.0 0.3 0.4 3.4 0.8 0.2 0.1 0.1 0.0 0.0 0.2 189.0 0.1 0.3 0.0 0.0 0.0 0.1 5.3 0.0 2.4 0.0 0.7 0.4 0.0 0.0 0.0 0.0 1.4 1.0 1.1 0.0 92.2 0.8 5.8 0.4 9.1 0.1 0.0 0.1 0.0 0.5 0.5 0.8 0.0 0.0 0.0 0.1 0.9 0.2 0.7 3.4 0.0 0.3 0.0 0.0 0.0 0.5 0.8 0.6 0.1 0.3 0.2 0.0 0.1 0.2 0.0 0.1 0.1 0.0 0.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.9 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 25.2 0.0 0.2 0.2 2.7 0.0 0.2 0.0 0.1 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.8 0.2 0.0 0.1 0.7 0.4 1.0 0.1 0.8 0.7 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.4 0.1 1.3 0.1 0.0 0.0 7.3 0.0 1.4 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.0 0.0 0.7 0.0 0.1 0.0 0.7 0.0 16.6 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.4 P2RX2 "DFNA41, P2X2" ENSG00000187848 "Purinergic receptor P2X 2" Q9UBL9 12 132618776-132622388 "Disease related genes, Human disease related genes, Predicted membrane proteins" "Hearing, Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Deafness, Disease variant, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 11.3;epididymis: 21.8;prostate: 14.1" "Cell type enhanced" "Detected in some" "Breast glandular cells: 1.6;Endometrial ciliated cells: 2.6;Fibroblasts: 8.3;Gastric mucus-secreting cells: 1.1;Peritubular cells: 3.0" "Cancer enhanced" "Detected in some" "testis cancer: 1.3" "Group enriched" "Detected in many" 7 "amygdala: 9.2;cerebral cortex: 11.3;hippocampal formation: 10.1" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "MCF7: 5.1;T-47d: 11.2" "Not detected" "Not detected" "Low region specificity" "Detected in some" NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 6: T47d - Mammary gland" "Cluster 50: Fibroblasts - ECM organization" "unprognostic (1.12e-1)" "unprognostic (1.49e-2)" "unprognostic (5.92e-2)" "unprognostic (5.94e-2)" "unprognostic (2.79e-1)" "unprognostic (1.07e-1)" "unprognostic (3.12e-1)" "unprognostic (5.79e-3)" "unprognostic (6.75e-2)" "unprognostic (2.92e-1)" "unprognostic (1.11e-2)" "unprognostic (3.66e-2)" "unprognostic (1.88e-2)" "unprognostic (6.21e-2)" "unprognostic (3.05e-1)" "unprognostic (9.12e-2)" 1.1 0.1 9.2 0.6 0.4 0.1 0.2 0.3 11.3 0.7 0.0 2.4 1.1 0.2 21.8 7.2 9.3 0.1 0.0 10.1 1.5 2.5 0.4 4.9 1.9 0.1 0.2 0.3 0.5 0.7 1.3 0.4 0.1 14.1 0.3 0.0 0.1 9.0 0.0 0.2 4.3 0.1 0.0 3.2 1.7 1.5 1.0 0.4 0.2 0.0 0.8 1.0 1.9 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.0 5.1 0.1 0.3 0.5 0.0 0.0 0.1 0.1 0.0 0.0 0.3 0.1 0.0 0.0 1.9 0.0 0.6 11.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 9.2 0.4 0.3 11.3 10.1 1.5 0.1 0.2 0.1 0.0 1.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.6 0.1 0.1 0.0 0.0 0.1 0.0 0.1 8.3 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 3.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.1 PAGE4 "CT16.7, GAGEC1, PAGE-4" ENSG00000101951 "PAGE family member 4" O60829 X 49829260-49834264 "Cancer-related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "epididymis: 871.9;placenta: 1023.1" "Group enriched" "Detected in some" 10 "Cytotrophoblasts: 13314.7;Syncytiotrophoblasts: 8524.1" "Group enriched" "Detected in some" 17 "liver cancer: 14.8;prostate cancer: 7.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 10.2;U-266/70: 11.7;U-266/84: 45.1" "Not detected" "Not detected" HPA023880 Enhanced Approved "Golgi apparatus,Vesicles" NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 16: U-266 - Nucleosome" "Cluster 47: Cytotrophoblasts - Unknown function" Vesicles "Golgi apparatus" "HPA023880: AB_1854930" "unprognostic (8.56e-2)" "unprognostic (1.47e-1)" "unprognostic (1.04e-1)" "unprognostic (4.82e-3)" "unprognostic (5.37e-2)" 0.3 5.7 0.1 0.3 0.2 0.0 0.0 0.1 0.5 7.0 0.1 0.2 0.4 51.2 871.9 0.0 21.4 0.0 0.4 0.1 0.2 3.1 0.3 0.2 0.0 0.1 0.1 3.7 2.5 0.0 1.3 1023.1 0.1 171.8 0.0 0.0 0.6 77.2 2.3 0.0 0.3 24.2 0.0 0.3 0.2 5.6 0.1 0.1 0.0 0.0 0.0 0.2 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 10.2 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 2.5 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 1.7 0.2 0.0 0.0 0.0 0.1 0.0 0.1 11.7 45.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.5 0.1 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 13314.7 0.0 0.0 0.0 0.0 4.4 1.9 72.5 25.9 0.0 0.0 0.0 0.0 905.4 72.5 0.0 1.9 0.0 0.0 0.0 0.0 1052.1 0.0 0.0 0.0 0.0 0.0 0.0 8.9 0.9 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 1.7 48.8 20.7 0.0 0.0 8524.1 0.3 0.0 0.0 0.1 PCCA ENSG00000175198 "Propionyl-CoA carboxylase subunit alpha" P05165 13 100089015-100530437 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" Ligase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 218.2" "Cell type enhanced" "Detected in all" "Astrocytes: 152.8;Excitatory neurons: 152.8;Inhibitory neurons: 166.5;Microglial cells: 217.4;Oligodendrocyte precursor cells: 200.6;Oligodendrocytes: 182.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 167.0;SCLC-21H: 91.1;U-937: 131.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041716, HPA047792" Enhanced Supported Mitochondria NA NA 290000 "Cluster 27: Non-specific - Gene expression" "Cluster 68: Epididymis - Unknown function" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 68: Oligodendrocytes - Mixed function" Mitochondria "HPA041716: AB_2677635, HPA047792: AB_2680156" "unprognostic (1.18e-1)" "unprognostic (2.13e-1)" "unprognostic (1.97e-2)" "unprognostic (4.71e-2)" "unprognostic (1.11e-2)" "unprognostic (1.71e-2)" "unprognostic (1.55e-1)" "unprognostic (5.90e-3)" "unprognostic (2.41e-1)" "unprognostic (1.55e-1)" "unprognostic (6.14e-2)" "unprognostic (1.42e-1)" "prognostic favorable (0.00e+0)" "unprognostic (7.08e-2)" "unprognostic (1.12e-1)" "unprognostic (1.18e-1)" "unprognostic (9.32e-2)" 35.4 56.3 29.0 12.4 29.8 6.2 25.8 55.5 34.6 22.3 44.4 37.5 13.2 14.9 218.2 19.4 17.4 11.6 35.4 28.6 26.3 111.7 104.3 12.0 8.0 28.9 27.4 19.9 27.6 25.7 12.3 21.3 31.1 25.9 27.6 25.2 26.9 16.9 17.6 18.6 18.0 13.7 30.3 17.2 40.9 9.2 33.9 11.4 20.4 27.2 6.4 21.3 17.5 38.7 10.6 18.5 29.8 9.9 27.9 24.2 16.6 10.2 15.4 9.5 9.0 23.0 13.9 0.8 15.2 10.1 12.0 11.8 9.1 14.1 15.6 17.5 10.1 24.6 12.7 49.7 15.4 1.2 11.3 22.4 15.2 8.8 14.6 23.0 19.6 13.0 9.8 13.4 17.1 11.6 2.6 54.8 18.6 37.2 8.1 21.4 12.9 17.3 167.0 20.5 91.1 10.9 7.0 38.4 17.9 31.9 27.9 43.1 14.3 9.6 8.0 6.7 7.3 13.1 12.9 0.4 18.4 131.6 6.9 1.6 9.1 1.7 4.5 11.2 5.9 3.6 2.8 4.2 13.5 2.3 3.9 4.9 1.1 8.7 12.3 1.1 6.5 5.2 29.0 29.8 55.5 34.6 28.6 26.3 28.9 27.4 31.1 30.3 33.9 38.7 11.3 3.2 8.7 152.8 6.6 1.9 29.1 12.7 8.6 15.5 13.5 8.8 10.5 52.9 14.8 20.2 29.2 25.7 4.3 20.7 99.7 19.7 17.6 76.5 22.4 12.0 3.6 3.4 152.8 8.4 6.9 12.9 12.2 72.9 14.0 20.7 12.1 48.8 11.8 28.6 166.5 12.4 12.2 14.2 2.2 12.0 8.7 8.2 5.4 217.4 6.0 11.5 10.3 200.6 182.5 5.8 17.5 13.5 9.4 11.2 13.2 86.9 13.2 31.7 13.1 12.3 10.1 7.2 6.2 10.6 3.8 30.2 6.4 17.6 27.6 19.2 PCDHB3 PCDH-BETA3 ENSG00000113205 "Protocadherin beta 3" Q9Y5E6 5 141100473-141103827 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Adipocytes: 2.8;Cone photoreceptor cells: 2.1;Endometrial stromal cells: 2.6;Horizontal cells: 8.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 11.3;HAP1: 3.5;SH-SY5Y: 15.2;U-138 MG: 5.3" "Low region specificity" "Detected in all" HPA050296 Uncertain Supported Vesicles NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 50: Fibroblasts - ECM organization" Vesicles "HPA050296: AB_2681078" "unprognostic (2.72e-2)" "unprognostic (7.47e-4)" "unprognostic (1.22e-1)" "unprognostic (1.95e-4)" "unprognostic (9.34e-3)" "unprognostic (3.42e-2)" "unprognostic (2.29e-2)" "unprognostic (3.17e-1)" "unprognostic (1.37e-1)" "unprognostic (3.34e-1)" "unprognostic (8.52e-3)" "unprognostic (3.45e-2)" "unprognostic (1.82e-2)" "unprognostic (2.37e-3)" "unprognostic (1.24e-1)" "unprognostic (1.82e-2)" "unprognostic (5.18e-4)" 1.8 1.2 0.4 0.7 1.1 0.0 1.7 0.6 1.5 1.2 0.0 0.9 0.3 1.5 0.7 0.3 0.9 0.8 1.1 1.0 0.2 1.1 0.1 1.1 0.1 0.3 0.5 1.6 1.2 1.7 1.8 0.4 0.1 1.4 0.5 1.0 0.7 0.5 0.7 0.7 0.5 1.0 0.2 0.4 0.5 3.6 0.6 0.0 0.7 0.9 0.1 0.8 0.9 0.8 0.0 0.0 1.1 3.1 1.9 0.3 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 11.3 0.2 1.7 0.0 3.5 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 1.3 0.0 0.5 0.0 0.2 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.6 15.2 0.0 0.1 0.0 0.5 1.9 0.1 0.0 5.3 0.7 0.5 0.3 0.3 0.0 0.0 0.3 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.1 0.6 1.5 1.0 0.2 0.3 0.5 0.1 0.2 0.6 0.8 2.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.5 0.9 0.8 0.3 0.0 0.0 0.0 2.1 0.0 0.0 0.0 1.9 0.3 0.8 0.4 2.6 1.1 0.0 0.0 0.0 0.2 0.0 1.4 0.0 0.2 0.0 0.0 1.8 0.0 0.0 8.4 0.0 0.2 0.0 0.0 0.3 0.0 0.6 0.0 1.8 0.0 0.0 0.9 0.0 0.0 0.0 0.3 0.0 0.7 0.0 0.5 0.0 0.1 0.0 0.3 0.0 1.7 1.1 1.8 0.7 0.1 0.3 0.0 0.0 0.4 0.0 0.3 PCDHB5 "DKFZp586B0217, PCDH-BETA5" ENSG00000113209 "Protocadherin beta 5" Q9Y5E4 5 141135206-141138615 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Bipolar cells: 5.2;Early spermatids: 8.2;Muller glia cells: 5.0;Spermatocytes: 13.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 18.7;GAMG: 13.9;NTERA-2: 17.7;RH-30: 14.0;SCLC-21H: 16.4;SuSa: 21.7;T-47d: 17.6;U-138 MG: 32.4;U-2 OS: 14.1;WM-115: 14.7" "Low region specificity" "Detected in many" "HPA013191, HPA067473" Approved Approved "Vesicles,Plasma membrane" NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 12: NES - Nervous system development" "Cluster 66: Spermatocytes - Spermatogenesis" "Plasma membrane" Vesicles "HPA013191: AB_1855059, HPA067473: " "unprognostic (2.21e-1)" "unprognostic (4.71e-2)" "unprognostic (4.05e-3)" "unprognostic (1.81e-1)" "unprognostic (2.84e-2)" "unprognostic (5.23e-2)" "unprognostic (2.27e-2)" "unprognostic (1.76e-1)" "unprognostic (9.41e-2)" "unprognostic (1.25e-1)" "unprognostic (1.32e-2)" "unprognostic (3.16e-1)" "unprognostic (1.32e-1)" "unprognostic (1.06e-3)" "unprognostic (6.65e-2)" "unprognostic (3.14e-2)" "unprognostic (1.55e-3)" 1.4 1.6 2.2 0.4 1.7 0.0 1.6 1.1 3.2 3.4 0.0 1.4 0.2 4.2 3.5 0.7 2.8 1.8 1.9 2.8 0.6 2.4 0.7 1.7 0.2 2.5 1.6 5.9 4.7 2.7 3.2 0.4 1.3 2.9 0.3 2.4 2.2 2.1 1.1 0.6 0.6 2.1 1.7 0.7 1.0 3.1 1.8 0.4 2.5 0.6 0.1 1.6 1.3 2.3 0.0 1.0 18.7 0.3 1.3 0.8 0.2 0.4 0.1 0.3 0.3 0.0 0.0 0.0 9.6 0.0 13.9 0.0 9.8 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.3 0.0 1.0 0.7 0.0 0.0 0.1 3.8 0.9 0.0 0.7 0.1 0.0 0.0 0.1 0.0 17.7 0.0 0.0 0.0 14.0 0.0 0.0 0.0 16.4 0.5 0.0 0.2 6.1 21.7 17.6 4.3 0.0 32.4 14.1 5.3 0.0 0.0 0.0 0.0 1.7 0.0 14.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 1.7 1.1 3.2 2.8 0.6 2.5 1.6 1.3 1.7 1.8 2.3 1.9 0.0 0.0 0.0 0.0 0.0 1.5 0.8 0.6 5.2 0.9 2.2 1.1 1.5 1.8 1.8 0.0 0.0 0.0 0.0 0.0 2.5 8.2 0.5 4.3 1.1 0.0 0.0 0.0 3.6 0.0 1.5 0.0 0.2 0.0 0.5 0.4 0.4 0.0 3.3 0.0 0.0 0.0 0.0 0.0 3.8 3.1 0.1 0.0 0.0 0.0 5.0 0.0 0.0 0.0 2.2 0.0 4.5 0.0 1.1 0.0 0.5 0.1 0.7 0.0 2.1 2.7 13.0 0.0 0.2 0.1 0.0 0.0 0.3 0.0 0.6 PCDHB6 PCDH-BETA6 ENSG00000113211 "Protocadherin beta 6" Q9Y5E3 5 141150057-141153287 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in some" "Cell type enriched" "Detected in some" 5 "Spermatocytes: 7.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 16.6;SH-SY5Y: 7.1;T-47d: 5.4;U-2197: 7.6;WM-115: 10.5" "Low region specificity" "Detected in many" "HPA029566, HPA075308" Uncertain Approved Nucleoplasm NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 38: EFO-21 - Unknown function" "Cluster 66: Spermatocytes - Spermatogenesis" Nucleoplasm "HPA029566: AB_10601385, HPA075308: " "unprognostic (3.25e-2)" "unprognostic (1.54e-2)" "unprognostic (1.81e-1)" "unprognostic (8.05e-2)" "unprognostic (7.65e-3)" "unprognostic (2.82e-1)" "unprognostic (1.73e-3)" "unprognostic (9.64e-3)" "unprognostic (8.62e-2)" "unprognostic (1.54e-3)" "unprognostic (2.28e-2)" "unprognostic (6.33e-2)" "prognostic unfavorable (5.52e-4)" "unprognostic (8.60e-4)" "unprognostic (2.31e-2)" "unprognostic (7.08e-3)" "unprognostic (6.52e-2)" 0.8 0.7 0.9 0.2 0.9 0.0 1.1 0.4 1.6 1.2 0.0 0.7 0.0 1.9 1.1 0.2 1.0 0.3 0.7 1.4 0.3 0.6 0.1 0.7 0.1 0.8 0.7 1.2 0.5 1.8 1.0 0.4 0.8 0.5 0.1 0.9 0.7 0.3 0.4 0.7 0.3 0.9 0.6 0.2 0.4 1.9 0.8 0.1 0.4 0.3 0.1 0.7 0.7 1.3 0.0 0.4 0.3 0.1 0.2 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 16.6 0.2 1.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 1.2 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.3 7.1 0.0 0.1 3.7 0.4 5.4 2.3 0.0 0.6 1.2 7.6 0.0 0.0 0.0 0.0 3.8 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.9 0.4 1.6 1.4 0.3 0.8 0.7 0.8 0.6 0.8 1.3 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.6 0.4 0.6 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.0 0.1 1.0 0.7 0.0 0.0 0.0 0.8 0.0 0.6 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.1 0.2 0.0 1.5 0.8 7.6 0.1 0.0 0.4 0.0 0.0 0.2 0.0 0.0 PCDHB8 "PCDH-BETA8, PCDH3I" ENSG00000120322 "Protocadherin beta 8" Q9UN66 5 141177790-141180539 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in some" "Group enriched" "Detected in some" 5 "Early spermatids: 5.0;Spermatocytes: 6.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 20.9;T-47d: 31.4;U-138 MG: 12.1;U-2197: 34.2" HPA057773 Uncertain NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 6: T47d - Mammary gland" "Cluster 66: Spermatocytes - Spermatogenesis" "HPA057773: AB_2683525" "unprognostic (1.16e-3)" "unprognostic (1.56e-1)" "unprognostic (5.33e-2)" "unprognostic (1.72e-1)" "unprognostic (7.56e-2)" "unprognostic (2.02e-2)" "unprognostic (5.72e-3)" "unprognostic (5.82e-4)" "unprognostic (3.54e-2)" "unprognostic (5.52e-3)" "unprognostic (1.95e-2)" "unprognostic (2.42e-1)" "unprognostic (2.62e-2)" "unprognostic (1.11e-2)" "unprognostic (8.09e-2)" "unprognostic (3.12e-2)" "unprognostic (6.30e-4)" 0.8 0.5 0.2 0.2 0.5 0.0 0.5 0.1 1.8 0.6 0.0 0.4 0.1 1.3 0.7 0.3 0.5 0.6 0.6 1.0 0.0 0.4 0.1 0.6 0.0 0.6 0.5 0.9 0.5 1.0 0.8 0.2 0.4 0.4 0.2 0.8 0.3 0.3 0.1 0.4 0.1 0.7 0.2 0.2 0.2 1.1 0.7 0.0 0.2 0.3 0.0 0.3 0.3 1.0 0.0 0.0 0.1 1.3 3.8 2.4 0.2 0.2 7.7 0.0 0.1 0.0 0.0 0.0 20.9 0.1 7.2 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.3 0.2 0.4 0.0 0.0 1.3 0.0 0.3 0.1 1.7 6.2 0.2 0.0 0.0 0.0 0.0 0.5 0.1 8.4 0.0 0.1 0.0 6.0 1.6 0.1 0.0 1.1 0.0 31.4 0.0 0.9 12.1 6.0 34.2 0.0 0.0 0.0 0.0 3.6 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.1 1.8 1.0 0.0 0.6 0.5 0.4 0.2 0.7 1.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 6.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 PCP4 PEP-19 ENSG00000183036 "Purkinje cell protein 4" P48539 21 39867438-39929397 "Predicted intracellular proteins" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 647.3;seminal vesicle: 1280.1" "Group enriched" "Detected in many" 4 "Bipolar cells: 600.9;Distal tubular cells: 645.6;Horizontal cells: 1398.2;Proximal tubular cells: 941.2" "Cancer enhanced" "Detected in many" "prostate cancer: 41.7;thyroid cancer: 48.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "RPMI-8226: 215.9;T-47d: 64.7" "Low region specificity" "Detected in all" HPA005792 Enhanced Supported Approved "Nucleoplasm,Nucleoli fibrillar center" NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 25: RPMI-8226 - Immune response" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Nucleoplasm, Nucleoli fibrillar center" "HPA005792: AB_1855086" "unprognostic (6.82e-2)" "prognostic favorable (9.76e-4)" "unprognostic (5.26e-2)" "unprognostic (1.56e-1)" "unprognostic (4.03e-2)" "unprognostic (2.94e-1)" "unprognostic (2.87e-2)" "unprognostic (1.07e-1)" "unprognostic (1.04e-1)" "unprognostic (3.95e-3)" "unprognostic (2.63e-1)" "prognostic favorable (1.85e-7)" "unprognostic (9.00e-2)" "unprognostic (2.99e-3)" "unprognostic (1.10e-1)" "unprognostic (1.07e-2)" 5.2 52.9 197.6 2.0 647.3 0.0 8.4 166.2 202.0 180.9 509.6 135.5 5.1 126.9 365.6 228.2 10.2 4.2 4.6 121.8 175.9 52.1 0.5 0.6 0.2 75.6 299.1 3.5 6.2 19.7 8.8 2.0 70.2 323.4 32.4 385.3 21.3 1280.1 0.6 14.8 6.0 54.6 64.1 2.6 7.1 0.9 491.1 7.9 227.7 0.0 1.0 468.0 128.6 85.5 0.0 0.0 3.1 0.5 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 6.1 0.0 2.3 1.9 0.0 0.0 0.0 0.0 215.9 0.5 0.0 0.3 0.3 0.0 34.8 0.0 0.2 64.7 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 197.6 647.3 166.2 202.0 121.8 175.9 75.6 299.1 70.2 64.1 491.1 85.5 0.0 0.0 1.5 15.3 2.9 3.1 0.4 0.0 0.0 600.9 0.4 0.4 8.8 2.8 0.0 77.3 62.6 0.3 0.0 0.1 645.6 0.4 1.3 0.0 0.2 5.0 1.2 0.0 71.3 0.2 0.3 1.5 0.0 0.0 0.0 0.4 0.0 0.1 0.2 1398.2 21.5 0.2 0.0 0.0 7.5 0.4 9.6 7.0 21.4 8.4 0.0 68.4 0.0 7.5 11.9 0.8 0.2 0.4 0.0 4.4 0.0 941.2 0.0 200.0 0.0 0.0 77.4 3.4 9.5 0.0 6.0 2.9 2.2 0.5 0.5 1.0 PEF1 PEF1A ENSG00000162517 "Penta-EF-hand domain containing 1" Q9UBV8 1 31629866-31644896 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 182.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061608 Supported Nucleoplasm,Vesicles,Cytosol NA NA 570000 "Cluster 2: Granulocytes - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 47: Cytotrophoblasts - Unknown function" "Nucleoplasm, Vesicles, Cytosol" "HPA061608: AB_2684567" "unprognostic (2.92e-2)" "prognostic favorable (3.95e-4)" "unprognostic (1.59e-1)" "unprognostic (2.30e-2)" "unprognostic (1.11e-1)" "unprognostic (8.40e-2)" "prognostic unfavorable (2.88e-4)" "unprognostic (5.22e-3)" "unprognostic (1.04e-1)" "unprognostic (2.79e-2)" "unprognostic (1.60e-2)" "unprognostic (2.12e-1)" "unprognostic (1.35e-1)" "unprognostic (8.85e-3)" "unprognostic (2.38e-1)" "unprognostic (1.60e-1)" "unprognostic (2.89e-3)" 57.3 67.1 76.4 28.5 78.6 37.9 56.4 80.1 81.3 56.3 77.8 59.0 31.3 63.3 84.4 62.1 54.6 38.6 63.8 77.9 81.6 69.4 71.3 61.3 38.5 81.9 78.6 50.2 40.9 69.1 52.1 61.4 84.7 59.4 45.1 26.6 39.9 59.1 42.5 85.7 44.0 60.0 79.9 55.9 51.3 40.1 78.9 56.6 110.9 39.3 61.6 61.9 52.2 81.4 56.9 65.0 53.1 41.3 61.2 63.8 51.0 52.8 89.8 124.4 109.0 38.7 83.2 60.2 71.9 118.3 63.9 58.1 103.9 134.5 100.1 76.0 112.6 49.9 49.4 78.6 107.9 49.0 45.3 66.3 152.6 122.0 113.2 79.2 122.2 72.6 52.4 60.6 90.4 67.1 75.6 47.5 74.3 69.7 72.9 72.5 51.7 66.2 98.6 60.8 75.8 43.9 60.2 56.1 81.0 82.9 50.0 35.5 65.7 54.0 46.0 92.7 71.3 38.7 42.2 65.4 67.7 71.8 65.9 147.3 75.6 93.0 90.2 69.4 86.8 70.9 75.5 81.4 77.5 76.4 70.2 70.6 76.2 87.4 67.2 71.4 84.0 104.8 76.4 78.6 80.1 81.3 77.9 81.6 81.9 78.6 84.7 79.9 78.9 81.4 58.2 41.7 37.7 5.9 31.6 36.2 66.6 70.8 29.6 41.2 34.7 36.2 20.4 21.5 35.3 69.9 12.5 160.0 33.9 36.6 113.5 72.0 81.3 17.4 20.0 60.3 44.3 40.0 8.0 61.9 106.1 34.0 21.9 19.8 72.9 34.3 35.3 24.4 61.9 53.8 7.4 49.8 50.8 18.5 21.8 87.5 45.1 27.8 49.8 7.5 81.6 59.6 46.4 6.0 13.8 59.1 44.0 58.6 23.6 65.4 48.9 57.8 23.5 26.5 19.7 25.8 38.8 44.1 44.2 24.6 51.4 182.8 33.6 50.9 39.5 58.3 PHF8 "JHDM1F, KDM7B, KIAA1111, ZNF422" ENSG00000172943 "PHD finger protein 8" Q9UPP1 X 53936676-54048958 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Cell cycle, Transcription, Transcription regulation" "Activator, Chromatin regulator, Dioxygenase, Oxidoreductase" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 70.6" "Cell type enhanced" "Detected in many" "Spermatocytes: 57.9;Spermatogonia: 58.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038779, HPA062015" Approved Supported Nucleoplasm NA NA "Cluster 46: Basophils - DNA binding" "Cluster 68: Epididymis - Unknown function" "Cluster 5: NTERA-2 - Transcription" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" Nucleoplasm "HPA038779: AB_10675950, HPA062015: AB_2684658" "unprognostic (6.35e-2)" "unprognostic (2.16e-2)" "unprognostic (1.70e-2)" "unprognostic (1.04e-1)" "unprognostic (8.76e-2)" "unprognostic (1.05e-1)" "unprognostic (1.40e-1)" "unprognostic (2.66e-3)" "unprognostic (1.97e-3)" "unprognostic (1.22e-1)" "unprognostic (5.64e-2)" "unprognostic (1.02e-1)" "unprognostic (5.17e-2)" "unprognostic (1.22e-1)" "unprognostic (9.94e-2)" "unprognostic (1.85e-2)" "prognostic favorable (3.74e-5)" 11.6 8.1 8.3 13.3 11.1 16.2 13.8 9.5 10.3 13.9 20.0 11.6 10.3 14.1 70.6 13.4 14.1 9.2 9.8 7.8 11.2 9.7 28.7 13.5 16.3 10.1 9.4 19.3 17.8 10.8 13.9 13.2 11.2 16.0 9.6 14.6 12.8 18.3 11.0 13.1 14.2 9.4 8.1 13.9 12.7 40.1 10.2 18.6 13.2 7.8 15.8 14.1 13.5 13.3 16.1 14.0 20.4 19.9 12.2 9.6 33.3 12.0 10.4 12.9 11.4 15.7 12.8 23.4 6.9 10.8 13.9 16.5 51.1 10.3 13.7 36.4 23.8 14.2 18.1 15.8 9.6 22.4 25.6 10.9 14.0 15.0 20.2 9.7 12.0 24.3 18.7 33.2 7.6 16.1 30.6 16.9 37.2 11.0 19.6 29.7 22.5 22.9 8.9 19.2 29.2 14.5 31.6 20.5 10.5 31.2 20.5 15.5 14.3 10.3 14.5 19.2 10.0 25.1 25.4 28.3 12.2 27.9 11.3 6.1 2.7 4.4 3.2 4.8 5.1 2.3 3.3 3.9 2.9 3.1 2.5 2.8 4.4 3.5 3.2 2.3 5.3 3.4 8.3 11.1 9.5 10.3 7.8 11.2 10.1 9.4 11.2 8.1 10.2 13.3 9.5 9.6 10.3 17.3 11.2 8.9 9.4 4.5 15.4 13.7 13.9 8.1 7.8 5.7 5.4 9.2 12.5 13.9 14.1 8.3 0.0 5.1 54.9 34.5 11.3 11.3 5.4 5.2 19.7 4.6 4.7 6.9 10.7 40.2 14.0 15.0 7.9 39.4 6.8 8.4 22.0 8.8 10.2 11.8 6.4 31.4 9.3 11.6 3.6 20.6 9.2 6.1 9.2 27.2 30.0 4.4 9.4 6.4 14.4 10.9 9.2 3.7 16.5 15.3 6.6 11.6 9.2 57.9 58.7 15.2 9.8 12.2 13.5 6.3 8.3 14.7 PIGC ENSG00000135845 "Phosphatidylinositol glycan anchor biosynthesis class C" Q92535 1 172370189-172444086 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins" "GPI-anchor biosynthesis" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036663 Uncertain NA NA "Cluster 44: Non-specific - Transcription" "Cluster 68: Epididymis - Unknown function" "Cluster 21: OE19 - Mitochondria" "Cluster 47: Cytotrophoblasts - Unknown function" "HPA036663: AB_10669912" "unprognostic (3.35e-1)" "unprognostic (3.01e-1)" "unprognostic (2.14e-1)" "unprognostic (1.01e-1)" "unprognostic (2.65e-1)" "unprognostic (3.72e-3)" "prognostic unfavorable (4.49e-4)" "unprognostic (7.25e-2)" "unprognostic (2.20e-2)" "unprognostic (4.69e-2)" "unprognostic (3.08e-2)" "unprognostic (1.24e-1)" "prognostic unfavorable (1.43e-8)" "unprognostic (1.09e-1)" "unprognostic (1.77e-1)" "unprognostic (6.04e-2)" "unprognostic (1.90e-1)" 18.2 20.8 12.8 13.0 13.2 27.2 21.8 13.8 16.2 21.4 13.8 20.7 15.4 24.3 38.9 16.6 23.5 18.1 14.9 13.3 14.4 20.0 16.0 15.0 19.7 14.1 13.8 22.4 25.9 19.6 18.1 20.2 14.4 16.4 19.3 17.7 20.7 17.5 13.6 40.7 21.6 18.9 13.6 20.3 19.6 18.3 13.7 27.6 15.3 11.1 20.9 18.8 18.8 14.5 33.3 28.1 37.2 25.5 27.8 25.0 27.8 21.1 23.5 35.6 30.9 25.6 47.6 17.7 30.4 25.4 28.3 35.0 24.6 30.8 28.6 39.5 28.4 21.8 25.5 31.9 30.6 44.9 27.4 37.4 36.0 25.6 27.9 27.7 23.0 33.5 33.5 32.9 29.2 17.3 34.4 40.1 38.5 67.4 38.7 27.9 30.3 31.9 55.5 24.1 19.5 37.1 30.5 35.6 50.3 52.4 31.9 31.6 21.0 22.6 37.8 28.0 22.8 21.8 33.1 27.6 16.2 29.0 43.9 71.5 28.1 55.6 35.4 26.9 29.8 37.2 40.6 37.4 24.3 33.8 60.1 43.4 18.2 51.6 29.5 24.1 40.0 40.9 12.8 13.2 13.8 16.2 13.3 14.4 14.1 13.8 14.4 13.6 13.7 14.5 19.4 9.6 10.3 0.0 24.2 13.5 19.7 31.2 18.2 15.7 20.9 29.5 20.7 17.2 17.7 29.5 8.4 61.6 23.9 20.6 33.2 31.9 78.2 15.2 19.3 20.0 7.8 58.9 0.0 41.1 50.9 31.0 15.8 18.6 7.6 21.6 22.9 15.4 35.3 20.2 0.0 19.6 32.6 23.7 16.9 80.8 47.2 20.0 26.6 0.0 27.6 30.1 42.2 0.0 0.0 34.8 27.6 40.6 12.4 14.2 25.2 20.9 20.1 17.9 32.9 22.2 18.7 30.0 18.8 17.7 19.0 23.7 29.1 21.5 18.9 15.5 PIGF ENSG00000151665 "Phosphatidylinositol glycan anchor biosynthesis class F" Q07326 2 46580937-46617055 "Metabolic proteins, Predicted membrane proteins" "GPI-anchor biosynthesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051389 Uncertain NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 68: Epididymis - Unknown function" "Cluster 25: RPMI-8226 - Immune response" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "HPA051389: AB_2681464" "unprognostic (3.85e-3)" "unprognostic (5.42e-2)" "unprognostic (1.11e-3)" "unprognostic (8.18e-2)" "unprognostic (2.56e-1)" "unprognostic (4.52e-3)" "prognostic unfavorable (1.39e-5)" "unprognostic (4.97e-2)" "unprognostic (9.29e-3)" "unprognostic (6.08e-2)" "unprognostic (5.89e-2)" "unprognostic (9.40e-2)" "unprognostic (1.02e-1)" "unprognostic (7.30e-3)" "unprognostic (1.84e-1)" "unprognostic (6.04e-2)" "unprognostic (6.71e-2)" 16.7 29.0 16.8 18.3 19.3 10.3 17.0 20.3 21.0 12.7 19.8 18.4 17.3 11.1 27.8 15.7 14.9 18.2 17.0 17.1 20.9 20.1 16.6 12.6 15.7 19.8 19.2 13.7 23.0 20.1 15.5 17.4 20.2 15.4 19.1 25.3 21.9 9.9 25.8 12.2 17.9 7.6 21.5 13.3 16.4 26.2 18.4 8.4 22.8 14.4 12.4 18.5 11.6 22.5 31.0 18.9 39.7 22.9 47.2 48.8 22.1 37.5 22.8 15.1 15.1 9.4 22.2 18.2 68.8 25.3 39.9 25.1 35.9 27.1 30.4 52.1 36.7 36.2 13.9 49.9 27.5 23.1 25.6 33.4 40.7 23.1 34.7 50.5 41.8 16.6 33.8 51.5 56.7 8.7 18.1 22.5 31.3 64.9 29.7 18.7 36.4 38.2 44.0 32.9 27.6 35.1 17.1 24.4 57.0 35.1 14.4 27.7 27.1 25.2 29.0 35.8 36.7 25.8 31.2 32.2 27.6 43.8 45.0 3.6 12.5 11.5 9.3 18.4 10.2 11.8 11.2 9.4 14.4 14.0 8.2 10.7 6.2 10.9 17.7 19.1 14.7 6.6 16.8 19.3 20.3 21.0 17.1 20.9 19.8 19.2 20.2 21.5 18.4 22.5 35.0 9.6 18.5 32.0 23.8 25.5 38.0 93.5 30.1 32.9 35.9 34.0 3.7 30.0 54.3 20.2 29.2 39.2 24.6 18.3 35.2 29.6 65.0 31.9 26.3 26.4 17.4 17.9 21.9 29.7 53.4 24.7 18.8 25.8 19.0 34.5 26.7 22.4 37.6 37.0 24.4 26.3 81.4 22.5 21.5 29.5 14.9 24.8 30.2 30.0 27.9 71.1 23.7 41.2 70.7 21.1 23.8 16.1 38.6 45.6 26.0 31.7 38.1 27.4 6.6 20.9 31.3 96.4 41.8 37.9 34.1 32.3 19.7 39.1 36.8 44.9 PIGM GPI-MT-I ENSG00000143315 "Phosphatidylinositol glycan anchor biosynthesis class M" Q9H3S5 1 160024953-160031990 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins" "GPI-anchor biosynthesis" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA047418 Uncertain NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 5: Muller glia cells - Visual perception" "HPA047418: AB_2680039" "unprognostic (1.55e-2)" "unprognostic (1.91e-1)" "unprognostic (1.37e-1)" "unprognostic (1.58e-1)" "unprognostic (9.89e-2)" "unprognostic (2.88e-2)" "unprognostic (2.69e-3)" "unprognostic (1.52e-1)" "unprognostic (3.85e-2)" "prognostic favorable (3.27e-4)" "unprognostic (2.63e-2)" "unprognostic (2.77e-2)" "unprognostic (3.01e-2)" "unprognostic (8.55e-2)" "unprognostic (1.69e-1)" "unprognostic (2.06e-2)" "unprognostic (1.50e-1)" 3.2 4.2 3.0 4.0 4.8 1.8 5.2 4.6 3.7 4.1 3.3 3.8 4.4 3.6 6.0 3.4 3.9 3.3 2.6 3.2 4.0 4.0 5.2 3.6 4.3 5.7 4.3 4.0 7.8 6.7 3.6 3.4 5.3 6.1 4.3 8.1 6.3 4.1 1.4 5.5 4.8 3.2 4.7 4.2 4.6 3.5 4.4 4.9 6.1 1.7 4.0 3.0 2.6 8.6 5.8 5.2 6.1 9.1 8.0 6.5 2.0 8.6 5.4 5.6 5.1 2.8 10.3 4.1 6.9 5.6 4.8 11.5 6.9 6.9 7.0 8.7 7.2 9.3 6.8 4.2 4.9 12.1 7.0 6.0 4.5 6.6 5.0 4.8 4.7 8.9 5.1 7.5 6.5 9.8 7.9 6.4 6.5 10.9 7.4 2.3 6.4 18.0 6.1 7.9 8.7 13.5 9.4 11.0 6.9 5.8 20.7 14.4 6.7 7.3 6.4 11.1 5.3 13.5 16.0 0.2 6.7 6.1 8.3 8.9 12.4 5.3 6.7 10.4 6.9 5.1 6.7 5.3 7.7 4.8 8.4 6.7 2.2 8.9 13.8 9.1 7.8 7.3 3.0 4.8 4.6 3.7 3.2 4.0 5.7 4.3 5.3 4.7 4.4 8.6 10.0 12.8 19.8 7.5 7.7 4.2 4.7 6.4 17.1 16.1 14.1 9.0 5.3 17.2 13.2 16.5 10.4 7.6 5.0 7.3 1.9 13.3 6.7 5.5 12.5 10.0 12.6 14.1 5.7 18.5 3.2 11.9 7.1 8.1 5.1 9.6 15.4 22.2 7.3 16.8 5.5 12.8 2.0 14.5 5.0 3.9 8.4 9.2 8.8 4.7 12.3 27.9 9.2 12.5 23.1 12.0 5.3 9.1 11.2 8.1 10.1 6.6 10.2 13.6 19.7 10.7 8.6 29.3 8.1 17.0 4.5 1.8 7.3 11.0 12.1 3.7 PIP4K2C "FLJ22055, PIP5K2C" ENSG00000166908 "Phosphatidylinositol-5-phosphate 4-kinase type 2 gamma" Q8TBX8 12 57591174-57603418 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 121.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RH-30: 130.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028658 Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 43: Cardiomyocytes - Nuclear processes" Cytosol "Nucleoplasm, Plasma membrane" "HPA028658: AB_10601245" "unprognostic (7.84e-3)" "unprognostic (1.51e-1)" "unprognostic (2.42e-1)" "unprognostic (2.77e-2)" "unprognostic (2.49e-2)" "unprognostic (3.37e-2)" "prognostic unfavorable (7.98e-4)" "unprognostic (3.17e-2)" "unprognostic (6.00e-2)" "unprognostic (5.51e-2)" "unprognostic (1.75e-1)" "unprognostic (1.88e-1)" "prognostic favorable (2.06e-6)" "unprognostic (1.87e-1)" "unprognostic (2.16e-1)" "unprognostic (3.27e-1)" "unprognostic (3.42e-1)" 13.6 17.2 18.4 11.6 24.0 26.5 20.0 13.4 32.8 18.4 20.7 24.1 16.0 18.5 81.6 28.2 26.6 16.1 15.0 22.3 11.5 36.0 14.8 19.7 13.5 14.9 13.0 16.0 21.0 39.1 18.7 12.1 16.0 21.6 26.3 29.1 25.6 18.4 14.0 27.1 19.2 15.9 11.9 14.6 39.8 28.1 15.7 11.4 22.4 10.5 18.8 18.2 20.5 20.9 52.0 36.4 14.8 17.6 0.0 0.1 47.0 21.4 40.6 38.7 35.1 46.7 73.4 11.3 44.1 25.6 47.4 46.1 24.2 42.2 30.3 15.9 26.1 20.0 17.5 33.7 32.8 19.3 35.0 12.9 70.0 14.7 26.9 46.4 19.6 12.1 26.8 33.3 20.0 52.6 16.5 16.7 28.1 32.1 31.2 0.5 130.9 17.2 39.6 91.1 23.7 30.0 45.8 30.4 29.7 49.3 83.2 17.8 4.2 18.5 26.1 27.7 22.8 25.1 31.5 25.6 36.0 16.0 32.1 58.8 8.2 25.8 24.3 10.5 16.1 8.7 14.8 18.4 8.6 11.0 13.8 16.7 16.3 16.2 14.6 3.8 19.9 11.0 18.4 24.0 13.4 32.8 22.3 11.5 14.9 13.0 16.0 11.9 15.7 20.9 4.1 9.6 8.6 4.9 6.9 12.4 6.2 11.7 10.8 14.3 13.2 8.0 121.7 12.8 11.9 35.0 18.8 11.3 7.4 33.7 21.5 17.7 25.7 14.2 4.2 8.8 22.2 5.2 28.0 19.7 15.2 5.4 26.0 20.3 3.8 4.0 9.3 12.6 8.9 8.4 11.8 18.4 10.2 6.0 2.2 47.9 6.8 5.7 12.4 2.8 5.9 7.5 5.2 5.0 11.5 40.5 12.8 5.3 9.4 10.1 14.2 13.3 15.3 8.1 19.7 3.8 13.1 12.0 9.0 14.3 12.8 17.4 11.9 5.5 10.4 9.2 PJA1 "FLJ11830, RNF70" ENSG00000181191 "Praja ring finger ubiquitin ligase 1" Q8NG27 X 69160851-69165521 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 160.0" "Cell type enhanced" "Detected in many" "Early spermatids: 74.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HAP1: 99.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000595 Approved Approved Nucleoplasm,Nucleoli NA NA "Cluster 22: NK-cells - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 29: Early spermatids - Spermatogenesis" "Nucleoplasm, Nucleoli" "HPA000595: AB_1079826" "unprognostic (3.40e-2)" "unprognostic (2.28e-1)" "unprognostic (4.03e-2)" "unprognostic (2.58e-3)" "unprognostic (5.44e-2)" "unprognostic (1.30e-2)" "unprognostic (1.26e-3)" "unprognostic (4.61e-2)" "unprognostic (3.82e-3)" "unprognostic (1.84e-2)" "unprognostic (6.10e-2)" "unprognostic (1.60e-1)" "prognostic favorable (7.44e-5)" "unprognostic (1.49e-1)" "unprognostic (2.35e-1)" "unprognostic (2.01e-1)" "unprognostic (2.10e-1)" 22.9 14.5 46.8 8.7 50.5 3.6 19.4 37.2 78.0 19.9 33.0 15.4 6.4 16.4 160.0 12.3 16.0 11.1 15.0 47.1 48.9 19.2 9.4 13.8 10.0 38.9 41.7 25.8 14.5 38.7 28.1 17.3 40.6 15.3 7.6 17.6 10.6 32.4 7.9 14.6 11.1 16.0 40.1 13.3 14.0 26.4 49.0 10.0 22.7 8.8 12.1 17.4 15.1 43.5 27.3 19.6 62.9 43.7 21.3 22.5 18.7 17.8 22.0 16.7 22.3 17.1 25.8 4.4 26.7 28.1 39.2 24.0 99.0 34.9 21.2 20.2 33.0 8.1 16.0 10.9 25.7 4.9 14.4 23.1 23.6 28.6 17.0 15.8 19.0 13.2 7.8 3.0 16.9 14.1 2.1 8.4 43.4 23.1 32.0 20.0 28.2 6.9 23.4 22.6 46.4 30.7 28.6 4.9 22.2 50.1 7.7 7.0 17.8 13.9 22.6 41.7 8.3 0.0 0.2 9.1 15.3 13.1 19.4 6.6 6.8 2.1 29.6 9.2 34.3 16.4 26.1 27.5 7.3 22.8 26.5 31.3 2.3 30.0 6.5 8.9 17.5 19.4 46.8 50.5 37.2 78.0 47.1 48.9 38.9 41.7 40.6 40.1 49.0 43.5 4.7 16.0 4.8 2.9 9.7 41.0 19.4 30.8 23.9 16.8 5.0 6.2 7.1 4.3 14.8 3.7 8.4 35.6 5.9 1.0 15.6 24.9 74.7 3.9 10.4 6.6 5.4 10.8 8.1 11.7 15.3 18.2 7.1 5.8 4.5 27.9 6.8 1.7 7.0 5.0 8.3 3.6 6.1 2.9 9.9 32.7 27.1 5.7 5.4 2.8 2.9 30.6 14.4 5.0 3.7 18.0 1.7 19.5 7.7 17.0 0.5 6.5 4.4 6.1 6.6 9.4 16.3 1.4 1.5 11.2 29.5 20.8 11.2 27.0 2.6 22.5 PJVK DFNB59 ENSG00000204311 Pejvakin Q0ZLH3 2 178451346-178462102 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Hearing "Deafness, Disease variant, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 20.7" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 6.4;Alveolar cells type 2: 9.1;Distal tubular cells: 3.9;Granulosa cells: 6.1;Theca cells: 4.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 5 "plasmacytoid DC: 2.8" "Lineage enriched" "Detected in single" 5 "dendritic cells: 2.8" "Cell line enhanced" "Detected in many" "SuSa: 6.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA042621 Approved Mitochondria No No "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 68: Epididymis - Unknown function" "Cluster 12: NES - Nervous system development" "Cluster 7: Non-specific - Mitochondria" Mitochondria "HPA042621: AB_10797503" "unprognostic (4.01e-2)" "unprognostic (4.28e-2)" "unprognostic (1.58e-2)" "unprognostic (2.64e-1)" "unprognostic (7.21e-3)" "unprognostic (9.36e-2)" "unprognostic (1.22e-1)" "unprognostic (1.14e-1)" "unprognostic (8.60e-3)" "unprognostic (4.57e-2)" "unprognostic (1.90e-3)" "unprognostic (9.13e-2)" "prognostic unfavorable (8.92e-4)" "unprognostic (1.22e-1)" "unprognostic (1.47e-1)" "unprognostic (2.41e-2)" "unprognostic (8.06e-3)" 3.0 1.8 6.9 1.3 7.2 1.4 4.8 6.9 10.7 2.7 6.9 1.9 1.2 3.9 7.3 1.2 2.8 2.9 1.4 7.0 7.0 3.2 2.8 1.5 1.9 7.6 7.3 7.1 1.3 1.1 4.1 1.2 7.5 2.8 1.2 6.4 2.7 3.0 3.5 4.2 1.4 2.0 7.3 1.4 1.2 20.7 7.1 1.2 2.5 0.9 1.7 1.9 1.4 7.7 0.2 1.8 2.3 1.9 3.0 3.1 1.2 1.5 1.4 1.2 2.0 0.7 3.1 2.1 1.5 0.9 1.0 0.9 1.7 1.0 0.9 0.7 0.6 0.7 2.9 0.4 3.0 0.6 0.2 3.2 2.2 1.4 3.2 3.8 1.5 4.1 0.4 1.3 1.5 0.5 2.1 1.3 2.8 0.2 0.8 2.7 1.7 1.3 2.0 1.0 1.6 1.3 0.5 0.3 0.6 6.8 0.7 0.7 1.0 1.5 0.6 0.4 0.1 4.3 2.8 0.7 0.7 1.1 0.6 0.1 0.1 0.0 0.1 0.1 0.2 0.3 0.2 0.1 0.0 0.5 0.5 0.3 0.4 0.2 0.0 2.8 0.0 0.0 6.9 7.2 6.9 10.7 7.0 7.0 7.6 7.3 7.5 7.3 7.1 7.7 1.6 6.4 9.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 3.0 2.4 0.0 0.0 1.8 1.8 0.0 1.1 0.5 0.0 3.9 1.4 0.0 1.8 2.6 0.4 0.0 0.0 0.0 0.9 0.5 1.4 0.0 1.6 0.0 6.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 2.6 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.6 4.7 0.0 0.0 PLA1A ps-PLA1 ENSG00000144837 "Phospholipase A1 member A" Q53H76 3 119597875-119629811 "Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 138.4;parathyroid gland: 65.8;seminal vesicle: 67.2" "Cell type enhanced" "Detected in many" "Collecting duct cells: 14.7;Endothelial cells: 14.3;Hepatocytes: 26.0;Langerhans cells: 15.6;Peritubular cells: 14.3" "Group enriched" "Detected in many" 5 "liver cancer: 14.8;melanoma: 55.4;prostate cancer: 24.2;renal cancer: 21.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 18 "SK-MEL-30: 25.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059740 Approved "Nucleoplasm,Nuclear speckles,Cytoplasmic bodies" "Secreted in other tissues" NA NA 420000 "Cluster 4: T-regs - Cell cycle regulation" "Cluster 68: Epididymis - Unknown function" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 10: Non-specific - Unknown function" "Nuclear speckles, Cytoplasmic bodies" Nucleoplasm "HPA059740: AB_2684118" "unprognostic (1.35e-1)" "prognostic favorable (2.81e-7)" "unprognostic (2.24e-2)" "unprognostic (3.46e-2)" "unprognostic (3.18e-2)" "unprognostic (1.94e-2)" "unprognostic (1.11e-2)" "unprognostic (2.43e-1)" "unprognostic (3.87e-1)" "unprognostic (1.43e-2)" "unprognostic (1.25e-1)" "unprognostic (9.09e-2)" "unprognostic (1.55e-3)" "unprognostic (9.53e-3)" "unprognostic (3.94e-2)" "unprognostic (1.67e-1)" "unprognostic (2.67e-1)" 4.9 0.7 12.1 3.5 11.3 0.3 3.4 11.6 16.3 4.7 26.8 2.7 1.1 4.7 138.4 1.5 5.7 2.8 4.9 12.5 12.0 7.7 39.6 21.2 15.6 13.2 12.3 1.1 3.7 65.8 1.7 9.8 13.2 9.1 2.5 1.0 3.5 67.2 16.2 0.8 3.5 8.8 13.4 1.0 4.4 3.7 14.7 1.6 6.9 3.1 8.7 3.9 1.9 12.4 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.8 0.3 0.5 0.1 0.0 0.2 0.0 0.0 25.0 0.0 0.0 0.0 1.3 0.0 0.1 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 12.1 11.3 11.6 16.3 12.5 12.0 13.2 12.3 13.2 13.4 14.7 12.4 6.5 0.0 1.7 0.0 0.0 0.6 0.5 0.4 0.6 0.0 0.1 0.1 2.8 2.8 1.0 14.7 0.0 0.2 0.1 0.0 1.9 4.7 6.6 0.1 0.1 14.3 1.8 0.0 0.2 2.2 0.0 1.6 0.0 0.9 1.3 0.7 7.9 26.0 1.6 0.0 0.1 0.1 0.0 1.0 15.6 3.2 0.3 5.4 1.8 4.7 4.2 0.0 0.0 0.0 0.0 1.3 0.6 14.3 0.0 0.5 0.0 5.1 7.5 0.1 0.0 0.9 5.9 0.0 0.2 0.0 0.6 1.9 0.1 0.0 0.1 0.2 PMFBP1 ENSG00000118557 "Polyamine modulated factor 1 binding protein 1" Q8TBY8 16 72112157-72176878 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 20.9" "Group enriched" "Detected in some" 6 "Early spermatids: 115.6;Late spermatids: 259.5" "Low cancer specificity" "Detected in single" "Region enhanced" "Detected in many" "pons: 13.3" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SCLC-21H: 21.0;SH-SY5Y: 10.7" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA056716, HPA075825" Approved Uncertain "Endoplasmic reticulum" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 68: Epididymis - Unknown function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 31: Spermatids - Spermatogenesis" "Endoplasmic reticulum" "HPA056716: AB_2683215, HPA075825: " "unprognostic (1.46e-1)" "unprognostic (3.62e-1)" "unprognostic (5.95e-2)" "unprognostic (1.04e-1)" "unprognostic (2.44e-2)" "unprognostic (7.03e-2)" "unprognostic (1.06e-4)" "unprognostic (1.60e-1)" "unprognostic (3.81e-1)" "unprognostic (2.67e-1)" "unprognostic (1.03e-1)" "unprognostic (2.82e-1)" "unprognostic (2.68e-5)" "unprognostic (9.85e-2)" "unprognostic (2.66e-1)" "unprognostic (9.85e-2)" "unprognostic (8.67e-2)" 1.7 2.2 0.4 1.3 0.9 4.5 1.5 2.5 0.8 1.8 0.5 3.2 2.9 1.7 13.5 2.9 2.0 0.9 3.3 0.8 1.9 3.0 3.1 1.6 2.0 3.5 3.9 2.6 6.5 1.2 2.7 0.6 13.3 3.6 3.3 3.5 1.7 0.3 0.6 4.4 3.9 0.3 1.9 4.7 2.6 20.9 1.0 2.4 2.1 0.0 0.5 1.8 1.9 1.4 0.2 0.4 2.8 2.8 0.0 0.6 1.9 0.6 0.2 0.6 2.1 1.1 2.8 1.9 0.4 0.1 0.1 1.8 1.0 0.1 1.4 0.2 4.3 1.9 3.7 3.1 0.0 4.2 3.2 0.0 0.9 0.1 2.1 0.6 0.8 2.3 0.4 1.7 0.1 2.4 1.1 6.8 0.8 0.1 1.2 2.9 0.2 1.5 0.3 0.8 21.0 10.7 0.0 0.0 0.2 2.0 0.5 2.7 1.8 1.3 2.2 0.6 1.4 3.9 1.5 1.2 0.6 2.8 0.7 0.0 0.3 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.4 0.9 2.5 0.8 0.8 1.9 3.5 3.9 13.3 1.9 1.0 1.4 0.0 0.0 0.6 1.0 0.3 0.4 0.1 0.1 1.2 0.9 0.1 0.0 0.7 0.0 1.3 0.0 0.0 0.0 0.1 0.3 0.0 0.2 115.6 0.3 0.2 0.3 5.4 0.8 0.7 0.2 0.1 0.6 0.0 0.1 3.8 0.3 0.0 0.1 4.7 30.3 0.7 0.7 0.0 1.9 5.5 259.5 1.2 2.4 0.0 1.0 0.0 1.1 0.0 1.0 1.6 0.1 0.1 1.5 0.0 0.1 0.2 0.6 1.6 0.2 0.0 0.0 0.1 2.9 0.9 0.3 0.0 0.1 1.0 0.0 0.9 0.2 PNMA3 "MA3, MA5, MGC132756, MGC132758" ENSG00000183837 "PNMA family member 3" Q9UL41 X 153056409-153060467 "Predicted intracellular proteins" "Tumor antigen" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 37.3" "Group enriched" "Detected in some" 4 "Excitatory neurons: 42.1;Inhibitory neurons: 38.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NTERA-2: 3.2;SCLC-21H: 1.0" "Low region specificity" "Detected in all" HPA047920 Approved NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 5: NTERA-2 - Transcription" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "HPA047920: AB_2680210" "unprognostic (1.66e-2)" "unprognostic (8.97e-3)" "unprognostic (8.70e-2)" "prognostic unfavorable (4.14e-5)" "unprognostic (9.43e-2)" "unprognostic (3.10e-3)" "unprognostic (1.16e-1)" "unprognostic (3.77e-4)" "unprognostic (2.84e-2)" "unprognostic (6.20e-2)" "unprognostic (7.62e-4)" "unprognostic (1.93e-1)" "unprognostic (5.92e-3)" "unprognostic (2.93e-3)" "unprognostic (7.25e-2)" "unprognostic (7.84e-2)" "unprognostic (2.07e-2)" 0.2 1.3 4.3 0.8 5.2 0.3 0.2 1.5 9.4 0.3 0.3 0.4 0.2 0.3 37.3 0.3 1.6 0.2 1.4 5.0 5.4 1.4 0.4 0.4 1.5 5.5 3.6 0.5 0.3 0.6 9.3 0.1 5.4 0.5 0.1 2.1 0.3 0.4 0.1 0.4 2.2 0.1 2.0 2.5 0.4 8.9 5.9 0.5 1.2 0.2 1.3 0.2 0.3 5.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.7 0.0 0.0 0.0 0.2 0.0 0.8 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 5.2 1.5 9.4 5.0 5.4 5.5 3.6 5.4 2.0 5.9 5.5 0.1 0.0 0.0 9.4 0.3 0.3 0.0 0.0 0.0 7.5 0.2 0.4 2.9 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.3 0.1 0.3 0.2 0.0 0.0 42.1 0.0 0.0 0.2 0.0 0.0 0.0 3.5 0.4 0.0 0.1 6.7 38.6 0.0 0.0 0.9 0.3 1.4 1.2 0.4 0.0 3.7 0.1 3.4 1.0 9.5 2.7 0.0 0.0 0.4 0.2 0.2 0.0 3.8 0.0 2.9 0.0 0.0 0.3 0.1 2.1 0.0 0.0 0.0 1.0 0.7 0.0 0.1 PNMA6E ENSG00000214897 "PNMA family member 6E" A0A0J9YXQ4 X 153395639-153401392 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 3.2;ovary: 2.4;testis: 12.0" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 68: Epididymis - Unknown function" "unprognostic (5.82e-2)" "unprognostic (1.71e-1)" "unprognostic (2.99e-2)" "unprognostic (1.77e-1)" 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 12.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PNP "NP, PUNP" ENSG00000198805 "Purine nucleoside phosphorylase" P00491 14 20468954-20477089 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Purine salvage" "Glycosyltransferase, Transferase" "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 333.9;epididymis: 594.8" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 360.6;Erythroid cells: 227.3;Syncytiotrophoblasts: 646.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HL-60: 531.3;U-937: 593.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA001625 Enhanced Supported Cytosol NA NA 58000000 "Cluster 16: MAIT-cells - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 32: U-937 - Innate immune response" "Cluster 47: Cytotrophoblasts - Unknown function" Cytosol "HPA001625: AB_1854577" "unprognostic (1.20e-3)" "unprognostic (2.68e-2)" "unprognostic (1.04e-2)" "unprognostic (1.70e-1)" "unprognostic (3.10e-1)" "unprognostic (7.06e-2)" "prognostic unfavorable (4.43e-4)" "unprognostic (4.94e-3)" "unprognostic (3.87e-2)" "unprognostic (7.45e-2)" "unprognostic (1.85e-2)" "unprognostic (2.21e-1)" "prognostic favorable (2.24e-4)" "unprognostic (1.69e-1)" "unprognostic (7.54e-2)" "unprognostic (2.46e-1)" "unprognostic (1.64e-3)" 78.6 24.8 16.1 46.8 16.6 333.9 34.6 22.6 22.7 25.3 18.9 52.2 120.3 14.2 594.8 87.4 18.2 56.8 29.0 17.7 19.6 206.8 98.0 48.6 46.7 20.3 18.1 5.0 23.2 32.0 19.8 132.6 20.1 15.0 61.8 27.1 22.6 27.4 7.3 29.6 60.3 38.7 23.1 44.5 50.6 7.4 21.1 33.5 17.8 10.0 64.4 100.4 41.5 20.1 86.1 113.4 24.0 53.9 26.0 21.0 71.8 85.2 40.3 68.2 67.0 66.1 76.5 227.1 96.8 45.5 81.5 89.9 125.2 159.8 89.5 75.0 109.6 189.1 89.9 109.3 24.2 531.3 94.7 14.4 57.4 206.0 91.0 37.8 295.9 141.0 95.4 137.4 86.7 79.1 157.6 311.3 67.5 215.7 186.1 130.2 35.9 88.3 243.7 79.6 101.9 22.6 163.4 205.0 13.2 32.6 75.5 92.5 240.0 46.1 62.6 105.1 148.4 63.1 113.3 258.9 39.3 593.0 4.6 12.0 30.6 10.3 39.8 27.3 73.6 25.7 44.2 45.0 48.1 28.8 27.6 35.9 3.7 38.5 26.6 27.3 16.7 31.1 16.1 16.6 22.6 22.7 17.7 19.6 20.3 18.1 20.1 23.1 21.1 20.1 149.6 0.0 23.5 5.9 50.3 84.6 67.4 12.6 112.7 4.7 56.3 62.6 3.5 27.1 13.4 82.8 14.6 360.6 45.2 61.1 39.2 43.2 1.3 36.0 12.7 139.4 46.4 227.3 0.6 51.5 41.8 32.4 106.5 65.3 57.7 5.0 24.3 30.6 70.9 16.8 1.1 51.3 18.3 18.1 58.4 0.8 0.3 83.3 30.2 3.7 13.2 78.8 29.9 3.0 0.9 130.8 83.9 0.7 88.6 27.5 41.2 118.9 10.5 18.1 0.0 23.9 41.3 0.4 0.7 114.7 63.9 646.2 62.3 3.1 51.4 77.1 PPP2CB PP2Abeta ENSG00000104695 "Protein phosphatase 2 catalytic subunit beta" P62714 8 30774457-30814314 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Peritubular cells: 264.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB018600, HPA043236" Approved Supported Nucleoplasm NA NA "Cluster 6: Non-specific - Transcription" "Cluster 68: Epididymis - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 53: Intestinal epithelial cells - Unknown function" Nucleoplasm "CAB018600: AB_675841, HPA043236: AB_2678379" "unprognostic (9.77e-2)" "unprognostic (1.30e-1)" "unprognostic (2.51e-2)" "unprognostic (3.82e-1)" "unprognostic (6.70e-2)" "unprognostic (7.79e-2)" "unprognostic (1.13e-2)" "unprognostic (3.51e-1)" "unprognostic (2.28e-1)" "unprognostic (2.86e-2)" "unprognostic (4.50e-2)" "unprognostic (1.89e-2)" "prognostic favorable (5.82e-7)" "unprognostic (9.24e-2)" "unprognostic (2.04e-1)" "unprognostic (1.39e-1)" "unprognostic (2.65e-3)" 89.9 66.6 190.2 42.2 196.1 10.5 68.4 189.1 220.1 84.0 147.9 79.3 72.9 112.1 117.1 95.1 87.8 74.2 94.7 191.6 190.7 131.9 118.6 90.6 32.5 199.7 184.1 147.4 75.7 93.3 52.5 91.0 190.4 74.9 76.2 77.9 68.6 87.1 105.7 63.7 87.0 122.3 195.1 52.9 71.2 64.7 204.4 41.4 126.7 122.7 47.4 76.8 70.0 200.1 96.5 82.7 136.4 54.4 134.6 120.0 78.0 124.0 114.0 123.1 129.5 86.6 68.3 45.6 118.7 165.4 117.9 56.5 84.4 142.1 167.3 28.5 44.2 61.8 52.7 86.9 157.3 28.1 34.2 108.6 157.4 105.2 115.9 124.2 152.5 73.6 97.7 47.6 212.4 48.4 77.1 34.9 102.6 139.3 47.0 53.9 55.7 34.5 168.5 73.6 134.3 55.0 57.8 61.1 127.0 150.5 34.1 47.8 164.0 109.1 81.7 36.1 105.5 24.0 33.6 53.7 93.4 26.0 141.4 3.4 2.5 1.7 1.8 3.1 2.3 2.9 1.7 1.9 1.7 1.1 1.7 2.1 2.3 3.8 1.5 3.8 1.3 0.8 190.2 196.1 189.1 220.1 191.6 190.7 199.7 184.1 190.4 195.1 204.4 200.1 81.0 70.5 60.7 68.6 13.0 104.1 115.9 44.4 44.9 36.6 64.9 51.8 80.2 45.8 54.3 86.5 31.3 41.1 23.6 186.1 46.9 40.6 21.8 98.5 109.8 60.9 32.3 16.6 41.0 48.9 52.8 79.0 34.7 89.2 17.7 95.4 87.8 95.5 58.4 47.1 59.1 65.3 28.5 55.4 60.4 20.3 73.3 36.0 40.9 52.5 27.4 127.2 17.5 37.7 60.4 81.1 78.9 264.0 15.8 125.4 115.6 95.9 68.2 26.5 46.0 93.1 73.0 37.2 40.4 50.3 95.6 70.6 17.4 75.3 41.2 149.9 PRAF2 "JM4, Yip6a" ENSG00000243279 "PRA1 domain family member 2" O60831 X 49071161-49074002 "Predicted membrane proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 163.4" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002859, HPA005504, CAB011655" Enhanced Approved "Endoplasmic reticulum,Vesicles" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 33: Fibroblasts - ECM organization" "Endoplasmic reticulum" Vesicles "CAB011655: , HPA002859: AB_1079672, HPA005504: AB_2667340" "unprognostic (1.50e-1)" "prognostic favorable (7.42e-4)" "unprognostic (1.17e-2)" "unprognostic (1.32e-2)" "unprognostic (4.29e-1)" "unprognostic (3.67e-1)" "prognostic unfavorable (1.66e-6)" "prognostic favorable (2.81e-4)" "unprognostic (6.10e-2)" "unprognostic (3.77e-1)" "prognostic favorable (4.88e-6)" "unprognostic (8.39e-3)" "prognostic unfavorable (5.83e-6)" "unprognostic (4.96e-2)" "unprognostic (1.69e-1)" "unprognostic (1.15e-1)" "unprognostic (1.50e-1)" 26.5 38.7 66.9 15.6 67.3 8.2 23.2 67.2 82.5 43.2 63.8 32.3 6.1 51.5 163.4 11.7 36.0 14.8 32.0 66.7 72.1 26.3 11.5 29.7 12.8 69.4 73.8 37.7 10.5 29.2 74.5 11.4 73.9 26.4 11.1 21.6 13.9 35.8 12.1 14.7 17.8 43.6 66.1 21.7 21.9 28.2 71.1 21.5 27.7 9.0 14.9 33.1 26.0 69.8 17.0 35.0 40.0 51.5 140.4 84.7 5.0 59.1 61.9 39.7 43.2 2.0 5.3 1.7 14.0 129.3 32.6 15.5 1.6 32.3 43.6 31.3 45.4 13.4 43.0 1.8 143.2 8.8 25.0 108.3 27.0 75.0 54.0 80.9 61.6 41.3 2.1 4.6 69.5 31.4 56.6 10.6 22.5 8.3 2.3 30.8 21.9 3.8 60.0 5.0 26.6 66.3 49.5 25.5 35.2 35.1 25.0 6.2 37.8 30.1 39.6 65.6 17.5 71.7 19.8 13.4 72.7 15.3 48.1 47.0 13.0 18.5 38.6 15.0 43.2 32.0 41.6 33.9 14.9 30.2 36.7 40.1 34.1 39.0 11.2 5.9 68.4 26.0 66.9 67.3 67.2 82.5 66.7 72.1 69.4 73.8 73.9 66.1 71.1 69.8 21.5 12.8 10.0 7.5 8.7 7.6 14.9 34.8 11.4 23.1 8.0 10.7 5.8 11.5 16.3 11.0 12.5 3.3 13.2 2.2 11.7 16.7 3.4 6.8 31.6 30.9 10.2 5.2 5.8 5.7 13.4 29.9 4.1 9.2 15.9 13.4 33.5 3.6 6.1 16.8 7.0 4.7 40.7 5.7 11.3 6.0 38.2 6.6 14.2 5.6 5.6 29.2 16.5 3.5 9.9 4.1 0.8 41.3 10.5 10.1 1.5 18.5 17.7 8.6 19.7 13.2 33.4 14.7 4.5 5.0 7.4 9.7 17.5 36.3 1.5 9.3 PRCP "HUMPCP, PCP" ENSG00000137509 Prolylcarboxypeptidase P42785 11 82822936-82970584 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Carboxypeptidase, Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Hepatic stellate cells: 348.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 463.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017065, HPA071115" Approved Supported Vesicles "Intracellular and membrane" NA NA 42000000 "Cluster 28: Myeloid DCs - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" Vesicles "HPA017065: AB_1855676, HPA071115: " "unprognostic (3.24e-1)" "unprognostic (2.25e-1)" "unprognostic (1.76e-1)" "unprognostic (1.51e-1)" "unprognostic (2.54e-1)" "unprognostic (1.33e-2)" "unprognostic (9.22e-2)" "unprognostic (1.42e-1)" "unprognostic (7.97e-2)" "unprognostic (2.61e-1)" "unprognostic (2.70e-1)" "unprognostic (1.88e-2)" "prognostic favorable (2.65e-6)" "unprognostic (7.16e-2)" "unprognostic (1.73e-2)" "unprognostic (3.49e-1)" "unprognostic (4.07e-1)" 74.8 87.3 81.1 57.8 82.1 37.7 70.0 84.3 109.1 91.9 95.0 49.3 28.6 62.9 81.4 62.1 57.0 64.3 70.0 76.6 85.6 144.7 151.9 58.1 92.1 84.4 82.1 53.5 37.9 78.4 34.5 152.8 80.9 52.5 46.6 21.9 85.6 55.5 15.9 54.1 31.8 80.8 89.0 54.0 32.0 41.8 86.0 33.7 63.7 28.5 85.0 100.2 57.5 86.7 34.9 41.8 49.6 121.0 463.5 146.7 67.1 67.5 131.9 70.9 97.0 103.5 70.7 55.9 100.7 117.9 72.6 53.2 53.7 45.2 72.0 43.9 38.3 37.7 56.5 76.7 86.2 31.0 124.7 122.0 39.3 72.7 68.6 166.5 224.0 26.3 39.1 69.8 72.7 19.5 4.9 171.7 33.9 90.3 31.1 27.1 97.0 65.1 118.0 71.2 24.0 51.9 101.9 60.2 41.5 80.6 66.6 49.6 65.0 78.8 77.4 71.1 33.5 64.2 113.6 46.3 32.9 41.7 44.5 53.5 76.9 50.9 13.7 79.0 16.1 31.7 14.0 15.9 140.2 34.2 12.0 17.4 89.0 34.7 64.8 27.9 14.8 49.6 81.1 82.1 84.3 109.1 76.6 85.6 84.4 82.1 80.9 89.0 86.0 86.7 86.9 19.2 12.9 58.8 45.5 31.4 41.5 53.4 25.0 11.7 26.2 25.1 26.6 37.1 25.2 62.5 2.1 65.1 29.0 9.8 29.4 32.9 44.9 17.4 37.7 180.4 19.7 13.7 42.2 12.0 120.1 73.6 23.9 29.9 12.7 18.2 348.7 65.4 80.7 16.8 38.5 19.1 14.2 152.9 118.9 47.6 44.1 88.0 71.2 33.7 79.5 53.5 28.8 34.7 10.5 8.2 10.2 46.3 62.2 23.3 3.9 83.8 9.1 5.3 65.7 25.5 25.6 60.8 6.3 54.3 34.9 52.9 22.3 27.7 20.9 39.2 PROKR1 "GPR73, GPR73a, PKR1, ZAQ" ENSG00000169618 "Prokineticin receptor 1" Q8TCW9 2 68643579-68658251 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adipose tissue: 1.6;epididymis: 3.5" "Cell type enhanced" "Detected in single" "Adipocytes: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "NTERA-2: 2.0" "Low region specificity" "Detected in all" HPA029396 Uncertain NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 5: NTERA-2 - Transcription" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "HPA029396: AB_10610285" "unprognostic (5.46e-2)" "unprognostic (1.60e-2)" "unprognostic (8.75e-2)" "unprognostic (4.99e-4)" "unprognostic (1.18e-1)" "unprognostic (2.55e-3)" "unprognostic (1.07e-1)" "unprognostic (2.91e-2)" "unprognostic (1.85e-1)" "unprognostic (4.52e-2)" "unprognostic (1.89e-1)" "unprognostic (9.72e-2)" "unprognostic (8.96e-7)" "unprognostic (4.07e-2)" "unprognostic (2.53e-1)" "unprognostic (4.19e-1)" "unprognostic (7.22e-2)" 1.6 1.1 0.0 0.2 0.0 0.0 0.6 0.2 0.1 0.0 0.0 0.2 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.5 0.0 0.5 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.7 0.6 0.4 0.5 0.4 0.1 0.1 1.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRR23D1 ENSG00000255251 "Proline rich 23 domain containing 1" E9PI22 8 7539628-7542450 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 37 "epididymis: 46.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 68: Epididymis - Unknown function" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 46.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRR23D2 ENSG00000255378 "Proline rich 23 domain containing 2" P0DMB1 8 7778591-7781413 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in some" 33 "epididymis: 46.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 68: Epididymis - Unknown function" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 46.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRSS45P "PRSS45, TESPL, TESSP5" ENSG00000188086 "Serine protease 45, pseudogene" Q7RTY3 3 46742092-46750891 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protease, Serine protease" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "epididymis: 6.4;skeletal muscle: 10.4" "Not detected" "Not detected" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA060284 Uncertain NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 68: Epididymis - Unknown function" "HPA060284: AB_2684242" "unprognostic (4.55e-3)" "unprognostic (3.49e-2)" "unprognostic (1.07e-2)" "unprognostic (2.50e-1)" "unprognostic (6.07e-2)" "unprognostic (1.28e-2)" "unprognostic (1.06e-1)" "unprognostic (6.20e-2)" "unprognostic (1.54e-1)" "unprognostic (1.30e-1)" "unprognostic (3.83e-4)" "unprognostic (2.33e-2)" "unprognostic (6.60e-3)" "unprognostic (1.27e-2)" "unprognostic (1.57e-2)" "unprognostic (2.15e-1)" "unprognostic (5.97e-3)" 0.3 0.2 0.3 0.0 0.3 0.0 1.1 0.5 0.4 1.6 1.0 0.5 0.1 0.3 6.4 0.2 0.9 0.0 3.5 0.2 0.7 1.7 1.3 0.6 0.1 0.6 0.7 0.4 2.1 2.8 1.9 0.1 0.7 1.4 0.0 0.2 0.9 1.0 10.4 0.3 0.3 0.1 0.5 0.3 0.3 2.2 0.6 0.2 4.9 0.9 0.0 0.7 0.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.5 0.4 0.2 0.7 0.6 0.7 0.7 0.5 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PSMD10 p28 ENSG00000101843 "Proteasome 26S subunit, non-ATPase 10" O75832 X 108084207-108091549 "Predicted intracellular proteins" Apoptosis Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002920, CAB010434" Approved Supported "Intermediate filaments,Cytosol" NA NA 250000 "Cluster 45: Eosinophils - Innate immune response" "Cluster 68: Epididymis - Unknown function" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 10: Non-specific - Unknown function" Cytosol "Intermediate filaments" "CAB010434: AB_640866, HPA002920: AB_1079708" "unprognostic (1.59e-3)" "unprognostic (4.12e-3)" "unprognostic (3.83e-1)" "unprognostic (3.00e-1)" "unprognostic (4.65e-2)" "unprognostic (1.50e-2)" "unprognostic (3.85e-3)" "unprognostic (2.35e-1)" "unprognostic (1.44e-1)" "unprognostic (2.06e-2)" "unprognostic (4.95e-2)" "unprognostic (7.37e-3)" "unprognostic (1.64e-2)" "unprognostic (1.42e-2)" "unprognostic (2.09e-1)" "unprognostic (5.07e-2)" "unprognostic (1.09e-1)" 28.2 38.6 49.4 26.2 52.3 28.7 35.1 54.5 68.3 34.3 47.4 32.7 25.3 36.4 48.3 34.5 44.9 25.8 26.0 49.9 58.9 34.6 33.4 28.6 34.8 55.4 58.6 31.7 18.6 41.4 33.1 40.4 61.4 31.6 33.2 44.6 26.2 30.4 24.8 26.8 27.0 36.2 56.4 27.1 27.8 27.5 57.5 41.9 38.1 23.9 39.1 33.4 27.7 59.4 101.3 100.5 68.9 62.6 102.6 77.3 61.8 81.6 69.2 73.9 64.0 60.7 64.4 86.0 119.7 80.2 107.6 54.0 109.8 80.3 113.4 91.3 94.8 50.5 91.0 78.2 51.8 79.2 54.8 58.2 85.9 67.2 82.2 73.2 186.4 83.2 99.9 114.3 94.0 133.0 75.3 70.9 124.1 96.9 138.3 74.2 97.5 92.7 80.7 64.8 44.2 42.1 124.8 52.4 86.0 87.4 56.5 66.9 130.5 58.1 33.1 98.3 61.4 88.5 128.5 90.5 80.4 109.2 69.7 83.6 46.8 72.3 45.9 58.1 49.0 47.9 45.8 49.2 52.2 48.0 45.6 51.4 22.0 58.3 71.4 53.0 57.8 69.9 49.4 52.3 54.5 68.3 49.9 58.9 55.4 58.6 61.4 56.4 57.5 59.4 14.2 19.2 19.8 3.3 23.4 22.6 25.9 31.8 23.9 15.1 20.4 20.6 11.2 8.6 35.4 11.0 2.1 28.3 12.8 16.5 31.3 19.9 4.1 38.3 26.9 22.8 14.4 35.7 3.4 18.7 35.3 22.6 11.7 21.6 34.1 17.9 22.1 25.6 31.3 13.5 4.5 16.8 16.2 29.5 19.0 4.4 25.7 20.2 17.8 0.0 26.1 18.3 20.6 5.5 9.6 24.5 14.1 21.1 34.7 26.6 14.9 34.8 69.9 7.7 0.0 13.8 32.1 46.2 40.3 32.4 29.1 25.0 20.2 24.6 19.2 33.7 PTCHD4 "C6orf138, dJ402H5.2, FLJ41841, PTCH53" ENSG00000244694 "Patched domain containing 4" Q6ZW05 6 47856673-48111197 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in some" "Cell type enriched" "Detected in some" 5 "Inhibitory neurons: 479.8" "Group enriched" "Detected in some" 6 "melanoma: 1.1;renal cancer: 1.6;thyroid cancer: 4.0" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 9.4;BEWO: 12.4;Hep G2: 21.8;LHCN-M2: 9.6;SuSa: 20.1;TIME: 9.9;WM-115: 11.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA041276 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Plasma membrane, Cytosol" "HPA041276: AB_10796570" "unprognostic (1.35e-4)" "unprognostic (1.66e-2)" "unprognostic (3.25e-1)" "unprognostic (3.11e-3)" "unprognostic (1.07e-2)" "unprognostic (1.57e-3)" "unprognostic (7.94e-2)" "unprognostic (3.59e-3)" "unprognostic (2.80e-1)" "unprognostic (1.50e-1)" "unprognostic (2.55e-1)" "unprognostic (1.92e-1)" "prognostic favorable (1.49e-6)" "unprognostic (5.03e-4)" "unprognostic (9.84e-2)" "unprognostic (1.57e-2)" "unprognostic (5.56e-3)" 0.5 0.1 0.6 0.0 0.6 0.0 0.3 0.0 1.5 0.6 0.1 0.3 0.1 0.3 0.6 0.3 0.5 0.2 0.5 0.8 0.5 0.4 0.3 0.5 0.0 0.2 1.0 0.2 0.2 0.0 0.9 0.3 0.0 0.5 0.1 0.8 0.5 1.0 0.1 0.0 0.1 0.3 0.5 0.0 0.1 0.2 0.3 0.0 0.8 0.1 0.0 0.3 0.3 0.4 0.0 0.0 9.4 0.0 1.3 3.9 12.4 1.2 2.8 0.0 0.4 0.0 0.5 0.0 0.0 0.9 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.2 21.8 0.5 0.0 0.0 6.2 5.4 0.0 0.1 4.4 1.8 2.5 0.0 0.0 9.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.8 0.5 0.1 0.0 0.0 20.1 0.0 0.0 9.9 2.3 1.9 0.0 0.2 0.0 0.0 0.0 3.3 0.0 11.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.6 0.0 1.5 0.8 0.5 0.2 1.0 0.0 0.5 0.3 0.4 0.5 0.0 1.1 6.5 0.0 0.1 0.0 1.0 0.0 1.0 0.4 0.3 0.2 0.0 1.3 1.8 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.6 0.0 0.0 90.6 0.0 0.1 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 479.8 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 89.9 0.0 0.6 0.0 2.5 2.8 0.1 0.0 0.4 0.0 0.2 0.0 0.0 1.1 0.9 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 PTRH2 "BIT1, CFAP37, CGI-147, PTH2" ENSG00000141378 "Peptidyl-tRNA hydrolase 2" Q9Y3E5 17 59674636-59707626 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins" Apoptosis Hydrolase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012897 Supported Supported Mitochondria NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 68: Epididymis - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" Mitochondria "HPA012897: AB_1855949" "unprognostic (2.26e-1)" "unprognostic (2.80e-2)" "unprognostic (1.02e-2)" "unprognostic (3.89e-2)" "unprognostic (1.31e-2)" "unprognostic (3.38e-2)" "prognostic unfavorable (1.50e-4)" "unprognostic (6.38e-2)" "unprognostic (2.02e-1)" "unprognostic (9.59e-3)" "unprognostic (2.72e-1)" "unprognostic (1.40e-1)" "prognostic unfavorable (1.01e-8)" "unprognostic (5.43e-3)" "unprognostic (6.82e-2)" "unprognostic (1.32e-1)" "unprognostic (1.49e-2)" 20.8 25.9 24.3 17.3 25.1 14.5 27.6 25.0 31.9 19.7 23.6 24.1 15.3 18.8 48.5 18.1 18.4 18.2 14.5 25.1 26.1 18.5 45.7 14.7 19.0 25.9 26.1 16.9 19.5 18.6 14.1 18.6 26.7 20.7 27.5 10.2 15.9 18.6 25.0 15.7 13.2 22.9 24.8 17.5 16.1 19.5 24.9 17.3 16.2 20.9 24.1 44.0 11.8 27.4 75.9 142.9 44.3 40.8 84.8 72.6 47.4 70.6 63.8 60.7 89.0 94.1 57.7 54.1 105.0 60.9 101.1 73.3 98.4 93.8 89.4 104.2 133.2 96.7 72.3 176.2 129.4 86.0 52.5 82.0 120.9 93.9 108.5 42.8 102.5 37.4 111.3 58.2 92.4 187.9 74.2 71.2 38.0 194.5 113.4 39.1 74.8 80.7 103.7 109.2 57.9 74.2 36.7 39.6 91.5 50.7 93.1 61.1 67.2 77.8 77.8 47.1 77.9 73.6 91.9 82.3 50.7 54.4 60.4 6.1 69.0 2.9 22.7 67.4 30.9 43.1 26.3 25.7 50.0 33.1 37.4 27.0 29.0 34.8 86.0 59.4 34.0 37.9 24.3 25.1 25.0 31.9 25.1 26.1 25.9 26.1 26.7 24.8 24.9 27.4 21.4 16.0 13.6 5.5 18.7 36.7 50.1 48.1 27.9 4.1 17.1 22.4 15.4 11.5 51.6 11.0 4.2 26.8 13.0 8.9 11.7 27.2 22.1 23.4 33.1 22.5 6.7 17.9 9.8 25.6 25.0 29.7 17.3 24.1 22.8 12.8 12.8 31.5 16.9 8.4 9.1 10.3 22.4 9.7 17.2 12.0 17.4 14.6 14.2 2.8 11.4 7.2 13.4 7.5 11.5 28.8 12.3 9.8 24.8 35.1 10.0 16.5 33.3 3.4 13.1 25.4 32.2 33.4 13.3 21.3 35.7 31.7 12.6 22.4 16.7 37.5 PXYLP1 "ACPL2, FLJ23751" ENSG00000155893 "2-phosphoxylose phosphatase 1" Q8TE99 3 141228726-141367753 "Metabolic proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 148.2" "Cell type enhanced" "Detected in many" "Early spermatids: 196.8;Late spermatids: 131.1;Spermatocytes: 95.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017243 Uncertain "Intracellular and membrane" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 68: Epididymis - Unknown function" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 66: Spermatocytes - Spermatogenesis" "HPA017243: AB_1844509" "unprognostic (9.55e-2)" "unprognostic (3.48e-3)" "unprognostic (1.81e-1)" "unprognostic (2.06e-1)" "unprognostic (8.45e-2)" "unprognostic (8.04e-3)" "unprognostic (4.05e-3)" "unprognostic (5.43e-2)" "unprognostic (1.27e-1)" "unprognostic (6.95e-2)" "unprognostic (5.07e-3)" "unprognostic (4.67e-2)" "unprognostic (1.29e-2)" "unprognostic (5.20e-2)" "unprognostic (1.37e-1)" "unprognostic (8.56e-2)" "unprognostic (8.17e-3)" 4.2 6.3 5.6 4.3 6.4 5.0 8.3 1.7 13.5 7.3 0.3 5.4 5.5 8.8 148.2 2.6 6.4 8.2 13.8 6.3 6.5 7.5 5.1 4.9 9.1 1.0 3.0 8.6 9.2 16.2 7.4 18.2 1.1 10.1 5.6 18.3 6.6 28.9 2.9 4.6 6.4 7.2 3.4 5.3 5.0 8.9 3.4 53.3 5.9 2.0 9.9 7.0 4.7 6.6 5.3 5.5 23.3 18.5 9.0 7.7 5.6 3.6 9.0 9.1 12.5 9.2 1.8 0.3 4.9 8.2 1.9 1.2 24.7 2.3 8.7 17.4 16.3 1.9 7.5 7.4 19.2 4.8 1.0 7.3 10.4 2.8 1.0 11.3 0.6 17.8 0.9 2.1 4.1 4.5 25.8 6.0 9.7 13.2 3.1 3.5 13.6 3.2 6.5 22.8 10.1 17.8 9.3 2.9 7.6 4.2 9.7 2.8 1.1 11.6 6.9 8.0 3.5 4.9 0.4 0.7 10.7 6.5 10.4 15.2 6.0 9.4 13.4 4.0 8.6 0.7 7.5 8.9 5.3 0.5 21.6 17.6 3.8 19.3 2.0 1.9 4.3 8.9 5.6 6.4 1.7 13.5 6.3 6.5 1.0 3.0 1.1 3.4 3.4 6.6 1.1 9.6 8.7 14.0 2.2 0.0 4.6 0.0 6.2 3.3 9.5 6.7 7.6 2.8 1.8 46.0 6.2 2.1 3.4 2.1 0.0 3.2 196.8 1.0 9.3 1.4 4.2 4.4 41.3 3.7 8.2 7.9 1.1 1.8 2.5 5.4 1.4 3.8 0.7 6.7 31.8 3.9 0.0 1.8 0.0 131.1 20.2 2.0 0.0 1.0 3.5 8.0 3.1 32.6 6.5 3.0 8.6 15.1 2.7 7.6 4.2 11.7 2.9 5.2 13.1 6.6 4.2 95.9 13.8 2.2 0.0 1.1 4.9 0.9 4.7 6.6 QPCT "GCT, QC" ENSG00000115828 "Glutaminyl-peptide cyclotransferase" Q16769 2 37342827-37373322 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 170.3;epididymis: 104.0" "Group enriched" "Detected in many" 4 "Enteroendocrine cells: 217.0;Ionocytes: 138.4;Langerhans cells: 163.4;Melanocytes: 528.3" "Cancer enhanced" "Detected in all" "melanoma: 97.4" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 4 "neutrophil: 1527.7" "Lineage enriched" "Detected in many" 4 "granulocytes: 1527.7" "Cell line enhanced" "Detected in many" "SCLC-21H: 117.1;SK-MEL-30: 426.8;U-266/84: 341.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008406 Enhanced Approved Cytosol "Secreted to blood" NA NA 390000 "Cluster 9: Neutrophils - Innate immune response" "Cluster 68: Epididymis - Unknown function" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 48: Smooth muscle cells - ECM organization" Cytosol "HPA008406: AB_1855981" "unprognostic (6.25e-3)" "unprognostic (6.69e-2)" "unprognostic (4.95e-2)" "unprognostic (1.44e-1)" "unprognostic (1.44e-2)" "unprognostic (9.32e-2)" "unprognostic (1.13e-3)" "unprognostic (9.73e-2)" "unprognostic (2.71e-3)" "unprognostic (7.86e-2)" "unprognostic (3.67e-2)" "unprognostic (1.17e-1)" "unprognostic (6.78e-2)" "unprognostic (7.76e-3)" "unprognostic (1.21e-1)" "unprognostic (9.48e-3)" "unprognostic (3.62e-3)" 5.6 170.3 8.4 14.2 7.5 47.3 15.8 5.1 11.5 21.2 4.2 25.3 5.6 9.8 104.0 3.4 2.2 10.8 5.1 8.9 27.4 6.1 2.6 5.6 8.1 9.7 11.6 1.0 13.7 14.8 27.0 9.2 14.7 7.2 10.2 11.9 25.5 6.7 4.1 36.3 4.5 8.3 7.8 13.9 7.6 2.0 20.3 5.1 3.8 2.8 12.5 15.2 4.6 6.7 1.0 40.7 0.1 0.0 6.0 13.3 0.1 6.6 86.5 6.4 10.1 2.9 7.1 0.2 3.0 32.6 72.9 0.1 2.7 0.6 10.3 0.6 76.0 18.7 0.3 7.7 0.6 3.0 0.1 8.5 0.0 47.3 0.2 0.4 26.2 0.0 0.0 0.0 0.2 4.5 0.0 1.7 0.6 0.3 0.0 0.0 0.0 0.8 42.6 10.9 117.1 0.2 6.4 1.4 426.8 8.0 0.7 2.9 19.4 0.0 0.2 0.1 0.6 15.3 341.7 0.3 25.8 0.3 0.0 9.8 344.8 3.2 0.4 38.7 1.0 2.6 0.6 0.5 124.7 1.2 0.5 0.3 1527.7 0.2 3.3 2.4 0.1 169.8 8.4 7.5 5.1 11.5 8.9 27.4 9.7 11.6 14.7 7.8 20.3 6.7 1.8 3.2 2.3 0.3 12.5 39.0 13.6 40.0 2.2 21.8 7.9 8.5 1.1 1.5 17.7 22.0 2.1 0.7 0.8 6.1 1.9 45.4 0.6 2.6 24.7 17.5 217.0 1.7 8.5 2.4 6.1 26.7 3.1 4.0 55.3 1.6 22.5 0.3 20.5 43.7 7.3 6.6 138.4 21.2 163.4 2.9 3.1 26.8 528.3 6.5 64.3 0.8 3.1 3.0 1.3 31.8 1.8 23.7 26.0 9.1 0.2 11.7 4.3 3.2 13.1 0.6 6.6 1.7 0.7 0.6 14.5 4.7 5.6 5.0 7.3 5.8 RAB11FIP2 "KIAA0941, nRip11, Rab11-FIP2" ENSG00000107560 "RAB11 family interacting protein 2" Q7L804 10 118004916-118046941 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 82.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037726 Approved Supported Nucleoplasm,Vesicles NA NA "Cluster 46: Basophils - DNA binding" "Cluster 68: Epididymis - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 50: Fibroblasts - ECM organization" Vesicles Nucleoplasm "HPA037726: AB_10672390" "unprognostic (1.97e-1)" "unprognostic (1.68e-2)" "unprognostic (3.61e-1)" "unprognostic (4.45e-2)" "unprognostic (1.30e-1)" "unprognostic (5.58e-2)" "unprognostic (2.17e-2)" "unprognostic (3.34e-2)" "unprognostic (1.83e-2)" "unprognostic (2.15e-1)" "unprognostic (2.06e-1)" "unprognostic (1.47e-1)" "prognostic favorable (9.69e-5)" "unprognostic (1.17e-1)" "unprognostic (1.56e-1)" "unprognostic (1.90e-1)" "unprognostic (2.17e-1)" 8.6 6.6 5.2 6.6 7.0 13.8 6.9 4.8 8.5 10.2 2.4 8.2 3.6 18.8 28.5 6.3 11.8 8.3 6.1 7.1 3.4 12.2 5.4 7.6 6.9 2.8 4.6 9.9 5.6 6.3 4.3 8.2 2.2 10.8 4.9 10.3 4.8 24.7 5.0 5.9 5.5 19.5 3.7 6.6 17.2 7.8 5.3 6.2 11.4 7.5 5.5 7.6 6.2 6.1 7.1 8.8 7.3 9.3 11.9 15.0 7.8 13.8 15.8 8.3 8.6 7.4 7.4 14.5 10.8 14.0 6.1 4.8 10.1 6.1 12.8 3.8 10.9 5.1 9.1 5.1 17.2 9.7 5.5 14.8 11.3 11.6 25.4 11.0 5.1 9.3 3.9 12.1 10.9 2.5 7.5 7.3 6.2 3.1 6.2 6.4 26.0 4.9 12.4 5.6 1.7 13.5 9.8 3.9 17.3 8.7 3.0 8.9 7.7 11.2 8.9 13.3 13.8 8.9 7.8 9.4 11.5 16.4 7.0 0.2 0.2 0.2 0.2 0.1 0.2 0.3 0.2 0.2 0.1 0.4 0.4 0.2 0.3 0.1 0.1 0.5 0.1 0.0 5.2 7.0 4.8 8.5 7.1 3.4 2.8 4.6 2.2 3.7 5.3 6.1 16.7 57.7 31.5 79.7 17.7 10.3 8.8 4.4 12.5 28.1 10.1 10.7 25.8 24.3 6.0 42.3 29.2 11.6 15.1 5.5 7.9 12.6 16.5 13.1 31.0 14.1 14.5 17.4 63.8 18.7 7.9 29.1 14.8 15.7 3.8 28.0 11.4 8.6 11.4 38.7 57.9 6.6 4.1 23.0 12.2 6.6 33.5 16.2 23.2 34.7 19.4 26.0 15.5 53.8 82.9 16.6 4.7 28.6 17.0 11.1 5.4 18.1 7.3 31.4 26.3 34.0 25.8 14.9 21.2 9.2 9.5 5.2 12.9 19.2 6.5 6.4 RAB40A "Rar-2, RAR2A" ENSG00000172476 "RAB40A, member RAS oncogene family" Q8WXH6 X 103499130-103519489 "Cancer-related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Cancer-related genes" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "epididymis: 8.0" "Group enriched" "Detected in some" 5 "Astrocytes: 4.9;Excitatory neurons: 7.4;Inhibitory neurons: 7.3;Microglial cells: 5.6;Oligodendrocyte precursor cells: 6.6;Oligodendrocytes: 3.3;Peritubular cells: 6.0" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 3.3;NTERA-2: 3.7" HPA076172 Uncertain Vesicles NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 18: U-2197 - ECM organization" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Vesicles "HPA076172: " "unprognostic (3.49e-1)" "unprognostic (6.01e-2)" "unprognostic (4.33e-2)" "unprognostic (4.49e-3)" "unprognostic (8.73e-2)" "unprognostic (1.08e-1)" "unprognostic (8.21e-2)" "unprognostic (1.72e-1)" "unprognostic (1.24e-1)" "unprognostic (4.05e-1)" "unprognostic (3.82e-2)" "unprognostic (4.43e-1)" "unprognostic (7.36e-4)" "unprognostic (7.85e-3)" "unprognostic (9.39e-5)" "unprognostic (1.43e-1)" "unprognostic (1.11e-3)" 2.0 1.2 1.0 0.2 3.1 0.1 0.9 0.7 1.4 3.0 6.4 0.6 0.4 4.5 8.0 7.1 2.3 0.5 0.7 1.6 1.2 1.3 0.3 1.3 0.2 0.8 0.3 4.6 0.5 0.2 2.4 0.6 0.3 3.5 0.3 1.3 0.4 2.1 0.2 0.5 0.5 0.9 0.0 0.6 0.8 3.8 1.1 0.1 0.7 0.2 0.1 2.3 1.5 1.0 0.2 0.9 3.3 0.1 0.7 0.9 1.6 1.0 0.2 0.1 0.3 0.7 0.5 0.8 1.2 0.2 1.0 0.0 0.2 0.0 0.1 0.0 2.0 0.2 1.8 0.2 0.3 0.0 0.1 0.7 0.1 0.3 0.2 1.2 0.2 0.3 1.2 0.5 0.3 0.2 0.2 0.1 3.7 0.0 0.5 0.0 0.2 0.0 0.0 0.3 1.4 1.7 0.3 0.0 0.7 0.9 0.0 0.1 1.7 1.3 0.8 2.1 0.9 0.6 0.4 0.6 1.5 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 3.1 0.7 1.4 1.6 1.2 0.8 0.3 0.3 0.0 1.1 1.0 0.3 0.0 0.0 4.9 0.0 0.0 0.7 0.1 0.0 0.2 0.1 0.4 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.6 0.1 0.0 0.0 7.4 0.0 0.2 0.2 0.0 0.1 0.0 1.0 0.0 0.0 0.1 0.0 7.3 0.1 0.0 0.0 0.0 0.7 0.9 0.0 0.0 5.6 0.0 0.2 0.0 6.6 3.3 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.2 0.0 0.1 0.0 0.1 0.3 0.0 0.3 0.0 0.0 RABL2B ENSG00000079974 "RAB, member of RAS oncogene family like 2B" Q9UNT1 22 50767501-50783662 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Endometrial ciliated cells: 99.4;Respiratory ciliated cells: 188.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA042642, HPA042700, HPA044007" Approved Approved Vesicles,Centrosome NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 68: Epididymis - Unknown function" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 49: Ciliated cells - Cilium organization" Centrosome Vesicles "HPA042642: , HPA042700: AB_2678120, HPA044007: AB_2678770" "unprognostic (2.09e-1)" "unprognostic (1.47e-2)" "unprognostic (1.86e-3)" "prognostic favorable (5.58e-4)" "unprognostic (7.85e-2)" "unprognostic (9.98e-2)" "prognostic unfavorable (4.58e-5)" "unprognostic (3.14e-1)" "unprognostic (6.97e-2)" "unprognostic (7.33e-2)" "unprognostic (1.19e-2)" "unprognostic (7.51e-2)" "unprognostic (3.71e-3)" "unprognostic (7.43e-3)" "unprognostic (1.37e-1)" "unprognostic (1.25e-1)" "unprognostic (8.37e-3)" 13.2 12.9 18.1 18.6 18.8 14.4 15.8 18.1 22.4 23.9 73.6 16.5 12.5 21.7 90.3 13.3 66.6 14.5 10.2 23.3 17.0 17.7 12.2 21.8 23.1 23.3 33.2 22.5 16.3 14.6 26.7 11.6 17.9 16.2 16.7 30.2 16.8 16.9 8.8 22.2 15.6 15.6 21.9 19.3 14.5 23.1 20.1 21.6 28.2 4.6 20.3 17.0 15.7 18.5 23.0 20.4 34.1 26.7 37.3 29.6 25.0 16.7 18.5 13.2 18.1 5.8 19.7 14.7 14.7 24.1 21.6 29.5 15.8 19.6 14.2 13.3 23.2 12.8 40.2 15.1 15.4 36.1 13.0 25.3 26.2 17.5 21.9 39.2 15.0 26.0 9.9 17.9 26.7 28.8 18.2 15.9 13.2 14.0 15.0 30.1 19.8 16.1 25.9 22.4 14.6 26.5 20.5 17.8 13.4 23.4 17.7 11.2 23.2 12.6 25.1 10.9 11.4 15.2 7.4 7.2 23.8 8.8 18.1 1.8 14.4 13.1 21.4 23.5 15.5 15.2 16.4 17.3 15.7 19.2 18.7 18.3 5.4 15.9 28.4 18.0 18.6 14.7 18.1 18.8 18.1 22.4 23.3 17.0 23.3 33.2 17.9 21.9 20.1 18.5 6.2 12.8 13.4 14.4 16.8 5.4 13.4 13.3 15.9 15.2 13.3 11.8 5.1 12.8 24.1 22.0 31.3 12.1 16.2 10.6 13.7 21.3 25.7 99.4 11.2 7.2 5.4 9.9 25.7 10.8 11.1 11.4 9.7 8.6 3.8 22.1 5.3 8.9 12.0 16.8 18.9 8.0 22.4 10.1 6.9 24.2 14.0 8.4 17.8 4.7 14.4 13.9 36.0 7.1 15.1 10.4 4.9 10.9 8.0 7.3 8.6 16.3 188.6 40.0 6.6 15.0 14.8 38.8 27.0 8.8 5.7 6.7 16.0 11.9 10.7 6.5 RAD51B "hREC2, R51H2, RAD51L1, REC2" ENSG00000182185 "RAD51 paralog B" O15315 14 67819779-68730218 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "DNA damage, DNA recombination, DNA repair" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 10 "Astrocytes: 150.8;Microglial cells: 263.3;Oligodendrocyte precursor cells: 157.3;Oligodendrocytes: 375.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "CAB016191, HPA051869" Enhanced Approved "Nucleoplasm,Nuclear bodies" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 68: Epididymis - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Nuclear bodies" Nucleoplasm "CAB016191: AB_2238209, HPA051869: AB_2681644" "unprognostic (9.10e-3)" "unprognostic (5.45e-2)" "unprognostic (4.92e-1)" "unprognostic (6.65e-2)" "unprognostic (2.38e-2)" "unprognostic (4.85e-2)" "unprognostic (6.42e-3)" "unprognostic (2.54e-2)" "unprognostic (1.06e-1)" "unprognostic (3.08e-1)" "unprognostic (6.80e-3)" "unprognostic (1.47e-1)" "unprognostic (6.25e-2)" "unprognostic (1.77e-1)" "unprognostic (2.49e-2)" "unprognostic (6.79e-2)" "unprognostic (8.13e-3)" 3.1 2.3 3.0 2.9 5.7 7.3 5.5 3.8 3.3 5.8 5.8 3.0 1.1 4.4 9.0 3.7 3.9 4.3 1.7 3.4 3.7 2.7 2.1 2.7 4.8 5.7 4.7 6.3 2.1 4.9 2.0 4.1 5.7 2.5 2.6 3.0 13.1 2.3 1.2 4.2 2.4 4.4 4.3 2.6 2.6 1.8 5.0 5.9 2.5 1.2 4.3 3.6 4.5 7.3 15.3 5.9 6.5 3.9 5.9 10.0 4.0 7.6 5.8 8.2 10.5 4.2 20.1 18.6 4.8 4.7 9.4 13.4 4.1 12.1 11.1 8.4 4.2 8.9 5.4 3.3 3.2 7.6 8.6 5.1 9.0 9.4 9.9 3.8 7.4 13.5 7.3 8.4 6.7 11.9 14.9 2.7 3.8 14.6 5.9 16.6 7.7 6.8 6.3 4.3 4.4 2.9 6.0 2.2 13.1 7.6 10.1 6.8 2.0 9.9 9.6 7.8 6.3 4.0 4.4 14.9 5.5 13.1 5.7 17.4 5.7 5.7 8.1 4.8 6.6 14.2 7.6 8.6 6.5 11.8 9.4 8.9 0.7 8.5 4.7 6.4 9.4 4.5 3.0 5.7 3.8 3.3 3.4 3.7 5.7 4.7 5.7 4.3 5.0 7.3 5.1 0.0 1.1 150.8 13.3 6.6 5.1 6.4 5.7 1.8 8.4 5.1 1.6 0.0 4.0 1.8 8.4 5.4 3.5 1.1 3.9 1.9 3.0 5.3 3.7 4.5 4.8 4.6 21.5 1.4 6.7 4.2 3.1 3.6 4.5 6.8 1.8 0.8 6.5 1.7 22.0 3.8 2.0 3.4 3.5 1.9 3.7 4.2 8.8 263.3 6.8 5.8 3.1 157.3 375.2 1.0 0.6 4.5 8.9 2.4 2.7 1.8 8.4 6.0 0.0 3.6 7.0 6.2 3.2 5.6 7.0 4.0 7.0 4.4 1.8 4.6 RBM11 ENSG00000185272 "RNA binding motif protein 11" P57052 21 14216130-14228372 "Predicted intracellular proteins" "Differentiation, mRNA processing, mRNA splicing" "Developmental protein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "epididymis: 45.2" "Cell type enhanced" "Detected in many" "Distal tubular cells: 15.6;Excitatory neurons: 13.0;Inhibitory neurons: 14.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "naive CD4 T-cell: 1.2" "Lineage enriched" "Detected in single" 10 "T-cells: 1.2" "Cell line enhanced" "Detected in some" "HEL: 1.4;REH: 1.0;SuSa: 1.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA045885 Supported Nucleoplasm NA NA "Cluster 32: T-cells - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 36: HEL - Hemostasis" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Nucleoplasm "HPA045885: AB_10963937" "unprognostic (1.95e-2)" "unprognostic (1.35e-1)" "unprognostic (3.57e-1)" "unprognostic (5.44e-4)" "unprognostic (2.18e-1)" "unprognostic (7.97e-2)" "unprognostic (3.89e-1)" "unprognostic (1.38e-1)" "unprognostic (1.41e-1)" "unprognostic (3.23e-2)" "unprognostic (9.92e-4)" "unprognostic (5.74e-2)" "unprognostic (1.16e-4)" "unprognostic (3.45e-2)" "unprognostic (4.81e-2)" "unprognostic (2.69e-1)" "unprognostic (9.24e-3)" 0.2 0.7 2.4 0.3 2.1 0.5 0.4 1.8 2.9 0.3 1.5 0.3 0.2 0.7 45.2 0.6 0.9 0.2 0.6 2.2 2.2 1.2 0.0 0.3 0.3 2.2 2.4 2.0 0.3 1.2 1.6 0.1 2.5 0.5 0.1 2.4 0.4 1.1 0.0 0.1 0.3 0.4 2.2 0.4 0.3 1.5 2.3 0.6 1.1 0.0 0.2 0.4 0.4 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.4 1.4 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.5 0.3 0.0 0.9 0.0 0.0 1.0 0.0 0.0 0.2 0.4 0.1 0.0 0.1 0.9 0.0 1.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 1.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.4 2.1 1.8 2.9 2.2 2.2 2.2 2.4 2.5 2.2 2.3 2.5 0.3 3.2 2.7 2.0 2.9 1.8 6.5 0.7 1.8 7.0 2.8 3.7 0.1 0.0 0.8 1.8 0.0 2.3 1.5 0.2 15.6 2.5 9.3 0.7 0.7 0.8 7.7 0.8 13.0 1.2 0.8 1.5 2.6 0.6 2.5 1.3 0.0 0.0 0.8 5.0 14.7 0.9 2.0 0.0 0.4 5.2 0.6 0.3 0.0 0.0 0.8 9.4 2.1 4.0 6.3 0.8 0.4 0.7 0.3 5.1 0.0 0.8 0.8 4.4 0.0 2.1 2.4 7.2 9.8 2.8 1.1 1.2 1.6 1.8 0.4 5.6 RCBTB2 CHC1L ENSG00000136161 "RCC1 and BTB domain containing protein 2" O95199 13 48488963-48533256 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Microglial cells: 66.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in many" 9 "MOLT-4: 278.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040242 Approved Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 68: Epididymis - Unknown function" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 63: NK-cells & T-cells - Immune response" "Nucleoplasm, Golgi apparatus" "HPA040242: AB_10795362" "unprognostic (2.86e-1)" "unprognostic (5.93e-2)" "unprognostic (8.47e-2)" "unprognostic (9.47e-3)" "unprognostic (1.60e-1)" "unprognostic (1.86e-3)" "unprognostic (1.29e-1)" "unprognostic (5.40e-3)" "unprognostic (8.28e-3)" "unprognostic (1.20e-1)" "unprognostic (4.85e-2)" "unprognostic (3.60e-1)" "prognostic favorable (2.45e-4)" "unprognostic (1.06e-2)" "unprognostic (8.31e-2)" "unprognostic (4.75e-2)" "unprognostic (1.98e-1)" 12.9 11.1 10.0 12.9 11.2 5.2 10.8 11.1 13.9 15.6 17.4 8.9 5.3 15.0 12.3 13.0 12.9 12.3 12.5 9.5 13.2 16.6 9.5 10.5 11.3 11.9 11.7 19.9 6.8 6.6 13.4 17.7 12.5 13.5 8.0 8.3 23.3 19.9 7.0 5.4 7.2 13.7 13.0 17.4 8.8 7.1 10.8 11.8 27.5 10.8 10.7 11.5 12.4 14.4 1.5 1.2 22.0 1.4 17.1 15.1 0.0 6.8 8.4 4.0 3.0 0.8 1.4 4.7 5.0 10.7 2.7 3.1 3.2 2.8 4.6 5.7 4.3 12.2 3.2 1.2 6.6 5.6 7.4 15.6 6.5 5.3 2.6 9.2 12.3 29.8 0.9 7.1 14.6 0.5 278.7 15.6 12.3 0.5 3.7 23.9 2.2 20.3 7.5 3.7 5.1 4.3 5.3 1.1 8.7 9.1 0.5 14.2 10.3 4.6 2.0 1.2 2.7 0.3 0.4 5.7 2.7 12.5 9.1 4.6 39.8 4.6 14.0 28.8 8.7 1.1 11.4 14.2 27.1 1.1 6.6 10.2 55.0 15.5 27.9 0.5 15.5 20.5 10.0 11.2 11.1 13.9 9.5 13.2 11.9 11.7 12.5 13.0 10.8 14.4 23.1 3.2 3.3 9.1 5.5 6.1 11.6 9.5 21.1 1.9 4.9 9.3 16.1 4.3 9.8 5.5 2.1 1.4 20.7 1.3 7.9 1.2 9.0 5.1 6.6 19.7 8.3 6.1 12.3 0.8 1.4 11.6 2.6 5.0 8.8 9.9 24.7 5.2 25.0 1.7 17.0 2.2 2.0 26.6 24.4 8.1 9.3 30.6 8.8 66.5 38.3 33.7 24.7 6.6 13.2 1.3 1.6 14.3 17.4 6.0 0.7 11.2 6.9 4.9 13.1 14.9 14.1 9.6 4.4 12.6 5.7 1.0 24.0 11.9 2.4 6.7 RCN1 "FLJ37041, PIG20, Rcal, RCN" ENSG00000049449 "Reticulocalbin 1" Q15293 11 32091074-32105722 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "epididymis: 660.2" "Cell type enhanced" "Detected in all" "Extravillous trophoblasts: 288.2;Muller glia cells: 327.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA038474, HPA062104" Approved Supported "Endoplasmic reticulum" "Intracellular and membrane" NA NA 9400000 "Cluster 39: Non-specific - mRNA processing" "Cluster 68: Epididymis - Unknown function" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 33: Fibroblasts - ECM organization" "Endoplasmic reticulum" "HPA038474: AB_10672595, HPA062104: AB_2684683" "unprognostic (1.65e-1)" "unprognostic (7.69e-3)" "unprognostic (1.24e-1)" "unprognostic (2.03e-2)" "unprognostic (7.20e-3)" "unprognostic (1.70e-2)" "unprognostic (6.92e-3)" "prognostic unfavorable (7.13e-6)" "unprognostic (8.85e-2)" "unprognostic (1.30e-2)" "unprognostic (2.12e-1)" "unprognostic (9.32e-2)" "prognostic unfavorable (2.70e-13)" "unprognostic (1.78e-2)" "unprognostic (2.04e-1)" "unprognostic (1.14e-1)" "unprognostic (6.93e-3)" 81.8 54.4 26.7 58.3 39.6 8.1 64.6 24.0 28.2 73.9 37.2 54.7 43.4 79.7 660.2 25.7 69.5 50.1 46.0 26.4 37.2 39.2 100.7 50.6 29.2 29.9 27.6 83.6 21.9 62.2 67.3 129.0 29.0 85.6 53.7 48.7 89.9 82.5 32.7 26.8 41.5 79.5 31.8 35.9 40.7 22.5 36.7 19.0 63.4 28.8 23.1 113.1 41.1 31.3 130.0 143.7 335.9 217.4 720.2 548.1 340.4 425.5 501.5 286.6 515.6 123.6 157.2 0.4 293.3 718.4 380.4 157.6 118.0 135.2 450.2 63.9 231.9 28.2 104.7 58.4 519.7 21.7 42.0 780.1 154.8 197.1 215.4 333.7 647.7 60.6 17.4 25.8 342.1 116.0 61.4 50.2 137.2 2.7 143.9 45.1 393.5 39.2 270.1 355.8 82.1 42.6 117.1 26.2 333.1 227.2 171.0 77.5 350.8 417.0 215.8 338.5 364.6 1.0 0.9 1.7 514.2 28.3 224.9 0.3 13.6 0.5 14.9 16.2 11.8 6.2 6.9 12.3 15.2 4.8 5.1 9.5 0.6 10.9 10.3 8.2 2.7 9.3 26.7 39.6 24.0 28.2 26.4 37.2 29.9 27.6 29.0 31.8 36.7 31.3 131.3 54.5 34.8 9.8 11.8 41.6 80.8 78.2 34.1 40.4 47.9 37.5 9.0 42.9 55.1 47.8 12.5 172.6 10.5 14.3 7.9 143.4 210.4 60.7 154.9 112.1 53.2 16.4 8.0 45.7 288.2 152.1 23.0 110.2 12.7 100.3 85.3 61.7 44.2 15.2 5.9 80.9 38.7 17.8 33.9 173.8 80.5 19.9 32.0 8.4 50.3 327.4 19.6 16.6 1.3 39.7 30.8 73.0 38.6 184.9 6.7 14.1 30.4 17.0 26.3 80.8 91.7 17.0 7.2 33.2 28.3 217.0 13.6 55.8 75.3 99.8 RCN2 "E6BP, ERC-55, ERC55, TCBP49" ENSG00000117906 "Reticulocalbin 2" Q14257 15 76931738-76954393 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 321.5" "Cell type enhanced" "Detected in all" "Spermatocytes: 528.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030694, HPA030695" Enhanced Supported Enhanced "Endoplasmic reticulum" "Intracellular and membrane" NA NA 92000 "Cluster 26: Non-specific - Mitochondria" "Cluster 68: Epididymis - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "Endoplasmic reticulum" "HPA030694: AB_2673573, HPA030695: AB_2673574" "unprognostic (1.69e-2)" "unprognostic (1.79e-1)" "unprognostic (1.92e-2)" "unprognostic (3.45e-2)" "unprognostic (2.42e-1)" "unprognostic (8.71e-2)" "prognostic unfavorable (7.36e-5)" "unprognostic (1.74e-1)" "unprognostic (2.20e-2)" "unprognostic (4.61e-3)" "unprognostic (1.39e-1)" "unprognostic (1.98e-1)" "unprognostic (1.70e-2)" "unprognostic (2.11e-2)" "unprognostic (2.99e-1)" "unprognostic (1.15e-1)" "unprognostic (3.67e-2)" 31.3 30.8 42.5 24.9 43.9 24.6 35.8 35.8 57.8 34.1 41.4 33.1 22.2 44.0 321.5 28.5 54.3 32.6 38.8 44.0 55.0 49.3 19.8 28.8 30.0 38.0 45.1 34.2 21.5 80.6 30.8 49.2 46.9 41.2 36.5 43.9 22.7 41.1 56.9 22.6 23.3 39.6 40.0 25.4 26.9 93.4 51.4 40.3 48.0 60.4 32.4 39.0 25.2 40.8 93.9 65.3 284.1 134.9 120.1 135.6 177.3 109.1 147.5 138.7 115.1 81.2 78.2 58.3 154.3 119.3 149.5 139.9 217.4 94.0 176.0 45.3 170.8 28.9 91.4 135.0 143.0 105.4 42.9 123.6 126.8 68.2 87.5 146.1 148.9 98.3 74.2 56.3 146.6 60.3 104.9 71.9 216.6 98.0 72.1 109.4 187.0 37.3 91.6 123.8 161.8 161.1 178.8 98.6 220.5 251.1 96.0 115.0 80.5 162.8 131.2 104.8 228.0 80.4 266.6 69.6 92.8 87.6 151.1 7.5 7.6 16.2 21.7 7.4 24.9 23.4 23.0 28.1 16.1 22.9 25.5 25.1 3.9 23.5 12.3 19.1 18.1 20.0 42.5 43.9 35.8 57.8 44.0 55.0 38.0 45.1 46.9 40.0 51.4 40.8 87.3 25.6 36.8 56.8 111.2 82.1 125.0 85.5 96.2 87.1 75.9 74.8 94.9 62.9 52.5 99.3 37.5 183.1 76.3 23.3 49.0 116.0 44.8 87.0 101.6 64.8 73.5 91.5 48.4 45.1 296.8 106.0 54.6 85.6 28.6 120.9 60.0 32.8 57.3 127.9 72.0 55.0 101.7 30.5 38.3 81.7 61.8 30.0 92.5 19.7 34.1 99.7 89.6 149.8 63.3 56.9 43.2 93.6 85.6 127.5 25.8 56.2 48.7 58.9 59.2 78.9 126.3 528.6 140.8 109.3 70.8 163.6 76.7 131.8 84.4 117.0 REPS1 ENSG00000135597 "RALBP1 associated Eps domain containing 1" Q96D71 6 138903493-138988261 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 207.3;Excitatory neurons: 114.3;Inhibitory neurons: 138.1;Oligodendrocyte precursor cells: 99.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029961, HPA029962" Approved Approved "Vesicles,Plasma membrane,Cytosol" NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 68: Epididymis - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Vesicles, Plasma membrane, Cytosol" "HPA029961: AB_10603233, HPA029962: AB_2673269" "unprognostic (1.72e-3)" "unprognostic (9.61e-2)" "unprognostic (5.82e-3)" "unprognostic (2.77e-2)" "unprognostic (6.30e-3)" "unprognostic (1.90e-1)" "prognostic unfavorable (9.47e-4)" "unprognostic (3.79e-1)" "unprognostic (2.49e-1)" "unprognostic (9.71e-3)" "unprognostic (4.29e-3)" "unprognostic (4.42e-2)" "unprognostic (2.69e-1)" "unprognostic (1.51e-1)" "unprognostic (1.27e-1)" "unprognostic (3.83e-2)" "unprognostic (2.69e-2)" 13.5 11.9 24.7 14.9 25.4 23.2 23.6 27.7 36.8 19.2 14.8 17.4 15.4 21.9 40.2 28.0 18.4 14.0 23.9 27.4 24.0 17.4 31.3 15.2 19.4 25.2 23.9 21.1 18.8 41.0 31.7 17.2 21.3 15.9 17.3 38.8 26.1 16.2 17.5 30.0 16.4 19.5 21.5 22.1 18.1 35.6 25.9 36.0 17.8 12.6 22.2 19.5 20.1 25.3 29.3 22.6 42.3 53.1 23.4 41.6 46.2 27.8 30.7 31.9 38.2 54.1 24.8 35.2 22.9 38.9 38.0 33.6 48.7 42.0 42.1 37.6 41.9 29.6 12.9 32.9 35.3 94.6 45.9 34.1 33.7 58.6 70.3 30.2 33.5 51.2 40.2 35.1 41.4 49.4 53.9 51.3 40.4 37.4 21.3 62.4 26.0 20.0 26.5 43.6 37.7 37.2 25.7 38.7 38.0 62.0 18.6 64.4 32.9 17.8 29.6 48.5 38.8 34.4 33.7 49.2 21.1 38.3 26.4 5.9 1.3 1.9 2.2 4.0 3.8 3.0 2.9 3.2 1.9 1.6 2.9 3.6 0.7 2.9 4.5 3.5 3.3 1.2 24.7 25.4 27.7 36.8 27.4 24.0 25.2 23.9 21.3 21.5 25.9 25.3 11.8 19.2 7.4 207.3 18.0 13.4 11.7 7.9 22.2 12.6 13.7 9.5 28.4 10.0 12.2 5.5 16.7 25.6 18.9 11.9 7.9 7.8 13.7 17.5 9.7 10.3 6.0 5.0 114.3 7.1 28.3 11.5 16.3 23.3 15.9 14.4 15.7 43.8 13.3 13.5 138.1 12.8 6.1 24.0 10.3 7.7 7.2 17.2 5.4 47.8 10.5 36.8 15.5 99.5 71.2 8.9 14.7 8.6 23.9 11.2 13.5 8.6 16.5 14.4 19.7 16.8 10.9 41.7 33.8 26.4 14.9 28.6 18.7 7.6 15.2 18.1 REPS2 POB1 ENSG00000169891 "RALBP1 associated Eps domain containing 2" Q8NFH8 X 16946658-17153272 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.1" "Cell type enhanced" "Detected in many" "Excitatory neurons: 117.9;Inhibitory neurons: 142.7;Oligodendrocyte precursor cells: 84.9;Oligodendrocytes: 204.0" "Cancer enhanced" "Detected in all" "prostate cancer: 13.7" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 16 "basophil: 5.8;eosinophil: 4.5;neutrophil: 14.3" "Lineage enriched" "Detected in single" 28 "granulocytes: 14.3" "Cell line enhanced" "Detected in some" "HDLM-2: 30.2;Karpas-707: 11.7;RH-30: 8.4;RPMI-8226: 9.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000565, HPA026073" Uncertain "Intracellular and membrane" NA NA "Cluster 50: Neutrophils - Cellular senescence" "Cluster 68: Epididymis - Unknown function" "Cluster 44: HDLM-2 - Immune response" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "HPA000565: AB_1079800, HPA026073: AB_1856176" "unprognostic (6.58e-2)" "unprognostic (2.14e-1)" "unprognostic (3.35e-2)" "unprognostic (7.83e-2)" "unprognostic (4.23e-2)" "unprognostic (3.70e-3)" "prognostic favorable (5.36e-4)" "unprognostic (4.85e-2)" "unprognostic (2.87e-2)" "unprognostic (5.53e-2)" "prognostic unfavorable (3.24e-4)" "unprognostic (1.83e-1)" "prognostic favorable (4.08e-4)" "unprognostic (5.89e-2)" "unprognostic (1.03e-1)" "unprognostic (2.43e-2)" "prognostic favorable (4.56e-4)" 2.4 11.1 7.6 1.2 9.4 3.0 3.3 2.4 29.1 15.9 1.6 4.3 2.1 4.2 12.6 1.3 2.1 2.1 1.6 11.2 9.2 11.0 7.6 4.6 0.5 2.4 4.4 4.0 10.3 9.4 6.0 2.6 3.4 8.2 4.6 9.3 5.1 7.8 0.9 0.9 2.0 4.2 0.9 1.2 6.3 2.1 9.3 0.7 2.0 1.3 0.6 1.8 0.9 12.5 1.4 0.6 0.0 0.1 0.8 0.5 0.1 0.0 0.0 0.1 0.2 0.1 5.2 0.0 0.6 0.0 3.9 0.2 1.1 2.8 0.5 30.2 0.6 0.0 0.7 0.0 0.7 0.0 0.1 5.3 0.9 0.0 4.7 4.9 1.6 0.0 0.0 11.7 0.3 1.4 0.0 0.4 0.2 4.3 0.9 0.0 8.4 9.4 0.3 2.8 4.2 0.3 2.2 2.1 1.7 1.7 3.9 0.2 0.2 0.0 0.2 0.1 0.4 0.5 0.0 0.4 0.0 0.4 0.2 5.8 0.3 4.5 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 14.3 0.0 0.2 0.3 0.0 0.1 7.6 9.4 2.4 29.1 11.2 9.2 2.4 4.4 3.4 0.9 9.3 12.5 11.7 32.1 13.5 6.5 0.9 0.6 9.6 4.4 1.2 49.5 7.9 5.5 6.6 4.3 8.8 14.7 0.0 0.2 1.5 10.4 1.9 3.0 0.2 7.1 4.0 2.3 9.5 4.4 117.9 14.6 9.1 4.1 9.7 9.6 0.0 7.9 4.2 15.1 4.2 38.7 142.7 7.8 0.0 5.7 6.4 0.9 9.3 6.6 1.8 21.5 4.9 0.9 0.0 84.9 204.0 7.9 5.1 12.8 1.3 10.6 2.3 11.6 2.7 2.6 0.0 0.8 2.0 0.7 2.6 0.9 1.3 0.7 0.5 16.3 10.2 6.5 RERGL FLJ22655 ENSG00000111404 "RERG like" Q9H628 12 18080869-18320107 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 37 "Sertoli cells: 164.3;Smooth muscle cells: 381.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 719 "REH: 230.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA041740 Uncertain Approved Nucleoplasm NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 14: REH - Unknown function" "Cluster 48: Smooth muscle cells - ECM organization" Nucleoplasm "HPA041740: AB_10795694" "unprognostic (3.53e-2)" "unprognostic (7.03e-4)" "unprognostic (6.29e-2)" "unprognostic (1.56e-1)" "unprognostic (1.09e-2)" "unprognostic (4.39e-2)" "unprognostic (1.10e-2)" "unprognostic (3.14e-2)" "unprognostic (5.51e-2)" "unprognostic (7.26e-2)" "unprognostic (8.47e-2)" "unprognostic (1.25e-1)" "unprognostic (6.76e-3)" "unprognostic (1.96e-1)" "unprognostic (2.39e-2)" "unprognostic (1.66e-2)" 43.5 5.4 14.3 2.5 14.8 0.0 29.1 14.7 41.0 25.3 14.6 14.4 3.0 25.2 37.9 7.2 25.8 10.2 6.6 14.3 16.1 15.9 2.1 4.4 1.2 15.4 15.1 19.8 1.8 1.1 1.6 0.0 15.3 7.1 16.8 0.2 3.8 19.4 6.0 11.9 13.4 16.0 14.6 2.7 7.8 2.9 15.7 1.2 13.4 30.2 1.4 11.2 14.7 15.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 230.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.3 14.8 14.7 41.0 14.3 16.1 15.4 15.1 15.3 14.6 15.7 15.0 6.9 0.0 0.0 2.0 0.1 4.5 0.3 0.0 4.0 0.0 2.8 5.2 4.1 1.5 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 2.7 0.7 0.7 7.2 0.0 0.0 0.1 0.0 0.5 2.1 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 6.5 0.4 0.3 0.6 5.4 3.7 0.0 0.0 0.0 0.0 0.2 0.1 0.0 1.5 0.0 0.3 0.0 0.6 0.0 0.1 164.3 0.6 381.7 0.1 1.1 0.8 2.4 0.1 0.9 0.3 0.1 0.4 RGSL1 RGSL2 ENSG00000121446 "Regulator of G protein signaling like 1" A5PLK6 1 182409192-182560599 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "testis: 5.0" "Group enriched" "Detected in some" 31 "Early spermatids: 123.9;Late spermatids: 33.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 23: Spermatids - Flagellum & Golgi organization" "unprognostic (1.33e-1)" "unprognostic (5.20e-2)" "unprognostic (2.07e-1)" "unprognostic (6.47e-2)" "unprognostic (4.45e-1)" "unprognostic (1.64e-1)" "unprognostic (2.69e-5)" "unprognostic (2.93e-1)" "unprognostic (9.18e-2)" "unprognostic (1.42e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 123.9 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.4 0.1 0.0 0.5 0.0 0.0 0.0 0.4 33.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.5 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.5 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 RNASE11 "C14orf6, RAJ1" ENSG00000173464 "Ribonuclease A family member 11 (inactive)" Q8TAA1 14 20583559-20609884 "Predicted secreted proteins" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "epididymis: 444.4" "Group enriched" "Detected in some" 63 "Early spermatids: 32.1;Late spermatids: 57.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA003724 Uncertain "Secreted in male reproductive system" NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 25: Spermatids - Spermatogenesis" "HPA003724: AB_1079817" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 444.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 61.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 57.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RNF152 FLJ39176 ENSG00000176641 "Ring finger protein 152" Q8N8N0 18 61808067-61894247 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 48.3;choroid plexus: 62.3;kidney: 56.5" "Cell type enhanced" "Detected in many" "Hepatocytes: 96.4;Proximal tubular cells: 159.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HaCaT: 21.5;SH-SY5Y: 13.4;TIME: 14.2;U-138 MG: 21.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "unprognostic (3.30e-2)" "unprognostic (1.97e-2)" "unprognostic (1.64e-1)" "unprognostic (8.55e-3)" "unprognostic (2.05e-1)" "unprognostic (2.09e-1)" "unprognostic (2.96e-3)" "unprognostic (3.62e-1)" "unprognostic (1.51e-2)" "unprognostic (8.13e-2)" "unprognostic (5.14e-2)" "unprognostic (6.73e-2)" "prognostic favorable (1.13e-8)" "prognostic unfavorable (2.85e-5)" "unprognostic (3.26e-2)" "unprognostic (2.82e-2)" "unprognostic (4.83e-2)" 7.4 3.4 5.4 0.9 13.9 0.9 6.7 48.3 5.3 8.2 62.3 7.2 1.7 6.3 3.6 4.5 5.2 3.8 7.6 6.1 10.6 56.5 22.1 7.0 0.5 25.5 13.7 4.0 2.5 2.4 2.9 6.5 28.7 5.3 6.6 5.0 14.0 2.8 2.3 11.4 5.5 4.1 8.5 0.6 6.3 1.3 21.1 0.6 5.4 2.3 0.8 4.2 7.5 14.9 0.0 0.0 4.8 1.0 4.4 0.6 0.0 3.1 9.4 0.7 0.5 0.0 0.1 0.1 0.9 4.9 0.1 21.5 5.9 11.4 1.3 0.0 0.6 0.0 0.0 0.0 2.3 0.0 0.1 0.7 8.1 3.6 2.4 2.1 8.7 0.1 0.0 0.1 1.4 0.9 0.8 0.0 0.3 0.7 0.0 0.3 3.1 0.0 0.5 3.7 3.9 13.4 0.0 8.7 1.5 4.2 5.1 0.0 14.2 21.6 2.2 0.0 0.5 0.1 0.0 0.0 0.7 0.0 7.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 5.4 13.9 48.3 5.3 6.1 10.6 25.5 13.7 28.7 8.5 21.1 14.9 26.8 0.0 0.0 9.4 0.2 42.3 28.1 11.1 11.4 19.1 16.2 10.3 4.8 12.8 10.5 20.2 0.0 0.4 0.9 58.1 46.9 2.5 0.4 16.8 18.5 17.1 16.2 8.0 9.9 2.7 0.1 9.5 18.3 29.9 0.0 0.1 10.8 96.4 0.1 21.9 20.0 5.6 32.6 1.8 7.7 1.4 8.7 2.2 28.4 2.8 0.0 3.5 0.0 16.6 27.5 1.7 34.9 18.4 0.3 8.7 46.6 159.0 1.8 3.6 65.7 2.8 59.7 0.2 0.5 28.0 32.5 0.3 1.7 18.7 16.2 21.2 RNF183 MGC4734 ENSG00000165188 "Ring finger protein 183" Q96D59 9 113297093-113303376 "Enzymes, Predicted membrane proteins" "Apoptosis, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 16.4;kidney: 11.5" "Cell type enhanced" "Detected in some" "Basal respiratory cells: 15.9;Club cells: 9.8;Endometrial ciliated cells: 13.4;Glandular and luminal cells: 20.5;Ionocytes: 22.4;Proximal tubular cells: 26.4;Respiratory ciliated cells: 13.0" "Cancer enhanced" "Detected in many" "endometrial cancer: 7.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "SCLC-21H: 18.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA057675 Uncertain NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 44: Endometrium - Transcription" "HPA057675: AB_2683499" "unprognostic (1.23e-2)" "unprognostic (3.17e-1)" "unprognostic (1.11e-1)" "prognostic favorable (7.95e-6)" "unprognostic (2.56e-1)" "unprognostic (1.75e-2)" "unprognostic (1.54e-3)" "unprognostic (1.27e-2)" "unprognostic (1.03e-1)" "unprognostic (7.65e-2)" "unprognostic (3.27e-1)" "unprognostic (1.98e-1)" "prognostic favorable (3.51e-4)" "unprognostic (5.50e-2)" "unprognostic (8.84e-2)" "unprognostic (9.61e-2)" "unprognostic (2.53e-3)" 0.1 0.1 0.3 0.4 0.2 0.0 1.0 0.2 0.4 1.5 0.2 0.5 0.4 1.2 16.4 4.9 1.3 5.7 0.1 0.2 0.1 11.5 0.2 0.3 0.0 0.2 0.2 0.3 0.3 0.1 2.0 0.0 0.2 1.0 0.4 1.2 6.8 0.3 0.0 0.4 0.3 0.0 0.3 0.1 3.4 5.0 0.4 0.0 0.4 0.0 0.1 0.3 0.5 0.3 0.0 0.1 0.0 0.0 0.0 0.1 2.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 18.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.2 0.4 0.2 0.1 0.2 0.2 0.2 0.3 0.4 0.3 0.3 0.0 0.0 0.3 0.5 0.0 0.4 15.9 0.0 0.6 3.8 2.9 0.4 5.7 9.8 5.5 0.0 0.0 0.2 0.9 1.9 0.2 0.2 13.4 1.1 0.5 8.4 0.0 0.0 0.9 0.1 0.2 4.6 20.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.5 22.4 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.2 2.2 0.7 0.4 0.0 0.5 0.2 26.4 13.0 3.3 0.0 0.4 0.6 3.3 0.7 1.4 0.0 0.0 0.3 0.1 1.5 1.0 RPRD1A "FLJ10656, HsT3101, P15RS" ENSG00000141425 "Regulation of nuclear pre-mRNA domain containing 1A" Q96P16 18 35984387-36067576 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 233.0;Late spermatids: 362.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040602 Supported Supported "Nucleoplasm,Golgi apparatus" NA NA "Cluster 23: Antigen presenting cells - Antigen presentation" "Cluster 68: Epididymis - Unknown function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 34: Spermatids - Unknown function" "Nucleoplasm, Golgi apparatus" "HPA040602: AB_10673137" "unprognostic (2.06e-1)" "unprognostic (9.14e-2)" "unprognostic (1.41e-3)" "unprognostic (2.22e-1)" "unprognostic (9.92e-3)" "unprognostic (2.69e-1)" "unprognostic (2.93e-3)" "unprognostic (1.68e-1)" "unprognostic (2.80e-2)" "unprognostic (3.94e-3)" "unprognostic (1.13e-1)" "unprognostic (1.89e-1)" "unprognostic (5.50e-3)" "unprognostic (7.95e-2)" "unprognostic (6.78e-3)" "unprognostic (1.49e-1)" "unprognostic (4.30e-1)" 23.3 34.8 40.6 16.4 44.4 11.3 24.7 40.7 59.9 21.1 34.6 29.6 19.0 25.7 115.2 23.6 25.3 18.5 29.1 45.5 43.2 26.7 21.8 19.2 19.5 39.5 40.3 24.1 23.4 26.1 27.8 17.8 40.0 29.6 20.5 41.5 28.3 28.9 54.7 20.9 19.0 21.3 41.4 22.3 21.3 28.0 42.6 19.9 32.1 46.5 19.3 27.6 20.0 44.4 31.6 34.1 57.0 60.8 30.6 35.8 35.5 55.6 54.5 31.7 44.5 9.4 34.2 44.1 57.2 40.7 16.9 51.2 64.1 56.3 44.7 39.2 36.6 46.9 48.9 37.0 53.9 78.9 24.3 27.6 73.7 30.2 85.4 39.8 46.0 51.5 42.8 46.7 41.1 39.3 42.4 33.3 45.9 16.2 24.4 34.7 18.3 70.8 48.4 66.9 99.1 83.4 46.5 25.7 48.3 46.2 35.2 55.9 56.4 33.0 20.6 17.7 46.0 52.5 77.6 45.0 33.6 64.1 33.9 0.7 4.7 2.2 2.9 6.3 4.4 5.0 4.0 3.4 7.8 5.4 5.0 4.0 3.5 7.0 4.2 5.4 2.3 3.3 40.6 44.4 40.7 59.9 45.5 43.2 39.5 40.3 40.0 41.4 42.6 44.4 19.0 32.1 20.7 54.9 40.6 34.4 35.9 23.6 54.7 49.6 29.9 22.2 39.4 17.2 21.0 35.0 31.3 17.1 28.7 13.6 27.4 21.0 233.0 36.3 30.2 23.1 28.8 24.6 105.0 19.9 17.6 19.0 25.0 52.5 13.3 50.7 20.7 29.3 9.8 37.0 91.0 16.7 22.4 20.1 24.2 362.4 22.1 18.8 30.2 58.1 18.1 32.2 18.6 84.9 98.5 20.4 25.2 23.0 33.1 41.5 17.8 26.2 20.3 50.8 13.1 26.1 27.0 39.5 42.2 45.2 38.2 14.6 21.9 51.9 22.2 38.2 RWDD2A "dJ747H23.2, MGC13523, RWDD2" ENSG00000013392 "RWD domain containing 2A" Q9UIY3 6 83193357-83198935 "Metabolic proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 52.3;Spermatocytes: 65.2" "Cancer enhanced" "Detected in all" "prostate cancer: 11.6" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030105, HPA030106, HPA030107" Uncertain Approved Vesicles NA NA "Cluster 29: Plasmacytoid DCs - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 66: Spermatocytes - Spermatogenesis" Vesicles "HPA030105: AB_10599826, HPA030106: AB_10600896, HPA030107: AB_10601009" "unprognostic (2.51e-3)" "unprognostic (1.25e-1)" "unprognostic (2.48e-2)" "unprognostic (1.33e-1)" "unprognostic (1.19e-3)" "unprognostic (3.99e-2)" "unprognostic (1.01e-1)" "unprognostic (1.13e-1)" "unprognostic (1.60e-1)" "prognostic favorable (3.82e-5)" "prognostic favorable (1.38e-4)" "unprognostic (1.26e-1)" "unprognostic (2.73e-1)" "unprognostic (1.91e-2)" "unprognostic (2.57e-2)" "unprognostic (1.85e-3)" "unprognostic (2.59e-2)" 2.9 6.9 7.1 2.1 7.0 0.5 3.2 6.1 8.1 3.4 6.3 2.9 2.5 3.3 9.4 1.7 3.8 4.6 4.4 6.9 7.9 4.5 5.9 2.8 2.5 5.6 6.0 4.0 9.6 4.0 5.6 2.5 5.9 11.5 2.5 4.7 6.0 4.7 2.3 1.9 2.7 3.2 5.7 2.9 3.9 8.9 8.4 1.8 6.2 4.0 2.6 2.6 1.8 6.1 2.1 1.9 4.4 8.3 5.2 3.7 3.0 4.8 10.1 3.5 4.2 2.8 1.1 1.6 3.8 5.8 8.0 2.1 3.7 2.8 5.4 2.0 3.8 1.9 3.0 6.2 8.0 0.5 1.5 4.9 4.6 4.4 9.2 11.5 6.6 4.5 3.1 2.8 4.3 3.1 0.7 1.5 1.5 1.9 1.9 2.4 9.1 1.0 7.4 2.4 1.5 5.3 2.9 4.5 4.4 6.3 2.8 2.9 7.1 2.4 1.5 3.5 2.1 6.2 2.7 0.9 2.8 0.8 2.9 0.3 0.9 0.0 1.2 0.8 1.8 1.9 1.7 1.7 1.0 1.0 2.2 2.1 0.3 0.4 2.2 3.5 2.2 1.0 7.1 7.0 6.1 8.1 6.9 7.9 5.6 6.0 5.9 5.7 8.4 6.1 2.4 0.0 6.7 9.8 4.2 3.7 3.6 5.3 3.4 5.6 3.7 3.2 5.4 2.8 3.3 1.8 0.0 7.7 3.9 2.4 5.9 8.9 52.3 4.8 4.5 3.5 5.4 0.4 10.8 9.1 3.3 6.5 3.6 4.0 0.0 7.0 5.0 6.8 5.0 1.7 11.2 6.1 8.2 1.6 2.5 14.8 9.0 2.2 8.8 3.7 3.8 11.0 0.0 13.6 4.5 5.8 2.5 6.0 11.2 8.7 4.1 13.3 4.9 5.0 6.6 7.0 5.2 65.2 10.5 1.2 2.4 5.7 2.9 6.3 3.4 2.8 SARAF "MGC8721, TMEM66" ENSG00000133872 "Store-operated calcium entry associated regulatory factor" Q96BY9 8 30063003-30083208 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040400 Supported "Endoplasmic reticulum,Rods & Rings" NA NA 41000 "Cluster 20: T-cells - T-cell receptor" "Cluster 68: Epididymis - Unknown function" "Cluster 21: OE19 - Mitochondria" "Cluster 24: Non-specific - Transcription regulation" "Endoplasmic reticulum" "Rods & Rings" "HPA040400: AB_2676962" "unprognostic (1.11e-1)" "unprognostic (4.78e-2)" "unprognostic (4.27e-3)" "unprognostic (1.38e-3)" "unprognostic (7.86e-3)" "unprognostic (1.91e-1)" "unprognostic (2.32e-1)" "prognostic favorable (5.28e-4)" "unprognostic (1.98e-1)" "unprognostic (1.74e-2)" "unprognostic (8.03e-2)" "unprognostic (6.70e-3)" "unprognostic (1.06e-2)" "unprognostic (5.09e-2)" "unprognostic (3.88e-2)" "unprognostic (3.87e-2)" "unprognostic (2.18e-1)" 139.9 294.5 208.6 169.1 228.0 253.0 169.9 187.2 246.6 153.8 196.2 143.0 123.9 152.1 408.6 91.0 205.9 182.1 151.8 234.6 308.8 205.2 302.3 167.5 218.9 214.0 258.8 255.7 231.4 236.5 138.9 309.2 247.6 228.2 143.5 219.1 212.9 172.7 111.1 70.8 140.5 139.1 219.5 159.0 161.1 104.3 290.5 243.4 245.4 129.0 186.5 141.0 64.0 218.5 119.9 112.4 147.9 79.9 209.3 149.8 69.7 139.2 247.0 128.5 173.7 72.2 139.9 80.9 183.5 156.0 134.7 97.7 100.8 112.4 146.9 33.6 49.5 112.2 87.3 119.2 189.6 48.8 130.6 175.2 260.0 121.6 125.5 257.4 192.0 150.7 128.4 191.2 142.9 74.2 128.4 88.8 96.0 253.6 61.3 98.7 88.4 107.4 220.3 100.4 48.6 162.5 140.6 160.5 208.2 115.7 112.2 93.3 144.0 89.6 230.5 35.0 56.5 103.4 110.6 81.0 215.8 118.4 146.5 964.6 252.9 443.1 321.2 253.2 364.8 233.1 473.0 377.9 247.0 302.4 776.2 543.6 478.1 258.8 335.3 212.0 483.8 920.3 208.6 228.0 187.2 246.6 234.6 308.8 214.0 258.8 247.6 219.5 290.5 218.5 179.8 169.9 147.6 79.0 458.5 0.0 331.6 0.0 154.8 291.5 247.8 166.2 135.4 261.7 82.3 211.5 123.0 235.9 566.8 142.2 127.2 387.5 629.8 235.9 114.8 170.8 115.3 145.4 128.0 358.9 254.5 181.7 170.7 133.6 223.3 325.7 240.2 273.4 292.0 139.7 157.8 122.0 0.0 448.6 0.0 908.1 218.7 387.9 0.0 60.9 298.5 317.2 358.4 82.9 111.7 250.1 137.0 294.2 505.1 280.7 252.6 289.7 212.1 252.5 177.5 203.7 177.1 194.7 133.9 133.4 0.0 276.9 794.4 167.8 115.9 310.6 SARM1 "KIAA0524, SAMD2, SARM" ENSG00000004139 "Sterile alpha and TIR motif containing 1" Q6SZW1 17 28364356-28404049 "Enzymes, Predicted intracellular proteins" "Differentiation, Immunity, Innate immunity, Neurogenesis" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Bipolar cells: 27.8;Cone photoreceptor cells: 29.2;Inhibitory neurons: 28.9;Oligodendrocyte precursor cells: 27.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CACO-2: 32.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024359, HPA024759" Uncertain Supported Mitochondria "Intracellular and membrane" NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 39: CACO-2 - Unknown function" "Cluster 56: Bipolar cells - Visual perception" Mitochondria "HPA024359: AB_1856582, HPA024759: AB_1856581" "unprognostic (1.40e-4)" "unprognostic (9.00e-2)" "unprognostic (2.47e-1)" "unprognostic (2.41e-2)" "unprognostic (1.18e-1)" "unprognostic (1.08e-2)" "unprognostic (1.27e-1)" "unprognostic (1.27e-2)" "unprognostic (1.87e-2)" "unprognostic (7.01e-2)" "unprognostic (2.49e-4)" "unprognostic (6.40e-2)" "unprognostic (5.20e-2)" "unprognostic (1.20e-1)" "unprognostic (2.14e-1)" "unprognostic (4.84e-2)" "unprognostic (7.62e-4)" 2.2 5.9 3.9 3.3 3.6 1.4 2.1 7.3 4.2 3.1 1.6 3.3 7.5 4.0 4.0 1.4 3.6 1.5 1.8 3.9 3.1 2.7 3.4 2.0 2.0 3.3 2.7 2.8 7.1 2.6 6.1 1.2 3.2 3.5 2.2 7.0 2.6 4.2 1.5 2.3 5.2 3.5 2.4 4.4 3.3 1.3 3.6 1.1 2.8 1.0 2.1 3.8 1.9 2.8 0.2 3.0 3.8 4.8 2.7 1.9 0.6 2.1 4.1 4.4 2.9 32.2 0.5 0.6 0.2 3.0 2.6 1.3 2.7 0.1 3.7 7.0 1.8 0.0 5.5 0.8 2.0 0.1 1.9 1.3 0.2 2.1 0.6 4.2 0.2 0.9 0.1 2.4 1.2 2.8 0.4 0.0 2.6 0.6 0.2 1.1 3.2 0.8 1.4 2.2 9.9 9.2 9.2 1.3 3.5 1.6 0.4 0.7 0.4 4.0 0.4 1.4 2.9 4.0 2.9 0.6 4.2 0.3 2.0 0.1 0.1 0.0 0.2 0.2 0.2 0.1 0.3 0.3 0.2 0.2 0.2 0.3 0.1 0.3 0.5 0.0 0.4 0.1 3.9 3.6 7.3 4.2 3.9 3.1 3.3 2.7 3.2 2.4 3.6 2.8 2.7 3.2 4.2 19.6 4.0 0.9 1.8 1.2 4.6 27.8 3.1 4.2 0.8 7.2 4.8 3.7 29.2 0.6 2.9 3.0 3.9 4.4 6.6 3.8 5.4 2.9 9.5 0.4 23.5 10.7 0.8 3.5 8.2 3.7 4.5 6.1 3.6 2.3 1.5 21.9 28.9 4.1 2.0 13.8 0.3 3.5 3.4 2.8 3.6 2.8 2.4 6.1 3.1 27.6 14.8 3.4 2.3 1.5 2.6 2.3 9.9 5.9 4.3 17.2 6.6 5.9 4.0 0.3 0.4 3.1 0.6 0.5 4.7 2.0 4.9 1.4 SCGB2A1 "LPHC, MGB2, MGC71973, UGB3" ENSG00000124939 "Secretoglobin family 2A member 1" O75556 11 62208673-62213943 "Cancer-related genes, Predicted secreted proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "cervix: 2021.0;epididymis: 1372.0" "Group enriched" "Detected in many" 6 "Endometrial ciliated cells: 2506.4;Glandular and luminal cells: 2597.0" "Cancer enriched" "Detected in many" 5 "endometrial cancer: 971.9" "Region enhanced" "Detected in some" "medulla oblongata: 3.5" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "EFO-21: 8.6" HPA034584 Enhanced Approved Vesicles "Secreted in other tissues" NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 38: EFO-21 - Unknown function" "Cluster 44: Endometrium - Transcription" Vesicles "HPA034584: AB_10602221" "unprognostic (7.73e-2)" "unprognostic (3.77e-1)" "prognostic favorable (1.22e-4)" "prognostic favorable (1.54e-8)" "unprognostic (2.98e-2)" "unprognostic (1.86e-2)" "unprognostic (3.39e-1)" "unprognostic (1.95e-1)" "unprognostic (2.69e-1)" "unprognostic (6.87e-3)" "prognostic favorable (6.36e-4)" "unprognostic (5.67e-2)" "unprognostic (1.19e-1)" "unprognostic (1.18e-3)" "unprognostic (3.35e-1)" 0.2 0.0 0.0 0.2 0.0 0.0 57.8 0.0 0.0 2021.0 0.1 12.7 1.3 118.8 1372.0 4.2 238.4 13.4 0.2 0.1 0.4 1.9 0.1 2.4 0.0 3.5 1.4 0.7 17.2 1.1 5.1 0.1 0.8 6.8 16.3 0.0 29.6 15.6 0.0 8.6 1.0 2.2 0.5 0.0 45.9 0.0 1.1 2.7 5.8 0.0 0.1 0.3 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.3 0.0 0.1 0.0 0.7 0.1 0.0 1.6 0.4 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 3.5 1.4 0.8 0.5 1.1 0.2 0.6 0.0 4.8 0.0 0.4 0.1 3.8 4.8 0.0 0.0 123.6 71.0 0.0 48.6 10.1 16.5 0.0 0.2 1.6 9.7 3.9 6.6 0.0 2506.4 397.7 7.6 37.1 0.0 0.0 5.3 0.0 3.8 26.5 2597.0 0.0 0.3 0.0 0.1 4.9 0.0 0.0 59.9 10.2 0.3 0.0 0.0 0.0 14.1 5.4 0.0 0.0 0.0 0.0 0.0 0.0 15.3 10.8 0.0 0.0 27.0 0.7 0.1 109.3 0.0 0.0 0.0 8.5 0.0 0.0 1.7 0.4 0.0 13.7 0.1 7.0 16.6 SCUBE2 "Cegb1, Cegf1, FLJ16792" ENSG00000175356 "Signal peptide, CUB domain and EGF like domain containing 2" Q9NQ36 11 9019476-9138114 "Predicted intracellular proteins, Predicted secreted proteins" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 48.8" "Cell type enhanced" "Detected in many" "Adipocytes: 30.3;Basal prostatic cells: 51.4;Breast glandular cells: 45.0;Breast myoepithelial cells: 31.5;Prostatic glandular cells: 39.8" "Cancer enhanced" "Detected in all" "breast cancer: 54.7" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 5 "non-classical monocyte: 1.0" "Lineage enriched" "Detected in single" 6 "monocytes: 1.0" "Cell line enhanced" "Detected in some" "HAP1: 5.7;SK-MEL-30: 8.1;T-47d: 28.4" "Group enriched" "Detected in some" 4 "olfactory bulb: 4.6;thalamus: 2.7" "Low region specificity" "Detected in all" "HPA006353, HPA029871" Uncertain "Secreted to blood" NA NA 1100000 "Cluster 7: Monocytes - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 6: T47d - Mammary gland" "Cluster 35: Glandular cells - Unknown function" "HPA006353: AB_1856642, HPA029871: AB_10602299" "prognostic favorable (2.41e-4)" "unprognostic (5.72e-3)" "unprognostic (2.91e-1)" "unprognostic (1.76e-2)" "unprognostic (2.73e-1)" "unprognostic (6.12e-4)" "unprognostic (3.11e-1)" "unprognostic (6.39e-2)" "unprognostic (2.08e-1)" "unprognostic (9.39e-2)" "unprognostic (1.54e-2)" "unprognostic (3.04e-1)" "unprognostic (1.94e-2)" "unprognostic (9.12e-4)" "unprognostic (4.35e-1)" "unprognostic (5.94e-2)" "unprognostic (2.88e-1)" 14.8 2.0 3.5 3.7 3.5 0.0 32.2 13.7 3.1 17.6 0.2 11.1 3.6 13.4 48.8 4.5 18.2 7.9 4.3 4.0 4.9 1.3 0.9 4.6 3.9 3.0 3.6 0.9 22.0 19.5 9.6 22.5 3.7 33.3 4.5 1.9 2.3 8.7 9.0 12.3 16.3 13.0 5.4 5.0 21.4 2.2 4.7 2.4 5.2 6.2 7.6 28.6 6.9 5.1 0.0 0.1 1.5 0.9 0.5 0.6 0.2 1.6 0.8 0.9 0.6 0.3 0.0 0.0 0.6 3.9 0.1 0.0 5.7 0.0 1.4 0.1 0.3 0.0 0.0 0.0 0.6 0.0 0.1 1.3 0.0 0.4 0.0 0.3 0.6 0.0 0.0 0.0 1.1 0.0 0.0 1.3 0.9 0.0 0.0 0.1 0.0 0.2 0.4 3.1 0.7 1.0 1.1 0.1 8.1 1.3 28.4 0.0 0.0 0.6 0.4 0.6 0.2 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 3.5 3.5 13.7 3.1 4.0 4.9 3.0 3.6 3.7 5.4 4.7 5.1 30.3 16.0 9.2 1.6 0.0 7.4 51.4 0.3 1.2 0.4 45.0 31.5 0.6 0.0 5.6 1.8 0.0 0.2 0.1 1.0 0.0 0.1 3.4 2.2 8.8 3.3 1.2 0.0 3.1 1.8 0.2 9.4 0.0 6.4 0.0 0.3 1.1 0.1 0.8 13.5 14.9 5.2 6.1 0.3 1.5 2.5 0.3 0.7 19.6 5.6 0.1 0.0 0.0 13.6 4.6 0.1 4.3 0.7 0.0 39.8 0.6 0.0 1.5 0.3 0.0 5.2 1.5 0.6 0.7 0.1 1.8 0.4 0.3 6.6 9.6 15.6 SEC14L6 ENSG00000214491 "SEC14 like lipid binding 6" B5MCN3 22 30522799-30546682 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "epididymis: 21.2;parathyroid gland: 30.5" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 12.8;Alveolar cells type 2: 10.5;Cholangiocytes: 11.5;Collecting duct cells: 12.9;Ductal cells: 6.6;Muller glia cells: 18.6" "Cancer enriched" "Detected in many" 7 "renal cancer: 12.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "K-562: 12.3;RPTEC TERT1: 21.8;SiHa: 6.6" HPA067695 Approved Nucleoplasm NA NA "Cluster 35: T-regs - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 5: Muller glia cells - Visual perception" Nucleoplasm "HPA067695: AB_2685889" "unprognostic (3.49e-2)" "unprognostic (4.76e-2)" "unprognostic (4.79e-2)" "unprognostic (4.09e-2)" "unprognostic (3.04e-2)" "unprognostic (1.12e-1)" "unprognostic (7.28e-3)" "unprognostic (3.88e-2)" "unprognostic (3.13e-1)" "unprognostic (3.35e-1)" "unprognostic (1.29e-1)" "unprognostic (9.25e-2)" "unprognostic (8.69e-2)" "unprognostic (8.20e-2)" "unprognostic (2.12e-1)" "unprognostic (2.48e-2)" "unprognostic (6.02e-2)" 1.4 1.4 5.3 0.3 4.6 2.1 3.9 4.5 4.7 3.5 5.9 0.5 0.6 3.2 21.2 0.3 1.7 4.5 0.3 4.4 5.0 8.4 0.4 11.9 0.4 8.6 6.2 2.4 5.5 30.5 2.5 0.5 8.8 1.7 0.3 5.0 0.4 2.6 0.2 10.0 0.5 2.2 5.2 0.4 1.2 5.4 8.7 0.3 0.3 0.8 0.6 0.4 0.4 4.9 0.2 0.1 0.9 0.3 0.0 0.0 1.0 0.1 0.0 0.1 0.0 0.2 0.5 0.3 1.1 0.1 0.1 0.2 0.1 0.0 0.3 0.0 0.0 3.0 0.3 0.3 0.1 0.2 0.4 0.0 0.1 0.1 0.1 0.7 0.0 0.1 12.3 0.2 0.0 0.5 0.1 0.4 0.5 0.0 0.1 0.2 0.0 0.1 21.8 0.2 0.2 0.1 6.6 0.1 0.0 0.2 1.8 0.0 0.0 0.2 0.1 0.2 0.1 0.1 0.1 0.2 0.0 0.3 0.1 0.5 0.1 0.1 0.1 0.1 0.3 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.4 0.3 0.1 0.1 0.5 0.0 5.3 4.6 4.5 4.7 4.4 5.0 8.6 6.2 8.8 5.2 8.7 4.9 0.0 12.8 10.5 0.3 0.2 0.1 0.5 0.0 0.0 0.2 0.4 0.5 0.3 11.5 3.7 12.9 0.0 0.0 0.0 0.0 1.9 6.6 0.0 0.3 0.4 1.0 0.0 0.0 0.7 0.8 0.0 0.2 0.0 1.5 1.3 0.2 0.7 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.3 0.3 0.1 0.0 0.0 0.6 18.6 0.0 1.5 0.6 1.8 0.0 0.7 0.0 0.1 0.0 2.9 0.0 0.5 0.0 2.7 0.1 0.9 0.4 0.0 0.0 0.1 0.9 0.0 0.0 0.2 SEC62 "Dtrp1, HTP1, TLOC1" ENSG00000008952 "SEC62 homolog, preprotein translocation factor" Q99442 3 169966635-169998373 "Predicted membrane proteins, Transporters" "Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014059, HPA061450" Approved Approved "Endoplasmic reticulum,Intermediate filaments" NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 68: Epididymis - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 6: Erythroid cells - Oxygen transport" "Endoplasmic reticulum" "Intermediate filaments" "HPA014059: AB_1858029, HPA061450: AB_2684524" "unprognostic (8.15e-2)" "unprognostic (6.84e-2)" "unprognostic (2.72e-1)" "unprognostic (4.93e-3)" "unprognostic (5.13e-1)" "unprognostic (1.10e-3)" "unprognostic (1.24e-1)" "unprognostic (4.04e-1)" "unprognostic (6.78e-2)" "unprognostic (5.97e-2)" "unprognostic (6.36e-2)" "unprognostic (3.15e-1)" "unprognostic (2.83e-2)" "unprognostic (4.81e-2)" "unprognostic (2.76e-1)" "unprognostic (1.20e-1)" "unprognostic (2.02e-1)" 104.9 86.5 82.9 58.6 94.3 94.4 64.5 88.1 120.6 74.4 74.6 60.9 58.5 74.7 131.9 44.4 52.3 58.5 49.1 81.8 108.1 118.6 193.7 67.6 63.3 94.9 97.7 75.9 116.5 109.7 41.5 71.0 97.9 82.5 56.6 128.9 130.4 83.5 55.3 27.4 59.4 68.3 95.5 83.5 91.1 34.6 92.3 51.1 120.9 60.2 67.0 63.7 31.7 99.9 140.4 96.6 74.2 66.3 217.9 114.7 46.7 175.5 128.3 80.0 82.5 104.0 143.9 156.8 190.7 125.9 132.5 130.3 92.3 84.8 124.7 123.1 89.2 108.6 57.2 105.6 157.9 111.6 68.5 115.0 79.7 88.0 85.3 108.8 80.1 47.3 68.0 147.2 96.3 117.2 58.9 59.0 76.4 110.8 62.5 77.6 107.6 212.8 115.1 88.5 76.1 71.9 143.7 155.8 125.3 71.3 233.5 101.0 107.8 113.1 51.0 95.6 143.1 168.8 134.9 240.8 118.5 85.1 108.0 17.2 34.8 62.3 44.2 37.1 49.2 77.6 40.6 43.5 30.9 82.1 50.9 46.6 52.0 31.8 29.0 35.1 39.1 27.6 82.9 94.3 88.1 120.6 81.8 108.1 94.9 97.7 97.9 95.5 92.3 99.9 419.0 237.2 291.5 64.6 362.7 254.4 252.8 511.1 144.0 362.0 223.3 278.5 582.1 320.3 431.7 680.5 277.3 218.7 209.5 144.7 195.6 256.4 31.6 302.9 424.8 363.7 261.1 874.1 79.3 347.6 215.0 396.3 104.5 455.3 293.5 105.2 463.7 1081.6 214.7 452.6 86.8 285.4 364.2 237.2 268.0 43.4 560.1 208.4 279.3 48.7 280.0 486.8 183.4 47.3 103.1 283.4 217.4 435.6 469.8 223.5 233.7 416.9 385.8 418.4 295.9 358.9 423.4 206.5 142.2 90.2 172.3 434.1 205.5 175.9 182.2 176.8 SERTM2 LINC00890 ENSG00000260802 "Serine rich and transmembrane domain containing 2" A0A1B0GWG4 X 111511662-111522399 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "endometrium 1: 27.3;epididymis: 41.9;seminal vesicle: 75.8" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 3.2;Alveolar cells type 2: 4.6;granulocytes: 1.3" "Cancer enhanced" "Detected in some" "prostate cancer: 2.9;renal cancer: 1.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "HMC-1: 16.9" "Region enhanced" "Detected in some" "basal ganglia: 2.8" "Low region specificity" "Detected in many" NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 3: HMC-1 - Innate immune response" "Cluster 11: Alveolar cells - Smell perception" "unprognostic (9.56e-2)" "unprognostic (1.63e-2)" "unprognostic (1.55e-1)" "unprognostic (2.42e-1)" "unprognostic (2.65e-1)" "unprognostic (3.79e-2)" "unprognostic (5.74e-2)" "unprognostic (1.93e-2)" "unprognostic (4.03e-2)" "unprognostic (3.51e-1)" "unprognostic (8.77e-3)" "unprognostic (3.86e-3)" "unprognostic (1.94e-1)" "unprognostic (2.26e-1)" "unprognostic (9.57e-3)" 0.0 0.1 0.0 0.8 0.0 0.0 0.3 0.0 0.0 13.1 0.0 1.8 0.1 27.3 41.9 0.0 4.2 0.2 0.0 0.0 0.8 0.2 5.4 0.2 0.1 0.3 0.3 0.8 0.0 0.0 1.0 0.3 0.4 9.8 0.1 0.3 0.0 75.8 0.0 0.0 0.4 4.8 0.1 0.4 2.1 0.0 0.8 0.0 0.0 0.0 0.3 0.7 3.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.7 0.0 16.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.9 0.0 0.0 0.0 0.0 0.0 0.9 0.0 2.8 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.3 0.3 0.4 0.1 0.8 0.1 0.1 3.2 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 SFT2D3 MGC5391 ENSG00000173349 "SFT2 domain containing 3" Q587I9 2 127701497-127705242 "Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 7.4;ASC TERT1: 4.2;BJ hTERT+: 4.2;HHSteC: 5.0;hTCEpi: 7.0;hTERT-HME1: 5.2;RPTEC TERT1: 6.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 68: Epididymis - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 41: Macrophages - Immune response" 0.9 0.0 2.4 0.0 2.4 0.0 5.2 2.4 3.1 3.8 2.4 3.3 0.0 1.2 6.1 0.0 4.1 0.0 0.0 2.4 2.4 3.2 6.0 1.6 0.0 2.5 2.6 1.3 1.0 5.0 0.0 1.6 2.5 2.8 5.5 0.0 0.0 3.5 0.0 0.0 0.0 2.9 2.4 1.1 1.5 1.3 2.4 4.7 1.0 2.6 4.8 1.0 0.0 2.5 0.0 0.0 0.0 0.0 7.4 4.2 0.0 0.0 4.2 4.1 3.2 0.0 0.0 0.0 0.0 3.1 0.0 0.0 3.5 2.9 3.3 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 3.8 7.0 2.0 5.2 0.0 4.1 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.4 2.4 2.4 3.1 2.4 2.4 2.5 2.6 2.5 2.4 2.4 2.5 6.9 3.2 6.8 1.6 7.6 1.3 8.2 1.6 5.7 7.9 7.1 7.0 0.0 2.8 1.5 7.3 16.7 4.2 9.5 6.4 9.8 2.8 4.9 9.3 8.7 5.2 5.4 5.5 1.8 6.2 4.4 6.4 7.7 7.4 1.3 7.5 4.2 9.5 4.1 8.4 2.5 10.5 0.0 8.4 3.0 2.7 5.6 10.5 3.6 3.7 5.1 10.0 8.2 3.0 5.1 3.1 7.0 7.5 5.6 9.3 5.6 6.4 3.4 10.1 0.0 5.2 5.2 18.3 3.8 7.1 2.7 2.9 6.5 9.7 8.7 5.9 SH3BGRL3 ENSG00000142669 "SH3 domain binding glutamate rich protein like 3" Q9H299 1 26280086-26281522 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Hofbauer cells: 2516.1;Langerhans cells: 2368.4;Pancreatic endocrine cells: 2492.4;Urothelial cells: 2342.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030848, HPA076219" Enhanced Approved "Nuclear bodies" NA NA 41000000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 68: Epididymis - Unknown function" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 16: Pancreatic endocrine cells - Mixed function" "Nuclear bodies" "HPA030848: AB_10602398, HPA076219: AB_2686787" "unprognostic (4.97e-2)" "unprognostic (9.57e-2)" "unprognostic (1.07e-1)" "unprognostic (4.73e-3)" "unprognostic (4.95e-2)" "unprognostic (8.68e-2)" "unprognostic (4.29e-3)" "unprognostic (3.16e-1)" "unprognostic (3.62e-2)" "unprognostic (4.32e-1)" "unprognostic (1.98e-2)" "unprognostic (9.55e-2)" "prognostic unfavorable (2.17e-10)" "unprognostic (1.66e-1)" "unprognostic (1.59e-1)" "unprognostic (6.35e-2)" "unprognostic (4.43e-2)" 221.9 102.0 289.8 423.0 302.9 530.2 141.8 306.0 380.2 135.5 269.7 416.3 161.9 85.8 708.2 368.2 101.4 177.5 120.8 299.4 321.7 115.9 121.6 289.5 404.4 316.2 340.4 66.7 157.4 85.5 83.2 155.4 320.6 82.5 437.9 32.2 139.6 112.3 47.6 305.9 164.7 202.6 297.0 313.1 223.2 26.2 351.0 306.7 82.9 81.0 437.0 424.5 176.3 325.7 501.1 274.9 187.5 265.7 769.3 2090.9 23.2 895.6 1315.0 959.2 611.0 220.3 460.4 120.8 297.9 1963.3 268.2 182.6 108.9 1030.2 642.6 192.0 109.3 976.3 212.1 213.3 604.8 280.1 1447.9 836.8 652.4 912.9 742.0 1115.0 1200.3 244.7 112.2 430.6 1767.3 337.8 182.1 478.2 221.6 434.8 2003.4 341.1 229.0 170.5 762.6 216.7 119.7 189.8 331.2 338.1 374.1 199.3 65.7 431.9 1451.5 1071.0 370.8 1492.9 402.3 135.7 241.6 104.0 2253.9 792.3 532.5 4277.3 7085.6 6427.9 4340.1 6247.2 3228.5 2422.2 3706.5 4249.4 5891.3 2181.2 1591.2 3072.9 7753.8 2344.8 6190.5 3152.1 5092.0 13045.6 289.8 302.9 306.0 380.2 299.4 321.7 316.2 340.4 320.6 297.0 351.0 325.7 445.2 96.1 168.0 9.8 603.5 984.1 995.1 708.3 373.9 17.1 216.7 227.1 7.8 193.0 290.5 367.8 4.2 133.1 1060.9 1614.6 313.1 1108.5 15.8 178.9 410.9 502.9 339.8 220.0 12.9 1031.5 436.1 493.8 388.4 344.0 1017.6 67.2 346.6 121.7 2516.1 16.8 8.2 1430.3 205.4 1796.4 2368.4 52.8 139.1 2209.6 779.1 16.9 1116.8 76.9 1251.3 4.0 20.2 2492.4 1309.6 162.1 397.9 1754.9 391.7 498.6 202.8 16.4 151.2 71.9 336.4 9.1 23.5 788.1 1058.7 227.1 1380.4 99.2 507.5 2342.3 SLC15A2 PEPT2 ENSG00000163406 "Solute carrier family 15 member 2" Q16348 3 121894401-121944188 "Metabolic proteins, Predicted membrane proteins, Transporters" "Immunity, Innate immunity, Peptide transport, Protein transport, Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix: 50.9;epididymis: 39.2;prostate: 39.7" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 99.3;Astrocytes: 139.7;Club cells: 64.8;Microglial cells: 49.6;Muller glia cells: 51.4" "Cancer enhanced" "Detected in many" "prostate cancer: 12.1" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "NB-4: 5.7;U-937: 4.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 37: B-cells - Transcription" "Cluster 68: Epididymis - Unknown function" "Cluster 32: U-937 - Innate immune response" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "unprognostic (4.72e-2)" "prognostic favorable (2.37e-4)" "unprognostic (3.50e-2)" "prognostic favorable (6.96e-4)" "unprognostic (1.80e-2)" "unprognostic (1.78e-1)" "unprognostic (8.03e-3)" "prognostic favorable (6.74e-4)" "unprognostic (3.21e-1)" "unprognostic (1.28e-1)" "unprognostic (9.92e-2)" "unprognostic (1.43e-1)" "unprognostic (5.53e-3)" "unprognostic (1.63e-1)" "unprognostic (2.58e-1)" "unprognostic (2.67e-2)" "unprognostic (4.60e-2)" 1.0 1.3 14.0 3.0 15.0 5.9 4.8 10.1 15.0 50.9 2.4 2.6 2.2 2.0 39.2 3.4 11.3 6.3 2.0 12.9 11.8 11.0 0.9 20.1 6.0 9.4 13.6 0.8 5.5 1.7 3.4 2.2 12.6 39.7 2.9 20.9 24.6 22.0 0.8 0.9 2.0 1.2 9.0 6.0 1.6 4.1 17.1 1.6 6.7 0.4 6.0 4.9 2.3 7.7 1.3 0.6 0.7 0.2 0.8 0.4 0.9 0.1 0.1 0.3 0.4 1.2 2.1 2.4 0.1 0.1 0.4 1.4 0.5 1.2 0.4 2.0 0.5 3.3 1.0 0.6 0.1 3.6 3.2 0.7 3.6 0.4 0.2 0.4 0.2 0.7 0.5 1.0 0.4 1.0 0.7 5.7 3.7 1.4 0.3 0.8 0.3 0.7 0.8 0.8 0.3 0.3 0.3 0.2 0.1 1.1 0.2 3.1 0.1 0.3 0.2 0.2 0.3 1.2 0.4 3.3 0.4 4.8 0.3 0.9 0.4 0.1 0.0 0.1 0.1 1.3 0.1 0.0 0.1 1.3 0.1 0.1 0.2 0.0 1.0 0.6 0.0 0.1 14.0 15.0 10.1 15.0 12.9 11.8 9.4 13.6 12.6 9.0 17.1 7.7 0.4 99.3 22.8 139.7 5.9 0.5 2.8 22.5 1.2 1.0 5.0 2.0 2.6 4.3 64.8 11.0 0.0 2.5 3.2 1.4 3.9 0.6 0.4 8.9 2.0 1.0 0.0 1.7 15.4 8.3 0.6 1.3 0.5 21.3 3.8 1.0 1.4 0.0 2.7 0.0 22.6 1.4 14.2 13.5 3.8 0.6 6.5 5.3 0.0 49.6 3.1 51.4 1.0 16.6 5.0 2.0 1.0 5.3 7.7 14.4 0.2 1.6 28.8 2.9 0.0 0.9 2.4 0.4 0.5 10.4 0.6 1.4 1.2 0.3 1.6 12.7 SLC25A17 PMP34 ENSG00000100372 "Solute carrier family 25 member 17" O43808 22 40769630-40819399 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052708, HPA060972" Approved Supported Peroxisomes NA NA "Cluster 6: Non-specific - Transcription" "Cluster 68: Epididymis - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" Peroxisomes "HPA052708: AB_2681924, HPA060972: AB_2684400" "unprognostic (2.75e-1)" "unprognostic (1.11e-3)" "unprognostic (1.91e-3)" "unprognostic (2.44e-2)" "unprognostic (2.61e-1)" "unprognostic (1.96e-2)" "unprognostic (2.85e-3)" "unprognostic (2.16e-1)" "unprognostic (1.72e-1)" "unprognostic (1.63e-3)" "unprognostic (8.44e-2)" "unprognostic (2.72e-1)" "unprognostic (5.59e-2)" "unprognostic (8.54e-2)" "unprognostic (1.55e-1)" "unprognostic (1.76e-1)" "unprognostic (1.18e-1)" 7.4 12.3 9.4 5.3 9.2 3.3 14.3 9.9 10.7 9.3 11.5 6.3 5.4 13.2 19.6 7.1 11.4 5.7 4.3 9.2 10.2 13.6 16.9 6.6 9.4 9.9 9.6 20.6 8.8 13.6 9.2 10.0 9.7 10.7 7.3 9.2 9.8 5.9 3.9 9.6 6.0 10.5 10.1 7.3 7.8 10.0 10.0 9.3 12.7 3.6 9.7 8.1 7.2 11.2 23.5 13.5 21.0 18.5 12.8 15.9 16.8 20.7 22.7 32.5 35.7 16.5 8.8 26.7 12.2 20.4 17.7 18.6 30.6 16.6 33.4 27.0 41.3 31.1 18.4 21.1 18.3 35.8 16.2 15.3 22.8 28.6 18.4 14.7 19.4 21.4 46.5 12.9 26.5 19.2 22.0 24.2 17.7 33.2 20.6 23.8 32.4 40.3 27.6 19.7 14.2 12.5 42.8 26.6 26.7 20.3 22.0 10.7 11.8 18.5 24.4 16.1 19.2 13.9 29.6 25.7 19.7 18.4 20.4 7.0 3.3 4.2 4.9 3.9 6.9 8.4 5.8 5.5 4.2 7.6 8.2 6.7 1.5 8.3 3.3 5.4 8.6 4.7 9.4 9.2 9.9 10.7 9.2 10.2 9.9 9.6 9.7 10.1 10.0 11.2 8.4 19.2 9.5 23.2 10.9 16.6 16.8 29.8 10.8 12.1 13.6 9.3 4.0 7.2 20.7 12.9 8.4 39.8 8.0 5.8 21.5 17.9 9.6 17.9 16.5 10.4 6.1 11.6 17.3 17.7 31.9 15.9 8.2 14.2 5.1 15.5 8.2 24.8 12.9 11.8 21.5 6.5 26.4 7.9 6.0 16.0 27.1 7.4 16.0 7.5 17.6 7.9 10.3 18.1 28.0 18.1 4.4 26.7 11.9 18.1 8.2 21.1 15.0 7.0 32.9 9.3 11.6 51.0 38.0 11.7 17.2 28.6 9.7 16.4 7.5 14.9 SLC30A3 ZNT3 ENSG00000115194 "Solute carrier family 30 member 3" Q99726 2 27253684-27275817 "Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 22.2;epididymis: 68.5;testis: 35.2" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 8.4;Early spermatids: 17.8;Excitatory neurons: 15.6;Late spermatids: 42.4;Peritubular cells: 15.1;Spermatocytes: 16.6;Spermatogonia: 10.7" "Cancer enhanced" "Detected in some" "thyroid cancer: 1.3" "Group enriched" "Detected in many" 10 "amygdala: 14.5;basal ganglia: 10.3;cerebral cortex: 18.2;hippocampal formation: 22.2" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 8.8;HAP1: 11.2;Hep G2: 12.0;REH: 22.8;RH-30: 11.0" "Group enriched" "Detected in all" 4 "amygdala: 130.7;basal ganglia: 48.2;cerebral cortex: 110.9;hippocampal formation: 69.1;white matter: 34.7" "Group enriched" "Detected in many" 6 "amygdala: 18.5;cerebral cortex: 55.5;hippocampal formation: 43.0" "HPA060505, HPA067637, CAB079044" Enhanced Approved Approved Nucleoplasm,Nucleoli,Vesicles,Cytosol NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 14: REH - Unknown function" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Vesicles "Nucleoplasm, Nucleoli, Cytosol" "CAB079044: , HPA060505: AB_2684296, HPA067637: AB_2685875" "unprognostic (2.05e-4)" "unprognostic (1.17e-1)" "unprognostic (6.84e-4)" "unprognostic (5.26e-2)" "unprognostic (2.34e-1)" "unprognostic (1.13e-1)" "unprognostic (1.43e-2)" "unprognostic (2.93e-2)" "unprognostic (2.64e-2)" "unprognostic (3.05e-1)" "unprognostic (2.20e-1)" "unprognostic (1.89e-1)" "unprognostic (4.65e-12)" "unprognostic (3.23e-2)" "unprognostic (1.76e-1)" "unprognostic (2.74e-2)" "unprognostic (2.63e-4)" 0.1 2.1 14.5 0.1 10.3 0.3 0.1 0.0 18.2 0.2 0.0 0.1 0.0 0.4 68.5 0.1 0.3 0.1 7.9 22.2 0.0 0.1 0.2 0.2 0.5 0.5 0.0 0.2 0.0 0.5 0.3 0.0 0.8 0.3 0.0 0.2 0.0 0.5 0.1 0.1 0.1 0.1 0.0 0.1 0.1 35.2 0.0 0.0 0.2 0.0 0.1 0.0 0.2 1.5 0.4 1.3 0.1 2.0 0.2 0.2 0.3 0.0 0.0 1.3 1.4 0.5 0.5 0.0 0.1 0.0 8.8 0.3 11.2 0.0 0.3 0.0 1.2 5.9 0.5 12.0 0.2 0.2 2.3 0.0 0.0 0.6 0.0 0.2 0.9 2.9 1.7 0.1 0.2 3.9 0.1 0.4 1.8 0.4 0.0 22.8 11.0 1.4 0.0 0.3 0.0 0.7 2.8 0.0 0.0 0.1 0.0 0.8 0.1 0.3 5.1 0.3 0.2 0.1 0.0 0.0 0.1 0.2 0.2 0.4 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.0 14.5 10.3 0.0 18.2 22.2 0.0 0.5 0.0 0.8 0.0 0.0 1.5 0.3 0.0 0.0 2.0 0.1 0.0 0.2 0.0 0.0 0.0 0.3 0.1 8.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 17.8 0.0 0.1 0.4 0.0 0.0 15.6 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.4 0.0 0.1 0.0 2.1 0.0 0.0 0.0 0.4 42.4 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.0 0.0 15.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.3 16.6 10.7 0.0 0.1 0.1 0.1 0.0 0.0 0.0 SLC35A5 FLJ20730 ENSG00000138459 "Solute carrier family 35 member A5" Q9BS91 3 112561709-112585579 "Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "Early spermatids: 156.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035519, HPA057964" Uncertain Approved "Golgi apparatus" NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 29: Early spermatids - Spermatogenesis" "Golgi apparatus" "HPA035519: AB_10601487, HPA057964: AB_2683566" "unprognostic (7.89e-2)" "unprognostic (2.33e-1)" "unprognostic (7.17e-2)" "unprognostic (1.11e-1)" "unprognostic (1.89e-1)" "unprognostic (7.09e-2)" "unprognostic (1.45e-1)" "unprognostic (4.78e-2)" "unprognostic (8.60e-3)" "unprognostic (2.60e-1)" "unprognostic (8.21e-2)" "unprognostic (3.51e-1)" "prognostic favorable (4.10e-5)" "unprognostic (2.26e-1)" "unprognostic (1.97e-1)" "unprognostic (8.05e-2)" "unprognostic (3.42e-1)" 15.5 19.3 18.2 13.4 23.9 5.7 14.8 22.4 26.9 15.5 18.4 15.6 16.7 15.6 16.0 14.3 14.6 15.4 9.7 18.1 21.4 20.2 21.0 14.7 15.7 24.0 21.7 17.9 9.5 17.2 9.1 18.4 24.3 16.0 16.1 21.7 11.4 13.9 6.1 9.2 18.3 15.9 23.2 14.2 14.5 18.8 21.2 12.7 26.1 10.2 15.3 12.6 8.3 30.0 20.4 18.4 31.2 18.8 39.3 37.4 18.0 33.2 23.7 27.5 31.5 13.6 22.8 18.1 27.4 28.8 31.3 25.3 22.4 15.6 34.6 14.2 11.1 23.2 15.9 11.4 33.6 20.7 21.5 31.8 30.9 24.3 14.9 34.8 25.1 13.8 13.5 22.1 38.7 7.2 16.2 13.1 20.8 24.0 19.2 14.4 11.4 19.7 34.2 14.9 18.3 24.1 21.3 10.4 38.0 20.9 14.2 13.9 28.3 40.3 21.8 8.6 15.7 15.7 24.4 32.2 29.9 17.2 30.8 14.8 16.4 21.0 10.9 25.9 10.3 14.7 10.2 8.6 19.7 13.6 13.6 11.2 14.6 7.3 27.4 9.4 11.2 10.8 18.2 23.9 22.4 26.9 18.1 21.4 24.0 21.7 24.3 23.2 21.2 30.0 9.9 3.2 10.1 13.1 12.5 6.4 8.3 9.9 11.4 12.8 8.5 6.5 5.5 7.2 12.6 14.7 0.0 36.1 12.5 16.4 9.8 7.8 156.8 9.2 9.1 12.9 7.7 9.2 15.0 7.7 25.6 14.0 10.7 10.0 14.0 9.0 19.6 13.1 17.9 37.0 15.2 11.8 20.3 23.2 9.2 23.5 17.1 13.0 26.6 5.6 14.0 20.3 9.2 23.1 36.6 8.1 13.1 17.3 14.3 8.5 25.8 14.8 10.4 16.9 26.3 9.6 10.6 14.9 15.7 8.9 6.7 29.8 10.7 14.6 10.0 6.5 SLC35E2B ENSG00000189339 "Solute carrier family 35 member E2B" P0CK96 1 1659529-1692795 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 77.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045641, HPA062711" Uncertain Uncertain Nucleoplasm NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 68: Epididymis - Unknown function" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 9: Photoreceptor cells - Phototransduction" Nucleoplasm "HPA045641: AB_2679402, HPA062711: AB_2684844" "unprognostic (9.00e-2)" "unprognostic (2.13e-1)" "unprognostic (8.74e-3)" "unprognostic (1.01e-1)" "unprognostic (1.82e-1)" "prognostic favorable (7.64e-4)" "unprognostic (1.18e-1)" "unprognostic (4.09e-2)" "unprognostic (5.70e-2)" "unprognostic (5.83e-2)" "unprognostic (2.04e-2)" "unprognostic (2.20e-1)" "unprognostic (2.92e-1)" "unprognostic (2.68e-2)" "unprognostic (6.61e-2)" "unprognostic (2.54e-2)" "prognostic favorable (5.15e-4)" 21.0 29.7 38.1 20.9 35.9 17.3 25.8 30.7 38.5 35.3 31.3 30.8 31.9 31.8 34.2 20.8 29.2 19.5 19.4 38.8 27.8 27.8 26.1 22.9 32.4 28.8 29.9 39.0 30.7 20.3 43.1 20.4 29.4 30.2 22.1 42.6 29.1 22.5 29.1 29.5 34.1 30.6 26.2 40.1 28.7 10.9 31.1 34.5 30.8 14.6 28.0 26.0 26.5 33.3 13.0 17.4 58.3 49.8 42.3 40.0 16.9 15.6 35.8 16.9 19.7 12.8 33.6 22.6 24.2 33.7 20.9 16.9 23.0 14.9 16.8 28.4 20.1 30.6 37.2 21.7 31.5 24.6 26.2 35.0 31.2 21.4 30.5 47.3 35.5 40.9 31.1 30.8 19.4 9.2 32.3 29.2 19.0 11.2 18.5 28.3 15.9 29.5 29.1 13.1 50.9 46.8 26.4 31.5 50.8 23.8 38.9 34.8 33.5 29.9 12.6 11.7 8.6 25.0 19.6 35.2 22.8 45.2 16.5 1.8 3.7 2.8 7.0 3.3 7.6 3.9 5.9 8.1 2.4 3.9 6.8 5.9 5.5 4.0 2.4 7.6 6.0 5.0 38.1 35.9 30.7 38.5 38.8 27.8 28.8 29.9 29.4 26.2 31.1 33.3 8.2 12.8 28.3 9.8 19.8 7.4 7.1 14.1 18.8 35.5 12.0 8.6 17.1 34.3 24.6 3.7 77.2 14.1 26.0 28.3 0.0 5.7 1.1 9.1 14.8 16.8 25.4 21.5 12.0 6.1 9.6 18.4 30.5 6.8 23.4 13.9 25.4 22.2 10.5 30.3 12.1 24.3 18.3 31.5 8.2 3.9 30.4 13.8 12.4 9.4 21.8 12.3 29.9 14.6 12.9 6.2 17.8 26.7 28.0 9.3 38.1 3.4 23.4 66.5 6.6 16.8 12.0 8.5 16.1 16.3 9.7 8.8 23.1 10.1 26.4 8.7 SLC38A11 "AVT2, FLJ39822" ENSG00000169507 "Solute carrier family 38 member 11" Q08AI6 2 164896186-164955525 "Predicted membrane proteins, Transporters" "Amino-acid transport, Ion transport, Sodium transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 28.7;epididymis: 38.6" "Cell type enhanced" "Detected in many" "Cholangiocytes: 28.6;Enteroendocrine cells: 174.1;Excitatory neurons: 53.4;Sertoli cells: 72.3;Smooth muscle cells: 39.8" "Cancer enriched" "Detected in many" 5 "prostate cancer: 7.6" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 28 "memory B-cell: 1.6;naive B-cell: 3.9" "Lineage enriched" "Detected in single" 39 "B-cells: 3.9" "Cell line enriched" "Detected in some" 9 "BJ hTERT+: 249.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA043432 Uncertain NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 68: Epididymis - Unknown function" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 17: Intestinal endocrine cells - Hormone signaling" "HPA043432: AB_10793948" "unprognostic (1.52e-1)" "unprognostic (2.59e-1)" "unprognostic (4.14e-1)" "unprognostic (1.41e-1)" "unprognostic (1.41e-1)" "unprognostic (1.69e-2)" "unprognostic (6.28e-3)" "unprognostic (3.53e-2)" "unprognostic (2.41e-1)" "unprognostic (2.12e-1)" "unprognostic (1.15e-3)" "unprognostic (1.99e-1)" "prognostic favorable (2.00e-8)" "unprognostic (1.69e-1)" "unprognostic (1.20e-1)" "unprognostic (2.43e-2)" "unprognostic (2.36e-2)" 2.0 4.0 6.0 1.5 6.4 0.1 0.8 3.8 11.2 2.6 28.7 1.5 6.0 1.7 38.6 1.0 0.8 17.7 1.3 6.2 3.9 7.9 2.6 0.4 2.0 3.9 4.2 0.3 2.2 1.3 3.3 0.3 4.3 10.8 2.7 0.3 0.6 16.9 0.9 0.6 2.7 2.0 3.5 8.1 11.7 0.2 5.8 0.3 2.1 4.0 1.3 1.5 1.1 6.3 0.0 0.6 0.0 0.0 0.0 0.0 0.1 28.9 249.7 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.4 0.0 0.1 0.0 5.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 6.0 6.4 3.8 11.2 6.2 3.9 3.9 4.2 4.3 3.5 5.8 6.3 0.9 0.0 0.0 6.2 7.0 0.0 0.3 0.0 0.0 0.1 0.1 0.0 0.9 28.6 0.0 3.7 0.0 0.7 2.7 0.5 0.0 3.2 2.1 0.1 0.5 2.7 174.1 2.7 53.4 0.6 0.6 0.3 5.1 0.1 0.0 0.0 0.4 3.7 0.0 0.0 2.9 6.4 0.0 0.0 0.3 1.2 0.0 0.0 0.0 17.8 0.0 0.1 0.0 0.5 1.2 0.8 2.3 0.0 0.0 3.2 1.0 2.0 0.0 0.1 72.3 0.5 39.8 0.1 0.0 0.2 0.3 1.5 0.9 4.4 0.7 0.2 SLC66A3 "C2orf22, MGC33602, PQLC3" ENSG00000162976 "Solute carrier family 66 member 3" Q8N755 2 11155198-11178870 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Adipocytes: 15.5;Cytotrophoblasts: 17.5;Extravillous trophoblasts: 82.4;Fibroblasts: 16.1;Hofbauer cells: 56.3" "Cancer enhanced" "Detected in all" "testis cancer: 72.1" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 64.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA061607 Approved Cytosol NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 68: Epididymis - Unknown function" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 24: Non-specific - Transcription regulation" Cytosol "HPA061607: AB_2797264" "unprognostic (3.22e-2)" "unprognostic (1.17e-1)" "unprognostic (2.19e-1)" "unprognostic (5.55e-2)" "unprognostic (1.65e-2)" "unprognostic (2.16e-1)" "unprognostic (1.09e-3)" "unprognostic (9.11e-2)" "unprognostic (3.14e-1)" "unprognostic (2.24e-1)" "unprognostic (4.93e-3)" "unprognostic (2.93e-1)" "unprognostic (1.19e-2)" "unprognostic (1.12e-1)" "unprognostic (2.21e-1)" "unprognostic (2.34e-1)" "unprognostic (4.00e-2)" 30.6 26.3 9.7 17.3 9.8 9.9 29.2 10.2 14.0 38.4 17.0 17.6 10.8 23.8 47.3 14.3 19.8 27.8 15.1 9.6 10.2 25.8 17.5 27.0 22.5 12.0 10.1 29.9 29.0 13.2 5.8 14.4 12.0 22.6 19.3 2.5 17.1 19.8 8.5 14.7 15.5 21.4 11.3 39.8 20.0 11.6 10.2 14.3 17.3 17.1 16.8 22.5 17.2 14.2 7.1 23.3 4.3 13.4 64.6 43.9 15.5 14.8 19.3 6.8 8.0 4.3 27.3 2.5 10.5 28.5 29.3 9.1 6.9 7.3 6.8 43.8 3.2 6.5 2.7 3.0 26.1 3.3 19.5 31.7 24.5 4.3 9.7 14.5 15.5 15.3 6.2 14.8 18.8 31.6 4.8 6.6 9.1 25.2 7.6 6.2 7.2 7.7 25.8 11.6 1.6 7.2 12.4 37.9 27.9 19.1 33.9 12.2 22.0 9.6 3.8 10.2 4.1 25.2 19.6 1.2 24.9 15.5 19.4 79.4 153.7 150.3 68.8 194.9 60.7 42.4 65.6 66.7 153.6 31.9 35.9 49.5 9.5 59.9 207.4 28.7 73.2 166.2 9.7 9.8 10.2 14.0 9.6 10.2 12.0 10.1 12.0 11.3 10.2 14.2 15.5 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 17.5 11.9 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 82.4 16.1 0.0 0.0 0.0 0.0 0.0 0.0 56.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.0 11.2 2.2 0.0 0.0 0.0 SLF2 "C10orf6, FAM178A, FLJ10512, FLJ25012" ENSG00000119906 "SMC5-SMC6 complex localization factor 2" Q8IX21 10 100912963-100965134 "Predicted intracellular proteins, Predicted membrane proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Leydig cells: 108.1;Peritubular cells: 105.7;Theca cells: 77.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RH-30: 145.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038499, HPA057568" Approved Approved Nucleoplasm,Vesicles NA NA "Cluster 6: Non-specific - Transcription" "Cluster 68: Epididymis - Unknown function" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Vesicles" "HPA038499: AB_10672520, HPA057568: AB_2683471" "unprognostic (9.05e-2)" "unprognostic (1.18e-2)" "unprognostic (3.89e-2)" "unprognostic (4.54e-2)" "unprognostic (1.13e-1)" "unprognostic (6.19e-3)" "unprognostic (2.16e-2)" "unprognostic (7.87e-2)" "unprognostic (2.02e-1)" "unprognostic (1.30e-1)" "unprognostic (2.66e-2)" "unprognostic (1.54e-2)" "unprognostic (1.16e-3)" "unprognostic (2.85e-1)" "unprognostic (4.90e-2)" "unprognostic (1.39e-1)" "unprognostic (2.41e-1)" 9.1 17.2 17.3 10.9 29.2 11.8 8.8 20.4 23.1 14.0 9.3 12.6 7.9 20.8 48.6 8.9 17.6 8.0 10.8 17.0 24.9 11.3 11.6 10.8 14.7 24.5 24.7 25.1 13.1 7.9 23.8 15.4 25.7 15.2 10.1 11.7 9.4 12.9 17.8 13.4 12.7 10.7 19.1 23.1 10.4 25.8 25.3 12.2 11.3 13.3 11.5 11.3 11.2 46.2 25.7 20.6 29.6 31.4 16.1 20.9 11.3 26.3 18.5 24.1 29.0 15.2 17.5 24.1 15.8 11.3 17.9 25.3 20.4 8.8 29.1 26.6 16.6 21.7 14.2 31.0 11.7 28.0 24.9 10.0 13.2 18.6 19.9 25.1 15.7 14.7 15.6 22.5 37.3 17.7 19.1 16.0 13.7 9.9 15.2 18.5 145.7 8.3 10.1 12.8 6.6 12.9 16.5 4.6 30.6 14.1 26.3 10.7 20.6 28.2 23.4 18.0 31.1 18.1 28.5 19.1 20.0 32.9 15.1 6.1 6.6 7.0 9.8 6.7 8.9 8.6 7.8 8.5 5.2 11.0 8.5 7.8 3.6 9.1 7.5 7.5 8.0 4.6 17.3 29.2 20.4 23.1 17.0 24.9 24.5 24.7 25.7 19.1 25.3 46.2 18.4 25.6 18.9 0.0 18.2 0.0 8.4 0.0 12.5 33.8 13.8 12.6 0.0 5.7 8.6 25.8 25.0 17.4 29.4 9.0 13.7 11.0 8.4 22.7 64.8 20.8 12.2 11.3 0.0 8.0 7.1 20.2 10.7 25.0 24.0 32.3 26.7 12.8 17.9 38.7 0.0 10.5 0.0 18.2 0.0 10.4 108.1 18.6 0.0 0.0 19.2 19.7 46.4 0.0 0.0 7.0 8.4 105.7 12.3 9.4 9.3 8.9 13.8 31.4 19.7 44.5 12.8 33.5 43.0 10.4 0.0 5.1 19.7 77.6 8.2 6.0 SLFN11 FLJ34922 ENSG00000172716 "Schlafen family member 11" Q7Z7L1 17 35350305-35373701 "Predicted intracellular proteins" "Antiviral defense, DNA damage, Immunity" "Helicase, Hydrolase, RNA-binding, tRNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 70.6;dendritic cells: 39.9;Endothelial cells: 38.8;Langerhans cells: 53.0;Macrophages: 47.0;Smooth muscle cells: 38.8;T-cells: 37.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MOLT-4: 118.2" "Low region specificity" "Detected in many" "HPA023030, HPA062062" Uncertain Supported Nucleoplasm,Cytosol No NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 68: Epididymis - Unknown function" "Cluster 14: REH - Unknown function" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" Nucleoplasm Cytosol "HPA023030: AB_1856613, HPA062062: AB_2684673" "unprognostic (1.93e-2)" "unprognostic (2.56e-1)" "unprognostic (3.04e-2)" "unprognostic (1.03e-2)" "unprognostic (3.48e-3)" "unprognostic (1.01e-1)" "unprognostic (5.19e-2)" "unprognostic (1.31e-1)" "unprognostic (1.34e-1)" "unprognostic (1.08e-1)" "unprognostic (1.39e-1)" "unprognostic (2.54e-1)" "prognostic unfavorable (9.93e-10)" "unprognostic (1.65e-1)" "unprognostic (5.71e-3)" "unprognostic (6.33e-2)" "unprognostic (8.81e-3)" 31.7 8.2 5.6 20.0 6.1 12.8 17.1 6.4 5.2 21.1 8.2 10.2 6.2 12.1 42.2 8.4 20.6 18.3 20.0 6.0 8.0 6.4 6.8 37.7 21.2 9.5 6.3 23.1 5.4 6.1 6.5 10.5 9.7 9.1 11.1 1.4 11.8 12.3 7.3 5.2 13.9 19.1 7.6 23.3 9.0 2.7 11.0 22.9 24.1 19.0 20.9 17.9 12.6 9.4 29.3 25.6 0.1 0.0 25.4 72.0 0.4 35.3 25.2 59.9 103.9 0.0 0.0 0.2 0.6 46.4 18.8 13.9 78.8 0.0 72.1 16.6 94.2 63.0 0.3 0.0 33.0 82.4 0.1 29.5 0.9 66.5 0.2 0.0 99.4 46.8 0.1 0.3 10.1 0.0 118.2 66.4 0.6 0.0 0.1 98.9 73.3 0.2 0.7 13.8 0.2 0.1 0.0 13.0 0.1 0.0 20.7 58.6 52.1 16.3 0.4 61.9 53.7 2.3 1.0 0.2 12.2 70.3 36.0 0.5 18.2 2.1 6.1 27.6 8.4 4.6 3.8 5.5 14.0 1.5 2.8 4.1 1.4 3.1 18.2 19.4 6.3 8.7 5.6 6.1 6.4 5.2 6.0 8.0 9.5 6.3 9.7 7.6 11.0 9.4 70.6 0.0 5.2 0.3 19.5 7.5 1.1 1.1 5.7 0.4 6.7 2.8 9.2 1.5 2.7 1.8 0.0 1.4 39.9 0.1 0.0 0.0 1.4 5.9 16.0 38.8 0.0 9.9 0.3 0.6 0.5 29.2 6.6 2.2 3.8 0.3 15.0 0.4 32.8 0.0 2.6 0.1 0.0 36.5 53.0 1.7 10.2 47.0 12.4 17.8 17.2 0.3 3.1 0.0 0.1 0.1 1.2 3.0 24.7 1.3 0.1 0.2 13.3 0.1 6.6 7.9 38.8 0.0 0.2 1.9 8.5 0.8 37.3 7.7 0.1 0.7 SMARCA1 "hSNF2L, ISWI, NURF140, SNF2L, SNF2L1, SNF2LB, SWI" ENSG00000102038 "SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 1" P28370 X 129446501-129523500 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Chromatin regulator, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Leydig cells: 142.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "naive CD4 T-cell: 1.1" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003335, HPA064712" Uncertain Supported Nucleoplasm,Vesicles NA NA "Cluster 40: NK-cells - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 36: Stromal cells - Cell proliferation" Nucleoplasm Vesicles "HPA003335: AB_1080024, HPA064712: AB_2685332" "unprognostic (1.40e-1)" "unprognostic (8.28e-3)" "unprognostic (2.30e-1)" "unprognostic (5.06e-2)" "unprognostic (6.21e-2)" "unprognostic (2.16e-2)" "unprognostic (5.44e-2)" "unprognostic (7.15e-2)" "unprognostic (3.41e-2)" "unprognostic (1.53e-1)" "prognostic favorable (3.03e-4)" "unprognostic (9.26e-2)" "prognostic favorable (5.09e-4)" "unprognostic (1.87e-3)" "unprognostic (1.28e-1)" "unprognostic (6.14e-2)" "unprognostic (2.33e-2)" 19.0 78.6 15.7 9.0 17.8 0.3 20.6 14.0 18.1 27.9 36.0 20.9 6.7 27.2 34.7 11.3 20.1 21.4 24.5 19.9 31.6 23.9 62.1 16.3 4.6 17.0 19.0 72.6 15.8 44.6 34.8 38.0 20.3 36.7 7.0 26.7 18.5 35.4 17.3 8.1 8.4 25.9 17.1 8.9 17.3 57.7 26.7 7.9 45.3 19.8 4.2 30.0 14.0 18.1 23.5 53.5 104.8 67.9 76.3 67.1 36.6 46.8 133.2 68.6 76.7 18.3 80.9 0.0 71.8 88.7 81.1 22.1 66.6 27.5 76.4 0.1 12.9 0.2 46.9 100.0 32.6 0.0 0.1 84.2 7.8 49.0 9.3 104.3 50.4 13.1 12.4 5.7 76.1 0.0 0.6 0.2 42.6 9.0 31.0 0.0 56.7 0.2 67.4 28.3 26.0 69.8 6.6 0.9 12.1 73.1 46.9 0.6 35.7 46.0 23.3 30.3 26.4 0.0 0.0 0.2 40.7 0.0 28.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.3 0.0 0.5 0.0 0.2 0.0 0.1 15.7 17.8 14.0 18.1 19.9 31.6 17.0 19.0 20.3 17.1 26.7 18.1 23.2 96.1 55.0 24.2 1.5 23.3 35.4 28.3 47.3 26.5 34.8 24.1 80.5 12.8 47.6 40.5 45.9 56.9 1.8 0.1 29.4 30.1 3.7 32.2 80.2 25.6 16.8 3.2 29.3 12.0 15.7 64.3 23.4 42.7 2.5 84.3 22.9 67.0 15.0 92.5 43.4 2.6 14.2 3.2 9.9 18.4 142.9 3.0 28.4 22.5 5.7 47.7 0.0 41.2 17.2 14.0 0.1 125.6 0.1 24.9 0.2 34.9 41.0 13.4 65.7 40.0 49.7 11.4 23.9 17.5 11.8 58.4 2.0 82.9 2.3 29.2 SMIM24 "C19orf77, HSPC323" ENSG00000095932 "Small integral membrane protein 24" O75264 19 3473986-3480525 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "epididymis: 1580.8;intestine: 753.9;kidney: 844.8" "Group enriched" "Detected in many" 12 "Proximal enterocytes: 4096.4;Proximal tubular cells: 1884.8" "Group enriched" "Detected in many" 5 "colorectal cancer: 23.7;pancreatic cancer: 37.4;renal cancer: 78.4;stomach cancer: 52.6" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "NK-cell: 5.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 154.9;HEL: 74.0;Hep G2: 117.7;MOLT-4: 113.8;OE19: 185.0;REH: 61.5;U-937: 87.1" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA045046, HPA056027" Enhanced Approved Nucleoplasm,Cytosol NA NA "Cluster 10: Basophils - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 39: CACO-2 - Unknown function" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Nucleoplasm Cytosol "HPA045046: AB_10964444, HPA056027: AB_2683012" "unprognostic (2.18e-4)" "unprognostic (4.63e-1)" "unprognostic (5.68e-2)" "unprognostic (9.60e-2)" "unprognostic (1.93e-1)" "unprognostic (6.23e-2)" "unprognostic (1.03e-1)" "unprognostic (1.61e-1)" "unprognostic (1.64e-1)" "unprognostic (2.85e-1)" "unprognostic (2.84e-1)" "unprognostic (1.07e-1)" "prognostic favorable (4.13e-10)" "unprognostic (1.68e-2)" "unprognostic (2.14e-1)" "unprognostic (8.36e-2)" "unprognostic (3.11e-2)" 0.2 0.0 4.2 2.7 5.0 91.3 0.8 4.1 6.8 0.6 5.5 30.4 753.9 0.7 1580.8 0.4 2.8 82.0 0.1 4.7 4.3 844.8 35.8 0.4 1.6 4.3 4.6 0.3 8.0 0.2 3.5 0.1 4.3 1.0 24.5 91.6 0.3 2.3 0.3 1.2 628.2 0.8 4.0 1.2 150.1 2.9 4.6 50.4 0.2 0.1 2.0 0.2 0.2 4.4 0.0 0.0 0.2 0.0 0.0 0.0 2.6 0.1 0.0 0.3 0.0 154.9 0.5 0.2 7.9 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 74.0 1.0 117.7 0.0 6.4 1.7 0.0 0.0 0.0 0.0 0.0 0.0 10.7 1.5 0.1 0.1 0.0 113.8 15.8 0.0 185.0 0.3 61.5 0.1 4.3 1.6 0.1 1.4 2.3 0.1 0.1 1.6 0.4 0.0 1.9 0.0 0.0 0.4 1.2 0.1 0.0 0.0 6.5 0.0 87.1 0.0 1.9 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.3 0.4 1.0 0.0 5.9 0.0 1.5 1.6 0.8 4.2 5.0 4.1 6.8 4.7 4.3 4.3 4.6 4.3 4.0 4.6 4.4 0.1 0.0 0.0 0.0 6.6 0.0 0.1 0.0 0.0 14.1 0.1 0.8 0.2 188.8 0.0 58.8 27.1 0.0 0.5 35.1 238.7 4.0 5.1 7.7 0.8 0.3 139.0 22.3 0.7 12.4 0.2 0.3 205.4 13.0 1.3 0.2 0.4 36.3 0.1 0.0 0.1 136.6 0.0 0.6 0.0 15.0 0.3 11.6 0.0 0.0 0.7 4.1 0.0 0.0 0.2 12.4 178.9 0.0 1.7 0.3 4096.4 1884.8 0.0 34.9 0.0 0.2 0.3 0.6 0.7 0.0 0.0 0.0 7.4 0.0 141.3 0.2 SMIM7 "C19orf42, MGC2747" ENSG00000214046 "Small integral membrane protein 7" Q9BQ49 19 16630751-16660442 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043127 Uncertain Approved "Golgi apparatus" "Intracellular and membrane" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 68: Epididymis - Unknown function" "Cluster 18: U-2197 - ECM organization" "Cluster 39: Non-specific - Basic cellular processes" "Golgi apparatus" "HPA043127: AB_10806378" "unprognostic (6.61e-2)" "unprognostic (1.61e-2)" "unprognostic (1.90e-1)" "unprognostic (3.71e-2)" "unprognostic (2.52e-1)" "unprognostic (2.28e-1)" "unprognostic (9.65e-2)" "unprognostic (1.79e-2)" "unprognostic (6.60e-3)" "unprognostic (1.90e-1)" "unprognostic (2.75e-1)" "unprognostic (1.76e-3)" "unprognostic (8.29e-3)" "unprognostic (2.94e-1)" "unprognostic (2.29e-1)" "unprognostic (8.38e-2)" "unprognostic (7.64e-2)" 41.6 39.5 39.6 24.8 41.8 19.9 47.2 41.4 48.5 36.7 39.8 34.1 34.4 32.5 72.9 30.0 36.9 30.5 35.8 37.8 41.3 52.7 66.7 33.5 33.7 42.9 41.1 32.2 47.7 54.1 16.1 34.7 42.2 46.5 42.0 18.6 52.3 39.3 18.7 32.1 25.4 36.4 43.0 26.7 38.2 21.0 41.7 29.3 50.0 21.0 34.0 32.8 17.9 44.2 60.6 52.1 48.7 42.3 74.4 64.4 48.9 50.4 69.4 70.7 68.8 45.2 111.8 44.4 67.7 69.3 50.5 48.0 44.5 69.8 86.7 38.1 34.4 42.4 34.9 48.5 43.3 64.2 46.5 49.3 49.8 51.5 52.9 43.0 68.9 40.3 59.9 53.7 81.6 120.2 42.4 55.1 45.2 121.5 77.4 41.3 32.9 43.4 83.4 66.3 26.0 48.2 37.8 41.0 51.2 26.8 59.9 80.5 41.5 55.4 35.7 130.3 83.2 46.4 72.6 56.0 56.3 75.6 71.2 47.5 73.3 38.3 37.1 65.8 35.3 49.6 38.0 37.0 58.8 44.3 37.0 33.6 31.0 42.8 78.3 79.2 44.9 45.3 39.6 41.8 41.4 48.5 37.8 41.3 42.9 41.1 42.2 43.0 41.7 44.2 63.5 67.3 64.5 29.0 75.5 34.2 62.8 114.3 70.6 70.1 69.0 84.6 38.5 57.2 68.8 57.0 95.9 144.1 68.5 67.6 129.1 85.2 18.4 58.2 60.8 61.5 73.0 54.7 35.3 86.3 105.2 74.9 57.1 51.5 50.1 42.3 66.0 85.7 115.6 63.9 32.1 78.3 77.3 77.2 43.9 21.6 88.9 64.6 48.0 21.5 102.4 101.3 98.9 21.6 44.8 87.6 87.0 83.1 76.5 77.6 85.1 140.0 54.6 121.4 72.3 42.3 64.8 84.0 81.0 74.7 35.8 156.4 54.7 66.7 62.7 57.7 SMYD3 "KMT3E, ZMYND1, ZNFN3A1" ENSG00000185420 "SET and MYND domain containing 3" Q9H7B4 1 245749342-246507312 "Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins" "Chromatin regulator, Methyltransferase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 406.1;Excitatory neurons: 725.6;Inhibitory neurons: 788.3;Microglial cells: 277.3;Oligodendrocyte precursor cells: 372.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 402.2;K-562: 162.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012229, HPA045821, HPA054352" Approved Approved Nucleoplasm,Cytosol NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 3: HMC-1 - Innate immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Nucleoplasm Cytosol "CAB012229: , HPA045821: AB_2679461, HPA054352: AB_2682458" "unprognostic (7.00e-3)" "unprognostic (7.45e-2)" "unprognostic (1.52e-1)" "unprognostic (6.18e-3)" "unprognostic (3.32e-2)" "unprognostic (5.08e-3)" "unprognostic (3.25e-3)" "unprognostic (1.72e-3)" "unprognostic (4.53e-2)" "unprognostic (1.57e-1)" "unprognostic (1.71e-1)" "unprognostic (2.10e-1)" "unprognostic (3.78e-5)" "unprognostic (9.03e-3)" "unprognostic (2.14e-1)" "unprognostic (1.08e-2)" "unprognostic (1.58e-1)" 7.9 12.1 9.5 5.0 9.6 9.7 11.1 16.4 9.6 9.1 5.8 7.5 5.0 7.1 22.1 6.4 10.3 8.2 6.7 10.4 10.2 9.4 6.0 9.8 7.7 7.0 10.3 8.2 7.8 9.5 9.2 5.3 9.8 6.8 8.8 7.0 6.6 5.4 11.6 8.0 6.0 6.7 4.4 5.7 7.3 8.7 11.6 10.8 16.0 9.8 7.7 10.1 5.9 6.8 20.8 12.6 17.8 15.4 19.9 27.1 17.3 28.7 21.4 33.4 74.4 16.2 23.7 33.5 22.6 27.0 20.8 13.2 16.3 32.1 111.3 17.7 16.4 20.0 17.9 19.5 37.3 20.1 402.2 73.5 7.6 44.3 28.5 25.3 23.1 23.5 162.0 11.5 33.0 7.0 38.8 38.8 15.9 29.1 19.5 35.5 21.3 48.9 24.5 29.3 41.9 19.8 13.5 2.0 26.4 19.3 16.5 33.8 17.6 15.9 11.0 11.4 34.8 57.0 16.7 17.3 30.5 27.3 18.8 13.1 4.6 11.5 12.9 4.1 13.7 14.2 13.7 16.4 8.0 15.8 15.1 16.1 3.2 27.5 4.6 5.0 16.2 12.1 9.5 9.6 16.4 9.6 10.4 10.2 7.0 10.3 9.8 4.4 11.6 6.8 14.2 6.4 30.7 406.1 16.2 12.2 14.7 26.5 13.1 7.7 8.7 9.3 9.1 4.3 18.9 12.9 22.9 8.1 15.8 5.1 15.6 22.3 54.8 24.9 14.3 12.7 25.1 6.3 725.6 31.1 42.6 15.9 9.2 13.6 110.9 25.7 12.5 4.9 12.3 10.1 788.3 7.9 26.4 4.1 10.2 110.9 11.1 6.0 12.4 277.3 3.7 7.6 16.5 372.4 136.5 24.0 3.7 17.3 19.9 4.8 4.0 19.3 36.9 13.2 0.0 12.1 20.7 19.6 27.5 12.0 11.5 7.3 18.3 46.3 8.8 10.0 SNX1 "HsT17379, MGC8664, SNX1A, Vps5" ENSG00000028528 "Sorting nexin 1" Q13596 15 64094123-64146090 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 177.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in single" "HPA047373, HPA052761" Approved Enhanced Endosomes,Lysosomes NA NA 6100000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 68: Epididymis - Unknown function" "Cluster 16: U-266 - Nucleosome" "Cluster 10: Non-specific - Unknown function" "Endosomes, Lysosomes" "HPA047373: AB_2680018, HPA052761: AB_2681939" "unprognostic (3.99e-2)" "unprognostic (8.65e-3)" "unprognostic (1.96e-1)" "unprognostic (1.50e-2)" "unprognostic (7.13e-2)" "unprognostic (2.73e-1)" "unprognostic (7.15e-2)" "unprognostic (6.49e-3)" "unprognostic (1.53e-1)" "unprognostic (8.28e-2)" "unprognostic (2.47e-2)" "unprognostic (3.26e-1)" "prognostic favorable (9.88e-6)" "unprognostic (2.27e-1)" "unprognostic (3.98e-1)" "unprognostic (2.59e-2)" "unprognostic (1.95e-1)" 63.4 69.0 47.1 59.0 64.1 34.8 46.2 60.9 49.8 52.8 44.5 60.2 49.8 47.6 67.7 60.6 37.5 42.9 50.4 46.2 51.4 56.8 69.3 54.7 67.1 67.5 63.6 39.0 44.3 72.1 32.0 57.8 66.4 51.9 47.6 27.0 55.4 64.4 69.1 48.5 52.4 53.0 62.5 61.0 54.8 34.2 57.2 79.5 102.9 36.8 66.8 62.1 51.2 76.8 75.4 93.5 69.1 60.8 116.4 81.3 23.0 93.5 91.5 81.4 94.5 64.6 115.6 74.4 100.5 86.7 79.7 113.8 102.6 95.2 63.5 136.1 56.0 101.2 110.4 98.2 63.6 94.7 108.0 102.9 62.6 65.2 50.2 59.7 86.1 77.0 74.0 29.2 85.1 107.8 111.4 80.2 54.5 103.2 52.1 100.0 65.3 118.1 127.1 170.5 56.3 56.4 91.4 61.1 86.3 59.5 87.0 86.6 103.0 80.1 120.2 50.8 52.5 93.4 220.5 120.1 72.9 123.5 85.8 144.1 149.1 162.1 83.4 143.1 70.9 101.1 70.4 82.2 127.3 101.9 67.0 66.6 113.7 98.1 144.2 86.1 95.8 156.0 47.1 64.1 60.9 49.8 46.2 51.4 67.5 63.6 66.4 62.5 57.2 76.8 34.4 115.4 74.2 35.6 32.9 26.5 38.1 39.3 29.0 18.9 29.7 29.2 50.6 34.3 52.8 18.4 22.9 51.5 51.6 32.1 33.2 40.9 3.7 36.4 36.7 34.2 26.5 26.5 44.2 37.2 35.1 36.2 27.5 44.9 39.2 44.9 35.3 34.2 72.2 15.2 39.3 28.3 28.5 46.8 27.4 4.0 32.3 42.7 32.0 44.0 56.3 19.7 35.0 121.7 177.7 34.6 30.3 37.6 34.0 32.7 39.2 53.6 31.9 16.5 46.0 36.0 64.0 33.3 23.4 33.8 27.1 47.7 35.0 39.3 28.8 33.9 SNX14 RGS-PX2 ENSG00000135317 "Sorting nexin 14" Q9Y5W7 6 85505496-85594156 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Disease variant, Mental retardation, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 173.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017639 Approved Supported Vesicles,Cytosol NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 68: Epididymis - Unknown function" "Cluster 32: U-937 - Innate immune response" "Cluster 66: Spermatocytes - Spermatogenesis" "Vesicles, Cytosol" "HPA017639: AB_1857345" "unprognostic (1.16e-2)" "unprognostic (3.29e-2)" "unprognostic (2.19e-2)" "unprognostic (1.52e-2)" "unprognostic (5.23e-2)" "prognostic unfavorable (2.78e-4)" "unprognostic (1.92e-2)" "unprognostic (3.45e-2)" "unprognostic (4.60e-1)" "unprognostic (1.57e-2)" "unprognostic (3.14e-2)" "unprognostic (2.37e-2)" "unprognostic (1.10e-3)" "unprognostic (1.02e-1)" "unprognostic (1.38e-1)" "unprognostic (1.87e-3)" "unprognostic (4.72e-3)" 27.3 39.9 39.0 23.0 40.5 31.4 41.7 44.4 61.0 30.8 49.7 39.7 29.8 23.5 57.3 24.3 28.2 28.3 24.8 40.7 47.0 54.4 69.6 39.6 32.6 40.1 40.7 26.8 43.6 47.1 36.3 36.2 43.1 33.2 35.1 47.2 27.8 30.8 16.4 28.6 31.7 22.4 40.9 37.4 45.3 87.0 42.5 18.9 40.5 12.9 28.8 35.1 24.7 44.2 46.1 27.3 44.5 64.9 98.3 71.6 46.0 58.0 78.5 44.2 67.5 49.0 75.4 60.3 69.8 74.4 85.9 60.7 30.5 58.8 69.4 53.3 18.0 66.1 36.4 75.1 80.9 62.4 65.0 63.0 43.7 52.0 51.6 81.1 79.4 23.2 67.7 50.4 96.9 52.1 4.4 117.0 18.3 72.1 31.1 26.2 90.6 29.1 107.1 82.7 19.8 44.5 35.0 76.6 56.3 57.9 47.9 108.9 71.6 35.4 21.8 44.1 60.3 50.4 87.0 22.8 71.3 72.2 71.8 36.7 21.5 33.0 19.9 33.6 14.7 13.3 13.4 18.1 26.2 14.7 12.0 15.0 9.9 22.9 40.9 7.9 16.7 15.7 39.0 40.5 44.4 61.0 40.7 47.0 40.1 40.7 43.1 40.9 42.5 44.2 28.5 93.0 47.2 76.4 25.3 14.7 18.7 32.8 15.9 36.4 23.3 15.1 16.9 15.7 39.1 22.0 56.3 50.4 32.6 30.7 5.9 31.7 87.1 37.3 22.2 26.9 31.8 13.2 115.2 41.6 31.9 23.1 37.8 32.5 31.6 36.0 26.0 28.7 35.4 15.2 124.4 26.1 65.1 37.7 22.3 21.6 19.6 33.4 28.4 63.7 43.1 26.1 41.2 85.5 91.0 34.4 22.0 29.3 23.8 15.7 31.9 25.1 58.9 40.7 19.7 26.2 33.0 173.0 14.9 15.9 14.8 56.5 26.4 26.5 28.6 17.7 SPACA9 "C9orf9, Mast" ENSG00000165698 "Sperm acrosome associated 9" Q96E40 9 132878027-132890201 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 74.0;testis: 131.2" "Cell type enhanced" "Detected in many" "Collecting duct cells: 23.9;Distal tubular cells: 33.2;Endometrial ciliated cells: 99.8;Proximal tubular cells: 23.9;Respiratory ciliated cells: 63.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in many" 4 "JURKAT: 48.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA022243, HPA051600" Enhanced Approved Mitochondria No No "Cluster 19: B-cells - Humoral immune response" "Cluster 68: Epididymis - Unknown function" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 49: Ciliated cells - Cilium organization" Mitochondria "HPA022243: AB_1845844, HPA051600: AB_2681546" "unprognostic (2.69e-1)" "unprognostic (2.14e-3)" "unprognostic (8.00e-3)" "prognostic favorable (8.61e-4)" "unprognostic (1.59e-1)" "unprognostic (5.73e-2)" "unprognostic (3.76e-3)" "unprognostic (2.60e-1)" "unprognostic (6.43e-2)" "unprognostic (1.12e-1)" "unprognostic (1.15e-2)" "unprognostic (9.51e-2)" "prognostic favorable (8.31e-4)" "unprognostic (5.11e-2)" "unprognostic (1.22e-2)" "unprognostic (1.20e-1)" "unprognostic (1.22e-2)" 5.0 7.6 17.4 1.3 17.7 1.5 5.2 17.4 19.5 9.7 18.2 11.5 1.3 8.3 74.0 9.5 39.2 5.4 10.4 16.8 19.0 12.2 2.3 7.4 2.2 20.3 22.2 11.3 5.2 3.8 11.5 3.2 19.1 7.0 1.9 8.2 9.8 7.1 1.7 11.9 3.7 4.9 21.3 3.6 6.5 131.2 18.5 7.9 15.6 1.8 3.2 6.1 8.1 19.0 3.0 3.2 4.8 3.9 6.6 8.4 5.7 1.9 3.5 2.6 2.8 0.8 9.1 0.7 4.3 8.7 5.4 4.2 2.0 5.4 2.3 3.5 3.9 0.8 2.3 1.0 9.6 2.2 0.3 9.6 11.4 6.4 6.9 10.6 3.0 48.5 0.8 2.4 7.1 6.4 7.6 8.6 1.0 5.6 3.0 3.6 1.0 2.1 10.5 1.1 1.2 4.7 8.0 1.3 6.3 3.6 10.3 0.7 2.9 5.5 3.7 5.3 0.8 1.0 1.7 2.6 10.2 0.8 2.7 4.0 1.1 1.9 1.1 1.1 1.3 3.0 1.2 0.6 1.6 2.6 1.3 1.3 1.5 4.4 1.9 0.5 2.0 0.9 17.4 17.7 17.4 19.5 16.8 19.0 20.3 22.2 19.1 21.3 18.5 19.0 3.6 3.2 2.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 10.3 17.9 0.0 0.0 5.0 23.9 0.0 18.2 0.8 0.0 33.2 8.6 0.0 99.8 7.1 1.9 0.0 0.0 0.0 7.1 12.4 3.9 0.0 8.1 0.0 6.7 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 1.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 23.9 63.4 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 7.3 0.8 7.7 0.0 0.0 SPART "KIAA0610, SPG20, TAHCCP1" ENSG00000133104 Spartin Q8N0X7 13 36301638-36370180 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Granulosa cells: 75.0;Proximal tubular cells: 90.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 5 "basophil: 172.7" "Lineage enriched" "Detected in all" 7 "granulocytes: 172.7" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039053, HPA039054" Approved Supported "Plasma membrane,Cytosol" NA NA "Cluster 46: Basophils - DNA binding" "Cluster 68: Epididymis - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" Cytosol "Plasma membrane" "HPA039053: AB_10672769, HPA039054: AB_2676323" "unprognostic (3.73e-2)" "unprognostic (9.39e-2)" "unprognostic (3.06e-2)" "unprognostic (4.60e-2)" "unprognostic (2.21e-2)" "unprognostic (1.10e-2)" "unprognostic (9.18e-3)" "unprognostic (9.58e-2)" "unprognostic (3.36e-2)" "unprognostic (2.22e-1)" "unprognostic (7.62e-2)" "unprognostic (8.14e-2)" "unprognostic (1.54e-1)" "unprognostic (9.26e-2)" "unprognostic (1.22e-1)" "unprognostic (1.54e-2)" "unprognostic (5.79e-2)" 42.3 48.4 36.9 18.0 42.8 23.6 32.5 43.4 50.6 49.2 42.3 37.8 12.7 42.4 67.1 24.5 44.5 37.4 25.7 35.3 39.4 48.4 19.9 27.0 15.7 42.4 40.5 63.6 14.6 29.5 29.6 39.8 42.1 34.7 13.3 43.3 17.3 36.4 33.5 18.4 15.4 52.8 41.2 30.7 21.1 27.6 38.3 16.7 35.6 33.7 11.2 35.5 29.9 51.0 0.1 22.4 59.5 0.0 127.9 106.6 42.4 54.1 81.3 53.7 52.8 0.1 0.0 0.0 32.9 65.9 98.2 31.2 81.4 38.0 57.5 4.4 46.9 69.4 28.3 14.6 128.0 72.8 134.3 106.2 59.5 44.4 61.9 131.7 79.6 18.7 30.6 11.9 97.5 5.2 21.7 120.8 30.0 0.0 7.8 0.0 99.4 2.5 62.5 28.2 6.2 14.5 46.3 18.3 58.9 85.3 10.5 84.7 66.8 40.0 20.1 55.9 32.2 14.2 0.2 0.1 44.6 61.8 71.0 172.7 22.1 30.1 13.5 21.7 13.1 10.1 18.6 5.4 15.7 9.7 24.5 13.1 35.0 14.2 23.8 19.3 4.8 18.1 36.9 42.8 43.4 50.6 35.3 39.4 42.4 40.5 42.1 41.2 38.3 51.0 43.5 35.3 51.5 0.0 6.1 0.0 0.0 0.0 0.0 0.0 30.8 30.1 0.0 0.0 40.2 27.6 0.0 52.7 18.6 0.0 66.5 26.2 0.0 59.4 62.6 15.9 0.0 0.0 0.0 15.0 59.7 39.8 0.0 38.1 58.0 75.0 0.0 0.0 42.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.0 0.0 0.0 24.3 0.0 0.0 0.0 0.0 16.8 0.0 0.0 3.5 0.0 0.0 90.4 65.6 0.0 0.0 0.0 27.8 0.0 0.0 0.0 0.0 64.3 10.8 59.2 0.0 0.0 SPIN1 "SPIN, TDRD24" ENSG00000106723 "Spindlin 1" Q9Y657 9 88388430-88478694 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Meiosis, Wnt signaling pathway" "Chromatin regulator, Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 178.2;Oligodendrocytes: 220.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000162, HPA068784" Uncertain Supported Nucleoplasm NA NA "Cluster 44: Non-specific - Transcription" "Cluster 68: Epididymis - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 34: Spermatids - Unknown function" Nucleoplasm "HPA000162: AB_1080079, HPA068784: AB_2686033" "unprognostic (1.53e-1)" "unprognostic (2.29e-1)" "unprognostic (2.74e-1)" "unprognostic (1.01e-1)" "unprognostic (2.91e-1)" "unprognostic (1.53e-1)" "unprognostic (6.11e-2)" "unprognostic (1.19e-2)" "unprognostic (2.08e-2)" "unprognostic (8.96e-2)" "unprognostic (8.78e-2)" "unprognostic (8.32e-2)" "prognostic favorable (8.69e-6)" "unprognostic (4.73e-3)" "unprognostic (1.20e-1)" "unprognostic (1.05e-1)" "unprognostic (1.56e-1)" 23.3 26.6 42.3 17.4 44.7 14.7 35.2 30.1 46.2 59.3 35.4 29.0 19.3 61.3 76.9 27.7 50.9 31.7 29.5 45.4 42.4 44.8 20.9 26.1 15.9 32.5 38.8 55.9 21.7 41.7 28.7 33.1 34.4 37.8 25.1 34.8 24.4 42.2 6.9 24.9 22.5 46.1 35.5 19.3 21.3 35.6 44.0 31.0 41.3 14.1 17.3 27.3 31.5 39.5 68.5 32.8 54.0 46.2 36.0 42.1 63.0 67.1 62.0 75.1 54.8 24.6 38.9 37.7 38.5 82.8 48.5 102.4 40.6 61.1 85.7 39.6 24.4 18.0 67.4 26.4 33.3 41.8 19.0 35.2 62.4 50.9 71.2 74.0 43.4 47.2 23.5 0.1 85.5 46.8 71.1 18.8 89.2 56.9 30.5 93.6 58.6 12.2 68.3 47.2 76.1 57.2 79.5 49.7 30.1 62.2 38.3 32.7 41.4 49.6 52.4 74.3 48.2 15.3 24.2 32.3 60.1 38.0 47.3 7.4 2.6 4.1 3.9 2.2 4.1 2.5 2.8 4.0 5.0 1.9 3.9 4.4 0.4 2.6 2.1 2.3 2.8 3.1 42.3 44.7 30.1 46.2 45.4 42.4 32.5 38.8 34.4 35.5 44.0 39.5 26.4 51.3 15.4 139.4 13.1 40.0 26.1 23.1 47.3 22.9 45.4 31.2 35.8 42.9 22.2 44.1 25.0 28.6 17.0 29.1 25.4 24.2 178.2 56.4 73.3 24.5 41.3 19.6 136.8 18.3 44.4 39.6 22.4 68.5 34.8 74.3 26.4 17.5 33.6 25.2 173.3 23.6 30.5 35.2 21.8 123.4 33.5 22.8 21.4 89.9 13.0 38.5 13.4 123.1 220.1 25.4 17.7 44.4 9.6 34.6 20.9 47.6 22.2 15.1 26.3 28.3 38.0 25.7 54.1 37.7 44.8 24.9 16.9 37.9 21.8 28.9 SPINK2 HUSI-II ENSG00000128040 "Serine peptidase inhibitor Kazal type 2" P20155 4 56809860-56821742 "Disease related genes, Human disease related genes, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 15 "epididymis: 5310.4" "Group enriched" "Detected in many" 10 "Early spermatids: 1217.2;Late spermatids: 1399.4;Spermatocytes: 1989.6" "Group enriched" "Detected in some" 5 "lung cancer: 1.3;testis cancer: 4.6;thyroid cancer: 2.4" "Not detected" "Not detected" "Immune cell enriched" "Detected in many" 7 "NK-cell: 146.4" "Lineage enriched" "Detected in many" 7 "NK-cells: 146.4" "Cell line enriched" "Detected in some" 4 "U-266/70: 90.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB020824, HPA026813" Enhanced "Secreted to blood" NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 29: U-266 - Adaptive immune response" "Cluster 66: Spermatocytes - Spermatogenesis" "CAB020824: , HPA026813: AB_1857446" "unprognostic (5.56e-3)" "unprognostic (3.60e-1)" "unprognostic (7.54e-2)" "unprognostic (2.35e-2)" "unprognostic (1.54e-1)" "unprognostic (1.60e-1)" "prognostic favorable (2.82e-4)" "unprognostic (9.83e-2)" "unprognostic (6.62e-2)" "unprognostic (9.40e-3)" "unprognostic (2.06e-1)" "unprognostic (2.49e-1)" "unprognostic (4.10e-3)" "unprognostic (3.18e-2)" "unprognostic (2.19e-2)" "unprognostic (3.87e-2)" 0.5 0.1 0.1 1.1 0.2 13.5 1.3 0.1 0.6 1.3 1.8 2.8 1.9 0.3 5310.4 0.2 0.3 0.1 7.4 0.2 0.2 0.3 0.2 0.2 4.7 0.3 0.3 0.4 0.1 0.0 4.2 0.0 0.2 3.5 2.1 0.0 2.0 240.7 1.8 0.5 3.1 0.3 0.2 1.7 3.0 346.1 0.3 3.9 0.6 2.3 4.8 0.5 4.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 21.4 0.0 0.0 0.0 0.0 1.2 0.1 0.1 0.0 2.5 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.6 0.0 0.0 0.0 0.7 2.9 18.0 0.5 0.0 0.0 0.0 0.0 4.5 0.0 6.0 0.3 3.0 0.0 0.0 0.2 0.7 0.0 0.4 0.0 0.0 0.0 0.2 0.0 90.5 0.4 0.0 0.0 0.0 0.0 4.4 0.0 1.1 0.5 0.1 0.6 9.1 5.1 5.4 1.4 10.5 11.1 21.6 0.9 146.4 0.0 0.8 0.3 5.4 0.1 0.2 0.1 0.6 0.2 0.2 0.3 0.3 0.2 0.2 0.3 0.1 0.2 0.0 0.0 0.0 7.2 2.0 14.2 1.8 1.8 0.0 0.2 0.6 3.4 0.0 0.2 0.0 0.0 0.0 2.5 1.4 0.0 0.0 1217.2 0.2 0.1 1.6 1.8 32.4 0.3 0.0 0.3 0.8 0.5 0.2 1.3 0.3 0.0 0.0 0.1 0.0 0.2 10.4 0.0 0.0 3.6 1399.4 37.9 2.5 12.4 0.0 1.6 1.5 1.0 0.0 0.1 0.0 13.1 24.5 35.2 9.5 0.4 0.3 0.3 0.0 13.1 0.4 1.9 1989.6 149.9 0.1 0.3 0.0 16.8 0.0 2.6 2.6 ST3GAL4 "CGS23, FLJ11867, NANTA3, SAT3, SIAT4, SIAT4C, STZ" ENSG00000110080 "ST3 beta-galactoside alpha-2,3-sialyltransferase 4" Q11206 11 126355640-126440344 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Granulosa cells: 270.0;Paneth cells: 214.3;Syncytiotrophoblasts: 962.5" "Cancer enhanced" "Detected in all" "melanoma: 57.2" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 111.9;neutrophil: 71.8;plasmacytoid DC: 93.7" "Group enriched" "Detected in many" 12 "dendritic cells: 93.7;granulocytes: 111.9" "Cell line enhanced" "Detected in all" "SK-MEL-30: 234.7;WM-115: 515.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049827 Approved "Intracellular and membrane" NA NA 15000 "Cluster 38: Basophils - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 17: WM-115 - Nervous system development" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" "HPA049827: AB_2680900" "unprognostic (8.89e-2)" "unprognostic (1.10e-2)" "unprognostic (4.92e-2)" "unprognostic (6.93e-2)" "unprognostic (8.33e-2)" "unprognostic (3.80e-2)" "unprognostic (2.71e-3)" "unprognostic (1.90e-3)" "unprognostic (2.62e-1)" "unprognostic (1.80e-2)" "unprognostic (1.57e-1)" "unprognostic (1.45e-1)" "unprognostic (3.16e-3)" "unprognostic (2.79e-2)" "unprognostic (1.28e-1)" "unprognostic (8.36e-3)" "unprognostic (8.78e-3)" 23.4 117.1 25.2 14.4 41.2 19.0 19.5 43.5 28.9 29.2 36.5 58.1 4.2 16.3 87.6 70.7 19.2 23.9 60.0 24.3 28.7 41.0 28.4 38.2 10.0 42.3 41.3 111.3 13.7 1.7 15.7 35.3 39.5 22.6 66.4 10.8 44.2 16.0 6.1 16.7 12.3 19.0 31.9 41.5 13.3 42.2 37.6 6.3 14.7 7.7 22.7 49.3 33.8 57.2 26.4 21.4 17.0 13.6 46.8 39.4 38.5 30.2 56.6 26.5 18.2 11.4 44.5 7.0 21.9 47.0 88.0 37.1 34.0 19.2 20.0 27.7 9.7 62.8 52.7 13.4 29.9 78.8 126.1 31.5 30.7 39.9 60.9 47.7 34.6 27.5 41.4 18.8 32.2 107.3 25.7 76.5 10.2 166.2 136.6 25.8 50.3 3.3 6.0 74.1 29.5 18.4 32.8 193.5 234.7 10.6 66.3 52.2 13.2 61.7 14.2 44.1 56.2 2.0 4.3 4.0 28.5 118.7 515.8 111.9 5.3 0.7 5.2 8.7 4.8 0.4 1.7 3.3 20.6 0.1 0.6 2.6 71.8 4.7 3.8 93.7 0.3 6.4 25.2 41.2 43.5 28.9 24.3 28.7 42.3 41.3 39.5 31.9 37.6 57.2 10.3 9.6 0.6 17.0 1.9 10.6 6.6 23.0 0.6 4.0 12.8 6.7 25.9 5.7 23.1 31.3 10.4 115.9 37.5 149.2 49.0 6.1 1.5 3.2 9.8 15.0 5.3 3.4 16.3 6.6 72.3 43.2 2.0 10.2 41.9 270.0 31.8 11.9 17.8 5.0 17.5 115.7 16.2 5.9 14.9 7.2 76.1 11.2 78.2 3.7 9.5 5.4 18.6 5.0 83.3 5.3 214.3 93.6 6.7 16.5 0.0 3.9 5.5 10.0 13.1 4.3 43.1 1.5 17.4 0.7 6.7 962.5 8.4 36.8 23.2 41.1 ST6GAL2 "KIAA1877, SIAT2, St6GalII" ENSG00000144057 "ST6 beta-galactoside alpha-2,6-sialyltransferase 2" Q96JF0 2 106801600-106887108 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 11.0;thyroid gland: 28.7" "Group enriched" "Detected in some" 4 "Astrocytes: 58.8;Excitatory neurons: 78.7;Granulosa cells: 111.5;Inhibitory neurons: 44.8;Oligodendrocyte precursor cells: 94.0" "Cancer enriched" "Detected in many" 7 "thyroid cancer: 16.0" "Group enriched" "Detected in many" 77 "amygdala: 6.9;basal ganglia: 7.4;cerebral cortex: 11.0;hippocampal formation: 10.8;thalamus: 4.6" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 5.3;hTERT-RPE1: 6.4;NTERA-2: 4.4;PC-3: 5.9;RPMI-8226: 9.6;SCLC-21H: 6.1;U-138 MG: 7.5;U-266/70: 9.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014459 Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center" NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 25: RPMI-8226 - Immune response" "Cluster 40: Granulosa cells - Unknown function" "Nucleoli fibrillar center" Nucleoplasm "HPA014459: AB_1857528" "unprognostic (2.08e-1)" "unprognostic (5.80e-2)" "unprognostic (1.55e-1)" "unprognostic (4.63e-2)" "unprognostic (6.44e-3)" "unprognostic (1.62e-1)" "unprognostic (2.35e-2)" "unprognostic (1.10e-2)" "unprognostic (1.29e-4)" "unprognostic (4.56e-3)" "unprognostic (7.04e-2)" "unprognostic (1.84e-2)" "unprognostic (7.01e-4)" "unprognostic (4.70e-4)" "unprognostic (4.06e-2)" "unprognostic (2.83e-1)" "unprognostic (2.07e-2)" 0.5 0.1 6.9 0.2 7.4 1.0 0.7 0.0 11.0 1.7 0.0 1.1 0.2 2.6 0.3 1.8 0.7 5.1 0.5 10.8 0.0 0.4 2.6 0.6 0.3 0.0 0.0 0.6 0.1 0.1 0.1 1.5 0.0 0.8 2.3 1.9 0.8 0.8 0.1 0.7 0.4 2.0 0.0 0.1 0.6 5.3 4.6 0.1 28.7 0.0 0.3 0.6 1.0 0.1 0.0 5.3 2.8 0.0 0.0 0.0 0.1 0.2 0.0 1.2 0.3 0.1 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.1 0.0 0.0 0.9 0.0 6.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 4.4 0.0 5.9 0.0 0.0 9.6 0.2 0.0 6.1 3.9 0.0 0.0 0.0 0.2 0.0 0.1 0.0 7.5 0.1 0.2 0.0 9.9 0.2 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 6.9 7.4 0.0 11.0 10.8 0.0 0.0 0.0 0.0 0.0 4.6 0.1 0.0 0.0 0.0 58.8 0.0 0.9 0.2 0.0 18.8 6.6 0.2 3.4 1.4 0.0 0.6 1.8 0.0 0.0 0.0 4.7 0.0 0.1 0.4 0.8 12.2 0.3 1.2 6.3 78.7 0.0 0.0 1.7 0.0 0.5 0.0 111.5 2.2 0.0 0.2 0.0 44.8 3.3 0.0 0.0 0.0 1.2 0.3 0.1 0.0 2.8 0.0 0.9 0.0 94.0 1.9 0.0 1.0 0.7 0.0 0.3 0.0 0.6 0.0 0.5 0.0 0.2 2.9 0.1 1.1 4.3 0.0 0.3 0.1 0.1 3.2 0.0 ST7 "ETS7q, FAM4A, FAM4A1, HELG, RAY1, SEN4, TSG7" ENSG00000004866 "Suppression of tumorigenicity 7" Q9NRC1 7 116953238-117230176 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 184.1;Early spermatids: 131.4;Excitatory neurons: 191.5;Inhibitory neurons: 176.0;Oligodendrocyte precursor cells: 111.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-BR-3: 115.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038325, HPA038326" Approved Supported Nucleoplasm,Cytosol No No "Cluster 15: NK-cells - Transcription" "Cluster 68: Epididymis - Unknown function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 64: Astrocytes - Nervous system maintenance" Nucleoplasm Cytosol "HPA038325: AB_10671740, HPA038326: AB_10672644" "unprognostic (3.40e-2)" "unprognostic (1.04e-1)" "unprognostic (1.33e-1)" "unprognostic (4.70e-2)" "unprognostic (1.09e-1)" "unprognostic (8.18e-2)" "unprognostic (3.32e-2)" "unprognostic (1.74e-2)" "unprognostic (1.02e-1)" "unprognostic (4.45e-3)" "unprognostic (1.46e-1)" "unprognostic (2.48e-2)" "prognostic favorable (3.39e-5)" "unprognostic (1.80e-1)" "unprognostic (1.96e-1)" "unprognostic (8.41e-2)" "unprognostic (3.40e-2)" 13.5 21.7 22.6 6.7 22.0 17.8 15.2 50.6 24.7 19.9 11.1 13.6 12.1 14.5 35.8 9.7 18.6 12.3 22.4 21.8 22.6 29.4 41.3 26.1 7.6 15.0 17.4 17.4 32.9 19.0 24.5 20.9 15.9 13.8 12.4 12.6 21.7 21.2 12.5 11.5 11.0 12.6 14.6 10.4 17.3 8.7 22.5 8.6 28.4 11.2 8.6 12.6 11.1 19.7 29.4 17.2 28.2 24.4 31.0 20.5 12.3 23.0 30.2 24.4 35.2 24.0 32.8 7.7 25.5 21.4 34.7 24.6 24.2 24.5 31.3 11.1 33.9 23.4 26.5 20.2 21.8 27.4 39.4 16.1 24.3 30.7 21.8 21.6 24.9 5.2 36.0 54.6 22.3 18.1 0.2 21.0 26.9 40.1 19.3 6.7 18.8 33.6 25.5 16.2 42.2 33.8 27.8 115.5 32.0 20.6 10.1 23.3 19.1 27.6 11.0 30.5 23.3 34.7 28.2 29.6 22.9 24.0 28.6 1.5 3.1 0.4 7.3 1.2 5.1 2.2 4.4 6.2 5.7 1.0 2.9 3.0 0.0 7.0 1.1 5.6 10.3 3.0 22.6 22.0 50.6 24.7 21.8 22.6 15.0 17.4 15.9 14.6 22.5 19.7 6.3 22.4 38.1 184.1 5.0 7.5 8.6 8.8 10.8 12.2 9.0 7.4 13.5 12.8 12.9 5.5 0.0 21.1 6.4 3.1 5.9 6.0 131.4 7.1 5.9 9.5 3.6 15.8 191.5 13.4 22.8 10.6 12.8 14.2 19.6 3.5 8.6 24.5 8.7 3.3 176.0 6.8 8.2 14.4 6.0 53.5 11.1 7.9 7.2 44.0 7.5 12.8 4.1 111.1 46.9 8.8 3.6 6.0 10.3 6.7 3.6 17.3 6.3 1.3 0.0 9.9 12.1 12.8 5.8 7.4 5.5 21.2 4.6 4.6 5.3 8.8 STX12 "STX13, STX14" ENSG00000117758 "Syntaxin 12" Q86Y82 1 27773219-27824443 "Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041038, HPA055300" Approved Enhanced "Nucleoplasm,Golgi apparatus,Vesicles" No No "Cluster 51: Monocytes - Innate immune response" "Cluster 68: Epididymis - Unknown function" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 53: Intestinal epithelial cells - Unknown function" "Nucleoplasm, Golgi apparatus, Vesicles" "HPA041038: AB_10794261, HPA055300: AB_2682778" "unprognostic (3.47e-1)" "unprognostic (1.27e-1)" "unprognostic (1.60e-1)" "unprognostic (8.16e-3)" "unprognostic (2.83e-1)" "unprognostic (2.85e-1)" "unprognostic (1.26e-2)" "unprognostic (3.52e-1)" "unprognostic (1.14e-2)" "unprognostic (2.78e-2)" "unprognostic (9.35e-2)" "unprognostic (3.55e-1)" "unprognostic (1.91e-2)" "unprognostic (8.43e-2)" "unprognostic (2.06e-1)" "unprognostic (1.47e-1)" "unprognostic (2.24e-1)" 64.2 30.1 38.1 26.6 39.0 10.8 37.0 40.8 45.6 28.8 25.4 30.7 36.3 30.9 62.9 39.2 23.9 39.8 20.9 37.3 41.7 35.2 29.1 50.0 25.6 42.0 45.3 22.1 30.3 46.5 26.6 33.3 43.6 30.7 32.5 43.2 26.9 32.1 21.4 27.0 32.8 35.9 42.2 30.5 65.5 13.4 38.4 17.3 94.7 27.1 22.2 39.1 23.4 44.6 23.2 10.9 28.8 19.0 53.9 65.0 14.8 47.9 70.3 43.1 48.5 13.5 29.5 25.2 49.6 64.6 18.5 19.0 19.2 23.9 42.9 22.2 22.8 14.4 12.0 13.7 42.2 16.1 29.0 61.3 28.7 60.6 34.5 35.3 70.3 14.3 19.1 24.6 47.7 8.5 13.7 12.3 12.1 34.3 15.3 8.7 23.1 15.5 38.1 37.5 32.3 17.6 22.4 19.3 35.2 23.3 13.1 14.0 76.2 21.9 12.5 50.0 16.6 14.5 11.2 14.3 35.1 24.1 31.2 24.6 35.7 13.7 6.1 39.4 10.6 13.6 7.3 9.7 25.2 10.8 8.1 6.8 16.5 9.2 40.6 12.4 7.9 17.4 38.1 39.0 40.8 45.6 37.3 41.7 42.0 45.3 43.6 42.2 38.4 44.6 93.0 54.5 36.3 25.1 43.6 109.4 97.2 30.7 51.2 46.2 42.0 25.7 18.9 30.0 40.8 57.0 31.3 30.0 28.3 82.8 37.2 51.9 2.0 34.7 33.1 71.1 41.3 17.7 70.9 58.4 33.5 53.2 108.6 49.4 22.8 26.7 47.8 20.4 50.6 26.9 65.7 29.5 14.2 91.4 77.7 4.2 36.1 62.3 53.4 56.2 41.3 67.9 36.0 34.7 59.1 68.4 58.6 47.4 33.9 74.9 51.3 69.7 27.4 51.2 39.5 45.7 57.5 20.0 20.1 69.9 99.2 78.0 31.6 54.0 29.9 99.9 SULT1C4 "SULT1C, SULT1C2" ENSG00000198075 "Sulfotransferase family 1C member 4" O75897 2 108377911-108388989 "Metabolic proteins, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 13.3;Cholangiocytes: 37.1;Endothelial cells: 13.2;Granulosa cells: 15.3;Hepatic stellate cells: 17.9;Muller glia cells: 12.3;Oligodendrocyte precursor cells: 17.6" "Group enriched" "Detected in many" 6 "glioma: 7.1;renal cancer: 20.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 9.5;HUVEC TERT2: 10.7;SH-SY5Y: 42.0;SuSa: 11.6" "Low region specificity" "Detected in many" HPA034530 Approved Cytosol NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 40: Granulosa cells - Unknown function" Cytosol "HPA034530: AB_10670170" "unprognostic (2.47e-1)" "unprognostic (1.85e-1)" "unprognostic (3.45e-1)" "unprognostic (2.89e-1)" "unprognostic (5.54e-2)" "unprognostic (1.06e-1)" "unprognostic (3.35e-2)" "unprognostic (5.77e-2)" "unprognostic (1.56e-3)" "unprognostic (1.68e-1)" "unprognostic (2.91e-2)" "unprognostic (8.45e-3)" "prognostic favorable (9.99e-7)" "unprognostic (1.79e-2)" "unprognostic (2.96e-2)" "unprognostic (1.85e-2)" "unprognostic (1.38e-1)" 6.2 2.0 15.5 1.1 16.1 0.5 5.2 16.9 17.2 21.9 12.9 3.4 1.5 11.1 8.0 2.3 9.3 27.1 10.9 13.6 18.9 18.2 3.7 10.3 1.8 18.8 27.3 27.9 2.9 1.0 5.2 13.0 20.4 6.6 2.2 8.6 1.6 8.9 3.1 0.7 3.2 5.5 18.1 1.4 2.0 1.4 19.0 5.0 4.5 6.2 1.3 3.8 5.3 15.8 0.0 0.1 9.5 0.0 0.0 0.0 1.4 0.0 0.3 0.0 0.0 4.8 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.1 0.0 1.2 0.8 0.0 0.0 1.2 0.0 0.0 0.0 0.0 10.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 42.0 0.0 0.0 0.0 11.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 15.5 16.1 16.9 17.2 13.6 18.9 18.8 27.3 20.4 18.1 19.0 15.8 13.3 0.0 0.5 10.4 0.0 0.3 0.7 0.0 0.0 2.0 0.4 0.3 0.7 37.1 0.0 9.2 0.0 0.3 0.0 0.0 0.0 0.3 5.9 10.9 3.1 13.2 0.0 2.7 0.6 0.2 0.1 4.9 0.0 3.8 0.0 15.3 17.9 0.0 0.9 1.7 0.5 0.0 0.0 1.3 1.0 1.1 1.5 0.4 0.0 7.5 0.1 12.3 0.0 17.6 0.4 0.1 0.0 4.5 1.4 0.7 0.0 7.7 0.0 1.0 0.0 1.4 1.8 0.6 0.7 0.0 0.4 0.3 0.2 7.2 0.0 0.2 SVIP DKFZp313A2432 ENSG00000198168 "Small VCP interacting protein" Q8NHG7 11 22813799-22830299 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 406.9;Early spermatids: 945.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SCLC-21H: 50.2" "Low region specificity" "Detected in all" HPA039807 Approved NA NA "Cluster 6: Non-specific - Transcription" "Cluster 68: Epididymis - Unknown function" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 29: Early spermatids - Spermatogenesis" "HPA039807: AB_10795232" "unprognostic (1.18e-2)" "unprognostic (2.05e-1)" "unprognostic (2.21e-1)" "unprognostic (2.72e-2)" "unprognostic (1.66e-1)" "unprognostic (1.77e-2)" "unprognostic (2.34e-2)" "unprognostic (1.73e-1)" "unprognostic (8.80e-2)" "unprognostic (2.02e-2)" "unprognostic (9.31e-2)" "unprognostic (2.44e-1)" "prognostic favorable (1.77e-8)" "unprognostic (2.18e-2)" "unprognostic (1.24e-1)" "unprognostic (5.21e-2)" "unprognostic (1.16e-2)" 3.3 8.4 11.6 5.6 14.4 17.5 10.7 13.3 18.5 6.9 9.4 7.7 10.4 7.2 18.2 5.6 8.2 7.2 5.6 12.1 14.7 15.5 4.0 6.7 7.8 15.1 13.1 8.2 13.3 14.0 11.9 2.7 14.9 12.8 8.2 9.2 11.8 8.0 5.5 5.4 11.1 3.6 16.2 8.2 18.6 4.8 15.2 6.2 23.7 4.2 7.2 6.3 3.3 19.0 0.1 4.5 10.0 0.3 1.2 0.4 5.9 4.1 3.0 5.6 4.5 2.9 3.8 0.1 6.3 3.1 6.0 2.6 14.6 4.1 7.3 28.9 11.3 14.5 4.2 7.2 2.9 24.3 20.3 0.6 5.5 0.0 3.6 6.9 21.3 26.3 29.9 31.2 5.6 7.2 26.4 3.2 5.7 24.8 11.5 22.7 10.0 21.8 10.4 12.8 50.2 11.2 0.0 12.3 13.9 2.5 20.8 4.6 14.9 2.4 8.7 34.9 7.0 7.8 0.0 8.4 16.2 0.0 10.4 9.6 1.3 23.3 8.0 0.7 10.6 12.4 12.8 9.1 1.7 12.5 15.8 11.3 4.4 6.6 0.9 24.0 9.6 6.3 11.6 14.4 13.3 18.5 12.1 14.7 15.1 13.1 14.9 16.2 15.2 19.0 68.8 80.1 66.9 4.9 80.1 26.8 69.0 61.6 12.5 48.9 141.2 110.4 157.7 82.9 71.4 161.8 22.9 34.8 89.6 63.8 406.9 89.9 945.7 64.2 9.3 79.4 112.5 187.8 4.8 143.5 7.4 24.9 57.6 80.2 125.4 36.4 79.9 100.7 24.2 26.9 3.8 105.9 111.9 22.1 64.8 319.1 34.8 55.6 55.2 7.5 62.0 67.0 65.9 6.0 62.0 156.5 63.4 47.0 67.1 77.3 100.8 224.4 59.2 79.3 13.1 23.7 32.5 201.7 87.6 28.6 77.4 32.8 89.2 23.2 84.6 92.8 SWI5 "bA395P17.9, C9orf119, SAE3" ENSG00000175854 "SWI5 homologous recombination repair protein" 9 128275379-128316123 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 142.5" "Group enriched" "Detected in all" 9 "Early spermatids: 1180.8;Late spermatids: 1131.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052032 Approved Supported Nucleoplasm,Cytosol NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 34: Spermatids - Unknown function" "Nucleoplasm, Cytosol" "HPA052032: AB_2681702" "unprognostic (1.27e-2)" "unprognostic (1.74e-2)" "unprognostic (3.56e-3)" "unprognostic (3.21e-2)" "unprognostic (1.42e-3)" "unprognostic (3.28e-2)" "prognostic unfavorable (6.78e-4)" "unprognostic (2.11e-1)" "unprognostic (1.19e-1)" "unprognostic (1.81e-1)" "unprognostic (4.58e-3)" "unprognostic (1.15e-1)" "prognostic favorable (9.39e-4)" "unprognostic (1.43e-1)" "unprognostic (6.73e-2)" "unprognostic (2.40e-1)" "unprognostic (7.38e-2)" 27.5 26.5 29.0 11.2 31.3 11.0 28.2 31.3 40.8 39.2 32.7 23.5 15.9 27.5 68.8 33.3 31.7 17.8 34.9 28.7 31.9 36.4 42.3 20.6 12.5 30.4 30.8 40.8 21.2 71.4 54.5 17.6 30.4 32.8 12.7 21.1 25.6 37.1 25.2 26.0 18.6 20.3 29.7 18.0 23.0 142.5 30.4 17.1 44.0 25.6 17.7 26.4 31.5 31.6 29.2 51.4 29.7 34.8 79.2 71.8 33.7 50.6 66.7 64.2 42.6 66.6 33.5 27.7 65.7 82.6 39.5 47.8 48.1 67.5 42.6 41.4 35.7 21.0 97.5 52.9 101.9 13.6 18.6 60.8 31.7 107.4 57.8 55.9 62.5 96.8 50.5 42.8 66.5 119.9 29.6 19.6 20.3 67.8 105.3 27.1 41.0 44.4 43.6 15.2 34.0 18.9 63.0 39.8 63.0 32.9 66.2 14.5 39.0 46.4 38.0 90.9 43.3 45.6 75.0 37.0 61.8 20.9 50.7 54.3 14.2 25.8 14.5 8.7 17.0 17.6 14.1 14.4 14.7 20.2 16.7 21.6 9.0 22.2 9.1 21.4 15.6 15.3 29.0 31.3 31.3 40.8 28.7 31.9 30.4 30.8 30.4 29.7 30.4 31.6 33.8 6.4 17.4 5.2 18.0 24.5 35.1 54.0 31.3 13.7 33.6 38.9 36.2 31.5 33.5 36.8 12.5 65.7 13.7 15.7 66.5 25.5 1180.8 30.7 29.1 31.3 25.6 17.2 2.9 38.5 41.1 40.7 19.9 30.7 9.5 27.9 35.7 82.4 33.2 1.7 3.3 27.5 28.5 20.8 13.0 1131.1 43.2 31.5 37.4 2.8 23.8 50.7 20.6 4.5 7.8 29.8 27.1 31.6 17.9 34.9 68.4 84.1 29.5 21.1 32.9 25.7 31.3 93.7 44.3 33.5 21.9 117.0 18.6 32.8 23.4 36.6 TBC1D8B "FLJ20298, GRAMD8B, RP11-321G1.1" ENSG00000133138 "TBC1 domain family member 8B" Q0IIM8 X 106802673-106876150 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "GTPase activation" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Alveolar cells type 1: 230.8;Alveolar cells type 2: 234.5;Club cells: 92.9;granulocytes: 113.0;Respiratory ciliated cells: 108.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023883, HPA027527" Enhanced Approved Cytosol NA NA "Cluster 17: Basophils - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 11: Alveolar cells - Smell perception" Cytosol "HPA023883: AB_1857794, HPA027527: AB_2199395" "unprognostic (6.69e-2)" "unprognostic (1.06e-1)" "unprognostic (8.19e-2)" "unprognostic (4.69e-3)" "unprognostic (8.15e-2)" "unprognostic (6.97e-2)" "unprognostic (2.08e-1)" "unprognostic (1.88e-2)" "unprognostic (1.48e-1)" "unprognostic (1.94e-1)" "unprognostic (2.75e-1)" "unprognostic (4.89e-2)" "unprognostic (3.32e-2)" "unprognostic (4.77e-2)" "unprognostic (1.62e-1)" "unprognostic (9.97e-2)" "unprognostic (5.16e-2)" 4.5 19.6 5.8 4.2 11.5 5.2 4.6 15.3 19.6 6.9 15.0 6.3 7.8 5.4 10.0 3.0 3.9 7.0 3.4 8.0 5.1 8.4 12.0 4.5 2.7 2.0 1.5 6.4 9.0 8.6 6.4 4.5 3.6 6.8 7.3 9.6 7.7 6.4 3.1 4.1 9.5 5.1 0.5 3.2 11.0 8.5 5.9 1.6 8.8 1.6 2.0 4.5 2.5 24.4 14.7 4.6 1.8 7.1 21.9 30.9 7.9 16.3 16.9 2.8 8.5 8.1 12.6 5.1 12.9 16.6 11.6 7.6 5.9 8.2 7.2 2.5 6.5 7.1 6.4 7.7 5.7 1.8 2.6 13.7 6.5 6.0 2.9 17.2 7.9 4.1 2.4 8.3 10.0 7.4 4.6 2.7 9.2 21.6 7.3 2.0 3.9 2.1 7.9 10.7 3.3 2.7 13.4 9.7 6.0 9.1 11.0 2.2 10.0 10.4 11.2 13.9 6.0 7.6 8.4 1.3 20.2 1.5 13.1 2.1 0.8 0.4 0.7 0.4 0.5 0.7 0.6 0.5 0.2 1.4 0.4 0.5 1.9 0.5 0.4 1.0 0.2 0.1 5.8 11.5 15.3 19.6 8.0 5.1 2.0 1.5 3.6 0.5 5.9 24.4 7.0 230.8 234.5 1.0 2.2 2.4 7.8 8.4 7.4 4.1 6.9 3.3 2.6 4.3 92.9 7.3 4.2 2.8 0.6 9.5 7.9 8.8 0.9 4.9 12.5 19.2 4.8 1.3 8.3 9.3 3.0 25.2 21.9 6.8 113.0 4.8 3.3 13.5 1.7 0.0 7.5 15.1 6.1 2.2 0.4 2.2 9.0 12.7 3.6 14.0 1.0 1.8 1.0 13.6 25.4 6.1 9.2 8.6 0.2 8.0 14.0 12.1 108.3 3.6 0.0 8.3 5.7 3.6 3.2 3.5 1.4 2.6 9.4 31.4 10.1 10.3 TBL1X "EBI, TBL1" ENSG00000101849 "Transducin beta like 1 X-linked" O60907 X 9463295-9741037 "Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" Activator "Congenital hypothyroidism, Deafness, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 103.8;Oligodendrocytes: 109.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 18.7" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "CAB005363, HPA067703" Approved Approved Nucleoplasm,Nucleoli NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 68: Epididymis - Unknown function" "Cluster 3: HMC-1 - Innate immune response" "Cluster 36: Stromal cells - Cell proliferation" Nucleoplasm Nucleoli "CAB005363: AB_2240272, HPA067703: AB_2685892" "prognostic unfavorable (8.50e-4)" "unprognostic (2.03e-1)" "unprognostic (2.12e-1)" "unprognostic (2.89e-2)" "unprognostic (2.44e-1)" "unprognostic (1.40e-2)" "unprognostic (2.21e-3)" "unprognostic (3.09e-1)" "unprognostic (2.70e-1)" "unprognostic (3.27e-1)" "prognostic favorable (1.32e-4)" "unprognostic (2.66e-1)" "prognostic favorable (4.58e-4)" "unprognostic (6.71e-2)" "unprognostic (6.38e-2)" "unprognostic (3.40e-3)" "unprognostic (1.53e-1)" 9.3 9.1 20.0 8.7 21.3 7.2 9.7 17.4 16.7 18.1 14.2 9.4 2.8 38.4 35.3 10.2 16.6 7.1 7.3 16.7 21.1 16.6 13.6 5.8 9.0 23.8 20.2 18.0 9.2 23.9 18.7 20.7 19.7 25.4 5.3 16.5 7.3 43.2 4.6 7.5 5.0 26.6 18.6 8.4 8.1 9.7 26.7 18.4 12.0 5.2 10.2 13.5 12.7 20.0 0.1 29.6 18.5 49.2 16.8 17.4 18.4 11.3 25.0 21.3 22.2 22.4 20.2 31.6 0.8 22.7 9.1 6.7 40.7 8.9 30.9 13.0 19.6 20.0 35.6 26.5 23.7 7.2 68.6 15.6 10.1 22.3 11.8 11.7 19.9 17.2 35.8 53.5 12.5 25.6 17.8 27.2 36.7 14.2 31.5 39.3 14.5 39.3 28.9 16.9 23.4 10.6 27.2 6.8 16.9 48.2 13.3 15.6 29.1 7.5 18.3 0.8 4.6 32.6 27.8 25.1 27.2 17.4 7.1 6.3 4.7 5.7 2.2 2.9 1.8 2.2 1.7 2.0 3.5 3.6 3.1 2.9 18.7 0.3 2.0 0.3 2.9 2.1 20.0 21.3 17.4 16.7 16.7 21.1 23.8 20.2 19.7 18.6 26.7 20.0 12.6 0.0 4.5 103.8 17.3 6.5 13.2 3.8 9.1 11.8 19.1 18.0 10.1 20.0 6.8 31.3 22.9 78.1 20.4 7.9 13.7 10.7 1.0 34.4 80.7 10.3 22.8 3.8 12.5 7.8 6.0 13.1 9.7 51.1 11.4 32.5 11.4 64.3 11.3 6.7 17.1 5.4 2.0 33.0 22.8 3.2 14.3 19.7 5.4 61.8 37.5 46.6 19.6 46.3 109.7 7.5 7.9 28.6 9.5 24.1 0.2 21.8 10.0 24.5 0.0 9.4 27.9 1.4 18.0 16.5 12.4 45.0 18.8 22.3 4.9 23.7 TCEAL8 "MGC45400, WEX3" ENSG00000180964 "Transcription elongation factor A like 8" Q8IYN2 X 103252995-103255192 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059115 Uncertain Approved Nucleoplasm NA NA "Cluster 6: Non-specific - Transcription" "Cluster 68: Epididymis - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 39: Non-specific - Basic cellular processes" Nucleoplasm "HPA059115: AB_2683909" "unprognostic (1.51e-2)" "unprognostic (4.56e-2)" "unprognostic (9.24e-2)" "unprognostic (7.13e-3)" "unprognostic (1.03e-1)" "prognostic unfavorable (8.53e-6)" "unprognostic (3.71e-3)" "unprognostic (1.88e-2)" "unprognostic (5.52e-2)" "unprognostic (4.80e-3)" "unprognostic (4.03e-2)" "unprognostic (1.01e-1)" "unprognostic (1.12e-2)" "unprognostic (3.26e-2)" "unprognostic (7.22e-2)" "unprognostic (9.12e-2)" "unprognostic (9.32e-2)" 42.9 62.6 51.9 36.3 53.1 29.3 60.0 55.0 69.6 67.2 53.8 47.9 30.5 58.3 131.1 38.8 45.3 57.1 93.1 53.1 54.6 69.4 42.7 43.9 47.6 53.4 52.2 69.4 40.9 71.0 56.5 62.2 53.9 59.2 49.5 33.2 61.5 56.1 18.8 39.3 40.4 63.2 55.1 45.8 42.0 42.9 53.4 71.9 71.3 32.0 45.7 57.3 36.5 55.9 49.2 26.4 110.9 51.8 161.9 269.3 53.2 104.9 154.7 90.6 141.0 20.6 94.5 25.8 68.2 120.7 157.7 32.1 19.6 120.0 116.5 0.4 61.5 111.2 34.5 30.8 98.8 114.4 105.6 184.9 68.0 79.5 0.0 190.3 123.9 75.3 135.0 23.8 223.6 0.0 98.2 43.9 123.2 4.4 52.7 37.1 152.8 7.6 124.7 36.4 57.7 75.4 58.3 18.1 130.8 105.7 33.9 38.0 83.1 53.5 71.0 164.4 35.2 26.2 49.8 1.1 86.7 61.0 87.6 73.7 31.9 20.0 66.3 29.3 76.6 62.4 78.1 71.4 58.2 52.6 84.5 73.5 3.0 120.6 23.2 101.3 109.5 54.5 51.9 53.1 55.0 69.6 53.1 54.6 53.4 52.2 53.9 55.1 53.4 55.9 72.3 51.3 66.7 6.8 32.7 60.8 83.9 169.4 68.9 52.3 70.5 69.2 76.6 104.4 89.4 97.5 10.4 188.8 48.5 27.5 273.9 137.8 6.8 46.2 71.8 85.0 78.5 33.2 10.3 109.4 176.3 93.9 29.6 49.7 69.6 76.2 169.6 102.5 98.7 50.5 10.0 133.7 81.4 90.6 81.1 17.2 125.9 52.4 120.9 10.3 71.4 110.4 104.0 7.1 11.3 68.2 49.2 121.9 27.2 51.3 73.5 276.2 60.1 37.5 85.5 80.6 77.4 5.6 4.0 47.6 59.5 134.9 45.1 68.1 78.7 79.5 TCERG1L FLJ38950 ENSG00000176769 "Transcription elongation regulator 1 like" Q5VWI1 10 131092391-131311721 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 5.0;retina: 6.1;thyroid gland: 14.9" "Group enriched" "Detected in some" 5 "Excitatory neurons: 69.9;Horizontal cells: 102.6" "Cancer enriched" "Detected in some" 14 "thyroid cancer: 20.3" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 4.3;RPMI-8226: 1.1;SuSa: 1.9;U-2 OS: 1.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA030816 Approved Nucleoplasm,Cytosol NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 28: BEWO - Transcription regulation" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Nucleoplasm Cytosol "HPA030816: AB_10601721" "unprognostic (6.61e-2)" "unprognostic (1.29e-1)" "unprognostic (8.99e-2)" "unprognostic (1.45e-2)" "unprognostic (3.03e-1)" "unprognostic (6.69e-2)" "unprognostic (1.62e-1)" "unprognostic (4.96e-1)" "unprognostic (9.71e-2)" "unprognostic (2.02e-1)" "unprognostic (5.01e-2)" "unprognostic (1.08e-5)" "unprognostic (1.28e-1)" "unprognostic (2.83e-1)" "unprognostic (2.96e-2)" "unprognostic (2.03e-1)" 0.0 0.9 1.3 0.0 3.5 0.0 0.1 0.3 5.0 0.1 0.0 0.0 0.0 0.1 0.3 0.4 0.0 0.0 0.0 2.5 1.6 0.2 0.0 0.0 0.0 2.2 1.5 3.0 0.3 0.5 1.3 0.0 0.9 0.6 0.0 6.1 0.0 0.6 0.0 0.5 0.0 0.0 1.5 0.2 0.0 1.6 2.0 0.6 14.9 0.0 0.1 0.1 0.1 2.1 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 3.5 0.3 5.0 2.5 1.6 2.2 1.5 0.9 1.5 2.0 2.1 0.0 0.0 0.0 0.7 0.0 0.6 0.2 0.0 2.2 5.9 0.5 0.1 1.1 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 69.9 0.0 0.7 0.9 0.5 0.1 0.0 0.1 0.0 0.0 0.0 102.6 14.5 0.0 0.0 0.0 0.0 0.1 4.7 0.2 10.6 1.0 0.0 0.9 0.0 3.0 2.3 0.1 0.0 4.5 0.0 0.7 0.0 0.0 0.0 4.3 0.0 0.3 0.2 0.4 3.7 2.8 0.6 0.1 0.1 2.5 0.0 0.1 TCP10L2 bA517H2.3 ENSG00000166984 "T-complex 10 like 2, pseudogene" B9ZVM9 6 167146414-167196913 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "epididymis: 1.3;testis: 1.1" "Group enriched" "Detected in some" 13 "Early spermatids: 11.7;Late spermatids: 10.8;Spermatocytes: 39.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "CAB034197, HPA044709" Uncertain NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 66: Spermatocytes - Spermatogenesis" "CAB034197: AB_2202388, HPA044709: AB_10961410" "unprognostic (5.07e-2)" "unprognostic (1.22e-2)" "unprognostic (1.35e-1)" "unprognostic (2.52e-1)" "unprognostic (1.24e-1)" "unprognostic (1.12e-1)" "unprognostic (5.40e-4)" "unprognostic (1.73e-1)" "unprognostic (1.19e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 11.7 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.0 0.0 0.0 10.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 39.5 0.5 0.0 0.0 0.0 0.2 0.0 0.3 0.0 TCTA ENSG00000145022 "T cell leukemia translocation altered" P57738 3 49412206-49416475 "Disease related genes, Predicted membrane proteins" Proto-oncogene "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007342 Approved Approved Cytosol NA NA "Cluster 51: Monocytes - Innate immune response" "Cluster 68: Epididymis - Unknown function" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 59: Non-specific - Transcription" Cytosol "HPA007342: AB_2202399" "unprognostic (5.58e-2)" "unprognostic (4.33e-2)" "unprognostic (6.86e-2)" "unprognostic (5.71e-3)" "unprognostic (2.17e-2)" "unprognostic (3.35e-2)" "unprognostic (2.18e-1)" "prognostic favorable (6.76e-4)" "unprognostic (3.74e-1)" "unprognostic (3.38e-3)" "unprognostic (1.82e-3)" "unprognostic (1.03e-1)" "prognostic favorable (5.00e-15)" "unprognostic (1.68e-1)" "unprognostic (1.96e-1)" "unprognostic (3.43e-1)" "unprognostic (6.41e-3)" 21.7 48.0 49.1 13.1 52.3 12.3 21.5 50.1 52.9 23.2 47.0 24.7 18.9 23.1 60.6 15.6 26.1 16.6 22.6 48.4 50.6 51.0 41.9 23.5 15.8 51.6 51.6 27.1 24.1 39.8 48.8 14.5 52.3 34.5 28.8 14.0 21.8 25.1 19.6 14.2 23.1 21.8 48.8 25.9 23.3 15.7 52.1 20.1 45.3 13.8 16.0 25.4 15.9 51.5 12.8 15.5 9.8 14.8 42.5 18.5 12.9 26.0 19.2 25.8 21.6 9.1 13.6 15.2 18.6 61.5 29.6 14.4 19.3 26.2 21.0 22.9 13.4 25.4 19.6 11.9 25.8 10.9 31.9 40.2 26.8 28.7 22.9 24.7 27.0 12.0 9.4 33.8 63.8 11.7 13.4 9.8 8.0 24.1 35.5 8.1 10.6 36.0 44.5 16.7 26.3 8.7 30.9 33.8 28.6 19.7 28.8 10.2 24.5 19.3 11.9 40.4 9.8 18.4 26.1 10.4 45.4 19.3 27.2 20.4 17.8 23.2 19.1 34.2 11.1 12.0 12.0 14.7 10.1 13.7 14.9 15.5 20.1 23.0 47.5 15.6 17.8 22.4 49.1 52.3 50.1 52.9 48.4 50.6 51.6 51.6 52.3 48.8 52.1 51.5 15.5 25.6 15.6 8.8 19.3 2.7 10.0 10.3 14.2 10.2 19.9 18.0 14.1 20.0 12.9 27.6 12.5 25.9 20.5 34.0 46.9 15.3 8.0 15.5 15.0 14.7 17.5 9.0 12.3 11.6 11.5 17.6 53.5 17.0 5.7 7.1 11.4 31.8 24.8 10.1 11.0 19.1 20.3 18.6 6.0 14.3 15.5 19.2 14.2 11.2 15.5 26.3 26.8 11.1 16.8 15.1 28.6 16.1 13.2 13.4 34.9 50.3 22.8 11.3 6.6 13.7 16.6 8.2 6.1 10.4 4.5 20.0 21.6 22.1 16.6 7.9 TDRD12 "ECAT8, FLJ13072" ENSG00000173809 "Tudor domain containing 12" Q587J7 19 32719753-32829580 "Enzymes, Predicted intracellular proteins" "Differentiation, Meiosis, RNA-mediated gene silencing, Spermatogenesis" "Developmental protein, Helicase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "epididymis: 7.3;testis: 16.7" "Cell type enhanced" "Detected in some" "Early spermatids: 24.0;Late spermatids: 12.0;Spermatocytes: 65.0;Spermatogonia: 43.5" "Cancer enriched" "Detected in many" 9 "testis cancer: 10.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 30 "HDLM-2: 25.5;NTERA-2: 81.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 5: NTERA-2 - Transcription" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" "unprognostic (5.43e-2)" "unprognostic (3.97e-1)" "unprognostic (1.14e-1)" "unprognostic (1.87e-7)" "unprognostic (5.44e-2)" "unprognostic (1.78e-1)" "unprognostic (6.79e-2)" "unprognostic (1.20e-1)" "unprognostic (2.07e-1)" "unprognostic (1.40e-1)" "unprognostic (9.69e-2)" "unprognostic (1.90e-1)" "unprognostic (1.43e-4)" "unprognostic (2.09e-1)" "unprognostic (4.75e-2)" "unprognostic (3.08e-2)" "unprognostic (2.69e-2)" 0.2 0.8 0.2 0.1 0.2 0.1 0.2 0.1 0.3 0.7 0.0 0.2 0.0 1.1 7.3 0.3 0.8 0.1 0.1 0.2 0.6 0.1 0.0 0.1 0.2 0.4 0.2 1.6 0.0 0.0 0.1 0.0 0.2 0.2 0.1 0.4 0.1 0.3 0.1 1.7 1.2 0.1 0.1 0.3 0.1 16.7 0.9 0.4 0.4 0.0 0.2 0.2 0.2 0.2 0.0 1.1 0.2 1.3 0.1 0.1 1.7 0.2 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.3 0.0 25.5 0.2 0.0 0.0 0.3 0.0 0.0 0.1 0.5 0.5 0.0 0.0 0.2 0.0 0.1 0.0 0.2 0.1 0.3 0.1 0.0 81.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.3 0.3 0.1 0.0 0.0 0.4 0.1 0.3 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.3 0.2 0.6 0.4 0.2 0.2 0.1 0.9 0.2 0.3 0.0 0.0 1.3 0.0 0.0 0.4 0.0 0.0 0.4 0.6 0.3 0.9 0.0 0.0 1.8 0.0 0.4 0.2 0.1 0.0 0.0 24.0 0.3 1.2 0.4 0.0 0.0 2.2 0.0 1.3 0.2 0.0 1.1 0.0 0.2 0.4 0.0 0.1 0.0 2.1 0.1 0.0 0.0 0.3 12.0 2.1 0.1 0.0 1.0 0.0 0.2 0.0 0.0 1.4 0.1 0.2 1.5 0.1 0.1 0.1 0.2 0.0 0.2 0.0 0.4 0.3 65.0 43.5 0.0 0.1 0.3 0.2 2.9 0.4 0.2 TDRD5 "FLJ34823, TUDOR3" ENSG00000162782 "Tudor domain containing 5" Q8NAT2 1 179591613-179691272 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 6.5;testis: 21.9" "Group enriched" "Detected in some" 4 "Early spermatids: 36.1;Late spermatids: 12.1;Spermatocytes: 26.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "MCF7: 3.7;SK-BR-3: 5.8;T-47d: 10.3;U-266/70: 14.3;U-266/84: 13.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in some" HPA029418 Enhanced NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 29: U-266 - Adaptive immune response" "Cluster 29: Early spermatids - Spermatogenesis" "HPA029418: AB_10603035" "unprognostic (1.87e-1)" "unprognostic (1.43e-1)" "unprognostic (2.08e-1)" "unprognostic (2.15e-4)" "unprognostic (3.96e-1)" "unprognostic (4.39e-3)" "unprognostic (4.41e-4)" "unprognostic (3.18e-1)" "unprognostic (4.30e-1)" "unprognostic (3.75e-2)" "unprognostic (1.18e-1)" "unprognostic (3.37e-1)" "unprognostic (1.44e-2)" "unprognostic (1.28e-1)" "unprognostic (2.78e-2)" "unprognostic (6.89e-2)" "unprognostic (2.31e-1)" 0.2 0.3 0.8 0.1 1.4 0.3 3.6 0.0 0.8 0.1 0.0 0.6 0.5 0.0 6.5 0.5 0.9 0.2 0.0 0.7 0.4 1.8 0.0 0.1 0.0 0.9 0.9 0.0 0.2 0.3 2.3 0.2 1.0 0.6 0.7 0.3 0.8 0.3 0.0 0.3 0.4 0.0 0.6 0.0 0.3 21.9 1.1 0.1 0.8 0.0 0.4 0.3 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.7 0.0 0.0 1.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 5.8 0.0 0.7 10.3 0.2 0.0 0.0 1.5 0.0 0.0 14.3 13.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.4 0.0 0.8 0.7 0.4 0.9 0.9 1.0 0.6 1.1 0.2 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 3.5 1.8 0.7 0.0 0.0 0.0 0.0 0.4 0.1 0.1 0.0 0.1 36.1 1.0 0.0 0.1 0.0 0.0 5.2 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.9 0.0 0.0 0.0 12.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 1.1 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.4 5.7 0.0 0.3 0.0 0.0 0.0 0.3 0.1 TEX30 C13orf27 ENSG00000151287 "Testis expressed 30" Q5JUR7 13 102765888-102773811 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "epididymis: 71.3;liver: 40.1;testis: 122.8" "Cell type enhanced" "Detected in many" "Early spermatids: 384.7;Spermatocytes: 958.6;Spermatogonia: 283.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 5 "basophil: 364.5" "Lineage enriched" "Detected in all" 13 "granulocytes: 364.5" "Cell line enhanced" "Detected in many" "NB-4: 295.3;THP-1: 188.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053545 Enhanced NA NA "Cluster 10: Basophils - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "HPA053545: AB_2682181" "unprognostic (5.26e-2)" "prognostic favorable (2.09e-5)" "unprognostic (1.09e-1)" "unprognostic (2.09e-2)" "unprognostic (7.48e-2)" "unprognostic (1.54e-2)" "unprognostic (7.49e-2)" "unprognostic (9.86e-3)" "unprognostic (1.22e-1)" "unprognostic (1.25e-1)" "unprognostic (4.65e-2)" "prognostic unfavorable (2.10e-6)" "unprognostic (1.89e-2)" "unprognostic (1.79e-1)" "unprognostic (8.66e-3)" "unprognostic (1.62e-1)" "unprognostic (3.35e-1)" 8.4 6.0 8.5 6.7 7.8 14.4 7.7 8.6 12.3 7.3 8.0 5.6 5.5 10.4 71.3 8.4 6.1 4.9 9.1 7.7 7.9 19.2 40.1 5.9 11.8 7.7 8.2 7.2 5.6 4.3 7.2 14.9 7.7 4.6 4.5 7.5 5.2 13.1 9.7 7.5 5.4 7.3 7.8 6.5 5.7 122.8 9.1 16.1 5.5 9.3 7.4 6.8 6.4 8.5 44.0 16.1 39.0 30.8 23.3 16.8 0.4 59.0 14.9 39.9 35.6 41.2 43.0 25.6 25.0 22.4 52.5 23.8 35.3 21.0 53.9 53.8 21.3 44.2 34.9 0.4 15.7 92.5 86.0 8.9 13.6 33.2 20.8 14.4 30.8 64.9 27.6 0.0 47.6 24.5 61.0 295.3 14.1 63.4 38.3 37.8 18.0 18.4 61.7 18.5 51.2 22.1 33.3 42.9 37.8 23.0 30.0 188.3 12.0 27.3 21.2 44.0 63.7 23.9 30.3 0.1 46.9 54.0 45.9 364.5 7.6 79.4 10.6 9.4 15.2 12.9 11.6 13.6 8.8 11.8 13.1 11.2 3.9 28.5 9.7 17.8 18.8 8.8 8.5 7.8 8.6 12.3 7.7 7.9 7.7 8.2 7.7 7.8 9.1 8.5 12.4 0.0 3.7 1.6 15.0 23.7 16.2 35.3 12.0 7.4 12.1 21.5 12.2 7.2 14.3 12.9 4.2 110.9 10.9 3.4 37.2 16.0 384.7 11.1 10.2 15.5 3.0 34.1 5.1 9.7 113.9 15.7 5.1 6.7 27.3 11.3 13.6 39.5 46.6 6.7 6.3 4.9 22.4 5.3 18.9 79.2 30.4 11.7 28.4 4.7 17.7 8.0 14.4 5.0 4.6 9.7 2.2 18.8 15.8 16.0 8.1 100.8 11.2 5.9 92.1 15.4 29.7 958.6 283.2 16.9 19.9 142.3 20.2 5.0 8.3 10.9 TFAP2B AP2-B ENSG00000008196 "Transcription factor AP-2 beta" Q92481 6 50818723-50847619 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 33.3;retina: 14.8" "Cell type enhanced" "Detected in some" "Basal squamous epithelial cells: 145.7;Bipolar cells: 76.4;Horizontal cells: 437.4;Melanocytes: 106.7" "Cancer enriched" "Detected in some" 8 "breast cancer: 12.1" "Group enriched" "Detected in many" 6 "cerebellum: 3.5;medulla oblongata: 3.9;midbrain: 9.0;pons: 10.2" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "AF22: 109.6;SH-SY5Y: 208.1" "Region enhanced" "Detected in many" "cerebellum: 10.0" "Low region specificity" "Detected in many" "HPA034683, HPA062942" Enhanced Approved Nucleoplasm NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 62: Horizontal cells - Visual perception" Nucleoplasm "HPA034683: AB_10670966, HPA062942: AB_2684909" "unprognostic (2.02e-1)" "unprognostic (2.29e-2)" "unprognostic (4.27e-2)" "unprognostic (5.88e-4)" "unprognostic (9.76e-2)" "unprognostic (2.10e-1)" "unprognostic (1.00e-1)" "unprognostic (4.57e-1)" "unprognostic (6.58e-6)" "unprognostic (1.13e-2)" "unprognostic (1.88e-1)" "unprognostic (7.17e-3)" 0.1 3.4 0.0 0.0 0.0 0.0 8.2 3.5 0.1 0.1 0.0 0.1 0.0 0.0 33.3 3.9 0.0 0.0 0.0 0.0 0.1 9.8 0.0 0.0 0.0 3.9 9.0 0.0 0.0 0.0 0.6 0.2 10.2 0.0 0.0 14.8 6.4 0.7 0.0 8.6 0.0 0.0 0.6 0.0 0.0 0.4 1.1 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 109.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 35.5 0.1 0.2 208.1 0.0 0.8 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.1 0.0 0.1 3.9 9.0 10.2 0.6 1.1 0.2 0.2 0.0 0.0 0.0 0.0 11.7 0.0 0.0 145.7 76.4 43.0 29.7 0.9 0.0 0.0 51.5 8.4 14.9 0.1 0.0 54.8 0.0 17.4 0.0 0.0 0.7 0.0 0.0 0.0 0.0 4.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.1 437.4 0.0 0.0 0.0 0.0 1.5 2.0 0.0 0.5 106.7 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.4 1.2 0.0 0.0 0.7 0.0 11.8 0.0 0.0 0.3 1.9 0.6 31.1 4.3 4.9 0.2 0.0 0.0 0.0 TGIF1 "HPE4, TGIF" ENSG00000177426 "TGFB induced factor homeobox 1" Q15583 18 3411608-3459978 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Cancer-related genes, Disease variant, Holoprosencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 783.4;Basal respiratory cells: 419.8;Basal squamous epithelial cells: 483.2;Urothelial cells: 426.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA062160 Supported Nucleoplasm NA Yes "Cluster 44: Non-specific - Transcription" "Cluster 68: Epididymis - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 22: Epithelial cell types - Mixed function" Nucleoplasm "HPA062160: AB_2684701" "unprognostic (1.11e-2)" "unprognostic (5.20e-2)" "unprognostic (2.40e-1)" "unprognostic (1.97e-1)" "unprognostic (3.57e-3)" "unprognostic (3.10e-2)" "unprognostic (2.75e-1)" "unprognostic (4.34e-2)" "unprognostic (1.94e-2)" "unprognostic (1.96e-3)" "prognostic unfavorable (6.47e-4)" "unprognostic (9.60e-2)" "unprognostic (1.12e-2)" "unprognostic (9.81e-2)" "unprognostic (4.60e-1)" "unprognostic (7.07e-2)" "unprognostic (2.48e-3)" 51.2 40.1 21.7 43.3 20.8 41.5 57.6 22.4 25.7 68.9 30.2 51.5 31.6 51.2 133.7 46.7 74.7 65.3 29.8 20.2 29.3 74.0 61.5 47.6 26.4 29.8 27.3 67.3 46.9 26.9 22.0 63.8 25.7 54.6 65.7 8.0 56.5 56.1 34.4 60.2 37.8 37.4 27.5 35.5 49.1 25.9 25.7 40.0 66.7 26.9 27.0 112.1 40.0 28.4 33.6 148.5 92.7 29.3 90.0 121.7 235.7 63.1 236.6 49.9 62.1 61.0 142.6 1.9 20.9 49.8 165.7 33.7 35.0 73.8 61.6 13.9 16.8 4.3 73.2 110.5 178.8 47.6 38.3 89.5 291.7 89.7 233.7 131.3 104.4 22.3 36.0 0.4 95.6 65.8 31.1 58.8 240.8 119.0 34.8 32.8 43.2 10.3 198.1 156.7 27.1 26.5 166.2 123.0 92.5 151.3 28.1 43.7 49.6 77.5 65.6 92.7 41.1 5.0 0.6 15.7 78.5 18.6 98.2 65.4 42.8 7.6 62.9 16.6 67.8 46.5 52.5 61.9 35.1 32.2 37.1 43.5 19.8 21.5 16.7 3.3 32.1 36.3 21.7 20.8 22.4 25.7 20.2 29.3 29.8 27.3 25.7 27.5 25.7 28.4 41.0 35.3 40.2 8.1 106.5 359.6 783.4 419.8 483.2 0.0 114.1 72.1 5.6 100.1 128.3 123.2 0.0 161.6 60.1 30.0 49.0 117.1 41.5 167.2 58.5 66.6 46.4 25.7 2.7 75.0 220.9 102.8 79.0 240.2 68.0 71.5 29.3 35.7 71.8 1.7 0.6 99.4 136.3 44.9 221.1 9.7 28.6 126.8 76.5 7.5 71.9 6.7 11.3 4.0 1.7 106.0 53.0 15.4 15.1 308.1 24.9 113.1 93.3 0.1 32.9 90.9 86.6 7.9 15.4 223.9 257.1 150.4 103.7 8.0 91.8 426.2 THAP2 DKFZP564I0422 ENSG00000173451 "THAP domain containing 2" Q9H0W7 12 71664301-71680644 "Plasma proteins, Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 367.4;Late spermatids: 183.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039790 Approved Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 68: Epididymis - Unknown function" "Cluster 12: NES - Nervous system development" "Cluster 41: Macrophages - Immune response" "Golgi apparatus" Nucleoplasm "HPA039790: AB_10795157" "unprognostic (5.62e-2)" "unprognostic (2.01e-1)" "unprognostic (5.55e-2)" "unprognostic (2.90e-2)" "unprognostic (1.80e-2)" "unprognostic (1.51e-4)" "unprognostic (1.24e-4)" "unprognostic (7.00e-2)" "unprognostic (1.02e-1)" "unprognostic (7.20e-2)" "unprognostic (3.73e-3)" "unprognostic (6.83e-2)" "unprognostic (3.13e-2)" "unprognostic (7.82e-2)" "unprognostic (1.25e-1)" "unprognostic (2.38e-1)" "unprognostic (4.80e-2)" 16.1 26.1 5.7 9.1 7.1 14.8 4.2 11.6 9.2 4.8 3.1 4.1 5.7 6.3 17.0 6.5 4.6 8.6 5.2 5.5 6.3 5.6 4.4 4.7 7.9 6.7 6.0 8.6 3.8 3.4 11.1 6.8 6.6 4.7 5.7 11.3 4.7 4.1 5.0 5.7 4.3 4.4 6.9 5.1 6.4 18.2 5.7 5.4 4.6 5.7 7.1 28.2 4.1 10.8 3.9 4.9 11.2 8.6 8.2 7.2 5.6 6.0 5.5 5.7 4.8 5.1 5.1 2.7 4.0 4.0 6.9 6.8 10.9 3.4 7.4 11.5 6.0 7.8 8.6 8.0 7.4 4.8 3.4 5.1 15.1 5.4 12.0 11.9 9.0 13.2 5.7 5.6 7.9 1.3 3.9 4.7 5.7 7.9 8.2 5.5 3.8 13.3 7.1 6.0 7.9 12.4 6.6 3.8 5.8 7.8 7.1 5.4 4.0 5.9 2.8 5.1 4.1 6.9 9.4 6.2 3.4 5.7 3.6 1.4 2.2 2.2 3.7 3.0 6.0 4.1 5.1 3.6 3.0 4.8 8.1 5.5 1.9 6.4 3.7 1.4 5.5 2.1 5.7 7.1 11.6 9.2 5.5 6.3 6.7 6.0 6.6 6.9 5.7 10.8 15.1 0.0 11.0 11.1 36.2 19.6 27.7 13.7 20.5 11.5 9.9 13.6 12.4 4.3 7.9 3.7 4.2 4.0 24.4 8.1 9.8 7.7 367.4 12.2 13.5 10.6 5.4 3.4 14.8 5.4 7.3 47.1 12.8 20.2 58.3 9.4 6.1 4.3 12.3 13.5 20.8 8.1 2.0 11.3 93.2 183.7 11.5 75.2 78.2 5.6 9.9 10.2 9.2 14.1 24.3 7.0 9.4 5.7 44.3 16.7 15.6 19.2 10.5 7.5 0.0 22.2 64.1 26.1 7.2 44.8 29.5 3.0 20.0 6.7 9.5 25.7 TK2 SCA31 ENSG00000166548 "Thymidine kinase 2" O00142 16 66508003-66552544 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "DNA synthesis" "Kinase, Transferase" "Disease variant, FDA approved drug targets, Primary mitochondrial disease, Progressive external ophthalmoplegia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041162 Uncertain NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 68: Epididymis - Unknown function" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 50: Fibroblasts - ECM organization" "HPA041162: AB_10961178" "unprognostic (1.12e-1)" "unprognostic (2.11e-1)" "unprognostic (1.12e-1)" "unprognostic (6.27e-3)" "unprognostic (3.94e-1)" "unprognostic (2.93e-1)" "unprognostic (1.10e-1)" "unprognostic (4.83e-2)" "unprognostic (3.35e-2)" "unprognostic (3.45e-1)" "unprognostic (3.59e-2)" "unprognostic (2.85e-1)" "prognostic favorable (2.18e-6)" "unprognostic (3.05e-2)" "unprognostic (1.74e-1)" "unprognostic (2.71e-1)" "unprognostic (7.05e-2)" 48.1 30.2 24.2 11.8 27.6 8.5 25.6 24.7 25.7 20.0 19.7 15.0 10.9 16.2 29.3 12.3 19.0 21.1 19.2 24.1 25.6 25.1 37.3 18.7 11.7 26.5 27.8 26.8 24.4 38.0 22.4 15.1 27.6 19.2 12.7 11.7 22.6 19.9 11.5 12.7 13.5 18.9 27.5 23.0 15.7 33.9 25.8 13.0 25.6 14.6 9.9 17.8 15.4 28.3 13.3 26.5 12.1 14.5 64.3 52.2 0.7 22.0 22.3 15.1 16.8 6.5 26.4 0.1 23.8 63.9 19.0 11.8 5.3 17.7 10.4 8.5 6.2 4.1 17.2 12.9 45.1 5.6 9.2 39.4 15.3 18.5 26.1 62.5 19.9 13.1 6.8 28.1 37.9 4.1 5.5 14.9 5.9 5.1 15.4 7.0 21.0 28.1 44.1 12.5 4.4 8.9 63.2 6.1 26.9 6.6 9.6 16.3 29.7 30.8 15.9 26.3 7.6 30.3 12.2 11.6 38.9 5.7 18.4 5.6 9.4 6.0 1.8 5.1 1.2 0.1 1.3 1.0 8.7 1.7 0.6 0.9 8.5 2.7 4.3 1.8 1.2 2.5 24.2 27.6 24.7 25.7 24.1 25.6 26.5 27.8 27.6 27.5 25.8 28.3 25.0 22.4 9.3 19.6 7.3 5.7 5.1 5.8 12.5 15.5 15.4 11.4 8.0 17.2 7.5 22.0 22.9 10.0 7.6 6.0 9.8 15.7 25.2 15.2 23.2 14.4 9.6 10.3 10.1 22.4 6.0 19.9 11.7 13.0 24.8 20.6 31.1 48.9 21.7 21.9 12.0 6.5 2.0 55.6 10.1 40.5 23.3 23.6 10.6 10.3 22.6 18.4 12.3 14.6 19.4 28.9 3.3 19.2 12.4 4.3 14.4 45.9 9.0 20.5 0.0 14.4 10.6 48.9 11.1 9.6 3.8 2.9 8.6 22.2 7.6 4.2 TMC1 "DFNA36, DFNB11, DFNB7" ENSG00000165091 "Transmembrane channel like 1" Q8TDI8 9 72521608-72838297 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Hearing, Ion transport, Transport" "Ion channel" "Deafness, Disease variant, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "cervix: 1.0" "Cell type enhanced" "Detected in some" "Astrocytes: 19.2;Early spermatids: 7.9;Endometrial stromal cells: 5.5;Microglial cells: 5.6;Urothelial cells: 6.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 2.7;HAP1: 5.2;NTERA-2: 1.9;SuSa: 1.0;U-266/70: 1.3;U-266/84: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 5: NTERA-2 - Transcription" "Cluster 64: Astrocytes - Nervous system maintenance" "unprognostic (6.36e-2)" "unprognostic (1.45e-1)" "unprognostic (1.79e-1)" "unprognostic (7.19e-3)" "unprognostic (3.97e-1)" "unprognostic (5.67e-4)" "unprognostic (1.63e-1)" "unprognostic (1.91e-1)" "unprognostic (2.10e-2)" "unprognostic (3.74e-1)" "unprognostic (3.94e-2)" "unprognostic (2.12e-1)" "unprognostic (2.67e-3)" "unprognostic (1.80e-1)" "unprognostic (2.35e-1)" "unprognostic (3.94e-2)" "unprognostic (1.31e-1)" 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.5 0.5 1.0 0.1 0.0 0.0 0.1 0.8 0.1 0.1 0.0 0.0 0.4 0.6 0.7 0.0 0.0 0.0 0.6 0.6 0.0 0.0 0.0 0.0 0.4 0.6 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.5 0.5 0.4 0.6 0.6 0.6 0.6 0.5 0.4 0.7 1.3 0.0 0.0 19.2 0.0 0.3 2.9 0.1 0.6 0.2 0.1 0.1 0.4 0.0 0.0 1.8 0.0 4.0 0.1 0.4 0.0 0.2 7.9 1.4 5.5 1.2 0.0 0.0 1.5 0.6 2.8 0.3 0.0 0.9 0.0 0.0 0.0 0.0 0.5 0.0 1.2 0.0 0.0 0.0 0.0 2.6 0.3 0.1 0.0 5.6 0.6 1.1 0.0 1.5 1.3 0.5 2.2 0.0 0.0 3.1 0.0 3.0 0.0 0.0 0.0 0.3 0.2 1.8 3.1 0.5 0.0 2.6 0.1 0.5 0.0 6.8 TMEM126B HT007 ENSG00000171204 "Transmembrane protein 126B" Q8IUX1 11 85628573-85636539 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Chaperone "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014480, HPA019186" Uncertain Supported Mitochondria NA NA "Cluster 44: Non-specific - Transcription" "Cluster 68: Epididymis - Unknown function" "Cluster 21: OE19 - Mitochondria" "Cluster 39: Non-specific - Basic cellular processes" Mitochondria "HPA014480: AB_1858083, HPA019186: AB_1858084" "unprognostic (1.11e-1)" "unprognostic (4.97e-2)" "unprognostic (1.10e-1)" "unprognostic (2.79e-2)" "unprognostic (5.67e-1)" "unprognostic (1.44e-1)" "unprognostic (5.55e-3)" "unprognostic (1.22e-1)" "unprognostic (1.45e-2)" "unprognostic (6.70e-3)" "unprognostic (4.42e-2)" "unprognostic (4.30e-2)" "unprognostic (1.94e-2)" "unprognostic (1.78e-1)" "unprognostic (6.50e-2)" "unprognostic (5.86e-2)" "unprognostic (2.66e-2)" 16.1 16.7 29.2 13.0 29.4 6.5 19.3 28.9 38.9 18.2 25.9 21.4 19.6 19.3 30.7 14.3 15.8 17.3 24.7 30.4 31.7 15.3 17.2 15.8 18.7 29.7 30.0 16.4 15.9 11.0 20.8 13.3 30.9 17.0 17.6 18.6 15.7 14.1 16.2 13.8 19.8 21.4 30.1 16.5 17.6 10.9 30.2 16.0 16.8 20.1 17.5 18.6 14.8 32.3 37.9 29.8 33.1 16.0 60.2 49.6 10.6 33.1 36.1 25.6 38.1 84.8 37.1 39.9 72.2 27.1 28.6 45.0 53.2 33.0 23.8 56.5 49.7 30.1 49.1 36.1 35.6 75.4 34.7 37.9 38.3 38.6 47.0 41.1 38.6 49.5 72.5 31.2 58.8 47.9 29.4 91.3 36.1 129.6 50.1 25.0 25.4 33.6 49.5 42.1 30.8 19.1 31.2 24.9 31.9 42.5 50.1 45.4 20.5 38.2 26.5 96.9 35.4 14.6 91.1 47.7 19.4 60.4 20.6 21.5 15.6 7.9 19.0 18.2 24.8 18.3 23.4 23.5 20.1 17.7 23.3 23.4 5.9 23.4 14.5 18.4 25.9 15.9 29.2 29.4 28.9 38.9 30.4 31.7 29.7 30.0 30.9 30.1 30.2 32.3 44.9 22.4 40.7 16.6 34.6 26.1 32.2 80.8 22.8 32.5 36.8 31.1 87.3 54.3 57.2 40.5 14.6 41.0 54.2 33.6 168.3 76.0 5.4 27.2 39.2 46.1 34.6 34.5 19.3 49.0 54.5 45.1 15.8 25.8 42.5 27.8 42.5 43.6 84.1 23.5 20.1 41.3 81.4 47.4 44.6 8.3 66.5 43.5 72.9 9.4 48.8 79.0 80.3 20.6 29.7 51.5 52.8 88.4 22.4 35.3 56.5 162.9 51.3 31.2 39.5 30.0 43.8 34.4 46.8 23.1 36.9 25.2 49.7 45.4 52.0 45.4 TMEM128 MGC13159 ENSG00000132406 "Transmembrane protein 128" Q5BJH2 4 4235542-4248223 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044809 Uncertain NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 68: Epididymis - Unknown function" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "HPA044809: AB_10963539" "unprognostic (4.97e-2)" "unprognostic (4.32e-2)" "unprognostic (3.23e-2)" "unprognostic (3.65e-1)" "unprognostic (2.39e-1)" "unprognostic (2.10e-1)" "unprognostic (2.94e-2)" "unprognostic (8.81e-2)" "unprognostic (1.09e-1)" "unprognostic (9.11e-3)" "unprognostic (1.09e-1)" "unprognostic (1.07e-1)" "unprognostic (2.14e-3)" "unprognostic (1.72e-1)" "unprognostic (1.64e-1)" "unprognostic (2.63e-1)" "unprognostic (1.28e-2)" 22.5 27.2 21.7 15.4 24.0 8.4 33.0 24.0 34.8 25.3 21.9 23.1 20.7 27.3 47.0 20.4 29.2 16.9 22.9 21.1 23.8 33.5 19.7 25.0 23.3 25.2 23.5 36.6 21.4 44.7 17.8 26.9 24.9 26.8 24.9 16.2 22.0 25.5 14.4 22.5 19.4 16.4 24.6 22.2 23.7 25.3 23.2 23.6 37.2 15.3 23.2 17.9 18.4 29.1 15.7 12.0 43.7 33.3 34.8 29.0 31.1 33.2 37.2 34.8 33.0 13.5 60.9 9.1 17.0 29.6 33.0 13.3 21.1 22.5 33.0 25.0 13.1 17.1 8.8 19.0 48.9 41.4 30.0 40.6 38.7 13.5 27.0 31.1 20.9 29.9 24.7 17.9 40.7 17.1 34.0 55.3 36.3 22.8 23.4 13.2 17.5 19.7 52.9 24.4 24.5 39.6 13.5 12.9 41.2 28.6 44.4 40.5 20.5 32.8 13.8 30.9 35.0 49.8 43.9 30.6 34.2 28.6 40.7 25.7 36.5 42.8 36.3 50.4 45.8 38.1 43.9 36.2 38.1 34.3 59.0 49.9 17.4 45.6 45.0 61.5 36.7 37.9 21.7 24.0 24.0 34.8 21.1 23.8 25.2 23.5 24.9 24.6 23.2 29.1 20.7 12.8 22.7 8.8 13.8 17.8 20.3 63.5 12.0 9.9 25.5 22.0 9.1 24.3 30.5 31.3 2.1 45.3 17.3 24.2 29.4 28.7 25.9 16.3 19.6 18.6 17.3 15.2 11.1 23.7 44.4 23.1 7.1 14.6 15.8 14.3 27.8 18.2 30.2 13.5 12.3 23.2 28.5 23.5 14.0 8.9 40.7 14.9 39.2 10.3 25.2 26.4 23.7 14.1 24.5 18.2 33.9 37.6 5.7 24.0 24.9 38.3 32.6 11.7 46.0 18.9 20.3 76.7 34.4 12.8 25.1 43.8 16.3 17.0 17.7 20.6 TMEM150C "FLJ12993, TTN3" ENSG00000249242 "Transmembrane protein 150C" B9EJG8 4 82483170-82562357 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 134.9" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 88.6;Granulosa cells: 104.7;Syncytiotrophoblasts: 117.3" "Cancer enhanced" "Detected in all" "breast cancer: 23.8" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "basophil: 2.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 8.8;AN3-CA: 10.9;MCF7: 32.2;SCLC-21H: 20.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052921 Enhanced NA NA "Cluster 17: Basophils - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 40: Granulosa cells - Unknown function" "HPA052921: AB_2681988" "unprognostic (2.99e-1)" "unprognostic (4.31e-2)" "unprognostic (2.27e-1)" "unprognostic (1.89e-3)" "unprognostic (1.71e-3)" "prognostic favorable (7.87e-4)" "unprognostic (2.94e-2)" "unprognostic (5.55e-2)" "unprognostic (1.06e-1)" "unprognostic (3.94e-2)" "prognostic favorable (5.68e-4)" "unprognostic (4.57e-2)" "prognostic favorable (4.59e-6)" "unprognostic (4.18e-1)" "unprognostic (2.64e-2)" "unprognostic (1.19e-1)" "unprognostic (3.51e-3)" 13.1 43.1 12.9 4.6 15.3 1.9 22.0 9.7 16.8 15.1 6.3 7.7 7.4 4.9 134.9 3.6 7.4 6.5 12.7 15.7 12.7 17.3 13.9 6.2 14.7 12.9 15.9 31.5 3.4 5.4 8.4 9.8 14.7 12.6 4.3 4.5 17.0 7.6 6.9 4.3 6.9 6.9 12.0 14.3 5.0 3.2 12.2 9.1 11.4 9.7 12.8 5.0 5.2 12.5 0.1 1.0 8.8 10.9 0.1 0.1 0.4 1.9 4.7 1.3 1.2 0.0 0.6 0.3 0.9 0.3 3.6 0.2 5.0 0.0 1.4 0.4 2.3 0.7 1.2 0.1 0.0 0.0 1.0 4.5 0.6 0.0 0.0 0.8 2.7 5.3 0.0 0.0 0.2 32.2 0.6 0.8 3.9 0.0 0.5 1.0 0.2 1.2 0.2 4.8 20.1 3.5 0.5 0.4 2.8 4.1 0.5 0.2 0.8 0.5 0.3 0.1 1.1 0.1 0.5 0.4 0.6 0.1 2.2 2.6 0.3 0.5 0.2 0.2 0.1 1.0 0.3 0.2 0.1 1.1 0.2 0.2 1.4 0.5 0.3 0.6 0.1 0.1 12.9 15.3 9.7 16.8 15.7 12.7 12.9 15.9 14.7 12.0 12.2 12.5 30.7 0.0 1.1 36.6 0.2 2.4 3.5 1.9 0.6 1.1 19.3 13.6 10.1 5.7 6.1 14.7 2.1 88.6 1.4 0.2 0.0 7.2 5.5 2.6 11.2 24.8 1.2 3.0 35.6 2.5 1.3 13.1 0.5 10.5 6.3 104.7 25.4 20.4 5.7 1.7 24.2 1.1 0.0 1.0 3.6 2.9 14.3 1.8 1.8 7.5 7.8 14.8 0.0 17.6 13.1 1.4 0.2 9.8 1.2 4.9 0.4 2.6 7.1 2.2 0.0 3.9 7.8 1.1 4.1 1.6 1.1 117.3 0.6 1.8 4.3 0.9 TMEM30A "C6orf67, CDC50A, FLJ10856" ENSG00000112697 "Transmembrane protein 30A" Q9NV96 6 75252924-75284948 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014561 Approved NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 68: Epididymis - Unknown function" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "HPA014561: AB_10601823" "unprognostic (2.00e-1)" "unprognostic (2.00e-2)" "unprognostic (2.52e-1)" "unprognostic (1.27e-2)" "unprognostic (3.48e-1)" "unprognostic (1.02e-2)" "unprognostic (1.11e-1)" "unprognostic (1.10e-1)" "unprognostic (2.02e-1)" "unprognostic (1.06e-1)" "unprognostic (2.15e-1)" "unprognostic (4.80e-2)" "unprognostic (1.88e-1)" "unprognostic (5.06e-2)" "unprognostic (7.12e-2)" "unprognostic (8.96e-2)" "unprognostic (1.00e-1)" 62.9 57.0 60.3 59.1 70.2 53.7 54.0 65.2 67.5 61.3 72.8 64.7 43.9 62.0 50.2 58.1 47.4 60.0 45.3 67.2 73.5 77.3 99.6 91.7 53.5 63.3 64.5 47.6 70.8 96.2 47.6 48.5 64.6 64.7 70.8 57.0 55.2 58.6 29.2 38.3 46.4 79.1 73.5 62.1 59.4 28.8 69.5 47.6 84.5 40.4 60.9 66.4 34.8 82.1 54.2 60.6 91.5 77.6 228.2 212.0 76.3 217.9 171.3 82.3 128.2 56.3 129.1 61.9 148.3 194.8 82.7 62.4 41.5 120.4 211.5 84.9 63.8 60.4 55.1 56.7 129.2 73.7 104.6 197.2 116.5 116.9 63.7 175.2 262.4 59.1 59.4 107.8 158.4 37.2 27.1 54.2 32.7 46.1 46.7 44.4 65.6 78.5 315.3 131.1 64.9 62.9 111.9 52.8 74.9 105.8 58.6 224.8 234.5 103.8 116.9 65.6 153.3 90.3 136.1 27.9 81.7 137.2 165.7 44.5 85.8 59.0 37.1 84.7 44.8 27.1 37.3 36.7 78.6 22.6 34.8 34.5 138.3 42.5 87.5 33.2 53.0 61.5 60.3 70.2 65.2 67.5 67.2 73.5 63.3 64.5 64.6 73.5 69.5 82.1 73.2 163.5 132.5 7.5 38.8 71.2 33.7 67.6 42.1 24.5 53.1 27.6 43.8 40.0 96.1 66.2 45.9 39.6 51.0 67.6 11.7 51.0 11.1 46.7 57.0 68.0 36.2 20.8 15.8 111.2 52.1 65.7 43.3 76.0 39.8 31.4 66.0 79.1 54.3 20.2 14.5 44.3 54.9 89.3 79.1 9.5 45.4 57.8 48.0 10.3 62.4 40.7 35.0 17.1 15.6 101.6 38.5 62.4 55.8 80.9 31.1 33.2 95.2 24.0 32.9 56.1 77.2 45.0 21.2 41.8 78.3 94.4 43.3 62.5 28.8 65.9 TP53TG3B ENSG00000261509 "TP53 target 3B" Q9ULZ0 16 33360274-33363478 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 27 "epididymis: 18.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA047832, HPA060916" Approved "Centriolar satellite" NA NA "Cluster 68: Epididymis - Unknown function" "Centriolar satellite" "HPA047832: , HPA060916: " 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 18.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.2 0.3 0.2 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TP53TG3D ENSG00000205456 "TP53 target 3D" Q9ULZ0 16 32252719-32255922 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "epididymis: 3.4;testis: 2.2" "Group enriched" "Detected in some" 6 "Early spermatids: 77.5;Late spermatids: 21.1;Spermatocytes: 32.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 1.2;HEL: 1.1;HMC-1: 1.4;RH-30: 1.1;SCLC-21H: 1.2;U-2 OS: 1.2" "HPA047832, HPA060916" Approved "Centriolar satellite" NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 3: HMC-1 - Innate immune response" "Cluster 29: Early spermatids - Spermatogenesis" "Centriolar satellite" "HPA047832: , HPA060916: " "unprognostic (1.65e-2)" "unprognostic (1.92e-1)" "unprognostic (5.60e-2)" "unprognostic (1.57e-1)" "unprognostic (1.02e-1)" "unprognostic (1.21e-1)" "unprognostic (5.98e-3)" "unprognostic (1.47e-2)" "unprognostic (2.06e-2)" "unprognostic (1.48e-1)" "unprognostic (1.32e-1)" 0.1 0.8 0.1 0.1 0.2 0.0 0.2 0.8 0.3 0.3 0.0 0.2 0.0 0.4 3.4 0.7 0.2 0.0 0.3 0.1 0.3 0.5 0.0 0.1 0.1 0.3 0.2 0.2 0.1 0.0 0.5 0.4 0.4 0.3 0.0 0.1 0.1 0.0 0.0 0.3 0.1 0.0 0.1 0.2 0.1 2.2 0.4 0.0 0.2 0.0 0.0 0.2 0.4 0.4 0.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.0 1.2 0.3 0.0 0.0 0.3 0.2 0.3 0.0 0.0 0.1 1.2 0.2 0.0 0.6 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.8 0.3 0.1 0.3 0.3 0.2 0.4 0.1 0.4 0.4 0.3 0.0 0.0 0.0 0.0 0.5 0.2 0.1 0.0 0.1 0.5 0.8 0.3 0.0 0.1 0.0 2.1 0.1 0.5 0.0 0.0 0.0 77.5 0.1 1.0 0.1 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.6 21.1 1.2 0.1 5.4 0.0 0.0 0.4 0.0 0.0 0.4 0.1 0.0 1.2 0.1 0.2 0.0 0.0 0.2 0.1 6.6 0.6 0.3 32.5 6.6 0.0 0.1 0.0 0.1 0.4 0.0 0.0 TP53TG3F ENSG00000278848 "TP53 target 3 family member F" Q9ULZ0 16 33459045-33462249 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 19 "epididymis: 6.0;testis: 4.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 1.1;U-266/84: 1.2" "HPA047832, HPA060916" Approved "Centriolar satellite" NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 1: K-562 - Erythropoiesis" "Centriolar satellite" "HPA047832: , HPA060916: " 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 6.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.1 0.7 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAF3IP2 "ACT1, C6orf2, C6orf4, C6orf5, C6orf6, CIKS, DKFZP586G0522" ENSG00000056972 "TRAF3 interacting protein 2" O43734 6 111555381-111606906 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Inflammatory response, Ubl conjugation pathway" Transferase "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 61.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-2197: 149.7" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA036352 Approved Approved "Golgi apparatus,Vesicles" NA NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 68: Epididymis - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 22: Epithelial cell types - Mixed function" "Golgi apparatus" Vesicles "HPA036352: AB_10672085" "unprognostic (1.94e-1)" "prognostic unfavorable (3.21e-4)" "unprognostic (1.79e-1)" "prognostic favorable (4.73e-5)" "unprognostic (2.81e-2)" "unprognostic (3.03e-2)" "unprognostic (1.01e-2)" "unprognostic (9.93e-2)" "unprognostic (2.10e-1)" "unprognostic (1.13e-2)" "unprognostic (2.64e-2)" "unprognostic (1.05e-2)" "prognostic unfavorable (5.16e-5)" "unprognostic (1.11e-1)" "unprognostic (4.88e-1)" "unprognostic (2.34e-2)" "unprognostic (1.31e-1)" 19.7 16.3 24.8 19.5 24.8 32.4 19.9 24.3 29.4 24.9 23.7 34.0 28.6 36.2 47.2 26.5 34.7 14.2 8.3 24.4 26.0 9.3 8.6 17.5 16.3 27.2 28.2 13.9 21.6 13.6 9.3 14.2 25.6 19.2 26.4 5.9 25.3 30.8 11.4 35.0 25.1 22.1 21.7 6.8 35.5 3.0 28.7 21.0 14.8 14.8 22.5 26.5 18.1 22.9 32.2 11.0 6.8 15.7 35.9 39.0 15.6 39.8 62.2 9.9 14.1 8.7 14.1 6.2 13.2 33.5 35.5 58.2 8.0 86.2 18.4 43.2 11.6 12.7 10.6 11.9 13.9 6.9 22.6 47.1 57.5 29.9 110.1 24.9 20.0 15.2 13.6 1.9 13.2 22.0 51.2 19.4 9.0 30.6 8.8 53.3 12.4 2.7 29.5 52.4 27.3 6.9 12.1 71.8 47.8 12.7 31.6 18.0 9.2 19.2 7.6 149.7 35.5 0.8 12.4 16.8 45.8 10.8 50.1 25.8 2.5 5.3 3.8 0.8 12.7 6.4 7.6 5.6 2.6 8.6 7.6 7.4 3.5 5.7 0.3 0.8 17.9 3.1 24.8 24.8 24.3 29.4 24.4 26.0 27.2 28.2 25.6 21.7 28.7 22.9 24.7 3.2 13.8 26.1 10.8 30.1 61.5 46.3 11.4 7.5 8.3 8.6 4.9 7.2 21.6 3.7 12.5 19.3 3.8 30.0 5.9 35.4 0.1 20.9 14.5 18.3 13.2 5.2 5.9 31.9 28.8 14.4 18.3 32.7 20.2 7.7 3.9 5.5 6.0 6.7 10.8 16.9 16.2 1.3 10.7 0.5 7.2 5.8 12.4 7.5 6.2 14.2 8.2 19.6 6.6 20.2 26.3 7.5 4.5 42.9 18.5 5.9 18.3 5.5 0.0 14.7 10.5 0.8 2.1 16.2 24.6 20.9 7.9 4.6 21.9 45.0 TRAM1L1 MGC26568 ENSG00000174599 "Translocation associated membrane protein 1 like 1" Q8N609 4 117083554-117085576 "Predicted membrane proteins, Transporters" "Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Bipolar cells: 6.8;Oligodendrocyte precursor cells: 8.0;Oligodendrocytes: 13.5;Spermatogonia: 6.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SH-SY5Y: 9.0;U-138 MG: 11.0;U-266/70: 9.1" "Low region specificity" "Detected in all" HPA044560 Uncertain Uncertain Mitochondria NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Mitochondria "HPA044560: AB_10796097" "unprognostic (9.06e-2)" "unprognostic (2.87e-2)" "unprognostic (4.40e-2)" "unprognostic (2.17e-3)" "unprognostic (9.77e-2)" "unprognostic (2.37e-2)" "unprognostic (5.97e-2)" "unprognostic (3.02e-1)" "unprognostic (1.14e-1)" "unprognostic (3.25e-1)" "unprognostic (1.09e-3)" "unprognostic (1.56e-2)" "unprognostic (2.76e-2)" "unprognostic (1.68e-2)" "unprognostic (1.62e-1)" "unprognostic (4.82e-3)" "unprognostic (1.23e-2)" 1.2 2.4 4.7 0.5 6.0 0.0 4.2 5.4 7.0 2.5 2.9 1.2 0.4 1.9 6.0 0.8 3.9 1.7 1.0 4.9 6.1 6.9 0.1 1.6 0.5 5.7 5.5 2.2 2.9 2.4 3.2 0.6 6.1 4.3 1.1 5.5 1.4 2.5 0.3 2.4 0.6 2.0 5.5 0.6 1.9 3.6 6.0 0.2 4.9 0.6 0.4 1.1 0.8 6.5 1.4 0.9 4.2 2.1 0.0 0.0 0.0 0.6 0.4 0.9 2.5 0.1 5.0 0.0 0.5 1.1 5.4 0.1 2.0 2.3 3.4 0.0 0.1 1.2 1.2 0.5 1.2 1.3 0.0 4.5 1.9 1.1 0.0 3.5 0.0 0.0 0.0 2.6 7.0 0.3 2.3 0.0 0.3 0.0 1.1 0.0 5.5 0.0 0.7 0.3 2.4 9.0 0.0 3.6 4.5 2.2 6.2 1.3 3.0 11.0 4.8 0.1 1.7 9.1 2.1 0.0 4.2 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 6.0 5.4 7.0 4.9 6.1 5.7 5.5 6.1 5.5 6.0 6.5 0.6 0.0 1.5 2.6 0.5 0.9 0.3 0.3 1.8 6.8 2.8 2.0 0.7 0.0 1.6 1.8 4.2 1.9 0.0 0.0 1.9 2.3 0.3 0.5 2.2 2.0 0.0 0.0 3.0 0.7 0.4 2.5 0.0 0.5 0.0 1.5 0.0 0.0 0.3 5.0 3.8 0.3 2.0 0.0 0.4 0.1 0.9 0.1 3.6 0.0 0.0 3.3 0.0 8.0 13.5 0.6 0.0 1.9 0.0 0.9 0.0 2.1 2.3 3.1 0.0 1.7 0.8 1.9 6.2 1.5 1.4 0.3 0.1 1.8 0.1 0.1 TRDV3 hDV103S1 ENSG00000256590 "T cell receptor delta variable 3" A0JD37 14 22469041-22469698 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity, Innate immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 18 "epididymis: 12.5;lymphoid tissue: 9.2" "Cell type enhanced" "Detected in some" "Fibroblasts: 1.8;NK-cells: 1.0;T-cells: 5.1" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enriched" "Detected in some" 10 "gdT-cell: 63.4" "Lineage enriched" "Detected in single" 303 "T-cells: 63.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 68: Epididymis - Unknown function" "Cluster 58: T-cells - T-cell receptor" "unprognostic (1.31e-2)" "unprognostic (6.56e-2)" "unprognostic (1.43e-1)" 0.4 0.0 0.3 0.1 0.5 0.0 0.0 0.3 0.4 0.0 0.1 0.5 0.0 0.0 12.5 0.0 0.0 0.3 0.0 0.5 0.3 0.0 0.0 0.1 1.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.5 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.2 2.1 0.1 0.0 0.5 9.2 0.0 0.0 0.9 0.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 63.4 0.0 0.0 0.2 0.7 0.7 0.0 0.1 1.0 6.1 0.0 0.1 0.0 0.0 2.7 1.8 0.3 0.5 0.3 0.4 0.5 0.3 0.4 0.3 0.3 0.2 0.5 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 TSPYL5 KIAA1750 ENSG00000180543 "TSPY like 5" Q86VY4 8 97273488-97277928 "Predicted intracellular proteins" "Growth regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 44.7" "Group enriched" "Detected in many" 8 "Early spermatids: 172.9;Late spermatids: 419.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "JURKAT: 34.9;K-562: 30.5;SCLC-21H: 60.8;SH-SY5Y: 47.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031347 Enhanced Approved "Golgi apparatus,Cytosol" No No "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 68: Epididymis - Unknown function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 31: Spermatids - Spermatogenesis" Cytosol "Golgi apparatus" "HPA031347: AB_10601454" "prognostic favorable (1.21e-4)" "unprognostic (5.13e-2)" "unprognostic (4.90e-2)" "unprognostic (1.65e-2)" "unprognostic (1.67e-1)" "unprognostic (3.06e-1)" "unprognostic (1.01e-1)" "unprognostic (1.65e-1)" "unprognostic (1.64e-1)" "unprognostic (3.46e-2)" "unprognostic (1.25e-2)" "unprognostic (1.44e-1)" "prognostic favorable (1.40e-5)" "unprognostic (3.01e-2)" "unprognostic (1.74e-1)" "unprognostic (8.31e-2)" "unprognostic (3.13e-1)" 6.0 8.6 11.1 4.3 12.6 1.2 12.1 6.7 11.4 11.4 0.8 9.7 1.8 15.2 15.5 4.5 12.4 6.6 12.4 10.0 17.6 10.0 1.7 7.2 6.2 10.3 8.6 25.2 8.7 8.1 11.8 4.3 12.5 15.3 3.2 11.3 9.7 18.3 12.9 4.1 4.1 14.3 7.6 7.3 8.4 44.7 14.4 7.4 8.3 10.5 7.3 9.7 4.6 8.7 0.0 15.9 0.0 0.0 0.4 0.4 0.1 12.4 0.0 12.2 7.9 0.0 0.5 0.0 16.8 14.8 0.0 4.4 0.0 0.0 11.8 0.0 0.0 0.0 0.0 0.0 23.8 0.0 0.0 19.4 0.0 17.2 0.0 0.0 0.2 34.9 30.5 0.0 0.5 23.4 0.0 0.0 0.0 0.0 0.2 23.1 0.0 0.1 10.2 0.1 60.8 47.1 0.0 4.1 0.0 8.2 0.0 1.9 0.0 0.0 26.2 0.1 0.0 14.4 23.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.5 0.3 0.2 0.1 0.0 0.2 0.0 0.5 0.2 0.0 11.1 12.6 6.7 11.4 10.0 17.6 10.3 8.6 12.5 7.6 14.4 8.7 7.5 6.4 4.1 0.0 5.5 2.3 4.5 0.7 6.8 12.5 9.9 8.8 16.3 2.8 2.1 9.2 20.9 0.2 2.6 0.0 5.9 5.8 172.9 6.4 13.7 9.8 2.4 3.4 0.0 3.5 0.1 12.1 10.2 2.6 0.0 19.2 6.4 0.8 6.3 8.4 0.0 0.3 2.0 5.0 5.9 419.0 24.5 4.6 7.2 0.0 2.2 13.1 0.0 0.0 0.0 3.7 0.0 21.1 0.8 7.8 0.0 1.4 4.1 12.2 6.6 12.4 9.3 35.5 31.0 5.6 1.6 0.1 1.3 9.9 0.3 4.1 UBE2E2 "FLJ25157, UbcH8" ENSG00000182247 "Ubiquitin conjugating enzyme E2 E2" Q96LR5 3 23203020-23591794 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 652.7;Inhibitory neurons: 399.4;Microglial cells: 402.8;Oligodendrocyte precursor cells: 513.2;Oligodendrocytes: 845.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "classical monocyte: 41.7;intermediate monocyte: 50.3;memory B-cell: 35.1;myeloid DC: 57.6;naive B-cell: 40.1;non-classical monocyte: 54.4;plasmacytoid DC: 74.0" "Group enriched" "Detected in all" 6 "B-cells: 40.1;dendritic cells: 74.0;monocytes: 54.4" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003303, HPA028872, HPA030445, CAB073417" Approved Approved Nucleoplasm No No "Cluster 23: Antigen presenting cells - Antigen presentation" "Cluster 68: Epididymis - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Nucleoplasm "CAB073417: , HPA003303: AB_1858521, HPA028872: AB_10966277, HPA030445: AB_10669599" "unprognostic (2.20e-1)" "unprognostic (2.30e-1)" "unprognostic (1.52e-2)" "unprognostic (3.68e-3)" "unprognostic (3.74e-2)" "unprognostic (1.70e-1)" "unprognostic (9.19e-3)" "unprognostic (3.11e-3)" "unprognostic (1.32e-1)" "unprognostic (1.20e-1)" "unprognostic (4.20e-1)" "unprognostic (4.59e-2)" "unprognostic (1.60e-1)" "unprognostic (1.44e-2)" "unprognostic (2.68e-2)" "unprognostic (3.11e-2)" "unprognostic (6.11e-3)" 23.9 8.9 14.3 10.6 17.2 7.0 18.3 14.5 28.1 22.9 9.4 18.2 4.6 18.2 25.7 17.4 13.7 15.4 19.9 20.2 16.8 17.1 13.4 17.8 16.4 13.2 12.8 16.2 7.0 13.5 12.0 7.4 14.4 14.7 4.8 16.6 11.9 13.3 16.0 16.8 8.3 18.9 12.6 14.3 11.6 15.1 13.7 18.1 13.9 12.4 12.6 16.2 17.8 28.4 36.7 12.9 33.3 0.6 29.0 32.1 30.3 22.6 38.2 20.8 29.0 3.6 29.2 31.7 15.1 19.9 28.5 3.5 24.5 35.2 26.5 0.2 24.6 0.0 15.3 4.3 20.8 0.0 24.5 25.6 36.2 30.0 50.0 21.1 20.2 24.5 1.9 32.4 19.0 5.9 16.8 7.2 23.7 20.7 18.6 34.9 13.0 36.8 20.4 0.8 8.5 17.7 24.8 14.4 0.4 23.8 30.7 20.9 17.8 20.4 29.1 13.8 25.7 31.2 10.9 49.4 19.2 14.2 5.8 0.1 41.7 0.2 0.7 50.3 0.9 35.1 1.4 0.6 57.6 40.1 9.1 3.5 1.1 2.5 54.4 74.0 0.7 15.7 14.3 17.2 14.5 28.1 20.2 16.8 13.2 12.8 14.4 12.6 13.7 28.4 13.3 22.4 9.8 159.3 48.4 25.6 12.2 77.2 34.7 24.0 31.3 27.1 38.2 15.7 28.1 31.3 16.7 34.8 24.2 0.9 68.4 12.0 24.2 9.6 30.8 24.6 1.8 8.2 652.7 29.2 43.1 42.1 5.6 18.8 0.0 38.5 14.6 41.4 47.7 32.0 399.4 1.1 67.1 47.3 73.9 16.0 39.4 49.2 78.2 402.8 40.5 14.8 1.0 513.2 845.2 13.9 1.2 53.0 32.8 64.6 0.0 152.7 17.3 3.6 32.9 14.9 67.3 36.3 91.0 44.1 42.3 38.6 4.6 15.1 0.7 8.6 UFC1 HSPC155 ENSG00000143222 "Ubiquitin-fold modifier conjugating enzyme 1" Q9Y3C8 1 161152776-161158856 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Respiratory ciliated cells: 703.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027481, HPA028722" Enhanced Approved "Nuclear speckles,Cytosol" NA NA 62000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 68: Epididymis - Unknown function" "Cluster 43: THP-1 - Innate immune response" "Cluster 49: Ciliated cells - Cilium organization" "Nuclear speckles" Cytosol "HPA027481: AB_10599850, HPA028722: AB_10601674" "unprognostic (2.16e-1)" "unprognostic (6.17e-2)" "unprognostic (1.83e-1)" "unprognostic (8.25e-3)" "unprognostic (1.02e-1)" "unprognostic (1.18e-1)" "unprognostic (1.29e-3)" "unprognostic (2.15e-1)" "unprognostic (1.62e-2)" "unprognostic (3.40e-2)" "unprognostic (5.04e-2)" "unprognostic (1.86e-1)" "prognostic unfavorable (2.62e-6)" "unprognostic (3.49e-1)" "unprognostic (1.87e-1)" "unprognostic (2.13e-1)" "unprognostic (6.22e-2)" 85.3 112.1 135.3 76.1 139.3 134.5 134.0 137.6 167.5 100.4 138.9 114.5 112.6 91.7 170.6 100.2 209.3 103.2 111.9 135.4 149.2 129.5 115.4 87.8 107.6 136.4 139.0 140.7 164.7 148.0 102.4 92.9 143.0 106.5 141.9 85.1 126.0 112.2 101.0 110.5 103.1 108.4 139.6 79.1 116.3 56.3 137.6 110.4 108.9 108.3 128.6 125.9 76.8 142.3 140.7 119.8 107.8 129.9 137.5 226.7 223.5 124.7 154.0 122.7 111.8 165.0 268.6 183.2 232.8 180.7 77.3 65.7 89.1 127.2 96.1 154.4 238.6 109.4 163.0 200.9 139.8 233.4 271.9 190.4 202.6 152.5 104.6 207.4 227.9 189.4 183.0 123.8 159.8 161.3 126.1 234.9 198.9 387.9 128.5 152.6 80.8 258.6 248.4 158.2 112.9 196.2 108.1 324.2 163.8 176.8 148.2 482.1 165.6 90.5 92.2 90.7 196.1 233.3 322.2 177.5 140.7 164.8 119.7 137.3 156.7 104.5 174.7 164.1 212.8 209.3 185.0 188.2 192.4 164.1 161.9 175.4 28.4 208.3 121.6 206.4 274.4 268.1 135.3 139.3 137.6 167.5 135.4 149.2 136.4 139.0 143.0 139.6 137.6 142.3 107.0 70.5 85.3 18.3 151.9 99.8 173.3 244.6 106.4 57.4 174.2 177.5 117.6 147.3 171.6 104.8 41.7 253.8 170.8 150.8 440.3 224.2 131.0 421.2 96.6 123.3 204.5 124.7 8.7 380.8 386.9 99.2 111.6 113.2 119.7 143.1 116.7 106.2 244.7 47.1 7.7 240.0 205.4 150.7 138.5 392.3 105.0 132.0 131.6 9.4 229.3 161.8 195.7 11.1 13.3 265.5 189.1 91.0 182.6 148.0 243.5 380.9 703.0 72.0 65.7 86.3 106.7 96.6 42.4 125.2 120.9 431.9 155.1 124.4 193.7 218.6 UNC50 "GMH1, UNCL, URP" ENSG00000115446 "Unc-50 inner nuclear membrane RNA binding protein" Q53HI1 2 98608579-98618515 "Predicted membrane proteins" "Protein transport, Transport" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 215.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027009 Approved NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 68: Epididymis - Unknown function" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "HPA027009: AB_1858620" "prognostic unfavorable (4.79e-4)" "unprognostic (3.28e-2)" "unprognostic (1.23e-1)" "unprognostic (1.74e-2)" "unprognostic (5.54e-2)" "unprognostic (1.86e-2)" "prognostic unfavorable (4.89e-5)" "unprognostic (1.34e-1)" "unprognostic (2.59e-1)" "unprognostic (5.31e-2)" "unprognostic (6.31e-2)" "unprognostic (1.58e-1)" "unprognostic (1.43e-1)" "unprognostic (2.14e-1)" "unprognostic (4.38e-1)" "unprognostic (7.12e-3)" "unprognostic (4.82e-3)" 36.6 49.1 46.3 34.2 48.2 36.8 45.8 48.8 57.3 38.1 53.6 35.0 37.9 46.3 69.2 30.9 42.7 36.2 38.7 46.2 48.3 52.5 46.9 38.6 41.4 48.5 46.6 44.2 42.0 82.4 41.4 52.2 49.1 41.3 43.2 60.0 56.0 45.4 31.6 39.9 34.4 38.7 49.0 39.3 45.5 48.9 47.2 36.6 64.1 35.9 42.6 37.8 30.5 54.3 55.2 35.6 65.2 44.3 95.7 82.6 73.0 51.2 71.8 61.9 54.2 54.5 64.0 16.6 75.2 44.1 94.0 52.0 45.9 41.5 50.9 56.4 46.2 37.5 47.3 89.4 103.0 71.7 56.7 54.6 92.5 33.1 60.4 71.5 55.1 43.3 61.2 50.2 63.5 39.2 31.7 80.3 49.6 46.1 41.7 20.1 47.3 58.8 68.9 48.6 24.2 35.6 35.9 47.3 86.5 75.8 40.7 91.9 42.7 67.4 41.3 34.5 35.0 76.1 63.2 44.2 63.6 51.7 60.1 61.6 54.3 66.7 50.6 54.9 43.9 52.8 42.2 47.9 54.9 48.1 46.2 52.9 45.3 58.5 51.4 51.3 37.4 44.2 46.3 48.2 48.8 57.3 46.2 48.3 48.5 46.6 49.1 49.0 47.2 54.3 45.3 25.6 31.0 13.7 35.7 47.2 51.2 139.4 42.7 36.7 46.7 40.8 39.5 38.6 85.8 35.0 16.7 118.6 41.2 27.4 33.2 52.3 47.7 38.3 35.3 48.3 21.6 19.1 21.2 53.2 77.1 58.9 19.4 30.7 27.3 23.7 47.2 33.9 73.2 33.7 24.1 34.1 85.5 31.3 33.3 29.9 54.7 33.0 44.4 19.7 41.7 84.6 48.4 19.1 25.8 40.7 33.0 74.9 51.0 75.7 29.0 46.6 73.8 49.8 46.0 45.0 58.9 215.1 58.7 34.6 49.7 152.6 29.2 39.1 30.1 44.6 USP40 FLJ10785 ENSG00000085982 "Ubiquitin specific peptidase 40" Q9NVE5 2 233475520-233566782 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 79.3;Oligodendrocytes: 127.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005821 Uncertain Approved "Vesicles,Focal adhesion sites" NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 68: Epididymis - Unknown function" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 64: Astrocytes - Nervous system maintenance" Vesicles "Focal adhesion sites" "HPA005821: AB_1080526" "unprognostic (2.19e-1)" "unprognostic (1.04e-1)" "unprognostic (1.13e-1)" "unprognostic (1.33e-1)" "unprognostic (3.70e-1)" "unprognostic (2.15e-1)" "unprognostic (5.30e-2)" "unprognostic (2.25e-1)" "unprognostic (1.80e-2)" "unprognostic (1.18e-1)" "unprognostic (1.96e-1)" "unprognostic (1.26e-1)" "unprognostic (2.22e-1)" "unprognostic (1.45e-1)" "unprognostic (4.09e-2)" "unprognostic (1.90e-2)" "unprognostic (2.53e-2)" 11.8 12.0 10.4 7.5 17.0 3.4 13.9 12.8 11.4 10.0 16.5 9.4 10.5 10.6 24.0 10.4 11.5 11.6 8.2 10.2 12.0 14.2 13.2 12.5 7.2 19.4 14.2 15.9 14.0 16.8 8.5 12.4 19.0 13.5 9.5 14.2 12.9 10.4 9.6 19.7 10.1 8.5 12.3 9.9 13.1 14.7 16.2 10.1 16.4 7.6 7.8 9.6 7.5 25.4 17.3 19.9 17.6 12.0 25.2 23.0 15.7 16.4 12.4 14.7 16.0 14.3 20.2 0.4 4.7 26.4 38.6 30.3 13.3 29.7 20.6 0.0 9.0 13.3 17.4 24.3 22.3 5.8 8.9 22.2 21.1 22.2 30.9 26.2 17.3 8.1 22.0 3.2 21.4 14.0 6.2 8.5 7.9 17.8 16.0 0.0 36.3 8.1 17.9 27.6 9.6 10.3 13.5 13.5 16.9 12.9 15.4 12.9 17.3 20.9 13.1 8.9 20.6 6.0 4.9 0.8 27.1 10.2 18.6 0.0 1.0 0.0 0.5 1.1 0.2 0.4 0.5 0.4 1.5 0.7 0.7 0.7 0.1 0.5 0.9 1.9 0.8 0.5 10.4 17.0 12.8 11.4 10.2 12.0 19.4 14.2 19.0 12.3 16.2 25.4 11.8 32.1 35.5 79.3 7.9 7.4 9.1 13.6 15.4 18.1 17.0 14.7 10.7 10.0 19.9 16.5 25.0 21.2 6.7 9.9 7.9 9.4 8.4 19.8 18.3 11.1 15.0 5.7 25.9 12.6 10.6 11.9 21.4 21.3 9.5 23.4 12.8 25.4 8.2 23.5 38.2 10.9 4.1 11.6 3.6 10.7 6.8 9.1 3.6 40.3 5.9 11.9 4.1 48.2 127.7 10.5 12.6 8.2 10.9 12.9 13.9 14.6 21.0 19.4 13.1 17.5 10.6 30.2 20.9 17.2 10.5 15.7 5.5 21.1 12.1 10.0 USP51 ENSG00000247746 "Ubiquitin specific peptidase 51" Q70EK9 X 55484616-55489202 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "epididymis: 51.7" "Cell type enhanced" "Detected in many" "Bipolar cells: 23.7;Muller glia cells: 32.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SuSa: 7.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA001942 Uncertain Approved "Nucleoli fibrillar center,Cytosol" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 68: Epididymis - Unknown function" "Cluster 12: NES - Nervous system development" "Cluster 5: Muller glia cells - Visual perception" Cytosol "Nucleoli fibrillar center" "HPA001942: AB_1080536" "unprognostic (1.19e-2)" "unprognostic (4.65e-2)" "unprognostic (3.67e-2)" "unprognostic (1.02e-3)" "unprognostic (8.08e-2)" "unprognostic (3.26e-1)" "unprognostic (3.17e-3)" "unprognostic (2.07e-3)" "unprognostic (5.69e-2)" "prognostic favorable (5.70e-4)" "unprognostic (1.01e-3)" "unprognostic (1.27e-1)" "prognostic favorable (2.63e-5)" "unprognostic (2.81e-3)" "unprognostic (5.92e-2)" "unprognostic (5.85e-2)" "unprognostic (1.63e-1)" 1.4 3.1 2.5 0.9 2.7 0.5 1.7 2.8 2.8 1.9 4.2 0.8 0.4 3.1 51.7 0.6 5.5 0.8 2.1 2.2 4.2 3.7 1.2 1.5 1.1 2.2 3.1 6.5 1.1 5.6 1.4 2.4 2.4 2.4 0.8 3.1 0.8 2.5 0.4 1.1 0.7 1.9 2.5 1.8 0.8 2.3 3.8 2.4 5.3 1.1 1.2 0.9 0.7 2.5 0.0 0.6 3.9 1.1 1.9 1.0 0.0 0.6 0.3 0.7 0.9 1.2 0.5 0.0 4.6 0.8 0.8 0.2 1.0 0.4 1.2 1.3 0.0 1.0 0.2 0.0 0.8 2.5 0.2 3.9 0.0 0.4 0.0 0.3 0.2 3.0 3.1 3.0 0.6 2.6 2.4 1.3 4.8 0.0 0.2 3.4 0.7 1.5 0.9 0.1 0.0 0.7 1.1 0.1 3.7 7.0 0.9 1.3 0.2 1.5 2.1 0.4 0.1 4.7 2.0 0.9 1.0 1.4 1.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.5 2.7 2.8 2.8 2.2 4.2 2.2 3.1 2.4 2.5 3.8 2.5 5.1 3.2 5.5 3.3 2.6 0.9 2.2 0.9 2.2 23.7 3.8 7.4 6.9 1.5 2.0 3.7 6.2 4.3 1.2 0.2 9.8 1.5 0.3 9.0 9.2 6.0 3.6 5.0 2.7 0.0 2.2 8.1 0.0 2.1 1.3 7.9 6.4 0.7 7.6 6.7 5.0 0.5 0.0 5.6 2.5 1.0 4.1 4.7 5.4 1.9 0.3 32.9 3.1 3.5 3.7 0.2 0.3 8.2 1.0 1.0 0.0 13.1 11.2 16.4 0.0 7.1 5.0 11.4 12.5 1.0 0.4 2.7 3.1 13.0 0.4 0.5 VRTN "C14orf115, FLJ10811, vertnin" ENSG00000133980 "Vertebrae development associated" Q9H8Y1 14 74303069-74360008 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 1.5;testis: 1.7" "Cell type enhanced" "Detected in single" "Spermatocytes: 2.7" "Cancer enriched" "Detected in single" 40 "testis cancer: 15.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "NTERA-2: 50.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA001460 Uncertain Approved Nucleoplasm NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 5: NTERA-2 - Transcription" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" Nucleoplasm "HPA001460: AB_1078318" "unprognostic (1.20e-1)" "unprognostic (4.31e-2)" "unprognostic (1.37e-1)" "unprognostic (5.98e-2)" "unprognostic (1.35e-1)" "unprognostic (3.78e-2)" "unprognostic (1.66e-1)" "unprognostic (1.77e-1)" 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.2 0.0 1.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.1 1.7 0.1 0.0 0.0 0.1 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 50.5 2.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 2.7 0.9 0.0 0.0 0.0 0.0 0.0 0.4 0.0 VWDE FLJ14712 ENSG00000146530 "Von Willebrand factor D and EGF domains" Q8N2E2 7 12330885-12403941 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 4.3;salivary gland: 3.3;thyroid gland: 3.1" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 8.8;Excitatory neurons: 11.8;Granulosa cells: 5.4;Inhibitory neurons: 11.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HeLa: 5.0;K-562: 13.0;NTERA-2: 4.8;SCLC-21H: 7.0" "Low region specificity" "Detected in many" "HPA026619, HPA036044, HPA036045" Uncertain Approved Cytosol "Secreted - unknown location" NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 1: K-562 - Erythropoiesis" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Cytosol "HPA026619: AB_2671920, HPA036044: AB_2674916, HPA036045: " "unprognostic (6.39e-2)" "unprognostic (1.65e-3)" "unprognostic (5.36e-3)" "unprognostic (1.78e-4)" "unprognostic (1.39e-2)" "unprognostic (4.19e-3)" "unprognostic (2.38e-1)" "unprognostic (1.85e-1)" "unprognostic (1.78e-1)" "unprognostic (6.25e-2)" "unprognostic (1.68e-1)" "unprognostic (6.72e-2)" "unprognostic (1.84e-1)" "unprognostic (2.11e-3)" "unprognostic (1.58e-1)" "unprognostic (1.10e-1)" "unprognostic (2.73e-1)" 0.0 0.3 0.5 0.1 0.8 2.3 1.6 0.0 0.5 0.1 0.0 0.3 0.1 0.4 4.3 0.1 1.1 0.4 2.0 0.4 0.3 0.2 0.1 0.2 0.1 0.4 0.4 0.0 0.0 0.3 0.4 0.1 0.3 1.1 0.1 0.0 3.3 1.6 0.0 0.4 0.1 0.1 0.5 0.1 0.7 0.2 0.3 0.1 3.1 0.0 0.0 0.4 0.0 0.1 0.0 0.8 0.0 1.2 0.0 0.2 2.4 0.0 1.5 0.5 0.7 0.3 2.4 0.1 0.0 0.0 0.9 0.7 1.7 1.6 1.1 2.7 2.4 3.4 5.0 0.0 0.0 1.9 1.5 0.1 0.2 0.0 1.1 2.4 1.0 1.3 13.0 0.0 0.0 1.6 0.0 0.0 4.8 0.0 0.8 0.0 0.0 1.1 0.4 1.2 7.0 1.5 0.0 1.4 0.0 1.7 0.0 0.8 0.1 0.0 0.9 0.0 1.5 2.2 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.8 0.0 0.5 0.4 0.3 0.4 0.4 0.3 0.5 0.3 0.1 0.1 0.0 1.5 0.3 0.0 0.3 2.1 0.9 2.8 0.0 1.6 1.0 8.8 0.0 1.2 0.0 0.0 0.3 0.0 0.2 0.0 0.1 1.2 0.7 0.2 0.2 0.0 3.0 11.8 0.0 0.5 1.1 0.0 1.8 0.0 5.4 0.0 0.0 0.1 0.0 11.6 0.1 2.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.4 1.2 0.0 0.0 2.9 0.0 0.0 1.5 0.0 0.0 0.0 0.2 0.4 0.4 0.7 0.1 0.1 0.7 0.4 0.5 1.8 WDR45 "JM5, NBIA5, WDRX1, WIPI4" ENSG00000196998 "WD repeat domain 45" Q9Y484 X 49074433-49101170 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Autophagy "Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027562 Uncertain NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 68: Epididymis - Unknown function" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "HPA027562: AB_10610565" "unprognostic (1.39e-1)" "prognostic favorable (1.21e-4)" "unprognostic (1.82e-2)" "unprognostic (1.33e-1)" "unprognostic (2.32e-1)" "prognostic favorable (1.61e-4)" "unprognostic (4.30e-2)" "unprognostic (6.66e-3)" "unprognostic (7.12e-2)" "unprognostic (3.57e-1)" "unprognostic (3.22e-2)" "unprognostic (1.77e-1)" "unprognostic (5.06e-3)" "unprognostic (2.85e-1)" "unprognostic (5.27e-1)" "unprognostic (3.60e-2)" "unprognostic (1.11e-3)" 58.0 74.7 53.3 22.4 59.1 43.2 54.3 56.1 57.8 54.8 59.4 52.3 27.6 51.5 208.4 38.5 45.7 29.7 79.6 53.6 55.3 61.8 68.5 46.6 25.7 63.8 61.1 49.0 58.6 54.8 43.4 21.9 58.1 48.9 19.6 21.2 50.8 34.4 115.9 48.5 38.2 24.7 57.8 45.0 59.0 10.0 61.0 32.3 52.9 87.5 23.2 45.9 43.0 52.7 36.3 41.9 23.4 23.7 50.1 63.7 45.7 39.0 80.6 30.1 42.1 22.1 51.5 25.1 21.6 77.1 38.6 30.8 35.3 31.6 21.6 27.6 61.0 15.6 79.5 33.5 114.2 12.1 34.5 57.2 54.9 49.4 52.1 47.8 30.7 23.8 33.3 42.8 40.3 40.9 25.6 31.0 23.8 15.9 36.3 20.4 34.8 85.7 53.2 32.8 31.3 46.8 49.2 37.5 120.5 29.9 23.9 43.4 41.8 32.8 29.4 65.6 16.6 66.2 48.9 18.1 60.1 19.5 24.1 125.4 89.0 82.0 54.5 81.6 54.3 49.1 41.0 51.4 67.1 48.4 32.0 36.5 88.9 83.7 97.9 68.0 65.3 72.0 53.3 59.1 56.1 57.8 53.6 55.3 63.8 61.1 58.1 57.8 61.0 52.7 36.5 32.1 34.6 15.0 34.0 46.5 54.2 49.3 36.5 18.8 43.7 41.8 35.8 35.8 42.6 35.0 12.5 30.6 56.5 37.9 56.7 71.3 1.3 22.5 35.0 30.5 28.8 71.8 8.9 98.5 56.8 50.8 43.3 26.1 27.3 27.5 35.0 49.7 42.1 26.9 9.3 32.2 10.2 38.8 44.1 3.8 40.4 47.1 35.6 6.5 74.8 38.7 68.0 4.5 11.0 109.6 44.0 32.4 86.5 67.9 68.5 131.2 23.4 24.0 19.7 42.4 44.5 2.6 5.0 24.8 47.3 62.1 33.4 48.3 28.7 73.4 WDR61 REC14 ENSG00000140395 "WD repeat domain 61" Q9GZS3 15 78277835-78299703 "Predicted intracellular proteins" "Transcription, Transcription regulation, Wnt signaling pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039932, HPA040065" Enhanced Enhanced Nucleoplasm,Cytosol NA NA 28000 "Cluster 28: Myeloid DCs - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 10: Non-specific - Unknown function" "Nucleoplasm, Cytosol" "HPA039932: AB_10796336, HPA040065: AB_10793926" "unprognostic (1.08e-1)" "unprognostic (1.85e-2)" "unprognostic (8.91e-2)" "unprognostic (1.07e-1)" "unprognostic (2.09e-1)" "unprognostic (3.36e-1)" "unprognostic (2.44e-1)" "unprognostic (1.60e-1)" "unprognostic (3.05e-1)" "unprognostic (2.74e-3)" "unprognostic (4.21e-1)" "unprognostic (5.72e-2)" "prognostic favorable (2.03e-10)" "unprognostic (1.04e-1)" "unprognostic (3.13e-1)" "unprognostic (3.18e-1)" "unprognostic (1.09e-2)" 38.8 52.7 34.5 29.6 36.5 61.5 59.9 50.4 63.0 40.8 31.1 39.5 36.2 34.9 115.7 40.1 46.6 28.6 41.0 40.8 40.4 60.8 50.9 34.6 37.4 41.5 41.2 34.6 41.3 55.6 49.9 35.5 40.0 46.0 43.5 49.4 39.5 37.4 45.4 52.1 30.4 41.4 38.2 29.9 33.5 49.0 37.0 48.5 56.8 38.2 46.0 41.4 32.4 61.5 39.3 92.4 74.3 77.4 74.1 61.6 56.1 60.9 68.6 76.6 73.6 87.9 67.9 80.7 72.6 69.8 119.2 78.2 165.8 71.5 58.3 53.9 123.8 66.2 79.9 84.6 62.6 99.2 63.3 52.8 50.5 30.8 24.0 52.7 82.7 80.0 113.1 78.8 92.5 116.6 82.3 81.6 54.3 98.5 76.2 74.7 59.7 89.1 81.3 112.3 103.7 56.2 88.0 90.9 323.7 76.9 56.0 124.2 58.2 53.7 66.0 38.2 103.6 69.3 113.7 113.0 80.5 153.3 112.6 39.0 91.2 33.6 59.6 100.0 65.0 66.4 59.7 62.1 134.2 53.5 62.2 68.6 7.7 72.4 86.0 71.6 72.7 89.1 34.5 36.5 50.4 63.0 40.8 40.4 41.5 41.2 40.0 38.2 37.0 61.5 38.7 35.3 44.7 20.5 26.7 49.1 61.5 105.0 31.9 57.2 44.8 47.2 25.8 28.6 57.5 38.6 47.9 106.1 29.2 23.2 125.2 62.5 32.2 41.5 38.6 42.2 23.4 37.6 34.6 55.6 78.1 51.0 20.4 29.1 47.5 49.1 40.0 47.0 66.1 43.7 36.8 38.0 93.6 37.0 47.2 12.4 50.1 37.0 58.7 12.2 61.1 81.9 42.2 17.1 33.1 41.0 28.5 50.8 36.4 51.6 35.4 132.7 70.1 50.7 6.6 37.8 90.2 122.4 60.2 38.3 58.7 92.4 31.7 59.4 52.4 57.7 WDR83OS "Asterix, C19orf56, PTD008" ENSG00000105583 "WD repeat domain 83 opposite strand" Q9Y284 19 12668073-12669415 "Predicted membrane proteins, Transporters" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065685 Approved Approved "Endoplasmic reticulum" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 68: Epididymis - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Basic cellular processes" "Endoplasmic reticulum" "HPA065685: AB_2685531" "unprognostic (1.73e-1)" "unprognostic (5.37e-3)" "unprognostic (1.03e-1)" "unprognostic (4.86e-2)" "unprognostic (1.27e-1)" "unprognostic (3.29e-2)" "unprognostic (7.47e-2)" "prognostic favorable (2.09e-4)" "unprognostic (1.71e-1)" "prognostic favorable (8.84e-4)" "unprognostic (4.17e-3)" "unprognostic (1.09e-1)" "unprognostic (7.87e-3)" "unprognostic (2.67e-1)" "unprognostic (1.02e-1)" "unprognostic (1.02e-1)" "unprognostic (8.34e-2)" 152.2 219.2 204.0 80.1 213.4 203.3 156.9 213.2 226.5 164.0 199.2 138.5 103.9 146.9 276.1 174.0 223.2 138.0 206.8 198.6 212.5 194.9 189.2 133.3 128.7 209.9 205.9 226.2 210.0 204.7 164.8 119.7 211.1 160.6 151.4 50.2 180.9 135.9 226.7 175.1 128.5 169.6 216.9 146.5 164.7 80.4 210.8 129.8 190.1 234.1 174.2 164.4 144.8 223.7 190.9 204.4 223.1 252.8 338.2 267.0 96.4 135.3 230.3 211.6 181.7 170.0 161.1 86.2 310.0 390.4 143.5 150.9 242.7 255.9 175.2 180.9 333.0 107.4 170.3 259.6 262.1 183.5 148.5 287.1 343.2 208.0 243.7 309.9 265.2 161.2 196.2 196.3 253.5 661.5 136.8 399.3 187.7 254.4 584.9 110.0 117.7 310.1 241.7 217.2 182.3 278.6 155.2 162.4 193.5 148.2 197.6 295.1 156.7 289.8 78.2 317.2 205.8 342.4 428.4 126.5 245.4 313.2 189.0 612.8 502.8 492.3 329.2 469.3 312.0 445.2 308.6 336.5 466.7 394.4 280.0 305.8 485.8 451.4 503.7 319.2 396.0 635.4 204.0 213.4 213.2 226.5 198.6 212.5 209.9 205.9 211.1 216.9 210.8 223.7 198.5 80.1 54.6 11.8 156.8 171.7 193.7 391.7 272.0 42.3 310.7 424.2 129.4 168.7 204.5 342.1 27.1 435.7 153.8 233.0 401.1 255.5 7.9 128.6 184.0 185.7 195.3 126.4 10.5 255.8 333.8 205.2 162.6 162.7 147.9 239.7 183.1 314.3 287.5 50.5 10.6 282.6 301.1 212.5 230.2 22.7 170.6 209.3 297.1 13.1 254.5 264.8 179.2 13.0 39.4 243.4 295.7 144.8 256.0 230.9 398.1 586.3 103.6 55.7 98.6 140.9 187.6 87.3 98.4 353.6 221.3 405.1 172.2 279.8 262.4 241.1 WFDC10B WAP12 ENSG00000182931 "WAP four-disulfide core domain 10B" Q8IUB3 20 45684653-45705019 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 27.3;retina: 11.7" "Cell type enhanced" "Detected in some" "Astrocytes: 3.6;Early spermatids: 5.5;Late spermatids: 10.1;Microglial cells: 3.7;Rod photoreceptor cells: 9.6;Spermatocytes: 4.8" "Cancer enhanced" "Detected in some" "lung cancer: 1.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "PC-3: 1.9" "Secreted in male reproductive system" NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 46: Photoreceptor cells - Phototransduction" "unprognostic (1.14e-1)" "unprognostic (2.31e-1)" "unprognostic (1.37e-4)" "unprognostic (1.60e-1)" "unprognostic (2.69e-1)" "unprognostic (4.81e-2)" "unprognostic (4.30e-3)" "unprognostic (5.64e-2)" "unprognostic (1.14e-2)" "unprognostic (3.36e-1)" "unprognostic (0.00e+0)" "unprognostic (1.39e-1)" "unprognostic (3.15e-2)" "unprognostic (2.21e-2)" "unprognostic (3.17e-1)" 0.2 0.0 0.2 0.0 0.2 0.0 0.3 0.2 0.6 0.4 0.2 0.6 0.0 0.3 27.3 0.1 0.4 0.2 0.1 0.2 0.1 0.1 0.0 0.7 0.0 0.5 0.6 0.1 0.0 0.0 0.1 0.4 0.3 0.7 0.5 11.7 0.0 0.2 0.0 1.2 0.2 0.4 0.4 0.0 0.3 4.3 0.2 0.2 0.0 0.0 0.0 5.9 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.7 0.9 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.6 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.2 0.6 1.9 0.0 0.1 0.0 0.2 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.6 0.2 0.1 0.5 0.6 0.3 0.4 0.2 0.3 0.0 0.0 0.5 3.6 0.0 0.0 0.1 0.4 0.0 0.2 0.3 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.5 0.3 0.0 0.1 0.0 0.0 1.3 0.4 0.1 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 1.3 0.4 2.0 0.0 0.0 10.1 0.0 0.0 0.0 3.7 0.0 0.9 0.0 1.5 0.9 1.2 0.1 0.0 0.0 0.4 0.3 0.0 0.0 9.6 0.0 0.0 0.1 4.8 0.3 0.0 0.0 0.1 0.0 0.1 0.1 0.7 WFDC11 WAP11 ENSG00000180083 "WAP four-disulfide core domain 11" Q8NEX6 20 45648563-45670270 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 18 "epididymis: 93.8" "Cell type enriched" "Detected in some" 12 "Early spermatids: 55.8" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Immune cell enriched" "Detected in single" 6 "basophil: 2.3" "Lineage enriched" "Detected in single" 6 "granulocytes: 2.3" "Group enriched" "Detected in some" 5 "HeLa: 8.7;RPMI-8226: 5.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Secreted in male reproductive system" NA NA "Cluster 34: Basophils - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 20: HeLa - Mitochondria" "Cluster 29: Early spermatids - Spermatogenesis" 0.0 0.4 0.8 0.2 0.5 2.9 0.3 2.9 2.4 0.1 0.8 0.2 0.0 0.2 93.8 0.2 0.2 0.5 0.1 0.4 0.5 0.2 0.3 0.1 0.2 0.5 0.1 0.2 0.2 0.1 0.0 0.2 0.6 0.4 0.0 2.0 0.6 0.1 0.1 1.5 0.2 0.1 0.0 0.2 0.3 5.0 0.4 0.0 0.3 0.0 0.1 0.2 0.0 3.0 0.1 0.7 0.0 0.1 0.4 0.5 0.8 0.7 0.1 0.0 0.0 0.5 0.2 0.4 0.2 0.0 0.1 0.4 0.0 0.1 0.0 0.0 0.5 0.8 8.7 0.5 0.0 0.4 0.4 0.2 0.0 0.0 0.1 0.1 0.0 0.3 0.4 0.1 0.0 0.1 0.3 0.7 0.7 0.2 0.4 0.1 0.3 5.3 0.0 0.2 0.1 0.0 0.0 0.2 0.0 0.6 0.0 0.7 0.0 0.1 0.4 0.2 0.1 0.3 0.3 0.0 0.0 1.4 0.2 2.3 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.2 0.1 0.2 0.3 0.3 0.0 0.2 0.0 0.0 0.8 0.5 2.9 2.4 0.4 0.5 0.5 0.1 0.6 0.0 0.4 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 55.8 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 WFDC6 "C20orf171, dJ461P17.11, WAP6" ENSG00000243543 "WAP four-disulfide core domain 6" Q9BQY6 20 45534196-45539482 "Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "epididymis: 250.9" "Cell type enriched" "Detected in some" 4 "Respiratory ciliated cells: 34.2" "Cancer enhanced" "Detected in some" "endometrial cancer: 0.9;testis cancer: 0.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "U-87 MG: 2.6" "Secreted in male reproductive system" NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 49: Ciliated cells - Cilium organization" "unprognostic (3.68e-3)" "unprognostic (2.21e-3)" "unprognostic (1.26e-2)" "unprognostic (8.74e-2)" "unprognostic (2.91e-2)" 0.2 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.4 1.0 0.0 0.0 0.0 0.2 250.9 0.1 7.7 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 1.9 0.0 0.5 0.1 0.0 0.0 0.0 0.0 37.6 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 6.8 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 34.2 0.0 0.0 0.0 0.2 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 WLS "C1orf139, EVI, FLJ23091, GPR177, mig-14, MRP" ENSG00000116729 "Wnt ligand secretion mediator" Q5T9L3 1 68098473-68233120 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Glandular and luminal cells: 235.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 8 "classical monocyte: 22.1;neutrophil: 61.7" "Group enriched" "Detected in many" 46 "granulocytes: 61.7;monocytes: 22.1" "Cell line enhanced" "Detected in many" "AF22: 392.1;ASC TERT1: 294.1;SuSa: 357.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069520 Approved Supported "Endoplasmic reticulum,Cytosol" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 68: Epididymis - Unknown function" "Cluster 12: NES - Nervous system development" "Cluster 44: Endometrium - Transcription" "Endoplasmic reticulum, Cytosol" "HPA069520: AB_2686144" "prognostic favorable (4.03e-4)" "unprognostic (8.73e-2)" "unprognostic (2.51e-2)" "unprognostic (8.13e-3)" "unprognostic (5.93e-2)" "unprognostic (4.51e-3)" "unprognostic (5.41e-3)" "unprognostic (7.46e-3)" "unprognostic (7.70e-2)" "prognostic favorable (9.43e-4)" "unprognostic (1.34e-1)" "unprognostic (4.82e-2)" "prognostic favorable (3.67e-7)" "unprognostic (4.48e-2)" "unprognostic (1.54e-1)" "unprognostic (1.41e-2)" "prognostic unfavorable (3.51e-4)" 36.8 42.9 77.4 21.5 70.8 4.6 36.4 63.6 73.5 46.9 124.7 73.9 23.8 49.1 135.8 62.3 48.7 68.2 63.7 62.0 89.1 92.6 23.4 53.0 13.0 109.4 127.8 76.7 83.6 38.5 16.9 77.3 91.6 71.7 57.4 137.2 32.6 102.0 14.2 45.9 34.0 61.9 101.6 29.7 56.6 23.9 132.2 13.5 22.6 25.2 19.2 64.4 37.8 98.8 11.5 17.3 392.1 0.3 214.0 294.1 228.4 55.6 135.1 75.7 104.0 24.3 26.2 0.2 54.9 16.0 70.7 116.0 89.3 91.7 63.6 0.6 67.8 0.4 45.4 0.2 187.2 0.1 0.9 214.0 60.3 185.3 60.6 77.2 181.0 21.4 0.0 1.0 113.0 1.7 0.3 1.3 17.7 24.7 27.3 0.1 82.2 0.5 13.5 60.3 21.8 46.0 51.0 2.3 67.3 357.0 10.6 1.6 209.7 71.7 56.9 116.9 76.1 26.6 0.8 0.2 165.0 1.8 134.1 0.0 22.1 0.0 0.0 5.4 0.1 0.1 0.0 0.0 0.9 0.1 0.0 0.0 61.7 0.0 0.7 0.3 0.0 4.8 77.4 70.8 63.6 73.5 62.0 89.1 109.4 127.8 91.6 101.6 132.2 98.8 20.9 48.1 34.6 145.3 1.2 42.4 60.1 28.5 95.0 8.9 25.4 61.2 32.6 42.9 41.3 27.6 139.7 134.7 0.9 65.7 9.8 74.3 15.3 110.8 60.1 31.5 9.6 0.0 27.0 60.3 6.7 44.9 28.5 235.3 5.7 4.6 43.5 10.9 24.9 13.5 132.3 24.5 61.1 10.6 11.2 9.4 32.6 14.7 19.6 61.8 18.0 11.8 0.0 59.3 3.7 69.1 27.2 55.3 0.2 31.3 8.9 36.2 81.1 166.4 39.5 15.7 46.4 0.8 1.0 39.7 30.0 55.1 3.2 39.2 38.4 46.8 WNK3 PRKWNK3 ENSG00000196632 "WNK lysine deficient protein kinase 3" Q9BYP7 X 54192823-54358642 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 11.7;testis: 9.9" "Group enriched" "Detected in many" 4 "Cardiomyocytes: 193.3;Granulosa cells: 199.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 4.5;AN3-CA: 3.4;HAP1: 5.2;NTERA-2: 9.1;SiHa: 4.5;SuSa: 3.8;U-2 OS: 3.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077678 Approved Approved Vesicles NA NA "Cluster 32: T-cells - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 12: NES - Nervous system development" "Cluster 40: Granulosa cells - Unknown function" Vesicles "HPA077678: AB_2686850" "unprognostic (1.86e-1)" "unprognostic (1.68e-3)" "unprognostic (2.44e-1)" "unprognostic (7.87e-5)" "unprognostic (4.82e-3)" "unprognostic (1.85e-3)" "unprognostic (1.85e-2)" "unprognostic (3.32e-2)" "unprognostic (3.38e-1)" "unprognostic (3.03e-2)" "unprognostic (5.78e-4)" "unprognostic (2.22e-1)" "unprognostic (2.64e-2)" "unprognostic (5.61e-2)" "unprognostic (9.99e-2)" "unprognostic (7.63e-2)" "unprognostic (8.74e-2)" 0.2 2.5 1.6 0.1 1.7 0.1 0.6 0.3 1.9 0.6 0.0 0.3 0.2 0.5 11.7 0.2 0.8 0.3 0.7 1.0 4.6 1.0 3.6 0.3 0.1 1.6 4.8 3.0 0.3 0.9 2.4 0.3 2.4 0.9 0.0 3.3 0.3 0.8 0.1 0.3 0.2 0.5 0.6 0.2 0.6 9.9 4.5 0.1 0.6 0.1 0.1 0.5 0.4 1.2 0.0 0.0 4.5 3.4 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 1.8 0.0 5.2 0.1 0.2 0.0 0.9 0.0 0.0 0.1 0.1 0.0 0.1 0.3 0.0 0.1 0.0 0.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 2.2 0.6 0.0 0.9 0.1 1.4 1.3 4.5 0.0 0.5 3.8 0.4 0.0 0.2 0.0 3.9 0.0 1.0 0.0 3.3 0.0 1.2 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 1.7 0.3 1.9 1.0 4.6 1.6 4.8 2.4 0.6 4.5 1.2 1.9 0.0 2.3 18.3 0.7 3.7 4.3 0.3 9.1 24.9 5.8 6.9 193.3 2.8 3.2 7.3 14.6 0.2 0.0 0.1 5.9 1.7 6.4 2.0 7.8 8.5 0.0 0.8 14.5 0.0 0.3 6.7 0.0 4.9 6.3 199.5 20.3 48.3 0.1 35.3 29.7 0.0 2.0 0.8 1.5 20.4 15.8 0.6 0.0 3.7 0.0 19.5 0.0 48.2 19.2 0.2 0.0 43.6 0.0 6.0 0.0 3.9 0.2 43.3 6.6 4.8 10.5 43.8 46.3 2.1 1.1 0.1 1.5 9.8 0.0 1.4 WWC3 "BM042, KIAA1280" ENSG00000047644 "WWC family member 3" Q9ULE0 X 10015254-10144474 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 68.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "T-47d: 131.5" "Low region specificity" "Detected in all" HPA039814 Uncertain Approved "Actin filaments,Cytosol" NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 68: Epididymis - Unknown function" "Cluster 6: T47d - Mammary gland" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" Cytosol "Actin filaments" "HPA039814: AB_10674987" "unprognostic (2.53e-1)" "unprognostic (2.17e-1)" "prognostic unfavorable (1.31e-4)" "unprognostic (9.84e-3)" "unprognostic (1.05e-1)" "unprognostic (1.80e-1)" "unprognostic (3.21e-3)" "unprognostic (1.36e-2)" "unprognostic (1.83e-2)" "unprognostic (3.58e-2)" "unprognostic (4.91e-2)" "unprognostic (1.28e-1)" "prognostic unfavorable (1.06e-5)" "unprognostic (9.90e-2)" "unprognostic (2.09e-1)" "unprognostic (5.03e-2)" "unprognostic (4.50e-2)" 11.2 13.8 13.7 9.6 16.9 5.5 10.9 13.0 11.8 11.2 12.2 15.2 4.0 11.3 19.3 11.3 9.7 9.7 18.6 10.3 11.4 7.3 3.4 21.7 12.6 14.1 15.1 18.1 8.5 7.8 6.5 15.7 13.4 11.3 4.8 1.9 9.3 26.7 8.5 13.5 11.6 8.3 12.4 11.6 10.8 5.4 15.1 7.1 12.2 6.4 9.6 11.0 11.3 16.6 17.2 19.1 22.7 7.5 9.4 13.2 21.6 9.6 16.5 5.7 6.2 2.5 17.5 1.8 0.2 12.8 22.0 8.8 5.3 9.9 4.7 13.0 1.9 3.9 13.1 1.7 20.1 0.0 5.8 8.5 20.4 14.1 14.8 30.0 26.7 3.2 0.3 22.4 13.7 35.2 4.2 1.1 21.4 9.0 6.7 12.5 1.1 7.5 5.5 8.7 2.4 6.4 11.7 14.9 10.2 42.0 131.5 1.4 36.0 16.4 0.5 24.4 10.8 18.2 13.3 6.3 10.0 6.3 24.7 4.0 0.8 0.2 5.8 0.7 4.9 2.0 2.8 4.3 0.4 5.0 2.5 3.0 10.7 2.6 0.7 0.6 1.4 1.8 13.7 16.9 13.0 11.8 10.3 11.4 14.1 15.1 13.4 12.4 15.1 16.6 41.0 22.4 68.4 20.2 15.4 5.6 12.9 8.2 7.4 6.1 22.9 15.9 20.5 5.7 13.0 5.5 6.2 14.3 7.1 7.9 0.0 6.2 0.7 6.3 15.4 26.9 16.1 24.8 29.0 9.5 6.3 15.3 2.6 7.5 3.8 12.7 31.8 5.6 11.6 3.3 21.1 4.2 8.2 19.4 11.8 1.4 12.8 12.2 16.0 12.2 6.8 4.1 10.3 13.0 35.7 9.5 7.4 24.8 10.2 14.8 8.1 2.5 11.5 2.0 19.7 11.9 20.2 0.7 2.5 8.8 13.1 7.9 12.0 15.8 3.6 9.4 WWOX "FOR, SDR41C1, WOX1" ENSG00000186153 "WW domain containing oxidoreductase" Q9NZC7 16 78099430-79212667 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Apoptosis, Wnt signaling pathway" Oxidoreductase "Disease variant, Epilepsy, Neurodegeneration, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 14 "Astrocytes: 927.8;Excitatory neurons: 270.5;Inhibitory neurons: 540.9;Microglial cells: 471.2;Oligodendrocyte precursor cells: 914.9;Oligodendrocytes: 793.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 85.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050992 Approved Supported "Golgi apparatus,Cytosol" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 68: Epididymis - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Golgi apparatus" Cytosol "HPA050992: AB_2681299" "prognostic unfavorable (9.07e-5)" "unprognostic (1.14e-2)" "unprognostic (1.92e-1)" "unprognostic (9.27e-2)" "unprognostic (2.32e-1)" "unprognostic (1.81e-1)" "unprognostic (6.24e-2)" "unprognostic (1.69e-1)" "unprognostic (1.65e-1)" "unprognostic (3.61e-3)" "unprognostic (4.33e-2)" "unprognostic (3.50e-2)" "prognostic favorable (4.49e-5)" "unprognostic (3.75e-1)" "unprognostic (1.78e-1)" "unprognostic (2.36e-2)" "unprognostic (1.77e-1)" 8.6 6.3 18.6 4.0 23.9 4.2 7.4 24.0 20.3 8.6 21.2 5.2 5.3 8.2 10.1 7.7 9.0 7.4 5.2 18.8 22.5 12.7 12.0 5.3 4.6 24.0 22.4 7.6 8.3 12.1 9.8 5.3 25.3 7.7 3.2 6.9 8.5 6.4 3.3 7.1 4.5 5.1 22.0 4.7 6.0 9.3 21.0 9.0 21.8 2.1 6.0 6.7 7.1 30.0 11.1 9.5 9.2 7.7 11.0 5.3 11.1 1.6 3.2 3.7 3.2 7.0 9.6 19.5 8.6 1.5 5.2 10.0 5.1 1.3 2.6 11.0 26.8 6.0 1.9 15.7 7.5 16.7 3.4 5.9 3.8 2.3 2.4 0.9 4.4 25.9 9.2 4.2 2.6 85.7 27.7 21.9 8.6 5.9 5.7 32.2 3.9 19.1 5.3 3.9 17.6 10.0 7.1 11.9 4.0 9.3 12.8 12.0 1.6 2.7 10.4 2.2 6.4 0.0 18.3 41.2 10.4 8.4 4.6 7.0 9.1 2.1 11.4 7.9 13.4 9.3 8.2 9.1 7.7 6.6 8.4 8.3 0.7 9.1 5.8 14.5 13.5 6.0 18.6 23.9 24.0 20.3 18.8 22.5 24.0 22.4 25.3 22.0 21.0 30.0 12.0 6.4 6.9 927.8 9.0 9.2 21.2 8.0 19.4 7.4 12.1 16.1 8.8 17.2 13.3 14.7 4.2 25.7 10.9 4.5 33.2 12.4 43.1 18.2 13.9 9.5 9.6 13.3 270.5 10.3 11.9 12.0 9.2 7.6 12.7 18.7 13.2 18.9 9.2 5.0 540.9 5.1 0.0 5.6 5.7 38.2 14.0 7.7 5.4 471.2 5.9 46.3 9.2 914.9 793.5 4.5 5.9 17.7 18.4 11.5 8.7 28.3 18.7 12.2 6.6 10.3 11.8 19.7 17.9 13.3 6.8 17.4 9.9 12.1 6.8 13.0 ZBED9 "Buster4, FLJ31087, KIAA1925, SCAND3, ZFP38-L, ZNF305P2, ZNF452" ENSG00000232040 "Zinc finger BED-type containing 9" Q6R2W3 6 28570535-28616212 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "testis: 8.7" "Group enriched" "Detected in many" 4 "Early spermatids: 27.2;Spermatocytes: 24.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 4.7;hTCEpi: 4.4;K-562: 8.3;U-266/84: 3.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007246 Uncertain Approved "Nucleoplasm,Nucleoli,Golgi apparatus" NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 1: K-562 - Erythropoiesis" "Cluster 66: Spermatocytes - Spermatogenesis" Nucleoli "Nucleoplasm, Golgi apparatus" "HPA007246: AB_1080727" "unprognostic (1.01e-1)" "unprognostic (5.16e-5)" "unprognostic (1.88e-1)" "unprognostic (1.27e-4)" "unprognostic (3.96e-2)" "unprognostic (9.46e-3)" "unprognostic (3.40e-1)" "unprognostic (2.73e-2)" "unprognostic (4.24e-2)" "unprognostic (2.34e-3)" "unprognostic (8.21e-3)" "unprognostic (4.31e-1)" "unprognostic (2.42e-2)" "unprognostic (1.14e-2)" "unprognostic (7.66e-3)" "unprognostic (3.92e-2)" "unprognostic (1.59e-1)" 0.1 0.5 0.8 0.1 0.6 0.1 0.9 1.6 0.8 0.8 0.1 0.4 0.2 0.6 3.1 0.2 1.2 0.2 0.3 0.6 0.6 0.8 1.2 0.5 0.1 0.2 0.3 1.6 0.8 0.9 0.7 0.6 0.3 1.4 0.5 1.5 0.7 1.9 0.0 0.2 0.2 0.3 0.1 0.0 0.3 8.7 0.4 0.4 1.7 0.0 0.1 0.2 0.3 0.4 1.1 1.2 1.2 0.0 0.0 0.0 1.3 0.2 0.0 0.2 0.7 0.0 0.7 0.0 4.7 0.1 2.4 0.6 0.0 1.3 0.2 0.0 3.0 0.2 0.8 1.1 0.7 0.0 0.0 0.6 4.4 0.1 2.1 0.7 0.0 0.0 8.3 0.0 0.0 0.9 0.0 0.0 1.1 0.0 0.6 0.4 0.5 0.0 1.3 1.3 1.2 2.8 0.0 1.2 0.0 1.6 0.0 0.3 0.0 0.0 1.3 0.0 0.8 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.6 1.6 0.8 0.6 0.6 0.2 0.3 0.3 0.1 0.4 0.4 0.0 0.0 3.2 0.3 0.2 0.0 0.9 0.0 2.2 1.6 1.5 0.8 1.9 2.8 0.6 0.0 2.1 2.8 0.0 1.0 1.9 1.7 27.2 1.1 0.3 0.3 1.2 0.0 5.2 1.3 1.5 0.3 0.0 1.1 0.0 1.7 0.0 1.9 0.4 0.0 5.7 1.4 0.0 0.0 0.0 5.4 2.5 0.1 0.0 0.0 0.1 1.1 0.0 1.0 0.2 0.4 0.8 0.0 0.0 0.9 0.5 0.6 0.7 1.5 0.0 0.2 0.2 24.9 3.5 1.3 0.0 1.0 0.0 0.2 1.2 0.6 ZC2HC1C "C14orf140, FAM164C" ENSG00000119703 "Zinc finger C2HC-type containing 1C" Q53FD0 14 75064109-75119502 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 23.9;testis: 55.3" "Group enriched" "Detected in many" 5 "Early spermatids: 165.2;Late spermatids: 195.1;Spermatocytes: 198.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "NK-cell: 1.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "CAPAN-2: 6.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "HPA050928, HPA065062" Enhanced Approved "Nuclear speckles,Mitochondria" No No "Cluster 22: NK-cells - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 29: U-266 - Adaptive immune response" "Cluster 66: Spermatocytes - Spermatogenesis" "Nuclear speckles" Mitochondria "HPA050928: AB_2681277, HPA065062: AB_2732728" "unprognostic (8.01e-2)" "unprognostic (2.01e-2)" "unprognostic (9.61e-2)" "unprognostic (8.01e-2)" "unprognostic (1.97e-3)" "unprognostic (6.00e-2)" "unprognostic (8.94e-2)" "unprognostic (1.20e-2)" "unprognostic (3.71e-3)" "unprognostic (3.22e-2)" "unprognostic (1.09e-3)" "unprognostic (2.26e-1)" "prognostic favorable (4.63e-13)" "unprognostic (4.69e-3)" "unprognostic (7.37e-2)" "unprognostic (3.12e-1)" "unprognostic (1.81e-1)" 1.1 2.5 2.5 0.6 2.7 0.4 1.7 2.8 2.9 1.8 5.1 2.7 3.1 1.3 23.9 1.3 11.0 1.6 5.2 2.4 2.9 5.5 8.4 2.5 0.2 3.1 3.7 0.6 5.1 6.9 6.1 0.8 2.9 1.3 2.4 2.6 2.9 3.4 4.7 1.6 2.4 1.0 2.8 0.8 1.6 55.3 2.9 2.3 7.0 1.5 0.5 1.4 0.6 3.3 3.8 2.8 0.3 3.3 0.2 0.0 1.8 0.3 1.1 1.4 0.8 4.8 6.9 3.3 2.6 0.4 2.6 1.0 0.0 0.0 1.2 3.9 0.3 0.6 1.0 2.3 2.5 0.0 1.8 0.3 0.4 1.6 0.0 1.7 1.1 0.2 5.8 1.0 0.7 0.6 0.4 0.3 0.7 2.4 1.8 0.0 0.2 0.7 4.3 0.3 5.7 1.3 2.4 2.0 1.5 0.6 2.9 0.9 0.7 0.9 0.9 1.0 0.8 4.0 4.9 1.1 1.4 0.4 0.6 0.3 0.0 0.2 0.6 0.0 0.1 0.4 0.3 0.1 0.1 0.2 0.1 0.1 0.1 1.2 0.1 0.2 0.9 0.1 2.5 2.7 2.8 2.9 2.4 2.9 3.1 3.7 2.9 2.8 2.9 3.3 0.8 6.4 9.7 2.0 0.9 1.8 1.9 1.3 4.6 4.5 7.9 5.1 7.0 2.8 6.6 11.0 10.4 2.3 1.6 2.5 3.9 4.6 165.2 21.0 2.1 2.0 5.3 0.4 2.4 1.4 1.1 2.5 1.1 1.9 1.3 1.1 2.9 4.7 1.7 11.8 2.1 2.3 0.0 1.0 0.7 195.1 3.1 1.0 3.6 1.0 0.9 3.0 8.2 0.5 1.0 1.6 0.6 2.6 0.6 2.8 4.2 7.4 32.5 8.5 6.6 5.2 2.0 198.5 5.5 1.9 0.9 5.1 0.9 2.3 3.9 1.3 ZCCHC17 "HSPC251, pNO40, PS1D" ENSG00000121766 "Zinc finger CCHC-type containing 17" Q9NP64 1 31296982-31364953 "Predicted intracellular proteins" Ribonucleoprotein "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 249.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053727 Approved NA NA "Cluster 44: Non-specific - Transcription" "Cluster 68: Epididymis - Unknown function" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "HPA053727: AB_2732581" "unprognostic (1.49e-3)" "unprognostic (1.47e-2)" "unprognostic (1.04e-1)" "unprognostic (8.72e-3)" "unprognostic (2.01e-1)" "unprognostic (3.81e-1)" "prognostic unfavorable (3.27e-4)" "unprognostic (1.18e-1)" "unprognostic (4.43e-2)" "unprognostic (1.00e-3)" "unprognostic (2.70e-1)" "unprognostic (2.43e-1)" "unprognostic (2.40e-1)" "unprognostic (1.44e-1)" "unprognostic (8.41e-2)" "unprognostic (4.88e-2)" "unprognostic (2.17e-1)" 22.3 26.9 69.7 16.9 71.0 19.2 29.7 63.0 92.1 21.7 50.1 25.1 12.5 21.3 57.8 21.9 20.6 15.0 51.7 73.8 72.0 31.7 16.9 18.2 21.3 68.7 75.4 19.7 17.8 23.6 26.1 21.3 74.1 21.8 19.9 37.9 19.7 26.4 32.1 23.3 18.5 22.7 69.7 20.6 20.4 48.1 68.1 26.9 21.0 24.2 25.9 23.6 20.8 77.5 42.5 35.4 59.4 38.9 55.5 46.4 34.8 63.7 56.1 71.4 64.5 58.0 38.0 45.3 48.2 48.5 31.3 30.6 67.9 59.9 81.2 29.8 45.4 60.5 53.5 66.4 46.5 56.1 25.1 34.0 60.8 81.7 84.1 50.9 77.6 48.7 64.8 26.8 65.6 35.6 48.8 59.1 105.8 51.8 61.3 46.0 81.4 41.3 78.2 42.2 42.7 26.7 54.7 43.9 205.9 87.9 32.2 34.9 52.7 36.1 38.8 83.1 66.2 26.0 45.1 55.6 49.1 69.4 103.5 87.1 35.8 60.2 41.0 38.5 36.9 39.7 41.1 43.1 35.9 47.7 37.7 45.5 12.2 36.6 38.3 40.7 42.2 52.3 69.7 71.0 63.0 92.1 73.8 72.0 68.7 75.4 74.1 69.7 68.1 77.5 38.1 19.2 23.7 25.5 31.6 31.0 36.4 55.1 20.5 52.8 34.8 43.3 61.6 31.5 37.0 27.6 27.1 87.7 48.7 24.7 72.4 54.3 80.4 37.4 39.8 41.3 24.7 48.0 46.9 52.4 71.8 33.3 13.7 41.9 41.8 50.2 36.4 24.3 54.2 85.8 41.3 28.5 32.6 26.8 30.8 122.7 42.9 50.6 35.6 24.4 56.5 71.5 69.0 39.2 33.2 54.8 35.4 53.8 27.8 54.0 22.3 64.7 29.2 53.8 46.0 35.5 50.5 249.2 177.6 28.7 34.2 83.9 41.8 45.3 29.4 58.6 ZMAT1 KIAA1789 ENSG00000166432 "Zinc finger matrin-type 1" Q5H9K5 X 101882288-101932079 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 190.3;Oligodendrocyte precursor cells: 111.1;Oligodendrocytes: 112.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 8.2;U-266/70: 4.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012827 Enhanced Approved Nucleoplasm NA NA "Cluster 46: Basophils - DNA binding" "Cluster 68: Epididymis - Unknown function" "Cluster 2: Karpas-707 - Immune response" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA012827: AB_1859070" "unprognostic (9.30e-2)" "unprognostic (4.13e-2)" "unprognostic (2.51e-2)" "unprognostic (2.80e-1)" "unprognostic (1.08e-1)" "unprognostic (1.08e-5)" "unprognostic (1.20e-3)" "unprognostic (2.22e-2)" "unprognostic (3.70e-2)" "unprognostic (6.09e-2)" "prognostic favorable (1.72e-5)" "unprognostic (6.33e-3)" "unprognostic (1.72e-2)" "unprognostic (3.05e-1)" "unprognostic (5.28e-2)" "unprognostic (2.21e-1)" "unprognostic (1.38e-2)" 6.4 9.3 11.1 2.8 11.5 6.3 7.5 10.5 15.1 8.0 10.6 7.3 1.8 5.5 21.2 2.4 10.0 2.1 7.9 10.7 10.7 18.3 9.7 5.7 6.6 11.5 10.9 15.2 10.3 4.3 34.8 0.7 11.0 10.7 1.3 9.4 6.7 3.7 2.6 3.0 7.5 1.3 11.1 13.8 5.8 6.7 10.9 3.2 25.0 1.5 2.6 6.0 4.8 12.1 0.2 0.0 1.0 1.0 0.0 0.0 0.1 0.4 0.0 0.0 0.4 0.0 1.2 1.8 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.4 0.0 0.0 0.0 0.2 0.2 0.7 1.9 0.0 8.2 0.6 0.0 0.1 0.1 1.3 0.0 0.1 1.5 0.0 0.1 2.3 0.0 0.4 1.1 0.7 0.0 0.1 1.1 1.4 2.1 2.0 0.6 0.0 0.0 0.1 4.1 0.3 0.0 0.4 2.0 0.6 0.8 0.3 0.5 0.2 0.1 0.4 0.6 0.3 0.4 0.0 0.9 0.4 0.3 0.2 0.1 0.1 0.9 0.2 0.1 11.1 11.5 10.5 15.1 10.7 10.7 11.5 10.9 11.0 11.1 10.9 12.1 18.9 16.0 31.2 190.3 30.2 4.1 7.6 0.2 7.4 38.1 18.2 12.3 25.4 11.5 14.4 14.7 43.8 0.1 16.5 0.6 3.9 5.0 14.9 28.2 3.7 16.8 10.3 6.9 30.7 2.7 0.0 10.3 2.0 21.6 15.8 51.5 13.6 10.6 3.3 16.8 32.8 2.8 0.0 9.7 11.1 9.7 1.8 11.7 7.2 71.2 10.7 25.8 10.3 111.1 112.8 1.5 1.6 1.2 7.4 6.1 2.7 5.7 13.0 57.5 0.0 27.5 9.0 22.4 10.2 3.2 2.8 0.1 16.3 5.4 2.6 4.3 ZNF189 ENSG00000136870 "Zinc finger protein 189" O75820 9 101398873-101410660 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 86.0" "Cell type enriched" "Detected in all" 4 "Oligodendrocytes: 124.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034814 Uncertain Approved "Intermediate filaments" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 68: Epididymis - Unknown function" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Intermediate filaments" "HPA034814: AB_10601030" "unprognostic (3.87e-2)" "unprognostic (3.47e-1)" "unprognostic (5.30e-2)" "unprognostic (2.75e-1)" "unprognostic (6.45e-2)" "unprognostic (1.42e-1)" "unprognostic (1.26e-2)" "unprognostic (3.59e-3)" "unprognostic (1.70e-2)" "unprognostic (1.15e-1)" "unprognostic (1.38e-1)" "unprognostic (1.10e-1)" "prognostic favorable (5.32e-4)" "unprognostic (3.31e-1)" "unprognostic (4.58e-1)" "unprognostic (1.86e-2)" "unprognostic (6.57e-2)" 24.2 21.6 15.7 9.4 20.3 4.0 16.2 16.8 24.0 12.5 13.8 10.8 12.3 13.8 86.0 7.4 10.5 23.3 15.4 27.8 15.8 14.6 18.6 9.5 10.7 17.9 15.7 16.0 31.3 14.2 19.7 8.8 17.0 13.9 10.2 12.7 9.8 11.6 16.4 5.9 12.3 13.3 16.4 12.6 12.7 13.7 15.0 11.2 13.3 16.8 15.2 8.4 7.0 27.2 7.4 6.0 19.1 14.0 16.7 11.6 9.1 10.3 15.8 11.9 10.2 12.7 5.7 9.9 6.8 12.5 12.4 14.1 9.6 9.8 10.5 13.1 6.6 10.8 9.6 27.3 12.4 11.5 9.1 14.2 13.3 10.6 16.3 16.3 15.0 11.9 13.0 13.9 17.7 4.1 13.8 4.9 13.8 16.2 6.7 9.7 27.3 7.6 11.4 8.4 19.7 12.4 11.2 7.6 11.4 12.5 6.3 14.3 12.6 11.6 8.4 9.6 8.1 13.1 21.7 4.7 10.0 4.4 12.0 0.5 0.8 1.4 0.7 1.0 0.7 0.9 1.2 1.5 0.7 1.0 1.4 1.2 0.4 1.3 0.8 0.5 0.6 0.6 15.7 20.3 16.8 24.0 27.8 15.8 17.9 15.7 17.0 16.4 15.0 27.2 7.5 9.6 6.4 11.1 9.7 9.8 8.2 4.9 8.0 7.4 8.9 6.5 22.2 25.8 11.9 1.8 4.2 4.6 6.4 6.2 9.8 7.2 3.1 5.2 8.7 9.4 5.4 6.5 29.1 18.0 2.1 9.0 6.1 5.4 9.5 9.8 8.9 9.0 5.5 8.4 17.4 6.3 8.2 14.4 7.6 3.1 11.1 9.6 7.2 11.2 3.9 6.8 6.2 17.1 124.9 7.2 6.7 10.9 4.9 6.2 7.2 14.5 8.2 3.9 13.1 10.6 8.9 7.0 3.6 9.1 6.5 1.9 6.2 7.8 5.9 5.2 ZNF280C "FLJ20095, SUHW3, ZNF633, ZPET" ENSG00000056277 "Zinc finger protein 280C" Q8ND82 X 130202707-130268899 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 9.4" "Cell type enhanced" "Detected in many" "Oligodendrocyte precursor cells: 20.1;Spermatocytes: 27.5;Spermatogonia: 33.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051494, HPA055788" Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center" NA NA "Cluster 40: NK-cells - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 32: U-937 - Innate immune response" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "Nucleoplasm, Nucleoli fibrillar center" "HPA051494: AB_2681506, HPA055788: AB_2682921" "unprognostic (2.97e-1)" "unprognostic (2.02e-1)" "unprognostic (3.97e-1)" "unprognostic (5.69e-3)" "unprognostic (2.98e-2)" "unprognostic (8.52e-2)" "unprognostic (1.16e-6)" "unprognostic (1.96e-2)" "unprognostic (3.33e-2)" "unprognostic (9.77e-2)" "unprognostic (1.06e-2)" "unprognostic (3.69e-2)" "unprognostic (3.27e-8)" "unprognostic (1.71e-1)" "unprognostic (1.77e-2)" "unprognostic (3.66e-2)" "unprognostic (6.85e-2)" 1.6 1.4 0.6 1.7 1.3 2.6 1.6 1.5 1.3 2.9 0.3 1.5 1.3 2.7 5.1 1.4 1.5 1.8 0.9 0.7 1.3 1.1 1.2 1.5 2.3 0.5 0.8 1.8 1.3 1.7 1.6 1.8 0.7 1.5 1.4 1.8 1.2 1.2 1.3 1.6 1.4 1.8 0.5 1.7 1.1 9.4 0.8 2.2 1.6 1.1 2.6 1.6 1.6 1.1 3.3 4.1 10.7 9.6 3.1 4.3 4.0 3.1 4.0 3.2 4.8 2.5 5.2 7.8 12.0 2.2 6.3 3.2 7.5 2.4 5.7 6.9 2.1 3.4 3.2 1.9 2.5 11.1 3.0 3.2 1.1 4.6 4.7 3.2 3.7 5.0 1.7 4.6 3.8 4.2 6.0 4.5 6.2 4.9 3.4 8.2 3.6 3.0 3.4 5.2 5.2 7.1 3.0 1.7 3.4 4.3 1.9 3.7 3.7 3.5 2.9 5.8 8.2 1.9 1.3 4.3 3.3 9.9 3.3 1.0 0.5 0.6 1.0 0.8 1.7 1.4 1.2 1.2 0.7 1.0 0.9 1.3 0.2 1.8 1.1 0.8 1.8 0.4 0.6 1.3 1.5 1.3 0.7 1.3 0.5 0.8 0.7 0.5 0.8 1.1 3.1 3.2 3.6 8.8 6.8 0.9 2.1 1.3 3.4 2.4 2.1 3.2 1.3 0.0 1.4 1.8 2.1 2.0 8.1 1.2 0.0 1.3 0.3 2.9 7.4 2.8 4.8 3.4 13.1 1.8 1.7 2.9 5.1 3.6 0.0 7.4 3.6 2.7 1.6 5.0 11.2 0.9 4.1 3.2 1.0 0.3 3.4 2.4 0.0 9.4 4.3 0.9 0.0 20.1 11.8 1.1 1.8 3.0 3.2 2.1 1.0 2.1 3.2 3.1 6.6 3.8 3.2 27.5 33.8 4.3 1.6 0.8 4.3 5.0 2.3 2.5 ZNF365 "KIAA0844, UAN" ENSG00000138311 "Zinc finger protein 365" Q70YC5 10 62374192-62480288 "Predicted intracellular proteins" Neurogenesis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 22.7;esophagus: 10.2" "Group enriched" "Detected in some" 6 "Excitatory neurons: 112.7;Oligodendrocyte precursor cells: 113.6;Oligodendrocytes: 195.5" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 4 "cerebral cortex: 22.7;hippocampal formation: 8.3;thalamus: 8.0;white matter: 16.6" "Group enriched" "Detected in many" 9 "gdT-cell: 2.4;memory CD4 T-cell: 2.1;memory CD8 T-cell: 2.7;naive CD8 T-cell: 2.7;NK-cell: 6.4;T-reg: 5.9" "Group enriched" "Detected in many" 62 "NK-cells: 6.4;T-cells: 5.9" "Cell line enhanced" "Detected in many" "HaCaT: 22.3;PC-3: 13.9;U-251 MG: 18.6;U-87 MG: 12.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052446 Supported Approved Vesicles,Centrosome NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Vesicles, Centrosome" "HPA052446: AB_2681836" "unprognostic (7.46e-2)" "unprognostic (1.42e-1)" "unprognostic (1.36e-1)" "unprognostic (1.26e-3)" "unprognostic (1.21e-1)" "unprognostic (4.05e-3)" "unprognostic (1.73e-1)" "unprognostic (7.67e-2)" "unprognostic (2.15e-2)" "unprognostic (3.11e-3)" "unprognostic (3.06e-2)" "unprognostic (7.90e-2)" "unprognostic (1.12e-6)" "unprognostic (2.49e-3)" "unprognostic (1.58e-1)" "unprognostic (1.20e-4)" "unprognostic (2.89e-2)" 0.1 1.3 1.0 0.1 2.8 0.0 0.3 1.5 22.7 0.9 0.0 0.0 0.1 0.1 0.2 10.2 0.1 0.3 1.0 8.3 0.0 0.1 0.0 0.7 0.0 0.0 3.2 0.0 0.4 5.6 1.6 0.1 0.0 1.8 0.1 5.1 1.1 2.0 0.0 0.8 0.1 0.1 0.0 0.3 0.0 0.5 8.0 0.5 0.6 0.1 1.4 0.8 1.1 16.6 6.3 0.6 0.1 0.0 0.1 0.0 0.0 5.5 5.8 2.6 2.1 0.0 1.0 0.0 0.2 3.1 8.4 22.3 0.0 0.4 3.5 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.2 7.2 0.9 6.6 0.9 0.0 0.0 0.0 5.5 2.1 0.7 0.0 0.9 0.0 13.9 0.0 0.2 0.0 0.3 2.8 0.1 1.2 1.1 0.2 0.6 0.0 0.0 0.0 0.0 1.1 6.1 0.0 18.6 0.0 0.0 0.0 12.9 0.0 1.8 0.0 0.0 0.0 2.4 0.0 0.0 0.0 2.1 2.7 0.0 0.0 0.4 2.7 0.0 6.4 0.0 0.0 5.9 0.8 1.0 2.8 1.5 22.7 8.3 0.0 0.0 3.2 0.0 0.0 8.0 16.6 0.0 0.0 0.0 15.3 0.2 0.5 3.7 0.6 0.0 13.5 0.3 0.3 2.6 1.5 0.1 3.7 2.1 0.0 2.8 0.0 0.0 0.2 0.5 0.3 0.2 0.2 0.0 0.0 112.7 0.0 0.0 0.9 0.0 0.6 0.0 0.1 0.0 0.0 0.1 18.5 23.4 0.0 0.0 0.3 1.1 0.3 0.0 0.4 0.0 6.5 0.0 2.7 0.0 113.6 195.5 0.9 0.0 0.0 1.9 1.2 0.0 0.7 0.1 5.3 0.0 0.8 0.8 0.1 0.7 0.0 0.4 0.0 3.9 0.2 0.0 6.0 ZNF391 dJ153G14.3 ENSG00000124613 "Zinc finger protein 391" Q9UJN7 6 27374615-27403908 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in many" 4 "Early spermatids: 52.5" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 5 "amygdala: 2.1;basal ganglia: 3.1;cerebral cortex: 3.3;hippocampal formation: 2.8;white matter: 2.2" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA050886 Uncertain NA NA "Cluster 30: Non-specific - Translation" "Cluster 68: Epididymis - Unknown function" "Cluster 1: K-562 - Erythropoiesis" "Cluster 29: Early spermatids - Spermatogenesis" "HPA050886: AB_2681262" "unprognostic (1.59e-1)" "unprognostic (4.97e-2)" "unprognostic (1.85e-1)" "unprognostic (1.41e-1)" "unprognostic (1.88e-1)" "unprognostic (4.68e-3)" "unprognostic (6.27e-5)" "unprognostic (2.18e-2)" "unprognostic (2.50e-1)" "prognostic favorable (1.89e-4)" "unprognostic (5.62e-2)" "unprognostic (3.02e-1)" "unprognostic (3.73e-2)" "unprognostic (2.39e-2)" "unprognostic (3.40e-1)" "unprognostic (1.08e-1)" "unprognostic (2.82e-2)" 2.3 2.1 2.1 0.9 3.1 0.3 3.3 0.5 3.3 3.6 0.0 1.6 0.8 3.1 3.1 1.8 3.9 1.3 1.1 2.8 0.0 2.8 0.3 1.9 1.9 0.4 0.0 5.0 2.1 3.7 1.7 1.4 0.1 2.5 1.7 2.1 2.2 3.4 0.6 1.8 1.1 2.4 0.0 2.3 1.6 4.9 0.3 1.4 4.0 0.8 1.7 1.7 1.5 2.2 4.9 0.7 2.9 10.2 1.2 1.6 5.9 1.2 0.9 1.7 3.9 2.7 1.0 0.0 4.3 1.1 3.4 1.6 5.8 4.5 2.7 0.0 3.5 1.8 0.2 0.9 1.9 5.4 2.5 4.9 5.7 0.3 4.5 3.5 0.2 8.1 8.1 0.0 0.3 1.0 6.4 7.6 3.6 0.7 3.2 0.0 0.0 1.3 1.1 1.9 1.1 4.7 0.0 6.7 0.5 4.7 1.1 4.6 0.6 5.5 1.7 0.3 3.7 3.1 8.1 0.0 0.2 0.5 6.0 0.1 0.0 0.0 0.3 0.0 0.7 1.4 0.5 0.2 0.0 1.3 1.0 0.7 0.0 0.3 0.0 0.4 0.1 0.2 2.1 3.1 0.5 3.3 2.8 0.0 0.4 0.0 0.1 0.0 0.3 2.2 1.7 0.0 1.1 2.3 1.2 0.9 0.5 0.7 0.6 2.2 1.8 1.7 1.0 0.0 2.9 1.8 0.0 2.4 0.1 0.1 0.0 1.0 52.5 7.0 2.4 2.0 1.8 1.3 12.1 1.4 1.1 2.4 0.0 1.7 0.0 3.9 1.8 0.0 1.1 3.3 6.7 0.2 2.0 0.0 0.6 4.7 1.8 0.4 0.0 3.7 0.0 4.4 0.0 7.5 1.7 1.2 0.6 2.6 0.3 0.2 0.0 1.3 12.4 0.9 0.0 1.6 1.3 6.5 2.8 1.3 0.3 0.3 0.6 1.9 1.1 0.4 ZNF417 MGC34079 ENSG00000173480 "Zinc finger protein 417" Q8TAU3 19 57900296-57916610 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 57.4" "HPA042125, HPA043288, HPA056213" Uncertain Uncertain Nucleoplasm NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 68: Epididymis - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 6: Erythroid cells - Oxygen transport" Nucleoplasm "HPA042125: AB_2677862, HPA043288: AB_2678410, HPA056213: AB_2683069" "unprognostic (2.48e-1)" "unprognostic (2.55e-1)" "unprognostic (1.28e-1)" "unprognostic (3.74e-2)" "unprognostic (8.93e-2)" "unprognostic (1.63e-2)" "unprognostic (1.85e-1)" "unprognostic (5.76e-2)" "unprognostic (2.59e-3)" "unprognostic (2.34e-1)" "unprognostic (7.65e-3)" "unprognostic (5.33e-2)" "unprognostic (7.63e-2)" "unprognostic (1.01e-1)" "unprognostic (1.93e-2)" "unprognostic (8.75e-2)" "prognostic favorable (3.48e-4)" 7.7 9.7 29.5 9.7 29.9 15.7 21.3 37.9 38.0 18.4 31.9 10.5 9.4 13.4 48.9 8.3 13.0 15.0 11.2 28.9 33.5 11.7 14.9 10.5 19.0 28.7 29.1 12.1 8.4 15.4 10.5 10.0 28.8 15.8 13.4 25.8 12.6 17.4 7.3 29.0 10.7 10.4 25.3 17.8 14.5 9.5 31.3 21.6 21.1 6.3 22.3 9.3 4.9 35.6 7.1 10.8 17.2 11.9 17.0 16.2 14.6 8.8 12.7 8.0 6.7 11.6 4.1 15.1 4.8 12.9 6.1 4.9 10.9 11.9 22.4 2.6 57.4 16.2 26.5 10.7 11.5 15.0 16.7 11.9 11.9 7.9 10.5 14.9 10.3 12.0 5.1 0.9 16.7 6.9 16.3 7.2 9.9 4.9 10.6 12.8 20.7 10.8 8.6 32.1 15.7 10.2 11.6 7.8 3.0 17.7 8.3 12.0 7.1 20.2 8.6 4.6 8.9 16.1 27.8 12.5 8.7 6.0 9.8 5.9 2.0 5.1 2.6 2.4 3.3 2.6 3.0 2.6 1.5 3.6 4.0 3.0 3.3 2.1 1.7 3.3 2.7 1.5 29.5 29.9 37.9 38.0 28.9 33.5 28.7 29.1 28.8 25.3 31.3 35.6 1.5 6.4 1.1 5.5 1.7 0.8 1.2 0.7 1.8 4.0 2.5 1.9 3.0 2.8 4.8 0.0 0.0 1.0 1.5 1.7 0.0 1.2 0.5 1.2 1.2 2.6 6.0 6.1 3.9 1.4 0.8 2.0 2.0 1.6 4.5 2.0 2.9 2.2 1.0 1.7 3.8 2.1 0.0 2.5 1.5 0.1 2.5 1.7 0.0 1.9 1.0 0.9 2.1 2.5 5.7 0.4 0.5 1.5 5.0 1.4 1.5 1.5 2.2 3.9 6.6 1.9 1.7 1.3 2.1 1.0 1.3 0.8 2.0 1.2 1.7 1.6 ZNF443 ZK1 ENSG00000180855 "Zinc finger protein 443" Q9Y2A4 19 12429706-12441021 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 10.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "MOLT-4: 13.3" "HPA003150, HPA018683" Approved Approved "Nucleoplasm,Centriolar satellite" NA NA "Cluster 46: Basophils - DNA binding" "Cluster 68: Epididymis - Unknown function" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 47: Cytotrophoblasts - Unknown function" Nucleoplasm "Centriolar satellite" "HPA003150: AB_1080725, HPA018683: AB_2669920" "unprognostic (5.64e-3)" "unprognostic (1.51e-2)" "unprognostic (7.98e-2)" "unprognostic (1.45e-2)" "unprognostic (1.92e-1)" "unprognostic (7.38e-3)" "unprognostic (3.42e-1)" "unprognostic (1.64e-3)" "unprognostic (1.28e-3)" "unprognostic (1.05e-2)" "unprognostic (7.10e-2)" "unprognostic (2.92e-2)" "prognostic favorable (2.74e-7)" "unprognostic (3.85e-3)" "unprognostic (2.16e-1)" "unprognostic (2.19e-2)" "prognostic favorable (3.91e-4)" 1.4 1.7 3.2 1.4 3.3 0.6 4.2 3.6 3.8 2.9 2.5 2.8 2.0 2.7 3.1 2.6 2.6 2.1 1.8 2.9 3.1 3.8 3.2 1.6 1.8 3.2 3.3 2.3 2.6 2.8 1.9 3.2 3.0 3.1 3.3 3.3 2.9 3.2 1.1 3.8 2.2 1.8 3.1 1.6 2.4 1.8 3.4 4.0 2.4 1.7 2.2 2.8 2.8 2.9 3.1 1.4 5.4 4.9 1.6 1.3 7.4 2.2 1.6 3.0 2.8 3.0 0.9 3.7 3.9 1.8 1.2 1.8 3.6 2.3 2.5 0.0 1.8 1.5 1.9 7.0 0.4 3.5 4.1 1.2 1.4 1.5 0.7 2.0 1.7 4.5 2.6 0.0 3.3 3.8 13.3 4.8 4.6 3.1 4.6 1.5 5.7 4.5 3.6 11.6 2.6 4.2 3.7 2.0 0.5 3.0 0.0 4.3 1.2 5.9 2.4 3.2 2.2 2.2 3.6 2.3 0.8 3.5 1.2 2.5 0.6 0.9 1.0 0.3 3.7 2.1 2.2 2.2 1.1 1.7 1.9 1.4 0.4 1.6 0.2 0.6 1.8 1.0 3.2 3.3 3.6 3.8 2.9 3.1 3.2 3.3 3.0 3.1 3.4 2.9 3.5 0.0 0.5 10.7 2.4 1.0 1.5 1.2 2.2 1.2 2.8 2.3 2.3 2.8 1.4 0.0 4.2 7.7 2.6 1.8 1.9 2.7 6.3 2.9 1.2 2.8 3.0 1.7 8.9 1.2 1.2 1.4 1.1 3.4 0.0 3.7 1.4 1.6 1.3 1.7 8.1 2.1 2.0 0.9 1.5 2.7 0.6 1.0 0.0 3.7 0.1 3.0 5.2 8.5 5.0 1.1 2.8 2.2 0.6 0.6 1.7 2.2 2.3 2.2 0.0 1.0 1.7 5.0 6.6 3.0 2.6 1.6 2.1 1.2 2.6 0.7 ZNF610 FLJ36040 ENSG00000167554 "Zinc finger protein 610" Q8N9Z0 19 52336243-52367778 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 35.6;Late spermatids: 10.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/84: 11.0" "HPA055771, HPA078134" Enhanced Approved Nucleoplasm NA NA "Cluster 46: Basophils - DNA binding" "Cluster 68: Epididymis - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 29: Early spermatids - Spermatogenesis" Nucleoplasm "HPA055771: AB_2682914, HPA078134: AB_2732372" "unprognostic (1.13e-1)" "unprognostic (5.48e-3)" "unprognostic (1.52e-1)" "unprognostic (8.75e-2)" "unprognostic (3.65e-2)" "unprognostic (1.27e-1)" "unprognostic (3.34e-1)" "unprognostic (2.84e-1)" "unprognostic (1.83e-1)" "prognostic favorable (3.38e-4)" "unprognostic (5.54e-2)" "unprognostic (1.14e-2)" "prognostic favorable (1.05e-7)" "unprognostic (2.46e-2)" "unprognostic (1.11e-2)" "unprognostic (1.88e-2)" "unprognostic (5.73e-3)" 1.2 2.7 4.9 0.8 5.5 0.3 3.2 5.6 7.4 3.8 4.6 1.7 0.7 2.9 6.7 1.1 4.3 2.6 2.6 4.9 5.9 3.6 0.4 1.9 1.5 5.3 6.2 8.2 1.4 4.0 2.4 2.7 5.9 4.5 1.5 6.2 1.2 2.6 1.1 0.7 0.9 2.5 5.0 2.4 1.5 12.1 5.5 3.1 4.6 1.5 1.1 1.8 1.2 5.9 0.1 0.0 5.0 4.2 3.5 2.8 4.2 1.5 3.5 0.9 3.0 0.0 0.3 0.4 3.1 0.7 6.6 0.1 0.0 0.0 2.1 0.1 2.3 0.1 0.3 0.2 5.1 0.0 1.0 3.8 0.1 0.9 0.2 2.5 3.0 2.8 0.2 0.1 5.0 1.0 2.9 0.8 5.7 0.0 0.3 1.9 3.9 0.5 2.3 3.7 6.4 3.9 0.0 0.3 1.6 7.4 3.0 2.3 2.3 0.2 1.5 0.0 2.0 0.1 11.0 0.0 0.0 0.1 2.0 1.7 0.2 0.5 1.1 0.0 1.7 1.0 0.9 0.8 0.5 1.1 1.6 0.7 0.4 1.2 0.0 0.6 1.3 0.7 4.9 5.5 5.6 7.4 4.9 5.9 5.3 6.2 5.9 5.0 5.5 5.9 0.9 0.0 0.5 4.2 0.5 0.0 0.6 0.5 1.2 3.1 1.3 1.8 3.1 2.8 2.1 3.7 4.2 1.3 0.3 0.2 5.9 1.9 35.6 3.0 1.0 1.5 0.0 1.7 3.8 0.0 1.6 1.2 0.5 1.7 2.5 4.4 0.7 0.0 0.6 0.0 5.5 0.3 0.0 0.3 0.0 10.0 0.9 0.2 1.8 0.0 0.0 4.3 0.0 5.5 7.5 0.2 0.1 1.2 0.1 0.7 0.3 0.8 2.3 2.5 6.6 0.4 1.2 5.7 3.6 0.1 0.3 0.7 0.6 1.6 0.5 0.5 ZNF705A FLJ16353 ENSG00000196946 "Zinc finger protein 705A" Q6ZN79 12 8157034-8188537 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 8.5" "Group enriched" "Detected in some" 12 "Early spermatids: 4.4;Late spermatids: 3.9;Sertoli cells: 6.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 5.8;BJ hTERT+: 6.7;HDLM-2: 5.8;HSkMC: 5.2;NTERA-2: 6.4" NA NA "Cluster 32: T-cells - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 44: HDLM-2 - Immune response" "Cluster 31: Spermatids - Spermatogenesis" "unprognostic (1.33e-1)" "unprognostic (4.96e-2)" "unprognostic (8.16e-2)" "unprognostic (4.16e-3)" "unprognostic (8.80e-2)" "unprognostic (2.52e-3)" "unprognostic (4.31e-6)" "unprognostic (2.61e-1)" "unprognostic (1.80e-1)" "unprognostic (1.41e-2)" 0.8 0.8 8.4 0.2 7.3 0.3 1.6 6.9 8.5 3.2 0.5 0.7 0.4 2.5 5.2 1.1 3.2 1.6 1.6 7.8 6.7 0.8 0.0 1.6 1.2 8.1 6.4 4.6 2.2 3.4 0.0 1.9 6.1 2.2 0.6 2.3 0.9 2.6 0.4 0.5 0.4 2.2 7.5 0.9 0.3 2.2 7.6 1.2 4.4 2.9 1.2 0.9 0.0 8.3 0.0 2.2 0.5 5.8 2.0 4.3 0.2 0.9 6.7 0.7 3.0 0.0 0.8 0.2 0.0 1.6 3.2 0.0 1.1 0.5 1.8 5.8 2.2 0.0 0.0 0.0 1.4 0.0 0.2 5.2 0.4 0.4 1.1 1.5 0.0 1.5 0.0 0.2 0.7 3.3 0.4 0.0 6.4 0.1 0.0 1.1 0.7 0.0 1.4 0.0 0.1 1.4 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.4 0.2 0.1 0.3 0.5 0.1 0.8 0.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 8.4 7.3 6.9 8.5 7.8 6.7 8.1 6.4 6.1 7.5 7.6 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 6.6 0.1 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZNF705D ENSG00000215343 "Zinc finger protein 705D" P0CH99 8 12104389-12115516 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 8 "epididymis: 3.7" "Group enriched" "Detected in some" 40 "Early spermatids: 5.1;Late spermatids: 3.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 34: Spermatids - Unknown function" "unprognostic (2.04e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZNF717 "X17, ZNF838" ENSG00000227124 "Zinc finger protein 717" 3 75678660-75785583 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 35.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "K-562: 47.7" HPA044549 Uncertain Approved "Nucleoplasm,Nuclear bodies,Plasma membrane" NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 68: Epididymis - Unknown function" "Cluster 1: K-562 - Erythropoiesis" "Cluster 68: Oligodendrocytes - Mixed function" "Nucleoplasm, Nuclear bodies" "Plasma membrane" "HPA044549: AB_10964630" "unprognostic (2.49e-1)" "unprognostic (4.44e-2)" "unprognostic (1.52e-1)" "unprognostic (2.49e-2)" "unprognostic (2.61e-1)" "unprognostic (1.00e-1)" "unprognostic (2.18e-1)" "unprognostic (3.80e-2)" "unprognostic (3.20e-1)" "unprognostic (2.16e-2)" "unprognostic (2.36e-1)" "unprognostic (1.45e-2)" "unprognostic (3.60e-6)" "unprognostic (3.88e-2)" "unprognostic (2.08e-2)" "unprognostic (1.00e-1)" "unprognostic (1.36e-1)" 5.1 5.7 7.6 3.3 9.6 2.8 7.3 7.7 9.5 5.7 4.4 5.1 5.7 5.9 15.4 5.4 7.2 4.5 5.9 7.2 8.1 9.9 7.9 4.6 4.8 9.0 8.5 7.9 8.9 8.3 9.3 5.0 9.2 6.7 6.6 7.8 7.2 4.7 4.2 9.9 5.2 4.2 8.5 7.1 7.4 8.2 8.7 4.7 9.3 4.4 7.1 5.8 5.4 12.3 11.4 5.8 5.2 3.6 6.1 8.5 3.9 3.5 5.2 5.1 5.9 9.4 9.8 5.2 4.6 6.0 5.0 6.3 6.8 4.5 4.2 0.5 7.0 8.6 9.4 0.9 15.9 0.5 8.6 10.4 4.8 12.8 17.4 4.3 0.7 0.5 47.7 11.6 5.7 1.8 0.6 17.1 5.2 8.9 6.3 7.7 4.5 27.0 7.6 3.8 4.2 17.4 3.5 6.6 14.6 5.1 16.8 4.6 1.6 9.3 10.9 6.4 1.4 12.0 19.9 5.2 4.7 1.3 6.0 1.3 2.6 5.1 2.1 3.8 1.2 5.1 3.3 2.0 2.7 6.1 6.3 3.7 0.7 3.0 3.8 4.1 1.1 2.0 7.6 9.6 7.7 9.5 7.2 8.1 9.0 8.5 9.2 8.5 8.7 12.3 6.6 3.2 3.1 28.1 6.0 3.2 4.2 3.4 5.2 8.5 9.1 8.3 5.6 8.6 4.2 7.3 2.1 5.2 5.8 2.2 11.7 4.6 5.0 3.4 4.8 5.1 5.3 7.4 21.7 4.4 1.8 5.7 4.6 2.6 8.9 11.4 7.9 8.2 7.3 10.1 27.2 7.0 4.1 5.7 4.1 2.1 2.5 4.5 1.8 16.9 5.0 5.2 5.2 25.6 35.4 3.9 2.0 3.0 0.7 5.1 6.3 17.5 6.3 8.1 0.0 5.1 5.3 11.1 8.6 7.0 4.4 3.4 3.1 7.9 5.0 3.9 ZNF761 "FLJ16231, FLJ35333, KIAA2033" ENSG00000160336 "Zinc finger protein 761" Q86XN6 19 53431984-53461862 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "prostate: 73.9" "Cell type enhanced" "Detected in many" "Syncytiotrophoblasts: 45.3" "Cancer enriched" "Detected in all" 5 "prostate cancer: 31.9" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 68: Epididymis - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" "unprognostic (8.10e-2)" "unprognostic (1.64e-1)" "unprognostic (2.89e-2)" "unprognostic (1.39e-1)" "unprognostic (7.03e-2)" "unprognostic (1.44e-1)" "prognostic unfavorable (2.04e-4)" "unprognostic (4.68e-2)" "unprognostic (3.74e-3)" "unprognostic (1.12e-1)" "unprognostic (2.19e-3)" "unprognostic (1.59e-1)" "unprognostic (2.33e-3)" "unprognostic (1.19e-1)" "unprognostic (4.13e-1)" "unprognostic (8.71e-2)" "unprognostic (1.38e-3)" 8.3 9.8 8.7 6.4 10.0 10.6 10.6 15.8 10.5 7.3 9.4 7.1 6.6 6.2 11.0 5.7 9.1 6.5 5.3 9.6 10.3 7.9 6.1 7.1 8.7 9.5 9.0 12.2 11.8 11.9 7.3 17.0 10.2 73.9 8.7 7.2 8.7 6.2 4.7 11.1 6.8 6.6 7.4 8.1 9.2 6.1 9.9 8.2 8.2 4.7 8.4 8.3 7.7 12.7 17.3 9.6 6.9 14.4 21.0 17.2 25.1 11.0 9.9 7.9 12.0 11.9 6.9 16.2 6.1 10.7 11.4 11.8 18.2 11.9 12.5 2.2 25.9 15.5 12.7 15.4 12.9 1.5 18.4 17.1 13.5 9.5 16.8 11.1 8.9 15.7 16.4 10.7 14.5 10.6 19.0 15.3 12.0 17.1 14.5 15.2 15.2 17.2 8.7 48.9 8.9 6.8 13.2 18.6 8.0 22.4 10.1 14.4 7.6 12.3 9.5 1.7 13.0 13.0 27.6 26.6 0.5 8.8 10.8 7.2 4.4 5.8 5.1 4.8 6.3 6.6 5.9 6.4 4.8 6.4 6.4 6.8 3.8 12.8 4.7 5.2 8.4 4.5 8.7 10.0 15.8 10.5 9.6 10.3 9.5 9.0 10.2 7.4 9.9 12.7 6.7 3.2 7.3 3.6 6.4 0.0 12.0 0.0 2.8 1.1 7.5 6.1 6.6 12.8 4.3 3.7 0.0 17.3 4.9 4.9 23.5 4.3 0.5 6.2 4.9 5.3 2.4 7.8 2.5 2.9 14.3 7.5 6.1 6.3 9.5 12.0 9.7 10.0 8.6 5.0 5.0 11.5 0.0 7.1 0.0 1.3 12.5 5.0 0.0 3.7 3.5 1.8 5.2 1.5 7.0 5.4 6.1 7.9 9.2 19.6 5.2 11.5 2.2 0.9 19.7 3.7 5.0 1.5 5.6 5.7 0.0 45.3 4.7 5.1 6.7 12.1 ZNF813 FLJ16542 ENSG00000198346 "Zinc finger protein 813" Q6ZN06 19 53467733-53496255 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Hepatic stellate cells: 13.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RT4: 18.1" HPA056406 Uncertain Approved Vesicles NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 68: Epididymis - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 40: Granulosa cells - Unknown function" Vesicles "HPA056406: AB_2683119" "unprognostic (1.20e-1)" "unprognostic (3.43e-2)" "unprognostic (1.17e-1)" "unprognostic (3.98e-3)" "unprognostic (2.28e-1)" "unprognostic (3.61e-3)" "unprognostic (1.48e-2)" "unprognostic (1.84e-3)" "unprognostic (3.39e-3)" "unprognostic (1.74e-1)" "unprognostic (3.75e-2)" "unprognostic (3.61e-2)" "unprognostic (1.25e-3)" "unprognostic (8.18e-2)" "unprognostic (1.97e-1)" "unprognostic (1.77e-2)" "unprognostic (6.56e-2)" 1.2 1.1 0.9 1.5 1.3 1.4 2.2 1.1 1.1 1.1 1.4 1.8 1.8 1.3 3.9 1.2 1.8 1.4 0.7 1.0 1.2 1.3 0.7 1.4 2.2 1.4 1.4 1.8 1.3 2.4 0.6 3.6 1.3 4.9 1.7 0.6 1.2 1.1 0.4 2.0 1.7 1.0 1.0 1.9 1.9 1.6 1.3 2.2 1.9 0.5 2.1 1.4 1.2 1.8 0.9 0.8 2.6 4.3 2.2 2.6 6.0 2.4 2.4 1.6 2.3 4.6 2.7 6.9 2.3 2.3 3.0 1.4 6.3 2.7 3.0 0.0 9.9 6.9 1.8 5.2 1.1 0.0 7.1 2.2 2.2 1.8 1.3 0.9 1.4 4.9 3.8 0.1 2.6 1.3 9.2 3.8 3.3 0.8 2.4 5.6 5.7 3.4 1.5 18.1 1.1 2.5 0.0 4.5 1.6 5.6 1.8 3.4 2.3 0.9 3.1 0.1 2.3 3.6 5.5 7.5 0.0 0.0 4.7 1.8 1.1 0.8 1.7 1.6 1.7 1.6 1.6 1.9 1.2 2.4 3.0 2.3 0.5 3.6 3.0 1.1 1.3 1.4 0.9 1.3 1.1 1.1 1.0 1.2 1.4 1.4 1.3 1.0 1.3 1.8 3.4 6.4 1.8 0.3 4.4 1.8 3.1 1.4 4.6 0.7 1.9 1.8 1.9 5.7 2.6 0.0 0.0 5.0 4.3 2.5 1.9 2.2 1.7 2.6 3.2 4.0 0.0 3.4 0.3 1.2 10.1 4.1 3.6 2.6 0.0 7.0 13.6 1.2 2.8 3.3 1.0 3.2 2.0 3.0 1.7 0.9 2.5 2.6 3.6 1.0 3.7 1.1 3.1 2.0 2.8 1.5 3.4 2.2 1.5 5.0 1.2 0.8 2.0 0.6 0.0 4.0 3.4 0.9 4.1 2.2 1.6 8.9 2.8 2.6 3.9 2.3 ZNF83 "FLJ11015, HPF1, ZNF816B" ENSG00000167766 "Zinc finger protein 83" P51522 19 52594060-52690496 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Granulosa cells: 130.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA025970 Approved Approved Nucleoplasm NA NA "Cluster 15: NK-cells - Transcription" "Cluster 68: Epididymis - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA025970: AB_1859463" "unprognostic (6.38e-2)" "unprognostic (1.55e-1)" "unprognostic (1.73e-2)" "unprognostic (1.78e-1)" "unprognostic (1.18e-1)" "prognostic favorable (3.83e-4)" "unprognostic (3.38e-3)" "unprognostic (3.67e-1)" "prognostic unfavorable (9.20e-4)" "prognostic favorable (9.06e-4)" "unprognostic (6.08e-2)" "unprognostic (3.85e-3)" "prognostic unfavorable (3.13e-5)" "unprognostic (2.81e-2)" "unprognostic (1.14e-1)" "unprognostic (3.33e-1)" "prognostic favorable (6.92e-6)" 42.7 54.4 35.4 24.7 49.8 30.1 45.6 53.3 47.7 82.9 35.5 55.6 14.9 50.8 92.0 28.7 88.2 28.2 36.5 33.9 40.8 99.3 13.1 42.8 36.2 43.7 38.0 100.8 36.5 26.1 77.3 30.0 44.8 81.2 24.2 67.4 33.3 40.5 9.8 30.8 40.4 29.3 36.8 48.9 34.2 22.1 40.2 19.1 71.5 8.9 29.6 50.2 61.0 51.0 19.6 1.0 27.0 19.6 23.7 47.4 15.0 29.9 20.4 17.6 23.7 7.2 16.5 20.2 14.9 20.3 13.0 8.6 16.3 20.1 24.5 2.7 18.4 16.5 18.9 9.3 19.5 12.3 23.1 38.4 24.2 14.7 73.0 61.8 19.9 22.6 19.3 15.7 29.2 13.2 17.4 20.5 7.4 3.4 18.3 17.3 23.2 13.5 45.0 39.1 15.2 12.5 19.2 18.6 7.7 42.9 19.8 12.7 27.0 17.7 10.7 8.5 31.1 1.4 18.3 27.5 1.0 12.8 14.2 4.1 3.0 7.5 5.7 3.2 6.1 5.7 7.0 7.5 3.6 9.3 6.0 6.7 2.7 10.9 4.7 2.5 3.8 3.2 35.4 49.8 53.3 47.7 33.9 40.8 43.7 38.0 44.8 36.8 40.2 51.0 28.1 35.3 20.0 53.8 20.3 10.3 52.9 23.6 11.4 25.2 23.1 20.7 15.4 12.8 38.1 40.5 35.5 48.4 22.6 10.6 19.6 21.2 24.5 35.2 30.7 28.9 10.8 14.1 26.9 6.9 20.8 32.9 16.3 47.4 37.2 130.5 23.2 1.1 13.5 48.8 57.2 11.3 18.3 5.7 15.8 17.3 42.6 12.0 30.2 46.9 14.6 16.6 37.0 56.8 80.0 10.7 18.5 34.6 9.9 90.8 8.2 23.9 34.9 38.3 6.6 43.3 21.4 15.4 15.8 6.4 9.7 64.0 26.0 62.5 8.8 116.2 ZNF84 HPF2 ENSG00000198040 "Zinc finger protein 84" P51523 12 133037292-133063304 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA028860 Approved Approved Nucleoplasm NA NA "Cluster 15: NK-cells - Transcription" "Cluster 68: Epididymis - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 59: Non-specific - Transcription" Nucleoplasm "HPA028860: AB_10604102" "unprognostic (2.39e-1)" "unprognostic (5.11e-3)" "unprognostic (3.09e-2)" "unprognostic (8.66e-2)" "unprognostic (8.16e-2)" "unprognostic (3.63e-2)" "prognostic unfavorable (1.59e-4)" "unprognostic (5.96e-3)" "unprognostic (9.73e-3)" "unprognostic (2.67e-1)" "unprognostic (1.27e-2)" "unprognostic (3.24e-3)" "unprognostic (8.61e-3)" "unprognostic (1.15e-1)" "unprognostic (2.32e-1)" "unprognostic (3.48e-2)" "unprognostic (7.30e-3)" 11.1 11.1 14.6 8.9 16.2 9.3 16.6 18.3 30.2 15.7 16.6 13.9 7.5 18.0 23.0 8.6 15.8 11.3 11.2 14.7 15.3 16.6 13.1 10.5 13.7 13.8 14.9 20.8 12.7 13.5 23.1 11.6 15.4 17.0 12.0 24.7 11.9 12.2 10.3 12.3 11.6 13.3 13.8 13.6 11.3 14.0 14.9 14.9 18.2 11.7 14.4 13.5 12.2 22.4 18.4 14.3 38.0 25.0 16.1 25.3 33.1 16.5 14.2 12.0 11.5 8.7 5.5 22.0 14.4 14.3 14.6 8.2 15.4 13.4 18.7 6.2 26.0 32.8 18.2 12.4 19.8 35.8 14.0 17.9 16.1 18.3 19.7 38.9 18.9 15.4 16.8 10.8 30.8 10.8 24.8 33.6 51.5 6.9 11.7 34.4 17.7 15.2 16.8 39.5 31.7 34.5 31.8 9.6 13.9 21.3 31.5 21.0 23.2 13.6 15.2 12.8 11.7 5.2 0.0 50.2 7.9 27.8 17.8 1.5 3.5 4.4 8.1 5.2 12.2 9.5 9.0 10.4 5.9 7.9 11.9 9.8 0.8 10.1 3.8 7.4 5.4 5.0 14.6 16.2 18.3 30.2 14.7 15.3 13.8 14.9 15.4 13.8 14.9 22.4 16.6 9.6 9.6 27.4 21.8 3.1 13.4 2.7 17.6 18.6 14.0 14.4 24.1 10.0 8.1 16.5 6.2 10.3 11.7 3.2 3.9 13.4 14.9 15.5 15.4 16.1 9.6 20.8 33.7 7.1 5.6 16.3 7.1 9.6 13.9 23.2 15.7 8.6 10.5 20.2 36.2 9.6 0.0 7.3 2.4 15.2 13.4 8.6 1.8 14.0 5.1 14.6 17.5 45.2 47.5 9.7 9.1 15.1 9.1 12.9 5.4 11.2 17.6 17.3 13.1 16.9 14.3 13.1 24.2 11.5 2.7 6.4 14.2 12.0 7.5 9.3 ZNF846 ENSG00000196605 "Zinc finger protein 846" Q147U1 19 9751993-9793180 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Early spermatids: 242.1;Late spermatids: 91.0;Spermatocytes: 177.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA034617, HPA034618" Approved Approved "Actin filaments" NA NA "Cluster 23: Antigen presenting cells - Antigen presentation" "Cluster 68: Epididymis - Unknown function" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 66: Spermatocytes - Spermatogenesis" "Actin filaments" "HPA034617: AB_10603942, HPA034618: AB_2674249" "unprognostic (1.36e-1)" "unprognostic (4.70e-2)" "unprognostic (1.82e-1)" "unprognostic (2.79e-2)" "unprognostic (6.73e-2)" "prognostic favorable (5.25e-8)" "unprognostic (2.57e-1)" "unprognostic (2.62e-2)" "unprognostic (2.96e-2)" "unprognostic (2.33e-3)" "unprognostic (1.85e-2)" "unprognostic (3.05e-2)" "unprognostic (2.31e-2)" "unprognostic (1.93e-1)" "unprognostic (2.10e-1)" "unprognostic (1.32e-1)" "unprognostic (9.05e-3)" 7.9 6.6 9.3 6.2 8.9 4.5 7.0 6.5 9.1 8.5 6.6 8.2 4.2 11.1 9.6 9.2 8.5 9.7 8.2 7.2 8.0 5.0 4.6 6.9 8.1 9.5 10.2 12.9 3.9 7.3 5.5 6.3 8.5 11.8 7.2 7.4 7.1 18.7 5.4 8.0 5.3 10.6 9.2 6.4 6.6 14.0 8.9 8.0 7.3 5.7 6.3 13.1 8.9 10.3 3.8 0.8 11.6 2.8 12.8 16.4 2.6 5.8 4.0 4.1 8.2 2.1 3.1 1.5 2.3 6.9 4.8 1.4 0.8 4.5 4.5 3.4 2.5 8.6 0.3 3.1 4.6 0.8 8.9 16.9 5.9 3.1 2.4 9.4 3.4 4.6 1.5 0.0 4.4 1.5 3.1 7.2 1.7 3.1 4.8 4.5 0.9 0.4 5.2 14.6 1.8 3.5 3.1 0.3 4.4 4.0 1.9 6.0 1.8 3.3 2.4 2.8 0.5 6.5 7.3 8.3 0.4 1.1 2.9 1.1 2.1 1.3 1.7 1.7 3.5 4.2 2.6 4.3 6.9 5.2 2.0 4.2 0.8 2.2 1.2 4.5 3.3 1.6 9.3 8.9 6.5 9.1 7.2 8.0 9.5 10.2 8.5 9.2 8.9 10.3 4.4 9.6 5.4 18.3 4.7 7.9 15.0 14.5 20.5 1.7 7.3 10.0 6.8 5.7 11.9 0.0 2.1 1.6 5.5 5.4 9.8 6.5 242.1 6.4 7.7 5.1 1.2 4.8 25.8 4.9 2.1 7.8 5.1 4.5 5.1 7.8 5.7 5.4 7.5 0.0 13.7 4.9 6.1 13.9 9.1 91.0 6.8 10.2 7.2 41.2 9.2 3.2 1.0 14.6 14.6 7.0 3.9 9.1 3.7 7.3 3.1 6.1 12.5 2.4 6.6 3.7 8.2 177.1 8.6 8.0 8.8 1.2 5.2 7.8 4.1 16.4 ZNRF3 "BK747E2.3, FLJ22057, KIAA1133, RNF203" ENSG00000183579 "Zinc and ring finger 3" Q9ULT6 22 28883572-29057488 "Enzymes, Predicted membrane proteins" "Ubl conjugation pathway, Wnt signaling pathway" "Developmental protein, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in many" 6 "Astrocytes: 504.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "Hep G2: 46.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036702, HPA036703" Uncertain Uncertain "Golgi apparatus" NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 64: Astrocytes - Nervous system maintenance" "Golgi apparatus" "HPA036702: , HPA036703: AB_10672227" "unprognostic (1.07e-1)" "unprognostic (2.13e-3)" "unprognostic (7.48e-3)" "unprognostic (5.72e-2)" "unprognostic (6.81e-2)" "unprognostic (1.36e-1)" "unprognostic (2.22e-2)" "unprognostic (1.75e-2)" "unprognostic (1.37e-1)" "unprognostic (3.68e-2)" "unprognostic (5.18e-2)" "unprognostic (3.94e-1)" "unprognostic (9.55e-5)" "unprognostic (6.49e-2)" "unprognostic (1.02e-1)" "unprognostic (3.70e-2)" "unprognostic (2.55e-2)" 2.8 7.1 11.3 1.3 11.2 0.3 2.6 8.1 13.8 4.4 1.0 3.9 3.0 5.1 13.4 3.4 4.8 2.1 2.6 12.1 5.5 8.2 6.6 4.3 0.5 13.2 9.2 5.9 3.3 8.7 2.7 5.0 4.2 7.2 3.4 1.1 7.5 7.7 3.8 5.3 2.7 4.6 5.1 1.2 4.4 5.0 13.6 1.3 4.1 1.9 0.6 3.2 3.3 6.2 5.8 13.7 12.5 3.5 2.3 2.6 23.7 3.5 1.7 2.7 2.6 20.8 3.2 0.1 5.4 1.8 4.9 9.8 8.7 5.5 3.3 7.8 8.9 2.3 2.5 46.1 2.0 6.9 2.3 2.7 5.0 4.3 4.3 2.3 2.4 4.1 5.0 3.2 3.9 5.6 0.2 3.5 4.6 7.3 5.4 6.9 8.2 5.3 11.6 8.5 20.6 7.6 6.2 6.1 3.5 3.8 4.1 3.1 2.3 10.3 8.8 8.2 5.8 4.3 6.3 8.1 4.4 3.9 5.5 0.2 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 11.3 11.2 8.1 13.8 12.1 5.5 13.2 9.2 4.2 5.1 13.6 6.2 4.2 12.8 23.6 504.1 0.3 12.6 5.2 4.9 15.9 3.7 5.7 9.5 7.5 8.6 5.3 12.9 0.0 28.1 0.5 2.1 1.9 5.0 12.7 8.0 8.0 5.8 8.4 4.0 62.9 2.5 2.5 5.8 5.6 15.5 0.0 5.4 2.2 17.6 3.5 1.7 37.4 9.4 0.0 1.0 3.1 15.0 10.8 0.8 0.0 82.4 0.0 6.0 0.0 54.8 34.4 3.7 2.1 12.8 0.6 9.6 2.4 11.6 4.9 3.9 0.0 16.0 6.6 4.6 3.2 7.8 7.5 7.7 0.7 14.5 12.9 2.8